Citrus Sinensis ID: 018702

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-
Protein Sequence
MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEEcccccccccHHHHHHHHccccccccEEcccccEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHccccccccccEEEcccccEEEEEEccccccHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEccccccccHHHccccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
cccccHEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEEcccccccHccccHEEEccccccEEEEEEEEcccHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHccccHHHccccHccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHHHHHHcccc
Coil and Loop (DISEMBL)
MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKrknmvytdsvsggkmvmfrsplihslqsdAIFKKTLKFsskdvigsggfgtvyrltvndsTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYElmpngsldtflhgksvnkknldwpsryKIAVGAARGIAYlhhdciphiihrdikssnilldqnmearvSDFGLATLMEAEKTHVSTIVAgtfgylapeyfdtgratakgdvYSFGVVLLELltgkrpmdeaFLEEGTKLVTWVKAVMQDKREEYVIdtslegcpineindVFSIAsmclepepskrptmTEVVKMLELIKSEKVV
Flexible Loop (DISEMBL)
MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKnmvytdsvsggkMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTafavkrlhrgttevdrgFERELeamgdikhrnIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSvnkknldwpsRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEpepskrptmteVVKMLeliksekvv
Low Complexity Region (SEG)
MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV
Disordered region (IsUnstruct)
****RIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCL**************************
Disordered Region (DISOPRED)
****RII*FYVTICCIAFVISKIIISVLLYR**********************SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG****DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE***
Disordered Region (DISEMBL)
MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV
Disordered Region (DISPRO)
***ARIIAFYVTICCIAFVISKIIISVLLYRRWKR*******************PLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS****
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	351	2.2.26 [Sep-21-2011]
Q9SYM9	355	Receptor-like serine/thre	yes	no	0.974	0.963	0.724	1e-151
C0LGF4	591	LRR receptor-like serine/	no	no	0.948	0.563	0.482	1e-89
C0LGL9	589	LRR receptor-like serine/	no	no	0.945	0.563	0.480	3e-87
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.843	0.248	0.494	3e-75
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.854	0.257	0.477	6e-75
Q9LJF3	1164	Receptor-like protein kin	no	no	0.843	0.254	0.486	3e-73
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.837	0.243	0.465	2e-70
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.837	0.243	0.465	4e-70
Q9FN37	1036	Phytosulfokine receptor 2	no	no	0.991	0.335	0.412	2e-69
Q9LRP3	467	Probable receptor-like pr	no	no	0.783	0.588	0.456	5e-69

>sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1

 Score =  533 bits (1373), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 255/352 (72%), Positives = 293/352 (83%), Gaps = 10/352 (2%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSV---SGGKMVMFRSPLI 57
           M NA+   FY+TI  +AFVI KI+I++L Y+RWKRK+ ++ +      GGKMVMFRS L+
Sbjct: 1   MANAKETTFYITISVVAFVIGKIVIALLFYKRWKRKHTIHENGFPVKGGGKMVMFRSQLL 60

Query: 58  HSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFEREL 117
           +S+ SD   KKT K S+KD++GSGGFGTVYRL ++DST FAVKRL+RGT+E DRGF REL
Sbjct: 61  NSVSSDMFMKKTHKLSNKDILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERDRGFHREL 120

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           EAM DIKHRNIVTLHGY+TS  YNLLIYELMPNGSLD+FLHG+    K LDW SRY+IAV
Sbjct: 121 EAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLHGR----KALDWASRYRIAV 176

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
           GAARGI+YLHHDCIPHIIHRDIKSSNILLD NMEARVSDFGLATLME +KTHVST VAGT
Sbjct: 177 GAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTFVAGT 236

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
           FGYLAPEYFDTG+AT KGDVYSFGVVLLELLTG++P D+ F EEGTKLVTWVK V++D+R
Sbjct: 237 FGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVTWVKGVVRDQR 296

Query: 298 EEYVIDTSLEGCPIN---EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
           EE VID  L G  +    E+NDVF IA MCLEPEP+ RP MTEVVK+LE IK
Sbjct: 297 EEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLEYIK 348

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  330 bits (845), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 164/340 (48%), Positives = 226/340 (66%), Gaps = 7/340 (2%)

Query: 6   IIAFYVTICCIAFVISKIIISVLLYRRWKRKNM--VYTDSVSGGKMVMFRSPLIHSLQSD 63
           +I+   T+  +  V         LY++  +  +  +  D   G  +VMF   L +S  S 
Sbjct: 240 LISASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYS--SK 297

Query: 64  AIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
            I KK    + + +IG GGFGTVY+L ++D   FA+KR+ +     DR FERELE +G I
Sbjct: 298 DIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSI 357

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
           KHR +V L GY  S    LL+Y+ +P GSLD  LH +    + LDW SR  I +GAA+G+
Sbjct: 358 KHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHERG---EQLDWDSRVNIIIGAAKGL 414

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           +YLHHDC P IIHRDIKSSNILLD N+EARVSDFGLA L+E E++H++TIVAGTFGYLAP
Sbjct: 415 SYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 474

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
           EY  +GRAT K DVYSFGV++LE+L+GKRP D +F+E+G  +V W+K ++ +KR   ++D
Sbjct: 475 EYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVD 534

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + EG  +  ++ + SIA+ C+ P P +RPTM  VV++LE
Sbjct: 535 PNCEGMQMESLDALLSIATQCVSPSPEERPTMHRVVQLLE 574

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGL9|FEI2_ARATH LRR receptor-like serine/threonine-protein kinase FEI 2 OS=Arabidopsis thaliana GN=FEI2 PE=1 SV=1

 Score =  322 bits (824), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 164/341 (48%), Positives = 225/341 (65%), Gaps = 9/341 (2%)

Query: 6   IIAFYVTICCIAFVISKIIISVLLYRRWKR---KNMVYTDSVSGGKMVMFRSPLIHSLQS 62
           +I+   T+  +  V         LY++  R   K++V  D   G  +VMF   L ++  S
Sbjct: 238 LISASATVGGLLLVALMCFWGCFLYKKLGRVESKSLV-IDVGGGASIVMFHGDLPYA--S 294

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGD 122
             I KK    + + +IG GGFGTVY+L+++D   FA+KR+ +     DR FERELE +G 
Sbjct: 295 KDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGS 354

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           IKHR +V L GY  S    LL+Y+ +P GSLD  LH +    + LDW SR  I +GAA+G
Sbjct: 355 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRG---EQLDWDSRVNIIIGAAKG 411

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           +AYLHHDC P IIHRDIKSSNILLD N+EARVSDFGLA L+E E++H++TIVAGTFGYLA
Sbjct: 412 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 471

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           PEY  +GRAT K DVYSFGV++LE+L+GK P D +F+E+G  +V W+  ++ + R + ++
Sbjct: 472 PEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIV 531

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           D S EG     ++ + SIA+ C+   P +RPTM  VV++LE
Sbjct: 532 DLSCEGVERESLDALLSIATKCVSSSPDERPTMHRVVQLLE 572

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  282 bits (721), Expect = 3e-75,   Method: Composition-based stats.
 Identities = 148/299 (49%), Positives = 194/299 (64%), Gaps = 3/299 (1%)

Query: 49   MVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE 108
            + MF  PL+     D I + T  FS K++IG GGFGTVY+  +      AVK+L    T+
Sbjct: 895  IAMFEQPLLKVRLGD-IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQ 953

Query: 109  VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
             +R F  E+E +G +KH N+V+L GY + S+  LL+YE M NGSLD +L  ++   + LD
Sbjct: 954  GNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLD 1013

Query: 169  WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
            W  R KIAVGAARG+A+LHH  IPHIIHRDIK+SNILLD + E +V+DFGLA L+ A ++
Sbjct: 1014 WSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACES 1073

Query: 229  HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE-EGTKLVT 287
            HVST++AGTFGY+ PEY  + RAT KGDVYSFGV+LLEL+TGK P    F E EG  LV 
Sbjct: 1074 HVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVG 1133

Query: 288  WVKAVMQDKREEYVIDTSLEGCPI-NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
            W    +   +   VID  L    + N    +  IA +CL   P+KRP M +V+K L+ I
Sbjct: 1134 WAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  281 bits (719), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 146/306 (47%), Positives = 202/306 (66%), Gaps = 6/306 (1%)

Query: 48   KMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT 107
             +  F  PL   L    + + T  FS++ ++GSGGFG VY+  + D +  A+K+L R T 
Sbjct: 836  NVATFEKPL-RKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITG 894

Query: 108  EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN- 166
            + DR F  E+E +G IKHRN+V L GY    +  LL+YE M  GSL+T LH KS  K   
Sbjct: 895  QGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGI 954

Query: 167  -LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
             L+W +R KIA+GAARG+A+LHH CIPHIIHRD+KSSN+LLD++ EARVSDFG+A L+ A
Sbjct: 955  YLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSA 1014

Query: 226  EKTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
              TH+S + +AGT GY+ PEY+ + R TAKGDVYS+GV+LLELL+GK+P+D     E   
Sbjct: 1015 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNN 1074

Query: 285  LVTWVKAVMQDKREEYVIDTSL--EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            LV W K + ++KR   ++D  L  +     E+     IAS CL+  P KRPTM +++ M 
Sbjct: 1075 LVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMF 1134

Query: 343  ELIKSE 348
            + +K++
Sbjct: 1135 KEMKAD 1140

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  275 bits (703), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 149/306 (48%), Positives = 200/306 (65%), Gaps = 10/306 (3%)

Query: 48   KMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT 107
             +  F  PL   L    + + T  FS+  +IGSGGFG VY+  + D +  A+K+L + T 
Sbjct: 835  NVATFEKPL-RKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTG 893

Query: 108  EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN- 166
            + DR F  E+E +G IKHRN+V L GY    +  LL+YE M  GSL+T LH K+  KK  
Sbjct: 894  QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKT--KKGG 951

Query: 167  --LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME 224
              LDW +R KIA+GAARG+A+LHH CIPHIIHRD+KSSN+LLDQ+  ARVSDFG+A L+ 
Sbjct: 952  IFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVS 1011

Query: 225  AEKTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT 283
            A  TH+S + +AGT GY+ PEY+ + R TAKGDVYS+GV+LLELL+GK+P+D     E  
Sbjct: 1012 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDN 1071

Query: 284  KLVTWVKAVMQDKREEYVIDTSL--EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
             LV W K + ++KR   ++D  L  +     E+     IAS CL+  P KRPTM +V+ M
Sbjct: 1072 NLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTM 1131

Query: 342  L-ELIK 346
              EL++
Sbjct: 1132 FKELVQ 1137

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  266 bits (680), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 143/307 (46%), Positives = 194/307 (63%), Gaps = 13/307 (4%)

Query: 48   KMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT 107
             +  F  PL   L    + + T  F +  ++GSGGFG VY+  + D +  A+K+L   + 
Sbjct: 865  NLAAFEKPL-RKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSG 923

Query: 108  EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL 167
            + DR F  E+E +G IKHRN+V L GY    +  LL+YE M  GSL+  LH +      L
Sbjct: 924  QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKL 983

Query: 168  DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
            +WP+R KIA+GAARG+A+LHH+CIPHIIHRD+KSSN+LLD+N+EARVSDFG+A LM A  
Sbjct: 984  NWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMD 1043

Query: 228  THVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV 286
            TH+S + +AGT GY+ PEY+ + R + KGDVYS+GVVLLELLTGK+P D A   +   LV
Sbjct: 1044 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGD-NNLV 1102

Query: 287  TWVKAVMQDK------REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
             WVK   + K      RE    D S+E     E+     +A  CL+    KRPTM +V+ 
Sbjct: 1103 GWVKLHAKGKITDVFDRELLKEDASIE----IELLQHLKVACACLDDRHWKRPTMIQVMA 1158

Query: 341  MLELIKS 347
            M + I++
Sbjct: 1159 MFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  265 bits (676), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 143/307 (46%), Positives = 194/307 (63%), Gaps = 13/307 (4%)

Query: 48   KMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT 107
             +  F  PL   L    + + T  F +  ++GSGGFG VY+  + D +  A+K+L   + 
Sbjct: 865  NLAAFEKPL-RKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSG 923

Query: 108  EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL 167
            + DR F  E+E +G IKHRN+V L GY    +  LL+YE M  GSL+  LH +      L
Sbjct: 924  QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKL 983

Query: 168  DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
            +WP+R KIA+GAARG+A+LHH+CIPHIIHRD+KSSN+LLD+N+EARVSDFG+A LM A  
Sbjct: 984  NWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMD 1043

Query: 228  THVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV 286
            TH+S + +AGT GY+ PEY+ + R + KGDVYS+GVVLLELLTGK+P D A   +   LV
Sbjct: 1044 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGD-NNLV 1102

Query: 287  TWVKAVMQDK------REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
             WVK   + K      RE    D S+E     E+     +A  CL+    KRPTM +V+ 
Sbjct: 1103 GWVKLHAKGKITDVFDRELLKEDASIE----IELLQHLKVACACLDDRHWKRPTMIQVMA 1158

Query: 341  MLELIKS 347
            M + I++
Sbjct: 1159 MFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score =  263 bits (671), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 148/359 (41%), Positives = 214/359 (59%), Gaps = 11/359 (3%)

Query: 2    GNARIIAFYVTICC-IAFVISKIIISVLLYRRWKRKNMVYTDSVSG-------GKMVMFR 53
            G + I+   +++   I  ++S I++ +       R N V  +++SG        K+V+F 
Sbjct: 676  GRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDEETISGVSKALGPSKIVLFH 735

Query: 54   SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGF 113
            S     L  + + K T  FS  ++IG GGFG VY+    D +  AVKRL     +++R F
Sbjct: 736  SCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREF 795

Query: 114  ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY 173
            + E+EA+   +H+N+V+L GY       LLIY  M NGSLD +LH +      L W  R 
Sbjct: 796  QAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRL 855

Query: 174  KIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI 233
            KIA GAARG+AYLH  C P++IHRD+KSSNILLD+  EA ++DFGLA L+    THV+T 
Sbjct: 856  KIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTD 915

Query: 234  VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
            + GT GY+ PEY  +  AT +GDVYSFGVVLLEL+TG+RP++    +    LV+ V  + 
Sbjct: 916  LVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMK 975

Query: 294  QDKREEYVIDTSLEGCPINE--INDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
             +KRE  +IDT++    +NE  + ++  IA  C++ EP +RP + EVV  LE +  E V
Sbjct: 976  AEKREAELIDTTIRE-NVNERTVLEMLEIACKCIDHEPRRRPLIEEVVTWLEDLPMESV 1033

Phytosulfokine receptor with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1

 Score =  261 bits (667), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 126/276 (45%), Positives = 184/276 (66%), Gaps = 1/276 (0%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           T  FS + +IG GG+G VY  T+ + T  AVK+L     + D+ F  E+EA+G ++H+N+
Sbjct: 151 TNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 210

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L GY     + +L+YE M NG+L+ +LHG  ++K +L W +R K+ VG A+ +AYLH 
Sbjct: 211 VRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHE 270

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
              P ++HRDIKSSNIL+D N +A++SDFGLA L+ A+  +VST V GTFGY+APEY ++
Sbjct: 271 AIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAPEYANS 330

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           G    K DVYS+GVVLLE +TG+ P+D A  +E   +V W+K ++Q K+ E V+D  LE 
Sbjct: 331 GLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEWLKLMVQQKQFEEVVDKELEI 390

Query: 309 CP-INEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            P  +E+      A  C++P+  KRP M++V +MLE
Sbjct: 391 KPTTSELKRALLTALRCVDPDADKRPKMSQVARMLE 426

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	351
359493971	354	PREDICTED: receptor-like serine/threonin	1.0	0.991	0.803	1e-170
224061369	355	predicted protein [Populus trichocarpa]	1.0	0.988	0.772	1e-163
225446829	352	PREDICTED: receptor-like serine/threonin	1.0	0.997	0.760	1e-162
449522582	376	PREDICTED: receptor-like serine/threonin	0.980	0.914	0.759	1e-156
356546782	354	PREDICTED: LOW QUALITY PROTEIN: receptor	1.0	0.991	0.720	1e-153
217074844	355	unknown [Medicago truncatula]	1.0	0.988	0.718	1e-153
297842629	352	hypothetical protein ARALYDRAFT_477017 [	0.974	0.971	0.736	1e-151
15218397	355	protein kinase-like protein [Arabidopsis	0.974	0.963	0.724	1e-149
147828317	347	hypothetical protein VITISV_004496 [Viti	0.863	0.873	0.712	1e-139
218187882	350	hypothetical protein OsI_01155 [Oryza sa	0.974	0.977	0.655	1e-137

>gi|359493971|ref|XP_002285658.2| PREDICTED: receptor-like serine/threonine-protein kinase At1g78530-like [Vitis vinifera] gi|302142794|emb|CBI20089.3| unnamed protein product [Vitis vinifera]

 Score =  602 bits (1552), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 282/351 (80%), Positives = 317/351 (90%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSL 60
           MGNARII  Y+T+CCIAFV SK+IISVLLY+RWKRK+ +Y DS SGGKMVMF SP++ SL
Sbjct: 1   MGNARIIVLYITVCCIAFVTSKVIISVLLYKRWKRKHSIYKDSFSGGKMVMFTSPMMQSL 60

Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAM 120
            SDA+ KK  + S+KDVIGSGG GTVYRLTV+ S AFAVKRL+RG+ + DRGFERELEAM
Sbjct: 61  NSDALLKKATRLSNKDVIGSGGHGTVYRLTVDGSVAFAVKRLNRGSADQDRGFERELEAM 120

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
           GDIKHRNIVTLHGYYT+  YNLLIYELMPNGSLD +LHG+   KK LDWPSRYKIAVGAA
Sbjct: 121 GDIKHRNIVTLHGYYTAPHYNLLIYELMPNGSLDAYLHGRLKEKKLLDWPSRYKIAVGAA 180

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME +KTHVST VAGTFGY
Sbjct: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEPDKTHVSTFVAGTFGY 240

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP DEAF+EEGT+LVTWVKAV+ +K+EE+
Sbjct: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPSDEAFIEEGTRLVTWVKAVVLEKKEEH 300

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
           V+D+SLE C ++E+N+VFSIA+MCLE EPSKRPTM EV+KMLE IKS+K+V
Sbjct: 301 VLDSSLECCSLDEVNNVFSIATMCLESEPSKRPTMAEVLKMLEQIKSDKLV 351

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224061369|ref|XP_002300445.1| predicted protein [Populus trichocarpa] gi|222847703|gb|EEE85250.1| predicted protein [Populus trichocarpa]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 272/352 (77%), Positives = 314/352 (89%), Gaps = 1/352 (0%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYT-DSVSGGKMVMFRSPLIHS 59
           M  A+ IAFY+T+CCIAF++SKI+ISVLLY+RWKRK+++   D  SGGKMVMF+S ++ S
Sbjct: 1   MAKAQYIAFYITVCCIAFIVSKIVISVLLYKRWKRKHLICEEDGFSGGKMVMFKSAMMQS 60

Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEA 119
           L+SD +FKKTLK S KD+IGSGG+GTVY+L +N+STA AVKRL+RGT E DRGFERELEA
Sbjct: 61  LKSDELFKKTLKLSYKDIIGSGGYGTVYKLMLNESTALAVKRLNRGTAERDRGFERELEA 120

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           MGDIKHRNI+TLHGY T+ QYNLLIYELMPNGSLDTFLHG+SV  K LDWPSRYKIA+GA
Sbjct: 121 MGDIKHRNILTLHGYCTTPQYNLLIYELMPNGSLDTFLHGRSVETKLLDWPSRYKIALGA 180

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           ARGI+YLHHDCIPHIIHRDIKSSNILLDQN+EA+VSDFGLATLME +KTHVST+VAGTFG
Sbjct: 181 ARGISYLHHDCIPHIIHRDIKSSNILLDQNIEAQVSDFGLATLMEPDKTHVSTLVAGTFG 240

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           YLAPEYFDTG+AT KGDVYSFGVVLLELLTG++P DE F +EGTKLVTWVKAV++ KREE
Sbjct: 241 YLAPEYFDTGKATVKGDVYSFGVVLLELLTGRKPTDEEFFKEGTKLVTWVKAVVEHKREE 300

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
           YV+D+SL+  P +EIN VF IA  CLEPEPSKRPTM +VVKMLE  KSE+VV
Sbjct: 301 YVLDSSLKCSPADEINKVFRIAFRCLEPEPSKRPTMADVVKMLEQAKSERVV 352

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225446829|ref|XP_002279394.1| PREDICTED: receptor-like serine/threonine-protein kinase At1g78530 [Vitis vinifera] gi|302143544|emb|CBI22105.3| unnamed protein product [Vitis vinifera]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 267/351 (76%), Positives = 308/351 (87%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSL 60
           MGN R++AFY+TICCIAF++SK+IIS LLY+RWKRK+ ++ DS+S GKMV+FRS L+  L
Sbjct: 1   MGNVRVLAFYITICCIAFIVSKVIISFLLYQRWKRKHSIFQDSISVGKMVIFRSELMRCL 60

Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAM 120
             D   KKT+K ++KD++GSGG+GTVY+LTVN+S AFAVKRL+RG+ + D+GFEREL+AM
Sbjct: 61  TEDVFLKKTMKLTNKDILGSGGYGTVYKLTVNESIAFAVKRLNRGSEDRDKGFERELKAM 120

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
           GDIKHRNIVTLHGY+ S QYNLLIYELMPNGSLD  LHGKS NK  LDW SRYKIAVGAA
Sbjct: 121 GDIKHRNIVTLHGYFRSPQYNLLIYELMPNGSLDALLHGKSSNKMTLDWHSRYKIAVGAA 180

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           RGI+YLHHDCIPHIIHRDIKSSNILLD NMEARVSDFGLATLME ++THVSTIVAGTFGY
Sbjct: 181 RGISYLHHDCIPHIIHRDIKSSNILLDDNMEARVSDFGLATLMEPDRTHVSTIVAGTFGY 240

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           LAPEY++TGRATAKGDVYSFGVVLLELLTGKRPMDE F+EEGTKLVTWVKAV+ +KREE 
Sbjct: 241 LAPEYYETGRATAKGDVYSFGVVLLELLTGKRPMDETFIEEGTKLVTWVKAVVDEKREEQ 300

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
            ID +L+ CP+ E+N VF +A  CLE EPSKRPTM EV+KMLE IKS K V
Sbjct: 301 AIDCNLDSCPVEEVNQVFYVALTCLESEPSKRPTMAEVLKMLEEIKSNKHV 351

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449522582|ref|XP_004168305.1| PREDICTED: receptor-like serine/threonine-protein kinase At1g78530-like, partial [Cucumis sativus]

 Score =  558 bits (1439), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 262/345 (75%), Positives = 305/345 (88%), Gaps = 1/345 (0%)

Query: 7   IAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIF 66
           IAFYVTI CIAFV+SKI I++LLY+RWKR++++Y D +SGGKMVMF+SP   SL+SDA  
Sbjct: 30  IAFYVTISCIAFVVSKIFIALLLYKRWKRRHIIYEDGISGGKMVMFKSPATKSLKSDAFL 89

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           KKTLK ++KD+IGSGG G VY+L ++DS  FAVKRL+RG+ E D+GFERELEAMGDIKHR
Sbjct: 90  KKTLKLNNKDIIGSGGHGIVYKLALSDSMRFAVKRLNRGSAERDQGFERELEAMGDIKHR 149

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           N+VTL+GYYT+  YNLL+YELMPNGSL  +LHGKS N+K LDW SRYKIAVGAARGI+YL
Sbjct: 150 NVVTLYGYYTAPHYNLLVYELMPNGSLYAYLHGKS-NEKVLDWSSRYKIAVGAARGISYL 208

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           HHDCIPHIIHRDIKSSNILLD+NM+A+VSDFGLATLME +KTHVSTIVAGTFGYLAPEYF
Sbjct: 209 HHDCIPHIIHRDIKSSNILLDENMDAQVSDFGLATLMEPDKTHVSTIVAGTFGYLAPEYF 268

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
           DTGRAT KGDVYSFGVVLLELLTGK+P DEAF+EEGTKLVTWVK V+Q+KREEYV+D  L
Sbjct: 269 DTGRATVKGDVYSFGVVLLELLTGKKPTDEAFMEEGTKLVTWVKTVVQEKREEYVLDRRL 328

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
             CP++E+N VFSIA  CLEPEP++RPTM EVVK+LE I+S   V
Sbjct: 329 GCCPVDEVNVVFSIALKCLEPEPAQRPTMAEVVKVLEQIRSNSNV 373

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546782|ref|XP_003541801.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like serine/threonine-protein kinase At1g78530-like [Glycine max]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 253/351 (72%), Positives = 304/351 (86%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSL 60
           M N+ +IAF +TIC IAFVISKI+ISVLLY+RW+RK++++ +   GGK+V+FRS  + SL
Sbjct: 1   MKNSLVIAFSITICSIAFVISKIVISVLLYKRWRRKHLIHEEGYPGGKIVIFRSSGLKSL 60

Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAM 120
           ++D I KKT K +SKD+IGSGG+G VY L ++DSTA A+KRL+RGT E D+GF RELEAM
Sbjct: 61  KADVILKKTQKLNSKDIIGSGGYGVVYELKLDDSTALAIKRLNRGTAERDKGFXRELEAM 120

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
            DIKHRNIVTLHGYY++  YNLLIYELMP+GSLD+FLHG+S  KK LDWP+RY+IA GAA
Sbjct: 121 ADIKHRNIVTLHGYYSAPHYNLLIYELMPHGSLDSFLHGRSREKKVLDWPTRYRIAAGAA 180

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           RGI+YLHHDCIPHIIHRDIKSSNILLD+NM+ARVSDFGLATLM+  KTHVSTIVAGTFGY
Sbjct: 181 RGISYLHHDCIPHIIHRDIKSSNILLDRNMDARVSDFGLATLMQPTKTHVSTIVAGTFGY 240

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           LAPEYFDTGRAT +GDVYSFGVVLLELLTGK+P DEAF+EEGT LVTWVKAV++DK+EE 
Sbjct: 241 LAPEYFDTGRATLQGDVYSFGVVLLELLTGKKPSDEAFMEEGTMLVTWVKAVVRDKKEEL 300

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
           V+D SL  C + E+N VFSIA MCLEP+P KRPTM EVV +LE  +++K++
Sbjct: 301 VLDNSLGSCSMQEVNKVFSIAMMCLEPDPLKRPTMAEVVSLLEQTEADKLI 351

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|217074844|gb|ACJ85782.1| unknown [Medicago truncatula]

 Score =  546 bits (1406), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 253/352 (71%), Positives = 304/352 (86%), Gaps = 1/352 (0%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSL 60
           M  + IIA  +TIC IAFVISKI IS+LLY+RW+RK+M+Y +  +GGKMV+FRS ++ SL
Sbjct: 1   MMKSLIIAVSITICFIAFVISKIFISILLYKRWRRKHMIYEEGYTGGKMVIFRSSILKSL 60

Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAM 120
            +D + KKT K ++KD+IGSGG+G VY L ++DS AFAVKRL+RGT E D+ FEREL+AM
Sbjct: 61  TTDMVLKKTQKLNNKDIIGSGGYGVVYELKLDDSAAFAVKRLNRGTAERDKCFERELQAM 120

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
            DIKHRN+V LHGYYT+  YNLLIYELMPNGSLD+FLHG+S+NKK LDWP+R +IA+GAA
Sbjct: 121 ADIKHRNVVALHGYYTAPHYNLLIYELMPNGSLDSFLHGRSMNKKILDWPTRQRIALGAA 180

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           RGI+YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  KTHVSTIVAGTFGY
Sbjct: 181 RGISYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEPNKTHVSTIVAGTFGY 240

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           LAPEYFDTGRAT KGDVYSFGVVLLELLTGK+P DE+F+EEGTKLVTWVKA +Q+++EE 
Sbjct: 241 LAPEYFDTGRATVKGDVYSFGVVLLELLTGKKPSDESFMEEGTKLVTWVKAAVQERKEEL 300

Query: 301 VIDTSL-EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
           V+D+SL   CP++E+N VF+IA MCLEP+P  RPT  EVV +LE  ++++VV
Sbjct: 301 VLDSSLGSCCPMHEVNKVFNIAMMCLEPDPLNRPTRAEVVNLLEKTQTDRVV 352

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297842629|ref|XP_002889196.1| hypothetical protein ARALYDRAFT_477017 [Arabidopsis lyrata subsp. lyrata] gi|297335037|gb|EFH65455.1| hypothetical protein ARALYDRAFT_477017 [Arabidopsis lyrata subsp. lyrata]

 Score =  541 bits (1393), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 257/349 (73%), Positives = 296/349 (84%), Gaps = 7/349 (2%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSV---SGGKMVMFRSPLI 57
           M NA+   FY+TI  +AFVI KI+I+VLLY+RWKRK+ V+ +      GGKMVMFRSPL+
Sbjct: 1   MTNAKETTFYITISVVAFVIGKIVIAVLLYKRWKRKHTVHENGFPVKGGGKMVMFRSPLL 60

Query: 58  HSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFEREL 117
           +S+ SD   KKT K S+KD++GSGG+GTVYRL ++DST FAVKRL+RGT+E DRGF REL
Sbjct: 61  NSVSSDMFMKKTHKLSNKDILGSGGYGTVYRLVIDDSTTFAVKRLNRGTSERDRGFHREL 120

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           EAM DIKHRNIVTLHGY+TS  YNLLIYELMPNGSLD+FLHG+    K LDW SRY+IAV
Sbjct: 121 EAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLHGR----KALDWASRYRIAV 176

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
           GAARGI+YLH+DCIPHIIHRDIKSSNILLD NMEARVSDFGLATLME +KTHVST VAGT
Sbjct: 177 GAARGISYLHYDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTFVAGT 236

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
           FGYLAPEYFDTG+AT KGDVYSFGVVLLELLTG++P D+ F EEGTKLVTWVK V++D+R
Sbjct: 237 FGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVTWVKGVVKDQR 296

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
           E+ VID  L G  + E+NDVF IA MCLEPEP+ RPTMTEVVK+LE IK
Sbjct: 297 EDVVIDNRLRGSSVQEMNDVFGIAMMCLEPEPAIRPTMTEVVKLLEYIK 345

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218397|ref|NP_177974.1| protein kinase-like protein [Arabidopsis thaliana] gi|75337872|sp|Q9SYM9.1|Y1853_ARATH RecName: Full=Receptor-like serine/threonine-protein kinase At1g78530 gi|4836880|gb|AAD30583.1|AC007260_14 putative protein kinase [Arabidopsis thaliana] gi|110740699|dbj|BAE98451.1| putative protein kinase [Arabidopsis thaliana] gi|332197996|gb|AEE36117.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  533 bits (1373), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 255/352 (72%), Positives = 293/352 (83%), Gaps = 10/352 (2%)

Query: 1   MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSV---SGGKMVMFRSPLI 57
           M NA+   FY+TI  +AFVI KI+I++L Y+RWKRK+ ++ +      GGKMVMFRS L+
Sbjct: 1   MANAKETTFYITISVVAFVIGKIVIALLFYKRWKRKHTIHENGFPVKGGGKMVMFRSQLL 60

Query: 58  HSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFEREL 117
           +S+ SD   KKT K S+KD++GSGGFGTVYRL ++DST FAVKRL+RGT+E DRGF REL
Sbjct: 61  NSVSSDMFMKKTHKLSNKDILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERDRGFHREL 120

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           EAM DIKHRNIVTLHGY+TS  YNLLIYELMPNGSLD+FLHG+    K LDW SRY+IAV
Sbjct: 121 EAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLHGR----KALDWASRYRIAV 176

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
           GAARGI+YLHHDCIPHIIHRDIKSSNILLD NMEARVSDFGLATLME +KTHVST VAGT
Sbjct: 177 GAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTFVAGT 236

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
           FGYLAPEYFDTG+AT KGDVYSFGVVLLELLTG++P D+ F EEGTKLVTWVK V++D+R
Sbjct: 237 FGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVTWVKGVVRDQR 296

Query: 298 EEYVIDTSLEGCPIN---EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
           EE VID  L G  +    E+NDVF IA MCLEPEP+ RP MTEVVK+LE IK
Sbjct: 297 EEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLEYIK 348

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147828317|emb|CAN75400.1| hypothetical protein VITISV_004496 [Vitis vinifera]

 Score =  499 bits (1286), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/344 (71%), Positives = 275/344 (79%), Gaps = 41/344 (11%)

Query: 49  MVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE 108
           MVMF SP++ SL SDA+ KK  + S+KDVIGSGG GTVYRLTV+ S AFAVKRL+RG+ +
Sbjct: 1   MVMFTSPMMQSLNSDALLKKATRLSNKDVIGSGGHGTVYRLTVDGSVAFAVKRLNRGSAD 60

Query: 109 VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
            DRGFERELEAMGDIKHRNIVTLHGYYT+  YNLL+YELMPNGSLD +LHG+   KK LD
Sbjct: 61  QDRGFERELEAMGDIKHRNIVTLHGYYTAPHYNLLMYELMPNGSLDAYLHGRLKEKKLLD 120

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME +KT
Sbjct: 121 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEPDKT 180

Query: 229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW 288
           HVST VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP DEAF+EEGT+LVTW
Sbjct: 181 HVSTFVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPSDEAFIEEGTRLVTW 240

Query: 289 -----------------------------------------VKAVMQDKREEYVIDTSLE 307
                                                    VKAV+ +K+EE+V+D+SLE
Sbjct: 241 MVEPSEVRIHPSVLGHAQFWMNMKIFLVHLSLTNDPCMLEQVKAVVLEKKEEHVLDSSLE 300

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
            C ++E+N+VFSIA+MCLE EPSKRPTM EV+KMLE IKS+K+V
Sbjct: 301 CCSLDEVNNVFSIATMCLESEPSKRPTMAEVLKMLEQIKSDKLV 344

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218187882|gb|EEC70309.1| hypothetical protein OsI_01155 [Oryza sativa Indica Group]

 Score =  493 bits (1269), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 225/343 (65%), Positives = 277/343 (80%), Gaps = 1/343 (0%)

Query: 6   IIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAI 65
           ++A Y+TIC I F++SK++IS LLY++W RK  +  +S++GGKMVMFRS  + SL   + 
Sbjct: 5   MVALYITICSILFIVSKMLISFLLYKKWARKKRIIENSLTGGKMVMFRSAAMQSLSPKSF 64

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH 125
               +  S+KD+IGSGG+GTVYRL+V +  AFAVK+L RG+ E+DRGFEREL+ MGDIKH
Sbjct: 65  LTMIMGLSNKDIIGSGGYGTVYRLSVGEKAAFAVKKLSRGSVEMDRGFERELDTMGDIKH 124

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           RNIV L GYY +  +NLLIYELMPNGSLDT LHGK   ++ L W +R+KIA G ARG+AY
Sbjct: 125 RNIVPLCGYYAAPHFNLLIYELMPNGSLDTILHGKEETRRALGWEARHKIAAGVARGLAY 184

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LHHDCIPH+IHRDIKSSNILLD NMEARVSDFGLATLM+   +HV+T+VAGTFGYLAPEY
Sbjct: 185 LHHDCIPHVIHRDIKSSNILLDHNMEARVSDFGLATLMKPNHSHVTTVVAGTFGYLAPEY 244

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           F+TGRAT KGDVYS+GVVLLELLTGKRP DE+FLE GT+LVTWVK  M++KREE+ +D++
Sbjct: 245 FETGRATTKGDVYSYGVVLLELLTGKRPTDESFLENGTRLVTWVKETMEEKREEHAVDSA 304

Query: 306 LEGC-PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
           LE   P+ E+  VF +A  CLE EP  RPTM EVVK+LEL K+
Sbjct: 305 LESSFPVEEVKLVFKVADKCLESEPCNRPTMAEVVKLLELAKN 347

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	351
TAIR|locus:2203000	355	AT1G78530 [Arabidopsis thalian	0.974	0.963	0.724	4.7e-135
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.951	0.564	0.485	7.4e-82
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.945	0.563	0.480	4.7e-80
TAIR|locus:2170668	604	AT5G62710 [Arabidopsis thalian	0.928	0.539	0.459	2.4e-76
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.888	0.267	0.461	2.6e-69
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.840	0.247	0.5	1e-68
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.840	0.227	0.474	1.7e-68
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.877	0.264	0.470	4.1e-68
TAIR|locus:2132168	725	AT4G02010 [Arabidopsis thalian	0.817	0.395	0.486	6.5e-67
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.968	0.351	0.443	1.5e-66

TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)]

 Score = 1323 (470.8 bits), Expect = 4.7e-135, P = 4.7e-135
 Identities = 255/352 (72%), Positives = 293/352 (83%)

Query:     1 MGNARIIAFYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSV---SGGKMVMFRSPLI 57
             M NA+   FY+TI  +AFVI KI+I++L Y+RWKRK+ ++ +      GGKMVMFRS L+
Sbjct:     1 MANAKETTFYITISVVAFVIGKIVIALLFYKRWKRKHTIHENGFPVKGGGKMVMFRSQLL 60

Query:    58 HSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFEREL 117
             +S+ SD   KKT K S+KD++GSGGFGTVYRL ++DST FAVKRL+RGT+E DRGF REL
Sbjct:    61 NSVSSDMFMKKTHKLSNKDILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERDRGFHREL 120

Query:   118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
             EAM DIKHRNIVTLHGY+TS  YNLLIYELMPNGSLD+FLHG+    K LDW SRY+IAV
Sbjct:   121 EAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLHGR----KALDWASRYRIAV 176

Query:   178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             GAARGI+YLHHDCIPHIIHRDIKSSNILLD NMEARVSDFGLATLME +KTHVST VAGT
Sbjct:   177 GAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTFVAGT 236

Query:   238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
             FGYLAPEYFDTG+AT KGDVYSFGVVLLELLTG++P D+ F EEGTKLVTWVK V++D+R
Sbjct:   237 FGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVTWVKGVVRDQR 296

Query:   298 EEYVIDTSLEGCPINE---INDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
             EE VID  L G  + E   +NDVF IA MCLEPEP+ RP MTEVVK+LE IK
Sbjct:   297 EEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLEYIK 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
 Identities = 165/340 (48%), Positives = 226/340 (66%)

Query:     6 IIAFYVTICCIAFVISKIIISVLLYRRWKRKNMV-YTDSVSGG-KMVMFRSPLIHSLQSD 63
             +I+   T+  +  V         LY++  +  +      V GG  +VMF   L +S  S 
Sbjct:   240 LISASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYS--SK 297

Query:    64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
              I KK    + + +IG GGFGTVY+L ++D   FA+KR+ +     DR FERELE +G I
Sbjct:   298 DIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSI 357

Query:   124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
             KHR +V L GY  S    LL+Y+ +P GSLD  LH +    + LDW SR  I +GAA+G+
Sbjct:   358 KHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHVE--RGEQLDWDSRVNIIIGAAKGL 415

Query:   184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
             +YLHHDC P IIHRDIKSSNILLD N+EARVSDFGLA L+E E++H++TIVAGTFGYLAP
Sbjct:   416 SYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 475

Query:   244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             EY  +GRAT K DVYSFGV++LE+L+GKRP D +F+E+G  +V W+K ++ +KR   ++D
Sbjct:   476 EYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVD 535

Query:   304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              + EG  +  ++ + SIA+ C+ P P +RPTM  VV++LE
Sbjct:   536 PNCEGMQMESLDALLSIATQCVSPSPEERPTMHRVVQLLE 575

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
 Identities = 164/341 (48%), Positives = 225/341 (65%)

Query:     6 IIAFYVTICCIAFVISKIIISVLLYRRWKR---KNMVYTDSVSGGKMVMFRSPLIHSLQS 62
             +I+   T+  +  V         LY++  R   K++V  D   G  +VMF   L ++  S
Sbjct:   238 LISASATVGGLLLVALMCFWGCFLYKKLGRVESKSLVI-DVGGGASIVMFHGDLPYA--S 294

Query:    63 DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGD 122
               I KK    + + +IG GGFGTVY+L+++D   FA+KR+ +     DR FERELE +G 
Sbjct:   295 KDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGS 354

Query:   123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
             IKHR +V L GY  S    LL+Y+ +P GSLD  LH +    + LDW SR  I +GAA+G
Sbjct:   355 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRG---EQLDWDSRVNIIIGAAKG 411

Query:   183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
             +AYLHHDC P IIHRDIKSSNILLD N+EARVSDFGLA L+E E++H++TIVAGTFGYLA
Sbjct:   412 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 471

Query:   243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
             PEY  +GRAT K DVYSFGV++LE+L+GK P D +F+E+G  +V W+  ++ + R + ++
Sbjct:   472 PEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIV 531

Query:   303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             D S EG     ++ + SIA+ C+   P +RPTM  VV++LE
Sbjct:   532 DLSCEGVERESLDALLSIATKCVSSSPDERPTMHRVVQLLE 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)]

 Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
 Identities = 154/335 (45%), Positives = 211/335 (62%)

Query:    16 IAFVISKIIISVLLYRRWKRKNMVYTD-------SVSGGKMVMFRSPLIHSLQSDAIFKK 68
             +AF++  + + + +  + +RK   YT+       S +  K++ F   L +S  S  + +K
Sbjct:   251 LAFIVIFVFLWIWMLSKKERKVKKYTEVKKQKDPSETSKKLITFHGDLPYS--STELIEK 308

Query:    69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
                   +D++GSGGFGTVYR+ +ND   FAVK++ R     DR FERE+E +G +KH N+
Sbjct:   309 LESLDEEDIVGSGGFGTVYRMVMNDLGTFAVKKIDRSRQGSDRVFEREVEILGSVKHINL 368

Query:   129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             V L GY       LLIY+ +  GSLD  LH ++     L+W +R KIA+G+ARG+AYLHH
Sbjct:   369 VNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGLLNWNARLKIALGSARGLAYLHH 428

Query:   189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
             DC P I+HRDIKSSNILL+  +E RVSDFGLA L+  E  HV+T+VAGTFGYLAPEY   
Sbjct:   429 DCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAPEYLQN 488

Query:   249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
             GRAT K DVYSFGV+LLEL+TGKRP D  F++ G  +V W+  V+++ R E VID     
Sbjct:   489 GRATEKSDVYSFGVLLLELVTGKRPTDPIFVKRGLNVVGWMNTVLKENRLEDVIDKRCTD 548

Query:   309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                  +  +  IA  C +  P  RP M +V ++LE
Sbjct:   549 VDEESVEALLEIAERCTDANPENRPAMNQVAQLLE 583

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 710 (255.0 bits), Expect = 2.6e-69, P = 2.6e-69
 Identities = 148/321 (46%), Positives = 208/321 (64%)

Query:    33 WKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVN 92
             WK  ++    S++   +  F  PL   L    + + T  FS++ ++GSGGFG VY+  + 
Sbjct:   824 WKLSSVPEPLSIN---VATFEKPL-RKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLR 879

Query:    93 DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS 152
             D +  A+K+L R T + DR F  E+E +G IKHRN+V L GY    +  LL+YE M  GS
Sbjct:   880 DGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGS 939

Query:   153 LDTFLHGKSVNKKN--LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM 210
             L+T LH KS  K    L+W +R KIA+GAARG+A+LHH CIPHIIHRD+KSSN+LLD++ 
Sbjct:   940 LETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDF 999

Query:   211 EARVSDFGLATLMEAEKTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT 269
             EARVSDFG+A L+ A  TH+S + +AGT GY+ PEY+ + R TAKGDVYS+GV+LLELL+
Sbjct:  1000 EARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLS 1059

Query:   270 GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN--DVFSIASMCLEP 327
             GK+P+D     E   LV W K + ++KR   ++D  L      ++       IAS CL+ 
Sbjct:  1060 GKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDD 1119

Query:   328 EPSKRPTMTEVVKMLELIKSE 348
              P KRPTM +++ M + +K++
Sbjct:  1120 RPFKRPTMIQLMAMFKEMKAD 1140

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 705 (253.2 bits), Expect = 1.0e-68, P = 1.0e-68
 Identities = 150/300 (50%), Positives = 198/300 (66%)

Query:    49 MVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE 108
             + MF  PL+     D I + T  FS K++IG GGFGTVY+  +      AVK+L    T+
Sbjct:   895 IAMFEQPLLKVRLGD-IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQ 953

Query:   109 VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
              +R F  E+E +G +KH N+V+L GY + S+  LL+YE M NGSLD +L  ++   + LD
Sbjct:   954 GNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLD 1013

Query:   169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
             W  R KIAVGAARG+A+LHH  IPHIIHRDIK+SNILLD + E +V+DFGLA L+ A ++
Sbjct:  1014 WSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACES 1073

Query:   229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE-EGTKLVT 287
             HVST++AGTFGY+ PEY  + RAT KGDVYSFGV+LLEL+TGK P    F E EG  LV 
Sbjct:  1074 HVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVG 1133

Query:   288 W-VKAVMQDKREEYVIDTSLEGCPI-NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
             W ++ + Q K  + VID  L    + N    +  IA +CL   P+KRP M +V+K L+ I
Sbjct:  1134 WAIQKINQGKAVD-VIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 682 (245.1 bits), Expect = 1.7e-68, Sum P(2) = 1.7e-68
 Identities = 142/299 (47%), Positives = 192/299 (64%)

Query:    49 MVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT- 107
             +  F   L+  + +D I K T  FS   +IG GGFGTVY+  + +    A+KRLH G   
Sbjct:   980 LATFEHALLR-VTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQF 1038

Query:   108 EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL 167
             + DR F  E+E +G +KH N+V L GY        LIYE M NGSL+ +L  ++   + L
Sbjct:  1039 QGDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEAL 1098

Query:   168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
              WP R KI +G+ARG+A+LHH  +PHIIHRD+KSSNILLD+N E RVSDFGLA ++ A +
Sbjct:  1099 GWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACE 1158

Query:   228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT 287
             THVST +AGTFGY+ PEY  T ++T KGDVYSFGVV+LELLTG+ P  +  ++ G  LV 
Sbjct:  1159 THVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVG 1218

Query:   288 WVKAVMQDKREEYVIDTSLEGCPI--NEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
             WV+ ++   ++  + D  L    +   ++  V +IA  C   EP KRPTM EVVK L++
Sbjct:  1219 WVRWMIARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLKM 1277

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 699 (251.1 bits), Expect = 4.1e-68, P = 4.1e-68
 Identities = 151/321 (47%), Positives = 206/321 (64%)

Query:    33 WKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVN 92
             WK  ++    S++   +  F  PL   L    + + T  FS+  +IGSGGFG VY+  + 
Sbjct:   823 WKLSSVHEPLSIN---VATFEKPL-RKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLA 878

Query:    93 DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS 152
             D +  A+K+L + T + DR F  E+E +G IKHRN+V L GY    +  LL+YE M  GS
Sbjct:   879 DGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGS 938

Query:   153 LDTFLHGKSVNKKN---LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN 209
             L+T LH K+  KK    LDW +R KIA+GAARG+A+LHH CIPHIIHRD+KSSN+LLDQ+
Sbjct:   939 LETVLHEKT--KKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQD 996

Query:   210 MEARVSDFGLATLMEAEKTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELL 268
               ARVSDFG+A L+ A  TH+S + +AGT GY+ PEY+ + R TAKGDVYS+GV+LLELL
Sbjct:   997 FVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELL 1056

Query:   269 TGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN--DVFSIASMCLE 326
             +GK+P+D     E   LV W K + ++KR   ++D  L      ++       IAS CL+
Sbjct:  1057 SGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLD 1116

Query:   327 PEPSKRPTMTEVVKML-ELIK 346
               P KRPTM +V+ M  EL++
Sbjct:  1117 DRPFKRPTMIQVMTMFKELVQ 1137

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)]

 Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
 Identities = 142/292 (48%), Positives = 194/292 (66%)

Query:    60 LQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEA 119
             L  + + + T  F S  ++G GGFG VYR  + D TA A+K+L  G  + D+ F+ E++ 
Sbjct:   368 LSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDM 427

Query:   120 MGDIKHRNIVTLHGYYTS--SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
             +  + HRN+V L GYY+S  S  +LL YEL+PNGSL+ +LHG       LDW +R KIA+
Sbjct:   428 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIAL 487

Query:   178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAG 236
              AARG+AYLH D  P +IHRD K+SNILL+ N  A+V+DFGLA    E    H+ST V G
Sbjct:   488 DAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVMG 547

Query:   237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             TFGY+APEY  TG    K DVYS+GVVLLELLTG++P+D +       LVTW + V++DK
Sbjct:   548 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDK 607

Query:   297 -REEYVIDTSLEG-CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
              R E ++D+ LEG  P  +   V +IA+ C+ PE S+RPTM EVV+ L++++
Sbjct:   608 DRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMVQ 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 678 (243.7 bits), Expect = 1.5e-66, P = 1.5e-66
 Identities = 157/354 (44%), Positives = 213/354 (60%)

Query:     4 ARIIAFYVTICCIAFVISKI-IISVLLYRRWKRKNMVYTDSVSG-G--KMVMFRSPL-IH 58
             +R+ +    IC +  VI+ + +I + +Y+  ++K ++   S    G  K+V+    + IH
Sbjct:   577 SRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIH 636

Query:    59 SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELE 118
             +   D I + T   + K +IG G   TVY+  +  S   A+KRL+       R FE ELE
Sbjct:   637 TF--DDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELE 694

Query:   119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
              +G I+HRNIV+LHGY  S   NLL Y+ M NGSL   LHG S+ K  LDW +R KIAVG
Sbjct:   695 TIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHG-SLKKVKLDWETRLKIAVG 753

Query:   179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
             AA+G+AYLHHDC P IIHRDIKSSNILLD+N EA +SDFG+A  + A KTH ST V GT 
Sbjct:   754 AAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTI 813

Query:   239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD-EAFLEEGTKLVTWVKAVMQDKR 297
             GY+ PEY  T R   K D+YSFG+VLLELLTGK+ +D EA L +          VM+   
Sbjct:   814 GYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADDNTVMEAVD 873

Query:   298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK-MLELIKSEKV 350
              E  + T ++   +  I   F +A +C +  P +RPTM EV + +L L+ S +V
Sbjct:   874 PEVTV-TCMD---LGHIRKTFQLALLCTKRNPLERPTMLEVSRVLLSLVPSLQV 923

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SYM9	Y1853_ARATH	2, ., 7, ., 1, 1, ., 1	0.7244	0.9743	0.9633	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	351
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-42
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-41
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-31
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-28
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-28
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-28
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-28
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-27
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-26
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-21
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  179 bits (456), Expect = 1e-54
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 28/275 (10%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAF-----AVKRLHRGTTEVDR-GFERELEAMGDIKHRNI 128
              +G G FG VY+  +           AVK L    +E     F RE   M  + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L G  T  +   ++ E M  G L ++L     N+  L        A+  ARG+ YL  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEYLES 120

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
               + IHRD+ + N L+ +N+  ++SDFGL+  +  +  +          ++APE    
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
           G+ T+K DV+SFGV+L E+ T G++P        G      ++ +    R          
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP------YPGMSNEEVLEYLKNGYRLP-----QPP 226

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            CP     +++ +   C   +P  RPT +E+V++L
Sbjct: 227 NCP----PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  179 bits (457), Expect = 1e-54
 Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 38/284 (13%)

Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
             +G G FG VY+         +T  AVK L    +E +R  F +E   M  + H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGK-----SVNKKNLDWPSRYKIAVGAARGIAY 185
           L G  T  +   L+ E M  G L  +L        S  K  L        A+  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST-----IVAGTFGY 240
           L        +HRD+ + N L+ +++  ++SDFGL+  +  +  +         +     +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           +APE    G  T+K DV+SFGV+L E+ T G  P      EE          V++  R+ 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------VLEYLRKG 223

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           Y +       P    ++++ +   C + +P  RPT +E+V+ LE
Sbjct: 224 YRLP-----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (445), Expect = 7e-53
 Identities = 83/284 (29%), Positives = 130/284 (45%), Gaps = 49/284 (17%)

Query: 77  VIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
            +G G FG VY+           T  AVK L  G +E +R  F  E   M  + H NIV 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G  T  +   ++ E MP G L  FL     + + L      ++A+  A+G+ YL    
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFG---YLAPEYF 246
             + +HRD+ + N L+ +N+  ++SDFGL+  + E +         G      ++APE  
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPESL 176

Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRP---MD----EAFLEEGTKLVTWVKAVMQDKRE 298
             G+ T+K DV+SFGV+L E+ T G++P   M        LE+G +L             
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR----------- 225

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                   E CP    ++++ +   C   +P  RPT +E+V+ L
Sbjct: 226 -------PENCP----DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  174 bits (443), Expect = 1e-52
 Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 27/275 (9%)

Query: 75  KDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
              +G G FG VY+              AVK L    +E     F RE   M  + H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L G  T  +  +++ E MP G L  +L  +    K L        A+  ARG+ YL  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
               + IHRD+ + N L+ +N+  ++SDFGL+  +  +  +          ++APE    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
           G+ T+K DV+SFGV+L E+ T G+ P        G      ++ + +  R          
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP------YPGMSNAEVLEYLKKGYRLP-----KPP 227

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            CP     +++ +   C   +P  RPT +E+V++L
Sbjct: 228 NCP----PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  173 bits (440), Expect = 3e-52
 Identities = 85/273 (31%), Positives = 125/273 (45%), Gaps = 21/273 (7%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNI 128
           +     +GSG FGTVY+          AVK L + +   + D+   RE+  +  + H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L   +    +  L+ E    G L  +L         L      KIA+   RG+ YLH 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFD 247
           +    IIHRD+K  NILLD+N   +++DFGLA  +    + ++T V GT  Y+APE    
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                 K DV+S GV+L ELLTGK P          +L      + +        D   +
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGE--NILDQLQL----IRRILGPPLEFD-EPK 225

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
               +E  +   +   CL  +PSKRPT  E+++
Sbjct: 226 WSSGSE--EAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (413), Expect = 1e-48
 Identities = 75/269 (27%), Positives = 117/269 (43%), Gaps = 58/269 (21%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G GGFGTVY           A+K + +  +        RE+E +  + H NIV L+G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
               +  L+ E    GSL   L     N+  L      +I +    G+ YLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 196 HRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATA 253
           HRD+K  NILLD  N + +++DFGL+ L+ ++K+ + TIV GT  Y+APE     G  + 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173

Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           K D++S GV+L EL                                              
Sbjct: 174 KSDIWSLGVILYEL---------------------------------------------- 187

Query: 314 INDVFSIASMCLEPEPSKRPTMTEVVKML 342
             ++  +    L+ +P KRP+  E+++ L
Sbjct: 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (411), Expect = 7e-48
 Identities = 71/273 (26%), Positives = 112/273 (41%), Gaps = 25/273 (9%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           +   + +G G FG VY           A+K + +   + DR    RE++ +  +KH NIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIAYLHH 188
            L+  +       L+ E    G L   L      +  L      +         + YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLS-EDEARFYLRQILSALEYLHS 115

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
                I+HRD+K  NILLD++   +++DFGLA  ++     ++T V GT  Y+APE    
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLG 170

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
                  D++S GV+L ELLTGK P    F  +   L  + K      + +         
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKI----GKPKPPFPPPEWD 222

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
                  +   +    L  +P KR T  E ++ 
Sbjct: 223 IS----PEAKDLIRKLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (376), Expect = 1e-42
 Identities = 79/270 (29%), Positives = 118/270 (43%), Gaps = 32/270 (11%)

Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           ++G G FG+VY  L  +     AVK   L   + E     ERE+  +  ++H NIV  +G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 134 YYTSSQYN-LLIY-ELMPNGSLDTFLHGKSVNKKNLDWP--SRYKIAVGAARGIAYLH-H 188
                + N L I+ E +  GSL + L         L  P   +Y   +    G+AYLH +
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQI--LEGLAYLHSN 120

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPEYFD 247
                I+HRDIK +NIL+D +   +++DFG A  + + E    +  V GT  ++APE   
Sbjct: 121 ----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                   D++S G  ++E+ TGK P    + E G  +    K     +  E     S E
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP----WSELGNPMAALYKIGSSGEPPEIPEHLSEE 232

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTE 337
                           CL  +P KRPT  E
Sbjct: 233 AK---------DFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  145 bits (367), Expect = 3e-41
 Identities = 78/268 (29%), Positives = 123/268 (45%), Gaps = 28/268 (10%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
            V+G G  G VY+         +A+K++H  G  E  +   REL+ +   +   +V  +G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 134 -YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDC 190
            +Y   + ++++ E M  GSL   L      KK    P      IA    +G+ YLH   
Sbjct: 67  AFYKEGEISIVL-EYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK- 118

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
             HIIHRDIK SN+L++   E +++DFG++ ++E      +T V GT  Y++PE      
Sbjct: 119 -RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176

Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
            +   D++S G+ LLE   GK P       + +        +MQ      + D      P
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPF--LPPGQPSFF-----ELMQ-----AICDGPPPSLP 224

Query: 311 INEINDVF-SIASMCLEPEPSKRPTMTE 337
             E +  F    S CL+ +P KRP+  E
Sbjct: 225 AEEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  135 bits (342), Expect = 2e-37
 Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 28/294 (9%)

Query: 67  KKTLKFSSKDVIGSGGFGTVY--RLTVNDSTAF---AVKRL-HRGTTEVDRGFERELEAM 120
           K+ LKF  +  +G G FG V   R            AVK L H G  +    FERE+E +
Sbjct: 3   KRHLKFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 121 GDIKHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
             + H NIV   G           LI E +P+GSL  +L     ++  ++       +  
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQ 117

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-- 236
             +G+ YL        IHRD+ + NIL++     ++SDFGLA ++  +K +      G  
Sbjct: 118 ICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 237 -TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLEEGTKLVTWVKA 291
             F Y APE   T + ++  DV+SFGV L EL T     + P  E     G      +  
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233

Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
            + +  +E         CP    ++V+ +  +C E EP  RP+  +++ +++ +
Sbjct: 234 RLLELLKEGERLPRPPSCP----DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (325), Expect = 3e-35
 Identities = 73/272 (26%), Positives = 113/272 (41%), Gaps = 30/272 (11%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            F   + IG GGFG VY+          A+K +   + E       E++ +   KH NIV
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 130 TLHGYYTSSQYNL---LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
               YY S        ++ E    GSL   L   +         +   +     +G+ YL
Sbjct: 61  ---KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIA--YVCKELLKGLEYL 114

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H +    IIHRDIK++NILL  + E ++ DFGL+  +   K   + +  GT  ++APE  
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVI 169

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE-YVIDTS 305
           +      K D++S G+  +EL  GK P  E         +  +KA+ +        +   
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSE---------LPPMKALFKIATNGPPGLRNP 220

Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTE 337
            +     E  D       CL+  P KRPT  +
Sbjct: 221 EKWSD--EFKD---FLKKCLQKNPEKRPTAEQ 247

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 74/283 (26%), Positives = 115/283 (40%), Gaps = 22/283 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKH-R 126
            +     +G G FG VY     D    A+K L +      +    F RE++ +  + H  
Sbjct: 1   SYRILRKLGEGSFGEVYL--ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NIV L+ ++       L+ E +  GSL+  L  K   K  L       I       + YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117

Query: 187 HHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVS-----TIVAGTFGY 240
           H      IIHRDIK  NILLD++    ++ DFGLA L+    +  S     +   GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 241 LAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
           +APE         A++  D++S G+ L ELLTG  P +    +  +     +K +++   
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPT 232

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  S    P         +    L  +P  R + +  + 
Sbjct: 233 PSLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (312), Expect = 2e-33
 Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 26/276 (9%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRN 127
           K+     IG G FG VY +   +D   + +K   L   + +       E++ +  + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           I+  +  +       ++ E    G L   +  +    K           V     + YLH
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                 I+HRDIK  NI L  N   ++ DFG++ ++ +      T+V GT  YL+PE   
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                 K D++S G VL EL T K P    F  EG  L+     +++ +           
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP----F--EGENLLELALKILKGQYP--------- 221

Query: 308 GCPINEI--NDVFSIASMCLEPEPSKRPTMTEVVKM 341
             PI     +++ ++ S  L+ +P +RP++ ++++ 
Sbjct: 222 --PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 5e-32
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 30/274 (10%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I + +++   K  +G+G FG V+    N++T  AVK L  GT +    F  E + M  ++
Sbjct: 3   IDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD-FLAEAQIMKKLR 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  ++ L+   T  +   ++ ELM  GSL  +L G +   + L  P    +A   A G+A
Sbjct: 60  HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMA 117

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YL      + IHRD+ + N+L+ +N   +V+DFGLA +++ +             + APE
Sbjct: 118 YLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174

Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAFLEEGTKLVTWVKAVMQDKREEY 300
                R + K DV+SFG++L E++T G+ P   M  A              V+Q   + Y
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------------EVLQQVDQGY 221

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT 334
            +      CP     +++ I   C + +P  RPT
Sbjct: 222 RMP-----CPPGCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 6e-32
 Identities = 84/276 (30%), Positives = 133/276 (48%), Gaps = 32/276 (11%)

Query: 77  VIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           VIG G FG V     +L        A+K L  G+++  R  F  E   MG   H NI+ L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T S+  ++I E M NGSLD FL     N           +  G A G+ YL     
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG---TFGYLAPEYFDT 248
              +HRD+ + NIL++ N+  +VSDFGL+  +E  +   +T   G      + APE    
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIRWTAPEAIAY 182

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+SFG+V+ E+++ G+RP    + +   + V  +KAV    R    +D    
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP----YWDMSNQDV--IKAVEDGYRLPPPMD---- 232

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP    + ++ +   C + + ++RPT +++V  L+
Sbjct: 233 -CP----SALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  126 bits (317), Expect = 8e-32
 Identities = 95/343 (27%), Positives = 161/343 (46%), Gaps = 31/343 (9%)

Query: 9   FYVTICCIAFVISKIIISVLLYRRWKRKNMVYTDSVSGG--KMVMFRSPLIHSLQSDAIF 66
           FY+T    AF++  ++    ++ R +    +       G  ++  F S +  S+  + I 
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL 689

Query: 67  KKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH 125
                   ++VI  G  G  Y+  ++ +   F VK       +V+     E+  MG ++H
Sbjct: 690 SSL---KEENVISRGKKGASYKGKSIKNGMQFVVKE----INDVNSIPSSEIADMGKLQH 742

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNK--KNLDWPSRYKIAVGAARGI 183
            NIV L G   S +   LI+E         ++ GK++++  +NL W  R KIA+G A+ +
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHE---------YIEGKNLSEVLRNLSWERRRKIAIGIAKAL 793

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
            +LH  C P ++  ++    I++D   E  +    L  L+  +     +       Y+AP
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAP 847

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
           E  +T   T K D+Y FG++L+ELLTGK P D  F   G+ +V W +    D   +  ID
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARYCYSDCHLDMWID 906

Query: 304 TSLEG---CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            S+ G      NEI +V ++A  C   +P+ RP   +V+K LE
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 8e-32
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRN 127
            +   D+IG G FG VY+ L +      A+K+  L +   E  +   +E++ + ++KH N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP----SRYKIAVGAARGI 183
           IV   G   +S    +I E   NGSL   +      KK   +P    + Y   V   +G+
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQV--LQGL 112

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           AYLH      +IHRDIK++NIL  ++   +++DFG+AT +          V GT  ++AP
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAP 168

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           E  +   A+   D++S G  ++ELLTG  P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  118 bits (299), Expect = 2e-31
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 28/269 (10%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           IG G FG VY  + ++     AVK  R+     +  +    E++ +  +KH N+V  +G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
               +   +  E    G+L+  L    +  +++     Y + +    G+AYLH      I
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHSH---GI 120

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG---YLAPEYFDTGRA 251
           +HRDIK +NI LD N   ++ DFG A  ++   T +   V    G   Y+APE    G+ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 252 TAKG---DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
              G   D++S G V+LE+ TGKRP   + L+   +++  V A  +       I  SL+ 
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKP-----PIPDSLQL 233

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTE 337
            P     +       CLE +P KRPT +E
Sbjct: 234 SP-----EGKDFLDRCLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  118 bits (297), Expect = 3e-31
 Identities = 86/283 (30%), Positives = 141/283 (49%), Gaps = 37/283 (13%)

Query: 73  SSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRN 127
           + + VIG+G FG V+R    +      A A+K L  G TE  R  F  E   MG   H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA--- 184
           I+ L G  T  +  ++I E M NG+LD +L      + +    S Y++ VG  RGIA   
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYL------RDHDGEFSSYQL-VGMLRGIAAGM 120

Query: 185 -YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YL 241
            YL      + +HRD+ + NIL++ N+E +VSDFGL+ ++E +     T   G     + 
Sbjct: 121 KYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE     + T+  DV+SFG+V+ E+++ G+RP  +    E          VM+   + +
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----------VMKAINDGF 227

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            +   +  CP    + V+ +   C + + ++RP   ++V +L+
Sbjct: 228 RLPAPM-DCP----SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (296), Expect = 4e-31
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 22/258 (8%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +GSG FG V+     +    A+K L        + F++E++A+  ++H+++++L    + 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I ELM  GSL  FL  +S   + L   S   +A   A G+AYL      + IHR
Sbjct: 74  GEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128

Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + NIL+ +++  +V+DFGLA L++ E  ++S+     + + APE    G  + K DV
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDV 187

Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFG++L E+ T G+ P       E    +T            Y +    + CP      
Sbjct: 188 WSFGILLYEMFTYGQVPYPGMNNHEVYDQIT----------AGYRMPCPAK-CPQE---- 232

Query: 317 VFSIASMCLEPEPSKRPT 334
           ++ I   C   EP  RP+
Sbjct: 233 IYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 9e-31
 Identities = 86/287 (29%), Positives = 130/287 (45%), Gaps = 37/287 (12%)

Query: 64  AIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           AI  K LK      IG G FG V           AVK L   +T     F  E   M  +
Sbjct: 2   AINSKELKL--GATIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQA-FLAEASVMTTL 57

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGAAR 181
           +H N+V L G         ++ E M  GSL  +L   G++V         +   A+    
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGFALDVCE 113

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF--G 239
           G+ YL      + +HRD+ + N+L+ +++ A+VSDFGLA   EA +   S    G     
Sbjct: 114 GMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDS----GKLPVK 164

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           + APE     + + K DV+SFG++L E+ + G+ P     L++       V  V +  R 
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPHVEKGYRM 218

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           E     + EGCP     +V+ +   C E +P+KRPT  ++ + L LI
Sbjct: 219 E-----APEGCP----PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 1e-29
 Identities = 78/282 (27%), Positives = 120/282 (42%), Gaps = 49/282 (17%)

Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLH 132
           +G G FG+V    Y +        AVK L +       + F RE   M  + H  IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKS-VNKKNL-DWPSRYKIAVGAARGIAYLHHDC 190
           G        +L+ EL P G L  +L  +  +   +L +   +       A G+AYL    
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLESK- 114

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF--GYLAPEYFDT 248
             H +HRD+ + N+LL    +A++SDFG++  + A   +     AG +   + APE  + 
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEGTKLVTWVKAVMQDKREEY 300
           G+ ++K DV+S+GV L E  + G +P  E       A LE G +L               
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL--------------- 217

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                 E CP      ++SI   C +  P  RPT +E+    
Sbjct: 218 ---PRPEECPQE----IYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (283), Expect = 4e-29
 Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHG 133
             +G+G  G V + L        AVK +     E  +    REL+ +       IV  +G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 134 -YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDC 190
            +Y +   ++ + E M  GSLD  L  K V  +    P R   KIAV   +G+ YLH   
Sbjct: 67  AFYNNGDISICM-EYMDGGSLDKIL--KEVQGR---IPERILGKIAVAVLKGLTYLHEKH 120

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLM--EAEKTHVSTIVAGTFGYLAPEYFDT 248
              IIHRD+K SNIL++   + ++ DFG++  +     KT V     GT  Y+APE    
Sbjct: 121 --KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQG 173

Query: 249 GRATAKGDVYSFGVVLLELLTGKRP 273
              + K D++S G+ L+EL TG+ P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 2e-28
 Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 44/279 (15%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTLHGYYT 136
           IG G FG VY+  +  +T  AVK          +  F +E E +    H NIV L G   
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 137 SSQYNLLIYELMPNGSLDTFLHGKS--VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
             Q   ++ EL+P GSL TFL  K   +  K L      ++++ AA G+ YL        
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYLESKN---C 114

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT----FGYLAPEYFDTGR 250
           IHRD+ + N L+ +N   ++SDFG++     E+  + T+  G       + APE  + GR
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL--- 306
            T++ DV+S+G++L E  + G  P                   M +++    I++     
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPG----------------MSNQQTRERIESGYRMP 215

Query: 307 --EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             + CP     +++ +   C   +P  RP+ +E+   L+
Sbjct: 216 APQLCP----EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  111 bits (279), Expect = 2e-28
 Identities = 88/297 (29%), Positives = 141/297 (47%), Gaps = 38/297 (12%)

Query: 70  LKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E +  ++
Sbjct: 6   LKFIQQ--LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ 63

Query: 125 HRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           H NIV   G  Y++ + NL L+ E +P GSL  +L     +++ LD       A    +G
Sbjct: 64  HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKG 120

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG---TFG 239
           + YL        +HRD+ + NIL++     ++ DFGL  ++  +K +      G    F 
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLE------EGTKLVTWV 289
           Y APE     + +   DV+SFGVVL EL T       P  E F+       +G  +V  +
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHL 235

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
             ++++         +  GCP     ++++I   C   +PS+RP+ +E+   +E I+
Sbjct: 236 IELLKNNGRL----PAPPGCP----AEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  110 bits (276), Expect = 3e-28
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 24/280 (8%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I ++++K   K  +G+G FG V+    N+ST  AVK L  GT  V + F  E   M  ++
Sbjct: 3   IPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQ 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+   T  +   +I E M  GSL  FL  KS     +  P     +   A G+A
Sbjct: 60  HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + IHRD++++N+L+ +++  +++DFGLA ++E  +            + APE
Sbjct: 118 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             + G  T K DV+SFG++L E++T GK P        G      + A+ +  R      
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPY------PGMSNSDVMSALQRGYRM----- 223

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             +E CP     +++ I   C + +  +RPT   +  +L+
Sbjct: 224 PRMENCPD----ELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 3e-28
 Identities = 80/258 (31%), Positives = 126/258 (48%), Gaps = 22/258 (8%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V+  T N +T  AVK L  GT   +  F +E + M  ++H  +V L+   + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   ++ E M  GSL  FL  KS   K L  P    +A   A G+AYL      + IHR
Sbjct: 73  EEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127

Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + NIL+ +N+  +++DFGLA L+E ++            + APE  + GR T K DV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFG++L E++T G+ P        G      ++ V +  R           CP      
Sbjct: 188 WSFGILLTEIVTYGRVPY------PGMTNREVLEQVERGYRMPRP-----PNCPEE---- 232

Query: 317 VFSIASMCLEPEPSKRPT 334
           ++ +   C + +P +RPT
Sbjct: 233 LYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  110 bits (275), Expect = 3e-28
 Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 25/280 (8%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +E + M  ++
Sbjct: 3   IPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLR 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+    S +   ++ E M  GSL  FL  K  + K L  P    +A   A G+A
Sbjct: 60  HDKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + IHRD++++NIL+  N+  +++DFGLA L+E  +            + APE
Sbjct: 117 YIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
               GR T K DV+SFG++L EL+T G+ P       E          V++     Y + 
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----------VLEQVERGYRMP 223

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              +GCP      +  +  +C + +P +RPT   +   LE
Sbjct: 224 CP-QGCP----ESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  109 bits (273), Expect = 7e-28
 Identities = 88/283 (31%), Positives = 133/283 (46%), Gaps = 31/283 (10%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +E + M  ++
Sbjct: 3   IPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLR 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +A   A G+A
Sbjct: 60  HEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMA 116

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +            + APE
Sbjct: 117 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               GR T K DV+SFG++L EL T  R             V +   V    RE  V+D 
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMV---NRE--VLDQ 215

Query: 305 SLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  109 bits (274), Expect = 9e-28
 Identities = 81/295 (27%), Positives = 130/295 (44%), Gaps = 51/295 (17%)

Query: 75  KDVIGSGGFGTVYR------LTVNDSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRN 127
           K  +G G FG V+          ND    AVK L    + +  + FERE E + + +H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVN--------KKNLDWPSRYKIAV 177
           IV  +G  T     ++++E M +G L+ FL  HG               L      +IAV
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI---- 233
             A G+ YL      H +HRD+ + N L+  ++  ++ DFG++         V T     
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-------RDVYTTDYYR 179

Query: 234 VAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW 288
           V G       ++ PE     + T + DV+SFGVVL E+ T GK+P      EE  + +T 
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              ++Q  R           CP    ++V+ I   C + +P +R  + ++ + L+
Sbjct: 239 QGRLLQRPR----------TCP----SEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  108 bits (272), Expect = 9e-28
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 29/270 (10%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V+  T N +T  AVK L  GT   +  F  E + M  ++H  +V L+    S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAV-VS 71

Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   ++ E M  GSL  FL  K    + L  P+   +A   A G+AY+      + IHR
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D++S+NIL+   +  +++DFGLA L+E  +            + APE    GR T K DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 258 YSFGVVLLELLT-GKRP---MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           +SFG++L EL+T G+ P   M+              + V++     Y +    + CPI+ 
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNN-------------REVLEQVERGYRMPCP-QDCPIS- 231

Query: 314 INDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              +  +   C + +P +RPT   +   LE
Sbjct: 232 ---LHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  108 bits (272), Expect = 1e-27
 Identities = 86/281 (30%), Positives = 137/281 (48%), Gaps = 41/281 (14%)

Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           VIG+G FG V     +L        A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIA----Y 185
            G  T S+  +++ E M NGSLD FL      +K+     ++ +   VG  RGIA    Y
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL------RKH---DGQFTVIQLVGMLRGIASGMKY 121

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAP 243
           L        +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + AP
Sbjct: 122 LSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E     + T+  DV+S+G+V+ E+++ G+RP    + E   + V  +KA+     E Y +
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP----YWEMSNQDV--IKAI----EEGYRL 228

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              +  CP      +  +   C + + ++RP   ++V +L+
Sbjct: 229 PAPM-DCPAA----LHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  107 bits (267), Expect = 4e-27
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 25/280 (8%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++LK   K  +G+G FG V+  T N  T  AVK +  G+  V+  F  E   M  ++
Sbjct: 3   IPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQ 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH   T      +I E M  GSL  FL     +K+ L  P     +   A G+A
Sbjct: 60  HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMA 116

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           ++      + IHRD++++NIL+  ++  +++DFGLA ++E  +            + APE
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             + G  T K DV+SFG++L+E++T G+ P        G      ++A+ +  R      
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPY------PGMSNPEVIRALERGYRMPRP-- 225

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              E CP     ++++I   C +  P +RPT   +  +L+
Sbjct: 226 ---ENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  106 bits (265), Expect = 1e-26
 Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 39/287 (13%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           + ++TLK   K  +G+G FG V+    N  T  A+K L +G+   +  F  E   M  ++
Sbjct: 3   VPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQ 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+   T      +I E M NGSL  FL  K+     L       +A   A G+A
Sbjct: 60  HPRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           ++      + IHRD++++NIL+ + +  +++DFGLA L+E  +            + APE
Sbjct: 117 FIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKR--------PMDEAFLEEGTKLVTWVKAVMQDK 296
             + G  T K DV+SFG++L E++T  R        P     LE G ++           
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---------- 223

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                        P N   +++ +  +C + +P +RPT   +  +LE
Sbjct: 224 ------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (262), Expect = 3e-26
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 44/277 (15%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRG-----TTEVDRGFERELEAMGDIKHRNIVTL 131
           +GSG FG+VY  L ++D   FAVK +          E  +  E+E+  +  ++H NIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 132 HGYYTSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR----GIAYL 186
            G       NL I+ EL+P GSL   L       K         +     R    G+ YL
Sbjct: 68  LGTEREED-NLYIFLELVPGGSLAKLL-------KKYG-SFPEPVIRLYTRQILLGLEYL 118

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H     + +HRDIK +NIL+D N   +++DFG+A  +       S    G+  ++APE  
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173

Query: 247 D-TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
              G      D++S G  +LE+ TGK P  +  LE        V AV +       I  S
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQ--LEG-------VAAVFK-------IGRS 217

Query: 306 LEGCPINE--INDVFSIASMCLEPEPSKRPTMTEVVK 340
            E  PI +   ++       CL+ +PS RPT  E+++
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (261), Expect = 5e-26
 Identities = 84/280 (30%), Positives = 126/280 (45%), Gaps = 41/280 (14%)

Query: 75  KDVIGSGGFGTVYR-------LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
           K  +G G +G VY        LTV      AVK L   T EV+  F +E   M +IKH N
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTV------AVKTLKEDTMEVEE-FLKEAAVMKEIKHPN 63

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V L G  T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL 
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT---FGYLAPE 244
                + IHRD+ + N L+ +N   +V+DFGL+ LM  +     T  AG      + APE
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPE 175

Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
                + + K DV++FGV+L E+ T G  P        G  L    + + +  R E    
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDLSQVYELLEKGYRME---- 225

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              EGCP      V+ +   C +  PS RP+  E+ +  E
Sbjct: 226 -RPEGCP----PKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (259), Expect = 5e-26
 Identities = 78/269 (28%), Positives = 123/269 (45%), Gaps = 23/269 (8%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +++G G FG V++ T+ D T  AVK        E+   F  E   +    H NIV L G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HDCIPH 193
            T  Q   ++ EL+P G   +FL  K   K  L      K A+ AA G+AYL   +CI  
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCI-- 115

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
             HRD+ + N L+ +N   ++SDFG++   +      S +      + APE  + GR ++
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S+G++L E  +               +  +     Q  RE+ V       CP   
Sbjct: 174 ESDVWSYGILLWETFS-------------LGVCPYPGMTNQQAREQ-VEKGYRMSCPQKC 219

Query: 314 INDVFSIASMCLEPEPSKRPTMTEVVKML 342
            +DV+ +   C + +P  RP  +E+ K L
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  105 bits (264), Expect = 7e-26
 Identities = 79/270 (29%), Positives = 120/270 (44%), Gaps = 43/270 (15%)

Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHG 133
           IGSG  GTVY++ ++  T   +A+K ++ G  E  V R   RE+E + D+ H N+V  H 
Sbjct: 82  IGSGAGGTVYKV-IHRPTGRLYALKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            +  +    ++ E M  GSL+    G  +  +         +A     GIAYLH     H
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----GTHIADE----QFLADVARQILSGIAYLHRR---H 188

Query: 194 IIHRDIKSSNILLDQNMEARVSDFG----LATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
           I+HRDIK SN+L++     +++DFG    LA  M+   + V     GT  Y++PE  +T 
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243

Query: 250 RATAK-----GDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                     GD++S GV +LE   G+ P       +G          M    E      
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPF--GVGRQGDWASLMCAICMSQPPE------ 295

Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPT 334
                P     +     S CL+ EP+KR +
Sbjct: 296 ----APATASREFRHFISCCLQREPAKRWS 321

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (261), Expect = 8e-26
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)

Query: 78  IGSGGFGTVYRLTV-NDSTAFAVKR-LHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           +G G  G+V +  + N    FA+K        ++ +   RELE     K   IV  +G +
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 136 TSSQYNLL--IYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCI 191
                + +    E    GSLD+    K V K+      +   KIA    +G++YLH    
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSI--YKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             IIHRDIK SNILL +  + ++ DFG++   E   +   T   GT  Y+APE       
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFT-GTSFYMAPERIQGKPY 180

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS---LEG 308
           +   DV+S G+ LLE+   + P    F  EG   +  ++ +       Y+++     L+ 
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLS------YIVNMPNPELKD 230

Query: 309 CPINEIN---DVFSIASMCLEPEPSKRPT 334
            P N I    +       CLE +P++RPT
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 20/221 (9%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +     V+GSG FGTVY+              A+K L   T+ + ++    E  
Sbjct: 3   ILKET-ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
            M  + H ++V L G   SSQ   LI +LMP G L  ++     +K N+         V 
Sbjct: 62  VMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQ 117

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-- 236
            A+G++YL       ++HRD+ + N+L+      +++DFGLA L++ ++        G  
Sbjct: 118 IAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGK 172

Query: 237 -TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD 275
               ++A E       T K DV+S+GV + EL+T G +P +
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  102 bits (255), Expect = 3e-25
 Identities = 92/294 (31%), Positives = 139/294 (47%), Gaps = 55/294 (18%)

Query: 77  VIGSGGFGTVYRLTVNDS----TAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVT 130
           VIG G FG VY  T+ DS       AVK L+R T   EV++ F +E   M D  H N+++
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVLS 60

Query: 131 LHGYYTSSQ-YNLLIYELMPNGSLDTFLHGKSVNK--KNLDWPSRYKIAVG--AARGIAY 185
           L G    S+   L++   M +G L  F+  ++ N   K+L       I  G   A+G+ Y
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-------IGFGLQVAKGMEY 113

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EAEKTHVSTIVAGTFGYLA 242
           L        +HRD+ + N +LD++   +V+DFGLA  +   E    H  T       ++A
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEA-------FLEEGTKLVTWVKAVMQ 294
            E   T + T K DV+SFGV+L EL+T G  P  +        +L +G +L+        
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-------- 222

Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
             + EY        CP    + ++ +   C  P+P  RPT +E+V  +E I S 
Sbjct: 223 --QPEY--------CP----DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  102 bits (257), Expect = 3e-25
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 34/277 (12%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            + + + IG G  G VY+ T        A+K++ R   +       E+  M D KH NIV
Sbjct: 20  LYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIV 78

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
             +  Y       ++ E M  GSL   +   + N   ++ P    +     +G+ YLH  
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
              ++IHRDIKS NILL ++   +++DFG A  +  EK+  +++V GT  ++APE     
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRK 191

Query: 250 RATAKGDVYSFGVVLLELLTGKRP-MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
               K D++S G++ +E+  G+ P + E  L                 R  ++I T  +G
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----------------RALFLITT--KG 232

Query: 309 CP----INEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
            P      + +  F    + CL  +P KRP+  E+++
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  102 bits (255), Expect = 3e-25
 Identities = 69/261 (26%), Positives = 105/261 (40%), Gaps = 28/261 (10%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLH 132
           VIG G FG V  +   D+   FA+K +++         R    E   + ++ H  +V L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI-AVGAARGIAYLHHDCI 191
             +   +   L+ +L+  G L   L  K    +      + K         + YLH    
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEYLHSK-- 119

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             IIHRDIK  NILLD+     ++DF +AT +  +    ST  +GT GY+APE       
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQGY 176

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           +   D +S GV   E L GKRP    +      +   ++A  +     Y         P 
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRP----YRGHSRTIRDQIRAKQETADVLY---------PA 223

Query: 312 NEINDVFSIASMCLEPEPSKR 332
               +     +  LE +P KR
Sbjct: 224 TWSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (256), Expect = 4e-25
 Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR---LTVND---STAFAVKRL---HRGTTEVDRGFER 115
           I    ++F  +  +G G FG VY+      N+   +T+ A+K L        + +  F +
Sbjct: 2   IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE--FRQ 57

Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN------------ 163
           E E M D++H NIV L G  T  Q   +++E + +G L  FL   S +            
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM 223
           K +LD      IA+  A G+ YL      H +HRD+ + N L+ + +  ++SDFGL+  +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Query: 224 -EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEE 281
             A+   V +       ++ PE    G+ T + D++SFGVVL E+ + G +P      +E
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234

Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                     V++  R   ++    E CP      V+++   C    P++RP   ++
Sbjct: 235 ----------VIEMIRSRQLLPCP-EDCPAR----VYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 4e-25
 Identities = 66/205 (32%), Positives = 95/205 (46%), Gaps = 22/205 (10%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G G FG V  +   D+   +A+K L +      +  E    E   +  I H  IV LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 134 YYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR---GIAYLH-H 188
           Y   ++  L L+ E  P G L + L      + + +    Y     AA     + YLH  
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFY-----AAEIVLALEYLHSL 112

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
                II+RD+K  NILLD +   +++DFGLA  + +E +  +T   GT  YLAPE    
Sbjct: 113 G----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLG 167

Query: 249 GRATAKGDVYSFGVVLLELLTGKRP 273
                  D +S GV+L E+LTGK P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (254), Expect = 4e-25
 Identities = 86/285 (30%), Positives = 139/285 (48%), Gaps = 43/285 (15%)

Query: 75  KDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           ++VIG+G FG V R    L        A+K L  G TE  R  F  E   MG   H NI+
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIA--- 184
            L G  T S+  ++I E M NG+LD+FL              ++ +   VG  RGIA   
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQND---------GQFTVIQLVGMLRGIAAGM 119

Query: 185 -YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME---AEKTHVSTIVAGT-FG 239
            YL      + +HRD+ + NIL++ N+  +VSDFGL+  +E   ++ T+ S++       
Sbjct: 120 KYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           + APE     + T+  DV+S+G+V+ E+++ G+RP    + +   + V  + A+ QD R 
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMSNQDV--INAIEQDYRL 230

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              +D     CP      +  +   C + + + RP   ++V  L+
Sbjct: 231 PPPMD-----CPTA----LHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (254), Expect = 5e-25
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 55/291 (18%)

Query: 76  DVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGFER----------ELEAMGDIK 124
           ++IG G +G VY  L V      AVK++    T   R   R          E+E + D+ 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARG 182
           H NIV   G+ T+ +Y  +  E +P GS+ + L  +G+       +             G
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR------FEEQLVRFFTEQVLEG 120

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI-VAGTFGYL 241
           +AYLH      I+HRD+K+ N+L+D +   ++SDFG++   +    +   + + G+  ++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 242 APEYFDTGRA--TAKGDVYSFGVVLLELLTGKRPM--DEAFLEEGTKLVTWVKAVMQDKR 297
           APE   +     +AK D++S G V+LE+  G+RP   +EA             A M    
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------------AAM---- 221

Query: 298 EEYVIDTSLEGCPINEINDVFSIASM--------CLEPEPSKRPTMTEVVK 340
             + +       PI    DV    S         C    P  RPT  E+++
Sbjct: 222 --FKLGNKRSAPPIPP--DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (251), Expect = 1e-24
 Identities = 78/279 (27%), Positives = 120/279 (43%), Gaps = 36/279 (12%)

Query: 76  DVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLH 132
           +VIG G    VY    L  N+  A     L +  T VD    +E++AM    H N+V  +
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNVVKYY 65

Query: 133 GYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
             +       L+   +  GS LD      S  +  LD      +     +G+ YLH +  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKS--SYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFG----LATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
              IHRDIK+ NILL ++   +++DFG    LA   +  +    T V GT  ++APE  +
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVME 179

Query: 248 TGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                  K D++SFG+  +EL TG  P         +K    +K +M        +    
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP--------YSKYPP-MKVLML------TLQNDP 224

Query: 307 EGCPINEINDVFSIA-----SMCLEPEPSKRPTMTEVVK 340
                      +S +     S+CL+ +PSKRPT  E++K
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 99.5 bits (248), Expect = 5e-24
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)

Query: 78  IGSGGFGTVYR------LTVNDSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVT 130
           IG G FG V++      L     T  AVK L    + ++   F+RE   M +  H NIV 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------------VNKKNLDWPSR 172
           L G     +   L++E M  G L+ FL  +S                  +N   L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVS 231
             IA   A G+AYL        +HRD+ + N L+ +NM  +++DFGL+  +  A+    S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVK 290
              A    ++ PE     R T + DV+++GVVL E+ + G +P      EE         
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY------ 243

Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                    YV D ++  CP N   +++++  +C    PS RP+   + ++L+
Sbjct: 244 ---------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 28/271 (10%)

Query: 77  VIGSGGFG--TVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           V+G G FG  T+YR T +DS   +    L R + +  R    E+  +  ++H NI+  + 
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV--GAARGIAYLHHDCI 191
           ++      LLI     NG     L+ K V +K   +     +         ++Y+H    
Sbjct: 67  HFMDDN-TLLIEMEYANGGT---LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRDIK+ NI L +    ++ DFG++ ++ +E +   T+V GT  Y++PE     + 
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
             K D+++ G VL ELLT KR     F  + T  +  V  ++Q      V   S E    
Sbjct: 179 NFKSDIWALGCVLYELLTLKR----TF--DATNPLNLVVKIVQGNYTPVVSVYSSE---- 228

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                + S+    L+ +P KRPT  EV+   
Sbjct: 229 -----LISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.3 bits (242), Expect = 1e-23
 Identities = 77/271 (28%), Positives = 131/271 (48%), Gaps = 33/271 (12%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           ++IG G FG V +         AVK +    T   + F  E   M  + H+N+V L G  
Sbjct: 12  EIIGEGEFGAVLQGEYTGQKV-AVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
             +   +++ ELM  G+L  FL  ++  +  +      + ++  A G+ YL       ++
Sbjct: 69  LHNGLYIVM-ELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATL--MEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           HRD+ + NIL+ ++  A+VSDFGLA +  M  + + +         + APE     + ++
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV------KWTAPEALKHKKFSS 176

Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV+S+GV+L E+ + G+ P  +  L+E        + V +  R E       EGCP  
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK------ECVEKGYRME-----PPEGCP-- 223

Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              DV+ + + C E EP KRP+  ++ + LE
Sbjct: 224 --ADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.1 bits (242), Expect = 2e-23
 Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 38/277 (13%)

Query: 72  FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGF----ER-----ELEAMG 121
           F     +G G +G+VY++    D+  +A+K       EVD G     ER     E+  + 
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALK-------EVDLGSMSQKEREDAVNEIRILA 54

Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
            + H NI++    +       ++ E  P G L   +  +   +K +     ++I +   R
Sbjct: 55  SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           G+  LH      I+HRD+KS+NILL  N   ++ D G++ ++   K +++    GT  Y+
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYM 168

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           APE +     + K D++S G +L E+ T   P       E           MQD R + V
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF------EARS--------MQDLRYK-V 213

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                   P     D+ +     L+ +P  RP   ++
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.4 bits (240), Expect = 3e-23
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 9/207 (4%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLH-RGTTEVDRGFE-RELEAMGDIKHRNI 128
           F   + IG G FG V+++    D   +A+K++        +R     E   +  +    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           +  +  +       ++ E   NG L   L  K    + L     ++  +    G+A+LH 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
                I+HRDIKS N+ LD     ++ D G+A L+       +TIV GT  YL+PE  + 
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCED 175

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMD 275
                K DV++ GVVL E  TGK P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.8 bits (238), Expect = 5e-23
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G    +  F  E + M  + H  +V L+G  T 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 138 SQYNLLIYELMPNGSLDTFLHGK--SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
                L++E M +G L  +L  +    +++ L       + +    G+AYL    +   I
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSNV---I 122

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HRD+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   + ++K 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 256 DVYSFGVVLLELLT-GKRPMD 275
           DV+SFGV++ E+ + GK P +
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.1 bits (239), Expect = 6e-23
 Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 41/281 (14%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLH--RGTT----EVDRGFERELEAMGDIKHRNIV 129
            +G+G F + Y+   V   T  AVK++   R T+    EV     +E+  M  + H +I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 130 TLHGYYT-SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
            + G     S +NL + E M  GS+   L      K+ +     Y   +   RG++YLH 
Sbjct: 67  RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAV--IINYTEQL--LRGLSYLHE 121

Query: 189 DCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI---VAGTFGYLAPE 244
           +    IIHRD+K +N+L+D      R++DFG A  + A+ T        + GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 245 YF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
                  GR+    DV+S G V++E+ T K P +         L+             + 
Sbjct: 179 VLRGEQYGRSC---DVWSVGCVIIEMATAKPPWNAEKHSNHLALI-------------FK 222

Query: 302 IDTSLEGCPINE--INDVFSIASMCLEPEPSKRPTMTEVVK 340
           I ++     I E     +  +   CLE +P  RP   E++K
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.8 bits (238), Expect = 1e-22
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 37/280 (13%)

Query: 78  IGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG V+       L   D    AVK L   +    + F+RE E +  ++H++IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLH-----------GKSVNKKNLDWPSRYKIAVGAA 180
           +G  T  +  L+++E M +G L+ FL            G+ V    L       IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFG 239
            G+ YL      H +HRD+ + N L+ Q +  ++ DFG++  +   +   V         
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           ++ PE     + T + D++SFGVVL E+ T GK+P  +    E  + +T  + + + +  
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR-- 247

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                     CP     +V++I   C + EP +R  + ++
Sbjct: 248 ---------TCP----PEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 41/285 (14%)

Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY             T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHG---KSVNKKNLDWPSRYKI---AVGAARGIA 184
           L G  ++ Q  L++ ELM  G L ++L     ++ N   L  P+  K    A   A G+A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAP 243
           YL        +HRD+ + N ++ +++  ++ DFG+   + E +             ++AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T K DV+SFGVVL E+ T  ++P      EE          V+     ++VI
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----------VL-----KFVI 235

Query: 303 DTSL----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           D       E CP    + +  +  MC +  P  RPT  E+V  L+
Sbjct: 236 DGGHLDLPENCP----DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 78  IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIVTLH 132
           +G GGFG V  + V   +  FA+K + +    V+ G +     E E + +  H  IV L+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL--DWPSRYKIAVGAARGIAYLHHDC 190
             +   +Y  ++ E    G L T L       + L  ++ +R+ IA        YLH+  
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILR-----DRGLFDEYTARFYIA-CVVLAFEYLHNR- 112

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTG 249
              II+RD+K  N+LLD N   ++ DFG A  ++  +KT   T   GT  Y+APE     
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII--- 164

Query: 250 RATAKG-----DVYSFGVVLLELLTGKRP 273
               KG     D +S G++L ELLTG+ P
Sbjct: 165 --LNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 49/235 (20%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRL-------HRGTTEVDRGFERELEAMGDI 123
           F    +IG G F TV        +  +A+K L        +    V    + E E +  +
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV----KIEKEVLTRL 58

Query: 124 K-HRNIVTLHGYYT-SSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIA--V 177
             H  I+ L  YYT   + NL  + E  PNG L  ++        +LD   +R+  A  +
Sbjct: 59  NGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEIL 112

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-----TLMEAEKTHVST 232
            A   + YLH      IIHRD+K  NILLD++M  +++DFG A               +T
Sbjct: 113 LA---LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 233 IVA--------------GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
            +               GT  Y++PE  +   A    D+++ G ++ ++LTGK P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 3e-22
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 33/210 (15%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIVTLH 132
           IG G +G VY+          A+K++ R   E + GF     RE++ +  ++H NIV L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI-RMENEKE-GFPITAIREIKLLQKLRHPNIVRLK 64

Query: 133 GYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR--------G 182
              TS       +++E M +  L   L    V           K      +        G
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV-----------KFTESQIKCYMKQLLEG 112

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           + YLH +    I+HRDIK SNIL++ +   +++DFGLA       +   T    T  Y  
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169

Query: 243 PE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           PE      R   + D++S G +L EL  GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 81/305 (26%), Positives = 132/305 (43%), Gaps = 46/305 (15%)

Query: 58  HSLQSDAIFKKTLKFSSKDVIGSGGFGTV-----YRLT-VNDSTAFAVKRLHRGTTEVDR 111
           H  + D + K+ L        G G FG V     Y L+   D    AVK L   T    +
Sbjct: 1   HIKRRDIVLKREL--------GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK 52

Query: 112 GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSV------- 162
            F+RE E + +++H +IV  +G        ++++E M +G L+ FL  HG          
Sbjct: 53  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112

Query: 163 ---NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL 219
               K  L       IA   A G+ YL      H +HRD+ + N L+  N+  ++ DFG+
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGM 169

Query: 220 A-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEA 277
           +  +   +   V         ++ PE     + T + DV+SFGV+L E+ T GK+P    
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---- 225

Query: 278 FLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE 337
           + +     V  ++ + Q +  E         CP     +V+ I   C + EP +R  + E
Sbjct: 226 WFQLSNTEV--IECITQGRVLE-----RPRVCP----KEVYDIMLGCWQREPQQRLNIKE 274

Query: 338 VVKML 342
           + K+L
Sbjct: 275 IYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 94.2 bits (234), Expect = 4e-22
 Identities = 82/283 (28%), Positives = 121/283 (42%), Gaps = 30/283 (10%)

Query: 77  VIGSGGFGTV--YRLT-VNDSTA--FAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           V+G G FG V  Y     ND T    AVK L R   + +  G+++E+  +  + H NIV 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 131 LHGYYTSS--QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             G  +    +   LI E +P GSL  +L    +N   L        A     G+AYLH 
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHS 125

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA--EKTHVSTIVAGTFGYLAPEYF 246
               H IHRD+ + N+LLD +   ++ DFGLA  +    E   V         + A E  
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 247 DTGRATAKGDVYSFGVVLLELLT------GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
              + +   DV+SFGV L ELLT            E  +      +T V+ +   +R   
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +       CP N   +V+ +   C E E   RPT   ++ +L+
Sbjct: 243 L------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.8 bits (230), Expect = 6e-22
 Identities = 81/274 (29%), Positives = 123/274 (44%), Gaps = 35/274 (12%)

Query: 78  IGSGGFGTVY--RLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G FG V+  RL   D+T  AVK   R T   ++   F +E   +    H NIV L G
Sbjct: 3   IGRGNFGEVFSGRLRA-DNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
             T  Q   ++ EL+  G   TFL   G  +  K L      ++   AA G+ YL     
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGMEYLESK-- 113

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST--IVAGTFGYLAPEYFDTG 249
            H IHRD+ + N L+ +    ++SDFG++   E +  + ST  +      + APE  + G
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 250 RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           R +++ DV+SFG++L E  + G  P              +     Q  RE       L  
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP--------------YANLSNQQTREAIEQGVRLP- 216

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           CP    + V+ +   C E +P +RP+ + V + L
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 8e-22
 Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 25/267 (9%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +GSG FG V+          A+K +  G    D   E E + M  + H N+V L+G  T 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSHPNLVQLYGVCTK 70

Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   ++ E M NG L  +L      K  L       +       + YL  +     IHR
Sbjct: 71  QRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF---IHR 124

Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ ++   +VSDFGLA  +  ++   S        +  PE FD  R ++K DV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA-VMQDKREEYVIDTSLEGCPINEIN 315
           +SFGV++ E+ + GK P +            +  + V++     Y +    +  P     
Sbjct: 185 WSFGVLMWEVFSEGKMPYE-----------RFSNSEVVESVSAGYRLYRP-KLAP----T 228

Query: 316 DVFSIASMCLEPEPSKRPTMTEVVKML 342
           +V++I   C   +P  RP   +++  L
Sbjct: 229 EVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 11/202 (5%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G+V ++  +   T  A K +H G  + V +   REL+ M + +   IV+ +G +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
            +     +  E M  GSLD     K      ++     KIAV    G+ YL++  +  I+
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILG--KIAVAVVEGLTYLYN--VHRIM 126

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HRDIK SNIL++   + ++ DFG++   E   +   T V GT  Y++PE    G+ T K 
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFV-GTSTYMSPERIQGGKYTVKS 183

Query: 256 DVYSFGVVLLELLTGKRPMDEA 277
           DV+S G+ ++EL  GK P   +
Sbjct: 184 DVWSLGISIIELALGKFPFAFS 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 77  VIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDR---------GFERELEAMGDIKH 125
           +IGSG FG+VY L +N S+    AVK++   +                 RE+  + +++H
Sbjct: 7   LIGSGSFGSVY-LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            NIV   G    + +  +  E +P GS+   L+    N    +            +G+ Y
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNY 121

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA-----GTFGY 240
           LH+     IIHRDIK +NIL+D     ++SDFG++  +EA      T  A     G+  +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           +APE       T K D++S G +++E+LTGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.8 bits (228), Expect = 2e-21
 Identities = 80/284 (28%), Positives = 122/284 (42%), Gaps = 54/284 (19%)

Query: 78  IGSGGFGTVYRLTVNDSTA-------FAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
           +GSG FG VY  T  D           AVK L +G T+ ++  F +E   M +  H NIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 130 TLHG--YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGAARGIA 184
            L G       QY  +I ELM  G L ++L    V +     L       I +  A+G  
Sbjct: 63  KLLGVCLLNEPQY--IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 185 YLHHDCIPHIIHRDIKSSNILL-----DQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTF 238
           YL      H IHRD+ + N L+     D +   ++ DFGLA  + +++            
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEGTKLVTWVK 290
            ++APE    G+ T + DV+SFGV++ E+LT G++P            +  G +L     
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL----- 232

Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT 334
                           E CP    + ++ + + C   +PS+RPT
Sbjct: 233 -------------QKPENCP----DKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 71/219 (32%), Positives = 102/219 (46%), Gaps = 21/219 (9%)

Query: 72  FSSKDV-----IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVD-RGFERELEA-MGDI 123
           F+++D+     IG G FGTV ++    S T  AVKR+     E + +    +L+  M   
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV-NKKNLDWPSRY--KIAVGAA 180
               IV  +G         +  ELM + SLD F   K V        P     KIAV   
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKFY--KYVYEVLKSVIPEEILGKIAVATV 117

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           + + YL  +    IIHRD+K SNILLD+N   ++ DFG++  +    +   T  AG   Y
Sbjct: 118 KALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPY 173

Query: 241 LAPEYFDTGRATA---KGDVYSFGVVLLELLTGKRPMDE 276
           +APE  D         + DV+S G+ L E+ TGK P  +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 7e-21
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)

Query: 75  KDVIGSGGFGTVYRLT----VNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
              IG G FG VY+       N+  A AVK     T+   R  F +E   M    H +IV
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T +    ++ EL P G L ++L    VNK +LD  S    +   +  +AYL   
Sbjct: 71  KLIGVITENPV-WIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESK 126

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
                +HRDI + N+L+      ++ DFGL+  +E E  + ++       ++APE  +  
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 250 RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           R T+  DV+ FGV + E+L  G +P               VK          VI     G
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF------------QGVK-------NNDVIGRIENG 224

Query: 309 ----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
                P N    ++S+ + C   +PSKRP  TE+   L  I  E
Sbjct: 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 9e-21
 Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 38/276 (13%)

Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           V+G G +G VY    ++     A+K +    +   +    E+     +KHRNIV   G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGK----SVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           + + +  +  E +P GSL   L  K      N++ + + ++  +      G+ YLH +  
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN-- 127

Query: 192 PHIIHRDIKSSNILLDQ-NMEARVSDFG----LATLMEAEKTHVSTIVAGTFGYLAPEYF 246
             I+HRDIK  N+L++  +   ++SDFG    LA +    +T       GT  Y+APE  
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQYMAPEVI 181

Query: 247 DTGRA--TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
           D G     A  D++S G  ++E+ TGK P    F+E G       K  M     E  I  
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP----FIELGEPQAAMFKVGMFKIHPE--IPE 235

Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           SL         +  +    C EP+P KR +  ++++
Sbjct: 236 SLS-------AEAKNFILRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHR 126
           +   + +G G +G VY+          A+K++     E   G      RE+  + ++KH 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE--GIPSTALREISLLKELKHP 58

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIAY 185
           NIV L     + +   L++E      L  +L         L  P+  K I     RG+AY
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLS-PNLIKSIMYQLLRGLAY 113

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPE 244
            H      I+HRD+K  NIL++++   +++DFGLA       +T+   +V  T  Y APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168

Query: 245 ------YFDTGRATAKGDVYSFGVVLLELLTGK 271
                 ++ T       D++S G +  E++TGK
Sbjct: 169 ILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.4 bits (222), Expect = 1e-20
 Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 44/281 (15%)

Query: 78  IGSGGFGTVYRLTVNDSTA----FAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG V R   + S       AVK L     +++   F +E   M  + H N++ L+
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G   +    +++ EL P GSL   L   ++    +     Y  AV  A G+ YL      
Sbjct: 63  GVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY--AVQIANGMRYLESK--- 116

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTI-VAGTFGYLAPEYFDTGR 250
             IHRD+ + NILL  + + ++ DFGL   L + E  +V    +   F + APE   T  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV--------KAVMQDKREEYV 301
            +   DV+ FGV L E+ T G+ P              W         K +  DK  E +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP--------------WAGLSGSQILKKI--DKEGERL 220

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                E CP     D++++   C    P+ RPT   + + L
Sbjct: 221 --ERPEACP----QDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 48/294 (16%)

Query: 78  IGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRNIV 129
           +G G FG V +         N+++  AVK L    TE D      E+E M  I KH+NI+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGK----SVNKKNLDWPSRYKI--------AV 177
            L G  T      ++ E   +G+L  FL  +         +   P    +        A 
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             ARG+ +L        IHRD+ + N+L+ ++   +++DFGLA  +     +  T    T
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT----T 192

Query: 238 FGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
            G L     APE       T + DV+SFGV+L E+ T G  P     +EE  KL+     
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL----- 247

Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                +E Y ++      P N   +++ +   C    PS+RPT  ++V+ L+ +
Sbjct: 248 -----KEGYRMEK-----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 17/208 (8%)

Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVD-----RGFERELEAMGDIKHRNIVT 130
           +G G FG VY L  +  T    AVK++       +        E E++ + +++H  IV 
Sbjct: 10  LGQGAFGRVY-LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
            +G     +   +  E MP GS+   L       + +      +I      G+ YLH + 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGYLAPEYFDT 248
              I+HRDIK +NIL D     ++ DFG +  ++   +  + +  V GT  +++PE    
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDE 276
                K DV+S G  ++E+LT K P  E
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAE 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)

Query: 72  FSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           F   + +G G +G+VY+ +        A+K +     E  +   +E+  +       IV 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAV---GAARGIAY 185
            +G Y  +    ++ E    GS+   +    K++ ++        +IA       +G+ Y
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE--------EIAAILYQTLKGLEY 114

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH +     IHRDIK+ NILL++  +A+++DFG++  +       +T V GT  ++APE 
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEV 170

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
                   K D++S G+  +E+  GK P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 47/296 (15%)

Query: 77  VIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIV 129
            +G G FG V + T          T  AVK L    +  + R    E   +  + H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLH------------GKSVNKKNLDWPSRYKIAV 177
            L+G  +     LLI E    GSL +FL               + N   LD P    + +
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 178 G--------AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
           G         +RG+ YL       ++HRD+ + N+L+ +  + ++SDFGL+  +  E ++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 230 VSTIVAGT-FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVT 287
           V          ++A E       T + DV+SFGV+L E++T G  P      E   +L  
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFN 240

Query: 288 WVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            +K   + +R            P N   +++++   C + EP KRPT  ++ K LE
Sbjct: 241 LLKTGYRMER------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 35/283 (12%)

Query: 72  FSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLH---RGTTEVDRGFERELEAMGDIKHRN 127
           F+    IG G FG VY    V  +   A+K++    + + E  +   +E++ +  IKH N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            +   G Y       L+ E     + D       V+KK L       I  GA +G+AYLH
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY-- 245
                ++IHRDIK+ NILL +  + +++DFG A++     + V     GT  ++APE   
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194

Query: 246 -FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
             D G+   K DV+S G+  +EL   K P+           +  + A+    + E     
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFN---------MNAMSALYHIAQNE---SP 242

Query: 305 SLEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVKMLELIK 346
           +L+    NE +D F +    CL+  P  RPT  E++K + +++
Sbjct: 243 TLQS---NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 87.6 bits (217), Expect = 8e-20
 Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 29/270 (10%)

Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLH 132
           ++++G G  GTVY+   +      AVK +    T E+ +    ELE +       I+  +
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G +       +  E M  GSLD +        + +      +IAV   +G+ YL      
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLM--EAEKTHVSTIVAGTFGYLAPEYFDTGR 250
            I+HRD+K SN+L++   + ++ DFG++T +     KT+V     GT  Y+APE     +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQ 169

Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
                DV+S G+  +EL  G+ P  +    +G+        +M  +  + ++D      P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGS--------LMPLQLLQCIVDEDPPVLP 221

Query: 311 INEINDVF-SIASMCLEPEPSKRPTMTEVV 339
           + + ++ F    + C+  +P +RP    ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 77/272 (28%), Positives = 122/272 (44%), Gaps = 37/272 (13%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRNIVTLH 132
           IG G FG VY  T N  T    AVK++     + +  ++   +E++ +  +KH N +   
Sbjct: 29  IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G Y       L+ E     + D       V+KK L       I  GA +G+AYLH   + 
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAITHGALQGLAYLHSHNM- 142

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY---FDTG 249
             IHRDIK+ NILL +  + +++DFG A+      + V     GT  ++APE     D G
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195

Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
           +   K DV+S G+  +EL   K P+           +  + A+    + +     +L+  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFN---------MNAMSALYHIAQND---SPTLQS- 242

Query: 310 PINEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
             NE  D F      CL+  P +RP   E+++
Sbjct: 243 --NEWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 51/284 (17%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           +G G +G V ++  V   T  AVKR+ R T    +  +R L  + DI  R   ++   YT
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVN-SQEQKRLLMDL-DISMR---SVDCPYT 62

Query: 137 SSQYNLLI--------YELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYL 186
            + Y  L          E+M + SLD F   K V  K L  P     KIAV   + + YL
Sbjct: 63  VTFYGALFREGDVWICMEVM-DTSLDKFY--KKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +IHRD+K SN+L+++N + ++ DFG++  +    +   TI AG   Y+APE  
Sbjct: 120 HSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERI 175

Query: 247 DTGRATA----KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           +          K DV+S G+ ++EL TG+ P D           +W     Q K+     
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPFQQLKQ----- 219

Query: 303 DTSLEGCPINEINDVFSI-----ASMCLEPEPSKRPTMTEVVKM 341
              +E        + FS       + CL+    +RP   E+++ 
Sbjct: 220 --VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 87/289 (30%), Positives = 133/289 (46%), Gaps = 38/289 (13%)

Query: 78  IGSGGFGTVYRLTVN---DSTA--FAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTL 131
           +G G FG V     +   D+T    AVK L   +        ++E+E + ++ H NIV  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 132 HGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            G  T    N   LI E +P+GSL  +L  ++ NK NL    +Y  AV   +G+ YL   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKY--AVQICKGMDYLGSR 128

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST---IVAGTFGYLAPEYF 246
                +HRD+ + N+L++   + ++ DFGL   +E +K + +    + +  F Y APE  
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184

Query: 247 DTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLE-----EGTKLVT-WVKAVMQDK 296
              +     DV+SFGV L ELLT       PM   FL+      G   VT  V+ + + K
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL-FLKMIGPTHGQMTVTRLVRVLEEGK 243

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           R            P N   +V+ +   C E +PSKR T   +++  E I
Sbjct: 244 RLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.1 bits (213), Expect = 2e-19
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD------RGFERELEAMGDIKHRNIV 129
           +V+G G +GTVY    N     AVK++   T+ V          + E++ +  +KH NIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 130 TLHGYYTSSQYNLL--IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
              G  T    N +    E +P GS+ + L+        L  P   K       G+AYLH
Sbjct: 66  QYLG--TCLDDNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA---TLMEAEKTHVSTI--VAGTFGYLA 242
           ++C+   +HRDIK +N++L  N   ++ DFG A     +    TH + +  + GT  ++A
Sbjct: 120 NNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           PE  +      K D++S G  + E+ TGK P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 86.7 bits (214), Expect = 2e-19
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 35/286 (12%)

Query: 75  KDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K  +G G FG V+           D    AVK L   +    + F RE E + +++H +I
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSV-------NKKNLDWPSRYKIAVGA 179
           V  +G        ++++E M +G L+ FL  HG              L       IA   
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTF 238
           A G+ YL      H +HRD+ + N L+ +N+  ++ DFG++  +   +   V        
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
            ++ PE     + T + DV+S GVVL E+ T GK+P  +    E  + +T  + V+Q  R
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPR 245

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                      CP     +V+ +   C + EP  R  + E+  +L+
Sbjct: 246 T----------CP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 69/289 (23%), Positives = 130/289 (44%), Gaps = 42/289 (14%)

Query: 77  VIGSGGFGTVYRLTVN-DSTAF---AVKRLH---RGTTEVDRGFERELEAMGDIKHRNIV 129
           ++G G FG+V    ++ D  +    AVK +       +E++  F  E   M D  H N++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE-EFLSEAACMKDFDHPNVM 64

Query: 130 TLHGY-YTSSQYN-----LLIYELMPNGSLDTFLHGKSV--NKKNLDWPSRYKIAVGAAR 181
            L G  + +S        ++I   M +G L +FL    +    + L   +  K  V  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE----KTHVSTIVAGT 237
           G+ YL +    + IHRD+ + N +L ++M   V+DFGL+  + +     +  ++ +    
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---P 178

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             ++A E       T+K DV++FGV + E+ T G+ P                  V   +
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY---------------PGVENHE 223

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
             +Y+   +    P + +++++ +   C   +P  RPT T++ ++LE I
Sbjct: 224 IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 78  IGSGGFGTVY--RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           IGSG +G VY  R         A+K +     +     ++E+  + + +H NIV   G Y
Sbjct: 11  IGSGTYGDVYKARDIATGELV-AIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA---VGAARGIAYLHHDCIP 192
                  ++ E    GSL        V +  L   S  +IA       +G+AYLH     
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQ---VTRGPL---SELQIAYVCRETLKGLAYLHET--- 120

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF---DTG 249
             IHRDIK +NILL ++ + +++DFG++  + A      + + GT  ++APE       G
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKG 179

Query: 250 RATAKGDVYSFGVVLLELLTGKRPM 274
               K D+++ G+  +EL   + PM
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPM 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 79/287 (27%), Positives = 112/287 (39%), Gaps = 43/287 (14%)

Query: 77  VIGSGGFGTVYRLTV----NDSTAFAVK-----RLHRGTTEVDRGFERELEAMGDIKHRN 127
            +G G FG VY         D+    V             E D  F  E   M    H+N
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD--FLMEALIMSKFNHQN 70

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY------KIAVGAAR 181
           IV L G         ++ ELM  G L +FL     N+   + PS          A   A+
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLR---ENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV---SDFGLAT-LMEAEKTHVSTIVAGT 237
           G  YL  +   H IHRDI + N LL      RV   +DFG+A  +  A            
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             ++ PE F  G  T+K DV+SFGV+L E+ + G  P      +E  + VT         
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------GGG 238

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           R +       +GCP      V+ I + C +  P  RP    +++ ++
Sbjct: 239 RLDPP-----KGCP----GPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 39/289 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGT-TEVDRG-FERELEAMGDIKHRN 127
            +   + IG G FGTV ++   +D      K +  G  TE ++     E+  + ++KH N
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 128 IVTLHGYY-----TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           IV    YY      S+Q   ++ E    G L   +      +K ++    ++I       
Sbjct: 61  IV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 183 IAYLHH--DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           +   H+  D    ++HRD+K +NI LD N   ++ DFGLA ++  + +   T V GT  Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYY 176

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           ++PE  +      K D++S G ++ EL     P       +   L + +K          
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIK---------- 223

Query: 301 VIDTSLEGCPINEI-----NDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
                 EG     I     +++  +    L  +P KRP+  E++++  +
Sbjct: 224 ------EG-KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 17/212 (8%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRNIVTLHG 133
           +G GGFG V    V  +   +A K+L +   +  +G +    E + +  +  R IV+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            + +     L+  LM  G  D   H  +V +           A     G+ +LH      
Sbjct: 61  AFETKDDLCLVMTLMNGG--DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---R 115

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I++RD+K  N+LLD +   R+SD GLA  L   +K       AGT GY+APE        
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYD 172

Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
              D ++ G  L E++ G+ P    F +   K
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP----FRQRKEK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 15/212 (7%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHG- 133
           + IG G +G VY++T     + A  ++    ++VD   E E   +  +  H N+V  +G 
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 134 YYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
           +Y + +       L+ EL   GS+   + G  +  + LD      I  GA  G+ +LH++
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               IIHRD+K +NILL      ++ DFG++  + + +   +T V GT  ++APE     
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 203

Query: 250 RA-----TAKGDVYSFGVVLLELLTGKRPMDE 276
           +       A+ DV+S G+  +EL  G  P+ +
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 1e-18
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 39/296 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE-----VDRGFERELEAMGDIK 124
           ++     +G G +  VY+          A+K++  G  +     ++    RE++ + ++K
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGI 183
           H NI+ L   +       L++E M    L+  +  KS+       P+  K   +   RG+
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLT----PADIKSYMLMTLRGL 115

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
            YLH +    I+HRD+K +N+L+  +   +++DFGLA    +    ++  V  T  Y AP
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171

Query: 244 EYFDTGRATAKG-DVYSFGVVLLELLTGK---------RPMDEAFLEEGTKLVTWVKAVM 293
           E     R    G D++S G +  ELL              + + F   GT        V 
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIAS--------MCLEPEPSKRPTMTEVVKM 341
                 YV        P+ +I   F  AS          L   P+KR T  + ++ 
Sbjct: 232 SLPD--YVEFKPFPPTPLKQI---FPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 81/296 (27%), Positives = 126/296 (42%), Gaps = 44/296 (14%)

Query: 75  KDVIGSGGFGTVYRLTVN---DSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRNIV 129
           +DVIG G FG V R  +         A+K L    +E D R F  ELE +  +  H NI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAV 177
            L G   +  Y  +  E  P G+L  FL    V                L      + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAG 236
             A G+ YL        IHRD+ + N+L+ +N+ ++++DFGL+     E+ +V  T+   
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS---RGEEVYVKKTMGRL 180

Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQD 295
              ++A E  +    T K DV+SFGV+L E+++ G  P        G       + + Q 
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC------GMTCAELYEKLPQG 234

Query: 296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV----KMLELIKS 347
            R E          P N  ++V+ +   C    P +RP   ++     +MLE  K+
Sbjct: 235 YRMEK---------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 35/286 (12%)

Query: 64  AIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           A+  K LK      IG G FG V  L        AVK +    T   + F  E   M  +
Sbjct: 2   ALNMKELKL--LQTIGKGEFGDVM-LGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQL 56

Query: 124 KHRNIVTLHGYYTSSQYNLLIY-ELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGAA 180
           +H N+V L G     +  L I  E M  GSL  +L   G+SV    L      K ++   
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVC 112

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
             + YL  +   + +HRD+ + N+L+ ++  A+VSDFGL    EA  T  +  +     +
Sbjct: 113 EAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKW 165

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
            APE     + + K DV+SFG++L E+ + G+ P     L++          V+    + 
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------VVPRVEKG 215

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           Y +D   +GCP      V+ +   C   + + RP+  ++ + LE I
Sbjct: 216 YKMDAP-DGCP----PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 81/300 (27%), Positives = 127/300 (42%), Gaps = 52/300 (17%)

Query: 75  KDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRNIV 129
           +DVIG G FG V +  +         A+KR+    ++ D R F  ELE +  +  H NI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAV 177
            L G      Y  L  E  P+G+L  FL    V                L        A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             ARG+ YL        IHRD+ + NIL+ +N  A+++DFGL+   E         V  T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181

Query: 238 FG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
            G     ++A E  +    T   DV+S+GV+L E+++ G  P              +   
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCGM 227

Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV----KMLELIKS 347
              +  E+      LE  P+N  ++V+ +   C   +P +RP+  +++    +MLE  K+
Sbjct: 228 TCAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLH---RGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G FG VY    V  +   A+K++    + + E  +   +E+  +  ++H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            Y       L+ E     + D       V+KK L       I  GA +G+AYLH      
Sbjct: 83  CYLREHTAWLVMEYCLGSASDIL----EVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY---FDTGR 250
            IHRDIK+ NILL +    +++DFG A+L+    + V     GT  ++APE     D G+
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQ 190

Query: 251 ATAKGDVYSFGVVLLELLTGKRPM 274
              K DV+S G+  +EL   K P+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.0 bits (205), Expect = 2e-18
 Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 46/283 (16%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRL--HRGTTEVDRGFERELEAMGDIKHRN 127
           K+    V+G G FG V+      D     +K++   + T +     + E + +  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN----KKNLDWPSRYKIAVGAARGI 183
           I+  +  +   +  +++ E  P G+L  ++  +  +       L +  +  +A       
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
             LHH     I+HRD+K+ NILLD++ M  ++ DFG++ ++ + K+   T+V GT  Y++
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYIS 169

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           PE  +      K D+++ G VL EL + KR    AF  E   L   V  +M         
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKR----AF--EAANLPALVLKIMSGT------ 217

Query: 303 DTSLEGCPINEINDVFS------IASMCLEPEPSKRPTMTEVV 339
                      I+D +S      I SM L  +PSKRP +++++
Sbjct: 218 --------FAPISDRYSPDLRQLILSM-LNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 83.2 bits (205), Expect = 3e-18
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 44/291 (15%)

Query: 76  DVIGSGGFGTVYRLTVND---STAFAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIVT 130
           DVIG G FG V +  +         A+KR+    ++ D R F  ELE +  + H  NI+ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVG 178
           L G      Y  L  E  P+G+L  FL    V                L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGT 237
            ARG+ YL        IHRD+ + NIL+ +N  A+++DFGL+     ++ +V  T+    
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRLP 174

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             ++A E  +    T   DV+S+GV+L E+++ G  P        G       + + Q  
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEKLPQGY 228

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV----KMLE 343
           R E          P+N  ++V+ +   C   +P +RP+  +++    +MLE
Sbjct: 229 RLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.6 bits (206), Expect = 3e-18
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 72  FSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           FS    IG G FG VY    V +S   A+K++     + +  ++   +E+  +  ++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            +   G Y       L+ E     + D       V+KK L       +  GA +G+AYLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY-- 245
                ++IHRD+K+ NILL +    ++ DFG A++M      V     GT  ++APE   
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184

Query: 246 -FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             D G+   K DV+S G+  +EL   K P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLH-GYY 135
           +G G FG VY+    ++  F A K +   + E    F  E++ + + KH NIV L+  Y+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 136 TSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             ++  +LI E    G+LD+ +    + + +  + +  R  +       + +LH      
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH---K 123

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTGRA 251
           +IHRD+K+ NILL  + + +++DFG++   ++      T + GT  ++APE    +T + 
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182

Query: 252 TA---KGDVYSFGVVLLELLTGKRP 273
                K D++S G+ L+EL   + P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 4e-18
 Identities = 62/203 (30%), Positives = 86/203 (42%), Gaps = 21/203 (10%)

Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF-----ERELEAMGDIKHRNIVT 130
           I  G FG+VY L    ST   FA+K L +              ER +  M   +   +  
Sbjct: 4   ISKGAFGSVY-LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAK 61

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L+  + S  Y  L+ E +  G   + +  K++     DW  +Y   V    G+  LH   
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEV--VLGVEDLHQR- 116

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              IIHRDIK  N+L+DQ    +++DFGL+      K  V     GT  YLAPE      
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVG 169

Query: 251 ATAKGDVYSFGVVLLELLTGKRP 273
                D +S G V+ E L G  P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 50/296 (16%)

Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK------------SVNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ L +      
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 198

Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 255

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 256 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 45/290 (15%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAF----AVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 3   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
            M  + + ++  L G   +S   L I +LMP G L  ++     +K N+         V 
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQ 117

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGT 237
            A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +      
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWV 289
             ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L    
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---- 230

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                               PI  I DV+ I   C   +   RP   E++
Sbjct: 231 -----------------PQPPICTI-DVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 72/289 (24%), Positives = 127/289 (43%), Gaps = 36/289 (12%)

Query: 72  FSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKH---R 126
           +   ++IG G +G VYR   V      A+K ++  T + D    +RE+  +  ++     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NI   +G Y       +I E    GS+ T +    + +K +    R  +       + Y+
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYI 117

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +IHRDIK++NIL+      ++ DFG+A L+    +  ST V GT  ++APE  
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173

Query: 247 DTGRA-TAKGDVYSFGVVLLELLTGKRPM--DEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             G+    K D++S G+ + E+ TG  P    +AF           +A+M       +  
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----------RAMM------LIPK 216

Query: 304 TSLEGCPINEIN-DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
           +       N  +  +    + CL+ EP +R +  E++K  + IK+    
Sbjct: 217 SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS-KWIKAHSKT 264

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 75/235 (31%), Positives = 109/235 (46%), Gaps = 44/235 (18%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKH 125
           KF     IG G +G VY+    D+    A+K++ R   E + GF     RE++ +  + H
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKE-GFPITAIREIKILRQLNH 65

Query: 126 RNIVTLHGYYTSSQYNL----------LIYELMPN---GSLDTFL------HGKSVNKKN 166
           RNIV L    T  Q  L          L++E M +   G L++ L      H KS  K+ 
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 167 LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE 226
           L+             G+ Y H     + +HRDIK SNILL+   + +++DFGLA L  +E
Sbjct: 126 LE-------------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 227 KTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE 280
           ++   T    T  Y  PE      R     DV+S G +L EL T K+P+ +A  E
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.8 bits (202), Expect = 7e-18
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 37/283 (13%)

Query: 76  DVIGSGGFGTVY--RLTVNDSTAFAVKRLH-------RGTTEVDRGFERELEAMGDIK-- 124
           + +GSG FG VY  R   N     A+K ++       +   E D+     +  +  IK  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 125 --HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--YKIAVGAA 180
             H NIV  +  +  +    ++ +L+    L    H  S+ +K   +     + I V   
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
             + YLH +    I+HRD+  +NI+L ++ +  ++DFGLA   + E    S  V GT  Y
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILY 179

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA-FLEEGTKLVTWVKAVMQDKREE 299
             PE         K DV++FG +L ++ T + P      L   TK+V            E
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV------------E 227

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            V +   EG    ++ DV    + CL P+   RP + +V  M+
Sbjct: 228 AVYEPLPEGMYSEDVTDVI---TSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRG----TTEVDRGFERELEAMGDIKHR 126
           F     +G+G FG V  +    S   +A+K L +       +V+     E   +  I+H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIRHP 61

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+G +       L+ E +P G L  F H +   +        Y   V  A  + YL
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQVVLA--LEYL 117

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      I++RD+K  N+LLD +   +++DFG A  ++  +T+  T+  GT  YLAPE  
Sbjct: 118 HSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTY--TLC-GTPEYLAPEII 170

Query: 247 ---DTGRATAKGDVYSFGVVLLELLTGKRP 273
                G+A    D ++ G+++ E+L G  P
Sbjct: 171 LSKGYGKAV---DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 34/282 (12%)

Query: 77  VIGSGGFGTVYR------LTVNDSTAFAVKRL-HRGTTEVDRGFERELEAMGDIKHRNIV 129
            +G G FG V+             T   VK L       +   F REL+    + H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFL-----HGKSVNKKNLDWPSRYKIAVGAARGIA 184
            L G    ++ + +I E    G L  FL       + +    L    +  +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLA 242
           +L +      +HRD+ + N L+    E +VS   L+            + ++     +LA
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--LRWLA 186

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           PE       + K DV+SFGV++ E+ T G+ P      EE       V   +Q  + E  
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKLELP 239

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +    EGCP      ++ + + C    P  RP+ +E+V  L 
Sbjct: 240 VP---EGCPSR----LYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 25/266 (9%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    V+G GGFG V    V  +   +A K+L +   +  +G      E + +  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V+L   Y +     L+  LM  G L    H   + +   +       A     G+  LH
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            +    I++RD+K  NILLD +   R+SD GLA  +   +T    +  GT GY+APE   
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVK 174

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV-TWVKAVMQDKREEYVIDTSL 306
             R T   D ++ G +L E++ G+ P    F +   K+    V+ ++++ +EEY    S 
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSP----FQQRKKKIKREEVERLVKEVQEEYSEKFS- 229

Query: 307 EGCPINEINDVFSIASMCLEPEPSKR 332
                    D  S+  M L  +P +R
Sbjct: 230 --------PDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)

Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HRD+ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---------------QGLSNEQVLKF 233

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P  RPT  E+V +L+
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 78  IGSGGFGTVYRLTV-NDSTAFAVKRLHR-GTTEVDRGFERELEAM---GDIKHRNIVTLH 132
           IGSG  G VY++         AVK++ R G  E ++    +L+ +    D  +  IV  +
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPY--IVKCY 80

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDC 190
           GY+ +     +  ELM    LD  L  K +       P     K+ V   + + YL    
Sbjct: 81  GYFITDSDVFICMELMST-CLDKLL--KRIQGP---IPEDILGKMTVAIVKALHYLKEK- 133

Query: 191 IPH-IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
             H +IHRD+K SNILLD +   ++ DFG++  +   K    T  AG   Y+APE  D  
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPP 189

Query: 250 RATAK----GDVYSFGVVLLELLTGKRPMDE 276
               K     DV+S G+ L+EL TG+ P   
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 51/288 (17%)

Query: 77  VIGSGGFG-----TVYRLTVNDST-AFAVKRL----HRGTTEVDRGFERELEAMGDI-KH 125
            +G+G FG     T Y L+ +D+    AVK L    H    E       EL+ M  +  H
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE---ALMSELKIMSHLGNH 98

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            NIV L G  T     L+I E    G L  FL  K   +  L        +   A+G+A+
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAF 156

Query: 186 L-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF---GYL 241
           L   +CI    HRD+ + N+LL      ++ DFGLA  +  +  +V            ++
Sbjct: 157 LASKNCI----HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK--GNARLPVKWM 210

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAFLEEGTKLVTWVKAVMQD 295
           APE       T + DV+S+G++L E+ + G  P     +D  F     KL+         
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY----KLI--------- 257

Query: 296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            +E Y +       P +   +++ I   C + +P KRPT  ++V+++ 
Sbjct: 258 -KEGYRMAQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 41/262 (15%)

Query: 115 RELEAMGDIKHRNIVTLHG-YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY 173
           REL+ + +     IV  +G +Y+  + ++ + E M  GSLD  L      KK    P   
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KKAGRIPENI 100

Query: 174 --KIAVGAARGIAYLH--HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
             KI++   RG+ YL   H     I+HRD+K SNIL++   E ++ DFG++   +   + 
Sbjct: 101 LGKISIAVLRGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSM 154

Query: 230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM---DEAFLE------ 280
            ++ V GT  Y++PE       T + D++S G+ L+E+  G+ P+   D   LE      
Sbjct: 155 ANSFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213

Query: 281 ----EGTKLVTWVKAVMQDKREEYVI----DTSLEGCPINEINDVFS-----IASMCLEP 327
               E  +    V     D      I    D  +   P    +  FS         CL+ 
Sbjct: 214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273

Query: 328 EPSKRPTMTEVVKMLELIKSEK 349
            P +R  + E+ K   + ++E 
Sbjct: 274 NPKERADLKELTKHPFIKRAEL 295

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 36/291 (12%)

Query: 72  FSSKDVIGSGGFGTVYR--LTVNDST--AFAVKRLHR---GTTEVDRGFERELEAMGDIK 124
           F+   ++G G FG+V    L   D +    AVK L      +++++  F RE   M +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE-FLREAACMKEFD 59

Query: 125 HRNIVTLHGYYTSSQYN------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--YKIA 176
           H N++ L G    S+        ++I   M +G L TFL    + ++    P +   +  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
           +  A G+ YL      + IHRD+ + N +L++NM   V+DFGL+  + +   +     + 
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 237 -TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
               +LA E       T   DV++FGV + E++T G+ P                  V  
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY---------------AGVEN 221

Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
            +   Y+I  +    P + + DV+ +   C  PEP  RP+   +   LELI
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 33/281 (11%)

Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHG---KSVNKKNLDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L     +  N      PS  K+   A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------QGMSNEQVLRFVM 235

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +  L   P N  + +F +  MC +  P  RP+  E++  ++
Sbjct: 236 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 24/215 (11%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVND---STAFAVKRLHR--GTTEVDRGFERELEA 119
           +F+ T ++     +G G FG V   +  D       A+K++ +   T  + +   REL+ 
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLV--CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL 62

Query: 120 MGDIKHRNIVTLHGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
           +  ++H NI++L   + S   ++  + EL+    L   L  + + K+ + +   Y+I   
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-FLYQIL-- 118

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGT 237
             RG+ Y+H      ++HRD+K SNIL+++N + ++ DFGLA + + + T +VST     
Sbjct: 119 --RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170

Query: 238 FGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGK 271
             Y APE   T  +   + D++S G +  E+L GK
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.8 bits (194), Expect = 7e-17
 Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 27/269 (10%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D   E E + M  + H  +V L+G  T 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMKLSHEKLVQLYGVCTK 70

Query: 138 SQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
            +   ++ E M NG L  +L  HGK      L      ++      G+AYL        I
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESK---QFI 122

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HRD+ + N L+D     +VSDFGL+  +  ++   S        +  PE     + ++K 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 256 DVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEI 314
           DV++FGV++ E+ + GK P +       ++ V  V   ++  R     +           
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE---RFNNSETVEKVSQGLRLYRPHLASEK---------- 229

Query: 315 NDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             V++I   C   +  +RPT  +++  +E
Sbjct: 230 --VYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 39/282 (13%)

Query: 78  IGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTL 131
           +G   FG +Y+       ++ +   A+K L         G F++E   M ++ H NIV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN-------------KKNLDWPSRYKIAVG 178
            G  T  Q   +++E +  G L  FL  +S +             K +LD      IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGT 237
            A G+ YL        +H+D+ + NIL+ + +  ++SD GL+  +  A+   V       
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             ++ PE    G+ ++  D++SFGVVL E+ + G +P      +E          V++  
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----------VIEMV 239

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
           R+  ++  S E CP      ++S+ + C +  PS+RP   ++
Sbjct: 240 RKRQLLPCS-EDCPPR----MYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 30/273 (10%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHG 133
           D +G G +G+VY+ L        A+K +     E        EL+ +       IV  +G
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            +       +  E M  GSLD  L+   V  + +      +I     +G+ +L  +   +
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAE--KTHVSTIVAGTFGYLAPEYFDTGRA 251
           IIHRD+K +N+L++ N + ++ DFG++  + A   KT++     G   Y+APE   +G  
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGP 178

Query: 252 TAKG------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
                     DV+S G+ +LE+  G+ P      E    +   + A         ++D  
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPP---ETYANIFAQLSA---------IVDGD 226

Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
               P    +D     + CL   P++RPT  ++
Sbjct: 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 79.6 bits (196), Expect = 9e-17
 Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 50/296 (16%)

Query: 78  IGSGGFGTVYRLTV--------NDSTAFAVKRLHRGTTEVDRG-FERELEAMGDI-KHRN 127
           +G G FG V R           + +   AVK L    T+ D      E+E M  I KH+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK------------SVNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  FL  +             V ++ L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +      +     
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH----DIDYYKK 192

Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            + G     ++APE       T + DV+SFG+++ E+ T G  P     +EE  KL+   
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL--- 249

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  RE + +D      P N  ++++ +   C    P++RPT  ++V+ L+ +
Sbjct: 250 -------REGHRMD-----KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 78.8 bits (194), Expect = 9e-17
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-----FER---ELEAMGDIKHRN 127
           +IG GGFG VY     D+   +A+K L +   ++ +G      ER    L + GD     
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF-- 58

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV +   + +      I +LM  G L   L    V        S  ++   AA  I  L 
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-------SEAEMRFYAAEIILGLE 111

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
           H     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+APE   
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168

Query: 248 TGRA-TAKGDVYSFGVVLLELLTGKRP 273
            G A  +  D +S G +L +LL G  P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 83/293 (28%), Positives = 125/293 (42%), Gaps = 50/293 (17%)

Query: 71  KFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLH-RGTTEVDRG-FERELEAMGDIKHRN 127
           K+    V+GSG  GTV     V+D   FAVK +   G +E D+   + E+  + +    +
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-- 185
           IV  H  +           LM    LD        N  +L    R +I   A     +  
Sbjct: 93  IVKCHEDFAKKDPRNPENVLMIALVLDY------ANAGDL----RQEIKSRAKTNRTFRE 142

Query: 186 -------------LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
                        +HH    H+IHRDIKS+NILL  N   ++ DFG + +  A    VS 
Sbjct: 143 HEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSD 199

Query: 233 IVAGTFG----YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW 288
            V  TF     Y+APE +     + K D++S GV+L ELLT KRP D   +EE       
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------- 252

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
              VM        +    +  P +   ++  I +  L  +P +RP+ ++++ M
Sbjct: 253 ---VMHK-----TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.0 bits (194), Expect = 1e-16
 Identities = 72/239 (30%), Positives = 117/239 (48%), Gaps = 29/239 (12%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAF----AVKRLHRGT-TEVDRGFERELE 118
           I K+T +     V+GSG FGTVY+ + V +        A+K L+  T  + +  F  E  
Sbjct: 3   ILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKI 175
            M  + H ++V L G   S    L + +LMP+G L  ++H    N  +   L+W      
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------ 114

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+E  EK + +   
Sbjct: 115 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E     + T + DV+S+GV + EL+T G +P D          LE+G +L
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR---LTVNDSTAF--AVKRLH-RGTTEVDRGFERELE 118
           I K+T +     ++GSG FGTV++   +   DS     A+K +  R   +  +     + 
Sbjct: 3   ILKET-ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
           AMG + H  IV L G    +   L + +L P GSL   +  H  S++ + L +W      
Sbjct: 62  AMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------ 114

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL    +   +HR++ + NILL  +   +++DFG+A L+   +K +  +  
Sbjct: 115 CVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-------GKRPMD-EAFLEEGTKL 285
                ++A E    GR T + DV+S+GV + E+++       G RP +    LE+G +L
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 78.6 bits (193), Expect = 1e-16
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 38/286 (13%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F+  + IG G FG V++   N +    A  +  L     E++   ++E+  +       +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 129 VTLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
              +G Y       +I E +  GS LD    G       LD      I     +G+ YLH
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLH 118

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            +     IHRDIK++N+LL ++ E +++DFG+A  +   +   +T V   F ++APE   
Sbjct: 119 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIK 174

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT--- 304
                +K D++S G+  +EL  G+ P  E                +   +  ++I     
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSE----------------LHPMKVLFLIPKNNP 218

Query: 305 -SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            +LEG   N    +      CL  EPS RPT  E++K   +++  K
Sbjct: 219 PTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 10/204 (4%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY    V      A+K+++            E+  M + KH NIV
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 77/296 (26%), Positives = 119/296 (40%), Gaps = 57/296 (19%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNI 128
            F   +VIG G +G VY+          A+K +     E +   + E   +     H NI
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKYSNHPNI 65

Query: 129 VTLHG-YYTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
            T +G +   +         L+ EL   GS+   + G     K L       I     RG
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           +AYLH +    +IHRDIK  NILL +N E ++ DFG++  +++     +T + GT  ++A
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMA 181

Query: 243 PE-----YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
           PE             A+ DV+S G+  +EL  GK P+ +                M   R
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD----------------MHPMR 225

Query: 298 EEYVIDTSLEGCPIN-------------EINDVFSIASMCLEPEPSKRPTMTEVVK 340
             + I       P N             + ND   I+  CL     +RP M E+++
Sbjct: 226 ALFKI-------PRNPPPTLKSPENWSKKFNDF--ISE-CLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 36/285 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F+  + IG G FG V++   N +    A  +  L     E++   ++E+  +       +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA---RGIAY 185
              +G Y       +I E +  GS    L     ++        ++IA       +G+ Y
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--------FQIATMLKEILKGLDY 116

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH +     IHRDIK++N+LL +  + +++DFG+A  +   +   +T V   F ++APE 
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
                  +K D++S G+  +EL  G+ P  +                M   R  ++I  +
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSD----------------MHPMRVLFLIPKN 216

Query: 306 LEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
                  E +  F      CL  +PS RPT  E++K   ++K+ K
Sbjct: 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.2 bits (190), Expect = 3e-16
 Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 23/266 (8%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +GSG FG V+          A+K ++ G    +   E E + M  + H  +V L+G  T 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE-EAKVMMKLSHPKLVQLYGVCTQ 70

Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   ++ E M NG L  +L  +   +  L       +      G+ YL  +     IHR
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124

Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+      +VSDFG+   +  ++   S+       +  PE F+  + ++K DV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ T GK P ++   +   ++V  +    +  R            P      
Sbjct: 185 WSFGVLMWEVFTEGKMPFEK---KSNYEVVEMISRGFRLYR------------PKLASMT 229

Query: 317 VFSIASMCLEPEPSKRPTMTEVVKML 342
           V+ +   C   +P  RPT  E+++ +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 32/280 (11%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLH---RGTTEVDRGFERELEAMGDIKHRN 127
           F  +  IG G F  VYR T + D    A+K++        +      +E++ +  + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           ++  +  +       ++ EL   G L   +      K+ +   + +K  V     + ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                 ++HRDIK +N+ +      ++ D GL     ++ T   ++V GT  Y++PE   
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                 K D++S G +L E+   + P                     DK   Y +   +E
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF------------------YGDKMNLYSLCKKIE 221

Query: 308 GCPINEI-NDVFS-----IASMCLEPEPSKRPTMTEVVKM 341
            C    + +D +S     + +MC+ P+P KRP +T V  +
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-----FER---ELEAMGDIKHRN 127
           +IG GGFG VY     D+   +A+K L +   ++ +G      ER    L + GD     
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF-- 58

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV-NKKNLDWPSRYKIAVGAARGIAYL 186
           IV +   + +      I +LM  G L   L    V ++K + +      A     G+ ++
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHM 113

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H+     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+APE  
Sbjct: 114 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167

Query: 247 DTGRA-TAKGDVYSFGVVLLELLTGKRPMDE 276
             G A  +  D +S G +L +LL G  P  +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 39/297 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLH--RGTTEVDRGFERELEAMGDIKHRN 127
           K+    V+G G +G V +     +    A+K+        +V +   RE++ +  ++H N
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV L   +       L++E +      T L     +   L   +         + IAY H
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 188 -HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-- 244
            H+    IIHRDIK  NIL+ ++   ++ DFG A  + A      T    T  Y APE  
Sbjct: 118 SHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173

Query: 245 --YFDTGRATAKGDVYSFGVVLLELLTGKRP-------MDEAFLEE---GTKLVTWVKAV 292
               + G+     DV++ G ++ ELL G  P       +D+ +L +   G    +  +  
Sbjct: 174 VGDTNYGKPV---DVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229

Query: 293 MQDKR-------EEYVIDTSLEGCPINEINDV-FSIASMCLEPEPSKRPTMTEVVKM 341
             + R       E    ++ LE     +++         CL  +P +R T  E+++ 
Sbjct: 230 SSNPRFAGVAFPEPSQPES-LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 44/295 (14%)

Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N     AVK L    T+ D      E+E M  I KH+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK------------SVNKKNLDWPSRYKI 175
           I+ L G  T      ++ E    G+L  +L  +             + ++ L +      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 176 AVGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           A   ARG+ YL    CI    HRD+ + N+L+ ++   +++DFGLA  +     +  T  
Sbjct: 140 AYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 235 AG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAV 292
                 ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+      
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL------ 249

Query: 293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
               +E + +D      P N  ++++ I   C    PS+RPT  ++V+ L+ + +
Sbjct: 250 ----KEGHRMDK-----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 80/293 (27%), Positives = 124/293 (42%), Gaps = 44/293 (15%)

Query: 78  IGSGGFGTVYRLTV--------NDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V              ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V  + + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 176 AVGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
               ARG+ YL    CI    HRD+ + N+L+ +N   +++DFGLA  +     +  T  
Sbjct: 143 TYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 235 AG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAV 292
                 ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+      
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------ 252

Query: 293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
               +E + +D      P N  N+++ +   C    PS RPT  ++V+ L+ I
Sbjct: 253 ----KEGHRMDK-----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 7e-16
 Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRN 127
            F+  + IG G FG VY+     +    A+K   L     E++   ++E++ +   +   
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSPY 60

Query: 128 IVTLHGYYTSSQYNL-LIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           I   +G +      L +I E    GS LD    GK      LD      I      G+ Y
Sbjct: 61  ITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEY 113

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH +     IHRDIK++NILL +  + +++DFG++  + +  +  +T V GT  ++APE 
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEV 169

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
                   K D++S G+  +EL  G+ P+ +         +  ++ +    +       S
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSD---------LHPMRVLFLIPKNN---PPS 217

Query: 306 LEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
           LEG   N+ +  F    S+CL  +P +RP+  E++K
Sbjct: 218 LEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHR--GTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +GSG +G V       +    A+K+L R   +    +   REL  +  + H N++ L   
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 135 YTSSQYN------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           +T +          L+  LM        L+     +K  D   ++ +     RG+ Y+H 
Sbjct: 83  FTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIHS 136

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPE-YF 246
                IIHRD+K SNI ++++ E ++ DFGLA   + E T +V      T  Y APE   
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 188

Query: 247 DTGRATAKGDVYSFGVVLLELLTGK 271
           +        D++S G ++ ELLTGK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.7 bits (186), Expect = 9e-16
 Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 37/277 (13%)

Query: 77  VIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           ++G+G FG + R    L        A+  L  G ++  R GF  E   +G   H NIV L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFL---HGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
            G  T     +++ E M NG+LD+FL    G+ V  + +       +  G A G+ YL  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYLSE 125

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL--APEYF 246
                 +H+ + +  +L++ ++  ++S F    L E +   + T ++G    L  APE  
Sbjct: 126 ---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
                ++  DV+SFG+V+ E+++ G+RP    + +   + V  +KAV    R        
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP----YWDMSGQDV--IKAVEDGFRLP------ 228

Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
               P N  N +  +   C + E  +RP  +++  +L
Sbjct: 229 ---APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 63/285 (22%), Positives = 107/285 (37%), Gaps = 32/285 (11%)

Query: 78  IGSGGFGTVYRL-TVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIVTLH 132
           IG G +G VY+          A+K++         G      RE++ + ++ H NI+ L 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLR--FESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             +       L++E M               ++ L             +G+A+ H     
Sbjct: 65  DVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            I+HRD+K  N+L++     +++DFGLA    +     +  V  T  Y APE     +  
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176

Query: 253 AKG-DVYSFGVVLLELLT------GKRPMDEAFLEEGTKLVTWVKAVMQD----KREEYV 301
           +   D++S G +  ELL+      GK  +D+ F    T L T    V        R    
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT-LGTPDPEVWPKFTSLARNYKF 235

Query: 302 IDTSLEGCPINEI-----NDVFSIASMCLEPEPSKRPTMTEVVKM 341
                 G P+ ++          + S  L  +P KR T  + +  
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 54/282 (19%)

Query: 78  IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFE-----------RELEAMGDIKH 125
           IG G F  VY+     D    A+K++        + FE           +E++ +  + H
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKV--------QIFEMMDAKARQDCLKEIDLLKQLDH 61

Query: 126 RNIVTLHGYYTSSQYN---LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
            N++    Y  S   N    ++ EL   G L   +      K+ +   + +K  V     
Sbjct: 62  PNVIK---YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           + ++H      I+HRDIK +N+ +      ++ D GL     ++ T   ++V GT  Y++
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           PE         K D++S G +L E+   + P                     DK   Y +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF------------------YGDKMNLYSL 216

Query: 303 DTSLEGCPINEI-NDVFS-----IASMCLEPEPSKRPTMTEV 338
              +E C    +  D +S     + S C+ P+P KRP ++ V
Sbjct: 217 CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 68  KTLKFSSKD-----VIGSGGFGTVYRLTVNDS-TAFAVKRLHR--GTTEVDRGF---ERE 116
             L+  ++D     VIG G FG V  +    S   +A+K L +       D  F   ER+
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 117 LEAMGDIKHRN---IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY 173
           + A     H N   IV LH  +   +Y  ++ E MP G L   +    + +K   W   Y
Sbjct: 96  IMA-----HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---WARFY 147

Query: 174 KIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI 233
              V  A  +  +H       IHRD+K  N+LLD++   +++DFG    M+A        
Sbjct: 148 TAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202

Query: 234 VAGTFGYLAPEYFDTGRATA----KGDVYSFGVVLLELLTGKRP 273
             GT  Y++PE   +         + D +S GV L E+L G  P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           I  G +G V+ L    ST   +A+K + +         ++   E + +   +   +V L 
Sbjct: 1   ISKGAYGRVF-LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58

Query: 133 GYYT-SSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHH 188
            YY+   + NL L+ E +P G L + L   +V   + D    Y  +I +     + YLH 
Sbjct: 59  -YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLA----LEYLHS 111

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGL--------ATLMEAEKTHVSTIVAGTFGY 240
           +    IIHRD+K  NIL+D N   +++DFGL           +  ++     IV GT  Y
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDY 167

Query: 241 LAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRP 273
           +APE    G+  +K  D +S G +L E L G  P
Sbjct: 168 IAPEVI-LGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 34/293 (11%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAF---------------AVKRLHRGTTEVDRG-FERELE 118
           K+ +G G FG V+         F               AVK L    T+  R  F +E++
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKK-----NLDWPSRY 173
            M  +K+ NI+ L G   S     +I E M NG L+ FL  + +        N+   S  
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 174 KI---AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTH 229
            +   AV  A G+ YL      + +HRD+ + N L+  +   +++DFG++  L   +   
Sbjct: 130 NLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWV 289
           +         ++A E    G+ T   DV++FGV L E+ T  +    + L +   +    
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           +      R+ Y+  T L  CP    + VF +   C   +   RPT  ++   L
Sbjct: 247 EFFRNQGRQIYLSQTPL--CP----SPVFKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 20/206 (9%)

Query: 77  VIGSGGFGTVY---RLTVNDS-TAFAVKRLHRGTTEV-DR---GFERELEAMGDIKHRNI 128
           V+G G FG V+   ++T  D+   +A+K L + T +V DR     ER++  + ++ H  I
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI--LAEVNHPFI 60

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V LH  + +     LI + +  G L T L  K V     D   ++ +A   A  + +LH 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEED--VKFYLA-ELALALDHLHS 116

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYLAPEYFD 247
                II+RD+K  NILLD+    +++DFGL+   ++ EK   S    GT  Y+APE  +
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVN 171

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
               T   D +SFGV++ E+LTG  P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGY 134
           IG G  G V++    ++    A+K++     E  +     RE++A+   +H  +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR----GIAYLHHDC 190
           +      +L+ E MP   L   L       ++ + P          R    G+AY+H + 
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVL-------RDEERPLPEAQVKSYMRMLLKGVAYMHAN- 118

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              I+HRD+K +N+L+  +   +++DFGLA L   E+  + +    T  Y APE     R
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 251 ATAKG-DVYSFGVVLLELLTG 270
               G D+++ G +  ELL G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 38/286 (13%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F+  + IG G FG VY+   N +    A  +  L     E++   ++E+  +       I
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYI 64

Query: 129 VTLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
              +G Y       +I E +  GS LD    G       L+      I     +G+ YLH
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILREILKGLDYLH 118

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            +     IHRDIK++N+LL +  + +++DFG+A  +   +   +T V   F ++APE   
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIK 174

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT--- 304
                 K D++S G+  +EL  G+ P  +                +   R  ++I     
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSD----------------LHPMRVLFLIPKNSP 218

Query: 305 -SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            +LEG       +       CL  +P  RPT  E++K   + +  K
Sbjct: 219 PTLEGQYSKPFKE---FVEACLNKDPRFRPTAKELLKHKFITRYTK 261

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.6 bits (187), Expect = 2e-15
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 37/215 (17%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT-TEVD--RGFERELEAMGDIKHRNIVTLH 132
            IGSG +G V       +    A+K++       +D  R   RE++ +  ++H NI+ L 
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLL 65

Query: 133 GYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIAYL 186
                          ++ ELM     +T LH    + + L      +       RG+ YL
Sbjct: 66  DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLKYL 119

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EAEKTHVSTIVAGTFGYLAP 243
           H     ++IHRD+K SNIL++ N + ++ DFGLA  +   E EK  ++  V  T  Y AP
Sbjct: 120 HS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAP 175

Query: 244 E-------YFDTGRATAKGDVYSFGVVLLELLTGK 271
           E       Y      T   D++S G +  ELLT K
Sbjct: 176 ELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 10/204 (4%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTV+    V      A+K+++            E+  M ++K+ NIV
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                +       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDV-----VTETCMDEAQIAAVCRECLQALEFLHAN 134

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS N+LL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 135 ---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 78  IGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFEREL---EAMGDIKHRNIVTLHG 133
           +G GGFG V  + V N    +A K+L +   +   G +  L   E +  +    IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            + S  +  L+  LM  G L    H  +V ++ L+       +     GI +LH      
Sbjct: 61  AFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           I++RD+K  N+LLD     R+SD GLA  ++  KT   T  AGT GY+APE       + 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173

Query: 254 KGDVYSFGVVLLELLTGKRP 273
             D ++ G  + E++ G+ P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRL-HRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V ++    S     ++L H       R    REL+ + +     IV  +G +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 136 TSSQYNLLIYELMPNGSLDTFL-HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            S     +  E M  GSLD  L   K + ++ L      K+++   RG+AYL       I
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--HQI 125

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV 181

Query: 254 KGDVYSFGVVLLELLTGKRPM 274
           + D++S G+ L+EL  G+ P+
Sbjct: 182 QSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 74.2 bits (182), Expect = 3e-15
 Identities = 80/282 (28%), Positives = 123/282 (43%), Gaps = 41/282 (14%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRN 127
           ++     IG G FG +Y      DS    +K   L +   +     ++E+  +  +KH N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 128 IVTLHGYYTSSQYN---LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA---VGAAR 181
           IVT   ++ S Q N    ++ E    G L      K +N++     S  +I    V  + 
Sbjct: 61  IVT---FFASFQENGRLFIVMEYCDGGDL-----MKRINRQRGVLFSEDQILSWFVQISL 112

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           G+ ++H      I+HRDIKS NI L +N M A++ DFG+A  +  +   ++    GT  Y
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYY 168

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           L+PE         K D++S G VL EL T K P       EG  L   V  + Q      
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF------EGNNLHQLVLKICQGYFA-- 220

Query: 301 VIDTSLEGCPI--NEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                    PI  N   D+ S+ S   +  P  RP++T ++K
Sbjct: 221 ---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 25/268 (9%)

Query: 78  IGSGGFGTVYRL-TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IGSG +G VY+   VN     A+K +     E     ++E+  M D KH NIV   G Y 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 137 SSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
                 +  E    GSL    H    +++  + + SR  +     +G+ YLH       +
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK---GKM 128

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HRDIK +NILL  N   +++DFG++  + A      + + GT  ++APE     R     
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187

Query: 256 ---DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
              D+++ G+  +EL   + PM +  L     L    K+  Q  + +  +  S       
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD--LHPMRALFLMTKSNFQPPKLKDKMKWS------- 238

Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
             N       M L   P KRPT  ++++
Sbjct: 239 --NSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.0 bits (181), Expect = 7e-15
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + +      A+K+++            E+  M + K+ NIV
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALDFLHSN 134

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLH------RGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V  + + ++   +A+K L+      R  T   R  ER++   GD   R I 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFRE-ERDVLVNGD--RRWIT 64

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAYLH 187
            LH  +       L+ +    G L T L  K  ++   D  +R+ +A  V A   +  L 
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDM-ARFYLAEMVLAIDSVHQLG 122

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
           +      +HRDIK  N+LLD+N   R++DFG    + A+ T  S +  GT  Y++PE   
Sbjct: 123 Y------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 248 -----TGRATAKGDVYSFGVVLLELLTGKRP 273
                 GR   + D +S GV + E+L G+ P
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 75/274 (27%), Positives = 113/274 (41%), Gaps = 41/274 (14%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMG--------D 122
           F    V+G GGFG V    V  +   +A K+L     E  R  +R+ EAM          
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKL-----EKKRIKKRKGEAMALNEKQILEK 56

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA--A 180
           +  R +V+L   Y +     L+  LM  G L   ++    N  N  +     +   A   
Sbjct: 57  VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFYAAEIT 112

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
            G+  LH +    I++RD+K  NILLD     R+SD GLA  +   +T    +  GT GY
Sbjct: 113 CGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGY 167

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW--VKAVMQDKRE 298
           +APE     R T   D +  G ++ E++ GK P       +  + V    V+  +++ +E
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP-----FRQRKEKVKREEVERRVKEDQE 222

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKR 332
           EY    S             SI    L  +P  R
Sbjct: 223 EYSEKFS---------EAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH-RNIVT 130
           F   +V+G+G +G VY+     +   A  ++   T + +   + E+  +    H RNI T
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 131 LHGYYTSSQYN------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
            +G +             L+ E    GS+   +     N    DW +   I     RG+A
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLA 135

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           +LH      +IHRDIK  N+LL +N E ++ DFG++  ++      +T + GT  ++APE
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 191

Query: 245 YF---DTGRAT--AKGDVYSFGVVLLELLTGKRPM 274
                +   AT   + D++S G+  +E+  G  P+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 32/272 (11%)

Query: 78  IGSGGFGTVYRLTVNDSTAFA------VKRLHRGTTEVDRGFERELEA--MGDIKHRNIV 129
           +G G FGTVY   V D  A A      +K +  G    +   +   EA  +  + H  IV
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
             H  +       +I E      LD  L       K L      +  +    G+ Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               I+HRD+K+ NI L  N+  ++ DFG++ L+      ++T   GT  Y++PE     
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALKHQ 180

Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT-SLEG 308
              +K D++S G +L E+      +  AF  EG   ++ V  +++         T SL  
Sbjct: 181 GYDSKSDIWSLGCILYEMCC----LAHAF--EGQNFLSVVLRIVEG-------PTPSLPE 227

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
               ++N   SI    L  +PS RP+  E+++
Sbjct: 228 TYSRQLN---SIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 23/223 (10%)

Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLH 132
           +GSG FG V    Y++        A+K L     +  R    RE E M  + +  IV + 
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G    ++  +L+ E+   G L+ FL GK   K  +   +  ++    + G+ YL      
Sbjct: 62  GV-CEAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK--- 114

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF--GYLAPEYFDTGR 250
           + +HRD+ + N+LL     A++SDFGL+  + A+ ++     AG +   + APE  +  +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEGTKL 285
            +++ DV+S+G+ + E  + G++P  +       +F+E+G +L
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           V+G G FG    +  VN    +A+K  RL + ++ V+    +E   +  +KH NIV    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKE 65

Query: 134 YYTSSQYNLLIYELMPNGSLDTFL---HGKSVNKKN-LDWPSRYKIAVGAARGIAYLHHD 189
            + +  +  ++ E    G L   +    GK   +   L W       V    G+ ++H  
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK 119

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               ++HRDIKS NI L QN + ++ DFG A L+ +   +  T V GT  Y+ PE ++  
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G +L EL T K P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGFG V    +  +   +A K+L++   +  +G+E    E   +  +  R IV+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA--RGIAYLHHDCI 191
            + +     L+  +M  G  D   H  +V+++N  +P        A    G+ +LH    
Sbjct: 61  AFQTKTDLCLVMTIMNGG--DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             II+RD+K  N+LLD +   R+SD GLA  ++  ++      AGT G++APE       
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG-YAGTPGFMAPELLQGEEY 174

Query: 252 TAKGDVYSFGVVLLELLTGKRP 273
               D ++ GV L E++  + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 72/230 (31%), Positives = 106/230 (46%), Gaps = 26/230 (11%)

Query: 72  FSSKDVIGSGGFGTVYRLTV-NDSTAFAVK------RLHRGTTEVDRGFERELEAMGDIK 124
           F    VIG G FG V  + + +    +A+K       L R  T   R  ER +   GD +
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE-ERNVLVNGDCQ 61

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARG 182
              I TLH  +    Y  L+ +    G L T L  K  ++   D  +R+ IA  V A   
Sbjct: 62  W--ITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDM-ARFYIAEMVLAIHS 117

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           I  LH+      +HRDIK  N+LLD N   R++DFG    M  + T  S++  GT  Y++
Sbjct: 118 IHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 243 PEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPM-DEAFLEEGTKLV 286
           PE         G+   + D +S GV + E+L G+ P   E+ +E   K++
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 10/197 (5%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH      +IH
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQ---GVIH 139

Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E     ++V GT  ++APE         + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198

Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRL-HRGTTEVDRG-FERELEAMGDIKHRNIV 129
           F     +G+G  G V++++   S     ++L H       R    REL+ + +     IV
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLH 187
             +G + S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE  
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 174

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
                + + D++S G+ L+E+  G+ P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 78  IGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           IG G +G VYR    T  +  A    R+      +     RE+  + +++H NIV L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 135 YTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWP---SRYK-IAVGAARGIAYLHH 188
                 +   L+ E      L + L        N+  P   S+ K + +   RG+ YLH 
Sbjct: 75  VVGKHLDSIFLVMEYCEQ-DLASLL-------DNMPTPFSESQVKCLMLQLLRGLQYLHE 126

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFD 247
           + I   IHRD+K SN+LL      +++DFGLA         ++  V  T  Y APE    
Sbjct: 127 NFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLG 182

Query: 248 TGRATAKGDVYSFGVVLLELLTGK 271
               T   D+++ G +L ELL  K
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 71/265 (26%), Positives = 111/265 (41%), Gaps = 23/265 (8%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    V+G GGFG V    V  +   +A K+L +   +  +G      E   +  +  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V+L   Y +     L+  +M  G L    H  ++     D       A     G+  L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            +    I++RD+K  NILLD     R+SD GLA  +   +T    +  GT GY+APE  +
Sbjct: 120 RE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVIN 174

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
             + T   D +  G ++ E++ G+ P  +   +E  K     + V +D+ EEY    S  
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKR--KERVKREEVDRRVKEDQ-EEYSEKFS-- 229

Query: 308 GCPINEINDVFSIASMCLEPEPSKR 332
                   D  SI  M L   P +R
Sbjct: 230 -------EDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 8/198 (4%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLH--RGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           V+G G +G V  +    D   + +K+L+    +    +  E+E + +  +KH NIV    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            +      L I      G  D +   K    K L      +  V  A  + YLH     H
Sbjct: 67  SWEGEDGLLYIVMGFCEGG-DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           I+HRD+K+ N+ L +    +V D G+A ++E +    ST++ GT  Y++PE F       
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNY 181

Query: 254 KGDVYSFGVVLLELLTGK 271
           K DV++ G  + E+ T K
Sbjct: 182 KSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVKRLH------RGTTEVDRGFERELEAMGDIKHRNIV 129
           ++G G FG VY     +     AVK++         + EV+   E E++ + ++ H  IV
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN-ALECEIQLLKNLLHERIV 67

Query: 130 TLHGYYTSSQYNLL--IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             +G         L    E MP GS+   L       +N+    +Y   +    G++YLH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT--RKYTRQI--LEGVSYLH 123

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA---EKTHVSTIVAGTFGYLAPE 244
            + I   +HRDIK +NIL D     ++ DFG +  ++      T + + V GT  +++PE
Sbjct: 124 SNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPE 179

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
                    K D++S G  ++E+LT K P  E
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 70/230 (30%), Positives = 107/230 (46%), Gaps = 26/230 (11%)

Query: 72  FSSKDVIGSGGFGTVYRLTV-NDSTAFAVK------RLHRGTTEVDRGFERELEAMGDIK 124
           F    VIG G FG V  + + N    FA+K       L R  T   R  ER++   GD  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-ERDVLVNGD-- 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARG 182
           ++ I TLH  +       L+ +    G L T L  K  ++   D  +R+ +A  V A   
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDM-ARFYLAEMVIAIDS 117

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           +  LH+      +HRDIK  NIL+D N   R++DFG    +  + T  S++  GT  Y++
Sbjct: 118 VHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 243 PEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPM-DEAFLEEGTKLV 286
           PE         G+   + D +S GV + E+L G+ P   E+ +E   K++
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 35/282 (12%)

Query: 78  IGSGGFGTVY--RLTVNDST-AFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG+V   +L  +DS    AVK +       +E++  F  E   M +  H N++ L
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65

Query: 132 HGYYTSSQYN------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGI 183
            G    +  +      ++I   M +G L +FL    +       P++   K     A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLA 242
            YL        IHRD+ + N +L++NM   V+DFGL+  +   +      I      ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
            E       T K DV+SFGV + E+ T G+ P       E +++  +++   + K+    
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLRQGNRLKQ---- 235

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                   P + ++ ++S+ S C    P  RP+   +   LE
Sbjct: 236 --------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVKRL-----HRGTTEVDRGFERELEAMGDIKHRNIVT 130
           ++G G FG VY     +     AVK++      + T++     E E++ + +++H  IV 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 131 LHG-YYTSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
            +G      +  L I+ E MP GS+   L       +N+    RY   +   +G++YLH 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT--RRYTRQI--LQGVSYLHS 124

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGYLAPEYF 246
           + I   +HRDIK +NIL D     ++ DFG +  ++      + I  V GT  +++PE  
Sbjct: 125 NMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
                  K DV+S    ++E+LT K P  E
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.9 bits (173), Expect = 6e-14
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + V      A+++++            E+  M + K+ NIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 51/293 (17%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLT-----VNDSTAFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +     V+GSG FGTVY+        N     A+K L   T+ + ++    E  
Sbjct: 3   ILKET-ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKI 175
            M  +    +  L G   +S   L + +LMP G L  ++     +  ++  L+W      
Sbjct: 62  VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------ 114

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            V  A+G++YL       ++HRD+ + N+L+      +++DFGLA L++ ++T       
Sbjct: 115 CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 171

Query: 236 GT-FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLV 286
                ++A E     R T + DV+S+GV + EL+T G +P D          LE+G +L 
Sbjct: 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP 231

Query: 287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                                  P     DV+ I   C   +   RP   E+V
Sbjct: 232 Q----------------------PPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 7e-14
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 18/215 (8%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH-RNIVT 130
           F   +++G+G +G VY+     +   A  ++   T + +   ++E+  +    H RNI T
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 131 LHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
            +G +             L+ E    GS+   +     N    +W +   I     RG++
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           +LH      +IHRDIK  N+LL +N E ++ DFG++  ++      +T + GT  ++APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181

Query: 245 YF---DTGRATA--KGDVYSFGVVLLELLTGKRPM 274
                +   AT   K D++S G+  +E+  G  P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 38/283 (13%)

Query: 72  FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH---RGTTEVDRGFERELEAMGDIKHRN 127
           F  +  IG G F  VYR T   D    A+K++        +  +   +E++ +  + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 128 IVT-LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--YKIAVGAARGIA 184
           ++  L  +   ++ N+++ EL   G L   +  K   K+    P R  +K  V     + 
Sbjct: 64  VIKYLDSFIEDNELNIVL-ELADAGDLSQMI--KYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           ++H      ++HRDIK +N+ +      ++ D GL     ++ T   ++V GT  Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                    K D++S G +L E+   + P                     DK   + +  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF------------------YGDKMNLFSLCQ 218

Query: 305 SLEGC-----PINEINDVF-SIASMCLEPEPSKRPTMTEVVKM 341
            +E C     P    ++    + SMC+ P+P +RP +  V ++
Sbjct: 219 KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRG--TTEVDRGFERELEAMGDIKHRN 127
           K+ +  ++G G +G V +    ++    A+K+         V +   RE+  +  ++H N
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V L   +   +   L++E + +  LD            LD     K      RGI + H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCH 117

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF- 246
                +IIHRDIK  NIL+ Q+   ++ DFG A  + A     +  VA T  Y APE   
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLV 173

Query: 247 -DT--GRATAKGDVYSFGVVLLELLTG 270
            DT  GRA    D+++ G ++ E+LTG
Sbjct: 174 GDTKYGRAV---DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 49/304 (16%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-----------------AVKRLHRGTTEV 109
           ++ L F  K  +G G FG V+    +    F                 AVK L    ++ 
Sbjct: 4   RQPLNFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 110 DRG-FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-------GKS 161
            R  F +E++ +  +   NI  L G  T      +I E M NG L+ FL        G +
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 162 VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA- 220
            N K+L + +   +A   A G+ YL      + +HRD+ + N L+ +N   +++DFG++ 
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----M 274
            L  ++   V         ++A E    G+ T K DV++FGV L E+LT  +        
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 275 DEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT 334
           D+  +E              D R+ Y+       CP     D++ +   C   +   RPT
Sbjct: 239 DQQVIENAGHFFR------DDGRQIYLPRPP--NCP----KDIYELMLECWRRDEEDRPT 286

Query: 335 MTEV 338
             E+
Sbjct: 287 FREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 11/206 (5%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    V+G GGFG V    V  +   +A KRL +   +  +G      E + +  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V L   Y +     L+  +M  G L    H  ++     +       A     G+  LH
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            +   + ++RD+K  NILLD     R+SD GLA  +   ++    +  GT GY+APE  +
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLN 174

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
             R T   D +  G ++ E++ G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 39/245 (15%)

Query: 108 EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL 167
                F      M  + H+++V L+G       N+++ E +  G LD FLH +  N  +L
Sbjct: 43  RDSLAFFETASLMSQLSHKHLVKLYGV-CVRDENIMVEEYVKFGPLDVFLH-REKNNVSL 100

Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNME----ARVSDFGLA 220
            W  +  +A   A  + YL       ++H ++   NIL+     N       ++SD G+ 
Sbjct: 101 HW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Query: 221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA--TAKGDVYSFGVVLLELLT-GKRPMDEA 277
             + + +  V  I      ++APE    G+A  T   D +SFG  LLE+ + G+ P+   
Sbjct: 156 ITVLSREERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210

Query: 278 FLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE 337
              E              K   Y     L   P+ +  ++ ++ + C   +P+KRP+   
Sbjct: 211 SSSE--------------KERFYQDQHRL---PMPDCAELANLINQCWTYDPTKRPSFRA 253

Query: 338 VVKML 342
           +++ L
Sbjct: 254 ILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 81/301 (26%), Positives = 127/301 (42%), Gaps = 57/301 (18%)

Query: 78  IGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHG 133
           IG GG G VY       S   A+K++    +E   + + F RE +   D+ H  IV ++ 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 134 YYTSSQYNLLIYELMP---NGSLDTFLHGKSV-NKKNLDWPSRYKIAVGA--------AR 181
             +       +Y  MP     +L + L  KSV  K++L      K +VGA          
Sbjct: 70  ICSDGD---PVYYTMPYIEGYTLKSLL--KSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI-------- 233
            I Y+H      ++HRD+K  NILL    E  + D+G A   + E+  +  I        
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 234 ---------VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
                    + GT  Y+APE      A+   D+Y+ GV+L ++LT   P      ++G K
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR---KKGRK 238

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS-IASMCLEPEPSKR-PTMTEVVKML 342
           +               VI + +E  P  EI    S IA   L  +P++R  ++ E+ + L
Sbjct: 239 IS-----------YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287

Query: 343 E 343
           E
Sbjct: 288 E 288

Length = 932

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 10/197 (5%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   T   +    AVK++     +       E+  M D  H N+V ++  Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   R ++YLH+     +IH
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQ---GVIH 141

Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E     ++V GT  ++APE         + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200

Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 63/244 (25%), Positives = 99/244 (40%), Gaps = 38/244 (15%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR---GTTEVDRGFERELEAMGDIKHR 126
           F  K ++G G FG V ++    +T   +A+K + +      E    FE E + +      
Sbjct: 3   FDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-------IAVGA 179
            I  L   +       L+ E  P G L + L             +RY+            
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-------------NRYEDQFDEDMAQFYL 108

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           A  +  +H       +HRDIK  N+L+D+    +++DFG A  + A K   S +  GT  
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 240 YLAPEYFDTGRATAKG------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
           Y+APE   T     KG      D +S GV+  E++ G+ P       EGT   T+   +M
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-----FHEGTSAKTYNN-IM 222

Query: 294 QDKR 297
             +R
Sbjct: 223 NFQR 226

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 28/224 (12%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEV---DRGFERELEAMG 121
           F    ++   + IGSG +G V       S    A+K++           R   REL+ + 
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILR 59

Query: 122 DIKHRNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
             KH NI+ +              Y  ++ +LM +  L   +H      +       Y++
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVY--VVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM----EAEKTHVS 231
                RG+ Y+H   +   IHRD+K SN+L++++ E R+ DFG+A  +       K  ++
Sbjct: 117 L----RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 232 TIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             VA T  Y APE        T   D++S G +  E+L G+R +
Sbjct: 170 EYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 37/174 (21%)

Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
           ARG+ +L    CI    HRD+ + NILL +N   ++ DFGLA  +  +  +V    A   
Sbjct: 183 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--- 295

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P     +++SI   C    P  RPT +E+V++L
Sbjct: 296 -------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 51/226 (22%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---------RELEAMG 121
           + +   IG G +G V   T   +    A+K++          FE         RE++ + 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--------FEHQTFCQRTLREIKILR 58

Query: 122 DIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSR---- 172
             KH NI+ +        +       ++ ELM      T L+ K +  ++L   S     
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELME-----TDLY-KLIKTQHL---SNDHIQ 109

Query: 173 ---YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
              Y+I     RG+ Y+H     +++HRD+K SN+LL+ N + ++ DFGLA + + E  H
Sbjct: 110 YFLYQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162

Query: 230 VSTI---VAGTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
              +   VA T  Y APE     +   K  D++S G +L E+L+ +
Sbjct: 163 TGFLTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEA-----MGDIKHRNIVT 130
           VIG G FG V      +D + +AVK L + T  + +  +  + A     + ++KH  +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI-LKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +++    + + +  G L  F H +   ++    P     A   A  I YLH   
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGEL--FFHLQ--RERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATL-MEAEKTHVSTIVAGTFGYLAPEYFDTG 249
             +II+RD+K  NILLD      ++DFGL    +E E+T  ++   GT  YLAPE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 58/256 (22%), Positives = 111/256 (43%), Gaps = 34/256 (13%)

Query: 100 KRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL----LIYELMPNGSLDT 155
           K+ H+G   +    E E++ +  I   NI+ ++G+      +L    LI E    G L  
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HDCIPHIIHRDIKSSNILLDQNMEARV 214
            L      +K+L + ++  +A+   +G+  L+ +   P+   +++ S + L+ +N + ++
Sbjct: 112 VLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKI 164

Query: 215 SDFGLATLMEAEK-THVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGK 271
              GL  ++ +    +V+ +V     Y + +  +      T K D+YS GVVL E+ TGK
Sbjct: 165 ICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Query: 272 RPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSK 331
            P +    +E          ++        +      CP+ EI     I   C   +  K
Sbjct: 220 IPFENLTTKE------IYDLIINKNNSLK-LPLD---CPL-EIK---CIVEACTSHDSIK 265

Query: 332 RPTMTEVVKMLELIKS 347
           RP + E++  L L K 
Sbjct: 266 RPNIKEILYNLSLYKF 281

Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 78  IGSGGFGTVY--RLTVNDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVTL 131
           +G+G FG V        D    A+KR  +       +VD  F  E + +  I H   V L
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG---AARGIAYLHH 188
           +G +    Y  L+ E +  G   TFL      ++N  +P+     VG   AA+ +    +
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFL------RRNKRFPND----VGCFYAAQIVLIFEY 146

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFD 247
               +I++RD+K  N+LLD++   +++DFG A +++      +  + GT  Y+APE   +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLN 202

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
            G   A  D ++ G+ + E+L G  P
Sbjct: 203 VGHGKA-ADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 36/213 (16%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH---RGTTEVDRGFERE---LEAMGDIKHRNIV 129
           +G G +G V++  ++  T    A+K++    R  T+  R F RE   L+ +GD  H NIV
Sbjct: 15  LGKGAYGIVWK-AIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGD--HPNIV 70

Query: 130 TLHGYYTSSQ----YNLLIYELMPNGSLDTFLHGKSVNKKNL--DWPSRYKIAVGAARGI 183
            L     +      Y  L++E M     +T LH  +V + N+  D   RY I     + +
Sbjct: 71  KLLNVIKAENDKDIY--LVFEYM-----ETDLH--AVIRANILEDVHKRY-IMYQLLKAL 120

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA----TLMEAEKTHVSTIVAGTFG 239
            Y+H     ++IHRD+K SNILL+ +   +++DFGLA     L E  +  V T    T  
Sbjct: 121 KYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
           Y APE         KG D++S G +L E+L GK
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 70/251 (27%), Positives = 100/251 (39%), Gaps = 64/251 (25%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRL------HRGTTEVDRGFERELEAMGDI 123
           F S  VIG G FG V RL     T   +A+K+L       +      R  ER++ A  D 
Sbjct: 3   FESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA-ERDILAEAD- 59

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAAR 181
            +  +V L+  +    Y  LI E +P G + T L  K    +     +R+ IA  + A  
Sbjct: 60  -NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---TRFYIAETILAID 115

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI-------- 233
            I  L +      IHRDIK  N+LLD     ++SDFGL T +  +K+H +          
Sbjct: 116 SIHKLGY------IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHAL 167

Query: 234 -------------------------------VAGTFGYLAPEYFDTGRATAKGDVYSFGV 262
                                            GT  Y+APE F       + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 263 VLLELLTGKRP 273
           ++ E+L G  P
Sbjct: 228 IMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.8 bits (165), Expect = 5e-13
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVKRLHRG-----TTEVDRGFERELEAMGDIKHRNIVT 130
           ++G G FG VY    V+     A K++        T++     E E++ + +++H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 131 LHG-YYTSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
            +G     ++  L I+ E MP GS+   L       +++      +I      G++YLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHS 124

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGYLAPEYF 246
           + I   +HRDIK +NIL D     ++ DFG +  ++      + I  V GT  +++PE  
Sbjct: 125 NMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
                  K DV+S G  ++E+LT K P  E
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 78  IGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHG 133
           +GSG +GTV   L        A+K+L+R         R + REL  +  +KH N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLD 81

Query: 134 YYTSSQYNLL----IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +T    +L      Y +MP    D    GK +  + L       +     +G+ Y+H  
Sbjct: 82  VFTPDL-SLDRFHDFYLVMPFMGTDL---GKLMKHEKLSEDRIQFLVYQMLKGLKYIHA- 136

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY-FDT 248
               IIHRD+K  N+ ++++ E ++ DFGLA   ++E T    +V  T  Y APE   + 
Sbjct: 137 --AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT--GYVV--TRWYRAPEVILNW 190

Query: 249 GRATAKGDVYSFGVVLLELLTGK 271
              T   D++S G ++ E+LTGK
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.3 bits (164), Expect = 7e-13
 Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 47/277 (16%)

Query: 78  IGSGGFGTV---YRLTVNDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLH 132
           +GSG FGTV              AVK L     +  +     RE   M  + +  IV + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           G   +  + +L+ EL   G L+ FL   K V +KN+      ++    + G+ YL     
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEET-- 114

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF--GYLAPEYFDTG 249
            + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +   + APE  +  
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 250 RATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVKAVMQDKREEYV 301
           + ++K DV+SFGV++ E  + G++P            +E G ++                
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---------------- 217

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                + CP     +++ +  +C      +RP    V
Sbjct: 218 --ECPQRCPP----EMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 19/213 (8%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFA---VKRLHRGTTEVDRG--FERELEAMGDIKHRNIVT 130
           D IG+G FG V     +   + A   VK L R +   D    F +E++   ++ H N++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAARGIAYLHHD 189
             G    S   LL+ E  P G L  +L         +       ++A   A G+ +LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST-IVAGTFGYLAPEYFD- 247
                IH D+   N  L  ++  ++ D+GLA     E  +++    A    +LAPE  + 
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 248 ------TGRATAKGDVYSFGVVLLELLT-GKRP 273
                     T K +++S GV + EL T   +P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 69/300 (23%), Positives = 133/300 (44%), Gaps = 61/300 (20%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDST-----AFAVKRLHRGTTEVDRG-FERELEAMGDIK 124
           + +  D++  G FG ++   + D          VK +    +E+      +E   +  + 
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66

Query: 125 HRNIVT-LHGYYTSSQYNLLIYELMPNGSLDTFL----HGKSVNKKNLDWPSRYKIAVGA 179
           H+NI+  LH      +   ++Y  M  G+L  FL     G++ N + L       +A+  
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA---------TLMEAEKTHV 230
           A G++YLH      +IH+DI + N ++D+ ++ +++D  L+          L + E   V
Sbjct: 127 ACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183

Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEG 282
                    ++A E       ++  DV+SFGV+L EL+T G+ P  E       A+L++G
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            +L                        PIN  +++F++ + C   +P +RP+ +++V+ L
Sbjct: 236 YRLAQ----------------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 38/216 (17%)

Query: 77  VIGSGGFGTVYRLTVNDSTA----FAVKRLHRGT----------TEVDRGFERELEAMGD 122
           V+G GG+G V+++           FA+K L + T          T+ +R     LEA   
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI---LEA--- 56

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           +KH  IV L   + +     LI E +  G L  F+H +       D    Y   +  A  
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA-- 112

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGY 240
           + +LH      II+RD+K  NILLD     +++DFGL   ++ E   TH      GT  Y
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEY 166

Query: 241 LAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRP 273
           +APE       G+A    D +S G ++ ++LTG  P
Sbjct: 167 MAPEILMRSGHGKAV---DWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 67.5 bits (165), Expect = 9e-13
 Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 9/158 (5%)

Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E+  M D +H NIV ++  Y       ++ E +  G+L        V    ++      +
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI-----VTHTRMNEEQIATV 120

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            +   + +++LH      +IHRDIKS +ILL  +   ++SDFG    +  E     ++V 
Sbjct: 121 CLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV- 176

Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           GT  ++APE         + D++S G++++E++ G+ P
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 21/215 (9%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERE---LEAMGDIKHRNIVTL 131
           + IG G +G V++ L   + +  AVK L     ++D   E E   L+A+ D  H N+V  
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSD--HPNVVKF 80

Query: 132 HG-YYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           +G YY     N     L+ EL   GS+   + G     + ++ P    I   A  G+ +L
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H +     IHRD+K +NILL      ++ DFG++  + + +   +T V GT  ++APE  
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196

Query: 247 DTGRA-----TAKGDVYSFGVVLLELLTGKRPMDE 276
              +       A+ DV+S G+  +EL  G  P+ +
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)

Query: 77  VIGSGGFGTVY----RLTVNDSTAFAVKRLHRG-------TTEVDRGFERELEAMGDIKH 125
           V+G+G +G V+        +    +A+K L +        T E  R   + LEA+     
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV----R 62

Query: 126 RN--IVTLH-GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA-AR 181
           R   +VTLH  + T ++ +L I + +  G L T L+     +++    S  ++ +     
Sbjct: 63  RCPFLVTLHYAFQTDTKLHL-ILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIVL 116

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + +LH      II+RDIK  NILLD      ++DFGL+    AE+   +    GT  Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 242 APEYFDTG-RATAKG-DVYSFGVVLLELLTGKRP 273
           APE    G     K  D +S GV+  ELLTG  P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 24/216 (11%)

Query: 72  FSSKDVIGSGGFGTVY---RLTVNDS-TAFAVKRLHRGT-------TEVDRGFERELEAM 120
           F    V+G+G +G V+   +++ +DS   +A+K L + T       TE  R   + LE +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
              +   +VTLH  + +     LI + +  G L T L  +   K+        ++ + + 
Sbjct: 62  R--QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSG 112

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
             +  L H     II+RDIK  NILLD N    ++DFGL+     ++   +    GT  Y
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 241 LAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRP 273
           +AP+     D G   A  D +S GV++ ELLTG  P
Sbjct: 173 MAPDIVRGGDGGHDKAV-DWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIVTLH 132
           IG G +G V++    ++    A+K+     +E D   +    RE+  +  +KH N+V L 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVE--SEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HDCI 191
             +   +   L++E   +    T L+    N + +      KI     + + + H H+CI
Sbjct: 67  EVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTG 249
               HRD+K  NIL+ +  + ++ DFG A ++       +  VA T  Y APE    DT 
Sbjct: 123 ----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVGDTQ 177

Query: 250 RATAKGDVYSFGVVLLELLTG 270
                 DV++ G V  ELLTG
Sbjct: 178 YGPPV-DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 20/213 (9%)

Query: 77  VIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRG-----FERELEAMGDIKHRNIVT 130
           V+G G FG V    +  +  F A+K L +     D        ER + A+   +H  +  
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTH 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L   + + ++   + E +  G  D   H +S  + +      Y  A     G+ +LH   
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGG--DLMFHIQSSGRFDEARARFY--AAEIICGLQFLHKK- 115

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              II+RD+K  N+LLD++   +++DFG+       +   ST   GT  Y+APE     +
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-CGTPDYIAPEILKGQK 172

Query: 251 ATAKGDVYSFGVVLLELLTGKRPM-----DEAF 278
                D +SFGV+L E+L G+ P      DE F
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRGFE----REL 117
           F K   +   D +G G + TVY+    LT N     A+K +     E + G      RE+
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDN---LVALKEIR---LEHEEGAPCTAIREV 55

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKI 175
             + D+KH NIVTLH    + +   L++E + +  L  +L   G S+N  N+        
Sbjct: 56  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-----F 109

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIV 234
                RG+ Y H      ++HRD+K  N+L+++  E +++DFGLA       KT+ + +V
Sbjct: 110 LFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166

Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             T  Y  P+    +   + + D++  G +  E+ TG RP+
Sbjct: 167 --TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHG-YY 135
           +G G FG VY+    ++ A A  ++    +E +   +  E+E +    H  IV L G +Y
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
              +  ++I E  P G++D  +       + L  P    I       + YLH      II
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KII 132

Query: 196 HRDIKSSNILLDQNMEARVSDFGL-ATLMEAEKTHVSTIVAGTFGYLAPEYF--DTGRAT 252
           HRD+K+ N+LL  + + +++DFG+ A  ++  +   S I  GT  ++APE    +T + T
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDT 190

Query: 253 A---KGDVYSFGVVLLELLTGKRPMDE 276
               K D++S G+ L+E+   + P  E
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHE 217

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRG----TTEVD--RGFERELEAMGDIKHR 126
           V+G G FG V    Y+ T      +A+K L +G      EV+     +R  E     +H 
Sbjct: 6   VLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   + +  +   + E    G L   +H           P     A     G+ YL
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYL 117

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H +    I++RD+K  N+LLD     +++DFGL           ST   GT  +LAPE  
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF-CGTPEFLAPEVL 173

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRP 273
                T   D +  GV++ E+L G+ P
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 28/220 (12%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRGFE----REL 117
           F K   +   D +G G + TV++    LT N     A+K +     E + G      RE+
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTEN---LVALKEIR---LEHEEGAPCTAIREV 54

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
             + ++KH NIVTLH    + +   L++E      LD+ L     N  NL      KI +
Sbjct: 55  SLLKNLKHANIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFM 109

Query: 178 -GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVA 235
               RG++Y H      I+HRD+K  N+L+++  E +++DFGLA       KT+ + +V 
Sbjct: 110 FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV- 165

Query: 236 GTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            T  Y  P+    +   +   D++  G +L E+ TG RPM
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPM 203

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLH----RGT--TEVDRGFERELEAMGDIKHRNIVT 130
           +G G + TVY+          A+K +H     GT  T +     RE+  M ++KH NIV 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIVR 62

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           LH    +    +L++E M +  L  ++  HG    +  LD  +         +GIA+ H 
Sbjct: 63  LHDVIHTENKLMLVFEYM-DKDLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
           +    ++HRD+K  N+L+++  E +++DFGLA          S  V  T  Y AP+    
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174

Query: 249 GRA-TAKGDVYSFGVVLLELLTGK 271
            R  +   D++S G ++ E++TG+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.1 bits (158), Expect = 7e-12
 Identities = 40/158 (25%), Positives = 80/158 (50%), Gaps = 9/158 (5%)

Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E+  M D +H+N+V ++  Y   +   ++ E +  G+L   +    +N++ +       +
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TV 122

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
                + + YLH      +IHRDIKS +ILL  +   ++SDFG    +  +     ++V 
Sbjct: 123 CESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV- 178

Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           GT  ++APE         + D++S G++++E++ G+ P
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 24/212 (11%)

Query: 70  LKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRG-TTEV--DRGFERELEAMGDIK 124
            +++S   +GSG +G+V    ++  T    A+K+L R   +E+   R + REL  +  ++
Sbjct: 15  ERYTSLKQVGSGAYGSVCS-AIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQ 72

Query: 125 HRNIVTLHGYYTS-SQYNLL--IYELMPNGSLD-TFLHGKSVNKKNLDWPSRYKIAVGAA 180
           H N++ L   +TS    +     Y +MP    D   + G  +++  + +     +     
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQML 127

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
            G+ Y+H      IIHRD+K  N+ ++++ E ++ DFGLA   +AE T    +V  T  Y
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT--GYVV--TRWY 180

Query: 241 LAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
            APE   +        D++S G ++ E+LTGK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHR---GTTEVDRGFERELEAMGDIKHRNIVTLH 132
           +GSG +G+V     +  T    AVK+L R         R + REL  +  +KH N++ L 
Sbjct: 25  VGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVN-----KKNLDWPSRYKIAVGAARGIAYLH 187
             +T ++      E   +  L T L G  +N     +K  D   ++ I     RG+ Y+H
Sbjct: 83  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 137

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YF 246
                 IIHRD+K SN+ ++++ E ++ DFGLA   + E T        T  Y APE   
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----YVATRWYRAPEIML 190

Query: 247 DTGRATAKGDVYSFGVVLLELLTGK 271
           +        D++S G ++ ELLTG+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 68/265 (25%), Positives = 107/265 (40%), Gaps = 57/265 (21%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFER----ELEAMGDIKHR 126
           F    VIG G FG V+ +   D+   +A+K L R +  + R        E + + D    
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSP 61

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL---DWPSRYKIA--VGAAR 181
            IV L+  +   ++  L+ E MP G L   L      +K++   +  +R+ IA  V A  
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-----IRKDVFPEET-ARFYIAELVLA-- 113

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM------------------ 223
            +  +H       IHRDIK  NIL+D +   +++DFGL   M                  
Sbjct: 114 -LDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 224 ----------EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
                       ++   +    GT  Y+APE         + D +S GV+L E+L G  P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Query: 274 MDEAFLEEGTKLVTWVKAVMQDKRE 298
               F  + T   T+ K ++  K  
Sbjct: 230 ----FYSD-TLQETYNK-IINWKES 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 9/97 (9%)

Query: 194 IIHRDIKSSNILL---DQNMEARVSDFGLATLM----EAEKTHVS--TIVAGTFGYLAPE 244
           I+HRD+K  NI++        A+V DFG+ TL+    +A+   ++  T V GT  Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE 281
                  T   D+Y++G++ LE LTG+R +  A + E
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 78  IGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGF-ERELEAMGDIKHRNIVTLHG 133
           +GSG +G VY+   L   +  A  + +L  G    D    ++E+  + + KH NIV   G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
            Y S +   +  E    GSL    H    +++  + +  R  +     +G+AYLH     
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK- 127

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF---DTG 249
             +HRDIK +NILL  N + +++DFG+A  + A      + + GT  ++APE       G
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184

Query: 250 RATAKGDVYSFGVVLLELLTGKRPM 274
                 D+++ G+  +EL   + PM
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEV--DRGFERELEAMGDIKHRNIVTLHGY 134
           +GSG +G+V            AVK+L R    +   R   REL  +  +KH N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 135 YTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           +T +     +N   L+  LM    L+  +  + ++ +++ +     +     RG+ Y+H 
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIHS 136

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFD 247
                IIHRD+K SN+ ++++ E R+ DFGLA   + E T        T  Y APE   +
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG----YVATRWYRAPEIMLN 189

Query: 248 TGRATAKGDVYSFGVVLLELLTGK 271
                   D++S G ++ ELL GK
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 72  FSSKDVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+    ++   L     Y   +   +G+A+ H 
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHS 118

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYFD 247
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 173

Query: 248 TGR--ATAKGDVYSFGVVLLELLTGK 271
             +  +TA  D++S G +  E++T +
Sbjct: 174 GCKYYSTAV-DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 70/284 (24%), Positives = 121/284 (42%), Gaps = 46/284 (16%)

Query: 71  KFSSKDVIGSGGFGTVYRL-TVNDSTAFAVKRLH--RGTTEVDRGFERELEAMGDIKHRN 127
           K+     IG G FG    + +  D   + +K ++  + + +      +E+  + ++KH N
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 128 IVTLHGYYTSSQYNLLIYELMP--NGSLDTFLHGKSVNKKN---------LDWPSRYKIA 176
           IV    Y  S + N  +Y +M    G  D +   K +N +          LDW  +  +A
Sbjct: 61  IVQ---YQESFEENGNLYIVMDYCEGG-DLY---KKINAQRGVLFPEDQILDWFVQICLA 113

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
                    L H     I+HRDIKS NI L ++   ++ DFG+A ++ +      T + G
Sbjct: 114 ---------LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-G 163

Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK 296
           T  YL+PE  +      K D+++ G VL E+ T K     AF E G      +K      
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK----HAF-EAGNMKNLVLK------ 212

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
               +I  S      +   D+ ++ S   +  P  RP++  +++
Sbjct: 213 ----IIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 77  VIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE------RELEAMGDIKHRNIV 129
           ++G G FG V+   +  +  F A+K L +    +D   E      R L    +  H  + 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLT 59

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L+  + + +    + E +  G  D   H +S +K +L   + Y  A     G+ +LH  
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSK 115

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               I++RD+K  NILLD +   +++DFG+    ++   KT       GT  Y+APE   
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILL 169

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
             +     D +SFGV+L E+L G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRL---HRGTTEVDRGFERELEAMGDIKHRNIVTL-- 131
           IG G FG V+ +T   D    A+K++    +      R F REL+ +   KH N+++   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 132 -----HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV-GAARGIAY 185
                H       Y  ++ ELM      + LH   V+ + L      K+ +    RG+ Y
Sbjct: 67  ILQPPHIDPFEEIY--VVTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKY 118

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH      I+HRDIK  N+L++ N   ++ DFGLA + E +++   T    T  Y APE 
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 246 FDTG--RATAKGDVYSFGVVLLELLTGK 271
              G    T+  D++S G +  ELL  +
Sbjct: 176 L-MGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 32/238 (13%)

Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--- 172
           EL  +    H  IV     + S    LLI E    G L+  +  K   K++L +      
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYEVG 172

Query: 173 ---YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKT 228
              Y+I +     +  +H   +   +HRD+KS+NI L      ++ DFG +    ++   
Sbjct: 173 LLFYQIVLA----LDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW 288
            V++   GT  YLAPE ++  R + K D++S GV+L ELLT  RP               
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-------------- 271

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
            K   Q +  + V+    +  P    + + ++    L   P+ RPT  +++   E +K
Sbjct: 272 -KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT-EFLK 327

Length = 478

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 43/226 (19%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLH--RGTTEVDRGFE------------RELEAMGD 122
           +G G +G V +          A+K++     + +V +  +            REL+ M +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAAR 181
           IKH NI+ L   Y    +  L+ ++M    L      K V++K     S+ K I +    
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLK-----KVVDRKIRLTESQVKCILLQILN 130

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT---------------LMEAE 226
           G+  LH     + +HRD+  +NI ++     +++DFGLA                 M+  
Sbjct: 131 GLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 227 KTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           +   S +V  T  Y APE      +     D++S G +  ELLTGK
Sbjct: 188 EEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 37/228 (16%)

Query: 75  KDVIGSGGFGTVYRLTVND-----------------STAFAVKRLHRGTTEVDRG-FERE 116
           K+ +G G FG V+   V +                     AVK L     +  R  F +E
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69

Query: 117 LEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---------- 166
           ++ +  +K  NI+ L G         +I E M NG L+ FL    ++ K           
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 167 -----LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA- 220
                + + S   +A+  A G+ YL      + +HRD+ + N L+ +N+  +++DFG++ 
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELL 268
            L   +   +         ++A E    G+ T   DV++FGV L E+L
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 37/174 (21%)

Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
           A+G+ +L    CI    HRD+ + NILL +N   ++ DFGLA  +  +  +V    A   
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 301

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                  +  +Y   T+ E         ++     C   EPS+RPT +E+V+ L
Sbjct: 302 -------RAPDY---TTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 22/208 (10%)

Query: 77  VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG----FERELEAMGDIKHRNIVTLH 132
           VIG G FG V  +    S      +L      + R     F  E + M       +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             +   +Y  ++ E MP G L   +    V +K   W   Y   V  A  +  +H     
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WAKFYTAEVVLA--LDAIHS---M 161

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT---HVSTIVAGTFGYLAPEYFDT- 248
            +IHRD+K  N+LLD++   +++DFG  T M+ ++T      T V GT  Y++PE   + 
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 249 ---GRATAKGDVYSFGVVLLELLTGKRP 273
              G    + D +S GV L E+L G  P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 33/208 (15%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIK---HRNIVTL 131
           IG G +GTVY+   +N     A+K++    +E  +     RE+  +  ++   H NIV L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 132 ----HGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIAY 185
               HG  T  +  L L++E + +  L T+L      K  L  P   K +     RG+ +
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLP-PETIKDLMRQLLRGVDF 122

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE- 244
           LH   I   +HRD+K  NIL+  + + +++DFGLA +   E    S +V  T  Y APE 
Sbjct: 123 LHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPEV 177

Query: 245 -----YFDTGRATAKGDVYSFGVVLLEL 267
                Y     AT   D++S G +  EL
Sbjct: 178 LLQSSY-----ATPV-DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 37/174 (21%)

Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
           ARG+ +L    CI    HRD+ + NILL +N   ++ DFGLA  +  +  +V    A   
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     ++E F   L++GT++   
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA- 298

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P N   +++ I   C + +P +RPT + +V++L
Sbjct: 299 ---------------------PENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 77  VIGSGGFGTVYRLTVNDSTA--FAVKRLHR--GTTEVDRGF---ERELEAMGDIKHRNIV 129
           VIG G FG V +L  + ST   +A+K L +       D  F   ER++ A  +     +V
Sbjct: 50  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW--VV 106

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L   +   +Y  ++ E MP G L   +    V +K   W   Y   V        L  D
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEV-------VLALD 156

Query: 190 CIPHI--IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            I  +  IHRD+K  N+LLD++   +++DFG    M  E         GT  Y++PE   
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216

Query: 248 T----GRATAKGDVYSFGVVLLELLTGKRP 273
           +    G    + D +S GV L E+L G  P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 32/229 (13%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVDRGFERELEAM-- 120
           T++F  +  +G   FG VY+  +        + A A+K L +   E     E + EAM  
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMR 62

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN------------KKNLD 168
             ++H NIV L G  T  Q   +I+    +  L  FL  +S +            K  L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                 I    A G+ +L      H++H+D+ + N+L+   +  ++SD GL    E    
Sbjct: 123 PADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL--FREVYAA 177

Query: 229 HVSTIVAGTF---GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP 273
               ++  +     +++PE    G+ +   D++S+GVVL E+ + G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 31/229 (13%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTV-----------------NDSTAFAVKRLHRGTTEV 109
           +K L F  K  +G G FG V+                     N     AVK L     + 
Sbjct: 4   RKRLTFKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 110 DRG-FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL-------HGKS 161
            R  F +E++ M  +K  NI+ L     +S    +I E M NG L+ FL         + 
Sbjct: 62  ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 162 VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA- 220
            +   + + +   +A   A G+ YL      + +HRD+ + N L+ +N   +++DFG++ 
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT 269
            L   +   +         +++ E    G+ T   DV++FGV L E+LT
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 25/220 (11%)

Query: 77  VIGSGGFGTVY---RLTVNDSTA-FAVKRLHRG-------TTEVDRGFERELEAMGDIKH 125
           V+G+G +G V+   ++T +D+   +A+K L +        T E  R     LE +     
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
             +VTLH  + +     LI + +  G + T L+ +       D  S  ++   +   I  
Sbjct: 67  --LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILA 117

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           L H     I++RDIK  NILLD      ++DFGL+    +E+   +    GT  Y+APE 
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 246 FDTGRATAKG-DVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
                   K  D +S G+++ ELLTG  P    F  EG +
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASP----FTLEGER 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 77  VIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEA-----MGDIKHRNIVT 130
           VIG G FG V       D   +AVK L +    ++R  ++ + A     + ++KH  +V 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV-LNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +++    + + +  G L  F H +   +++   P     A   A  + YLH   
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL--FFHLQ--RERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLAPEYFDT 248
             +I++RD+K  NILLD      ++DFGL    + +++ T   T   GT  YLAPE    
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK 170

Query: 249 GRATAKGDVYSFGVVLLELLTGKRP 273
                  D +  G VL E+L G  P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.9 bits (151), Expect = 7e-11
 Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 64/302 (21%)

Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIVTL 131
           I  G +G VYR   +  T    A+K+L     +   GF     RE+  +  ++H NIVT+
Sbjct: 13  IEEGTYGVVYR-ARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTV 69

Query: 132 HGYYTSSQYNLLIYELMP------NGSLDT----FLHG--KSVNKKNLDWPSRYKIAVGA 179
                 S  +  IY +M          ++T    FL    K +  + L            
Sbjct: 70  KEVVVGSNLDK-IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL------------ 116

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
             G+A+LH +    I+HRD+K+SN+LL+     ++ DFGLA    +     + +V  T  
Sbjct: 117 -SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLW 171

Query: 240 YLAPE-YFDTGRATAKGDVYSFGVVLLELLT------GKRPMDE---AFLEEGT------ 283
           Y APE        +   D++S G +  ELLT      GK  +D+    F   GT      
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 284 ----KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDV-FSIASMCLEPEPSKRPTMTEV 338
               +L    K        +Y  +   +  P   ++D  F + +  L  +P+KR +  + 
Sbjct: 232 PGFSELPGAKKK----TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Query: 339 VK 340
           +K
Sbjct: 288 LK 289

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 27/170 (15%)

Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT- 237
           A+G+ +L   +CI    HRD+ + N+LL     A++ DFGLA  +  +  +V   V G  
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274

Query: 238 ---FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+S+G++L E+ + GK P     +   +K    VK   
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYKMVKRGY 332

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           Q  R ++      E         ++SI  MC   EP++RPT +++ ++++
Sbjct: 333 QMSRPDF---APPE---------IYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 44/218 (20%)

Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHRN 127
           D +G G + TVY+    LT     A    RL     E + G      RE   + D+KH N
Sbjct: 11  DKLGEGSYATVYKGRSKLT-GQLVALKEIRL-----EHEEGAPFTAIREASLLKDLKHAN 64

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAV-GAARGIA 184
           IVTLH    + +   L++E + +  L  ++   G  ++  N+      ++ +    RG+A
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNV------RLFLFQLLRGLA 117

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAP 243
           Y H      ++HRD+K  N+L+ +  E +++DFGLA       KT+ + +V  T  Y  P
Sbjct: 118 YCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPP 172

Query: 244 -------EYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
                  EY      +   D++  G +  E+ TG RP+
Sbjct: 173 DVLLGSTEY------STSLDMWGVGCIFYEMATG-RPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKH 125
           K+   + IG G +GTV++    ++    A+KR+     + D G      RE+  + ++KH
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 58

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           +NIV L+    S +   L++E   +  L  +    S N   +D            +G+A+
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYF--DSCNGD-IDPEIVKSFMFQLLKGLAF 114

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE- 244
            H     +++HRD+K  N+L+++N E +++DFGLA          S  V  T  Y  P+ 
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 170

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            F     +   D++S G +  EL    RP+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 35/210 (16%)

Query: 78  IGSGGFGTVYRLTVNDSTA---FAVKRLHRGTTEVDR-----GFERELEAMGDIKHRNIV 129
           +G+G FG V+   V D  +   +A+K +     EV R         E   + ++ H  I+
Sbjct: 9   VGTGTFGRVHL--VRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64

Query: 130 TLHGYYTS-SQYNL-LIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGAARGIAY 185
            L  ++T   Q  L ++ E +P G L ++L   G+  N   L + S    A      + Y
Sbjct: 65  RL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA------LEY 116

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST-IVAGTFGYLAPE 244
           LH      I++RD+K  NILLD+    +++DFG      A+K    T  + GT  YLAPE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGF-----AKKLRDRTWTLCGTPEYLAPE 168

Query: 245 YF-DTGRATAKGDVYSFGVVLLELLTGKRP 273
                G   A  D ++ G+++ E+L G  P
Sbjct: 169 VIQSKGHNKAV-DWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)

Query: 77  VIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEA-----MGDIKHRNIVT 130
           VIG G FG V          F AVK L +    + +  ++ + A     + ++KH  +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI-LKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + ++     + + +  G L  F H +   +   +  +R+  A   A  + YLH   
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGEL--FFHLQR-ERSFPEPRARF-YAAEIASALGYLHS-- 114

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATL-MEAEKTHVSTIVAGTFGYLAPEYFDTG 249
             +II+RD+K  NILLD      ++DFGL    +E  KT  ++   GT  YLAPE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLHRG---TTEVDRGFERELEAMG 121
           F+   K+     IG G +G V     +++    A+K++        +  R   RE++ + 
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLR 59

Query: 122 DIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHG--KSVNKKNLDWPSRYK 174
            + H N++ +                ++YELM     DT LH   +S ++   D   +Y 
Sbjct: 60  HLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRS-SQTLSDDHCQYF 113

Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H     +++HRD+K SN+LL+ N + ++ DFGLA    +EK    T  
Sbjct: 114 L-YQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEY 168

Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +    T   DV+S G +  ELL  K
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
           ++   + IG G +G VY+      N++ A    RL +    V     RE+  + +++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNK--KNLDWPSRYKIAVGAARGIAY 185
           IV L     S +   L++E +    LD   H  S     KN      Y   +   RGIAY
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQI--LRGIAY 117

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAE-KTHVSTIVAGTFGYLAP 243
            H      ++HRD+K  N+L+D+   A +++DFGLA       +T    +V  T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAP 172

Query: 244 EYFDTGRA-TAKGDVYSFGVVLLELLTGK 271
           E     R  +   D++S G +  E++  K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 39/221 (17%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRL--HRGTTEVDRGFE----RELEAMGDIKHRNIVT 130
           +G G FG VY+   +      A+K++  H    E D GF     RE++ +  +KH N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMH---NEKD-GFPITALREIKILKKLKHPNVVP 71

Query: 131 L------HGYYTSSQYNLLIYELMP--NGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAAR 181
           L          +  +    +Y + P  +  L   L   SV        S+ K   +    
Sbjct: 72  LIDMAVERPDKSKRKRGS-VYMVTPYMDHDLSGLLENPSVKLT----ESQIKCYMLQLLE 126

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK----------THVS 231
           GI YLH +   HI+HRDIK++NIL+D     +++DFGLA   +             T   
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 232 TIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           T +  T  Y  PE      R T   D++  G V  E+ T +
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIKHRNIVTLHG 133
           ++IG+G FG VY  + ++ S   A+K++ +     D  ++ REL  M ++ H NI+ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKD 126

Query: 134 YYTS-----SQYNL---LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           YY +     ++ N+   ++ E +P  ++  ++   + N   L        +    R +AY
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           +H      I HRD+K  N+L+D N    ++ DFG A  + A +  VS I +    Y APE
Sbjct: 186 IHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YRAPE 240

Query: 245 -YFDTGRATAKGDVYSFGVVLLELLTG 270
                   T   D++S G ++ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 27/214 (12%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVTLH 132
           +G GG+G V+     D+    A+KR+ +       EV R    E + +   K   +V L 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV-RHVLTERDILTTTKSEWLVKLL 67

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI-----AVGAARGIAYLH 187
             +   +Y  L  E +P G   T L+   V  ++    +R+ +     AV A   + Y  
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFEAVDALHELGY-- 122

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                  IHRD+K  N L+D +   +++DFGL+       T+ +++V G+  Y+APE   
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVV-GSPDYMAPEVLR 171

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE 281
                   D +S G +L E L G  P   +   E
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 30/221 (13%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRGFE----REL 117
           F K   +   + +G G + TV++    LT N     A+K +     E + G      RE+
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTEN---LVALKEIR---LEHEEGAPCTAIREV 55

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKI 175
             + D+KH NIVTLH    + +   L++E + +  L  ++   G  ++  N+     Y+I
Sbjct: 56  SLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-FLYQI 113

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
                RG+AY H      ++HRD+K  N+L+++  E +++DFGLA       KT+ + +V
Sbjct: 114 L----RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166

Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             T  Y  P+    +   + + D++  G +  E+ +G RP+
Sbjct: 167 --TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYY 135
           +G G + TVY+ ++  +    A+K +   T E V     RE   +  +KH NIV LH   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 136 TSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            + +    ++E M +  L  ++  H   ++  N+             RG+AY+H     H
Sbjct: 73  HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-----FMFQLLRGLAYIHGQ---H 123

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYF--DTGR 250
           I+HRD+K  N+L+    E +++DFGLA       +T+ S +V  T  Y  P+     T  
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181

Query: 251 ATAKGDVYSFGVVLLELLTGK 271
           ++A  D++  G + +E+L G+
Sbjct: 182 SSAL-DIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 26/224 (11%)

Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFE------RELEAMGDIKHRNIV 129
           V+G G FG V    +      FAVK L +    +D   E      R L    +  +  + 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE--NPFLT 59

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR---GIAYL 186
            L+  + + ++   + E +  G  D   H +   + +L     Y+    AA    G+ +L
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFL 112

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      II+RD+K  N++LD++   +++DFG+           ST   GT  Y+APE  
Sbjct: 113 HSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDYIAPEIL 168

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM---DEAFLEEGTKLVT 287
              + T   D +SFGV+L E+L G+ P    DE  L E  ++ T
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 78  IGSGGFGTVY---RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G VY   R    D   +A+K++    T +     RE+  + ++KH N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66

Query: 135 YTSSQ----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHH 188
           + S      + L  Y       +  F      NKK +  P      +      GI YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 189 DCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGYLA 242
           + +   +HRD+K +NIL+     +    +++D G A L  +    ++ +  V  TF Y A
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 243 PEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
           PE     R   K  D+++ G +  ELLT +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 29/223 (13%)

Query: 62  SDAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFER 115
            D+ F    ++ +   IGSG  G V   Y      + A  +K+L R     T   R + R
Sbjct: 8   GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVA--IKKLSRPFQNVTHAKRAY-R 64

Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNL-------LIYELMPNGSLDTFLHGKSVNKKNLD 168
           EL  M  + H+NI+ L   +T  Q +L       L+ ELM     D  L    V + +LD
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTP-QKSLEEFQDVYLVMELM-----DANLC--QVIQMDLD 116

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                 +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA        
Sbjct: 117 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173

Query: 229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
               +V  T  Y APE           D++S G ++ E++ G 
Sbjct: 174 MTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 20/192 (10%)

Query: 99  VKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH 158
           +K L     ++   F      M  + H++IV L+G       N+++ E +  G LD F+H
Sbjct: 37  LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH 96

Query: 159 GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL-------DQNME 211
            KS     L  P ++K+A   A  ++YL       ++H ++ + NILL       +    
Sbjct: 97  RKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF 150

Query: 212 ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLEL-LT 269
            ++SD G+   + + +  V  I      ++APE   D+   +   D +SFG  L E+   
Sbjct: 151 IKLSDPGIPITVLSRQECVERI-----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205

Query: 270 GKRPMDEAFLEE 281
           G+ P+ +  L E
Sbjct: 206 GEIPLKDKTLAE 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 34/212 (16%)

Query: 78  IGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           IG G +G VY+       +  A    RL      V     RE+  + ++ H NIV L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA----------RGIA 184
             S     L++E      LD  L      KK +D  S     +             +GIA
Sbjct: 67  VHSENKLYLVFEF-----LDLDL------KKYMD--SSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAP 243
           Y H      ++HRD+K  N+L+D+    +++DFGLA       +T+   +V  T  Y AP
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 168

Query: 244 EYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           E     R  +   D++S G +  E++  +RP+
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 63/241 (26%), Positives = 100/241 (41%), Gaps = 33/241 (13%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR----GTTEVDRGFERELEAMGDIKH 125
           F   + +G+G FG V R+  +  T   +A+K L +       +V     +E   + ++ H
Sbjct: 20  FEMGETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
             IV +   +        + E +  G L  F H +   +   D    Y   +  A    Y
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLA--FEY 133

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH      II+RD+K  N+LLD     +V+DFG A  +  ++T     + GT  YLAPE 
Sbjct: 134 LHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPEV 186

Query: 246 FDT---GRATAKGDVYSFGVVLLELLTGKRP--------MDEAFLEEGTKLVTWVKAVMQ 294
             +   G+A    D ++ GV+L E + G  P        + E  L    K   W     +
Sbjct: 187 IQSKGHGKAV---DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR 243

Query: 295 D 295
           D
Sbjct: 244 D 244

Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 117 LEAM--GDIKHRNIVTLHGYYTSSQYNLLIYELMP--NGSLDTFLHGKSVNKKNLDWPSR 172
           +EAM   ++ H +++ +     S     ++   +P  +  L T+L   +   + L     
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL---TKRSRPLPIDQA 159

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             I      G+ YLH      IIHRD+K+ NI ++   +  + D G A         +  
Sbjct: 160 LIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG- 215

Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELL 268
            +AGT    APE     +  +K D++S G+VL E+L
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 17/210 (8%)

Query: 78  IGSGGFGTVYRLTVN---DSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHG 133
           IG+G FG V    VN         VK L    +  +   F  E +    ++H N++   G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHG-KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             T     LL+ E  P G L  +L   +       D  +  ++A   A G+ +LH +   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRA 251
           + IH D+   N LL  ++  ++ D+GL+     E  +V    +     ++APE  D    
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 252 -------TAKGDVYSFGVVLLELLT-GKRP 273
                  T + +V+S GV + EL   G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 78  IGSGGFGTVY---RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G VY   R    D   +A+K++    T +     RE+  + ++KH N+++L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66

Query: 135 YTSSQ----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPS------RYKIAVGAARGIA 184
           + S      + L  Y       +  F      NKK +  P        Y+I      GI 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL----DGIH 122

Query: 185 YLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTI--VAGTF 238
           YLH + +   +HRD+K +NIL+     +    +++D G A L  +    ++ +  V  TF
Sbjct: 123 YLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 239 GYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
            Y APE     R   K  D+++ G +  ELLT +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 78  IGSGGFGTVY---RLTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIVT 130
           IG G +G VY   R    D   +A+K+  +G  E   G      RE+  + ++KH N+V+
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---------GKSVNK---KNLDWPSRYKIAVG 178
           L   +     +  +Y L      D               S+     K+L W    +I   
Sbjct: 67  LVEVFLEHA-DKSVYLLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLW----QIL-- 118

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILL--DQNMEARV--SDFGLATLMEAEKTHVSTI- 233
              G+ YLH +    ++HRD+K +NIL+  +      V   D GLA L  A    ++ + 
Sbjct: 119 --NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 234 -VAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLT 269
            V  T  Y APE     R  T   D+++ G +  ELLT
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 67/262 (25%), Positives = 100/262 (38%), Gaps = 58/262 (22%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           F S  VIG G FG V  +   D+      ++ R    +++     + A  DI    +V  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI----LVEA 58

Query: 132 HG-------YYTSSQYNL-LIYELMPNGSLDTFLHGKSV--NKKNLDWPSRYKIAVGAAR 181
            G       Y    + NL LI E +P G + T L  K     +    + +   +A+ A  
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKT------------ 228
            + +         IHRDIK  N+LLD     ++SDFGL T L +A +T            
Sbjct: 119 QLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 229 ---------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLEL 267
                                 ++    GT  Y+APE F         D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 268 LTGKRPM-DEAFLEEGTKLVTW 288
           L G  P   E   E   K++ W
Sbjct: 230 LIGYPPFCSETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 15/203 (7%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEA-----MGDIKHRNIVT 130
           VIG G FG V       +   +AVK L +    + +  E+ + +     + ++KH  +V 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-LKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + ++     + + +  G L  F H +   +  L+  +R+  A   A  + YLH   
Sbjct: 61  LHFSFQTADKLYFVLDYINGGEL--FYHLQR-ERCFLEPRARF-YAAEIASALGYLHS-- 114

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
             +I++RD+K  NILLD      ++DFGL      E    ++   GT  YLAPE      
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 251 ATAKGDVYSFGVVLLELLTGKRP 273
                D +  G VL E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVK--RLHRGTTEVDRGFERE---LEAMGDIKHRNIVTL 131
           IG G +GTVY+     S  F A+K  R+      +     RE   L+ +    H NIV L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 132 HGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
                +S+ +      L++E + +  L T+L    V    L   +   +     RG+ +L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H +CI   +HRD+K  NIL+    + +++DFGLA +   +      +V  T  Y APE  
Sbjct: 125 HANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179

Query: 247 DTGRATAKGDVYSFGVVLLELLTGK 271
                    D++S G +  E+   K
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)

Query: 78  IGSGGFGTVYRLT---VNDSTAFAVKRLHR--GTTEVDRGFERELEAMGDIK-HRNIVTL 131
           +G G +G V        ++    A+K++        + +   REL+ +   + H+NI  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 132 HGY--YTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLDWPS-RYKIAVGAARGIAYLH 187
           +         +N L +YE +    L   +        +  + S  Y+I      G+ Y+H
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQIL----CGLKYIH 122

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA----TLMEAEKTHVSTIVAGTFGYLAP 243
                +++HRD+K  N+L++ + E ++ DFGLA             ++  VA T  Y AP
Sbjct: 123 S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAP 178

Query: 244 EYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           E   + ++  K  DV+S G +L ELL G++P+
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 8/165 (4%)

Query: 112 GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPS 171
           G   E   +  I H +I+ L G +T +++  LI   +P    D + +     K+N+    
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY--LAAKRNIAICD 183

Query: 172 RYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS 231
              I     R I YLH +    IIHRDIK+ NI ++   +  + DFG A        +  
Sbjct: 184 ILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240

Query: 232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
              AGT    APE           D++S G+VL E+ T    + E
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285

Length = 391

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTL-HGYY 135
           +G G FG VY+    ++   A  ++    +E +   +  E++ +    H NIV L   +Y
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
             +   +LI E    G++D  +      ++ L  P    +       + YLH +    II
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KII 125

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTGRATA 253
           HRD+K+ NIL   + + +++DFG++           + + GT  ++APE    +T +   
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184

Query: 254 ---KGDVYSFGVVLLELLTGKRPMDE 276
              K DV+S G+ L+E+   + P  E
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 73/263 (27%), Positives = 103/263 (39%), Gaps = 60/263 (22%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNI- 128
           F S  VIG G FG V  +   D+   +A+K L +           E E +G I+  R+I 
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-------LEKEQVGHIRAERDIL 55

Query: 129 -------VTLHGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                  V    Y    + NL LI E +P G + T L  K    +     +++ IA    
Sbjct: 56  VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIA-ETV 111

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKT----------- 228
             I  +H       IHRDIK  N+LLD     ++SDFGL T L +A +T           
Sbjct: 112 LAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168

Query: 229 ----------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLE 266
                                  ++    GT  Y+APE F         D +S GV++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 267 LLTGKRPM-DEAFLEEGTKLVTW 288
           +L G  P   E   E   K++ W
Sbjct: 229 MLIGYPPFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 37/175 (21%)

Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT- 237
           A+G+++L   +CI    HRD+ + NILL      ++ DFGLA  +  +  +V   V G  
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNA 276

Query: 238 ---FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAFLEEGTKLVTW 288
                ++APE       T + DV+S+G++L E+ +         P+D  F     K++  
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY----KMI-- 330

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                   +E Y +  S E  P    ++++ I   C + +P KRPT  ++V+++E
Sbjct: 331 --------KEGYRML-SPECAP----SEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 33/214 (15%)

Query: 77  VIGSGGFGTVY---RLTVNDSTAFAVKRLHRGTTEVDRGFE------RELEAMGDIKHRN 127
           V+G G FG V        ++   +AVK L +     D   E      R L   G  KH  
Sbjct: 2   VLGKGSFGKVLLAELKGTDE--LYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPF 57

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +  LH  + +      + E +  G  D   H +   +   D P     A     G+ +LH
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGG--DLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLH 113

Query: 188 -HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLAPE 244
                  II+RD+K  N+LLD     +++DFG+    ++    T   +   GT  Y+APE
Sbjct: 114 ERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE 166

Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
              Y   G A    D ++ GV+L E+L G+ P +
Sbjct: 167 ILSYQPYGPAV---DWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 17/211 (8%)

Query: 71  KFSSKDVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
            ++  + IG G +G VY+          A    RL      V     RE+  + +++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 128 IVTLHGYYTSSQYNLLIYELMP---NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           IV L           LI+E +       LD+   G+ ++ + +     Y+I     +GI 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK-SYLYQIL----QGIL 115

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           + H      ++HRD+K  N+L+D     +++DFGLA         V T    T  Y APE
Sbjct: 116 FCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPE 171

Query: 245 -YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
               + R +   D++S G +  E+ T K+P+
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 53/185 (28%), Positives = 74/185 (40%), Gaps = 16/185 (8%)

Query: 92  NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL-HGYYTSSQYNLLIYELMPN 150
                  VK +  G T       RE++ +  I HR I+ L H Y   S     +  +MP 
Sbjct: 117 EQRKKVIVKAVTGGKTP-----GREIDILKTISHRAIINLIHAYRWKS----TVCMVMPK 167

Query: 151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM 210
              D F +        L+      I       +AYLH      IIHRD+K+ NI LD+  
Sbjct: 168 YKCDLFTYVDRSGPLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPE 222

Query: 211 EARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT 269
            A + DFG A  L     T      +GT    +PE        AK D++S G+VL E+  
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282

Query: 270 GKRPM 274
               +
Sbjct: 283 KNVTL 287

Length = 392

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 24/224 (10%)

Query: 58  HSLQ-SDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHR---GTTEVDRG 112
           +S+Q +D+ F    ++     IGSG  G V            AVK+L R     T   R 
Sbjct: 8   YSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA 67

Query: 113 FERELEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKN 166
           + REL  +  + H+NI++L   +T        Q   L+ ELM + +L   +H        
Sbjct: 68  Y-RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIH------ME 119

Query: 167 LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE 226
           LD      +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A 
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAC 174

Query: 227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
              + T    T  Y APE           D++S G ++ EL+ G
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 38/215 (17%)

Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-------- 128
           IG G FG VY++   D+   +A+K L +      +    + E    I  RNI        
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 129 ----VTLHGYYTSSQYNLLIYELMPNGSLDTFLH----GKSVNKKNLDWPSRYKIAVGAA 180
               V L   + +     L+ + M  G L  F H    G+    +     +++ IA    
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDR-----AKFYIA-ELV 106

Query: 181 RGIAYLH-HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
             + +LH +D    I++RD+K  NILLD      + DFGL+          +    GT  
Sbjct: 107 LALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTE 161

Query: 240 YLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           YLAPE   D    T   D +S GV++ E+  G  P
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 15/216 (6%)

Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRG----TTEVDRGFERELEAMGDIKHRNIVTLH 132
           IG G FG V ++   D+   +A+K + +      +EV      E   +  +    IV L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + S +   L+   +  G L  F H +   + +L      +     A  +  L +    
Sbjct: 60  FSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDL-----SRARFYTAELLCALENLHKF 112

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           ++I+RD+K  NILLD      + DFGL  L   +    +T   GT  YLAPE       T
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-CGTPEYLAPELLLGHGYT 171

Query: 253 AKGDVYSFGVVLLELLTGKRPM-DEAFLEEGTKLVT 287
              D ++ GV+L E+LTG  P  DE   E   K++ 
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 15/210 (7%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE--RELEAMGDI 123
           F K   +   + +G G + TVY+     +      ++ R   E    F   RE   +  +
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAAR 181
           KH NIV LH    + +   L++E + +  L  ++  H   ++ +N+             R
Sbjct: 61  KHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKL-----FLFQLLR 114

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           G++Y+H     +I+HRD+K  N+L+    E +++DFGLA   ++  +H  +    T  Y 
Sbjct: 115 GLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYR 170

Query: 242 APE-YFDTGRATAKGDVYSFGVVLLELLTG 270
            P+    +   +   D++  G + +E++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.0 bits (136), Expect = 6e-09
 Identities = 50/171 (29%), Positives = 73/171 (42%), Gaps = 31/171 (18%)

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           M D  + N + L+   T+ + ++LI + + +G L   L      +  L      KI    
Sbjct: 65  MKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQL 118

Query: 180 ARGIAYLH-HDCIPHIIHRDIKSSNILLDQNME-ARVSDFGLATLMEAEKTHVSTIVAGT 237
              +  LH H    +IIH DIK  N+L D+  +   + D+GL  ++     +      GT
Sbjct: 119 VEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGT 169

Query: 238 FGYLAPEYFDTGRATAKGDVY--SF-----GVVLLELLTGKRPMDEAFLEE 281
             Y +PE         KG  Y  SF     GV+  ELLTGK P  E   EE
Sbjct: 170 LDYFSPEKI-------KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 30/213 (14%)

Query: 76  DVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFE--RELEAMGDIKHRNIVTL 131
           +VIG G +G V    ++  T    A+K+++     V       RE++ +  ++H +IV +
Sbjct: 6   EVIGKGSYGVVCS-AIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 132 -HGYYTSSQYNL----LIYELMPNGSLDTFLHGKSVNKKNLDW-PSRYKIAV-GAARGIA 184
            H     S+       +++ELM     ++ LH   V K N D  P  ++  +    R + 
Sbjct: 65  KHIMLPPSRREFKDIYVVFELM-----ESDLH--QVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM--EAEKTHVSTIVAGTFGYLA 242
           Y+H     ++ HRD+K  NIL + + + ++ DFGLA +   +       T    T  Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 243 PE----YFDTGRATAKGDVYSFGVVLLELLTGK 271
           PE    +F   + T   D++S G +  E+LTGK
Sbjct: 175 PELCGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 25/161 (15%)

Query: 72  FSSKDVIGSGGFGTVYRLT--VNDSTAFAVKRLHRGTTEVDRG-------FERELEAMGD 122
           F +  VIG G FG V RL    +    +A+K L +  +E+ +         ER++ A  D
Sbjct: 3   FHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLK--SEMFKKDQLAHVKAERDVLAESD 59

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAA 180
                +V+L+  +  +QY  LI E +P G L T L       +++   +R+ +A  V A 
Sbjct: 60  SPW--VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVLAI 114

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT 221
             +  L        IHRDIK  NIL+D+    ++SDFGL+T
Sbjct: 115 EAVHKLGF------IHRDIKPDNILIDRGGHIKLSDFGLST 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 55.6 bits (135), Expect = 7e-09
 Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 72/305 (23%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIK-HRNIVTLHGY 134
           +G G FG+VY     ++    A+K++ +     +     RE++++  +  H NIV L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
           +  +     ++E M  G+L   +  K    K         I     +G+A++H       
Sbjct: 67  FRENDELYFVFEYM-EGNLYQLM--KDRKGKPFSESVIRSIIYQILQGLAHIHKH---GF 120

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH---VSTIVAGTFGYLAPE------- 244
            HRD+K  N+L+      +++DFGLA  + +   +   VS     T  Y APE       
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS-----TRWYRAPEILLRSTS 175

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRP-------MDEAFL-------------EEGTK 284
           Y      ++  D+++ G ++ EL T  RP       +D+ +               EG K
Sbjct: 176 Y------SSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIAS--------MCLEPEPSKRPTMT 336
           L           +  +             ++ +   AS          L  +P KRPT +
Sbjct: 229 LA---------SKLGFRFPQ----FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS 275

Query: 337 EVVKM 341
           + ++ 
Sbjct: 276 QALQH 280

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 27/216 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGF-----ERELEAMGDIK 124
           F+   V+G G FG V  L     T   +A+K L +     D        E+ + A+   K
Sbjct: 2   FNFLMVLGKGSFGKVM-LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-K 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
              +  LH  + +      + E +  G  D   H + V K     P     A   A G+ 
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGG--DLMYHIQQVGK--FKEPHAVFYAAEIAIGLF 115

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLA 242
           +LH      II+RD+K  N++LD     +++DFG+    +   + T       GT  Y+A
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYIA 169

Query: 243 PE---YFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           PE   Y   G++    D ++FGV+L E+L G+ P D
Sbjct: 170 PEIIAYQPYGKSV---DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 21/208 (10%)

Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFE-----RELEAMGDIKHRNIVT 130
           V+G G FG V       +   +A+K L +     D   E     + + A+ D K   +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQ 65

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +      + E +  G  D   H + V K     P     A   + G+ +LH   
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGG--DLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR- 120

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE---YFD 247
              II+RD+K  N++LD     +++DFG+      +     T   GT  Y+APE   Y  
Sbjct: 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF-CGTPDYIAPEIIAYQP 177

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMD 275
            G++    D +++GV+L E+L G+ P D
Sbjct: 178 YGKSV---DWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 66

Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 119

Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 120 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 174

Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 19/174 (10%)

Query: 104 RGTTEVDRGFERELEAMGDIKHRNIVTL--------HGYYTSSQYNLLIYELMPNGSLDT 155
           +  +      E E+ A+G + H NI+ +        + Y  + +Y+  +Y  M + + D 
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260

Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS 215
                    + L   +R  I       + Y+H      +IHRDIK  NI L+ + +  + 
Sbjct: 261 -------KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309

Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT 269
           DFG A   E E+        GT    +PE           D++S G++LL++L+
Sbjct: 310 DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 21/209 (10%)

Query: 78  IGSGGFGTVY--RLTVNDSTAFAVKRLHRGTTEVDRGFE--RE---LEAMGDIKHRNIVT 130
           IG G +G V+  R   N     A+KR+   T E        RE   L  +   +H N+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 131 LHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           L    T S+ +      L++E + +  L T+L    V +  +   +   +     RG+ +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH      ++HRD+K  NIL+  + + +++DFGLA +   +     T V  T  Y APE 
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
                     D++S G +  E+   ++P+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 36/217 (16%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLH--RGTTEVDRGFERELEAMGDIKHRN 127
           KF    V+G G +G V +    ++    A+K+        EV     REL+ +  +K  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 128 IVTLH-------GYYTSSQY---NLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
           IV L          Y   +Y   N+L + E MPNG                  P + +  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----------------PEKVRSY 105

Query: 177 V-GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIV 234
           +    + I + H +    I+HRDIK  N+L+  N   ++ DFG A  L E    + +  V
Sbjct: 106 IYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162

Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
           A T  Y +PE           D++S G +L EL  G+
Sbjct: 163 A-TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 25/169 (14%)

Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
           ARG+ +L   +C+    HRD+ + N+LL Q    ++ DFGLA  +  +  +VS     TF
Sbjct: 247 ARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300

Query: 239 ---GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
               ++APE       T   DV+S+G++L E+ + G  P     ++      T+   +  
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----TFYNKIKS 355

Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             R            P +   +V+ I   C   EP KRP+   +  ++E
Sbjct: 356 GYRMAK---------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 10/94 (10%)

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           + YLH      +++RD+K  N++LD++   +++DFGL     ++   + T   GT  YLA
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLA 163

Query: 243 PEYF---DTGRATAKGDVYSFGVVLLELLTGKRP 273
           PE     D GRA    D +  GVV+ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 66/264 (25%)

Query: 78  IGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDR-------GFERELEAMGDIKHRNIV 129
           IG G FG V  +   D+ A +A+K L +   +V           ER++ A  D  +  +V
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRK--ADVLMRNQAAHVKAERDILAEAD--NEWVV 64

Query: 130 TLHGYYT-SSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            L  YY+   + NL  + + +P G + + L    + +++L   +R+ IA      I  +H
Sbjct: 65  KL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVH 118

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-------------------------- 221
                  IHRDIK  NIL+D++   +++DFGL T                          
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 222 -LMEAEKTHVSTI---------------VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLL 265
              E ++  +  +               + GT  Y+APE       T   D +S GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 266 ELLTGKRP-MDEAFLEEGTKLVTW 288
           E+L G+ P + +   E   K++ W
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 54/251 (21%), Positives = 115/251 (45%), Gaps = 43/251 (17%)

Query: 103 HRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV 162
           HR  +E    F      M  + H+++V  +G       ++++ E +  GSLDT+L  K+ 
Sbjct: 39  HRNYSE---SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNK 94

Query: 163 NKKNLDWPSRYKIAVGAARGIAY-LHHDCIPHIIHRDIKSSNILLDQNMEA--------R 213
           N  N+ W    K+ V  A+ +A+ LH      + H ++ + N+LL +  +         +
Sbjct: 95  NLINISW----KLEV--AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIK 148

Query: 214 VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA-KGDVYSFGVVLLELLTG-K 271
           +SD G++  +  ++  +  I      ++ PE  +  +  +   D +SFG  L E+ +G  
Sbjct: 149 LSDPGISITVLPKEILLERI-----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203

Query: 272 RPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSK 331
           +P+  + L+   KL  +     +D+ +           P  +  ++ ++ + C++ EP  
Sbjct: 204 KPL--SALDSQKKLQFY-----EDRHQ----------LPAPKWTELANLINQCMDYEPDF 246

Query: 332 RPTMTEVVKML 342
           RP+   +++ L
Sbjct: 247 RPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 16/198 (8%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIK-HRNIVTLHGY 134
           IG G F  V +  +      +A+K + +    +++    RE++A+  +  H NI+ L   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 135 -YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
            +      L L++ELM + +L   + G+   K+ L             + + ++H +   
Sbjct: 67  LFDRKTGRLALVFELM-DMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN--- 119

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRA 251
            I HRDIK  NIL+  +   +++DFG    + ++  +  T    T  Y APE   T G  
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYY 176

Query: 252 TAKGDVYSFGVVLLELLT 269
             K D+++ G V  E+L+
Sbjct: 177 GPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 10/94 (10%)

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           + YLH      +++RDIK  N++LD++   +++DFGL     ++   + T   GT  YLA
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLA 163

Query: 243 PEYF---DTGRATAKGDVYSFGVVLLELLTGKRP 273
           PE     D GRA    D +  GVV+ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 59/252 (23%), Positives = 96/252 (38%), Gaps = 48/252 (19%)

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
           +H NI+T    +T+  +  +I   M  GS ++ L  K+   + +       I  GA RG+
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGL 114

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG---- 239
            YLH +     IHR+IK+S+IL+    +  VS  GL+ L    +      V   F     
Sbjct: 115 NYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 240 ----YLAPEYF--DTGRATAKGDVYSFGVVLLELLTGKRPMDE----------------- 276
               +L+PE    D      K D+YS G+   EL TG+ P  +                 
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229

Query: 277 -----AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN---------DVFSIAS 322
                 F  E +++      V     E  V     +      +             ++  
Sbjct: 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289

Query: 323 MCLEPEPSKRPT 334
           +CL+ +P KRP+
Sbjct: 290 LCLQQDPEKRPS 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 8/148 (5%)

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V LH  + ++    L+ E +  G  D   H +   K   +    Y   +  A  + +LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGG--DLMFHMQRQRKLPEEHARFYAAEICIA--LNFLH 113

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                 II+RD+K  N+LLD +   +++D+G+           ST   GT  Y+APE   
Sbjct: 114 ER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF-CGTPNYIAPEILR 169

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMD 275
                   D ++ GV++ E++ G+ P D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 130 TLHGYYTSSQYNL-------LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           T H + TS +Y+         + E +  G L  F H       + D    Y   + +A  
Sbjct: 52  TRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSA-- 107

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           + YLH      I++RD+K  N++LD++   +++DFGL      +   + T   GT  YLA
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-CGTPEYLA 163

Query: 243 PEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           PE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 164 PEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKTHVSTIVAG--T 237
           RG+ Y+H     +++HRD+K +N+ ++  ++  ++ DFGLA +++   +H   +  G  T
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 238 FGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
             Y +P    +     K  D+++ G +  E+LTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 57/239 (23%)

Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVK-----------RLHRGTTEVDRGFERELEAMGDIK 124
           ++G G  G V+ + +  +   FA+K           ++ R  TE      +E+ A  D  
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE------QEILATLD-- 59

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL-DWPSRYKIA-VGAARG 182
           H  + TL+  + +  Y  L+ +  P G L   L  +    K L +  +R+  A V  A  
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLA-- 115

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS----------- 231
           + YLH   +  I++RD+K  NILL ++    +SDF L+   + E   VS           
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 232 -------TIVA----------GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
                  T             GT  Y+APE        +  D ++ G++L E+L G  P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YLH +   ++++RD+K  N++LD++   +++DFGL      +   + T   GT  YLAPE
Sbjct: 110 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPE 166

Query: 245 YF---DTGRATAKGDVYSFGVVLLELLTGKRP 273
                D GRA    D +  GVV+ E++ G+ P
Sbjct: 167 VLEDNDYGRAV---DWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73

Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 126

Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 181

Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++ G 
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 12/153 (7%)

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH  + +      + E +  G  D   H +   K   +    Y   +  A  + 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLA--LN 110

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLA 242
           YLH      II+RD+K  N+LLD     +++D+G+    L   + T   +   GT  Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           PE           D ++ GV++ E++ G+ P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 16/205 (7%)

Query: 79  GSGGFGTVYRLTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
                  + +    + T  AVK+  L   + E  +  ++E+     ++H NI+     + 
Sbjct: 11  EDLMIVHLAKHKPTN-TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++  LM  GS +  L  K+   + L   +   I       + Y+H       IH
Sbjct: 70  VDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIH 124

Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG------YLAPE--YFDT 248
           R +K+S+ILL  + +  +S    +  M         +            +L+PE    + 
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 249 GRATAKGDVYSFGVVLLELLTGKRP 273
                K D+YS G+   EL  G  P
Sbjct: 185 QGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 21/208 (10%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGF-----ERELEAMGDIKHRNIVT 130
           V+G G FG V    +  +   +A+K L +     D        E+ + A+   KH  +  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA-AKHPFLTA 60

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HD 189
           LH  + +      + E +  G L  F   +S   +  D P     A      + +LH H 
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDL-MFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLAPEYFD 247
               +I+RD+K  NILLD     +++DFG+    ++    T   T   GT  Y+APE   
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQ 169

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMD 275
                   D ++ GV++ E++ G+ P +
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 49/240 (20%), Positives = 99/240 (41%), Gaps = 48/240 (20%)

Query: 117 LEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
            +  G +K+ +I + +     S Y+  +         DT ++        L +      +
Sbjct: 193 QDMKGTVKYADIESSN---YESPYDQYLPSAPERTRRDTLINESPA----LSYMDLVGFS 245

Query: 177 VGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
              A G+ +L   +C+    HRD+ + N+L+ +    ++ DFGLA  +  +  ++S    
Sbjct: 246 YQVANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--G 299

Query: 236 GTF---GYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAF---LEEGT 283
            TF    ++APE       T   DV+SFG++L E+ T       + PM+E F   ++ G 
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           ++                        P +  ++++ I   C E +   RP  +++V ++ 
Sbjct: 360 RMAK----------------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 19/207 (9%)

Query: 77  VIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFE------RELEAMGDIKHRNI 128
           V+G G FG V  L     T   +A+K L +     D   E      R L   G  K   +
Sbjct: 7   VLGKGSFGKVM-LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG--KPPFL 63

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             LH  + +      + E +  G  D     + V +     P     A   A G+ +LH 
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGG--DLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHS 119

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
                II+RD+K  N++LD     +++DFG+      +     T   GT  Y+APE    
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF-CGTPDYIAPEIIAY 175

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMD 275
                  D ++FGV+L E+L G+ P +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 9/104 (8%)

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           II+RD+K  N+LLD     +++DFG+           ST   GT  Y+APE         
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-CGTPDYIAPEILQEMLYGP 175

Query: 254 KGDVYSFGVVLLELLTGKRPMD--------EAFLEEGTKLVTWV 289
             D ++ GV+L E+L G  P +        EA L +     TW+
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.8 bits (114), Expect = 9e-07
 Identities = 28/147 (19%), Positives = 57/147 (38%), Gaps = 16/147 (10%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT--LHGYY 135
           +  G    VY L       + +K         DR  ERE+  +  +  + +    +    
Sbjct: 6   LKGGLTNRVYLLG-TKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLASG 62

Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
            S  ++ L+ E         ++ G+++++ + +   +  IA   A  +A LH   +  + 
Sbjct: 63  ESDGWSYLLME---------WIEGETLDEVSEE--EKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATL 222
           H D+   NIL+D      + D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 51/225 (22%), Positives = 104/225 (46%), Gaps = 35/225 (15%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKH 125
           F +  +I +G +G VY +   ++   FA+K++++       ++ + F ER++    +  +
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--N 60

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
             +V++   + + ++  ++ E +  G   T L  K++    +D    Y      A  + Y
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLA--LEY 116

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL-------------MEAE-KTHVS 231
           LH+     I+HRD+K  N+L+      +++DFGL+ +             +E + +  + 
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 232 TIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRP 273
             V GT  Y+APE       G+     D ++ G++L E L G  P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPV---DWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 36/214 (16%)

Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKR-LHRGTTEVDRGFE----RELEAMGDIKHRNIVT 130
           IG G FG V++   +  T    A+K+ L     E   GF     RE++ +  +KH N+V 
Sbjct: 20  IGQGTFGEVFKAR-HKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVN 75

Query: 131 LHG--YYTSSQYN------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           L       ++ YN       L++E   +  L   L  K+V           K+      G
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK---FTLSEIKKVMKMLLNG 131

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA---TLMEAEKTHVSTIVAGTFG 239
           + Y+H +    I+HRD+K++NIL+ ++   +++DFGLA   +L +  K +  T    T  
Sbjct: 132 LYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 240 YLAPEYF----DTGRATAKGDVYSFGVVLLELLT 269
           Y  PE      D G      D++  G ++ E+ T
Sbjct: 189 YRPPELLLGERDYGPPI---DMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 15/89 (16%)

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           II+RD+K  N+LLD     +++D+G+           ST   GT  Y+APE         
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-CGTPNYIAPEIL------- 168

Query: 254 KGDVYSF-------GVVLLELLTGKRPMD 275
           +G+ Y F       GV++ E++ G+ P D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 30/228 (13%)

Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRL--HRGTTEVDRG-FERELEAMGDIKHRNIVTLHGY 134
           IG+G FG V+ +    +  F   +   +RG  E ++     E+  M ++KH+NIV     
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 135 Y--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH---- 188
           +   ++Q   ++ E    G L   +         ++  +   I       +AY H+    
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 189 DCIPHIIHRDIKSSNILLDQNME-----------------ARVSDFGLATLMEAEKTHVS 231
                ++HRD+K  NI L   +                  A++ DFGL+  +  E    S
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200

Query: 232 TIVAGTFGYLAPEYF--DTGRATAKGDVYSFGVVLLELLTGKRPMDEA 277
            +  GT  Y +PE    +T     K D+++ G ++ EL +GK P  +A
Sbjct: 201 CV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246

Length = 1021

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 43/148 (29%), Positives = 62/148 (41%), Gaps = 17/148 (11%)

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGAARGI 183
           N+V LH Y  S     L+ +    G L + +  K +N        W +   +A+ A    
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
             LH +    I+ RD+  +NILLD     +++ F      E E +     V     Y AP
Sbjct: 101 --LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAP 151

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGK 271
           E       T   D +S G +L ELLTGK
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 62/272 (22%), Positives = 105/272 (38%), Gaps = 66/272 (24%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGF-----ERELEAMGDIKH 125
           F     +G G FG V      D+ A +A+K L +    +         ER++ A  D  +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGI 183
             +V L+  +        + + +P G + + L    +  ++L   +R+ IA    A   +
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAELTCAVESV 117

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-------------------- 223
             +        IHRDIK  NIL+D++   +++DFGL T                      
Sbjct: 118 HKMG------FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171

Query: 224 -----------------------EAEKTH---VSTIVAGTFGYLAPEYFDTGRATAKGDV 257
                                   A + H   ++  + GT  Y+APE       T   D 
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231

Query: 258 YSFGVVLLELLTGKRP-MDEAFLEEGTKLVTW 288
           +S GV+L E+L G+ P + +  LE   K++ W
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 4/85 (4%)

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK-THVSTIVAGTFGYL 241
           I Y+H +    IIHRDIK+ N+L++   +  + DFG A        T     +AGT    
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 242 APEYFDTGRATAKGDVYSFGVVLLE 266
           APE       T   D++S G+V+ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 64/268 (23%), Positives = 100/268 (37%), Gaps = 58/268 (21%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI----KHRN 127
           F     +G G FG V      D+ A    +  R    ++R     ++A  DI     +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V L+  +        + + +P G + + L    V  + L   +R+ IA      I  +H
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIA-ELTLAIESVH 118

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--------------------LME--- 224
                  IHRDIK  NIL+D +   +++DFGL T                     ME   
Sbjct: 119 K---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 225 --------------------AEKTH---VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFG 261
                               A K H   ++  + GT  Y+APE       T   D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 262 VVLLELLTGKRP-MDEAFLEEGTKLVTW 288
           V+L E+L G+ P +     E   K++ W
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 15/149 (10%)

Query: 78  IGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI----KHRNIVTLH 132
           I  G FG VY     N+S  +AVK + +    +++    +++A  D     K   IV L+
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVV-KKADMINKNMVHQVQAERDALALSKSPFIVHLY 70

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
               S+    L+ E +  G + + LH         D     K     A  + YLH     
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHR---- 122

Query: 193 H-IIHRDIKSSNILLDQNMEARVSDFGLA 220
           H IIHRD+K  N+L+      +++DFGL+
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 53/234 (22%), Positives = 102/234 (43%), Gaps = 41/234 (17%)

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           M  + H ++  +HG       N+++ E + +G LD  L      K+    P  +KI V  
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-----KEKGRVPVAWKITVAQ 124

Query: 180 --ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-------RVSDFGLATLMEAEKTHV 230
             A  ++YL      +++H ++ + NILL +   A       ++SD G++    + +  V
Sbjct: 125 QLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV 181

Query: 231 STIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLEL-LTGKRPMDEAFLEEGTKLVTW 288
             I      ++APE        +   D +SFG  LLE+   G+ P+ E    E  +    
Sbjct: 182 ERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-- 234

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                  +++  + + S   C      ++ ++ S CL  EP++RP+   +++ L
Sbjct: 235 -------EKKHRLPEPS---CK-----ELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 21/206 (10%)

Query: 78  IGSGGFGTVYRLTVNDSTAFA---VKRL--HRGTTEVDRGFERELEAMGDIKHRNIVTLH 132
           IG+G FG V    +   T  A   VK L  +  + E +  F ++ +    ++H NI+   
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE-FLQQGDPYRILQHPNILQCL 61

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G    +   LL++E    G L ++L  +  +++N       ++A   A G+ ++H     
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE---KTHVSTIVAGTFGYLAPEYFD-- 247
           + +H D+   N  L  ++  +V D+G+      E   +T     V     +LAPE     
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LRWLAPELVGEF 176

Query: 248 -----TGRATAKGDVYSFGVVLLELL 268
                T   T   +V++ GV L EL 
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 8/93 (8%)

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAE-KTHVSTIVAGTF 238
           +G+A+ H      ++HRD+K  N+L+D Q    +++D GL        K++   IV  T 
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TL 175

Query: 239 GYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTG 270
            Y APE        +   D++S G +  E+   
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 25/81 (30%), Positives = 32/81 (39%), Gaps = 8/81 (9%)

Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HR  KS NILL    +  +   G       E     +     F   APE       T K 
Sbjct: 34  HRQAKSGNILL--TWDGLLKLDGSVAFKTPE----QSRPDPYFM--APEVIQGQSYTEKA 85

Query: 256 DVYSFGVVLLELLTGKRPMDE 276
           D+YS G+ L E L  + P +E
Sbjct: 86  DIYSLGITLYEALDYELPYNE 106

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	351
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.61
KOG1243	690	consensus Protein kinase [General function predict	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
COG4248	637	Uncharacterized protein with protein kinase and he	99.43
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.36
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.19
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.0
PRK09902	216	hypothetical protein; Provisional	98.99
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.95
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.85
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.55
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.53
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.49
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.48
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.47
PLN02876	822	acyl-CoA dehydrogenase	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.3
PRK10593	297	hypothetical protein; Provisional	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.19
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.13
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.12
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.99
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.98
PRK05231	319	homoserine kinase; Provisional	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.91
KOG2270	520	consensus Serine/threonine protein kinase involved	97.88
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.82
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.62
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.61
PLN02236	344	choline kinase	97.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.32
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.27
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.16
COG2334	331	Putative homoserine kinase type II (protein kinase	97.08
PRK12396	409	5-methylribose kinase; Reviewed	97.01
PLN02756	418	S-methyl-5-thioribose kinase	96.99
PRK11768	325	serine/threonine protein kinase; Provisional	96.9
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.83
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.69
PRK06148	1013	hypothetical protein; Provisional	96.55
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.27
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.18
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.17
PTZ00384	383	choline kinase; Provisional	96.11
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.02
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.64

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-55  Score=391.65  Aligned_cols=289  Identities=49%  Similarity=0.818  Sum_probs=251.5

Q ss_pred             ccccCChHHHHHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEE
Q 018702           56 LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY  135 (351)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  135 (351)
                      ....|++.++..+|++|...+.||+|+||.||+|...+++.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45678999999999999999999999999999999999999999988765443145599999999999999999999999


Q ss_pred             ecCC-eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          136 TSSQ-YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       136 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                      .+.+ ..+||+||+++|+|.++|......  +++|..+++||.++|+||+|||+.+.+.|+||||||+|||+|++..+||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999865322  8999999999999999999999998788999999999999999999999


Q ss_pred             eeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      +|||+++..+...........||.+|+|||+...+..+.++||||||+++.||++|+.|...........+..|....+.
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999965544112111111699999999999999999999999999999999999998876554445568999999998


Q ss_pred             cCccceeccccCC--CCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          295 DKREEYVIDTSLE--GCPI-NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       295 ~~~~~~~~~~~~~--~~~~-~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      +.....++|+.+.  ..+. .....+..+..+|++.+|.+||++.||+++|+.+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            8888889998875  3443 57778999999999999999999999999996654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-55  Score=368.80  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=214.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-eeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-YNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  147 (351)
                      +.+..+.||+|..|+||++.++ +++-+|+|++... .....+++.+|+++++..+|||||.++|.|..++ ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4556778999999999999986 5677999999654 4455678999999999999999999999999999 49999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      |++|||+.++.    ..+.+++...-.++.++++||.|||+.  .+|+||||||+|||++..|.+||||||.+....+. 
T Consensus       160 MDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999997    346799999999999999999999973  29999999999999999999999999999876554 


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                        ...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||... .+......+.+.....+..         .
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~pp---------P  300 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDEPP---------P  300 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcCCC---------C
Confidence              446678999999999999999999999999999999999999999765 1222333444444433322         2


Q ss_pred             CCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..|.. +++++++++..||++||.+|||+.|++++
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            34554 77899999999999999999999999876

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-53  Score=376.09  Aligned_cols=248  Identities=29%  Similarity=0.507  Sum_probs=216.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|...++||+|||+.||.+.. ..|..||+|++.+.   .....+.+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4799999999999999999998 78999999999763   3344567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |+|+.++|..+++    ..+++++.+++.+++||+.|+.|||++   +|+|||||..|+|++++.++||+|||+|.....
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999998    568899999999999999999999999   999999999999999999999999999998765


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      +.. ...+.||||.|.|||++....++..+||||+||++|.|+.|++||+.....+      .......   .++     
T Consensus       171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~---~~Y-----  235 (592)
T KOG0575|consen  171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKL---NEY-----  235 (592)
T ss_pred             ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHh---cCc-----
Confidence            432 3456899999999999999999999999999999999999999998754332      1111111   111     


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ..|...+.++.+||.++|+.||.+|||+++++.+
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              2355667889999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-53  Score=371.98  Aligned_cols=256  Identities=31%  Similarity=0.493  Sum_probs=219.9

Q ss_pred             CCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      ++..+.||+|.||+||.|.+++...||+|.++.. ....+.|.+|+.+|++++|+|||+++|+|..++..+|||||++.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4456789999999999999999889999999875 334466889999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      +|.+||...  ....+...+.+.++.|||+||+||+++   ++|||||.++||||++++.+||+|||+++....+.+...
T Consensus       287 sLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  287 SLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            999999862  467789999999999999999999999   999999999999999999999999999996555555444


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      ....-+..|.|||.+..+.++.+|||||||++||||+| |+.||......      +.+..+.+..         ...+|
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le~Gy---------Rlp~P  426 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLERGY---------RLPRP  426 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHhccC---------cCCCC
Confidence            44456789999999999999999999999999999999 99998665322      2222222221         12467


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ..++..+.++|..||..+|++|||++.+...|+.+...
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            77889999999999999999999999999999988654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-52  Score=366.91  Aligned_cols=257  Identities=38%  Similarity=0.579  Sum_probs=213.4

Q ss_pred             CCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhh--HHHHHHHHHHhhcCCCCceeeeeeEEecCC-eeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV--DRGFERELEAMGDIKHRNIVTLHGYYTSSQ-YNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  148 (351)
                      ....+.+|+|+||+||+|.+.+...||+|++.......  .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            44456699999999999999877779999997654322  458999999999999999999999999988 799999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCcEEEcCCC-ceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH-IIHRDIKSSNILLDQNM-EARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~  226 (351)
                      ++|+|.+++...  ....+++..+..++.||++||.|||++   + |+||||||+|||++.++ ++||+|||+++.....
T Consensus       123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999854  367899999999999999999999999   7 99999999999999997 9999999999865443


Q ss_pred             cccccccccccccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD--TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      . .......||+.|||||++.  ...|+.++||||||+++|||+||+.||.....      .+....+.......     
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp-----  265 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRP-----  265 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC-----
Confidence            2 2222356999999999999  56999999999999999999999999976432      22222222221111     


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         ..|..+++.+..++.+||..||..||++.+++..|+.+...
T Consensus       266 ---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  266 ---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             ---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence               12333557899999999999999999999999999987653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-53  Score=359.71  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh-------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE-------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  140 (351)
                      ...|...+.||+|+||.|-+|.. ++++.||||++......       ....+.+|+++|++++|||||+++++|+.+..
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            34678889999999999999985 57899999999653211       12235799999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CceEEeee
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN---MEARVSDF  217 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~df  217 (351)
                      .|+||||++||+|.+++-    ..+.+.+..-..+++|++.|+.|||++   ||+||||||+|||++.+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999997    456677777788999999999999999   99999999999999766   77999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA---TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      |+|+..+  ......+.||||.|.|||++.+..+   ..+.|+||+||++|-+++|.+||.+......      +.+.+.
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQIL  395 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHh
Confidence            9999776  3344577899999999999976543   3478999999999999999999977543221      111111


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+..+     ....+...+++..+||.+||..||++|||+.|+|++
T Consensus       396 ~G~y~f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  396 KGRYAF-----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cCcccc-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            111111     012355677899999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-51  Score=349.50  Aligned_cols=247  Identities=25%  Similarity=0.426  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|...+.||+|+||+||+|.++ ++..||||.+...  .....+.+..|+++|+.++|||||++++++..++..|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            47888888999999999999975 5788999999776  45556678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC------CceEEeeeccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN------MEARVSDFGLA  220 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~------~~~kl~dfg~~  220 (351)
                      ||+||+|.+|++    ..+.+++.....++.|++.|+++||++   +|+||||||+|||++.+      -.+||+|||++
T Consensus        90 yC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999998    455799999999999999999999999   99999999999999764      45899999999


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      +...+..  ...+.+|++-|||||++..++|+.|+|+||+|+++|+|++|++||......+-.      ....+...   
T Consensus       163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~------~~~~k~~~---  231 (429)
T KOG0595|consen  163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL------LYIKKGNE---  231 (429)
T ss_pred             hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHhcccc---
Confidence            9877433  345678999999999999999999999999999999999999999765433211      11111100   


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV  338 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~  338 (351)
                      +    ....+...+..+.+++...++.+|.+|-+..+-
T Consensus       232 ~----~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  232 I----VPVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             c----cCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            0    011222233445566666666676666665543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-52  Score=339.83  Aligned_cols=257  Identities=24%  Similarity=0.421  Sum_probs=213.1

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeee-EEecCCe-eEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHG-YYTSSQY-NLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~  145 (351)
                      +|++.+.||+|.||+||++.. .+|..+|.|.++-+..  ...+....|+.+|++++|||||++++ .+.+++. .+++|
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            577788999999999999984 6788999999874432  33456889999999999999999999 4555554 89999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC-IPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |+|.+|+|...++......+.+++..+|+++.|++.||.++|+.. +..|.||||||.||+++.+|.+||+|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999999877667888999999999999999999999942 1249999999999999999999999999999887


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      +.... ..+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.      ++........+.         
T Consensus       180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg---------  243 (375)
T KOG0591|consen  180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG---------  243 (375)
T ss_pred             chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC---------
Confidence            66544 34567999999999999999999999999999999999999999764      222222222221         


Q ss_pred             cCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          305 SLEGCP-INEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       305 ~~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ...++| ...+.++..++..|+..||+.||+...++..+.
T Consensus       244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            233456 678899999999999999999998655554443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=340.26  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=205.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..++||+|+||+||.++.+ +++-+|+|++++..-   ...+...+|..+|..++||+||+++..|++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3457999999999999999999875 467799999976432   234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      |+||+.||.|..+|+    .+..+++..+..++..|+.||.|||+.   +|+||||||+|||+|.+|+++|+|||+++..
T Consensus       103 Vld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999998    567799999999999999999999999   9999999999999999999999999999854


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      -.. .....+.+||+.|||||++.+..|+.++|.||||+++|||++|.+||....      ...+.......+.      
T Consensus       176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~------  242 (357)
T KOG0598|consen  176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKL------  242 (357)
T ss_pred             ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcC------
Confidence            332 223455799999999999999999999999999999999999999996543      2233333333331      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRP  333 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  333 (351)
                         ...|...+.+.++++.++|+.||++|.
T Consensus       243 ---~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence               112333558899999999999999996

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-50  Score=373.99  Aligned_cols=259  Identities=30%  Similarity=0.495  Sum_probs=218.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      +....+.||+|+||+||+|...      +...||||.++..... ..++|.+|++++..++|||||+++|+|.+++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3445678999999999999843      3456999999887666 66789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCC------C----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          144 IYELMPNGSLDTFLHGKSV------N----KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~------~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                      |+|||..|+|.+||.....      .    ..+++..+.+.||.|||.||.||-++   .+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence            9999999999999974322      1    23388899999999999999999998   999999999999999999999


Q ss_pred             EeeeccccccCcccccccc-cccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHH
Q 018702          214 VSDFGLATLMEAEKTHVST-IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      |+|||+++.....+++... ...-+.+|||||.+..+++|++|||||||+++||+++ |+.|+.+...++       +-+
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe  716 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIE  716 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHH
Confidence            9999999876655544332 3446889999999999999999999999999999999 999987653221       222


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .+        .+..+.++|.+++.++++||..||+.+|.+|||++||-..|+..-.
T Consensus       717 ~i--------~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  717 CI--------RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HH--------HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            22        2233446888899999999999999999999999999999987643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-49  Score=326.36  Aligned_cols=263  Identities=23%  Similarity=0.291  Sum_probs=204.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+...++|+|+||.||+++++ +|+-||||++....  +...+-.++|+++|++++|||+|.++.+|......++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            5777888999999999999986 47889999996643  33445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      |+.--|.+ |+.   ....++.....+++.|++.|+.|+|++   +++||||||+|||++.+|.+||||||+|+..... 
T Consensus        83 ~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   83 CDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             cchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            98855544 443   345688899999999999999999999   9999999999999999999999999999977642 


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH-HHHH-------HHHHhc-Cc
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL-VTWV-------KAVMQD-KR  297 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~-------~~~~~~-~~  297 (351)
                      ....+....|.+|.|||.+.+ .+|+...||||+||++.||++|.+-|.+...-+..-. ...+       ...... ..
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            233445668999999999877 7899999999999999999999999876533221110 0111       111111 00


Q ss_pred             cceeccccC------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTSL------EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      -..+.-+..      +.-.+..+.-+.+++..||+.||++|+|.+|++++
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            001111111      11123345568999999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=344.18  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=212.5

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCe
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  140 (351)
                      .+...+|..++.||.|+|++|++|... .++.||||++.+.-.   ...+.+..|-++|.+| .||.|++++-.|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445568999999999999999999864 578899999865321   1123467899999999 79999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      +|+|+||+++|+|.+++.+    -+.+++...+.++.+|+.|++|||++   ||+||||||+|||+++||++||+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999984    46799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCccccc----------c--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHH
Q 018702          221 TLMEAEKTH----------V--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW  288 (351)
Q Consensus       221 ~~~~~~~~~----------~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  288 (351)
                      +.+++....          .  ...++||..|.+||++..+..++.+|+|+|||++|+|+.|.+||.....      .-.
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yli  295 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLI  295 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHH
Confidence            876543221          1  1457899999999999999999999999999999999999999976421      222


Q ss_pred             HHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +++.+.-..          ..|.+.++.+.+|+.+.|..||.+|+|+++|-++
T Consensus       296 FqkI~~l~y----------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 FQKIQALDY----------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHhcc----------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            333332111          2466666899999999999999999999888654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=335.70  Aligned_cols=256  Identities=31%  Similarity=0.497  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC--eeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--YNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  146 (351)
                      .+|...+.||+|+||+||++...+ |...|+|..........+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            357778899999999999999764 7889999987764444567899999999999999999999744433  6899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~  225 (351)
                      |+++|+|.+++.+..  . .+++..+..+++||++||+|||++   +++||||||+|||++. ++.+||+|||++.....
T Consensus        97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999998542  2 699999999999999999999998   9999999999999999 79999999999987663


Q ss_pred             --ccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          226 --EKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       226 --~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                        ..........||+.|||||++..+ ....++|||||||++.||+||++||...     .....+.-......      
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------  239 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------  239 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence              222223346799999999999863 3345999999999999999999998653     11112222222111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                        .....|...+.++.+++.+|++.||.+||||.++|++...
T Consensus       240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence              1113566677899999999999999999999999987654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=314.02  Aligned_cols=236  Identities=25%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||.|+||.|.+++.+ ++..+|+|++.....-   ..+...+|..+|+.+.||+++++.+.|.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888899999999999999975 4677999999765432   2345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++||.|.++++    ..+.+++..++.++.||+.|++|||+.   +|++|||||+|||+|.+|.+||+|||+++....
T Consensus       124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999998    456799999999999999999999999   999999999999999999999999999987644


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .    ..+.||||.|+|||.+....|..++|.||||+++|||+.|.+||.....      ..........+.        
T Consensus       197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v--------  258 (355)
T KOG0616|consen  197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKV--------  258 (355)
T ss_pred             c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcc--------
Confidence            3    4568999999999999999999999999999999999999999976532      222333332221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKR  332 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~R  332 (351)
                        ..|...+.++.+|+.++|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              2466777899999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-49  Score=339.72  Aligned_cols=260  Identities=22%  Similarity=0.338  Sum_probs=208.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHH-HHHHHHHHhhcCC-CCceeeeeeEEecCC-eeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIK-HRNIVTLHGYYTSSQ-YNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~  145 (351)
                      .+|...+.||.|+||+||+|.. ..+..||||+++.......+ .-.+|++.|++++ ||||+++.+++.+.+ ..++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            4788889999999999999985 46788999999876544333 3468999999999 999999999998887 999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |||+ .+|+++++..   ++.+++..++.|+.||++||+|+|.+   |+.|||+||+|||++.+..+||+|||+|+....
T Consensus        90 E~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   90 EFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             Hhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence            9995 4999999864   67899999999999999999999999   999999999999999888999999999997654


Q ss_pred             ccccccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc------
Q 018702          226 EKTHVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE------  298 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  298 (351)
                      ..  ..+....|.+|+|||++ ..+.|+.+.|+||+|||++|+.+-++.|.+...-+.  +... -+++.....      
T Consensus       163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~KI-c~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYKI-CEVLGTPDKDSWPEG  237 (538)
T ss_pred             CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHHH-HHHhCCCccccchhH
Confidence            33  33556789999999977 457899999999999999999999999987543221  1111 111111111      


Q ss_pred             -----------ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 -----------EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 -----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                 .......+...-.+.+.++.+++.+|+++||.+||||+|++++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                       0111111222223467889999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=338.51  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=208.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC----Ch-hhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCe
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG----TT-EVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQY  140 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  140 (351)
                      ...+|...+.||+|+||+|+.|.. .++..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345899999999999999999975 46789999977553    12 23456778999999999 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeecc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGL  219 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~  219 (351)
                      .++||||+.||+|.+++.    +.+.+.+..+..+++|+++|++|||++   +|+||||||+|||++.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999997    456788899999999999999999999   99999999999999999 9999999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR-AT-AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||.+..      ........... .
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~-~  239 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKG-E  239 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcC-C
Confidence            98764 2233456678999999999999876 75 78999999999999999999997632      11122221111 1


Q ss_pred             cceeccccCCCCCHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          298 EEYVIDTSLEGCPINE-INDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                               -.+|... +.++.+|+.+||..||.+|+|+.++++
T Consensus       240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                     1234444 689999999999999999999999984

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-48  Score=341.02  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=211.5

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..|+....||+|+.|.||.+.. .+++.||+|++....-...+-+.+|+.+|+..+|+|||++++.|...+..|.||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            3678888999999999999985 567889999997766555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +||+|.+.+..     ..+++.++..+++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999999963     4489999999999999999999999   999999999999999999999999999987765544


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                       ...+..|||.|||||++....|+++.||||||++++||+-|.+||-....      .............. +      .
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~P~-l------k  490 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTPK-L------K  490 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCCCC-c------C
Confidence             33456799999999999999999999999999999999999999854211      11111111111110 0      2


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||+.|+++|||+.|+|++
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            356667889999999999999999999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4e-47  Score=306.70  Aligned_cols=261  Identities=22%  Similarity=0.357  Sum_probs=208.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|...+.||+|.||.||+|.+ .+|+.||||+++.....  ......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3677888999999999999986 56889999999775332  23457899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |++. +|...++.   +...++..++..++.++++|++|||++   .|.||||||.|+|++++|.+||+|||+++.+.+.
T Consensus        82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9966 99999975   456788999999999999999999999   9999999999999999999999999999988765


Q ss_pred             cccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc--
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID--  303 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  303 (351)
                      ...... ...|.+|.|||.+.+ ..|+...|+||.|||+.||+.|.+-|.+.+.-+.   ....-+.......+.+.+  
T Consensus       155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccc
Confidence            443322 257999999998866 5799999999999999999999988866432211   111112222221111111  


Q ss_pred             -------------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 -------------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 -------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                   +.....-...+.++.+|+.+||..||.+|+|++|++++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                         11112233456778999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-47  Score=333.98  Aligned_cols=261  Identities=25%  Similarity=0.330  Sum_probs=209.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  144 (351)
                      ..|+..++||+|+||.||+|+. .+|+.||+|++..+.  ........+|+.+|++++||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3577788999999999999986 568889999997654  34445678999999999999999999998776  689999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      +|||++ +|.-++..   ..-.++..++..+++|++.||+|+|++   ++.|||||.+|||||.+|.+||+|||+++++.
T Consensus       197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999977 88888864   244689999999999999999999999   99999999999999999999999999999887


Q ss_pred             cccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec-
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI-  302 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (351)
                      .......+..+.|.+|.|||.+.+ ..|+.+.|+||.|||+.||+.|++.|++...-+.....   ..+.......++. 
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI---fklcGSP~e~~W~~  346 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI---FKLCGSPTEDYWPV  346 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH---HHHhCCCChhcccc
Confidence            776665666678999999998876 57999999999999999999999999886543322111   1111111111111 


Q ss_pred             ---------------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          303 ---------------DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       303 ---------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                                     ...+.+.-...+....+|+..+|..||++|.|+.++|+
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                           00000111233466889999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-49  Score=357.63  Aligned_cols=255  Identities=31%  Similarity=0.524  Sum_probs=215.4

Q ss_pred             CCCCCcccccCceEEEEEEECC----CCEEEEEEecCCChhh-HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGTTEV-DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+.++||.|.||.||+|.++-    ...||||.++....+. ..+|..|..+|.+.+||||+++.|+.......++|+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3456789999999999999752    3469999999876554 4579999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      ||++|+|+.||+.+   ...+++.++.-+.++|+.||.||.+.   ++|||||.++|||++.+..+|++|||+++...++
T Consensus       711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999875   35589999999999999999999998   9999999999999999999999999999977655


Q ss_pred             cccccccccc--cccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 KTHVSTIVAG--TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ......+..|  +.+|.|||.+....++.+|||||+|+++||.++ |..||.+....+      ..+....    .+.  
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIkaIe~----gyR--  852 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEQ----GYR--  852 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH------HHHHHHh----ccC--
Confidence            4333333333  579999999999999999999999999999988 999997654321      2222222    221  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                         .+.|.+++..+.+|+..||++|-.+||++.+++..|+++..
T Consensus       853 ---LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  853 ---LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ---CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence               13477788999999999999999999999999999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=322.71  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=211.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhh-HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEV-DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ....|+..+.||.|..++||+|.. ..+..||||++..+.... .+.+.+|+..|+.++||||++++..|..+...|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            345799999999999999999985 567899999997654433 477999999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      +||.+||+.+.+...  -...+++..+..+.+++++||.|||++   |.+|||+|+.||||+++|.|||+|||.+-....
T Consensus       104 pfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999998754  235589999999999999999999999   999999999999999999999999998765543


Q ss_pred             cccc---ccccccccccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          226 EKTH---VSTIVAGTFGYLAPEYFD--TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       226 ~~~~---~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ....   ...+..||++|||||++.  ...|+.|+||||||++..||.+|..||....      ..+.+-..+++.....
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p------PmkvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP------PMKVLLLTLQNDPPTL  252 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC------hHHHHHHHhcCCCCCc
Confidence            3211   125668999999999953  3579999999999999999999999997642      2222333333332211


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .......+.....+..++.++..||++||++|||+++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11110111223344679999999999999999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-46  Score=337.97  Aligned_cols=262  Identities=29%  Similarity=0.456  Sum_probs=205.7

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC-Ce
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS-QY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  140 (351)
                      .+|+..+.||+|+||.||+|..      .++..||+|++..... .....+.+|+.++..+ +||||+++++++... +.
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            4788899999999999999974      2345799999875432 3345688999999999 899999999988764 45


Q ss_pred             eEEEEEecCCCCHHHhhcCCCC----------------------------------------------------------
Q 018702          141 NLLIYELMPNGSLDTFLHGKSV----------------------------------------------------------  162 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  162 (351)
                      .+++|||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            7899999999999999864321                                                          


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc-cccccccccccc
Q 018702          163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYL  241 (351)
Q Consensus       163 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~  241 (351)
                      ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........ ......+++.|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence            023577888899999999999999998   9999999999999999999999999999754332221 112234567899


Q ss_pred             CcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHH
Q 018702          242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSI  320 (351)
Q Consensus       242 aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  320 (351)
                      |||.+.+..++.++||||||+++|||++ |..||.......     ..... .....        ....+...++.+.++
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~-~~~~~--------~~~~~~~~~~~l~~l  309 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQR-LKDGT--------RMRAPENATPEIYRI  309 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHH-HhcCC--------CCCCCCCCCHHHHHH
Confidence            9999998899999999999999999997 999986532211     11111 11111        011233445789999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          321 ASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       321 i~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      +.+||+.||.+|||+.|+++.|+.+..+
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6e-47  Score=334.16  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=210.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|-..+.||+|.||.||||+.+ +.+.||+|.+.+...  ...+.+.+|+++++.++||||+.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            36777788999999999999965 467799998865422  234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+.| +|..++.    ....++++.+..++.+++.||.|||++   +|.|||+||+|||+..+|.+|+||||+++.....
T Consensus        82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9977 9999998    567899999999999999999999999   9999999999999999999999999999866543


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                       ........|||-|||||.+.++.|+..+|.||+||++||+++|++||....      +...++....+..         
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v---------  217 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPV---------  217 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCC---------
Confidence             334455679999999999999999999999999999999999999995532      2222233222221         


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ..|...+..+.+++...|.+||.+|.|..+++.+
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence             2356777899999999999999999999998764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.8e-46  Score=328.02  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=202.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+.++.||+|+||.||+|+.+ +|..+|+|++++....   ..+.+..|-.+|...++|+||+++..|++...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3457999999999999999999965 5788999999876433   33457889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||++||++..+|.    ....+++..+...+.+.+.|+..+|+.   |++||||||+|+|||..|++||+|||+|.-.
T Consensus       219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999998    567899999999999999999999999   9999999999999999999999999998532


Q ss_pred             Cc----------------------cccc-----c-------------------cccccccccccCcccccCCCCCchhhH
Q 018702          224 EA----------------------EKTH-----V-------------------STIVAGTFGYLAPEYFDTGRATAKGDV  257 (351)
Q Consensus       224 ~~----------------------~~~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv  257 (351)
                      ..                      ....     .                   .....|||.|+|||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                      0000     0                   012469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 018702          258 YSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT  334 (351)
Q Consensus       258 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps  334 (351)
                      ||||||+|||+.|.+||..............+...+..+.            ....+.++++||.+||. ||.+|.-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~------------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE------------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999977655443322222222222111            12233789999999999 9999975

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=356.62  Aligned_cols=260  Identities=29%  Similarity=0.445  Sum_probs=215.0

Q ss_pred             CCCCCCcccccCceEEEEEEECC--CC----EEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND--ST----AFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+..+.||+|.||.||.|...+  +.    .||+|.++.... +...+|.+|..+|+.++|||||+++|+|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            44566789999999999998643  33    389999987644 445689999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          144 IYELMPNGSLDTFLHGKSV---NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      ++|||+||+|.+||++.+.   ....++..+.+.++.|||+|+.||+++   +++||||..+|+|+++...+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence            9999999999999986532   356688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCccccccc-ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          221 TLMEAEKTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       221 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +......+... ....-+..|||||.+..+.++.|+||||||+++||++| |..||......+      ....+....  
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~gg--  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGG--  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCC--
Confidence            95544333322 22235679999999999999999999999999999999 999997643221      111122221  


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                             ..+.|..+++.++++|.+||+.+|++||++..+++++..+.++
T Consensus       922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                   2234677778999999999999999999999999999887664

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-47  Score=326.29  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=211.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .|+..+.||+|.||.||+|.+. .++.||+|++..+..+ ..+.+.+|+.++..++++||.++++.+..+...+++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            5777789999999999999975 5778999999776443 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      .||++.+.++    ....+++..+..++++++.|+.|||++   +.+|||||+.|||+..+|.+|++|||.+........
T Consensus        94 ~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   94 GGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             cCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999997    334447777788899999999999999   999999999999999999999999999988766555


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC-
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE-  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  307 (351)
                      .. .++.||+.|||||++.+..|+.++||||||++.+||.+|.+|+.+...                .+.-+++..... 
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP  229 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPP  229 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCC
Confidence            44 667899999999999988999999999999999999999999876432                122222332222 


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....++++.+++++..||++||+.||||.++|++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2344667889999999999999999999999975

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=326.76  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=215.6

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhH-HHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      ...+.+.||+|-||.|.++...++..||+|+++.+..... ++|.+|+++|.+++||||+.++|+|..++..++++||++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            3466789999999999999999889999999998765544 789999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+|+.....  .........+|+.||++||+||.+.   +++||||.++|+|++.++++||+|||+++......++
T Consensus       619 nGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  619 NGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             cCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999986522  2245556678999999999999998   9999999999999999999999999999865544443


Q ss_pred             -ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          230 -VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT--GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       230 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                       .......+.+|||||.+..+.++++||+|+||+++||+++  ...||.....+   +..+..............     
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~-----  765 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV-----  765 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee-----
Confidence             3334456889999999999999999999999999999876  78898765322   233333333332222111     


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ...|.-++..+.+++.+||+.+-.+|||++++...|++.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            123556668899999999999999999999999998764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.1e-45  Score=318.33  Aligned_cols=247  Identities=20%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhh---HHHHHHHHHHhhcCCCCceeeeeeEEec----CCeeEEEEEe
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAMGDIKHRNIVTLHGYYTS----SQYNLLIYEL  147 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  147 (351)
                      ...+|+|++|.||+|.. +++.||+|.+.......   .+.+.+|+.++++++||||++++|++.+    ....+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35799999999999998 57789999987643322   4567899999999999999999999876    3467899999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++|+|.+++..    .+.+++.....++.+++.|+.|||+.  .+++||||||+||++++++.+||+|||++.......
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999973    45688999999999999999999984  278899999999999999999999999987543322


Q ss_pred             ccccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          228 THVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .    ...++..|+|||.+.+  ..++.++||||||+++|||++|+.||.....      .............       
T Consensus       178 ~----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~-------  240 (283)
T PHA02988        178 F----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNNS-------  240 (283)
T ss_pred             c----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC-------
Confidence            1    2347889999999976  6899999999999999999999999975421      1122222211111       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                       ...|...++.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence             0123345578999999999999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-46  Score=332.79  Aligned_cols=248  Identities=28%  Similarity=0.394  Sum_probs=211.8

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      -|..++.||.|+-|.|-.|++ .+|+..|||++....   ......+.+|+-+|+.+.|||++++++++++...+|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            477788999999999999986 578999999997652   2234568999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |++||.|.+++.    ..+++++.++.+++.||+.|+.|+|..   +|+||||||+|+|++..+++||+|||+|..-...
T Consensus        93 yv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   93 YVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             ecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999997    567899999999999999999999999   9999999999999999999999999999754443


Q ss_pred             cccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..  -.+.||.|.|.+||++.+.+| +.++||||+|+|+|.|++|+.||.+.      ++...+..+....         
T Consensus       166 kl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G~---------  228 (786)
T KOG0588|consen  166 KL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRGV---------  228 (786)
T ss_pred             cc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCc---------
Confidence            32  345689999999999999887 57999999999999999999999643      2333333322221         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                       -..|.+.+.++++|+.+||..||+.|.|++||+++-.
T Consensus       229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence             1246777899999999999999999999999998753

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=333.80  Aligned_cols=258  Identities=29%  Similarity=0.448  Sum_probs=206.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ....+...||+|.||+||+|.+.+.  ||||.+....  .+..+.|..|+..+++-+|.||+-+.|+|..++. .+|+.+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            3556778999999999999998743  8999997653  4456789999999999999999999999999887 999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc-
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  226 (351)
                      |+|.+|+.+++..   +..++......|++||++||.|||.+   +|+|+|||..|||+.++++|||+|||++.....- 
T Consensus       469 CeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             ccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence            9999999999863   45688889999999999999999999   9999999999999999999999999998754322 


Q ss_pred             cccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .........|...|||||++.   ..+|+..+||||||+++|||++|..||....  .+..+.        ..-..+.. 
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIif--------mVGrG~l~-  611 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQIIF--------MVGRGYLM-  611 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheEE--------EecccccC-
Confidence            111222334778999999985   3578999999999999999999999997321  111100        00000000 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      +.......++++++.+|+..||.+++++||++.+++..|+++..
T Consensus       612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11112234556889999999999999999999999998887654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.7e-45  Score=321.78  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-----------------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-----------------STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTL  131 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  131 (351)
                      .+|...+.||+|+||.||++.+++                 +..||+|.+.... ......+.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            478888999999999999997532                 2369999987653 3334578999999999999999999


Q ss_pred             eeEEecCCeeEEEEEecCCCCHHHhhcCCCC---------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 018702          132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSV---------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH  196 (351)
Q Consensus       132 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H  196 (351)
                      ++++.+.+..+++|||+++|+|.+++.....               ....+++...+.++.|++.||.|||+.   +++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999999864321               123467888999999999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCC
Q 018702          197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT--GKRP  273 (351)
Q Consensus       197 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~--g~~p  273 (351)
                      +||||+|||+++++.+||+|||++........ .......++..|+|||.+.++.++.++||||||+++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999975533222 11223345788999999988899999999999999999987  5567


Q ss_pred             CCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          274 MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      |......   ................. .    ...+..++..+.+++.+||+.||.+|||+.++.+.|++
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGRQV-Y----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhccccc-c----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            7543211   12222222211111100 0    01123345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=331.54  Aligned_cols=244  Identities=29%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             CCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           74 SKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      .++-||+|+.|.||.|+..+ +.||||+++.-       -..+++-|++|+||||+.+.|+|.....+|+|||||..|.|
T Consensus       128 ELeWlGSGaQGAVF~Grl~n-etVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLHN-ETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeeccC-ceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            35679999999999999874 55999987531       23578889999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+.|+    ....++......|.++||.||.|||.+   .|+|||||.-||||+.+..+||+|||.++.....  .....
T Consensus       200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS  270 (904)
T KOG4721|consen  200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS  270 (904)
T ss_pred             HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence            99998    567888999999999999999999999   9999999999999999999999999999866544  22345


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC-CCCHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE-GCPIN  312 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  312 (351)
                      ++||..|||||++...+.++|.||||||++||||+||..||.+.....               ..-.+-.-.+. ..|..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGVGsNsL~LpvPst  335 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGVGSNSLHLPVPST  335 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEeccCCcccccCccc
Confidence            789999999999999999999999999999999999999996532110               00011111111 45677


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       313 ~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      +++.+.-|+++||+..|.+|||+++++.+|+-+.+|.
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            7788999999999999999999999999999876653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-46  Score=334.02  Aligned_cols=257  Identities=29%  Similarity=0.448  Sum_probs=209.8

Q ss_pred             CCCCCCcccccCceEEEEEEECC--C--CE-EEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND--S--TA-FAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      +....+.||+|+||.||+|.+..  +  .. ||+|..+..   ..+...+++.|.++|++++|||||+++|++...+..+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            44556899999999999998643  2  23 899998753   3556678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +|||+|+||+|.++|.+.   .+.++..++..++.+.++||+|||++   +++||||.++|+|++.++.+||+|||+++.
T Consensus       238 ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999854   23699999999999999999999999   999999999999999999999999999975


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ........ .....+..|+|||.+..+.|+.++||||||+++||+++ |..||.+....      +....+....     
T Consensus       312 ~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~-----  379 (474)
T KOG0194|consen  312 GSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNG-----  379 (474)
T ss_pred             Ccceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcC-----
Confidence            44111111 01135789999999999999999999999999999999 89998764322      1111111111     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         .....|...+..+..++.+||..+|++|||+.++.+.|+.+...
T Consensus       380 ---~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  380 ---YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             ---ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence               11123445668899999999999999999999999999987654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-45  Score=322.03  Aligned_cols=245  Identities=21%  Similarity=0.334  Sum_probs=203.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||+|... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            6888899999999999999975 57889999986532   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++.    ..+.+++.....++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          82 YVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999997    345688999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .    ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....      ............         
T Consensus       155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~---------  215 (291)
T cd05612         155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGKL---------  215 (291)
T ss_pred             c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCc---------
Confidence            1    234589999999999988899999999999999999999999965321      111222221110         


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKML  342 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~L  342 (351)
                       ..+...+..+.+++.+||+.||.+||+     +++++++-
T Consensus       216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence             123334578999999999999999995     88888763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=299.26  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=215.1

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEE-ECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----C
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----Q  139 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  139 (351)
                      .-.+.+|++.+.||+|||+-||.+. ..++..+|+|++.....+..+..++|++..++++|||+++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3455789999999999999999998 456778999999888877888899999999999999999999886443     3


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..|++++|...|+|.+.++.....+..+++.+.+.++.++++||.+||+. .+.+.||||||.|||+++++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            48999999999999999988776777899999999999999999999997 23499999999999999999999999999


Q ss_pred             ccccCccccc--------ccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHH
Q 018702          220 ATLMEAEKTH--------VSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW  288 (351)
Q Consensus       220 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  288 (351)
                      +....-.-..        .......|..|.|||.+.-   ...++++|||||||++|+|+.|..||+...... ..+.  
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSla--  252 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLA--  252 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEE--
Confidence            8754321111        1112346889999999854   467899999999999999999999997654322 1110  


Q ss_pred             HHHHHhcCccceeccccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          289 VKAVMQDKREEYVIDTSLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                                -.+.+..+. +-....++.+.+++.+||+.||.+||++.+++..++.+.
T Consensus       253 ----------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 ----------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      000010000 111226789999999999999999999999999998864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-44  Score=313.64  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|.++    .+..||+|.++.... .....+.+|+..++.++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888899999999999999753    356799999876533 3345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++...   ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999998742   34688999999999999999999998   99999999999999999999999999876433


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...........++..|+|||.+.+..++.++||||||+++|++++ |..||......      ...........      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~~~~~------  226 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAVEDGFR------  226 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCCC------
Confidence            222111112234678999999999999999999999999999775 99999654221      11111111110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                         ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               112334557899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.1e-45  Score=320.30  Aligned_cols=264  Identities=20%  Similarity=0.259  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|+||.||++..+ +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            6888999999999999999986 56789999987542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++++.+..+..    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          82 VEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99877765543    235688999999999999999999998   99999999999999999999999999998654333


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH---------HHHHHHHhcCcc
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV---------TWVKAVMQDKRE  298 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~  298 (351)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|++||......+.....         ............
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            22233346899999999998888999999999999999999999999764321110000         000000000000


Q ss_pred             ceeccccC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSL-------EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....+..       .......+..+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000       01112245679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-44  Score=316.74  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             CCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |+..+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.+++.++|+|++++.+.+.+.+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56678899999999999986 4688999999865422   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++|+|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999887533  234688999999999999999999998   99999999999999999999999999997653322


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ............         ..
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~---------~~  222 (285)
T cd05631         157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKED---------QE  222 (285)
T ss_pred             e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhcc---------cc
Confidence            1  123458999999999999999999999999999999999999997542211   111111111111         11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                      ..+...+.++.+|+.+||+.||.+||+     +++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            233445578999999999999999997     7888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-44  Score=309.46  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=204.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++..+++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3577788999999999999999888889999886543 234568889999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++++|||.+.........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999998643   23578999999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....      .............         .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~~---------~  221 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFRL---------Y  221 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC---------C
Confidence            2222235668999999988889999999999999999999 8999854321      1222222221111         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            12223467999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-44  Score=323.37  Aligned_cols=242  Identities=20%  Similarity=0.326  Sum_probs=198.1

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      +.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999874 67889999987532   223345778999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      +|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  152 (323)
T cd05571          81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence            9999987    345688999999999999999999998   999999999999999999999999999875322211 12


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCH
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI  311 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      ....||+.|+|||.+.+..++.++|||||||++|+|++|..||......      ..........          ...|.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~----------~~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE----------IRFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC----------CCCCC
Confidence            3356899999999999999999999999999999999999999653211      1111111111          11234


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          312 NEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       312 ~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ..+.++.+++.+||+.||++||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            4557899999999999999999     79998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-44  Score=310.82  Aligned_cols=255  Identities=28%  Similarity=0.485  Sum_probs=211.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++......+++|||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            46888899999999999999998889999999987666556778999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.........
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999999754  235688999999999999999999998   9999999999999999999999999999765433221


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . ....++..|+|||...+..++.++|+||||+++|+|++ |+.||......      ...........         ..
T Consensus       161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~  224 (261)
T cd05148         161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQITAGYR---------MP  224 (261)
T ss_pred             c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHHhCCc---------CC
Confidence            1 12335678999999988899999999999999999998 89998653211      11111111111         01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...++.+.+++.+||+.||++|||++++++.|+++
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            2334457899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-45  Score=327.82  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=203.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..+++||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6888899999999999999976 47889999987542   2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..... 
T Consensus        82 ~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          82 YVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999996    345688999999999999999999998   999999999999999999999999999975543 


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                         ......||+.|+|||.+.+..++.++|||||||++|+|++|..||......+      ...........  ...+..
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~--~~~~~~  222 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWKET--LQRPVY  222 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhcccc--ccCCCC
Confidence               2233468999999999998899999999999999999999999996543221      11111110000  000000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .......+.++.+++.+||+.+|.+|||+.+++++
T Consensus       223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00012345789999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=311.25  Aligned_cols=270  Identities=24%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecC--CChhhHHHHHHHHHHhhcCCCCceeeeeeEEec---
Q 018702           64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHR--GTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS---  137 (351)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---  137 (351)
                      +.+....+|...+.||+|+||.|+.+... +|..||+|++..  ...-..++..+|+++|+.++|+||+.+.+++..   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            33455667777889999999999999864 678899999873  344456788999999999999999999999865   


Q ss_pred             --CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          138 --SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       138 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                        -+..|+|+|+| +.+|...++    +++.++......+++|+++|+.|+|+.   +++||||||.|++++.+..+||+
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEec
Confidence              35779999999 569999997    556699999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCcc-cccccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH------
Q 018702          216 DFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT------  287 (351)
Q Consensus       216 dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------  287 (351)
                      |||+++..... .....+....|.+|.|||.+ ....|+.+.||||.|||+.||++|++-|.+...-+...+..      
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            99999976543 12223456689999999976 45789999999999999999999999997743322211110      


Q ss_pred             ---HHHHHHhcCccceeccc------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          288 ---WVKAVMQDKREEYVIDT------SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       288 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         .......+....++...      .....-++..+.+.+|+.+||..||.+|+|++|+|++
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               00111100001111100      0001112455779999999999999999999999865

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-44  Score=310.05  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=207.4

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|++|.||+|...++..+++|.+..... ..+.+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            46888899999999999999988888899998865433 35678899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            99999998643  235678888999999999999999998   9999999999999999999999999999865433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......      ............         .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~---------~  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------DVMSALQRGYRM---------P  224 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCC---------C
Confidence            2222335678999999988889999999999999999998 99998653211      111111111100         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+.++.+++.+||..+|++|||++++.+.|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1123346799999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=291.97  Aligned_cols=249  Identities=28%  Similarity=0.417  Sum_probs=211.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+.++.||+|.||.||.|+.+ ++--||+|++.+..   .....++.+|+++-+.++||||++++++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            47889999999999999999965 46679999987643   234467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||..+|+|...|...  ..+.+++.....++.|++.|+.|+|..   +++||||||+|+|++..+..|++|||-+...+.
T Consensus       102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999744  345688888999999999999999998   999999999999999999999999999976542


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                         ....+.+||..|.|||...+..++...|+|++|++.||++.|.+||......      +..++...-+    .    
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------etYkrI~k~~----~----  239 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------ETYKRIRKVD----L----  239 (281)
T ss_pred             ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------HHHHHHHHcc----c----
Confidence               2345678999999999999999999999999999999999999999765311      1112221111    1    


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                        ..|...+..+.++|.+|+.++|.+|.+..|++.+-
T Consensus       240 --~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  240 --KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             --cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence              13566678899999999999999999999998764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-45  Score=312.07  Aligned_cols=248  Identities=22%  Similarity=0.388  Sum_probs=209.2

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhH---HHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVD---RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|++.+.||+|+||+|-++.. ..|+.||||.++++.....   -.+.+|+++|..++||||++++.+|++.+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4788889999999999999885 7799999999977644333   35789999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||..+|.|++|+.    ..+.+++...+.+++||.+|+.|+|.+   +++|||||.+|||+|.|+++||+|||++..+..
T Consensus       133 EYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999997    567799999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .+  ..+++||.|-|.+||.+++.+| .+..|.||||+++|.|+.|..||.+..      ....+.........      
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaYr------  271 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAYR------  271 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhccccc------
Confidence            33  3467899999999999999888 578999999999999999999996642      11222222211111      


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                           .+..+.++.-||.+||..||++|.|+.++..+-+
T Consensus       272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                 1112256788999999999999999999987753

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=322.16  Aligned_cols=252  Identities=21%  Similarity=0.377  Sum_probs=214.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe-eEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY-NLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  145 (351)
                      .+|...+++|+|+||.++.+..+ +++.+++|.+.....  ...+...+|+.++++++|||||.+.+.|.+++. .+++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            36788899999999999998865 567899999865432  223467899999999999999999999999888 99999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      +||+||+|.+.+.+.  ....++++.+..++.|++.|+.|||++   +|+|||||+.|||++.++.++|+|||+++..++
T Consensus        84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            999999999999865  256789999999999999999999988   999999999999999999999999999998877


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .... ..+..||+.|++||.+.+.+|..++|+|||||++|||++-+++|.....      ..........         .
T Consensus       159 ~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~~---------~  222 (426)
T KOG0589|consen  159 EDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINRG---------L  222 (426)
T ss_pred             chhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhhc---------c
Confidence            6533 3456799999999999999999999999999999999999999966421      1222222211         1


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ....|...+.++..++..||+.+|+.|||+.++|.+-
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            2346778889999999999999999999999999863

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.4e-45  Score=324.37  Aligned_cols=245  Identities=22%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46888899999999999999975 57889999986532   123356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999973    45678888999999999999999998   999999999999999999999999999976543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..    ....||+.|+|||.+.+..++.++|||||||++|+|++|..||.....      ........... .       
T Consensus       171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~-~-------  232 (329)
T PTZ00263        171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGR-L-------  232 (329)
T ss_pred             Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCC-c-------
Confidence            22    234689999999999999999999999999999999999999965321      11112221111 0       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                        ..|...+..+.+++.+||+.||.+||+     +++++++
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              123334467899999999999999997     6888765

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.2e-44  Score=319.43  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..+++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57889999999999999999975 57789999887643 33446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..    ...+++..+..++.|++.|+.|||+..  +++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            999999999973    456889999999999999999999862  69999999999999999999999999987553322


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc---------
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE---------  298 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  298 (351)
                         .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......   +.............         
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence               223458999999999999899999999999999999999999996432211   10000000000000         


Q ss_pred             -------------------------ceeccccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          299 -------------------------EYVIDTSLEG-CPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       299 -------------------------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                                               ..+....... .....+.++.+|+.+||+.||++|||++|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                     0000000000 1113457899999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=327.45  Aligned_cols=242  Identities=25%  Similarity=0.378  Sum_probs=203.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  143 (351)
                      -.+|...++||+|.||+|+++..+ +++.+|||.++++.   .+..+..+.|.+++...+ ||+++++++.|+..++.|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            357888899999999999999976 46779999998763   334456778888887775 9999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+.||++..+.     ....+++..+..++..|+.||.|||++   +|+|||||.+|||+|.+|++||+|||+++..
T Consensus       447 vmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            99999999955444     356799999999999999999999999   9999999999999999999999999999854


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ..... ...+.+|||.|+|||++.+..|+.+.|.||||++||||+.|..||.+...++      .+.....+.       
T Consensus       519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~-------  584 (694)
T KOG0694|consen  519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDE-------  584 (694)
T ss_pred             CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC-------
Confidence            32222 4567899999999999999999999999999999999999999998654332      222222221       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                         ..+|...+.+..+++.++|.+||++|.-+
T Consensus       585 ---~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               12577777999999999999999999854

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-44  Score=307.99  Aligned_cols=255  Identities=30%  Similarity=0.458  Sum_probs=207.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|++|.||+|..++++.||+|.++... ...+.+.+|+.++++++|||++++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            4578889999999999999998888889999987643 334568899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++....  ...+++..+..++.|++.|+.+||+.   +++|+||||+||++++++.++|+|||++.........
T Consensus        85 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          85 YGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             CCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            999999997532  34689999999999999999999998   9999999999999999999999999999866532222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||......      ...........         ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~---------~~  224 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------EVLQQVDQGYR---------MP  224 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC---------CC
Confidence            1111223457999999998899999999999999999999 99998653211      11111111110         01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            2333457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-44  Score=327.98  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||+|..      .++..||+|+++... ....+.+.+|+.++..+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688899999999999999974      235579999987543 23345688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC-----------------------------------------------------------
Q 018702          142 LLIYELMPNGSLDTFLHGKSV-----------------------------------------------------------  162 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------------  162 (351)
                      +++|||+++|+|.+++.....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999864220                                                           


Q ss_pred             ------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          163 ------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       163 ------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                                  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                        112478888999999999999999998   99999999999999999999999999997654332211


Q ss_pred             -cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          231 -STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       231 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ....    ........        ..
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~--------~~  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYR--------ML  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCcc--------CC
Confidence             112234667999999999999999999999999999998 88898653211  1111    11111110        01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1222346799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.3e-44  Score=308.65  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=206.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +|+..+.||+|++|.||+|... .++.+++|.+.... .....+.+|++.++.++|||++++++++..++..+++|||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            4677788999999999999875 47789999987543 334568899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..++.++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.+.........
T Consensus        86 ~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          86 YGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999998643  234688999999999999999999998   9999999999999999999999999998765443322


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      .......+..|+|||.+.+..++.++||||||+++|+|++ |..||.....+      ............         .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~~~---------~  225 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKGYRM---------E  225 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCCC---------C
Confidence            2222234668999999998899999999999999999998 99998643211      111221111110         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2333457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.3e-44  Score=316.20  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..+++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57888999999999999999875 578899999865432 2334677999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 999988642   34578889999999999999999998   99999999999999999999999999987543322


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc--------
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE--------  298 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  298 (351)
                      .. .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||......+..   ............        
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhcccc
Confidence            11 223357899999998865 56899999999999999999999999654322111   001000000000        


Q ss_pred             -----ceecccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 -----EYVIDTS----LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 -----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ....+..    ........+.++.+|+.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 0000000    000111234678999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=355.63  Aligned_cols=260  Identities=32%  Similarity=0.543  Sum_probs=208.2

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..+...+.||+|+||.||+|.. .++..||+|++......    ..+|++.+++++||||++++|+|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            3567778999999999999997 57889999998653322    234588899999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++.       .++|..+..++.|+++|++|||+.+.++++|||+||+||+++.++..++. ||.+......  
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            9999999985       27899999999999999999996655699999999999999998888875 6654432211  


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC-
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE-  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  307 (351)
                         ....+++.|+|||++.+..++.++||||||+++|||++|+.||.... ........|..............++... 
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence               12247899999999999999999999999999999999999985432 2334556666554433333333444332 


Q ss_pred             --CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          308 --GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       308 --~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                        ..+.....++.+++.+||+.||++|||++|+++.|+++..
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence              2345566778999999999999999999999999998755

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.7e-44  Score=313.54  Aligned_cols=257  Identities=29%  Similarity=0.519  Sum_probs=207.0

Q ss_pred             CCCCCCcccccCceEEEEEEECCC------CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDS------TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      +|+..+.||+|+||.||+|...+.      ..+++|.+.... ......+.+|+..+..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            678889999999999999986432      469999887543 3344568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc
Q 018702          144 IYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME  211 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~  211 (351)
                      +|||+++++|.+++.....            ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence            9999999999999975321            114578889999999999999999998   9999999999999999999


Q ss_pred             eEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHH
Q 018702          212 ARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV  289 (351)
Q Consensus       212 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  289 (351)
                      ++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......      +..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------~~~  236 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------EVI  236 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence            99999999875433221 11223346788999999988899999999999999999998 99998654321      111


Q ss_pred             HHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      . ......        ....+...+.++.+++.+||+.||.+|||++|+++.|+++
T Consensus       237 ~-~i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         237 E-MIRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             H-HHHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1 111111        1123445568899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.1e-44  Score=333.17  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=206.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-C-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-D-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .|...+.||+|++|.||++... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999864 3 5678888776655555567788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++........++++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998865433455688999999999999999999998   999999999999999999999999999986543322


Q ss_pred             -cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 -HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ............         .
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~---------~  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKY---------D  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC---------C
Confidence             123345689999999999999999999999999999999999999964321      112222221111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+.++.+++.+||+.||++|||+.+++++
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1233445789999999999999999999998753

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-44  Score=323.32  Aligned_cols=245  Identities=23%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC--CCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND--STAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|...+  +..||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468888999999999999998643  3579999986432   22345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++.    ..+.+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       110 ~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999997    345688999999999999999999998   99999999999999999999999999997654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ...    ....||+.|+|||++.+..++.++|+|||||++|+|++|..||......      ..........        
T Consensus       183 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~--------  244 (340)
T PTZ00426        183 TRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGI--------  244 (340)
T ss_pred             CCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCC--------
Confidence            321    2346899999999999888999999999999999999999999653211      1111211111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                        ...|...+..+.+++.+||+.||.+|+     |+++++++
T Consensus       245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              112334457789999999999999995     89998876

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.3e-44  Score=318.71  Aligned_cols=242  Identities=21%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      +.||+|+||.||++... ++..||+|.+....   ......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999874 67889999987542   223345678999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      +|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  152 (323)
T cd05595          81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence            9999886    345688999999999999999999998   999999999999999999999999999875322211 12


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCH
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI  311 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      ....||+.|+|||.+.+..++.++|+|||||++|+|++|+.||......      ..........          ...|.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~----------~~~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE----------IRFPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC----------CCCCC
Confidence            2346899999999999999999999999999999999999999653211      1111111111          01233


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          312 NEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       312 ~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ..++.+.+++.+||+.||.+||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            4457899999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-43  Score=306.35  Aligned_cols=261  Identities=21%  Similarity=0.374  Sum_probs=210.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|.+...   .......+.+|+++++.++|||++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888999999999999999864 6788999987542   2333456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++.........++...+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998864433445678889999999999999999998   999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.....    ...............       
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~-------  226 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYP-------  226 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCC-------
Confidence            3221 1234578899999999888899999999999999999999999854321    112222221111100       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                       ...+...+..+.+++.+||+.+|++|||++++++.|++++
T Consensus       227 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 -PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             0112344578999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=317.61  Aligned_cols=240  Identities=24%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|+||.||++... ++..||+|.+....   ......+.+|+.++.+++||||+++++++.+.+..+++|||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999975 47789999986532   23345678899999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++...... .....
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            999973    45688999999999999999999998   99999999999999999999999999987533222 12234


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..||+.|+|||.+.+..++.++||||+|+++|+|++|..||.....      ...........          ...+...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~----------~~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP----------LRFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC----------CCCCCcC
Confidence            5689999999999999999999999999999999999999965321      12222222211          1234445


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPT---MTEVVKM  341 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps---~~e~l~~  341 (351)
                      +..+.+++.+||+.||.+||+   +.|++++
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            578999999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.8e-44  Score=326.17  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||++...      ++..||+|.+.... ......+.+|+.+++.+ +||||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            47889999999999999998742      23579999997543 33345688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC-----------------------------------------------------------
Q 018702          142 LLIYELMPNGSLDTFLHGKSV-----------------------------------------------------------  162 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------------  162 (351)
                      +++|||+++|+|.+++.....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999853210                                                           


Q ss_pred             -------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc-ccccc
Q 018702          163 -------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH-VSTIV  234 (351)
Q Consensus       163 -------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~  234 (351)
                             ...++++..+++++.|++.||.|||+.   +++||||||+||++++++.+||+|||++......... .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                   123478888999999999999999998   9999999999999999999999999998755432221 11122


Q ss_pred             cccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       235 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      .++..|+|||++.+..++.++||||||+++|+|++ |+.||.......  .    ..........        ...+...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~--------~~~~~~~  340 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQ--------MSRPDFA  340 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccC--------ccCCCCC
Confidence            35678999999988899999999999999999997 999996542211  1    1111111100        0112223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          314 INDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      +.++.+++.+||+.||.+|||+.++++.|+++
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            47899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.9e-44  Score=311.60  Aligned_cols=257  Identities=28%  Similarity=0.473  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|...+.||+|+||.||+|...+      +..||+|.+...... ..+.+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            357778899999999999998643      467999998765444 4567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCC----------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          143 LIYELMPNGSLDTFLHGKS----------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      ++|||+++++|.+++....          .....+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997542          1234578889999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHH
Q 018702          213 RVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      +|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......      ...
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~~  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIE  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHH
Confidence            9999999875433221 11222335788999999999999999999999999999998 999986542211      111


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ......         ....+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 CITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            111111         111223345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-44  Score=310.73  Aligned_cols=248  Identities=36%  Similarity=0.597  Sum_probs=194.5

Q ss_pred             CCcccccCceEEEEEEEC-----CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           75 KDVIGSGGFGTVYRLTVN-----DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+.||.|.||.||+|.+.     .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999987     246799999966433 34678999999999999999999999999888899999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc-
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK-  227 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  227 (351)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+++||++++++.+||+|||++....... 
T Consensus        84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999854  346789999999999999999999998   99999999999999999999999999998663221 


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ............|+|||.+.+..++.++||||||+++|||++ |+.||....      ..............        
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~~~~~~~--------  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKLKQGQRL--------  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHHHTTEET--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccccc--------
Confidence            122223346788999999988889999999999999999999 788875431      11222222211111        


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       ..+...+..+.+++.+||..||++|||++++++.|
T Consensus       225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             12333457899999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-43  Score=305.94  Aligned_cols=252  Identities=26%  Similarity=0.396  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|++|.||.+...++..+|+|.+..... ....+.+|+..+++++||||+++++++.+....+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            35778889999999999999988777899998875433 34568899999999999999999999999889999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ...+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.........
T Consensus        83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999998643   23689999999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||...+..++.++|+||||+++|+|++ |..||......      ............         .
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~---------~  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLRL---------Y  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCCC---------C
Confidence            1112235678999999988889999999999999999998 99998643211      111112111111         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            12223478999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-44  Score=324.22  Aligned_cols=258  Identities=24%  Similarity=0.302  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||++... +++.||+|....      ..+.+|+.++++++||||+++++++......++++|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            47999999999999999999874 578899996432      34678999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      . ++|..++.    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       166 ~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        166 K-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             C-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            5 68988886    345688999999999999999999998   999999999999999999999999999975433222


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc-ccHHHHHHHHHh---cCccc-----
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQ---DKREE-----  299 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~---~~~~~-----  299 (351)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ............   .....     
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223345689999999999989999999999999999999999988643221110 000000000000   00000     


Q ss_pred             --------------eeccccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 --------------YVIDTSLEG---CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 --------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                    ....+....   .....+.++.+|+.+||+.||.+|||++|++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                          000000000   011235678999999999999999999999864

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-43  Score=310.11  Aligned_cols=262  Identities=26%  Similarity=0.445  Sum_probs=210.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|...+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788899999999999999742      235589998877665556679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCC---------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          144 IYELMPNGSLDTFLHGKS---------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                      +|||+++++|.+++....         .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999986432         1223589999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHH
Q 018702          215 SDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      +|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......      ......
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~i  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECI  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence            999998755332211 1222335778999999998899999999999999999998 89998654221      111111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ......         ..+...+.++.+++.+||+.||.+|||+.++++.|+++....
T Consensus       236 ~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         236 TQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            111110         112233467999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.8e-44  Score=318.17  Aligned_cols=242  Identities=22%  Similarity=0.339  Sum_probs=198.0

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      +.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++.+.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999875 57889999987542   223356788999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      +|..++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  152 (328)
T cd05593          81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM  152 (328)
T ss_pred             CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence            9999886    345688999999999999999999998   99999999999999999999999999987532221 112


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCH
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI  311 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......      ..........          ...|.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~----------~~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMED----------IKFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCC----------ccCCC
Confidence            3356899999999999889999999999999999999999999653211      1111111110          11234


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          312 NEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       312 ~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ..+.++.+++.+||+.||++||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            4557899999999999999997     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.4e-44  Score=319.72  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             CCCCCCcccccCceEEEEEEE----CCCCEEEEEEecCCC----hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGT----TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      +|+..+.||+|+||.||++..    .+++.||+|++....    ....+.+..|+.++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477788999999999999875    357889999986432    22334577899999999 499999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999986    345688999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ..............||+.|+|||.+.+. .++.++||||||+++|+|++|..||.......  .............    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~----  227 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRILKCD----  227 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHhcCC----
Confidence            6543333333345689999999998765 47889999999999999999999996432111  1111111111110    


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                            ...+...+..+.+++.+||+.||++||     ++++++++
T Consensus       228 ------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 ------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                  112333457799999999999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.1e-43  Score=303.77  Aligned_cols=260  Identities=21%  Similarity=0.392  Sum_probs=211.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|++|.||+|... +++.+++|.++..   .....+.+.+|++++++++|+|++++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            47888999999999999999986 7889999988642   2233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++.........+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999875443456688999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....    ..............         
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~---------  224 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCD---------  224 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCC---------
Confidence            3221 122357889999999988889999999999999999999999985432    11222212111111         


Q ss_pred             CCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          306 LEGCPI-NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       306 ~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ....+. ..+..+.+++.+||..+|++|||+.+++++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111222 45578999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-43  Score=314.11  Aligned_cols=264  Identities=21%  Similarity=0.306  Sum_probs=198.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ...+|+..+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3468999999999999999999976 6788999998754322 2345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+. ++|.+++...   ...++...+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9995 5888887642   35588889999999999999999998   999999999999999999999999999875432


Q ss_pred             ccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce----
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY----  300 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  300 (351)
                      ... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||......  ..................    
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         156 PSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             CCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccch
Confidence            221 1223457899999998865 46889999999999999999999999753211  000011111000000000    


Q ss_pred             -----eccccCC-CCC---------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 -----VIDTSLE-GCP---------INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 -----~~~~~~~-~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ....... ..+         ...+..+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence                 0000000 000         0123568899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.6e-43  Score=314.52  Aligned_cols=260  Identities=23%  Similarity=0.388  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..+++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            57899999999999999999976 57788999887643 23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..    .+.+++.....++.|++.|+.|||+.  .+++|+||||+||++++++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          85 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            999999999973    45678889999999999999999975  279999999999999999999999999987543221


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc------------
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD------------  295 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  295 (351)
                         .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......   +..........            
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCCccccccCcccC
Confidence               123458899999999998899999999999999999999999996532211   00000000000            


Q ss_pred             ------------Ccc--------ceeccccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 ------------KRE--------EYVIDTSLEGC-PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ------------~~~--------~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                  ...        ..+........ ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                        000        00000000000 11134678999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-43  Score=304.36  Aligned_cols=255  Identities=30%  Similarity=0.486  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|.+..    ...+++|.+..... .....+.+|+..++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            468889999999999999998742    35799998875433 3345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999643   24688999999999999999999998   99999999999999999999999999998765


Q ss_pred             ccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          225 AEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       225 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......      ............    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~----  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYRL----  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCC----
Confidence            22211 1112234678999999998899999999999999999998 99998543211      111111111110    


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                           ..+...+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus       228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 11233457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.7e-43  Score=302.89  Aligned_cols=253  Identities=31%  Similarity=0.468  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      ++|+..+.||+|++|.||++..+++..+++|.+..... ..+.+.+|+.++++++|||++++++++.. ...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            46888899999999999999988888899999876433 34568899999999999999999998754 56789999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999998743  234578999999999999999999998   9999999999999999999999999999765433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||...+..++.++|+||||+++|+|++ |..||.....      ............         ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~---------~~  223 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYR---------MP  223 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC---------CC
Confidence            2222235668999999988889999999999999999999 8999865321      111121111111         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .+...+..+.+++.+||+++|++|||++++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            233445789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=319.76  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=218.0

Q ss_pred             CCCCcccccCceEEEEEEECC---C--CEEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVND---S--TAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +..++||.|-||.||+|.+.+   |  -.||||.-+.+ ..+..+.|..|..+|+.++||||++++|+|.+. ..|+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            445689999999999998643   3  34899988774 455667899999999999999999999999875 5699999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      .++-|.|..||+.+   ...++......++.||+.||+|||+.   +++||||..+|||+.+..-+||+|||+++....+
T Consensus       471 L~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  471 LAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             cccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999863   45688888899999999999999999   9999999999999999999999999999998877


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..+.......+..|||||.++-.+++.+||||.||+++||+++ |..||++-...               .....+-...
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DVI~~iEnGe  609 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DVIGHIENGE  609 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ceEEEecCCC
Confidence            7666555556789999999999999999999999999999988 99999764211               1222223334


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ..++|+++++.++.|+.+||..+|.+||.+.++...|+.+..++
T Consensus       610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            44789999999999999999999999999999999999888754

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-43  Score=302.95  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=202.4

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +|+..+.||+|++|.||++.++++..+++|.+..... ....+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5788899999999999999988777899998865432 234678899999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||+++.........
T Consensus        84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999998643   23688999999999999999999998   99999999999999999999999999987654322221


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......      ............         ..
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~  222 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------EVVESVSAGYRL---------YR  222 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------HHHHHHHcCCcC---------CC
Confidence            111223457999999998899999999999999999999 89998653211      111111111000         11


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      +...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            2234578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-43  Score=315.75  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=196.4

Q ss_pred             CcccccCceEEEEEEE----CCCCEEEEEEecCCC----hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +.||+|+||.||++..    .+++.||+|.+....    ......+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    356789999987532    12234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.    ....+.+..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999986    345678888899999999999999998   99999999999999999999999999987433222


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      . ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...........          .
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~----------~  217 (323)
T cd05584         155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK----------L  217 (323)
T ss_pred             C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC----------C
Confidence            1 12334689999999999988899999999999999999999999965321      11222222111          1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ..|...+..+.+++.+||+.||++||     ++.+++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            12334457899999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-43  Score=312.39  Aligned_cols=261  Identities=22%  Similarity=0.315  Sum_probs=194.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcC---CCCceeeeeeEEe-----c
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--DSTAFAVKRLHRGTT--EVDRGFERELEAMGDI---KHRNIVTLHGYYT-----S  137 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  137 (351)
                      ++|+..+.||+|+||.||+|...  ++..+|+|.+.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  467899998865432  2233456677766655   6999999999885     3


Q ss_pred             CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       138 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      ....+++|||++ ++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 5999998643  234588999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      |++......  .......||+.|+|||.+.+..++.++||||||+++|+|++|.+||......+   .............
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG  229 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence            999765433  12233458999999999988899999999999999999999999997643211   1111111100000


Q ss_pred             cc----------eecccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EE----------YVIDTS----LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~----------~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..          ......    ........+..+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00          000000    001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-44  Score=301.79  Aligned_cols=267  Identities=22%  Similarity=0.310  Sum_probs=204.7

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCc-eeeeeeEEecCC------e
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRN-IVTLHGYYTSSQ------Y  140 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~  140 (351)
                      .|+..+.||+|+||+||+|.. .+|+-||+|++.....+  ......+|+.+++.++|+| |+.+.+++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            466677899999999999996 46788999999765442  3445789999999999999 999999998877      8


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .++|+||++. +|..++.........++...+..++.|+++|++|||++   +|+||||||+|||++++|.+||+|||++
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999955 99999986543324677788999999999999999999   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      +...-.... .....+|.+|.|||++.+. .|+...||||+|||+.||+++++-|.+....+.  +. ...+........
T Consensus       168 ra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~-~If~~lGtP~e~  243 (323)
T KOG0594|consen  168 RAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LF-RIFRLLGTPNEK  243 (323)
T ss_pred             HHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HH-HHHHHcCCCCcc
Confidence            865533222 3345689999999998776 799999999999999999999999977543211  11 111111111111


Q ss_pred             ee----cccc----------CCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 018702          300 YV----IDTS----------LEGC---PINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELI  345 (351)
Q Consensus       300 ~~----~~~~----------~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~  345 (351)
                      ..    .-+.          ....   ......+..+++.+||+.+|.+|.|++.++++  +..+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            00    0000          0000   01112478999999999999999999999987  5544

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-44  Score=292.88  Aligned_cols=251  Identities=29%  Similarity=0.462  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC--------hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT--------TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  139 (351)
                      .+|...+.||.|..++|-++.. .++..+|+|++....        ....+.-.+|+.+|+++. ||+|+++.++++++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            3678888999999999988775 467889999884321        112234567999999994 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..++|+|.|+.|.|.++|.    +.-.++++..+++++|++.|++|||.+   +|+||||||+|||++++.+++|+|||+
T Consensus        97 F~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             hhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            9999999999999999997    667899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      ++...+...  ....||||+|+|||.+..      ..|+...|.|++|+|+|.|+.|.+||....      ..-.+. .+
T Consensus       170 a~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlMLR-~I  240 (411)
T KOG0599|consen  170 ACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLMLR-MI  240 (411)
T ss_pred             eeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHHH-HH
Confidence            997765433  345789999999998853      468889999999999999999999995421      011111 22


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+..-++ .+    +...+.+....+|+.+||+.||++|.|++|+|.+
T Consensus       241 meGkyqF-~s----peWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  241 MEGKYQF-RS----PEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             Hhccccc-CC----cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            2211111 11    2356677889999999999999999999999875

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=332.36  Aligned_cols=260  Identities=24%  Similarity=0.329  Sum_probs=210.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECCC-CEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeE-Ee---cC---
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGY-YT---SS---  138 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~---~~---  138 (351)
                      ...++++.+.|.+|||+.||.|.+..+ ..||+|++-..+....+.+.+|+++|+.|. |+|||.+++. ..   ..   
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            334677888999999999999998766 999999998877777788999999999997 9999999993 21   11   


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      -.++|+||||.||+|.+++..+.  ...+++.++++|+.++++|+++||.. .+.|+|||||-+||||+.+|+.||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            25689999999999999997553  33499999999999999999999997 4569999999999999999999999999


Q ss_pred             cccccCccc-ccc-c------ccccccccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH
Q 018702          219 LATLMEAEK-THV-S------TIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT  287 (351)
Q Consensus       219 ~~~~~~~~~-~~~-~------~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  287 (351)
                      .+.-.-... ... .      -...-|+.|++||++   .+..+++|+|||+|||+||-|+....||++...-       
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------  264 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------  264 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence            886322111 110 0      012258999999987   5678999999999999999999999999764111       


Q ss_pred             HHHHHHhcCccceeccccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          288 WVKAVMQDKREEYVIDTSLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                                  .+.+.... +-.+..+..+.+||..||+.||++||++-++++++-.+....
T Consensus       265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                        11222222 123577889999999999999999999999999999887654

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-43  Score=316.62  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... +++.||+|+++...   ......+.+|..++..+ +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999875 57889999997532   22334577899999888 699999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|.+++.    ..+.+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~  152 (329)
T cd05588          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT  152 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence            99999886    345689999999999999999999998   99999999999999999999999999986422211 12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc--cccHHHHHHHHHhcCccceeccccCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE--GTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      .....||+.|+|||++.+..++.++|+||||+++|+|++|+.||.......  ......+..........         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence            234568999999999999999999999999999999999999996432211  11122222222222111         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPT------MTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps------~~e~l~~  341 (351)
                      .|...+..+.+++.+||+.||.+|||      +++++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            23444578999999999999999997      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=329.59  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=206.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  139 (351)
                      ...+|...+.||+|+||+||++.. .+++.||+|.+....  ......+.+|+..+..++|+|++++.+.+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999986 468899999986542  333456788999999999999999988765332     


Q ss_pred             ---eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          140 ---YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       140 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999975444456789999999999999999999998   999999999999999999999999


Q ss_pred             eccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          217 FGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       217 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      ||+++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....      ...........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~  260 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAG  260 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcC
Confidence            999976543222 22334568999999999999999999999999999999999999996532      12222222211


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .         ....+...++++.+++.+||+.||.+|||+.+++++
T Consensus       261 ~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 R---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1         112344455789999999999999999999999875

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=318.14  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=195.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..+++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            35677889999999999999875 578999999865433 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|....        ...+..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||++.......
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986532        245667788999999999999998   99999999999999999999999999997654322


Q ss_pred             ccccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      . ......||..|+|||.+..     ...+.++|||||||++|+|++|+.||.....   ...............     
T Consensus       223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~-----  293 (353)
T PLN00034        223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---GDWASLMCAICMSQP-----  293 (353)
T ss_pred             c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHHHHHHHHhccCC-----
Confidence            1 1223458999999998743     2345689999999999999999999973211   111111111111110     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                          ...+...+.++.+++.+||+.||++|||+.|++++-
T Consensus       294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                112334457899999999999999999999999863

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.3e-43  Score=307.57  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|+||+||++... +++.+|+|.+......   ..+.+..|+.+++.++||||+++.+++...+..+++|||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999875 5788999998654222   224567899999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      ..++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            988754333456789999999999999999999998   9999999999999999999999999998765433221 223


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..||+.|+|||.+.+..++.++|+||||+++|+|++|+.||........  ...........          ....+...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~----------~~~~~~~~  224 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILND----------SVTYPDKF  224 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhccc----------CCCCcccC
Confidence            4589999999999999999999999999999999999999965321110  00111111100          01233445


Q ss_pred             HHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      +..+.+++.+||+.||++||     ++++++++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            67899999999999999999     77788764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-43  Score=309.35  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=209.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|...+.||+|+||.||++...      ++..+++|.+........+.+.+|+..+++++||||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            5777889999999999999743      3456899998776666667789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          145 YELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      |||+++++|.+++.....            ....+++..++.++.|++.|++|||++   +++|+||||+||++++++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            999999999999964321            224588999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHH
Q 018702          213 RVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      +|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ...
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~  236 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIE  236 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence            9999999875443221 11223346788999999998899999999999999999998 999986532211      111


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ......         ....+...+..+.+++.+||+.+|++|||+++++++|+++...
T Consensus       237 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         237 CITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111111         1111223446799999999999999999999999999988543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.1e-43  Score=301.92  Aligned_cols=254  Identities=31%  Similarity=0.471  Sum_probs=204.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|++.+.||+|+||.||+|...++..+++|.+..... ..+.+.+|+.+++.++||||+++++.+.+ ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            46888999999999999999987777899999875332 34568899999999999999999998754 55799999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999999643  234578899999999999999999998   9999999999999999999999999999765433322


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||...+..++.++|+||||+++|+|++ |..||......      ..........         ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~---------~~~  223 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY---------RMP  223 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC---------CCC
Confidence            2222345678999999988899999999999999999999 88888653211      1111111110         011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2334557899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.5e-43  Score=320.59  Aligned_cols=263  Identities=23%  Similarity=0.301  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----eeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----YNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  142 (351)
                      +|+..+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            467789999999999999987 46889999998653  2233457889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +++||+. ++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 58888875    345789999999999999999999998   999999999999999999999999999976


Q ss_pred             cCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH---------HH----
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV---------TW----  288 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~----  288 (351)
                      .............+++.|+|||.+.+. .++.++||||+||++|+|++|+.||............         ..    
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            543333222334578999999998764 5789999999999999999999999654321110000         00    


Q ss_pred             ---HHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          289 ---VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       289 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         .........................++++.+|+.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               00000000000000000001122335778999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.5e-43  Score=307.08  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=203.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      .++|+..+.||+|+||.||+|...      .+..+|+|.+.... .....++.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            457889999999999999998753      24569999886533 23345688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCC------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          142 LLIYELMPNGSLDTFLHGKSVN------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      +++|||+++++|.+++......      ...+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++++
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999998643211      23467788899999999999999998   99999999999999999999999


Q ss_pred             eeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHH
Q 018702          216 DFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       216 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      |||++......... ......+++.|+|||.+.++.++.++|+||||+++|+|++ |..||.....+      .......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~~  235 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFVM  235 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH
Confidence            99998754332221 1112235778999999998899999999999999999999 78888653221      1111111


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ...         ....+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111         111233344679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.1e-43  Score=301.92  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++|||++++++++. .+..+++|||+.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            46888899999999999999988889999999876443 3456889999999999999999999874 456899999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          84 NGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99999998643  234688899999999999999999998   9999999999999999999999999999765432222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||.+....++.++|+||||+++|+|++ |+.||......      ............         .
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~---------~  223 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLERGYRM---------P  223 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHcCCCC---------C
Confidence            2222335678999999998899999999999999999998 99998643211      111111111110         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+.++.+++.+||+.+|++|||++++++.|+++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            2333457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-43  Score=315.47  Aligned_cols=249  Identities=20%  Similarity=0.334  Sum_probs=196.7

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... +++.+|+|.+....   ......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 56789999987542   23334577888888776 799999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~  152 (329)
T cd05618          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T  152 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence            99998886    345689999999999999999999998   999999999999999999999999999875322211 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc--cccHHHHHHHHHhcCccceeccccCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE--GTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|+.||.......  ......+..........         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C
Confidence            233568999999999999999999999999999999999999996422111  11122222222222111         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTM------TEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~------~e~l~~  341 (351)
                      .|...+..+.+++.+||+.||.+|||+      .+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            344455789999999999999999984      566544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=301.31  Aligned_cols=255  Identities=31%  Similarity=0.487  Sum_probs=208.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      ++|++.+.||+|++|.||++..+++..+++|.+..... ..+.+.+|+..+++++|||++++++++......+++|||++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            47888999999999999999988888899999876433 34568899999999999999999999999889999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++++|||.+.........
T Consensus        85 ~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          85 KGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99999999753  234689999999999999999999998   9999999999999999999999999998766432222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      .......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||......      ............         .
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~---------~  224 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERGYRM---------P  224 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC---------C
Confidence            2222234678999999998889999999999999999998 99998653211      111221111100         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            1223357899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-43  Score=318.59  Aligned_cols=263  Identities=22%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----CeeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----QYNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  142 (351)
                      +|+..+.||+|+||.||+|... ++..||+|++....  ......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5778889999999999999865 67899999986432  22334688999999999999999999987543     2479


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||+. ++|.+++.    ....+++..+..++.|+++||.|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 68999886    345689999999999999999999998   999999999999999999999999999975


Q ss_pred             cCcccc--cccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc---------HHHHH
Q 018702          223 MEAEKT--HVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK---------LVTWV  289 (351)
Q Consensus       223 ~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------~~~~~  289 (351)
                      ......  .......+|+.|+|||++.+  ..++.++|||||||++|+|++|++||..........         .....
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211  11223468999999999865  678999999999999999999999996532211000         00000


Q ss_pred             HHHHhcCccce---ecc---ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          290 KAVMQDKREEY---VID---TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       290 ~~~~~~~~~~~---~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...........   ...   ..........+..+.+++.+||+.||++|||++|++++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000000000   000   00000001234678899999999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-43  Score=321.17  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ..+|+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            347888899999999999999875 57889999986422   22234577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999853     3478888899999999999999998   99999999999999999999999999997654


Q ss_pred             cccccccccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTG----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ...........||+.|+|||.+.+.    .++.++|+|||||++|+|++|..||.....      .............. 
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~-  266 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL-  266 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC-
Confidence            4332223345689999999988643    478899999999999999999999965422      11122222111100 


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~  341 (351)
                      ..     ......+.++.+++.+||+.+|.+  |||+.|++++
T Consensus       267 ~~-----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TF-----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC-----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00     011134578999999999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-43  Score=320.55  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=206.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCChh-hHHHHHHHHHHhhcCC-CCceeeeeeEEecCC
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTE-VDRGFERELEAMGDIK-HRNIVTLHGYYTSSQ  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  139 (351)
                      ...+|++.+.||+|+||.||+|....      +..||+|++...... ..+.+.+|++++.++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            34578899999999999999998532      246999999764333 3456889999999996 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC---------------------------------------------------------
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV---------------------------------------------------------  162 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  162 (351)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998864210                                                         


Q ss_pred             -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          163 -----------------------------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       163 -----------------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                                                         ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                               013477888899999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......    
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence            9999999999999765432221 1122346788999999998899999999999999999997 999986532111    


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                        ...........        ...+...+..+.+++.+||+.||++|||+.++.+.|+.+.
T Consensus       348 --~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 --TFYNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              11111111100        0123344578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-43  Score=308.83  Aligned_cols=266  Identities=28%  Similarity=0.422  Sum_probs=201.3

Q ss_pred             CCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLL  143 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  143 (351)
                      |+..+.||+|+||+||.+..     .++..+|+|.+..... .....+.+|++.++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47889999999999988653     3567899999876533 3445688999999999999999999987653  46789


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|||+++++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            9999999999999853     3589999999999999999999998   9999999999999999999999999998765


Q ss_pred             Cccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ......  ......++..|+|||...+..++.++||||||+++|+|++|..|+......- ...................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence            432221  1112235667999999988889999999999999999999999985432110 0000000000000000000


Q ss_pred             cccc-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          302 IDTS-LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       302 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .+.. ....+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000 01234445578999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=322.21  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            6888899999999999999975 57889999996532   2333457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          82 YLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999873    45689999999999999999999998   9999999999999999999999999998654321


Q ss_pred             ccc-------------------------------------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 018702          227 KTH-------------------------------------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT  269 (351)
Q Consensus       227 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~  269 (351)
                      ...                                     ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            100                                     0112358999999999998999999999999999999999


Q ss_pred             CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 018702          270 GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT---MTEVVKM  341 (351)
Q Consensus       270 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~e~l~~  341 (351)
                      |..||......      ............ ....     .....++++.+++.+|+. +|.+|++   +.|++++
T Consensus       235 G~~Pf~~~~~~------~~~~~i~~~~~~-~~~~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQ------ETYRKIINWKET-LQFP-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHH------HHHHHHHcCCCc-cCCC-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999654221      111111111100 0000     011234678999999997 9999998   9888774

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.2e-43  Score=313.98  Aligned_cols=245  Identities=25%  Similarity=0.380  Sum_probs=195.4

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHh---hcCCCCceeeeeeEEecCCeeEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAM---GDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      |++.+.||+|+||.||++... +++.||+|.++...   ....+.+.+|..++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556788999999999999875 57889999987532   22234456665554   567899999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|..++.     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999998884     34689999999999999999999998   99999999999999999999999999986432


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      ...........       
T Consensus       153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~-------  218 (324)
T cd05589         153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEV-------  218 (324)
T ss_pred             CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------
Confidence            2221 123456899999999999999999999999999999999999999654221      11122211111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                         ..|...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence               12334457889999999999999999     57777664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-43  Score=313.88  Aligned_cols=236  Identities=22%  Similarity=0.350  Sum_probs=191.3

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++..+ +++.||+|++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 57889999987532   22334567788888776 699999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ .
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~  152 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T  152 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence            999998863    45688999999999999999999998   999999999999999999999999999875322221 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|+.||......      ...........          ..|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~----------~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV----------VYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCC----------CCC
Confidence            23346899999999999889999999999999999999999999654221      12222221110          123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                      ...+.++.+++.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            3345789999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-44  Score=321.49  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=203.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|...+.||+|+||.||+|... +++.||+|++....   ......+.+|++++..++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6888899999999999999976 68899999987532   1334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          82 YMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999973    35688999999999999999999998   9999999999999999999999999999765433


Q ss_pred             c----------------------------ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcch
Q 018702          227 K----------------------------THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAF  278 (351)
Q Consensus       227 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  278 (351)
                      .                            ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                            111223458999999999999999999999999999999999999996543


Q ss_pred             hcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 018702          279 LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT-MTEVVKM  341 (351)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~e~l~~  341 (351)
                      ..      .......... .....+     .....++++.+++.+||+ ||.+||+ +.+++++
T Consensus       235 ~~------~~~~~i~~~~-~~~~~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQ------ETYNKIINWK-ESLRFP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH------HHHHHHhccC-CcccCC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11      1111221100 000000     011135789999999998 9999999 9999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-42  Score=297.27  Aligned_cols=247  Identities=31%  Similarity=0.508  Sum_probs=200.1

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHH
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLD  154 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  154 (351)
                      ++||+|+||.||+|...++..+|+|.+..... .....+.+|++.++.++||||+++++++...+..+++|||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988888999999876543 33446889999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccccccc
Q 018702          155 TFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV  234 (351)
Q Consensus       155 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  234 (351)
                      +++...   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            998642   34578999999999999999999998   999999999999999999999999999875433222211222


Q ss_pred             cccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       235 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      .++..|+|||.+.+..++.++|+||||+++|++++ |..||......      ...........         ...+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQVEKGYR---------MSCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHHcCCC---------CCCCCCC
Confidence            34678999999998899999999999999999998 99998654221      11111111110         0123334


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          314 INDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      +..+.+++.+||+.+|++|||+.|++++|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=294.04  Aligned_cols=261  Identities=24%  Similarity=0.287  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEe--cCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYT--SSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  144 (351)
                      ..|+..+.|++|+||.||+|.++ +++.||+|+++.+...  ..-...+|+.+|.+.+|||||.+..+..  +-+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            35777889999999999999975 5678999999765321  1123579999999999999999998865  34578999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      ||||+. +|.+.+...   .+++...++..++.|+++|++|||++   .|+||||||+|+|++..|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 999999864   36788999999999999999999999   99999999999999999999999999999887


Q ss_pred             cccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec-
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI-  302 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (351)
                      ..... .+....|.+|.|||.+.+ ..|+++.|+||+|||+.||+++++.|.+....+  ++...+..+ .......+. 
T Consensus       229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~ll-GtPte~iwpg  304 (419)
T KOG0663|consen  229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLL-GTPSEAIWPG  304 (419)
T ss_pred             CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHh-CCCccccCCC
Confidence            65433 344568999999998866 579999999999999999999999997754322  222222211 111000000 


Q ss_pred             ---ccc-----C---------CCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 ---DTS-----L---------EGCPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ---~~~-----~---------~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         -+.     .         ..++.. .++..++|+..+|..||.+|.|++|.|++
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence               000     0         011111 34778999999999999999999999865

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=307.91  Aligned_cols=259  Identities=25%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh--------------hhHHHHHHHHHHhhcCCCCceee
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT--------------EVDRGFERELEAMGDIKHRNIVT  130 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~  130 (351)
                      .+..+.|++.+.||+|.||.|-+|.. .+++.||+|++.+...              ...+.+.+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34556899999999999999999986 4688899999855321              11246889999999999999999


Q ss_pred             eeeEEecC--CeeEEEEEecCCCCHHHhhcCCCCCCCC-CChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          131 LHGYYTSS--QYNLLIYELMPNGSLDTFLHGKSVNKKN-LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       131 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ++.+..+.  +.+|||+|||..|.+...=     ..+. +++.++++++.++..||.|||.+   +|+||||||+|+|++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence            99998764  5889999999988875443     2334 89999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccccccCccccc----ccccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCcchh
Q 018702          208 QNMEARVSDFGLATLMEAEKTH----VSTIVAGTFGYLAPEYFDTGR----ATAKGDVYSFGVVLLELLTGKRPMDEAFL  279 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~  279 (351)
                      ++|++||+|||.+..+......    ......|||.|+|||...++.    .+.+.||||+|++||.|+.|+.||-+.+.
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            9999999999999866322111    112256999999999887633    35689999999999999999999966532


Q ss_pred             cccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .      ........+. ..+       .......+++.+||.+||++||++|.+..++..+..-.+
T Consensus       325 ~------~l~~KIvn~p-L~f-------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 L------ELFDKIVNDP-LEF-------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             H------HHHHHHhcCc-ccC-------CCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            2      1222222221 111       112235688999999999999999999999987765443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-43  Score=316.45  Aligned_cols=242  Identities=21%  Similarity=0.328  Sum_probs=196.7

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      +.||+|+||.||++... ++..||+|.+....   ......+..|+.++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999864 67889999987532   223345678999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      +|..++.    ....+++..+..++.|++.||.|||+ .   +++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  152 (325)
T cd05594          81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T  152 (325)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence            9999886    34568999999999999999999997 6   999999999999999999999999999875332221 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....+      ..........          ...|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~----------~~~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE----------IRFP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCC----------CCCC
Confidence            22346899999999999999999999999999999999999999653211      1111111111          0123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ...+.++.+++.+||+.||++|+     ++.+++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            34457899999999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.4e-43  Score=317.79  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||+||++... +++.||+|++....   ......+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888899999999999999865 57889999986532   223346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++.    ..+.+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999997    345789999999999999999999998   999999999999999999999999999875432


Q ss_pred             ccc----------------------------------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 018702          226 EKT----------------------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK  271 (351)
Q Consensus       226 ~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~  271 (351)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 018702          272 RPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLE--PEPSKRPTMTEVVKM  341 (351)
Q Consensus       272 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~Rps~~e~l~~  341 (351)
                      .||......      .......... .....++     ....++++.+++.+|+.  .++..||+++|++++
T Consensus       234 ~Pf~~~~~~------~~~~~i~~~~-~~~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQ------ETYKKVMNWK-ETLIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHH------HHHHHHHcCc-CcccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999653221      1112221111 0000111     11234678888888654  233356899999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.3e-43  Score=310.06  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=204.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    38999987543 34456788999999999999999999998765 5689


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ++||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999998743   34578889999999999999999998   9999999999999999999999999999866


Q ss_pred             Ccccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......      .. .........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~~-~~~~~~~~~---  229 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EI-SSILEKGER---  229 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHhCCCC---
Confidence            5432221 112234678999999999999999999999999999998 99998653211      11 111111100   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                           ...+..++.++.+++.+||+.+|++|||+.+++..|..+..+.
T Consensus       230 -----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                 0112233467899999999999999999999999998876653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-43  Score=312.53  Aligned_cols=252  Identities=25%  Similarity=0.314  Sum_probs=212.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChh---hHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTE---VDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  143 (351)
                      ...|+..+.||+|.||.||++..+. |+.+|+|.+.+....   ....+.+|+.+|+++. ||||+.+.++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3478889999999999999999765 899999999765443   3357899999999998 9999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC----CCceEEeeecc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ----NMEARVSDFGL  219 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~----~~~~kl~dfg~  219 (351)
                      |||++.||.|.+.+...     .+++..+..++.|++.++.|||+.   |++||||||+|+|+..    ++.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999754     389999999999999999999998   9999999999999964    35799999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      +.....  .......+||+.|+|||++....|+..+|+||+|+++|.|++|.+||.........      ........ .
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~~~~-~  256 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILRGDF-D  256 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHcCCC-C
Confidence            998766  33455678999999999999999999999999999999999999999775432211      11221111 0


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                           ...+.....++.+.+++.+|+..||..|+|+.++|++-
T Consensus       257 -----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  257 -----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             -----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence                 01134556678999999999999999999999999974

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-43  Score=307.29  Aligned_cols=263  Identities=28%  Similarity=0.456  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  142 (351)
                      .+|+..+.||+|+||.||++..     .++..|++|.+........+.+.+|+++++.++||||+++.+++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678889999999999999874     3577899999987666666788999999999999999999998753  34678


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++..
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            999999999999998642   34588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc---------ccHHHHHHH
Q 018702          223 MEAEKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG---------TKLVTWVKA  291 (351)
Q Consensus       223 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~~~~~  291 (351)
                      ........  .....++..|+|||.+.+..++.++|+||||+++|||++|..|+........         .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            54332211  1111234569999999888999999999999999999998777543211100         000001111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .....        .....+...+..+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus       238 ~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         238 LLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            11110        001123334578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.3e-43  Score=300.46  Aligned_cols=248  Identities=28%  Similarity=0.457  Sum_probs=197.7

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      +.||+|+||.||+|... +++.+|+|.+.... .+....+.+|+++++.++||||+++++++...+..+++|||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999874 67889999876543 34456789999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc-cc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-ST  232 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~  232 (351)
                      .+++...   ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||.+.......... ..
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998632   34578999999999999999999998   99999999999999999999999999987543221111 11


Q ss_pred             cccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCH
Q 018702          233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI  311 (351)
Q Consensus       233 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      ....+..|+|||.+.++.++.++|+||||+++|+|++ |..||.......       .........        ....+.
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~--------~~~~~~  219 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGV--------RLPCPE  219 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCC--------CCCCcc
Confidence            1123457999999998899999999999999999998 888885432111       111111110        011233


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       312 ~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ..+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            445789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.4e-43  Score=319.73  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=197.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .|+..+.||+|+||+||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778889999999999999864 56789999986532   2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999873    45688888999999999999999998   9999999999999999999999999987533110


Q ss_pred             cc----------------------------------------------cccccccccccccCcccccCCCCCchhhHHHH
Q 018702          227 KT----------------------------------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSF  260 (351)
Q Consensus       227 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  260 (351)
                      ..                                              .......||+.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123468999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHh--cCCCCCCCCCHHHH
Q 018702          261 GVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMC--LEPEPSKRPTMTEV  338 (351)
Q Consensus       261 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~~p~~Rps~~e~  338 (351)
                      ||++|||++|..||.......      ............ ..     ......+.++.+++.+|  +..+|..||++.++
T Consensus       235 G~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~-~~-----~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTE------TQLKVINWENTL-HI-----PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHH------HHHHHHcccccc-CC-----CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999996542211      111111100000 00     01123447788999884  45666679999999


Q ss_pred             HHH
Q 018702          339 VKM  341 (351)
Q Consensus       339 l~~  341 (351)
                      +++
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-44  Score=318.83  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... +++.+|+|+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            6888899999999999999875 678899999875422   234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          82 YQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999743   25689999999999999999999998   9999999999999999999999999999866544


Q ss_pred             cccccccccccccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD------TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      .........||+.|+|||.+.      ...++.++||||||+++|+|++|..||......      ..............
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~  229 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLK  229 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccC
Confidence            333333446899999999986      456789999999999999999999999653221      11222221111000


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           . ......+..+.+|+.+||+ +|.+|||+++++++
T Consensus       230 -----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 -----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                 0 0112345779999999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-44  Score=305.46  Aligned_cols=263  Identities=27%  Similarity=0.382  Sum_probs=200.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----eeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----YNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  144 (351)
                      .|...+++|.|+||.||.|... ++..||||++..+...    -.+|+.+|+.+.|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5677889999999999999975 4688999998765442    247899999999999999998875432     33589


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeecccccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLM  223 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~  223 (351)
                      |||++. +|.++++.....+..++...+.-++.||++|++|||+.   +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 99999986555677888888899999999999999998   99999999999999975 99999999999977


Q ss_pred             CcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee-
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV-  301 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  301 (351)
                      .......  ...-|.-|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+....+  ++... ..+......+.+ 
T Consensus       177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eI-ik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEI-IKVLGTPTREDIK  251 (364)
T ss_pred             ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHH-HHHhCCCCHHHHh
Confidence            6544332  2335788999998866 579999999999999999999999998743222  11111 111111111110 


Q ss_pred             ---------ccccCC-----C-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 018702          302 ---------IDTSLE-----G-CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIK  346 (351)
Q Consensus       302 ---------~~~~~~-----~-~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~  346 (351)
                               ..+.+.     . .....+.++.+|+.++|+.+|.+|.|+.|++.+  +++++
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                     001111     1 233455789999999999999999999998853  44444

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4e-43  Score=312.92  Aligned_cols=242  Identities=22%  Similarity=0.374  Sum_probs=195.3

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999875 46789999987532   22334567788888766 799999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~  152 (321)
T cd05591          81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T  152 (321)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence            99999886    345688999999999999999999998   999999999999999999999999999875332221 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......      ...........          ..|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~----------~~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDV----------LYP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC----------CCC
Confidence            23346899999999999889999999999999999999999999654221      12222221110          122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRP-------TMTEVVKM  341 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rp-------s~~e~l~~  341 (351)
                      ...+.++.+++.+||+.||++||       ++++++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            23447899999999999999999       88888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.3e-43  Score=312.77  Aligned_cols=243  Identities=21%  Similarity=0.321  Sum_probs=194.9

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... +++.+|+|++.....   ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875 567899999976422   2334577899998888 599999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++.    ..+.+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  152 (327)
T cd05617          81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT  152 (327)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence            99999886    345689999999999999999999998   99999999999999999999999999987432211 11


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||.............+..........         ..|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIP  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCC
Confidence            23356899999999999999999999999999999999999999654332222222233332222111         123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                      ...+..+.+++.+||+.||.+||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            4445778999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=317.75  Aligned_cols=257  Identities=29%  Similarity=0.441  Sum_probs=217.5

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +.+...+||-|.||.||.|.|+. .-.||||.++.+..+ .++|..|..+|+.++|||+|+++|+|..+..+|+|+|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            45566789999999999999875 456999999875544 5679999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      .|+|.+||+..  +...++....+.++.||.+||.||..+   +++||||..+|+|+.++..+|++|||+++.+..+.+.
T Consensus       347 yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  347 YGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             CccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            99999999876  556678888999999999999999999   9999999999999999999999999999988777665


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......-+..|.|||-+....++.++|||+||++|||+.| |..||.+....   +.    -.++..   .+.+     .
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---qV----Y~LLEk---gyRM-----~  486 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV----YGLLEK---GYRM-----D  486 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---HH----HHHHhc---cccc-----c
Confidence            5444445788999999999999999999999999999999 99998764211   11    111111   1111     2


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      -|+.|++.+++|+..||+++|.+||++.|+-+.++.+-.+
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            3566668899999999999999999999999999887554

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.1e-43  Score=310.49  Aligned_cols=241  Identities=23%  Similarity=0.369  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||+|... +++.||+|.++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 46789999987532   12233455666666654 799999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            999999863    45688999999999999999999998   99999999999999999999999999997543322 22


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.....      ...........          ...|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~----------~~~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDR----------PHFP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC----------CCCC
Confidence            2345689999999999988999999999999999999999999965321      11122221111          1123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMT-EVVK  340 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~-e~l~  340 (351)
                      ...+.++.+++.+||+.||++||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            34457789999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1e-42  Score=302.43  Aligned_cols=254  Identities=25%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4789999999999999999997 467889999987655555566889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++..    ...+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||++........
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999863    45688999999999999999999998   999999999999999999999999999976543221


Q ss_pred             cccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          229 HVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       ......+++.|+|||.+.   ...++.++|+||+|+++|+|++|..||........         .. .........+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---------~~-~~~~~~~~~~~  230 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---------LF-LMSKSNFQPPK  230 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---------he-eeecCCCCCCC
Confidence             112345788999999874   34578899999999999999999999854321110         00 00000000011


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      .. .+...+..+.+++.+||+.+|++|||+++++++|
T Consensus       231 ~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 LK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             Cc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11 1123457899999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=299.19  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-----hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-----EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|++|.||.+... ++.++++|.+.....     ...+.+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999864 578899998865322     123467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ++||+++++|.+++..    .+.+++.....++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+...
T Consensus        82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999999873    45678889999999999999999998   9999999999999999999999999998765


Q ss_pred             Cccccccc--ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTHVS--TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ........  ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......     ... .......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~-~~~~~~~-----  223 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAI-FKIATQP-----  223 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHH-HHHhccC-----
Confidence            43222111  2345788999999999988999999999999999999999998643111     111 1111110     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                         .....+...+..+.+++.+||+.+|.+|||+.+++++.
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence               01123444557899999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-42  Score=297.45  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|++|.||++... ++.+++|.+..... ..+.+.+|+.+++.++|+|++++++++.+.+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46788899999999999999876 67899999977644 45678999999999999999999999998999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          84 KGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999743  223689999999999999999999998   999999999999999999999999999976532222 


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                         ....+..|+|||.+.++.++.++|+||||+++|+|++ |..||.......       ..........        ..
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--------~~  219 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYR--------ME  219 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC--------CC
Confidence               1234667999999988889999999999999999997 999986532111       1111111100        01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...++.+.+++.+||+.+|++|||+.|++++|+++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            1233457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7e-43  Score=311.81  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=197.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCC-CceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKH-RNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  145 (351)
                      +|+..+.||+|+||.||+|... +++.||+|++....   ....+.+..|..++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777889999999999999875 46789999987532   2234567789999999976 56888999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999999863    45688899999999999999999998   999999999999999999999999999864322


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ... ......||+.|+|||++.+..++.++|+||+|+++|+|++|+.||......      ..........         
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~---------  217 (324)
T cd05587         154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN---------  217 (324)
T ss_pred             CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC---------
Confidence            111 123356899999999999999999999999999999999999999653211      1111111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTM-----TEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~e~l~~  341 (351)
                       ...|...+.++.+++.+||..||.+|++.     ++++++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             11233445789999999999999999976     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.8e-42  Score=301.40  Aligned_cols=258  Identities=29%  Similarity=0.431  Sum_probs=206.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|...+    ...+++|...... ....+.+.+|+..++.++|||++++++++.+. ..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence            357888999999999999998643    2468999887654 34456789999999999999999999998764 56899


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||++....
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999643   23588999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...........++..|+|||.+....++.++||||||+++|++++ |..||.......      ...........     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~-----  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGRIENGERL-----  227 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCcC-----
Confidence            432222222234568999999988889999999999999999986 999996543211      11111111111     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                          ..+...+..+.+++.+||..+|++|||+.++++.|++++.++
T Consensus       228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                123334578999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.7e-42  Score=297.82  Aligned_cols=253  Identities=31%  Similarity=0.494  Sum_probs=203.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|...+.||+|++|.||++...++..+++|.+.... ...+.+.+|+.+++.++|||++++++++.. +..+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            3577888999999999999998877789999886543 234568899999999999999999998754 56789999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999743  234578899999999999999999998   9999999999999999999999999999765433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||...+..++.++|+||||+++|+|++ |..||.......      ..........         ..
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERGYR---------MP  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC---------CC
Confidence            2222335678999999988899999999999999999999 899986532111      1111111100         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .+...+..+.+++.+||+.||++|||++++++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            233455789999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-42  Score=300.97  Aligned_cols=259  Identities=22%  Similarity=0.384  Sum_probs=208.5

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|++|.||++.. .++..+++|.+....   ......+.+|+.+++.++||||+++++++.+++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            577788999999999999996 478899999876532   2233568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++.........+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999875433456689999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....    ..............        .
T Consensus       160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~--------~  226 (267)
T cd08229         160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDY--------P  226 (267)
T ss_pred             Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCCC--------C
Confidence            221 1234578899999999888899999999999999999999999854321    11111111111000        0


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ...+...++.+.+++.+||+.||++|||+.++++.+.++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            011233557899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-43  Score=318.10  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ..+|+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            357889999999999999999975 46789999986421   22334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         122 MEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999853     3478888999999999999999998   99999999999999999999999999998664


Q ss_pred             cccccccccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTG----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ...........||+.|+|||++.+.    .++.++|+||+|+++|+|++|..||.....      ...............
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~  267 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSLN  267 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcccC
Confidence            4333233455699999999998653    378899999999999999999999965422      111222221111000


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~  341 (351)
                       .     ......+..+.+++.+||+.+|.+  |||+.|++++
T Consensus       268 -~-----p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 -F-----PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -C-----CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             0     011223577899999999865544  8999999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=307.72  Aligned_cols=252  Identities=27%  Similarity=0.358  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .|+..+.||+|+||.||++... +++.||+|.+.....   .....+.+|+.+++.++||||+++++.+..++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999874 678899999865322   223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888642  234689999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......   ............         .
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~---------~  221 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED---------Q  221 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc---------c
Confidence            21  123358999999999998899999999999999999999999997532111   111111111111         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ...+...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            122344557899999999999999999     88888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.6e-42  Score=297.38  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=197.0

Q ss_pred             cccccCceEEEEEEE---CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           77 VIGSGGFGTVYRLTV---NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .||+|+||.||+|.+   .++..+|+|+++...  ....+.+.+|+.+++.++||||+++++++.. +..+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975   356789999886543  2344678899999999999999999998764 5678999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc-
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-  230 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-  230 (351)
                      +|.+++..    ...+++..+..++.|++.|+.|||+.   +++|+||||.||++++++.++|+|||++.......... 
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999963    35688999999999999999999998   99999999999999999999999999997654433211 


Q ss_pred             -cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          231 -STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       231 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                       .....++..|+|||.+....++.++|+||||+++|||++ |..||......      ...........         ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i~~~~~---------~~  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMIESGER---------ME  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHCCCC---------CC
Confidence             111224578999999988889999999999999999998 99998653211      11111111111         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .|...+.++.+++.+||+.||++|||+++|.+.|++.
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2334557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.1e-43  Score=313.85  Aligned_cols=262  Identities=28%  Similarity=0.426  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEec-CCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTS-SQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~~  140 (351)
                      .+|++.+.||+|+||.||+|...      .++.||+|++..... ...+.+.+|+.++.++ +||||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            47889999999999999998642      246799999875432 2335678899999999 79999999998764 456


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCC---------------------------------------------------------
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVN---------------------------------------------------------  163 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------  163 (351)
                      .++++||+++++|.+++......                                                         
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            78999999999999998532110                                                         


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc-cccccccccccC
Q 018702          164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLA  242 (351)
Q Consensus       164 ~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~a  242 (351)
                      ...+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++.......... .....++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            13678999999999999999999998   99999999999999999999999999998654322211 122345678999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHH
Q 018702          243 PEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIA  321 (351)
Q Consensus       243 PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  321 (351)
                      ||++.+..++.++|||||||++|+|++ |..||......+      ...........        ...+...+.++.+++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~l~  309 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTR--------MRAPEYATPEIYSIM  309 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCC--------CCCCccCCHHHHHHH
Confidence            999999999999999999999999998 999986532111      11111111111        112333447899999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          322 SMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       322 ~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .+||+.+|++|||+.|++++|+.+..+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-42  Score=301.63  Aligned_cols=256  Identities=25%  Similarity=0.444  Sum_probs=202.8

Q ss_pred             CCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|+..+.||+|+||.||+|..     .++..+++|.+..... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            567778999999999999984     2457799999875433 3345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc
Q 018702          145 YELMPNGSLDTFLHGKSV-------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME  211 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~  211 (351)
                      |||+++++|.+++.....             ....+++.....++.|++.|++|||++   +++|+||||+||++++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence            999999999999853211             123578888999999999999999998   9999999999999999999


Q ss_pred             eEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHH
Q 018702          212 ARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV  289 (351)
Q Consensus       212 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  289 (351)
                      +||+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......      ...
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------~~~  236 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------EVI  236 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence            99999999976533221 11222335678999999988889999999999999999998 99998543211      111


Q ss_pred             HHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ........         ...+...+..+.+++.+||+.||++||++.+++++|..
T Consensus       237 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111110         11233345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-42  Score=302.17  Aligned_cols=257  Identities=27%  Similarity=0.452  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||++...      ++..+++|.+..........+.+|++.++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35777889999999999998642      345789998877666666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          144 IYELMPNGSLDTFLHGKSV-----------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      +|||+++++|.+++.....           ....+++..++.++.|++.|++|||+.   +++|+||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999864321           113578899999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHH
Q 018702          213 RVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      +|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+      ...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIE  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHH
Confidence            9999999875433221 11122235678999999998899999999999999999998 899985432111      111


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ........         ..+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       236 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11111110         1122344679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.5e-42  Score=298.66  Aligned_cols=255  Identities=26%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             CCCCcccccCceEEEEEEECCCC---EEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC------Cee
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDST---AFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS------QYN  141 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  141 (351)
                      .+.+.||+|+||.||+|.+.++.   .+|+|.++...  ....+.+.+|+.+++.++||||+++++.+...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45688999999999999976432   58999886542  33446788999999999999999999987432      246


Q ss_pred             EEEEEecCCCCHHHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          142 LLIYELMPNGSLDTFLHGKS--VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      +++|||+.+|+|.+++....  .....+++.....++.|++.|++|||+.   +++||||||+||++++++.++|+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999999875322  1234588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          220 ATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       220 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +......... ......+++.|++||...+..++.++|+||||+++|+|++ |..||.....   .   ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~---~~~~~~~~~~~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---S---EIYDYLRQGNR  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---H---HHHHHHHcCCC
Confidence            9865433221 1122335678999999998899999999999999999999 8889865321   1   11111111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .         ..+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 L---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0         11233446799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.3e-42  Score=302.33  Aligned_cols=262  Identities=23%  Similarity=0.374  Sum_probs=208.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-----CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEec-CCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-----STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTS-SQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  141 (351)
                      ..+|+..+.||+|+||.||+|...+     +..+++|++.... ....+.+.+|+.+++.++|||++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3578888999999999999999765     6789999887543 3334568899999999999999999998765 5678


Q ss_pred             EEEEEecCCCCHHHhhcCCCCC----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          142 LLIYELMPNGSLDTFLHGKSVN----KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      +++++|+++++|.+++......    ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322    25688999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhc
Q 018702          218 GLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       218 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      |+++........ ......++..|+|||.+.+..++.++||||||+++|++++ |+.||.....      ..+.......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAAYLKDG  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHHHHHcC
Confidence            999765433221 1122345678999999988889999999999999999999 9999865321      1111111111


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...         ..+...++.+.+++.+||..||++|||+.++++.|+++..+
T Consensus       236 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 YRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            100         01222346789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-42  Score=309.89  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... +++.||+|.+....   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 46789999987532   22334567888888877 699999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++........ .
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  152 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T  152 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence            999998863    44689999999999999999999998   999999999999999999999999999864322211 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....      ........... .         ..+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~-~---------~~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDE-V---------RYP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC-C---------CCC
Confidence            2234689999999999999999999999999999999999999965321      11112211111 0         123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTM-----TEVVKM  341 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~-----~e~l~~  341 (351)
                      ...+..+.+++.+||+.||.+|||+     .+++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            3345789999999999999999999     887764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-42  Score=301.61  Aligned_cols=245  Identities=26%  Similarity=0.366  Sum_probs=193.1

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|+||.||++..+ +++.+|+|.+.....   .....+..|++++++++||||+++.+.+.+....+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 588999999864321   1233456799999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++........  ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~  153 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ  153 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence            9888543  234588899999999999999999998   999999999999999999999999999876543221  223


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..+++.|+|||++.+..++.++|+||+|+++|+|++|..||.......  .............         ........
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE---------VKFEHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc---------cccccccC
Confidence            458899999999988889999999999999999999999986532111  1111111111111         00011234


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      +.++.+++.+||+.||++||+++|+++
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchh
Confidence            577999999999999999999976653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=299.99  Aligned_cols=264  Identities=27%  Similarity=0.431  Sum_probs=202.0

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhh--cCCCCceeeeeeEEecCC----eeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG--DIKHRNIVTLHGYYTSSQ----YNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~~~lv  144 (351)
                      ..+..+++|+|+||.||+|.+.+ +.||||++..   +..+.+..|-++.+  .++|+||+++++.-....    .++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            44566789999999999999875 7799999965   33445666666655  457999999999865444    78999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD------CIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      ++|.+.|+|.+||.     ...++|....+++..+++||+|||+.      +++.|+|||||++||||..|++.-|+|||
T Consensus       287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999996     45689999999999999999999975      45789999999999999999999999999


Q ss_pred             cccccCccccc-ccccccccccccCcccccCCC-CC-----chhhHHHHHHHHHHHHhCCC--------CCCcchhcc--
Q 018702          219 LATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGR-AT-----AKGDVYSFGVVLLELLTGKR--------PMDEAFLEE--  281 (351)
Q Consensus       219 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Dv~slG~il~~l~~g~~--------p~~~~~~~~--  281 (351)
                      ++..+...... .....+||.+|||||++.+.- ..     .+.||||+|.++|||++...        +|+..+..+  
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99877643322 223367999999999997642 22     36899999999999998542        233333321  


Q ss_pred             -cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          282 -GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       282 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                       ...+.+...-+..++....+.+.....   .....+++.+..||+.||+.|.|+.=+-+.+.++.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence             223344444445555555554443332   23467899999999999999999988888777664

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-42  Score=308.55  Aligned_cols=241  Identities=23%  Similarity=0.368  Sum_probs=191.8

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||+|... +++.||+|.++...   .........|..++... +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999975 46789999987542   12234456677777754 899999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence            999999863    35688899999999999999999998   999999999999999999999999999874322111 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||......      ..........          ...|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~----------~~~~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSIRMDN----------PCYP  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC----------CCCC
Confidence            23346899999999999889999999999999999999999999653211      1111111110          0122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMT-EVVK  340 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~-e~l~  340 (351)
                      ...+.++.+++.+||+.||++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            33447789999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-43  Score=319.39  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            6888899999999999999864 67889999986532   2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++..    .+.+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          82 FLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999863    45688889999999999999999998   9999999999999999999999999998632210


Q ss_pred             ccc----------------------------------------------ccccccccccccCcccccCCCCCchhhHHHH
Q 018702          227 KTH----------------------------------------------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSF  260 (351)
Q Consensus       227 ~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  260 (351)
                      ...                                              ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                              0012358999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHH
Q 018702          261 GVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKR---PTMTE  337 (351)
Q Consensus       261 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~e  337 (351)
                      ||++|||++|..||......      ...............      ......+.++.+++.+||. +|.+|   +|+.|
T Consensus       235 Gvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH------ETYRKIINWRETLYF------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH------HHHHHHHccCCccCC------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999999653221      111111111000000      0011234679999999998 67665   59999


Q ss_pred             HHHH
Q 018702          338 VVKM  341 (351)
Q Consensus       338 ~l~~  341 (351)
                      ++++
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-42  Score=298.98  Aligned_cols=256  Identities=25%  Similarity=0.407  Sum_probs=202.4

Q ss_pred             CCCCCcccccCceEEEEEEECC----CCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe-----
Q 018702           72 FSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY-----  140 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  140 (351)
                      |+..+.||+|+||.||+|....    +..+|+|.++....  .....+.+|+..++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4667889999999999998642    36799999875432  334568899999999999999999998866544     


Q ss_pred             -eEEEEEecCCCCHHHhhcCCCC--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          141 -NLLIYELMPNGSLDTFLHGKSV--NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       141 -~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                       .++++||+++++|..++.....  ....+++.....++.|++.||.|||+.   +++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7999999999999999854321  234688899999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhc
Q 018702          218 GLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       218 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      |+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....      ..........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC
Confidence            9997654332221 112234678999999988899999999999999999999 8888854321      1122222111


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .         ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 N---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1         1122444567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.5e-43  Score=306.47  Aligned_cols=261  Identities=29%  Similarity=0.450  Sum_probs=202.7

Q ss_pred             CCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  142 (351)
                      -|+..+.||+|+||.||.+..     .++..|++|.+.... ......+.+|+.+++.++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467888999999999999974     346789999987543 33446788999999999999999999998775  5678


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence            999999999999998642   23589999999999999999999998   999999999999999999999999999986


Q ss_pred             cCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhc--------ccccHHHHHHHH
Q 018702          223 MEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE--------EGTKLVTWVKAV  292 (351)
Q Consensus       223 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  292 (351)
                      .......  ......++..|+|||.+.+..++.++|+||||+++|+|++++.|.......        ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            5433221  112344677899999998888999999999999999999987764321110        000001111111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .....        ....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       239 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110        0112334557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.3e-42  Score=301.60  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=204.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      +|+..+.||+|+||.||+|...      +...+++|.+..... .....+.+|+..++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999853      235688888865443 234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 018702          144 IYELMPNGSLDTFLHGKSV--------------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSN  203 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  203 (351)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.|+.|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999864211                    123578889999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcc
Q 018702          204 ILLDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEE  281 (351)
Q Consensus       204 il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~  281 (351)
                      |++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....+ 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999998755332221 1122335678999999988889999999999999999998 99998653211 


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           .. .........        ...+...+.++.+++.+||+.+|++|||+.++++.|+++-.
T Consensus       237 -----~~-~~~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -----RL-FNLLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----HH-HHHHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 11 111111100        01233345789999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.1e-42  Score=299.10  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++.+++||||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577788999999999999986 467889999986543 334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|..+.        .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            999997653        357788899999999999999998   99999999999999999999999999987553322 


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc-HHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK-LVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ...............      . 
T Consensus       150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~-  220 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV------L-  220 (279)
T ss_pred             --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC------C-
Confidence              123458899999999998899999999999999999999999996533222111 111111111111000      0 


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       .....+.++.+++.+||+.+|++||+++|++++-
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence             0122346789999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.1e-42  Score=301.31  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.+. ++.    .+++|.+..... ....++..|+..+.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            36788899999999999999874 333    478888754332 233567788889999999999999998764 45688


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ++||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999999642   34689999999999999999999998   9999999999999999999999999999765


Q ss_pred             Ccccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ..... .......++..|+|||.+.++.++.++||||||+++|||++ |..||.......       ...........  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERL--  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC--
Confidence            43322 12223446778999999998899999999999999999998 999986542211       11111111110  


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                            ..+..++.++.+++.+||..||++|||+.|+++.|..+..+
T Consensus       231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                  11222346788999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6e-42  Score=296.37  Aligned_cols=250  Identities=29%  Similarity=0.466  Sum_probs=205.0

Q ss_pred             CcccccCceEEEEEEECC----CCEEEEEEecCCChhh-HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVND----STAFAVKRLHRGTTEV-DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++...+    +..+++|.+....... .+.+.+|++.++.++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999754    7789999997754443 56788999999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCC-----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          151 GSLDTFLHGKSVN-----KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       151 g~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ++|.+++......     ...+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999754211     36789999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          226 EKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       226 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ... .......+++.|+|||.+....++.++|+||+|+++|+|++ |..||.....      ...........       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~-------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRKGY-------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-------
Confidence            321 11223347889999999988899999999999999999999 6999866421      11122221111       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                        ....+...+.++.+++.+||+.+|++|||+.|++++|+
T Consensus       225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11234444678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-43  Score=313.72  Aligned_cols=238  Identities=26%  Similarity=0.364  Sum_probs=193.6

Q ss_pred             CcccccCceEEEEEEE----CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           76 DVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +.||+|+||.||++..    .+++.+|+|++......  ....+..|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5699999999999875    35788999998753322  23456789999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++.+    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            9999999863    45689999999999999999999998   999999999999999999999999999875433221 


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...........          ...
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~----------~~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAK----------LGM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCC----------CCC
Confidence            12235689999999999988899999999999999999999999965321      11112111111          112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTE  337 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e  337 (351)
                      |...+..+.+++.+||+.||++|||+.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3344578999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-42  Score=309.90  Aligned_cols=241  Identities=23%  Similarity=0.348  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      +|+..+.||+|+||.||+|... ++..+|+|.+.....   ...+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677889999999999999876 467899999875422   2223466777887777 5899999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999986    345688999999999999999999998   999999999999999999999999999875332


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ... ......||+.|+|||.+.+..++.++|+|||||++|+|++|+.||......      ..........         
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~~~---------  217 (323)
T cd05616         154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN---------  217 (323)
T ss_pred             CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---------
Confidence            221 123356899999999999999999999999999999999999999653211      1111111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                       ...|...+.++.+++.+||+.||++|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             11234455789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-42  Score=304.43  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  140 (351)
                      ..+|+..+.||+|+||.||++...+      ...+++|.+.... ......+.+|+.++.++ +||||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            3468888999999999999998642      3578999887543 23345688999999999 79999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 018702          141 NLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ  208 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~  208 (351)
                      .+++|||+++|+|.+++....            .....+++..++.++.|++.|++|||+.   +++|+||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            999999999999999986431            2345688999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHH
Q 018702          209 NMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLV  286 (351)
Q Consensus       209 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~  286 (351)
                      ++.+||+|||.+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......      
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  241 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------  241 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH------
Confidence            999999999999865433221 1112234678999999988899999999999999999998 99998643211      


Q ss_pred             HHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ............         ..+...+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       242 ~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 ELFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111111111110         123334578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.3e-42  Score=303.12  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=202.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CC--EEEEEEecCC-ChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-ST--AFAVKRLHRG-TTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998754 32  4788887643 233446788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          145 YELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      +||+++++|.+++.....            ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999964321            123588899999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHH
Q 018702          213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ||+|||++........  ......+..|+|||...+..++.++||||||+++|+|++ |..||......      .....
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK  230 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence            9999999863221111  111123557999999988889999999999999999997 99998654221      11121


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ......         ...+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus       231 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         231 LPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111110         01233345789999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-42  Score=308.72  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||+|... +++.||+|.++...   .........|..++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 57889999987532   12234466677777654 899999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence            999999863    45688899999999999999999998   99999999999999999999999999986432211 12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++||||+|+++|+|++|..||......      ..........          ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~~----------~~~~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVDT----------PHYP  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC----------CCCC
Confidence            23456899999999999999999999999999999999999999653211      1111111110          1123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMT-EVV  339 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~-e~l  339 (351)
                      ...+.++.+++.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            33457899999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.7e-43  Score=310.75  Aligned_cols=237  Identities=25%  Similarity=0.341  Sum_probs=189.7

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHH-HhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELE-AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||+||+|... +++.||+|++.....   .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999975 678899999865321   22234455544 56788999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (323)
T cd05575          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT  152 (323)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence            99999986    345688999999999999999999998   99999999999999999999999999987432221 12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....      ............          ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~----------~~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKPL----------RLK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCC----------CCC
Confidence            2334689999999999999999999999999999999999999965321      122222221110          122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMT  336 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~  336 (351)
                      ...+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23457899999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=296.67  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhH---HHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVD---RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .|+..+.||.|.-|+||++...+ +..+|+|++.+......   .+...|.++|..++||.++.++..|+.++..|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45666789999999999999875 47899999977544333   456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc-
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-  225 (351)
                      ||+||+|....++.  ..+.+++..++.++..++.||+|||-.   ||++|||||+||||-++|++.|+||.++..... 
T Consensus       158 yCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             cCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998865  467899999999999999999999998   999999999999999999999999998743210 


Q ss_pred             --------------------------------c-cc---------------------cccccccccccccCcccccCCCC
Q 018702          226 --------------------------------E-KT---------------------HVSTIVAGTFGYLAPEYFDTGRA  251 (351)
Q Consensus       226 --------------------------------~-~~---------------------~~~~~~~~~~~y~aPE~~~~~~~  251 (351)
                                                      . ..                     ......+||-+|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 00                     01123569999999999999999


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 018702          252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSK  331 (351)
Q Consensus       252 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  331 (351)
                      +.+.|+|+||+++|||+.|..||.+.....      .+..++.+..       .....+ ..+..+.+||+++|.+||++
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~------Tl~NIv~~~l-------~Fp~~~-~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE------TLRNIVGQPL-------KFPEEP-EVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh------hHHHHhcCCC-------cCCCCC-cchhHHHHHHHHHhccChhh
Confidence            999999999999999999999997754322      2222222211       111122 55678999999999999999


Q ss_pred             CCC----HHHHH
Q 018702          332 RPT----MTEVV  339 (351)
Q Consensus       332 Rps----~~e~l  339 (351)
                      |.-    +.||-
T Consensus       379 Rlg~~rGA~eIK  390 (459)
T KOG0610|consen  379 RLGSKRGAAEIK  390 (459)
T ss_pred             hhccccchHHhh
Confidence            987    66653

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-42  Score=302.35  Aligned_cols=256  Identities=24%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             CCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      +|...+.||+|+||.||+|...+      +..||+|++...... ....+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            45667789999999999998643      467999998765432 34568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc
Q 018702          144 IYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME  211 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~  211 (351)
                      ++||+.+++|.+++....            .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985221            1123578888999999999999999998   9999999999999999999


Q ss_pred             eEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHH
Q 018702          212 ARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV  289 (351)
Q Consensus       212 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  289 (351)
                      +||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||.....      ....
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence            99999999875533221 11122335778999999988889999999999999999998 8888865321      1222


Q ss_pred             HHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .......         ....+..++..+.+++.+||+.+|.+|||+++++..|+.
T Consensus       237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            2222211         112344455789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.2e-42  Score=299.67  Aligned_cols=257  Identities=28%  Similarity=0.407  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|++|.||+|.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            468888999999999999998753      4578999886543 333456889999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---ceEEee
Q 018702          143 LIYELMPNGSLDTFLHGKSV---NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---EARVSD  216 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~d  216 (351)
                      ++|||+++++|.+++.....   ....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence            99999999999999875431   123588999999999999999999998   999999999999998754   589999


Q ss_pred             eccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHh
Q 018702          217 FGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       217 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ||++.......... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.....+.      .......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~  236 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTG  236 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHc
Confidence            99997653222111 111223568999999988899999999999999999997 999986543221      1111111


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ....         ..+...+..+.+++.+||+.+|++|||+.+++++|++
T Consensus       237 ~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         237 GGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            1111         1233345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-42  Score=315.60  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=201.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|..+++.++||||+++++.+.+++..++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3468999999999999999999975 56789999986422   2223457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++..     ..++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         121 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            9999999999999853     3478888899999999999999998   9999999999999999999999999999866


Q ss_pred             CcccccccccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTG----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ............||+.|+|||++.+.    .++.++|||||||++|+|++|..||.....      ..............
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~  266 (371)
T cd05622         193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL  266 (371)
T ss_pred             CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence            54333333445699999999998653    378999999999999999999999965322      12222222211110


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKML  342 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~L  342 (351)
                      ..      ..+...+..+.+++.+||+.++.+  ||++.|++++.
T Consensus       267 ~~------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         267 TF------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cC------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00      112234578999999999854443  78999998865

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=300.71  Aligned_cols=257  Identities=27%  Similarity=0.423  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||.||+|...+      +..+++|.+.... ......+.+|+.++..++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            468888999999999999998643      3579999986543 233456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCC------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          143 LIYELMPNGSLDTFLHGKSV------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                      ++|||+++++|.+++.....      ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence            99999999999999864321      123478889999999999999999998   999999999999999999999999


Q ss_pred             eccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHh
Q 018702          217 FGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       217 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ||+++........ ......++..|+|||.+.++.++.++|+||||+++|++++ |..||.......      .......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~  236 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLKFVID  236 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HHHHHhc
Confidence            9998755433221 1222346788999999988889999999999999999998 999986532211      1111111


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      ..         ....|...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       237 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 GG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            11         111233345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.7e-42  Score=295.89  Aligned_cols=252  Identities=26%  Similarity=0.455  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++.+.++..+++|.+..... ....+.+|++++++++|||++++++++......+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            36777889999999999999987788899998875433 24568899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ...+++..+..++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999998642   24578899999999999999999998   9999999999999999999999999998755433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||.+.++.++.++|+||||+++|+|++ |..||......      ............         .
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~---------~  221 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINAGFRL---------Y  221 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhCCCCC---------C
Confidence            1222235678999999998899999999999999999998 99998653211      111111111000         0


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            11223478999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.9e-42  Score=303.80  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      .+|...+.||+|+||.||++...        ++..+++|.+.... ......+.+|+..++.+ +||||+++++++...+
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            46888899999999999999741        23468999886543 23346788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..+++|||+++|+|.+++.....            ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEc
Confidence            99999999999999999975321            124578888999999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.+||+|||.++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....      .
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~  245 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------V  245 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------H
Confidence            99999999999998664332221 122235678999999988889999999999999999998 788875432      1


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .............         ..+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus       246 ~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            1222222111111         1233445789999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.9e-42  Score=302.19  Aligned_cols=264  Identities=25%  Similarity=0.409  Sum_probs=205.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-----------------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-----------------STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTL  131 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  131 (351)
                      .+|+..+.||+|+||.||++...+                 +..+|+|.+.... ....+.+.+|++++.+++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            478899999999999999987643                 2458999987653 3345678899999999999999999


Q ss_pred             eeEEecCCeeEEEEEecCCCCHHHhhcCCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 018702          132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSV-------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNI  204 (351)
Q Consensus       132 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  204 (351)
                      ++++..++..+++||++++++|.+++.....       ....+++..++.++.|++.||+|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999999999999999999999999975431       123689999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCcchhcc
Q 018702          205 LLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT--GKRPMDEAFLEE  281 (351)
Q Consensus       205 l~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~--g~~p~~~~~~~~  281 (351)
                      ++++++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            999999999999999875433221 11223346778999999988889999999999999999998  6677754321  


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                       ..................     ....+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       240 -~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 -QQVIENAGHFFRDDGRQI-----YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -HHHHHHHHhccccccccc-----cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence             111111111111110000     011233345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-42  Score=304.73  Aligned_cols=259  Identities=29%  Similarity=0.476  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC--EEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST--AFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++|+..+.||+|+||.||+|.+. ++.  .+++|.++... ......+.+|++++.++ +||||+++++++...+..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999874 343  46777776432 33445788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          145 YELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      |||+++++|.+++.....            ....+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999964321            123578899999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHH
Q 018702          213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ||+|||++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......      .....
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK  235 (303)
T ss_pred             EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHH
Confidence            999999986322111  1111224567999999988889999999999999999998 99998643221      11111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ......         ...+...+..+.+++.+||+.+|++|||+.++++.|+.+..+
T Consensus       236 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         236 LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HhcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111100         012233446789999999999999999999999999886554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-41  Score=294.21  Aligned_cols=246  Identities=25%  Similarity=0.447  Sum_probs=196.3

Q ss_pred             ccccCceEEEEEEEC---CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN---DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|+||.||+|.+.   ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.. +..+++|||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999763   345699999876543 334568899999999999999999998864 467999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc--
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--  231 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--  231 (351)
                      .+++...   ...+++..++.++.|++.|++|||++   +++|+||||+||+++.++.+||+|||++...........  
T Consensus        82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998642   34689999999999999999999998   999999999999999999999999999975543322111  


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......      ...........         ...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSFIEQGKR---------LDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCCC---------CCCC
Confidence            11123578999999988889999999999999999996 99998654211      11111111111         1234


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ...++++.+++.+||..+|++||++.++.+.|+.+
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            45568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.3e-42  Score=295.97  Aligned_cols=254  Identities=28%  Similarity=0.481  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++..+++..+++|.+.... .....+.+|+++++.++|+|++++.+.+.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            4688889999999999999998888889999887543 234568899999999999999999999887 77899999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          84 KGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            99999999753  234578888999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......++..|+|||.+....++.++|+||||+++|++++ |..||......   ...   . .......        ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~---~-~~~~~~~--------~~  223 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI---R-ALERGYR--------MP  223 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH---H-HHhCCCC--------CC
Confidence            2222235677999999998889999999999999999998 99998653211   111   1 1111100        01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            1233447799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.6e-42  Score=294.70  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=204.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... +++.+++|.+...  .......+.+|+++++.++|||++++++++.+.+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3667788999999999999875 5788999988643  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++...  ....+++..++.++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999999753  245688999999999999999999998   99999999999999999999999999987654432


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .. .....+++.|+|||+..+..++.++|+||||+++|+|++|+.||......      ..........         ..
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~---------~~  219 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRGV---------FP  219 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC---------CC
Confidence            22 22345788999999999989999999999999999999999999654311      1111111111         11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1233445789999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.6e-43  Score=318.80  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=197.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... +++.||+|.+.....   .....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999865 578899999865321   223457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999973    45678888899999999999999998   9999999999999999999999999997532100


Q ss_pred             c------------------------------------------ccccccccccccccCcccccCCCCCchhhHHHHHHHH
Q 018702          227 K------------------------------------------THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVL  264 (351)
Q Consensus       227 ~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il  264 (351)
                      .                                          ........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                          0001124689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHH
Q 018702          265 LELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP---TMTEVVKM  341 (351)
Q Consensus       265 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~e~l~~  341 (351)
                      |+|++|+.||.......      ........ ......     ......+..+.+++.+|+ .+|.+|+   |+.+++++
T Consensus       235 yell~G~~Pf~~~~~~~------~~~~i~~~-~~~~~~-----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAE------TQLKVINW-ETTLHI-----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHH------HHHHHhcc-CccccC-----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999996543211      11111110 000000     011233467888998876 5999999   89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=294.16  Aligned_cols=248  Identities=28%  Similarity=0.457  Sum_probs=197.7

Q ss_pred             CcccccCceEEEEEEECC----CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVND----STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||+|.+..    +..+++|.+..... ...+.+.+|+.+++.+.|||++++++++.. +..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997532    26799999876544 244678899999999999999999998764 467999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.+..........
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999999974    34689999999999999999999998   99999999999999999999999999987654332221


Q ss_pred             cc--cccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          231 ST--IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       231 ~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      ..  ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....   ...   .........         .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~---~~~~~~~~~---------~  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEV---IAMLESGER---------L  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHH---HHHHHcCCc---------C
Confidence            11  1123467999999998899999999999999999998 9999865321   111   111111111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ..+...+..+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            123344578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.8e-42  Score=304.29  Aligned_cols=261  Identities=28%  Similarity=0.402  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      .+|.+.+.||+|+||.||++...        +...+|+|.+.... ......+.+|++++..+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46889999999999999998752        22469999987643 23345688899999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..+++|||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++|+||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999975321            123588899999999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.++|+|||.+.......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence            99999999999987554322111 111124568999999988889999999999999999998 8888854321      


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ............         ...+...+.++.+++.+||..+|++|||+.++++.|+.+.+.
T Consensus       249 ~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         249 EELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            111111111110         112334457899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-42  Score=317.71  Aligned_cols=251  Identities=21%  Similarity=0.256  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||+|... +++.+|+|++....   ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5778899999999999999874 57789999986532   2233568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++.+    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999999863    34678888999999999999999998   9999999999999999999999999997532100


Q ss_pred             c----------------------------------------------ccccccccccccccCcccccCCCCCchhhHHHH
Q 018702          227 K----------------------------------------------THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSF  260 (351)
Q Consensus       227 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  260 (351)
                      .                                              ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000112468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHH
Q 018702          261 GVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT---MTE  337 (351)
Q Consensus       261 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~e  337 (351)
                      ||++|||++|+.||......      .............. .     ......++++.+++.+|+ .+|.+|++   +.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~-~-----p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPL------ETQMKVINWQTSLH-I-----PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHH------HHHHHHHccCCCcC-C-----CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            99999999999999653211      11111111000000 0     011233467888998876 49999997   888


Q ss_pred             HHHH
Q 018702          338 VVKM  341 (351)
Q Consensus       338 ~l~~  341 (351)
                      ++++
T Consensus       302 i~~h  305 (382)
T cd05625         302 IKAH  305 (382)
T ss_pred             HhcC
Confidence            7764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.2e-42  Score=301.62  Aligned_cols=264  Identities=23%  Similarity=0.371  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-----------------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-----------------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTL  131 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  131 (351)
                      ++|+..+.||+|+||.||++...                 +...+|+|.+.... ......+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998532                 23358999987543 3344678899999999999999999


Q ss_pred             eeEEecCCeeEEEEEecCCCCHHHhhcCCCCC-------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 018702          132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN-------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNI  204 (351)
Q Consensus       132 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  204 (351)
                      ++++...+..+++|||+++++|.+++......       ...+++..+..++.|++.|++|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999998753211       23477888999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeeccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCcchhcc
Q 018702          205 LLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT--GKRPMDEAFLEE  281 (351)
Q Consensus       205 l~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~--g~~p~~~~~~~~  281 (351)
                      ++++++.++|+|||++.......... .....++..|++||...++.++.++|+||||+++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999987553322111 122234678999999888889999999999999999998  778875432211


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                         .................     ...+..++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       242 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 ---VIENTGEFFRDQGRQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHHHHHhhcccccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               11111111111100000     01123344789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.5e-42  Score=299.83  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.... ......+.+|..++..++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            46888899999999999999853 333    48999987543 33456788999999999999999999998764 4689


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||+++..
T Consensus        86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999998642   34688999999999999999999998   9999999999999999999999999999866


Q ss_pred             Ccccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ....... .....+++.|+|||...+..++.++||||||+++|||++ |..||......   ....    .......   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~---  229 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKGER---  229 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCc---
Confidence            4332211 111234678999999988899999999999999999998 89998643211   1111    1111100   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                           ...+...+.++.+++.+||+.||++|||+.++++.|..+..+
T Consensus       230 -----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         230 -----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                 011233457799999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.4e-42  Score=303.57  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|++|.||+|... ++..+++|.+........+.+.+|+.+++.++|||++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            47888899999999999999864 67889999997765555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.     ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus       100 ~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999985     23578889999999999999999998   999999999999999999999999999875443222


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......     .. .........       ...
T Consensus       172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~-~~~~~~~~~-------~~~  237 (296)
T cd06654         172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----AL-YLIATNGTP-------ELQ  237 (296)
T ss_pred             c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hH-HHHhcCCCC-------CCC
Confidence            1 122357889999999998889999999999999999999999996542211     11 111111100       001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            233445779999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.9e-42  Score=296.44  Aligned_cols=255  Identities=30%  Similarity=0.514  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-C---CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-S---TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|++|.||+|.... +   ..+++|.+.... ....+.+..|+++++.++|||++++.+++...+..+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            367778899999999999998752 2   368999887653 33446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++++|||++....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999998642   35688999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccccccc--cccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          225 AEKTHVST--IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       225 ~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ........  ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......      ...........    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~~----  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGFR----  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCCC----
Confidence            33221111  1123457999999988889999999999999999997 99998543211      11121111110    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                           ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 -----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 011223447799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-42  Score=306.67  Aligned_cols=264  Identities=20%  Similarity=0.302  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|...+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.++++++||||+++++++..++..+++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888899999999999999875 567899999875432 2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 888887542   34578889999999999999999998   99999999999999999999999999987543322


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH---------HHHHHHhcCc
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT---------WVKAVMQDKR  297 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~  297 (351)
                      .. .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+......         .+........
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            21 122347899999998864 568899999999999999999999997543222111000         0000000000


Q ss_pred             cceeccccC-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTSL-----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......+..     .......+.++.+++.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            000000000     00112245678999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.1e-42  Score=296.85  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|...    .+..+++|.+.... ....+.+.+|+.++++++||||+++++++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999863    23369999886543 23345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++++|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999643   34578899999999999999999998   99999999999999999999999999998664


Q ss_pred             ccccccccc--ccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          225 AEKTHVSTI--VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       225 ~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .........  ..++..|+|||.+.+..++.++|+||||+++|++++ |..||......+      ...........   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~---  228 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRL---  228 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCcC---
Confidence            432221111  123568999999998899999999999999999887 999986542211      11111111100   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                            ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  11223446789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-42  Score=302.34  Aligned_cols=264  Identities=24%  Similarity=0.376  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC---------------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND---------------STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHG  133 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~  133 (351)
                      .+|+..+.||+|+||.||++...+               ...||+|.++... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            478889999999999999987532               1248999987643 333456889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHhhcCCCC--------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 018702          134 YYTSSQYNLLIYELMPNGSLDTFLHGKSV--------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL  205 (351)
Q Consensus       134 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  205 (351)
                      ++...+..+++|||+.+++|.+++.....        ....+++..++.++.|++.|++|||+.   +++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999864211        112468888999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCcchhccc
Q 018702          206 LDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT--GKRPMDEAFLEEG  282 (351)
Q Consensus       206 ~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~--g~~p~~~~~~~~~  282 (351)
                      +++++.+||+|||++......... ......++..|+|||.+.++.++.++|+||||+++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            999999999999998754332211 1122335678999999988899999999999999999998  566775432111 


Q ss_pred             ccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                        ................     ....+...+..+.+++.+||+.||++|||+.++++.|.+
T Consensus       241 --~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 --VIENTGEFFRNQGRQI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHhhhhccccc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              1111111111110000     001122344789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-41  Score=294.24  Aligned_cols=249  Identities=25%  Similarity=0.416  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe-cCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT-SSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||++... +..+++|..+...  ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            36788899999999999999865 6679999886532  2456889999999999999999999754 556789999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...  ....+++..+..++.|++.|++|||++   +++|+||||+||++++++.+|++|||++....... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999998743  234578899999999999999999998   99999999999999999999999999987543222 


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                         ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....      ............         .
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~~---------~  218 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKGYK---------M  218 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCCC---------C
Confidence               12234668999999998899999999999999999997 9999864321      111111111110         0


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            12334457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=321.69  Aligned_cols=260  Identities=26%  Similarity=0.385  Sum_probs=193.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--------C
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--------Q  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~  139 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999874 57889999886432    2245799999999999999998876432        2


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeec
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFG  218 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg  218 (351)
                      ..+++|||+++ +|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999975 78777654333456789999999999999999999998   999999999999998654 69999999


Q ss_pred             cccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +++.......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+.  +..... ......
T Consensus       217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~-~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VLGTPT  291 (440)
T ss_pred             cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCC
Confidence            9986543222  123457999999998765 4689999999999999999999999975422111  111100 000000


Q ss_pred             -----------cce----eccccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 -----------EEY----VIDTSLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 -----------~~~----~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                 ...    .....+. ..|...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                       000    0000000 1233345789999999999999999999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=290.50  Aligned_cols=258  Identities=25%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +.|+..+.||+|.|+.|+++.. .+|+.+|+|++...  .....+++.+|+.+.+.++||||+++.+...+.+..|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            4677888999999999999775 56788888877432  22345679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~  223 (351)
                      ++.|++|..-+-    .+-.+++..+-..++||+.++.|+|.+   +|+|||+||+|+++.+   ...+||+|||++...
T Consensus        91 ~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   91 LVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999976554    223467777888999999999999999   9999999999999954   445899999999987


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      +.  ........|||.|+|||++...+|+..+|||+.|+++|-|+.|.+||.+....   .+   ..........   .+
T Consensus       164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rl---ye~I~~g~yd---~~  232 (355)
T KOG0033|consen  164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL---YEQIKAGAYD---YP  232 (355)
T ss_pred             CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HH---HHHHhccccC---CC
Confidence            72  22333456999999999999999999999999999999999999999763211   11   1222211111   11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         .+..++.++++.+|+.+||..||.+|.|+.|.|++=+--..+
T Consensus       233 ---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  233 ---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             ---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence               123456678999999999999999999999999875544433

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.4e-42  Score=294.71  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|+||.||++... ++..+++|.+.... ....+.+.+|+.+++.++|||++++.+.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4777889999999999999875 57889999986532 334456788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...  ....++......++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||.+........
T Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999999988643  234578889999999999999999998   999999999999999999999999999876543222


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.....      ...........         ...
T Consensus       156 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~~~  219 (255)
T cd08219         156 Y-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS---------YKP  219 (255)
T ss_pred             c-cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC---------CCC
Confidence            1 2234578899999999988899999999999999999999999965321      11111111111         111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||+.||++|||+.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            233445679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.6e-42  Score=296.48  Aligned_cols=240  Identities=22%  Similarity=0.413  Sum_probs=190.1

Q ss_pred             CcccccCceEEEEEEECC-------------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           76 DVIGSGGFGTVYRLTVND-------------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      +.||+|+||.||+|...+             ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998532             2258999887655555567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc-------eEEe
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME-------ARVS  215 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~-------~kl~  215 (351)
                      ++|||+++++|..++...   ...+++..+..++.|+++|++|||+.   +++||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999988642   34588999999999999999999998   9999999999999986654       8999


Q ss_pred             eeccccccCcccccccccccccccccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCcchhcccccHHHHHHHHH
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELL-TGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      |||.+.......     ...++..|+|||.+. +..++.++||||||+++|+|+ +|..||.......       .....
T Consensus       155 d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~  222 (262)
T cd05077         155 DPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY  222 (262)
T ss_pred             CCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH
Confidence            999886543221     234678899999886 567899999999999999998 5888875432111       01111


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ....          ........++.+++.+||+.||.+||++.++++.|+
T Consensus       223 ~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1100          011122367899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-42  Score=308.65  Aligned_cols=240  Identities=25%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHH-HHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFEREL-EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... +++.+|+|++.....   .....+.+|. ..++.++||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999975 467799999865321   1223344444 356788999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|.+++..    ...+.+.....++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            999999863    45577888889999999999999998   99999999999999999999999999987532221 12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ...........          ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~----------~~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL----------QLK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCc----------CCC
Confidence            23456899999999999999999999999999999999999999653221      12222221110          112


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVV  339 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l  339 (351)
                      ...+..+.+++.+||+.||.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            33457899999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.5e-42  Score=301.74  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      ..+|+..+.||+|+||.||+|..++      +..||+|.+..... .....+.+|+..++.++||||+++++++.+.+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            4578999999999999999987532      44799998865432 2334578899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          142 LLIYELMPNGSLDTFLHGKSV------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      +++|||+++|+|.+++.....      .....++..+..++.|++.|+.|||++   +++||||||+||++++++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence            999999999999999964321      123456778889999999999999998   99999999999999999999999


Q ss_pred             eeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHH
Q 018702          216 DFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       216 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      |||+++........ ......++..|+|||.+.++.++.++|+||||+++|+|++ |..||.....+      +......
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~  235 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVM  235 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence            99998754332211 1112234678999999998899999999999999999998 78888653221      1111111


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ...         ....+...+..+.+++.+||+.||++|||+.++++.|.+..
T Consensus       236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111         11112233478999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=301.22  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      ++|...+.||+|+||.||++...      .+..+|+|.++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            46888999999999999998742      23469999887543 23345688999999999 799999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+.+|+|.+++....  ...+++..+..++.|++.|+.|||++   +++|+||||+||++++++.++++|||++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999996432  23489999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ........ ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.......      ........... 
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~-  262 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYR-  262 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCc-
Confidence            65433221 1122345778999999998899999999999999999998 999986542211      11111111100 


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                             ...+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       263 -------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 -------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   011223347899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.3e-42  Score=304.93  Aligned_cols=197  Identities=24%  Similarity=0.396  Sum_probs=160.0

Q ss_pred             CCcccccCceEEEEEEEC---CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeEEEEEecC
Q 018702           75 KDVIGSGGFGTVYRLTVN---DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLLIYELMP  149 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  149 (351)
                      .+.||+|+||.||+|...   +++.+|+|.+....  ....+.+|+.++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            457999999999999864   45789999986542  23457789999999999999999998854  456789999985


Q ss_pred             CCCHHHhhcCCCC-----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCceEEeeeccc
Q 018702          150 NGSLDTFLHGKSV-----NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLA  220 (351)
Q Consensus       150 ~g~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~  220 (351)
                       ++|.+++.....     ....+++..+..++.|++.||.|||++   +++||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             588887753211     223588889999999999999999998   99999999999999    45678999999999


Q ss_pred             cccCccccc--ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          221 TLMEAEKTH--VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       221 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      .........  ......+|+.|+|||++.+ ..++.++|+||+||++|+|++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            865433221  1233568999999999876 46899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-41  Score=310.18  Aligned_cols=260  Identities=24%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCC-CCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  141 (351)
                      .+|...+.||+|+||.||+|.+.      .+..||+|++...... ..+.+.+|+.++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999864      2457999999765332 2346889999999997 99999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC-----------------------------------------------------------
Q 018702          142 LLIYELMPNGSLDTFLHGKSV-----------------------------------------------------------  162 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------------  162 (351)
                      ++||||+++|+|.+++.....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999864321                                                           


Q ss_pred             -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          163 -----------------------------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       163 -----------------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                                                         ....+++.....++.|++.||.|||+.   +++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence                                               112467778889999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.+||+|||+++....... .......++..|+|||.+.+..++.++|+||||+++|||++ |..||......     
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-----  348 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-----  348 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-----
Confidence            999999999999975432221 11122346788999999998889999999999999999998 88898543211     


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                       ............        ...|...+.++.+++.+||..+|++||+++|+++.|+.+.
T Consensus       349 -~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -EQFYNAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -HHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             111111111100        0123344578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-42  Score=309.17  Aligned_cols=238  Identities=26%  Similarity=0.368  Sum_probs=189.8

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHH-HhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELE-AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... +++.+|+|++....   ......+..|.. +++.++||||+++++.+..++..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999874 67889999986532   122334555554 46778999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||++....... ..
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            99998886    345689999999999999999999998   99999999999999999999999999987432221 11


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....      ............          ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~~----------~~~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKPL----------VLR  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCCc----------cCC
Confidence            2335689999999999999999999999999999999999999965321      112222221110          112


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTE  337 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e  337 (351)
                      ...+..+.+++.+||+.+|.+||++++
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            234467899999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.6e-42  Score=301.47  Aligned_cols=249  Identities=23%  Similarity=0.357  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++.+..++..+++|||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5789999999999999999986 468899999997665555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.     ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.+........
T Consensus        99 ~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999985     34578889999999999999999998   999999999999999999999999999876543322


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.........      .......       .....
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~-------~~~~~  236 (297)
T cd06656         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-------TPELQ  236 (297)
T ss_pred             C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC-------CCCCC
Confidence            2 22345788999999999888999999999999999999999999653211100      0000000       00001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            23344577899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-41  Score=292.52  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=200.3

Q ss_pred             CcccccCceEEEEEEECC--C--CEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVND--S--TAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|++|.||+|.+.+  +  ..+|+|.+..... ...+.+.+|+..+++++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  2589999987666 556789999999999999999999999888 888999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc-
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH-  229 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-  229 (351)
                      ++|.+++.....  ..+++...+.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999975421  5689999999999999999999998   9999999999999999999999999999866442221 


Q ss_pred             -ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          230 -VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       230 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......      +..........        ..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~--------~~  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGE--------RL  220 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCC--------cC
Confidence             1112346788999999998899999999999999999998 99998543211      11111111100        01


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            122334578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.2e-42  Score=301.33  Aligned_cols=257  Identities=29%  Similarity=0.481  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||++...      ++..+++|.+.... ......+.+|+..+++++|||++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            46888899999999999999864      35779999987643 334466889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCC------------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 018702          143 LIYELMPNGSLDTFLHGKS------------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNI  204 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  204 (351)
                      +++||+++++|.+++....                  .....+++..++.++.|++.||+|||+.   +++|+||+|+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence            9999999999999986421                  1123477888999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhccc
Q 018702          205 LLDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEG  282 (351)
Q Consensus       205 l~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~  282 (351)
                      ++++++.++++|||++......... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......  
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999999998754332211 1112234667999999988899999999999999999997 88888543221  


Q ss_pred             ccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                          .........         ....++...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       240 ----~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVIYYVRDG---------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                111111111         1112334455789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-41  Score=296.28  Aligned_cols=254  Identities=30%  Similarity=0.505  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCceEEEEEEECC-C---CEEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-S---TAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .|+..+.||+|+||.||+|.... +   ..|++|.+... .......+..|+..++.++||||+++.+++.++...+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999998653 2   35999998765 3334567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++.....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998743   34588999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccccc--ccccc--ccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          226 EKTHV--STIVA--GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       226 ~~~~~--~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      .....  .....  .+..|+|||.+.+..++.++||||||+++||+++ |..||......      ...........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~~~~~i~~~~~---  229 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVINAIEQDYR---  229 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------HHHHHHHcCCc---
Confidence            22211  11111  2457999999998899999999999999999886 99998653221      11111111100   


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                            ...+...+..+.+++.+||+.+|++||++++++..|+++
T Consensus       230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  011233446789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=295.09  Aligned_cols=254  Identities=21%  Similarity=0.358  Sum_probs=205.6

Q ss_pred             CCcccccCceEEEEEE-ECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           75 KDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      .+.||+|+|+.|-.+. +.++.+||||++.+.......++.+|++++.+.+ |+||++++++|+++..+|||||.+.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3679999999998876 5788999999998887778889999999999996 9999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---ceEEeeecccccc--Cccc
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---EARVSDFGLATLM--EAEK  227 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~--~~~~  227 (351)
                      |.+.+.    ..+.+++.++.++.++|+.||.+||.+   ||.|||+||+|||-....   -+|||||.+....  +.+-
T Consensus       163 lLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999998    567899999999999999999999999   999999999999997654   3799999886532  2211


Q ss_pred             ----ccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc----HHHHHHHH--
Q 018702          228 ----THVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK----LVTWVKAV--  292 (351)
Q Consensus       228 ----~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~--  292 (351)
                          .....+.+|+..|||||++.     ...|+.++|.||||+|+|-|++|.+||.+....+...    .....+..  
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                22233567899999999873     3468899999999999999999999999876654332    11111111  


Q ss_pred             --HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          293 --MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       293 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                        +++...++ .+    .-+.+++.+..++++.+|..|+.+|.++.++++
T Consensus       316 esIQEGkYeF-Pd----kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  316 ESIQEGKYEF-PD----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHhccCCcC-Ch----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              12111111 11    124567788999999999999999999999887

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-42  Score=300.21  Aligned_cols=253  Identities=31%  Similarity=0.523  Sum_probs=200.5

Q ss_pred             CCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHH--HHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDR--GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      |+..+.||+|+||+||++.... ++.+|+|.+.........  ...+|+..+++++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4566889999999999999865 457999999876554433  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.    ....+++..+..++.|+++||.+||+.   +++|+||||+||+++.++.++|+|||.+..... ..
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN  152 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence            9999999997    356689999999999999999999998   999999999999999999999999999975421 12


Q ss_pred             cccccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......++..|+|||.+. +..++.++|+||+|+++|+|++|..||.........   ..............    .  
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~----~--  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL---EIIEKILKRPLPSS----S--  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH---HHHHHHHHTHHHHH----T--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh---hhhhhccccccccc----c--
Confidence            2233445789999999998 888999999999999999999999999765111111   11111111000000    0  


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .........+.+++.+||+.||++|||+.+++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0001112789999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-41  Score=296.61  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+........+.+.+|+..++.++|||++++++.+..++..+++|||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            568889999999999999999754 7889999998776666777889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|..++...   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            999999887532   34688999999999999999999998   99999999999999999999999999886533221 


Q ss_pred             cccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          229 HVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||.....      ..............    
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~----  234 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPPT----  234 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCCcc----
Confidence            1122345788999999884     34567899999999999999999999865321      11111111111100    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ...+...+.++.+++.+||+.||++||++.+++++
T Consensus       235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         235 ---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               01233445679999999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=290.38  Aligned_cols=248  Identities=30%  Similarity=0.493  Sum_probs=200.1

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHH
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLD  154 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  154 (351)
                      ++||+|++|.||++...+++.|++|.+...... ....+.+|++++++++||||+++++++.+.+..+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877899999998765444 4567889999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc-cc
Q 018702          155 TFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS-TI  233 (351)
Q Consensus       155 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~  233 (351)
                      +++...   ...+++..+..++.+++.|+.|||++   +++|+||+|+||+++.++.++|+|||.+........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998642   34578889999999999999999998   999999999999999999999999999875542211111 11


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN  312 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (351)
                      ...+..|+|||.+.++.++.++|+||||+++|+|++ |..||.......      ..........         ...+..
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~  219 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERIESGYR---------MPAPQL  219 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHHhcCCC---------CCCCcc
Confidence            223567999999988899999999999999999999 888885532211      1111111000         012334


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       313 ~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            45789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=293.94  Aligned_cols=251  Identities=29%  Similarity=0.487  Sum_probs=196.6

Q ss_pred             CcccccCceEEEEEEECC-CC--EEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVND-ST--AFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||+|...+ +.  .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 33  46888886532 34456788999999999 799999999999999999999999999


Q ss_pred             CCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          151 GSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       151 g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      ++|.+++.....            ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999865321            123578899999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ++........  ......+..|+|||.+....++.++|+||||+++|+|++ |..||......      ...........
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~  229 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQGYR  229 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHhCCCC
Confidence            9853221111  111223567999999988889999999999999999997 99998543211      11111111110


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .         ..+...+.++.+++.+||+.||.+|||+.+++..|+.+.
T Consensus       230 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         230 L---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0         112234467899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.8e-42  Score=296.61  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=201.1

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh------hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT------EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|+..+.||+|+||+||+|...+++.+|+|.+.....      .....+.+|++.++.++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988888999998865321      1224578899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      +||+++++|.+++.+    ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999999963    34678899999999999999999998   99999999999999999999999999987543


Q ss_pred             ccc-----ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          225 AEK-----THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       225 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ...     ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......     ..........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~---  225 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRG---  225 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccC---
Confidence            211     111223457889999999998889999999999999999999999996431110     0000000000   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                           .....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 011223345578999999999999999999999976

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-41  Score=299.50  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+..++.++|||++++++.+...+..++++||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3688889999999999999986 568899999987665555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.     ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999985     34588999999999999999999998   999999999999999999999999999876543322


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......      ...........       ...
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~~~-------~~~  236 (296)
T cd06655         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTP-------ELQ  236 (296)
T ss_pred             c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCc-------ccC
Confidence            2 122357889999999998889999999999999999999999996542211      11111111100       001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||..||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            233345679999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.9e-42  Score=302.31  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=201.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|+||.||++... ++..+++|.+..... .....+.+|++++++++||||+++++.+.+++..+++|||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            6888899999999999999875 567789998865432 33456889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++..    .+.+++..+..++.|++.||.|||+.  .+++|+||+|+||++++++.++|+|||++....... 
T Consensus        82 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          82 DGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            99999999973    35688999999999999999999973  289999999999999999999999999986543221 


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc----------
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE----------  298 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------  298 (351)
                        .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   ..............          
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCC
Confidence              123457899999999988889999999999999999999999985432111   11000000000000          


Q ss_pred             --------------ceeccccCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          299 --------------EYVIDTSLEGCP-INEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       299 --------------~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                                    ...........| ...+.++.+++.+||..+|++|||+.+++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                          000000000011 124567999999999999999999999998743

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.6e-42  Score=299.68  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |+..+.||+|+||.||++... +++.+|+|.+.....   .....+..|+.++++++|+|++++.+.+.+.+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566788999999999999875 578899998865422   2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999988543  234588899999999999999999998   99999999999999999999999999987543322


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      ..  ....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.......   ..............         
T Consensus       157 ~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~---------  222 (285)
T cd05630         157 TI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEVQE---------  222 (285)
T ss_pred             cc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhhhhh---------
Confidence            21  22358999999999999999999999999999999999999997532111   00111111111000         


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                      ..+...+.++.+++.+||+.||++|||     +.|++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            122334467899999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8e-42  Score=299.67  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||+|... ++..||+|.+.....  .....+.+|+.+++.++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999875 578899999865422  2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++ ++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 58988886432 235689999999999999999999998   99999999999999999999999999987554322


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH-------------
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM-------------  293 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  293 (351)
                      . ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||........  .........             
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence            1 1122346889999998765 4578999999999999999999999975322110  000000000             


Q ss_pred             hc--CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          294 QD--KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       294 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..  ..................+.++.+++.+||+.||++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00  0000000000001122245778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-41  Score=295.40  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=204.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||+|..+      +...+++|.+...... ....+.+|++++++++|||++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46788899999999999999864      2456999988664443 4467899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHhhcCCCCC-----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          143 LIYELMPNGSLDTFLHGKSVN-----KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      ++|||+++++|.+++......     ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999754311     12689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......      ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~~~~~  235 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRLQAGK  235 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHHHcCC
Confidence            9986543322222233346778999999988888999999999999999998 88888543211      1111111111


Q ss_pred             ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                       ..       ...+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       236 -~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         236 -LE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -cC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence             00       01122344789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-41  Score=307.98  Aligned_cols=263  Identities=25%  Similarity=0.283  Sum_probs=197.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  139 (351)
                      ...+|+..+.||+|+||.||++... ++..||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4468999999999999999999874 57889999986542  233456789999999999999999999986543     


Q ss_pred             -eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          140 -YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       140 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                       ..+++|||+++ +|.+.+.      ..++...+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46999999965 6666653      2377888899999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc---------c---HH
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT---------K---LV  286 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------~---~~  286 (351)
                      ++.......  ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.........         .   ..
T Consensus       169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            997543221  122345799999999999999999999999999999999999999754211100         0   00


Q ss_pred             ----HHHHHHHhcCcc--ceecc--------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          287 ----TWVKAVMQDKRE--EYVID--------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       287 ----~~~~~~~~~~~~--~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                          ............  .....        +.....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                000000000000  00000        000011112346789999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.7e-42  Score=305.17  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=193.5

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      |+..+.||+|+||.||++... +++.||+|++....   ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            566788999999999999875 57889999987532   222345677888888886 5788889999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 y~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          82 YVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999999986    345689999999999999999999998   9999999999999999999999999998753322


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .. ......||+.|+|||++.+..++.++|+||+|+++|+|++|..||......      ..........          
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~----------  217 (323)
T cd05615         155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN----------  217 (323)
T ss_pred             Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC----------
Confidence            21 123345899999999999889999999999999999999999999654221      1122222111          


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                      ...|...+.++.+++.+||+.+|.+|++.
T Consensus       218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            01233445788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.2e-42  Score=305.83  Aligned_cols=237  Identities=26%  Similarity=0.351  Sum_probs=189.3

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHH-HhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELE-AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||.||++... ++..||+|.+.....   .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 578899999865322   22234555554 57889999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|..++.    ....+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            99998886    345688888999999999999999998   99999999999999999999999999987532221 12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|..||....      ............          ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~----------~~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP----------LQLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC----------CCCC
Confidence            233468999999999998899999999999999999999999996532      111222222111          1123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMT  336 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~  336 (351)
                      ...+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34457899999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-41  Score=293.73  Aligned_cols=250  Identities=23%  Similarity=0.389  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|+..+.||+|++|.||++...+ +..+++|.+.....  .+.+.+|++.++.++|||++++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            478889999999999999999865 78899999875433  567899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++..   ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999999864   235689999999999999999999998   999999999999999999999999999886543321


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........      ... .....      .....
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~------~~~~~  220 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IFM-IPNKP------PPTLS  220 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hhh-hccCC------CCCCC
Confidence             12223478899999999988999999999999999999999999865322110      000 00000      00011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||+.||++|||+.|++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            233445789999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-42  Score=305.09  Aligned_cols=255  Identities=24%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888899999999999999975 57889999986421   223345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++.+.   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999642   34688899999999999999999998   999999999999999999999999999876544


Q ss_pred             ccccccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ..........||+.|+|||++..     ..++.++||||+||++|+|++|+.||.....      .............. 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~-  227 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF-  227 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc-
Confidence            33322233458999999999863     4578899999999999999999999965321      11122222111100 


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPS--KRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~Rps~~e~l~~  341 (351)
                      ...    ......+..+.+++.+||..++.  .||++.+++++
T Consensus       228 ~~~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 QFP----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCC----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            011    11122457789999998865443  37899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-41  Score=292.20  Aligned_cols=251  Identities=31%  Similarity=0.450  Sum_probs=194.0

Q ss_pred             CcccccCceEEEEEEECC----CCEEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEe-cCCeeEEEEEecC
Q 018702           76 DVIGSGGFGTVYRLTVND----STAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYT-SSQYNLLIYELMP  149 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  149 (351)
                      +.||+|+||.||+|.+.+    ...+|+|.+... .....+.+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998632    356999988543 2334567889999999999999999999875 4556789999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ....++.....++.|++.|++|||+.   +++|+||||+||++++++.+||+|||++.........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999643   23456778889999999999999998   9999999999999999999999999998754322111


Q ss_pred             ---ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          230 ---VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG-KRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       230 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                         ......++..|+|||.+.+..++.++||||||+++|||++| .+||....      ..............       
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~-------  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRRL-------  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCC-------
Confidence               11123356789999999888999999999999999999994 56664321      11112222111110       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                        ..+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence              1122334679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=315.74  Aligned_cols=244  Identities=27%  Similarity=0.477  Sum_probs=204.1

Q ss_pred             cccccCceEEEEEEECCC-CEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018702           77 VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDT  155 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  155 (351)
                      +||+|+||+||.|++.+. ..+|||.+........+.+.+|+..-++++|.|||+++|.+.+++.+-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999998654 4689999988777777889999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCC--ChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCcccccccc
Q 018702          156 FLHGKSVNKKNL--DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKTHVST  232 (351)
Q Consensus       156 ~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~  232 (351)
                      +++...   +++  .+...-...+||++||.|||.+   .|+|||||-+|+|++. .|.+||+|||.++....- .....
T Consensus       662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TE  734 (1226)
T KOG4279|consen  662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTE  734 (1226)
T ss_pred             HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccc
Confidence            997543   334  5667788899999999999999   9999999999999976 799999999999876433 23345


Q ss_pred             cccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          233 IVAGTFGYLAPEYFDTG--RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       233 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      ++.||..|||||++..+  .|+.++|||||||++.||.||++||......    ....++.-...         ...+.|
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----qAAMFkVGmyK---------vHP~iP  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----QAAMFKVGMYK---------VHPPIP  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----hHhhhhhccee---------cCCCCc
Confidence            56799999999999765  5889999999999999999999999654221    11112211111         122468


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ...+.++..+|.+|+.+||.+|||++++|+
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888999999999999999999999999875

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-41  Score=294.91  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             CCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      |+..+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|||++++++.+...+..++++||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5667889999999999999764 667899988766655566788999999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|..++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........ .
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            999998763   235689999999999999999999998   999999999999999999999999999875433221 1


Q ss_pred             cccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          231 STIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .....+++.|+|||.+.     +..++.++|+||+|+++|+|++|.+||.....      ..............      
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~~------  227 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPPT------  227 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCCCC------
Confidence            22345889999999873     34577899999999999999999999864321      11111111111110      


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       ...+...+..+.+++.+||+.||++|||+.+++++-
T Consensus       228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence             012333457899999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=293.35  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|++|.||++... +++.+++|.+........+.+.+|+.++++++|||++++++.+...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            46888899999999999999875 56789999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999998642   25688999999999999999999998   999999999999999999999999999876543221


Q ss_pred             cccccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          229 HVSTIVAGTFGYLAPEYFDTG---RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||.......      ...........     ..
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~~~-----~~  224 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSNFP-----PP  224 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCC-----Cc
Confidence             12234578899999998776   78999999999999999999999986532111      00111111000     00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....+...+.++.+++.+||..+|.+|||+++++.+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111233456789999999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-41  Score=295.69  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=200.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh---------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  140 (351)
                      +|.....||+|++|.||+|... +++.+++|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 5788999988654322         12457889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+++|||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999999963    35678889999999999999999998   9999999999999999999999999998


Q ss_pred             cccCccccc-----ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          221 TLMEAEKTH-----VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       221 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      +........     ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......      .........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~  227 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGEN  227 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhcc
Confidence            765422111     112234788999999998888999999999999999999999999653211      111111110


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                               .....+...+..+.+++.+||+.||.+||++.+++++
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 ---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                     0112334455789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.9e-42  Score=312.18  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5788899999999999999875 57889999986432   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          82 FLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             CCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999987    345688999999999999999999998   9999999999999999999999999998644211


Q ss_pred             cc----------------------------------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 018702          227 KT----------------------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKR  272 (351)
Q Consensus       227 ~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~  272 (351)
                      ..                                  .......||+.|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                  00113468999999999999999999999999999999999999


Q ss_pred             CCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 018702          273 PMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT---MTEVVKM  341 (351)
Q Consensus       273 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~e~l~~  341 (351)
                      ||......      .......... .....++     ....++++.+++.+|+. ||.+|++   +.|++++
T Consensus       235 Pf~~~~~~------~~~~~i~~~~-~~~~~p~-----~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQ------ETYRKVMNWK-ETLVFPP-----EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHH------HHHHHHHcCC-CceecCC-----CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            99654321      1112222111 1111110     11234678999999774 9999985   6677654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-42  Score=312.89  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC---CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN---DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|...+.||+|+||.||++...   .+..|++|.+...     ....+|+++++.++||||+++++++...+..+++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            46999999999999999998753   3467999987643     234689999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      ++. ++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++......
T Consensus       167 ~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        167 KYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            995 68888884    346789999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc--------
Q 018702          227 KT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR--------  297 (351)
Q Consensus       227 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  297 (351)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......................        
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22 122235689999999999999999999999999999999999999966433221111111111111000        


Q ss_pred             ---------------cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 ---------------EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                     .....+..+  .....+.++.+++.+||..||++|||+.|++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVI--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchh--hccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                           000000000  001234578899999999999999999999876

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-42  Score=297.55  Aligned_cols=239  Identities=22%  Similarity=0.378  Sum_probs=188.4

Q ss_pred             cccccCceEEEEEEECC-------------------------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeee
Q 018702           77 VIGSGGFGTVYRLTVND-------------------------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL  131 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  131 (351)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999987421                         13489998876555555678899999999999999999


Q ss_pred             eeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-
Q 018702          132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-  210 (351)
Q Consensus       132 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-  210 (351)
                      ++++......++||||+++|+|..++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999999864   235688999999999999999999998   999999999999997643 


Q ss_pred             ------ceEEeeeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCcchhccc
Q 018702          211 ------EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELL-TGKRPMDEAFLEEG  282 (351)
Q Consensus       211 ------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~  282 (351)
                            .++++|||.+.......     ...++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||....... 
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             ccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                  37999999875432221     1236788999998865 56899999999999999995 6999986532211 


Q ss_pred             ccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                        ...    ......          ..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus       230 --~~~----~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KER----FYEKKH----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHH----HHHhcc----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              111    111100          112222357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.7e-41  Score=290.83  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|+||.||.+.. .++..+++|.+....  ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999999885 457889999886542  33445688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++....  ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999997532  34678899999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      . ......+++.|+|||...+..++.++|+||||+++|+|++|..||.....      ............         .
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~---------~  219 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQGNY---------T  219 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCC---------C
Confidence            2 22334588999999999888899999999999999999999999864321      112222221111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ..+...+.++.+++.+||..+|++|||+.++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11233457799999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.6e-42  Score=297.82  Aligned_cols=253  Identities=26%  Similarity=0.356  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||+|... +++.+++|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            36777788999999999999864 57889999987765555556788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.    ..+.+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        89 ~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          89 GGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            9999999986    345689999999999999999999998   999999999999999999999999999875543221


Q ss_pred             cccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          229 HVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       ......|+..|+|||.+.   ...++.++|+||||+++|+|++|..||.......      ...........    .+.
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~----~~~  230 (267)
T cd06645         162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQ----PPK  230 (267)
T ss_pred             -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCC----CCc
Confidence             122345889999999874   4568899999999999999999999985432111      00111111000    000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .. .....+..+.+++.+||+.+|++|||+++++++
T Consensus       231 ~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00 011234678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-41  Score=300.37  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      .+|...+.||+|+||.||++...        ....+|+|.+.... ......+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46888899999999999999742        23468999887543 23345688999999999 5999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..+++|||+++|+|.+++.....            ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            99999999999999999965321            234588899999999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.+||+|||.++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......     
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----  243 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-----  243 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            99999999999997654322211 111123467999999988899999999999999999999 88888543211     


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                       ...........         ...+...+.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       244 -~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 -ELFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence             11111111110         11233445689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-42  Score=300.72  Aligned_cols=263  Identities=27%  Similarity=0.468  Sum_probs=206.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-----CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEec--CCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-----DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  141 (351)
                      ..|+..+.||+|+||.||++...     ++..+|+|.+...... ..+.+.+|++.++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777889999999999999853     3578999999765543 45678999999999999999999999877  5578


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999999743   23589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc--------cHHHHHHH
Q 018702          222 LMEAEKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT--------KLVTWVKA  291 (351)
Q Consensus       222 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~  291 (351)
                      .........  .....++..|+|||...+..++.++|+||||+++|+|++|..|+.........        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            765322211  11123456799999998888999999999999999999999997653221100        00111111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .......        ...+..++..+.+++.+||+.+|++|||+.|++++|+.++
T Consensus       238 ~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         238 LLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1111100        0112334477999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.1e-42  Score=307.16  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC-Ce
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS-QY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  140 (351)
                      .+|+..+.||+|+||.||+|..      .+++.||+|.++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4789999999999999999974      3467899999976432 2345688999999999 689999999987654 46


Q ss_pred             eEEEEEecCCCCHHHhhcCCCC----------------------------------------------------------
Q 018702          141 NLLIYELMPNGSLDTFLHGKSV----------------------------------------------------------  162 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  162 (351)
                      .+++|||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999864211                                                          


Q ss_pred             -----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc-cccccccc
Q 018702          163 -----NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAG  236 (351)
Q Consensus       163 -----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~  236 (351)
                           ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||++........ .......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 012467888899999999999999998   999999999999999999999999999876432211 11112235


Q ss_pred             cccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHH
Q 018702          237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN  315 (351)
Q Consensus       237 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (351)
                      +..|+|||.+.+..++.++|+||||+++|+|++ |..||......      ............        ...|...++
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~--------~~~~~~~~~  309 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTR--------MRAPDYTTP  309 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCC--------CCCCCCCCH
Confidence            678999999988899999999999999999997 99998653211      011111111100        011222346


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          316 DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       316 ~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ++.+++.+||+.||++|||+.|++++|+.+.++
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.9e-42  Score=328.35  Aligned_cols=261  Identities=23%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|.+. +++.||+|++....   ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999875 57889999987542   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          146 ELMPNGSLDTFLHGKSV-------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      ||++||+|.+++.....       .....++..++.++.|+++||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211       123456677889999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccc-----------------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc
Q 018702          219 LATLMEAEKT-----------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE  281 (351)
Q Consensus       219 ~~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  281 (351)
                      ++........                 .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521100                 01112458999999999999999999999999999999999999996532111


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhccc
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP-TMTEVVKMLELIK  346 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~e~l~~L~~~~  346 (351)
                         ..  ......        ++.........+..+.+++.+||+.||++|| +++++++.|+...
T Consensus       239 ---i~--~~~~i~--------~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 ---IS--YRDVIL--------SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             ---hh--hhhhcc--------ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               00  000000        0000000123346788999999999999996 6677777776653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-42  Score=301.90  Aligned_cols=261  Identities=23%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|... ++..||+|.+..... .....+.+|+..++.++||||+++++++..++..+++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999875 578899999865432 2334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++ ++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            96 5898888642   34578899999999999999999998   99999999999999999999999999987543222


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc--------
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE--------  298 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  298 (351)
                      .. .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||......+.   .............        
T Consensus       159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence            11 122346889999998765 4578899999999999999999999975432211   1111111000000        


Q ss_pred             -ceeccccC--------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 -EYVIDTSL--------EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 -~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ........        .......+..+.+++.+||+.||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             00000000        01112345678999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-41  Score=298.10  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=193.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcC---CCCceeeeeeEEec-----CC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDI---KHRNIVTLHGYYTS-----SQ  139 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  139 (351)
                      +|+..+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778889999999999999875 578899998865322  1223455667666655   79999999998764     34


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..+++|||+.+ +|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999975 898888643  234589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc-
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE-  298 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  298 (351)
                      +........  .....+|+.|+|||.+.+..++.++||||+||++|+|++|.+||......+  ....... ....... 
T Consensus       155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGLPPED  229 (288)
T ss_pred             cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCCCChh
Confidence            976543221  123457899999999988899999999999999999999999986532211  1111111 0000000 


Q ss_pred             c---------eeccc----cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 E---------YVIDT----SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~---------~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .         .....    ....+....++.+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0         00000    0001122345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.6e-42  Score=310.59  Aligned_cols=198  Identities=25%  Similarity=0.355  Sum_probs=171.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-C-----CceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-H-----RNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  143 (351)
                      +|.+.++||+|+||.|.+|.+. +++.||||+++.. .....+...|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7888999999999999999864 5888999999764 344455678999999996 3     489999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCceEEeeecccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ--NMEARVSDFGLAT  221 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~  221 (351)
                      |+|.+ ..+|.++++.+  +..+++...++.++.||+.||..||+.   +|+|+||||+|||+.+  ...+||+|||.|.
T Consensus       266 VfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999 55999999977  456699999999999999999999998   9999999999999975  3479999999998


Q ss_pred             ccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchh
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL  279 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  279 (351)
                      .......    +...+.-|.|||++.+.+|+.+.||||||||+.||++|.+.|.+...
T Consensus       340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            6544332    34567889999999999999999999999999999999988877543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-41  Score=298.52  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |+..+.||+|+||+||++... +++.+|+|.+.....   .....+.+|+.+++.++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999874 578899999865432   2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999888643  234689999999999999999999998   99999999999999999999999999987543222


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .  .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||........  . ............         
T Consensus       157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~-~~~~~~~~~~~~---------  222 (285)
T cd05632         157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--R-EEVDRRVLETEE---------  222 (285)
T ss_pred             c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhhhcccc---------
Confidence            1  1234589999999999888999999999999999999999999965321110  0 111111111100         


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                      ..+...+..+.+++.+||+.||++||+     +.+++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            122334467899999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-41  Score=297.37  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=206.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++.+...+..+++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777889999999999999875 57889999876543 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..    .+.+++.....++.+++.|+.|||+.  .+++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            999999999863    45689999999999999999999974  289999999999999999999999999886442221


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc-----ccHHHHHHHHHhcCccceec
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-----TKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  302 (351)
                         .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........     ...............     
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  230 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-----  230 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-----
Confidence               1234588999999999888999999999999999999999999976433211     111122222221111     


Q ss_pred             cccCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          303 DTSLEGCP-INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       303 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                          ...+ ...+.++.+++.+||+.||++|||+.|++++..-++
T Consensus       231 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         231 ----PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             ----CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                1111 124567999999999999999999999998754433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.7e-41  Score=289.81  Aligned_cols=250  Identities=24%  Similarity=0.419  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec-CCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS-SQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  146 (351)
                      +|+..+.||+|++|.||++... +++.+++|.+....  ....+.+.+|++++++++|||++++.+.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999865 46789999986543  2334568889999999999999999998764 446789999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++...  ....+++..+..++.+++.|+++||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999998743  234689999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .. ......+++.|+|||...+..++.++|+||+|+++++|++|+.||....      ............         .
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~~---------~  219 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEGK---------L  219 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcC---------C
Confidence            22 2223457899999999999999999999999999999999999986432      112222222111         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            12234455789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=294.93  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|++.+.||+|++|.||++... ++..+++|.+........+.+.+|++++++++|||++++++.+...+..+++|||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46888889999999999999875 57889999998766666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999998642   34689999999999999999999999   999999999999999999999999998865433222


Q ss_pred             cccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          229 HVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                       ......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||......      ............     
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-----  226 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEPP-----  226 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCCC-----
Confidence             122345788999999874     345678999999999999999999998653211      111111111100     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ....+...+.++.+++.+||+.+|++|||+.+++++
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 --TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              001233445789999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.1e-41  Score=290.09  Aligned_cols=250  Identities=30%  Similarity=0.493  Sum_probs=201.8

Q ss_pred             CCCCcccccCceEEEEEEECC-----CCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVND-----STAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++.+.||.|+||.||++...+     +..+|+|.+...... ..+.+..|+..+..++|+|++++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999999754     377999999765443 45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++....  ...+++..+..++.|++.|+++||+.   +++|+||+|+||++++++.++++|||++......
T Consensus        82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999987431  12289999999999999999999998   9999999999999999999999999999766544


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .........+++.|+|||.+.+..++.++|+||+|+++++|++ |..||....      ..............       
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~-------  223 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKKGYRL-------  223 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCCC-------
Confidence            2222212236789999999988889999999999999999998 888876421      11122222211111       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                        ..+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              11223457899999999999999999999998865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-42  Score=307.20  Aligned_cols=261  Identities=25%  Similarity=0.326  Sum_probs=197.1

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecC---
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSS---  138 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  138 (351)
                      ......+|+..+.||+|+||.||++... ++..||+|.+.....  ...+.+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445678999999999999999999864 577899999875432  2334577899999999999999999987543   


Q ss_pred             ---CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          139 ---QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       139 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                         ...+++++++ +++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence               3568999988 779988874     34689999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      |||++.......    ....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........   .........
T Consensus       161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~  233 (343)
T cd07878         161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVG  233 (343)
T ss_pred             CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhC
Confidence            999997654321    23458999999999876 5789999999999999999999999965321110   000000000


Q ss_pred             cCcc------------------ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKRE------------------EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....                  ................+.+.+++.+||+.||.+|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000                  0000000000011123457899999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=293.47  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=205.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CC----EEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-ST----AFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|..++ +.    .+++|....... .....+.+|+..+.+++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467888999999999999998643 32    589998876543 344678899999999999999999999887 77899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.++..
T Consensus        86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999998743   34589999999999999999999998   9999999999999999999999999999866


Q ss_pred             Cccccccc-ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ........ ....++..|+|||.+....++.++|+||||+++|++++ |..||......      ...........    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~----  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKGER----  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCCCC----
Confidence            53322111 11223568999999988899999999999999999998 99998653221      11111111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                           ...+...+..+.+++.+||..+|.+|||+.++++.|+.+..+
T Consensus       230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                 112233446789999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-41  Score=304.21  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++..++ ++.+|+|.+....   ......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            68888999999999999999764 6779999985421   1223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++.+.   ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 y~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          82 YYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999642   34688889999999999999999998   9999999999999999999999999998755433


Q ss_pred             cccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .........||+.|+|||++.     ...++.++||||||+++|+|++|+.||....      ............... .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~-~  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERF-Q  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccc-c
Confidence            332233346899999999885     3468899999999999999999999996532      122222222211110 0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~  341 (351)
                          ........+.++.+++.+|+..+|.+  |+++.|++++
T Consensus       229 ----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                11112234578999999998655444  6899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.2e-41  Score=292.85  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=202.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++|||++++++.+.+++..+++|||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4677788999999999999875 57889999887543 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.     ...+++.....++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++........
T Consensus        85 ~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999985     24578888999999999999999998   999999999999999999999999999976543322


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......      .......         .....
T Consensus       157 ~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~~~---------~~~~~  220 (277)
T cd06640         157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFLIPK---------NNPPT  220 (277)
T ss_pred             c-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhhhhc---------CCCCC
Confidence            1 222357889999999988889999999999999999999999986532111      0000000         00112


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||+.+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            344566889999999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-41  Score=295.13  Aligned_cols=253  Identities=24%  Similarity=0.430  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5788899999999999999976 67889999887542 233457889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.... ....+++..+..++.|++.|+.|||+.  .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999986432 234689999999999999999999974  289999999999999999999999999987553222 


Q ss_pred             cccccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          229 HVSTIVAGTFGYLAPEYFDTG------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                        .....+++.|+|||.+.+.      .++.++|+||||+++|+|++|..||.....   .............       
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~-------  225 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVDG-------  225 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhhc-------
Confidence              1223478899999998554      357899999999999999999999964311   1111111111111       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         226 --DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence              1112344566889999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.2e-41  Score=295.96  Aligned_cols=261  Identities=22%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||+|... +++.+++|++....  ......+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778889999999999999974 67889999987654  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      + +++|.+++...   ...+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.++++|||.+.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999998643   35689999999999999999999998   99999999999999999999999999988665433


Q ss_pred             ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc--------
Q 018702          228 THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE--------  298 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  298 (351)
                      ........++..|+|||.+.+. .++.++||||+|+++++|++|.+||......   ...............        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence            2222334588999999988654 4689999999999999999998887543211   111111111000000        


Q ss_pred             ----ceeccc-----cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 ----EYVIDT-----SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ----~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ......     .......+.+..+.+++.+||+.+|++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                000000     0001112335789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-40  Score=289.08  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEECC---CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           76 DVIGSGGFGTVYRLTVND---STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      +.||+|+||.||+|...+   +..+++|.++.... .....+.+|+.++++++||||+++++++.+....+++|||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653   35689998876543 33346888999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc-
Q 018702          152 SLDTFLHGKSV-NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH-  229 (351)
Q Consensus       152 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-  229 (351)
                      +|.+++..... .....++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999964321 223456777888999999999999998   9999999999999999999999999998654332211 


Q ss_pred             ccccccccccccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          230 VSTIVAGTFGYLAPEYFDTG-------RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ......++..|+|||.+.+.       .++.++|+||||+++|+|++ |..||.......   .   ........... .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~---~~~~~~~~~~~-~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---V---LTYTVREQQLK-L  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---H---HHHHhhcccCC-C
Confidence            11223467889999988642       35789999999999999996 999996532211   1   11111111110 0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .++.   .....++.+.+++.+|+ .+|++|||++|++..|+
T Consensus       231 ~~~~---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPR---LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCc---cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111   11123466888999999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.9e-42  Score=295.76  Aligned_cols=240  Identities=20%  Similarity=0.422  Sum_probs=190.4

Q ss_pred             CcccccCceEEEEEEECC--------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVND--------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +.||+|+||.||+|....        ..++++|.+........+.+.+|..+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998642        234888887665555556788999999999999999999999998999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc--------eEEeeecc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME--------ARVSDFGL  219 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~--------~kl~dfg~  219 (351)
                      +++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999743   23578899999999999999999998   9999999999999987765        69999998


Q ss_pred             ccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCC-CCCCcchhcccccHHHHHHHHHhcCc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGK-RPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +......     ....++..|+|||.+.+ ..++.++|+||||+++|+|++|. .|+.......      ... ..... 
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~-~~~~~-  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQ-FYEDR-  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHH-HHHcc-
Confidence            8654322     22347888999999876 45789999999999999999985 5554321111      000 11110 


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                               ...|...+.++.+++.+||+.||++|||++++++.|+
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     1123334467999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-41  Score=292.88  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh------hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT------EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      +|+..+.||+|++|.||++.. .+++.+++|.+.....      ...+.+.+|+..+++++|||++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477888999999999999986 5678899999865321      234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATL  222 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~  222 (351)
                      ++||+++++|.+++..    ..++++.....++.|++.|++|||+.   +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999999863    45688899999999999999999998   999999999999998775 599999999876


Q ss_pred             cCccccc---ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          223 MEAEKTH---VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       223 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......   ......++..|+|||.+.+..++.++|+||+|+++++|++|..||.....   ..............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---  227 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH---SNHLALIFKIASAT---  227 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---cchHHHHHHHhccC---
Confidence            5433211   11234578899999999888899999999999999999999999864321   11111111111100   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           .....+...+.++.+++.+||+.+|++|||+.+++++
T Consensus       228 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         228 -----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                 0112445566889999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-41  Score=292.38  Aligned_cols=247  Identities=24%  Similarity=0.403  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||.|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|||++++.+++.++...++++||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            6788889999999999999975 57889999987653 333456889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||.+........
T Consensus        82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999999863     3789999999999999999999998   999999999999999999999999999987654322


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ........... .        ..
T Consensus       154 ~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~~~-~--------~~  217 (274)
T cd06609         154 K-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFLIPKNN-P--------PS  217 (274)
T ss_pred             c-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHHhhhcC-C--------CC
Confidence            1 2234578899999999988899999999999999999999999965321      11111111110 0        01


Q ss_pred             CCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+.. .+.++.+++.+||..+|++|||+++++++
T Consensus       218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1111 45779999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-41  Score=299.96  Aligned_cols=260  Identities=22%  Similarity=0.339  Sum_probs=187.1

Q ss_pred             CcccccCceEEEEEEECC---CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe--cCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVND---STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT--SSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~  150 (351)
                      ..||+|+||.||+|...+   +..+|+|.+....  ....+.+|+.+++.++||||+++++++.  .+...++++||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999998653   4679999886542  2345778999999999999999999885  35677999999865


Q ss_pred             CCHHHhhcCCC-----CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCceEEeeecccc
Q 018702          151 GSLDTFLHGKS-----VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLAT  221 (351)
Q Consensus       151 g~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~~  221 (351)
                       +|.+++....     .....+++..+..++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             7877764321     1223578888999999999999999998   99999999999999    456789999999998


Q ss_pred             ccCccccc--ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc-------cHHHHHHH
Q 018702          222 LMEAEKTH--VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT-------KLVTWVKA  291 (351)
Q Consensus       222 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~  291 (351)
                      ........  ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|.+||.....+...       ........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            66443221  1233457999999999876 45899999999999999999999999653221110       00000000


Q ss_pred             ----------HHhcCc----------cceecc----ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          292 ----------VMQDKR----------EEYVID----TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       292 ----------~~~~~~----------~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                ......          ......    .............+++|+.+||+.||.+|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                      000000          000000    00000111123568899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-41  Score=292.79  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..+.....||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            34444567999999999999865 56789999988776666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCC--ChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCc
Q 018702          149 PNGSLDTFLHGKSVNKKNL--DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEA  225 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~  225 (351)
                      ++++|.+++...   ...+  ++..+..++.|++.|++|||+.   +++|+||||+||+++. ++.++|+|||.+.....
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999998743   1234  7778889999999999999998   9999999999999976 67999999999875533


Q ss_pred             ccccccccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .... .....+++.|+|||.+.+..  ++.++|+||+|+++|+|++|..||.......    ..........        
T Consensus       162 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~~~~~--------  228 (268)
T cd06624         162 INPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKVGMFK--------  228 (268)
T ss_pred             CCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhhhhhc--------
Confidence            2221 12234788999999986543  7889999999999999999999986431110    0000000000        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       .....+...++++.+++.+||+.+|.+|||+.|++++
T Consensus       229 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 -IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence             0112344455789999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.9e-41  Score=305.36  Aligned_cols=263  Identities=24%  Similarity=0.273  Sum_probs=197.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----  138 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  138 (351)
                      ....+|+..+.||+|+||.||++... .++.||+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34568999999999999999999864 57889999987542  23345678999999999999999999987543     


Q ss_pred             -CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          139 -QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       139 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                       ...++||||+++ +|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence             357999999965 7777764      2477888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc------------H
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK------------L  285 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------~  285 (351)
                      |+++.......  .....+|+.|+|||.+.+..++.++|||||||++|+|++|+.||..........            .
T Consensus       171 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         171 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CCccccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99975533221  223458999999999999999999999999999999999999996532211000            0


Q ss_pred             H----HHHHHHHhcCcc--ceecccc--------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          286 V----TWVKAVMQDKRE--EYVIDTS--------LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       286 ~----~~~~~~~~~~~~--~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .    ............  ....+..        ...........+.+++.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0    000000000000  0000000        001111234578999999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.2e-41  Score=296.94  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=199.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... +++.||+|++....  ....+.+.+|+.+++.++|||++++++++......+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            6888899999999999999976 57889999886542  22335678999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|..+..    ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          82 CDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             cCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99988888775    334689999999999999999999998   99999999999999999999999999998654432


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc-HHHHHHH-------HHhcCc-
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK-LVTWVKA-------VMQDKR-  297 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~-------~~~~~~-  297 (351)
                      . ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+... .......       ...... 
T Consensus       155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            2 1122346889999998865 567899999999999999999999997543211100 0000000       000000 


Q ss_pred             cceeccccCC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTSLE------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......+...      ......+..+.+++.+||+.+|++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0000000000      0012235778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.4e-41  Score=300.09  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=205.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECC--------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND--------STAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      .+|++.+.||+|+||.||++...+        ...+|+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            368889999999999999997421        2358999887543 23346788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..++++||+++|+|.+++....            .....+++..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            9999999999999999987532            1234578889999999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccccc-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            99999999999987654322111 111224567999999998899999999999999999998 8888865322      


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .............         ..+...+..+.+++.+||+.+|.+|||+.|+++.|+.+..
T Consensus       243 ~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 EELFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1122222111111         1233344689999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.2e-41  Score=298.90  Aligned_cols=257  Identities=19%  Similarity=0.271  Sum_probs=193.4

Q ss_pred             CCCccccc--CceEEEEEEE-CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           74 SKDVIGSG--GFGTVYRLTV-NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        74 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..++||+|  +|++||++.. .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  6899999986 467889999987543  233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999998643  234588999999999999999999998   999999999999999999999999986543221111


Q ss_pred             c------ccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc-
Q 018702          229 H------VSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE-  299 (351)
Q Consensus       229 ~------~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  299 (351)
                      .      ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||.......      ............ 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~  230 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKLNGTVPCL  230 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHHhcCCcccc
Confidence            0      0112246778999999875  468999999999999999999999996432110      000000000000 


Q ss_pred             -----------------eecc------------------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 -----------------YVID------------------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 -----------------~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                       ...+                  ..........+..+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                             0000                  00001122345679999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-41  Score=289.12  Aligned_cols=248  Identities=29%  Similarity=0.448  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-----hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-----TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     .+..+.+.+|+..++.++|||++++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78899999886533     23446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      +||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999963    34588999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccccccccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...  ......++..|++||.+.... ++.++|+||||+++|+|++|..||.....      ............      
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~------  219 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKE------  219 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhccc------
Confidence            332  122345788999999987766 89999999999999999999999865321      111111111000      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence              111233445789999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-40  Score=288.51  Aligned_cols=253  Identities=22%  Similarity=0.370  Sum_probs=190.1

Q ss_pred             cccccCceEEEEEEECCC---CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           77 VIGSGGFGTVYRLTVNDS---TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      .||+|+||.||++...++   ..+++|.+.... ....+.+.+|+..++.++||||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   346677766543 2345678999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc-cccc
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK-THVS  231 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~  231 (351)
                      |.+++..........+......++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999975433344567777889999999999999998   99999999999999999999999999875422211 1112


Q ss_pred             ccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          232 TIVAGTFGYLAPEYFDT-------GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ....++..|+|||++..       ..++.++||||||+++|+|++ |..||.....      ............. ...+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~~-~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQQV-KLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhccc-ccCC
Confidence            23457889999998743       245789999999999999997 5677754221      1122222222111 1111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      +.   .+...++.+.+++.+|| .+|++|||++++++.|.
T Consensus       232 ~~---~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQ---LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             Cc---cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11   12224467888999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-40  Score=290.15  Aligned_cols=256  Identities=23%  Similarity=0.422  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCceEEEEEEECC--CCEEEEEEecCCC----------hhhHHHHHHHHHHhhc-CCCCceeeeeeEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND--STAFAVKRLHRGT----------TEVDRGFERELEAMGD-IKHRNIVTLHGYYTS  137 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  137 (351)
                      .|+..+.||+|+||.||++....  ++.+++|.+....          ......+.+|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37778899999999999999765  6789999875321          2223456778888765 789999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       138 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.|+.|||+.  .+++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998854332445688999999999999999999963  18999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      |.+.......  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....      ............
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~~~~  230 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVEAVY  230 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhhccC
Confidence            9997654432  22334578899999999988899999999999999999999999854321      111111111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .     +.   .....+..+.+++.+||+.||++|||+.|+..++.+
T Consensus       231 ~-----~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 E-----PL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             C-----cC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            0     00   011234679999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.4e-41  Score=291.51  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=190.2

Q ss_pred             cccccCceEEEEEEECC---CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           77 VIGSGGFGTVYRLTVND---STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      .||+|+||.||+|...+   ...+++|.+..... .....+.+|+..++.++||||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   34688888765433 334567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc-c
Q 018702          153 LDTFLHGKSV-NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH-V  230 (351)
Q Consensus       153 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~  230 (351)
                      |.+++..... .....++.....++.|++.|++|||+.   +++||||||+||++++++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999975432 123356778889999999999999998   9999999999999999999999999998653322211 1


Q ss_pred             cccccccccccCccccc-------CCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          231 STIVAGTFGYLAPEYFD-------TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      .....++..|+|||+..       ...++.++||||||+++|+|++ |..||......      ............. ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~~-~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQDIK-LP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccCcc-CC
Confidence            12233567899999864       3456889999999999999999 78888643211      1111111111111 11


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .   ...+...+..+.+++..|| .||++|||++++++.|.
T Consensus       232 ~---~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 K---PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             C---CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1   1123334567788999998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.2e-41  Score=291.57  Aligned_cols=251  Identities=30%  Similarity=0.489  Sum_probs=197.9

Q ss_pred             CcccccCceEEEEEEECC-------CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVND-------STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +.||+|+||.||+|...+       +..+++|.+..... .....+.+|+..++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998643       24689998865432 3455788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-----ceEEeeecc
Q 018702          148 MPNGSLDTFLHGKSV---NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-----EARVSDFGL  219 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-----~~kl~dfg~  219 (351)
                      +++++|.+++.....   ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999964321   224478899999999999999999998   999999999999999877     899999999


Q ss_pred             ccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          220 ATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       220 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +......... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||......      .......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~-  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHVTAGG-  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHHhcCC-
Confidence            8754332211 1112235678999999998999999999999999999998 99998643211      1111111111 


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                              ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    011233455789999999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.6e-41  Score=304.60  Aligned_cols=263  Identities=25%  Similarity=0.281  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----  138 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  138 (351)
                      ....+|+..+.||+|+||.||++... .++.+|+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34468999999999999999999864 57889999987542  23345678899999999999999999988643     


Q ss_pred             -CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          139 -QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       139 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                       ...+++|||+++ +|.+.+.      ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             356999999965 6777664      2478888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc-------------
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK-------------  284 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------------  284 (351)
                      |+++.......  .....+|+.|+|||.+.+..++.++|+||||+++|+|++|+.||..........             
T Consensus       164 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         164 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99975433221  223458999999999998899999999999999999999999996532111000             


Q ss_pred             ---HHHHHHHHHhcCcc-c-eecc----ccC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          285 ---LVTWVKAVMQDKRE-E-YVID----TSL----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       285 ---~~~~~~~~~~~~~~-~-~~~~----~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         .............. . ...+    ...    ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               00000000000000 0 0000    000    01122234678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-41  Score=290.85  Aligned_cols=238  Identities=23%  Similarity=0.440  Sum_probs=189.4

Q ss_pred             CcccccCceEEEEEEECCCC-----------EEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           76 DVIGSGGFGTVYRLTVNDST-----------AFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999976433           4788877654433 5678899999999999999999999888 778999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-------ceEEeee
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-------EARVSDF  217 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-------~~kl~df  217 (351)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++       .++++||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999997432   2688999999999999999999998   999999999999999887       7999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHh
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG--RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      |++......     ....++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.......   ...+..   .
T Consensus       153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~---~  221 (259)
T cd05037         153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ---D  221 (259)
T ss_pred             Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh---c
Confidence            998765431     123366789999998776  78999999999999999999 577775532111   011110   0


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ..           ..+......+.+++.+||..+|++|||+.++++.|+
T Consensus       222 ~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00           011111268999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.7e-41  Score=296.35  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=199.5

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      |+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+..+++++||||+++++.+...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            455678999999999999865 56789999887543 3344578899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++.     ...+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++++|||++........ 
T Consensus        86 ~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          86 GGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            999999985     34678899999999999999999998   999999999999999999999999999876543221 


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......      .... ....        .....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~-~~~~--------~~~~~  221 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFL-IPKN--------SPPTL  221 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhh-hhcC--------CCCCC
Confidence            1222357889999999998889999999999999999999999986432111      0010 0000        01112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +...+..+.+++.+||+.+|++|||+.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            23345779999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4e-41  Score=295.42  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=200.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEe-----cCC
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYT-----SSQ  139 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~  139 (351)
                      ....+|+..+.||+|+||.||++... +++.+++|.+.... .....+.+|+.+++.+ +|||++++++++.     .++
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            45568999999999999999999874 57789999876532 2335678899999999 6999999999873     345


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..+++|||+++++|.+++.........+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||+
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCc
Confidence            78999999999999998864333445688899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      +........ ......|++.|+|||.+..     ..++.++|+||+|+++|+|++|..||.......      .......
T Consensus       171 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~~~~~  243 (286)
T cd06638         171 SAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALFKIPR  243 (286)
T ss_pred             eeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHhhccc
Confidence            876543221 1223458899999998753     457889999999999999999999986532110      0011000


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      . .....      ..+...+..+.+++.+||+.||++|||+.|+++++
T Consensus       244 ~-~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         244 N-PPPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             c-CCCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0 00000      11222346799999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-41  Score=303.13  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999975 56789999986421   222345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999742   34688889999999999999999998   999999999999999999999999999976554


Q ss_pred             ccccccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ..........||+.|+|||.+.+     +.++.++|+||||+++|+|++|+.||.....      ............. .
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~-~  227 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEER-F  227 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCc-c
Confidence            43332333568999999999865     5678899999999999999999999965321      1112222211100 0


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~  341 (351)
                      ..+    ......++++.+++.+||..++++  |+++++++++
T Consensus       228 ~~p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 QFP----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCC----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            011    111234578999999999876554  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.9e-41  Score=288.43  Aligned_cols=250  Identities=21%  Similarity=0.370  Sum_probs=203.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|+||.+|++... +++.+++|.+...  .....+.+.+|+.++++++||||+++.+++...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5788899999999999999864 5788999998653  223345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +.+++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999998643  123578889999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .. .....+++.|+|||...+..++.++|+||||+++++|++|..||....      .............         .
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~---------~  219 (256)
T cd08218         156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSY---------P  219 (256)
T ss_pred             hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCC---------C
Confidence            21 223347889999999998889999999999999999999999985431      1122222222111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+.++.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1233445789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-41  Score=290.91  Aligned_cols=252  Identities=22%  Similarity=0.414  Sum_probs=203.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  145 (351)
                      +|+..+.||+|+||.||++... ++..+++|.+....  ....+.+..|+.+++.++|||++++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778889999999999999864 67889999886532  3334568889999999999999999998753  45678999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-----HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-----~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      ||+++++|.+++.........+++..++.++.|++.|+.|||     +.   +++|+||+|+||++++++.++++|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999754434567899999999999999999999     66   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ....... ...    
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~----  225 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASKI-KEG----  225 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHHH-hcC----
Confidence            866543321 2234588999999999988899999999999999999999999865421      1111111 111    


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          .....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       226 ----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ----KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                1112344556789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-41  Score=326.12  Aligned_cols=254  Identities=21%  Similarity=0.318  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  144 (351)
                      .+|.+.+.||+|+||.||++... ++..+|+|.+....  ......+..|+.++..++||||++++++|..  ...+++|
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            47899999999999999999975 45678999886532  2334568899999999999999999998854  4578999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCcEEEcC------------
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI----PHIIHRDIKSSNILLDQ------------  208 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~----~~i~H~dlkp~Nil~~~------------  208 (351)
                      |||+++++|.+++.........+++..++.++.||+.||+|||+...    .+|+|+||||+|||++.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            99999999999997543334679999999999999999999998511    25999999999999964            


Q ss_pred             -----CCceEEeeeccccccCcccccccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc
Q 018702          209 -----NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE  281 (351)
Q Consensus       209 -----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  281 (351)
                           .+.+||+|||++........  .....||+.|+|||++.+  ..++.++|||||||++|+|++|..||....   
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~---  247 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN---  247 (1021)
T ss_pred             cccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC---
Confidence                 23489999999976543221  223468999999998854  458899999999999999999999996421   


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                        ...............          .....+.++.+||.+||+.+|.+|||+.|+|.
T Consensus       248 --~~~qli~~lk~~p~l----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 --NFSQLISELKRGPDL----------PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             --cHHHHHHHHhcCCCC----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence              112222222111100          01123467999999999999999999999984

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.7e-41  Score=290.67  Aligned_cols=252  Identities=26%  Similarity=0.425  Sum_probs=204.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|++|.||++... +++.+++|.+..... .....+.+|++.+++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677788999999999999976 578899999876543 44467889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++++|.+++...   ...+++.....++.|++.|++|||+ .   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            999999999743   2678889999999999999999999 7   99999999999999999999999999987553322


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      ..   ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ................         .
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~---------~  222 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPP---------P  222 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCC---------C
Confidence            21   145788999999999889999999999999999999999998654211 1122222222222111         1


Q ss_pred             CCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+.. .+..+.+++.+||..||++|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            12222 55779999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-40  Score=287.81  Aligned_cols=251  Identities=27%  Similarity=0.471  Sum_probs=207.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+..+.+++|||++++++++...+..++++||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5778899999999999999976 488899999877654 44567899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++++|.+++..    ...+++..+..++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999973    3668999999999999999999999 8   99999999999999999999999999987654433


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      ... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ..............         ..
T Consensus       155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~---------~~  221 (264)
T cd06623         155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFELMQAICDGP---------PP  221 (264)
T ss_pred             Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHHHHHHHhcCC---------CC
Confidence            221 234578899999999988999999999999999999999999865432   11111122221111         11


Q ss_pred             CCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+.. .+..+.+++.+||..+|++|||+.+++++
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            12233 55789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.5e-41  Score=290.27  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-----hhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-----TEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  141 (351)
                      .+|+..+.||+|+||.||++... ++..+++|.+....     ......+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999874 57889999886432     1233467889999999999999999998865  3577


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++++||+++++|.+++..    ...+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999999863    34578889999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccc--cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKT--HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....     . ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~-~~~~~~~~~~---  225 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----M-AAIFKIATQP---  225 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----H-HHHHHHhcCC---
Confidence            5432211  111223478899999999988899999999999999999999999864311     1 1111111100   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           .....+....+.+.+++ +||..+|++|||++|++++
T Consensus       226 -----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 -----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                 01123444556778888 6788899999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-40  Score=289.04  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=198.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh----------hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT----------EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  139 (351)
                      +|...+.||+|++|.||+|... +++.+|+|.++....          ...+.+.+|+..++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5777889999999999999864 578899998854211          11235778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999999974    35688899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCccccc-ccccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          220 ATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       220 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      +......... ......++..|+|||.+....  ++.++|+||||+++|++++|..||.....     . ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----I-AAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----H-HHHHHhhccc
Confidence            8754432211 122345788999999987654  78999999999999999999999853211     1 1111111111


Q ss_pred             ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..... +   .......+..+.+++.+||..+|++|||+.+++++
T Consensus       229 ~~~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPI-P---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcC-C---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111 1   11122345789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-40  Score=301.19  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=192.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ....+|+..+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++...+..++++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34567999999999999999999975 4577999975432      2346899999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |++. ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            9995 588888864   345689999999999999999999998   999999999999999999999999999875332


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-Ccchhcccc---cHHHHHHHHHh---cCcc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM-DEAFLEEGT---KLVTWVKAVMQ---DKRE  298 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~-~~~~~~~~~---~~~~~~~~~~~---~~~~  298 (351)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||+++..|+ .........   ...........   ....
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            21  122345899999999999999999999999999999999855443 321111000   00000111000   0000


Q ss_pred             ceeccc------------cCCCC---------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDT------------SLEGC---------PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~------------~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....++            .....         ....+.++.+++.+||+.||.+|||+.|++++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000000            00000         01223456789999999999999999999875

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-40  Score=287.82  Aligned_cols=251  Identities=29%  Similarity=0.459  Sum_probs=201.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... ++..+++|.+......  ..+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999864 6788999998765443  556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..    ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999873    34578889999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccccc---cccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          228 THVST---IVAGTFGYLAPEYFDTGR---ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       228 ~~~~~---~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .....   ...++..|+|||.+.+..   ++.++||||||+++|++++|..||.....     ............ .   
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-~---  224 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGAGH-K---  224 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhcCC-C---
Confidence            22211   345788999999998766   88999999999999999999999964321     011111111100 0   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                        +... .....+..+.+++.+||+.+|++|||+.+++.
T Consensus       225 --~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 --PPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              0000 01122567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-40  Score=287.04  Aligned_cols=247  Identities=29%  Similarity=0.487  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++.. .++.+++|.++...  ....+.+|+.+++.++|||++++.+++..+ ..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3588889999999999999875 56779999986542  235688999999999999999999998765 4699999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.......  
T Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            99999999753  234578889999999999999999998   99999999999999999999999999987543221  


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                        .....+..|+|||.+.++.++.++|+||||+++|+|++ |+.||.......      ..........    .     .
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~----~-----~  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKGYR----M-----E  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhCCCC----C-----C
Confidence              11224568999999988899999999999999999998 999986543211      1111111110    0     1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .+...+..+.+++.+||+.+|++|||++++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            123345788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-41  Score=297.06  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||+|..+ +++.+|+|.+.....  ...+.+.+|+++++.++||||+++++++..++..++++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            6788899999999999999975 578899998765332  2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.++...    ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          82 VDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             CCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999887652    34589999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc-cHHH-------HHHHHHhcCcc
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT-KLVT-------WVKAVMQDKRE  298 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-------~~~~~~~~~~~  298 (351)
                      . ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......+.. ....       ...........
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            2 2223457889999998865 45788999999999999999999998643211100 0000       00000000000


Q ss_pred             -ceeccccC------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 -EYVIDTSL------EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 -~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       .....+..      .......+..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence             00000000      01122345779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-41  Score=296.21  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=199.9

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      |.....||+|+||.||++... ++..||+|.+........+.+.+|+..++.++|||++++++.+...+..+++|||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344567999999999999874 5788999998765555566788999999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|.+++.     ...+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||++........ .
T Consensus       104 ~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~  174 (292)
T cd06658         104 GALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K  174 (292)
T ss_pred             CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence            99999884     34578899999999999999999998   999999999999999999999999999875433222 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......      ........ ....     ... ..
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~-~~~~-----~~~-~~  241 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRRIRD-NLPP-----RVK-DS  241 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCC-----ccc-cc
Confidence            22345789999999998888999999999999999999999998643211      11111111 0000     000 11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+..+.+++.+||..||.+|||+++++++
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2234678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-40  Score=289.72  Aligned_cols=261  Identities=26%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  146 (351)
                      +|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  +..+++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5677788999999999999975 578899999875433 3456788999999999999999999988653  46899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++.........++...+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999998764333455688889999999999999999998   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .............. .....+.. 
T Consensus       159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~-  232 (287)
T cd06621         159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMP-NPELKDEP-  232 (287)
T ss_pred             cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCC-chhhccCC-
Confidence            21   12347889999999998899999999999999999999999997542211 11111111111111 11111000 


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ......++.+.+++.+||+.+|++|||+.|++++
T Consensus       233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence             0012245779999999999999999999999984

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.1e-41  Score=296.02  Aligned_cols=260  Identities=23%  Similarity=0.347  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-----hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-----VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|+..+.||+|++|.||+|... +++.|++|.+......     ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999975 5789999999765432     334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+ +++|.+++....   ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 889999997431   3689999999999999999999998   99999999999999999999999999997654


Q ss_pred             cccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc-----
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE-----  298 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  298 (351)
                      ..... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+   ..............     
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhh
Confidence            43221 122246788999998854 467899999999999999999988876432111   00000000000000     


Q ss_pred             -----cee-----ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 -----EYV-----IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 -----~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ...     .+..........+..+.+++.+||+.+|++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                 000     0000011223345789999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-40  Score=286.88  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=204.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||.|++|.||+|... ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+..++..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36888999999999999999864 57789999986543 23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.... ....+++..+..++.|++.|+++||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999997432 124688999999999999999999998   99999999999999999999999999987655432


Q ss_pred             cc---ccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          228 TH---VSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       228 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ..   ......++..|+|||.+... .++.++|+||||+++|+|++|+.||......      ................+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  230 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDPPSLETG  230 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCCCCcCCc
Confidence            22   12334578999999998776 7899999999999999999999998653221      11111111111100000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ......+..+.+++.+||+.||++|||+.+++++
T Consensus       231 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         231 ----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                0012445789999999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=295.99  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||+|... +++.|++|.++...  ....+.+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888899999999999999876 57789999886542  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++++.+..+..    ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99877776654    335588999999999999999999998   99999999999999999999999999988765543


Q ss_pred             ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc-----------
Q 018702          228 THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD-----------  295 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------  295 (351)
                      ........++..|+|||++.+. .++.++|+||||+++|+|++|.+||......+.   ..........           
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhccc
Confidence            3233334578899999999887 889999999999999999999999865322110   0000000000           


Q ss_pred             Ccc-c--eeccccC-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KRE-E--YVIDTSL-----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~-~--~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ... .  ...+...     ...+...+.++.+++.+||..+|++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000 0  0000000     01222336789999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-40  Score=293.79  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             CCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           73 SSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .....||+|+||.||++... +++.|++|.+........+.+.+|+..++.++|||++++++.+..++..++++||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            34457999999999999874 67899999987655555567889999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      +|.+++.     ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus       104 ~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~  174 (297)
T cd06659         104 ALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR  174 (297)
T ss_pred             CHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence            9999874     34588999999999999999999998   999999999999999999999999999875443222 12


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCH
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI  311 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......      .......... ..      ....+.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~~------~~~~~~  241 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDSP-PP------KLKNAH  241 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhccC-CC------CccccC
Confidence            2345889999999999888999999999999999999999998643211      1111111110 00      001122


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          312 NEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       312 ~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+..+.+++.+||+.+|++|||+++++++
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            334678999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=307.26  Aligned_cols=259  Identities=20%  Similarity=0.250  Sum_probs=194.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|.+.+.||+|+||.||++... .++.||+|....      ..+.+|++++++++||||+++++++...+..+++||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            36888899999999999999975 467899996432      23568999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      . ++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++.......
T Consensus       243 ~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        243 R-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            5 6888888642   34689999999999999999999998   999999999999999999999999999976543222


Q ss_pred             c-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhc-ccccHHHHHHHHHhcCcc--ceec--
Q 018702          229 H-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE-EGTKLVTWVKAVMQDKRE--EYVI--  302 (351)
Q Consensus       229 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~--  302 (351)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ........+.........  ....  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            1 122346899999999999999999999999999999999987664322111 111111111111110000  0000  


Q ss_pred             -----------------cccCC-CCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 -----------------DTSLE-GCP---INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 -----------------~~~~~-~~~---~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                       .+... ...   .....++.+|+.+||+.||.+|||+.|+|++
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                             00000 000   1223478899999999999999999999986

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-40  Score=288.81  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-----hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--Cee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-----TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  141 (351)
                      .+|+..+.||+|+||.||.+... ++..|++|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999875 57889999875321     12235688899999999999999999988763  467


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            899999999999999863    34578888999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccc--cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKT--HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......      ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~---  225 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP---  225 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC---
Confidence            5432111  1122345788999999998888999999999999999999999998643111      1111111111   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           .....|...+..+.+++.+|+. +|.+|||++|++++
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                 1112355566788999999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=294.80  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|++|.||++...+ +..+|+|.+......   ..+.+.+|++.++.++||||+++++.+...+..+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            67888999999999999999764 788999999765332   34568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+.+++|.+++...  ....+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998643  235688999999999999999999998   9999999999999999999999999998754321


Q ss_pred             ccc----------------------------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcch
Q 018702          227 KTH----------------------------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAF  278 (351)
Q Consensus       227 ~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  278 (351)
                      ...                            ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                            0112357889999999998889999999999999999999999996542


Q ss_pred             hcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 018702          279 LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT----MTEVVKM  341 (351)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~e~l~~  341 (351)
                      ..      ............       . ......+..+.+++.+||..||++|||    +.|++.+
T Consensus       237 ~~------~~~~~~~~~~~~-------~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RD------ETFSNILKKEVT-------F-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hH------HHHHHHhcCCcc-------C-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            21      111111111100       0 001114578999999999999999999    8888764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.5e-41  Score=291.93  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=197.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecC------Ce
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSS------QY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~  140 (351)
                      +..|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++.++ +|||++++.+++...      ..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            456778889999999999999875 57789999986543 3345688899999998 699999999998653      46


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+++|||+.+++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            78999999999999998743  234688999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      ........ ......|++.|+|||++.     +..++.++|+||+|+++|+|++|..||......     .... .....
T Consensus       159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~-~~~~~  231 (272)
T cd06637         159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF-LIPRN  231 (272)
T ss_pred             eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH-HHhcC
Confidence            75433221 223345889999999885     346788999999999999999999998543211     1111 11110


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      . .       ....+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       232 ~-~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 P-A-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             C-C-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0 0       001122334679999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.1e-41  Score=295.81  Aligned_cols=261  Identities=21%  Similarity=0.300  Sum_probs=195.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||+|... +|..+++|.+.....  .....+.+|+.++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999975 578899999865422  2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++ ++|.+++...   ...+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            96 5888877532   35689999999999999999999998   99999999999999999999999999987554322


Q ss_pred             ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh-----------c
Q 018702          228 THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ-----------D  295 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~  295 (351)
                      .. .....+++.|+|||.+.+. .++.++||||||+++|+|++|..|+......  ............           .
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence            21 1223468899999988664 4789999999999999999998886332110  000000000000           0


Q ss_pred             Cccceeccc-----cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYVIDT-----SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .........     .........++++.+++.+||+.||.+|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000000     0001122345788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-40  Score=287.69  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=198.7

Q ss_pred             CCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC------
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------  139 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  139 (351)
                      |...+.||+|+||.||+|...    .+..+|+|.+....  ....+.+.+|+..++.++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999853    35789999987643  334456889999999999999999999876532      


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV--NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      ..+++++|+++|+|..++.....  ....+++.....++.|++.|++|||+.   +++|+||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            23788999999999988753221  223578888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhc
Q 018702          218 GLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       218 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      |.+......... ......+++.|++||......++.++||||||+++|+|++ |.+||......      .........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------EIYNYLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------HHHHHHHcC
Confidence            998765432211 1122235678999999988889999999999999999999 88998643211      111111111


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ...         ..+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       232 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         232 NRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            100         112234478999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-40  Score=292.98  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|...+.||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            47888999999999999999864 57889999987655555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++.+     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999999853     3578889999999999999999998   999999999999999999999999998875543322


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....+++.|+|||.+.+..++.++|+||||+++|++++|+.||.........      .........       ...
T Consensus       171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~~~-------~~~  236 (293)
T cd06647         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTP-------ELQ  236 (293)
T ss_pred             c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCCCC-------CCC
Confidence            2 12235788999999998888999999999999999999999999653221100      000000000       011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            233345679999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=296.49  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=210.1

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      -|...+.||+|.|+.|-++++ -.|..||||++.+...+  ....+++|+..|+.++|||||++|.+.......|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            477788999999999998875 46889999999765443  335689999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCcc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAE  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~  226 (351)
                      -++|+|.+|+.+.   ...+.+....+++.||+.|+.|+|+.   .++||||||+|+.+-+ -|-+||+|||++..+.+.
T Consensus        99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999863   56789999999999999999999999   9999999999998854 688999999999877654


Q ss_pred             cccccccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRAT-AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..  ..+.||...|-|||.+.+..|+ ++.||||||+|+|-|++|++||+.....+...               .++|..
T Consensus       173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCK  235 (864)
T KOG4717|consen  173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCK  235 (864)
T ss_pred             ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhccc
Confidence            43  3567899999999999998886 68999999999999999999998764332211               112211


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      . ..|...+.++++||..||..||.+|.|.+|+...
T Consensus       236 Y-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  236 Y-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             c-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            1 3588899999999999999999999999998754

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-40  Score=292.37  Aligned_cols=244  Identities=23%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|++|.||++... +++.+|+|.+....   ......+.+|++++++++||||+++++++.+.+..+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            6888899999999999999875 57889999986532   2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++..    ...++...+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          82 YVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999873    35688999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                          .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...........          
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~----------  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGK----------  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC----------
Confidence                2234578999999999888889999999999999999999999865321      11111111111          


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      ...+...+..+.+++.+||+.||.+||     +++|++++
T Consensus       215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            012333457899999999999999999     77887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.2e-40  Score=293.09  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.+. ++.    .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778889999999999999864 333    478898865433 2334688999999999999999999998764 4679


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.+||+|||++...
T Consensus        86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999998642   33578889999999999999999998   9999999999999999999999999999865


Q ss_pred             Cccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......       ...........  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERL--  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC--
Confidence            432221 1122335678999999998899999999999999999997 899986532111       11111111100  


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                            ..+...+.++.+++.+||..+|++||+++++++.|+.+..+
T Consensus       231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  11222346789999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.9e-40  Score=290.73  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecC----
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSS----  138 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----  138 (351)
                      +.....+|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...    
T Consensus        17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            3345678999999999999999999874 57889999886532 2345677899999998 799999999998643    


Q ss_pred             -CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          139 -QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       139 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                       +..+++|||+++++|.+++.........+++..++.++.|++.|+.|||+.   +++|+||||+||++++++.++|+||
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeec
Confidence             357999999999999998865433456789999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      |++......... .....++..|+|||.+...     .++.++|+||||+++|+|++|+.||......      ......
T Consensus       173 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~~  245 (291)
T cd06639         173 GVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFKI  245 (291)
T ss_pred             ccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHHH
Confidence            998765432221 1223578899999987543     3688999999999999999999998653211      111111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....... .      ..+......+.+++.+||+.+|++|||+.|++++
T Consensus       246 ~~~~~~~-~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 PRNPPPT-L------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             hcCCCCC-C------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111100 0      1122344679999999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=288.72  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=209.6

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      |.+..+||+|+||+||++.++ .|..+|+|.+..+  ...+++..|+.++.+++.|++|+++|.+-....+|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            445678999999999999875 5888999988653  3456799999999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+..+.++.   .++++.+..+..+.+..+.||+|||..   .-+|||||+.|||++.+|..||+|||.+..+.. ....
T Consensus       113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK  185 (502)
T KOG0574|consen  113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK  185 (502)
T ss_pred             CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence            999999874   468899999999999999999999998   889999999999999999999999999976543 3334


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC---
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE---  307 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  307 (351)
                      ..++.|||.|||||++..-.|..++||||||++..||..|++||.+...-                +..+.++....   
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF  249 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTF  249 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCC
Confidence            55677999999999999999999999999999999999999999764321                11222222221   


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..|...+.++-+++++||-++|++|.|+-+++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            3467778889999999999999999999999876

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-40  Score=284.80  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... ++..+++|.+....  ....+.+.+|+.+++.++|||++++++.+...+..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5778889999999999999874 57889999986542  23446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeeccccccCcc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAE  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~  226 (351)
                      +++++|.+++...  ....+++..+..++.+++.|++|||++   +++|+||+|+||+++++ +.++++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999999753  234578899999999999999999998   99999999999999865 45799999999865433


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...........         .
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~---------~  218 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGT---------F  218 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcC---------C
Confidence            21  1224578899999999988899999999999999999999999855321      11111111111         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+...+..+.+++.+||+.+|++|||++|++++
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11233345789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-41  Score=300.97  Aligned_cols=241  Identities=22%  Similarity=0.264  Sum_probs=187.0

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHHHHHhhcC---CCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERELEAMGDI---KHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      ||+|+||+||+|... +++.||+|++......   .......|..++...   +||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 5788999998643221   122344566666555   699999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++........ .
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~  152 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T  152 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence            99999986    345689999999999999999999998   999999999999999999999999999875332221 1


Q ss_pred             cccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      .....||+.|+|||.+.+. .++.++||||||+++|+|++|..||.....      .............       ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~-------~~--  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKVR-------FP--  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCCC-------CC--
Confidence            2345689999999998654 588999999999999999999999965321      1111221111100       00  


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRP----TMTEVVKM  341 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rp----s~~e~l~~  341 (351)
                      ....+.++.+++.+||+.||.+||    ++.+++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            112346789999999999999998    56666653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.7e-40  Score=290.28  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=198.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... .++.|++|.+.....   .....+.+|+++++.++||||+++++.+..++..+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6788899999999999999875 467899998876432   223467899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++..    ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||+++.....
T Consensus        82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          82 YVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999963    35688999999999999999999998   9999999999999999999999999988632110


Q ss_pred             c--------------ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          227 K--------------THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       227 ~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      .              ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            0              0011123468899999999888899999999999999999999999864321      1122222


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ......    .+   ..+...+..+.+++.+||+.||++|||..++++.|+
T Consensus       229 ~~~~~~----~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         229 ISDDIE----WP---EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HhcccC----CC---CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            111100    00   011134477899999999999999998655554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=311.37  Aligned_cols=262  Identities=19%  Similarity=0.264  Sum_probs=187.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC------CCceeeeeeEEecC-C
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK------HRNIVTLHGYYTSS-Q  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~-~  139 (351)
                      .+.+|+..+.||+|+||+||+|... .++.||||+++... ........|+.++..++      |++++++++++... +
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            3467888999999999999999874 56789999986432 22233455666655554      55689999988764 5


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---------
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---------  210 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---------  210 (351)
                      ..+++|+++ +++|.+++..    ...+++..+..++.|++.||.|||++  .+|+||||||+|||++.++         
T Consensus       206 ~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             eEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccc
Confidence            788999988 7789988863    45689999999999999999999973  2999999999999998765         


Q ss_pred             -------ceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc
Q 018702          211 -------EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT  283 (351)
Q Consensus       211 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  283 (351)
                             .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             ccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   499999998754322    123356899999999999999999999999999999999999999653321110


Q ss_pred             cHH---------HHHHH--------HHhcCcc-ceeccc-cC----CCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 018702          284 KLV---------TWVKA--------VMQDKRE-EYVIDT-SL----EGC---PINEINDVFSIASMCLEPEPSKRPTMTE  337 (351)
Q Consensus       284 ~~~---------~~~~~--------~~~~~~~-~~~~~~-~~----~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~e  337 (351)
                      ...         .|...        ....... ....++ ..    ...   .......+.+|+.+||+.||.+|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            000         01000        0000000 000000 00    000   0012356789999999999999999999


Q ss_pred             HHHH
Q 018702          338 VVKM  341 (351)
Q Consensus       338 ~l~~  341 (351)
                      ++++
T Consensus       435 ~L~H  438 (467)
T PTZ00284        435 MTTH  438 (467)
T ss_pred             HhcC
Confidence            9974

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=296.16  Aligned_cols=266  Identities=24%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             CCCCCCcccccCceEEEEEEECC---CCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND---STAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  142 (351)
                      +|+..+.||+|++|.||+|....   +..||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47778899999999999999754   6889999997743   33345678899999999999999999999888  7899


Q ss_pred             EEEEecCCCCHHHhhcCCCCCC-CCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC----CCceEEeee
Q 018702          143 LIYELMPNGSLDTFLHGKSVNK-KNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ----NMEARVSDF  217 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~----~~~~kl~df  217 (351)
                      +||||+++ +|.+++....... ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999965 7777765432222 3688999999999999999999998   9999999999999999    999999999


Q ss_pred             ccccccCcccc--cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc-------cHHH
Q 018702          218 GLATLMEAEKT--HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT-------KLVT  287 (351)
Q Consensus       218 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~  287 (351)
                      |++........  .......+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||.........       .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886543322  12223457889999998765 45789999999999999999999999764332210       0000


Q ss_pred             HHHHHHhcCcc----------ceec---cccCCCCC---------H--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          288 WVKAVMQDKRE----------EYVI---DTSLEGCP---------I--NEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       288 ~~~~~~~~~~~----------~~~~---~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+. .......          ....   .......+         .  ..+.++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000 0000000          0000   00000001         1  334678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=287.97  Aligned_cols=256  Identities=28%  Similarity=0.407  Sum_probs=201.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC------
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ------  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------  139 (351)
                      .+.+|+..+.||+|++|.||+|..+ +++.+++|.+..... ....+.+|+.+++++ +||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4568999999999999999999975 567899999876543 345688999999999 6999999999986544      


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..+++|||+++++|.+++.........+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            48999999999999999875432356789999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      +........ ......++..|+|||.+..     ..++.++||||||+++|+|++|..||......      ........
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~  232 (275)
T cd06608         160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR  232 (275)
T ss_pred             ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhc
Confidence            875443222 1223457889999998753     34678999999999999999999999643111      11111111


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....       ....+...+..+.+++.+||..||++|||+.+++++
T Consensus       233 ~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 NPPP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             cCCC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1100       011233355789999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=305.16  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=207.4

Q ss_pred             CCCCCcccccCceEEEEEEEC--CCC--EEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN--DST--AFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ....++||+|.||.|++|.|+  +|+  .||||.+..+... ....|.+|+.+|.+++|||+++++|+..+ +...+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345678999999999999985  343  4899999876554 45689999999999999999999999887 77899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      .++.|+|.+.|++.  ....+-......++.||+.||.||.++   ++|||||..+|+|+.....+||+|||+.+.+...
T Consensus       191 LaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999862  456677888899999999999999999   9999999999999999999999999999877543


Q ss_pred             c-cccc-ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 K-THVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~-~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      . .+.. ........|+|||.+....++.++|||+||+++|||++ |..||.+...      .+.+..+..         
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL~~iD~---------  330 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQILKNIDA---------  330 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHHHhccc---------
Confidence            3 2222 22335778999999999999999999999999999999 8899865321      112222211         


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .....-|..+++++++++..||..+|++|||+..+.+.+-..+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            1122347778899999999999999999999999976554443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=315.15  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=211.5

Q ss_pred             CCCCCcccccCceEEEEEEE-CCC----CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTV-NDS----TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ....++||+|+||+||+|.+ .++    -+||+|++.... .....++.+|+.+|.+++|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34467899999999999986 333    368999886653 344578999999999999999999999998876 78999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      +|++.|+|.+|++.   .+..+..+..+.|..||++||.|||.+   +++||||..+|+||++-..+|+.|||+++....
T Consensus       777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999986   456788899999999999999999998   999999999999999999999999999998776


Q ss_pred             ccccccc-cccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          226 EKTHVST-IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       226 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      +...... ...-.+.|+|-|.+....|+.++||||||+++||++| |..|+.....++-.       ..+..        
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~--------  915 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEK--------  915 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhc--------
Confidence            6544322 2234678999999999999999999999999999999 99998765433221       11111        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....+|+.++.+++-++.+||..|+..||+++++...+..+-.+
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            112346778889999999999999999999999999988776443

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-41  Score=299.65  Aligned_cols=251  Identities=25%  Similarity=0.442  Sum_probs=199.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  143 (351)
                      .....|++.+.||+||.+.||++...+.+.+|+|++...  +.....-|..|+..|.+++ |.+|+++++|-..++..|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            355679999999999999999999888888999877543  4455577999999999996 9999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||- ..+|..+|.....  ....| .+..+..|++.++.++|.+   ||||.||||.|.|+- .|.+||+|||++...
T Consensus       438 vmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             Eeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            99997 4599999985432  22233 7788899999999999999   999999999999985 568999999999988


Q ss_pred             Cccccc-ccccccccccccCcccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHH
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDTG-----------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ..+... .....+||+.||+||.+...           ..++++||||||||||+|+.|++||.....       .|.+-
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl  582 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKL  582 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHH
Confidence            766544 34567899999999998432           256789999999999999999999965311       11111


Q ss_pred             HHhcCccceeccccC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          292 VMQDKREEYVIDTSL----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .       .+.++..    ...+..  .++.++++.||..||.+|||+.++|++
T Consensus       583 ~-------aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  583 H-------AITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             H-------hhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1       1122211    122222  239999999999999999999999874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-42  Score=295.56  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      +.|+.-++||+|+||.||-+... +|+.+|.|.+.+..   .........|-.+|.+++.++||.+--.|++.+.+|+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            35677789999999999998864 57889999875432   222344678999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ..|+||+|.-+|-+.  .+..+++..+...+.+|+.||.+||+.   +|++|||||+|||+|+.|++.|+|+|++..+..
T Consensus       265 tlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999888755  346899999999999999999999999   999999999999999999999999999987765


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ......  ..||.+|||||++.++.|+...|.|||||++|||+.|+.||...-....   ...+.......         
T Consensus       340 g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~~---------  405 (591)
T KOG0986|consen  340 GKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLED---------  405 (591)
T ss_pred             CCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhcc---------
Confidence            544332  3699999999999999999999999999999999999999976422111   11112211111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMT  336 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  336 (351)
                      ...++...++++.+++...|.+||.+|.-.+
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            1235777889999999999999999997443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=287.21  Aligned_cols=267  Identities=26%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhh--cCCCCceeeeeeEEecC----Ce
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG--DIKHRNIVTLHGYYTSS----QY  140 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~----~~  140 (351)
                      ...+..+..+.||+|.||+||+|.+. |..||||++...+   ++...+|.+++.  .++|+||+.+++.-..+    ..
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34456777889999999999999998 5669999996533   334556666655  45999999999884433    36


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD-----CIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      ++||++|.+.|||.+||.     ...++....++++..+++||++||..     .+|.|.|||||+.||||+.+|..-|+
T Consensus       284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            799999999999999995     46789999999999999999999964     46789999999999999999999999


Q ss_pred             eeccccccCccccc---ccccccccccccCcccccCCC----C--CchhhHHHHHHHHHHHHh----C------CCCCCc
Q 018702          216 DFGLATLMEAEKTH---VSTIVAGTFGYLAPEYFDTGR----A--TAKGDVYSFGVVLLELLT----G------KRPMDE  276 (351)
Q Consensus       216 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----~--~~~~Dv~slG~il~~l~~----g------~~p~~~  276 (351)
                      |+|++.........   ..+..+||-+|||||+++..-    +  -..+||||||+++||+.-    |      +.||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999876544322   234567999999999997531    1  236899999999999874    2      467655


Q ss_pred             chhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .-. .+....+..+.+..++... .++..+  ........+.++++.||..||.-|.|+=.+-+.|.++-
T Consensus       439 ~Vp-~DPs~eeMrkVVCv~~~RP-~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVP-SDPSFEEMRKVVCVQKLRP-NIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCC-CCCCHHHHhcceeecccCC-CCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            322 2222222222222111111 111111  23445577889999999999999999988888877765

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.3e-41  Score=288.99  Aligned_cols=248  Identities=27%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +|+..+.||+|+||.||++... ++..+++|.+....   ....+.+.+|++.+++++||||+++++.+.+....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777889999999999999975 57889999987543   2335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+.+++|.+++..    ...+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999999963    35788999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......    ............         .
T Consensus       154 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~---------~  218 (258)
T cd05578         154 TL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA---------D  218 (258)
T ss_pred             cc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc---------c
Confidence            21  22345788999999998888999999999999999999999998754321    111111111110         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTM--TEVVK  340 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~e~l~  340 (351)
                      ...|...+..+.+++.+||+.||.+||++  +|+++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            12334445889999999999999999999  66653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-42  Score=305.97  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=204.3

Q ss_pred             CCCCCcccccCceEEEEEEECCCCE-EEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      |.+...||.|+||.||++..++... -|.|++...+.+..+.++-|+++|..++||+||++++.|..++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            3445679999999999999876544 466777766677777899999999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |..+..+-.   -...+++.++..+++|++.||.|||++   +|+|||||+.|||++-+|.++|+|||.+-... .....
T Consensus       114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk  186 (1187)
T KOG0579|consen  114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK  186 (1187)
T ss_pred             chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence            999887653   356799999999999999999999999   99999999999999999999999999985432 22333


Q ss_pred             cccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          231 STIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ...+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|-...      +.+..+-.+......       
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKSePP-------  253 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEPP-------  253 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhcCCC-------
Confidence            45677999999999874     368999999999999999999999995432      222222222221111       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..-.|...+..+.+++.+||.+||+.||++.+++++
T Consensus       254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            112366777889999999999999999999999875

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.9e-40  Score=287.81  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=199.9

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      |+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+..+++++||||+++++.+..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            566778999999999999864 57889999876543 2334568899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++.     ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|||++........ 
T Consensus        86 ~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          86 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            999999985     34578999999999999999999998   999999999999999999999999999876543221 


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...........         ....
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~~~~  221 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKNN---------PPTL  221 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcCC---------CCCC
Confidence            12234578899999999888899999999999999999999999854321      11111111110         1112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +...+.++.+++.+||+.+|.+||++.+++++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            33345779999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=285.86  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355567899999999999986 4678899999876555555678899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||.+.........
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999999863     4578899999999999999999998   9999999999999999999999999988754432221


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                       .....+++.|+|||...+..++.++|+||||+++|+|++|..||.....      .............      .. ..
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~~~~------~~-~~  237 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDNLPP------KL-KN  237 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhcCCC------CC-cc
Confidence             2234578999999999888899999999999999999999999854321      1111111111100      00 01


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +...+..+.+++.+||+.+|++|||+.+++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            22244689999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.4e-40  Score=290.22  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=197.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||+|... +++.+++|.+.....  .....+.+|++.+++++||||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            3677889999999999999875 578899998865432  2335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +. ++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5898888643  245688999999999999999999998   99999999999999999999999999987554322


Q ss_pred             ccccccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc---------
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR---------  297 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  297 (351)
                      .. .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.......  ..............         
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHH
Confidence            11 12234678899999886644 6889999999999999999999996532211  11111110000000         


Q ss_pred             ------cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 ------EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                            ................+.++.+++.+||+.||++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                  00000000001112234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=291.43  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|++|.||+|... +++.|++|.+...... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999975 6788999998654322 224567899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +.+ +|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            975 999988643   23678899999999999999999998   99999999999999999999999999986543221


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc-------
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE-------  299 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------  299 (351)
                      .. .....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......  ................       
T Consensus       158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhh
Confidence            11 112236788999998865 568899999999999999999999996542110  0000000000000000       


Q ss_pred             ------eec----cccCCCCCHHH--HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 ------YVI----DTSLEGCPINE--INDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ------~~~----~~~~~~~~~~~--~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                            ...    ...........  ..++.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                  000    00000000011  2678899999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=286.92  Aligned_cols=247  Identities=23%  Similarity=0.383  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .|+..+.||+|+||.||+|.+ .++..+++|.+.... ......+.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 467889999986543 333456788999998886   999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..     ..+++..++.++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999999852     3688999999999999999999998   999999999999999999999999999886654


Q ss_pred             ccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......      .... ....        
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~~--------  217 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPKS--------  217 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cccC--------
Confidence            3322 223458889999998865 457899999999999999999999996532111      1110 0000        


Q ss_pred             cCCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPI-NEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....+. ..+.++.+++.+||+.||++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            0011111 144689999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.4e-40  Score=282.00  Aligned_cols=252  Identities=24%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... ++..+++|++.....  .....+.+|++.++.++|||++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999975 578899999876543  4456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.........+++..+..++.+++.|+.+||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999976433357789999999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                       .......+++.|+|||...+..++.++|+||+|+++++|++|..||....      ............         ..
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~---------~~  221 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQ---------YP  221 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCC---------CC
Confidence             22233458889999999988889999999999999999999999985432      111222222111         11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+..+.+++.+||..+|++|||+.+++++
T Consensus       222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2233455789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-41  Score=300.85  Aligned_cols=245  Identities=27%  Similarity=0.432  Sum_probs=198.4

Q ss_pred             CCCcccccCceEEEEEEEC-CCCEEEEEEecC----CChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe--eEEEEE
Q 018702           74 SKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHR----GTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY--NLLIYE  146 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e  146 (351)
                      ...+||+|+|-+||+|.+. +|-.||--.++.    ......+++..|+.+|+.|+||||++++++|.+...  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3457999999999999974 355555443322    133445779999999999999999999999987765  678999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~  225 (351)
                      .+..|+|..|..    ..+.++...+..|++||+.||.|||++. |+|+|||||-+||||+. .|.|||+|+|+|.....
T Consensus       124 L~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  124 LFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999998    4566888899999999999999999974 78999999999999987 59999999999987655


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ....   ...|||.|||||+.. ..|.+..||||||++++||+|+..||.     +..+..+..+.+........+    
T Consensus       199 s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGiKP~sl----  265 (632)
T KOG0584|consen  199 SHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGIKPAAL----  265 (632)
T ss_pred             cccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCCCHHHh----
Confidence            4432   367999999999998 789999999999999999999999985     344555555665544333211    


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ....   .++++++|.+||.. .++|||+.|+|+.
T Consensus       266 -~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  266 -SKVK---DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -hccC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence             1001   25799999999999 9999999999863

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-39  Score=278.53  Aligned_cols=250  Identities=28%  Similarity=0.459  Sum_probs=204.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +|+..+.||+|++|.||++... ++..+++|++........+.+.+|++.++.++|||++++.+.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999985 678899999987655556778999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ...+++..+..++.|++.|+.+||+.   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999998642   25789999999999999999999998   999999999999999999999999999876654332 


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                       .....++..|+|||.+.+..++.++|+||||+++++|++|..||......      ............. .      ..
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-~------~~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIATNGPPG-L------RN  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhcCCCC-c------Cc
Confidence             23345788999999998888999999999999999999999998653211      1111111100000 0      01


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +...+..+.+++.+||+.||++|||+.|++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11124679999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-40  Score=288.64  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=198.9

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEec----
Q 018702           64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTS----  137 (351)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----  137 (351)
                      ........|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|||++++++++..    
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            34445568889999999999999999974 57889999886543 2335678899999998 69999999999853    


Q ss_pred             --CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          138 --SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       138 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                        ....+++|||+++|+|.+++....  ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence              457899999999999999986432  34577888899999999999999998   99999999999999999999999


Q ss_pred             eeccccccCcccccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      |||++........ ......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||........      ..
T Consensus       164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~~  236 (282)
T cd06636         164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------LF  236 (282)
T ss_pred             eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------hh
Confidence            9999875432221 122345889999999875     34678899999999999999999999854321110      00


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...... .     .  .......+..+.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~-~-----~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 LIPRNP-P-----P--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hHhhCC-C-----C--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            010000 0     0  00122345789999999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.1e-40  Score=287.03  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=195.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHH-hhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEA-MGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|+||.||++... +++.||+|++..... .....+..|+.. ++..+|||++++++++..++..+++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            6788889999999999999875 588999999876432 233455566665 5667899999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++ |+|.+++.........+++..++.++.|++.|++|||++  .+++||||||+||+++.++.+||+|||.+.......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            96 688888765433446789999999999999999999985  289999999999999999999999999987653321


Q ss_pred             ccccccccccccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          228 THVSTIVAGTFGYLAPEYFDT----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .  .....++..|+|||.+.+    ..++.++|+||||+++|+|++|..||.....    . ..............    
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~~~~~~~~~----  227 (283)
T cd06617         159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----P-FQQLKQVVEEPSPQ----  227 (283)
T ss_pred             c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----C-HHHHHHHHhcCCCC----
Confidence            1  122347889999998864    4568899999999999999999999854211    1 11111111111110    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .  .....+.++.+++.+||..+|++|||+.+++++
T Consensus       228 --~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         228 --L--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0  011245789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.1e-39  Score=284.57  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=203.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ...|+..+.||+|++|.||++... ++..+++|.+..... ..+.+.+|++.++.++|+|++++++.+...+..++++||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            345777889999999999999976 678899999976544 456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++....   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999997432   3789999999999999999999998   99999999999999999999999999886544322


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......      .............       .
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-------~  236 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKGIPP-------L  236 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCC-------C
Confidence            1 122334788999999998888999999999999999999999998643211      1111111111000       0


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1122245789999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.3e-39  Score=279.64  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=205.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  145 (351)
                      +|+..+.||+|++|.||+|... +++.+++|.+.....  ...+.+.+|+..+++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677789999999999999976 688899999876543  3456788999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999974    33789999999999999999999998   999999999999999999999999999886654


Q ss_pred             cccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......++..|+|||.+.+..++.++|+||||+++++|++|..||....     ...........        ..
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~--------~~  220 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS--------SG  220 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc--------cC
Confidence            4321 1223457889999999988889999999999999999999999986543     11111111111        01


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....+...+..+.+++.+||+.||++||++.+++++
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            1112344446889999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-39  Score=281.33  Aligned_cols=242  Identities=26%  Similarity=0.359  Sum_probs=197.0

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||.|++|.||++... +++.+++|.+.....   ...+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 478899999865432   3346788999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+++.+    ...+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            999973    34588899999999999999999998   99999999999999999999999999998664432  1122


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....    +.............        ....|...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~--------~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNG--------KLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCC--------CCCCCccc
Confidence            3578899999999888899999999999999999999999965431    11122222221000        11123333


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPT-----MTEVVK  340 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps-----~~e~l~  340 (351)
                      +..+.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            578999999999999999999     888876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.1e-40  Score=285.97  Aligned_cols=242  Identities=25%  Similarity=0.337  Sum_probs=188.5

Q ss_pred             cccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHH---HhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           77 VIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELE---AMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +||+|+||.||++... +++.+|+|.+.....   .....+.+|..   .+...+|||++.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 578899998865422   11222344443   3344579999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++.    ..+.+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++++|||++........ 
T Consensus        81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            999999986    345689999999999999999999998   999999999999999999999999999865433221 


Q ss_pred             ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                        ....|++.|+|||...+ ..++.++|+||+|+++|+|++|..||.......    ...........         ...
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~---------~~~  217 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTV---------NVE  217 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHHHHHhhcC---------CcC
Confidence              22358999999998864 568899999999999999999999996542211    11111111100         012


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      .+...+.++.+++.+||+.||++||     |+++++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            3444567899999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=283.04  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=209.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEec-CCe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTS-SQY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  140 (351)
                      ..+++...++-+|.||.||.|.+.      +.+.|.+|.++....+ ....+..|--.+..+.|||+....+++.+ ...
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            345677778999999999999653      3455788887665333 33567889999999999999999999754 456


Q ss_pred             eEEEEEecCCCCHHHhhcCCC----CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          141 NLLIYELMPNGSLDTFLHGKS----VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                      .+.++.++.-|+|..|+.-.+    ...+.++..+...++.|++.|++|||+.   +++|.||..+|++|++..++||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEecc
Confidence            788999999999999998322    2345677888999999999999999999   999999999999999999999999


Q ss_pred             eccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHh
Q 018702          217 FGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       217 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      =.+++..-+.+++ .+...-.+..||+||.+....|+.++|+||||+++|||+| |+.|+.+.++.+.       ...+ 
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~yl-  511 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHYL-  511 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHHH-
Confidence            9999865444333 3333445788999999999999999999999999999999 9999876543321       1111 


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                             .|.-....|.+++++++.++..||..+|++|||++++..-|.++..
T Consensus       512 -------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  512 -------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             -------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                   1211223477788999999999999999999999999999988754

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-39  Score=286.28  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  144 (351)
                      .+|+..+.||+|++|.||+|..+ +++.+++|.++.....  ....+.+|+.++++++||||+++.+++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            36888899999999999999986 5788999998754322  223567899999999999999999998877  889999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++ +|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 999988642   23689999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh---------
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ---------  294 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  294 (351)
                      ..... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||........   .........         
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHH
Confidence            43211 1223468899999988654 468999999999999999999999965321110   000000000         


Q ss_pred             --c----C--ccceeccccC-CCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 --D----K--REEYVIDTSL-EGCPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 --~----~--~~~~~~~~~~-~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .    .  .........+ ...+.. .++.+.+++.+||+.+|++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              0    0  0000000000 112222 35778999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.1e-40  Score=286.60  Aligned_cols=245  Identities=25%  Similarity=0.348  Sum_probs=193.6

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|+||+||++... +++.+++|.+.....   .....+..|+++++.++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864 578899998865321   2234567899999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+++....  ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+........  ...
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence            99987432  24688999999999999999999998   999999999999999999999999999875543211  122


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........   ..........         .....+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~---------~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLE---------MAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhcccc---------ccccCCccC
Confidence            3478899999999888899999999999999999999999965432111   0011110000         011123344


Q ss_pred             HHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      +..+.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            57899999999999999999     67777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-40  Score=287.11  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      |+..+.||+|++|.||+|..+ ++..|++|++.....  .....+.+|++.++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566788999999999999874 688999999875432  22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      + ++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 69999986432  24689999999999999999999998   999999999999999999999999999875543222


Q ss_pred             cccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC-----------
Q 018702          229 HVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK-----------  296 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  296 (351)
                      . .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.......  .............           
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence            1 1122468899999987654 57899999999999999999999996532211  1111111000000           


Q ss_pred             --c--cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 --R--EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 --~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .  ................+..+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0  00000001111223344678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.1e-40  Score=287.38  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=197.4

Q ss_pred             CCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           75 KDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ...||+|+||.||++... ++..+++|++..........+.+|+..++.++|||++++++.+...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            356999999999999874 6788999998765555556788999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+++.     ...+++.....++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++........ ....
T Consensus       105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            99874     33578899999999999999999998   999999999999999999999999998875543221 1233


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......      ...... ......     ... .....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~~-~~~~~~-----~~~-~~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMI-RDNLPP-----KLK-NLHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhhCCc-----ccC-CcccC
Confidence            45789999999998888999999999999999999999998643211      111111 110000     000 11223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +..+.+++.+||+.+|.+||++.+++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            4678899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.8e-40  Score=282.30  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|...+.||+|+||.||++..+ ++..+++|.+.....  ...+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999975 478899999865321  2335678999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc-eEEeeeccccccCcc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME-ARVSDFGLATLMEAE  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~  226 (351)
                      +++++|.+++...  ....+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++. ++++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998643  223578999999999999999999998   9999999999999998754 699999998765433


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .. ......|++.|+|||...+..++.++|+||||+++|+|++|..||....      ............         .
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~---------~  219 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY---------F  219 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc---------C
Confidence            22 1223357889999999988889999999999999999999999985432      112222222111         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+...+.++.+++.+||+.+|++|||+.|++++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11222344689999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.7e-39  Score=285.77  Aligned_cols=248  Identities=28%  Similarity=0.397  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.|++|.+....   ....+.+.+|+++++.++|||++++.+++.+.+..++++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            35888899999999999999875 57889999886432   233356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+. |++.+++...   .+.+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 5777776532   34689999999999999999999998   999999999999999999999999999875433


Q ss_pred             ccccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ..     ...+++.|+|||.+.   ...++.++||||||+++|+|++|..||......      ...........     
T Consensus       168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~~-----  231 (307)
T cd06607         168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNDS-----  231 (307)
T ss_pred             CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCCC-----
Confidence            22     234788999999874   456889999999999999999999998543211      11111111100     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                         ....+...+..+.+++.+||+.+|++|||+.+++.+..
T Consensus       232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence               00112234578999999999999999999999988643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-39  Score=287.22  Aligned_cols=263  Identities=22%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|...+.||+|+||.||+|... ++..+++|.+...... ....+.+|+..++.++|+||+++.+++...+..++++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467889999999999999999864 5788999998654332 23457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+. ++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            995 6787776532   34577888899999999999999998   9999999999999999999999999998754322


Q ss_pred             cccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC---------
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK---------  296 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  296 (351)
                      ... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......  .............         
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence            111 122346889999999875 457889999999999999999999996532110  0000000000000         


Q ss_pred             ----ccceecc----ccCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 ----REEYVID----TSLEGC--PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 ----~~~~~~~----~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          .......    ......  ....+..+.+++.+|++.||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                0000000    000000  00124678899999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-39  Score=285.71  Aligned_cols=265  Identities=22%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +|+..+.||+|++|.||+|... ++..||+|.+...... ....+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778889999999999999975 5788999998765332 2356778999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++ +|.+++.... ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++........
T Consensus        81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            75 8988886433 235689999999999999999999998   999999999999999999999999999875533221


Q ss_pred             cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc-HHH--------HHHHHHhcCcc
Q 018702          229 HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK-LVT--------WVKAVMQDKRE  298 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~--------~~~~~~~~~~~  298 (351)
                      . .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||.......... ...        ...........
T Consensus       156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            1 122346889999998865 457889999999999999999999996543211100 000        00000000000


Q ss_pred             ce----eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EY----VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..    ..+..........+..+.+++.+||+.||.+||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00    00000001112335678999999999999999999999863

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-39  Score=287.12  Aligned_cols=263  Identities=19%  Similarity=0.263  Sum_probs=195.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCe-----e
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQY-----N  141 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~  141 (351)
                      +|+..+.||+|+||.||+|... +++.||+|.......  .....+.+|+.+++.+. ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6888899999999999999975 578999998765432  22356788999999995 6999999999876655     7


Q ss_pred             EEEEEecCCCCHHHhhcCCCCC-CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeecc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVN-KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGL  219 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~  219 (351)
                      +++|||+++ +|.+++...... ...+++..++.++.||+.||.|||+.   +++|+||+|+||+++. ++.++|+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999975 898888643322 45689999999999999999999998   9999999999999998 89999999999


Q ss_pred             ccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......  ....... .......
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~  233 (295)
T cd07837         158 GRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFK-LLGTPTE  233 (295)
T ss_pred             ceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HhCCCCh
Confidence            8755332211 112246788999998754 457899999999999999999999986532111  0000000 0000000


Q ss_pred             cee---------------ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYV---------------IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...               ............+..+.+++.+||+.||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000               0000000112345778999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=286.52  Aligned_cols=260  Identities=23%  Similarity=0.318  Sum_probs=197.6

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLIYE  146 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  146 (351)
                      |+..+.||+|++|.||+|... +++.+++|.+....  ......+.+|+++++.++|||++++++++...  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999976 47889999997653  33345688999999999999999999999888  88999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++ +|.+++...   ...+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 898888642   24689999999999999999999998   9999999999999999999999999999866544


Q ss_pred             cccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce-----
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY-----  300 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  300 (351)
                      .........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........   ...............     
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence            3222223346788999997764 4678999999999999999999999965432111   011111000000000     


Q ss_pred             ------------eccccCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 ------------VIDTSLEGCPIN-EINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ------------~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                  ............ .+..+.+++.+||+.+|++|||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                        000000000011 25778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-39  Score=282.98  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=193.2

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCC-CCceeeeeeEEecC--CeeEEEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIK-HRNIVTLHGYYTSS--QYNLLIYE  146 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  146 (351)
                      |+..+.||+|+||.||++... +++.+|+|+++..... ......+|+..+.++. |||++++++++.+.  +..+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456778999999999999864 5788999998754222 2234457888888885 99999999999887  88999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |++ ++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++. +.+||+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 5888887632   34689999999999999999999998   9999999999999999 99999999999765433


Q ss_pred             cccccccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh-----------
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ-----------  294 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  294 (351)
                      ...  ....++..|+|||.+. ++.++.++|+||+|+++|+|++|..||......+   ..........           
T Consensus       153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence            221  2234788999999764 4567889999999999999999999996543211   1111111110           


Q ss_pred             -cCccceecccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 -DKREEYVIDTS----LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 -~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ...........    ........+..+.+++.+||+++|++|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence             00000000000    001122456889999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-39  Score=279.85  Aligned_cols=250  Identities=23%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... ++..+++|.+....  ......+.+|+..++.++||||+++.+++.+....++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777889999999999999865 57789999987542  23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.........+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999875433346789999999999999999999998   99999999999999999999999999997665431


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                         .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||......      ........         ....
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------~~~~  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQR---------GKYP  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc---------CCCC
Confidence               12234788999999999888999999999999999999999998654221      11111111         1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+.++.+++.+||..+|++|||+.+++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2334556789999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.6e-39  Score=292.17  Aligned_cols=264  Identities=24%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC----
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS----  138 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  138 (351)
                      +....+|+..+.||+|+||.||++... +++.||+|.+...  .......+.+|+.++++++||||+++++++...    
T Consensus        12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            345578999999999999999999864 6789999998643  223345677899999999999999999988643    


Q ss_pred             --CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          139 --QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       139 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                        ...++||||+. ++|.+.+..      .++...+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence              35699999995 488888742      278888999999999999999998   999999999999999999999999


Q ss_pred             eccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc---------cHHH
Q 018702          217 FGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT---------KLVT  287 (351)
Q Consensus       217 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------~~~~  287 (351)
                      ||++........  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........         ....
T Consensus       162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999976543222  22334788999999999999999999999999999999999999653211100         0000


Q ss_pred             H-------HHHHHhcCccc------eecccc-----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          288 W-------VKAVMQDKREE------YVIDTS-----LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       288 ~-------~~~~~~~~~~~------~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +       ...........      ...+..     ....+...+..+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0       00000000000      000000     001122345678999999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=269.59  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=199.1

Q ss_pred             CCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecC
Q 018702           73 SSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +....||+|+.|.||++... .|..+|||...... .+..+++.+.+.++...+ +|+||+.+|+|..+...++.||.| 
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence            34457999999999999975 47789999987653 445578889999887776 999999999999999999999998 


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +..++.++.+   ..+++++..+-++...+..||.||..++  +|+|||+||+|||+|+.|++|+||||++...-....+
T Consensus       174 s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  174 STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            4466676654   3566888888899999999999999986  9999999999999999999999999999876555443


Q ss_pred             ccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          230 VSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .  ...|-+.|||||.+..   ..|+.++||||||++++||.||..||....     .-.+.+..+.++..      +.+
T Consensus       249 t--rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-----tdFe~ltkvln~eP------P~L  315 (391)
T KOG0983|consen  249 T--RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-----TDFEVLTKVLNEEP------PLL  315 (391)
T ss_pred             c--cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-----ccHHHHHHHHhcCC------CCC
Confidence            2  3358899999999965   468889999999999999999999996531     11223333333221      111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      . .....+.++++++..||++|+.+||...+++++
T Consensus       316 ~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 P-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             C-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1 122266889999999999999999999999876

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-39  Score=275.61  Aligned_cols=247  Identities=28%  Similarity=0.449  Sum_probs=203.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|||++++.+++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778889999999999999875 577899999977644  3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..    ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999873    35689999999999999999999998   99999999999999999999999999998665433


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .. .....++..|+|||...+..++.++|+||+|+++|+|++|..||.....     .... .......         ..
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~~~~---------~~  217 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAAL-FRIVQDD---------HP  217 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHH-HHHhccC---------CC
Confidence            22 2234578899999999888889999999999999999999999864321     1111 1111111         11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ..+...+..+.+++.+||..+|++|||+.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            123344578999999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=298.69  Aligned_cols=246  Identities=30%  Similarity=0.433  Sum_probs=199.6

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |+..+.||.|+||.||.+.+. +...||||+..-...+   .-+.+..|+..|++++|||.+.+.|+|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            566788999999999999864 5677999998644332   335689999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      |-| +-.+.+.-   ..+++.+..+..|+.+.++||+|||+.   +.+|||||+.|||+++.|.|||+|||.+....+. 
T Consensus       108 ClG-SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  108 CLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             Hhc-cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            955 77777654   357899999999999999999999999   9999999999999999999999999998754433 


Q ss_pred             ccccccccccccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          228 THVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                          ..+.|||.|||||++   +.+.|+-++||||||++..||...++|+.....      +..+-....+...      
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNesP------  243 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP------  243 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcCCC------
Confidence                346799999999987   568999999999999999999999999744311      1111111111111      


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .+  ...+.+..+++++..||++-|.+|||.++++++--
T Consensus       244 tL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  244 TL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             CC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence            11  13445678999999999999999999999998643

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.4e-39  Score=284.35  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=195.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|+..+.||+|++|.||+|..+ +++.|++|.+.....  .....+.+|++++++++|||++++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            36888899999999999999975 678899998865432  233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~  225 (351)
                      |++ ++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++. ++.+|++|||++.....
T Consensus        82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 5888877533  223457788889999999999999998   9999999999999985 56799999999975543


Q ss_pred             ccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce----
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY----  300 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  300 (351)
                      .... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||......+.  ..... ..........    
T Consensus       156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~  231 (294)
T PLN00009        156 PVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGV  231 (294)
T ss_pred             Cccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChhhcccc
Confidence            2211 122346889999998865 4578999999999999999999999965322110  00000 0000000000    


Q ss_pred             ------------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 ------------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                  .............+..+.+++.+||+.+|++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        00000001112345678999999999999999999999864

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-39  Score=285.02  Aligned_cols=256  Identities=29%  Similarity=0.394  Sum_probs=195.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|+..+.||+|+||.||++... +++.+|+|.+..... .....+.+|+..+.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999875 578899999875432 34456889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHhhcCC-CCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          148 MPNGSLDTFLHGK-SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      +.. ++.++.... ......+++..+..++.|++.|++|||+.  .+++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            854 665543211 11235689999999999999999999974  28999999999999999999999999998755432


Q ss_pred             cccccccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTG---RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...  ....+++.|+|||.+.+.   .++.++|+||+|+++|+|++|+.||....     ................  . 
T Consensus       162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~~--~-  231 (288)
T cd06616         162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDPPI--L-  231 (288)
T ss_pred             Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCCCc--C-
Confidence            221  223478899999998766   68999999999999999999999986432     1111111111111110  0 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ....+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 --SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011223355789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-39  Score=283.13  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=198.8

Q ss_pred             CCCCCCcccccCceEEEEEEE----CCCCEEEEEEecCCCh----hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGTT----EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      +|+..+.||+|+||.||.+..    .++..||+|.+.....    ...+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367788999999999999986    3678899999875322    2335678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999999873    45678889999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccccccccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTG--RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ..............++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.....  ...............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~---  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE---  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccC---
Confidence            6544333222334588999999998653  467899999999999999999999864211  111112222221111   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                             ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                   112333457789999999999999997     77777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-40  Score=307.59  Aligned_cols=268  Identities=22%  Similarity=0.333  Sum_probs=188.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC--CCEEEEE------------------EecCCChhhHHHHHHHHHHhhcCCCCce
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND--STAFAVK------------------RLHRGTTEVDRGFERELEAMGDIKHRNI  128 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~ni  128 (351)
                      ..+|+..+.||+|+||+||++....  +...+.|                  .+. ........+.+|+.++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            4589999999999999999987532  1111211                  111 112234467899999999999999


Q ss_pred             eeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCC-CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN-KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       129 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      +++++++...+..+++++++. ++|.+++...... ...........++.|++.||.|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999984 5777776533211 22234566778999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCcchhcccccHH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKR-PMDEAFLEEGTKLV  286 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~-p~~~~~~~~~~~~~  286 (351)
                      .++.+||+|||++...............||..|+|||++.+..++.++|||||||++|||++|.. |+..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999998765443333334568999999999999999999999999999999999875 44322111111111


Q ss_pred             HHHHHHHh--cCcc-------ceeccccC----CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          287 TWVKAVMQ--DKRE-------EYVIDTSL----EGCP-----INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       287 ~~~~~~~~--~~~~-------~~~~~~~~----~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........  ....       .++.....    ...+     ...+.++.+++.+||+.||.+|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11110000  0000       00000000    0000     1123467888999999999999999999875

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-40  Score=293.33  Aligned_cols=265  Identities=23%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----Ce
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----QY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  140 (351)
                      ..+|...+.||+|+||.||++... ++..||+|.+...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999864 5788999998653  222345677899999999999999999987644     34


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .++++||+. ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999995 68998886    345689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc-
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE-  298 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  298 (351)
                      ....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.......   .............. 
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  231 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE  231 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence            7654332 11223457889999998764 568899999999999999999999996532111   01111111000000 


Q ss_pred             -----------------ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 018702          299 -----------------EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELI  345 (351)
Q Consensus       299 -----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~  345 (351)
                                       ....+..........+.++.+++.+||+.+|++|||+++++++  +..+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                             0000000111123455779999999999999999999999987  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-39  Score=277.07  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=198.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC-----ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--Cee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG-----TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  141 (351)
                      .+|...+.||+|++|.||++... ++..+++|.+...     .......+.+|+.++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47888999999999999999874 5788999987532     122335688999999999999999999998664  467


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++++||+++++|.+++..    ...+++.....++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+.
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999999863    34578889999999999999999998   99999999999999999999999999997


Q ss_pred             ccCcccc--cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKT--HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....     .. .........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~-~~~~~~~~~---  225 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MA-AIFKIATQP---  225 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HH-HHHHHHcCC---
Confidence            5432111  111234578899999999888899999999999999999999999864311     11 111111111   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           .....|...++.+.+++.+||+ +|..|||+.+++++
T Consensus       226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                 1112355566889999999999 57999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-39  Score=283.98  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  145 (351)
                      +|...+.||+|++|.||++... ++..+++|++....   ....+.+.+|.+++++++ ||||+++++++...+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            6888899999999999999875 68899999886532   233456788999999998 999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |++++++|.+++..    ...+++..++.++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          82 EYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999973    34789999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccc-------------------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH
Q 018702          226 EKT-------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV  286 (351)
Q Consensus       226 ~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  286 (351)
                      ...                   .......++..|+|||...+..++.++|+||||++++++++|..||.....      .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------Y  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence            321                   112233578899999999888899999999999999999999999975421      1


Q ss_pred             HHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 018702          287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM----TEVVKM  341 (351)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~----~e~l~~  341 (351)
                      .........          ....+...++.+.+++.+||+.+|++|||+    ++++++
T Consensus       229 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 LTFQKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            111111111          011233445789999999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-39  Score=287.95  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|.+......  ....+.+|+.++++++|+|++++++++...  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            47888999999999999999975 5788999998654322  223466899999999999999999998754  568999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+.+ +|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+....
T Consensus        87 ~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          87 MEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            999964 898888643   35689999999999999999999999   99999999999999999999999999998654


Q ss_pred             cccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc----
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE----  299 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  299 (351)
                      ..... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.......   ...............    
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchh
Confidence            33211 122235788999998865 567899999999999999999999996532211   111111110000000    


Q ss_pred             ---------eecccc-CC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          300 ---------YVIDTS-LE---GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       300 ---------~~~~~~-~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                               ...... ..   ......++.+.+++.+||+.||++|||+.|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                     000000 00   00111356788999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=284.52  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=199.4

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      |+..+.||+|++|.||++... +++.+++|.+......  ....+..|+..+++++|||++++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456778999999999999875 6788999998765333  3456888999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++ +|.+++...   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            75 888888642   25789999999999999999999998   999999999999999999999999999876654431


Q ss_pred             cccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc--------
Q 018702          229 HVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE--------  299 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  299 (351)
                       ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+.   ..............        
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence             11223477889999998776 789999999999999999999999865332110   00000000000000        


Q ss_pred             ------eec---cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 ------YVI---DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ------~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                            ...   +..........+.++.+++.+||+.||.+||++++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                  000   000011223456789999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=276.33  Aligned_cols=240  Identities=23%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhH---HHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVD---RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|...++||+|.||+|.+++.+ .++.+|+|++++...-..   ..-..|-++|...+||.+..+.-.|+..+..|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            46788899999999999999865 578899999987543222   23456889999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||.+||.|.-+|.    ....+++...+..-..|+.||.|||++   +|++||||.+|.|+|.+|++||+|||+++.--.
T Consensus       248 eyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  248 EYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            9999999998887    456788899999999999999999999   999999999999999999999999999974322


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       ......+.||||.|+|||++....|..+.|.|.+|+++|||++|+.||....-+.   +   +.-.....         
T Consensus       321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---L---FeLIl~ed---------  384 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---L---FELILMED---------  384 (516)
T ss_pred             -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---H---HHHHHhhh---------
Confidence             2234567899999999999999999999999999999999999999996542221   1   11111110         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP  333 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp  333 (351)
                       ...|...++++..|+..+|.+||.+|.
T Consensus       385 -~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 -LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence             124556668899999999999999996

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.9e-39  Score=283.06  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCceEEEEEEE----CCCCEEEEEEecCCCh----hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGTT----EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      +|+..+.||+|++|.||++..    .+++.+|+|.+.....    ...+.+.+|+.++.++ +|||++++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999874    3567899999865321    2234578899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++||||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            999999999999999863    35688899999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccccccccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ..............++..|+|||.+.+..  .+.++|+||||+++|+|++|..||......  ..............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~---  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK---  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC---
Confidence            65443322222345788999999987654  788999999999999999999998542111  11111111111110   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                             ...+...+..+.+++.+||+.||++|||+.++.+.|+-
T Consensus       229 -------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 -------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                   11233345678999999999999999998877666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=293.05  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=195.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----Cee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----QYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  141 (351)
                      +.+|+..+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            457999999999999999999864 67899999986432 23345678899999999999999999886543     357


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++++||+.+ +|.+.+.     ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999964 8888774     35689999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCccccc--ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc---
Q 018702          222 LMEAEKTH--VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD---  295 (351)
Q Consensus       222 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  295 (351)
                      ........  ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......   ...........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence            65432211  1123457899999998654 568999999999999999999999996532111   00000000000   


Q ss_pred             ---------Cccceecc----ccC--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 ---------KREEYVID----TSL--EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ---------~~~~~~~~----~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                               ........    ...  .......+..+.+++.+||+.+|++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     00000000    000  00111235679999999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.5e-39  Score=282.76  Aligned_cols=255  Identities=18%  Similarity=0.262  Sum_probs=183.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC----CEEEEEEecCCChhh--H---------HHHHHHHHHhhcCCCCceeeeeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS----TAFAVKRLHRGTTEV--D---------RGFERELEAMGDIKHRNIVTLHGY  134 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~e~~~l~~l~h~niv~~~~~  134 (351)
                      .+|.+.+.||+|+||.||+|...++    ..+++|.........  .         .....+...+..++|+|++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999997553    445666533222111  1         112234455667789999999987


Q ss_pred             EecCC----eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 018702          135 YTSSQ----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM  210 (351)
Q Consensus       135 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~  210 (351)
                      +....    ..+++++++. .++.+.+..    ....++..+..++.|++.|++|||+.   +++||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            65433    3467777763 467666642    22356778899999999999999998   999999999999999999


Q ss_pred             ceEEeeeccccccCcccc------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc
Q 018702          211 EARVSDFGLATLMEAEKT------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK  284 (351)
Q Consensus       211 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  284 (351)
                      .++|+|||+++.......      .......||+.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999976542211      11122458999999999999999999999999999999999999997642111100


Q ss_pred             ---HHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          285 ---LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       285 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                         ..++........ .          ...+.++.+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~~~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIKRLHEGK-I----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHHHhhhhh-h----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence               001111111110 0          01122477999999999999999999999998764

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-39  Score=291.26  Aligned_cols=267  Identities=25%  Similarity=0.350  Sum_probs=204.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----eeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----YNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  142 (351)
                      +|+..+.||+|++|.||+|... ++..+++|++....  ....+.+.+|+..++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999975 47889999987644  334567889999999999999999999987765     789


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||++ ++|.+++..    ...+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 489888863    34789999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccc--cccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          223 MEAEKT--HVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       223 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ......  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||........   ..............
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChh
Confidence            554321  112233578899999999877 889999999999999999999999966432110   00000000000000


Q ss_pred             ------------eec------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccccc
Q 018702          300 ------------YVI------DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIKSE  348 (351)
Q Consensus       300 ------------~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~~~  348 (351)
                                  ...      ...........+..+.+++.+||+.+|++|||+.+++.+  ++.++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                        000      000001122245779999999999999999999999985  5554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=276.05  Aligned_cols=241  Identities=24%  Similarity=0.306  Sum_probs=186.7

Q ss_pred             CcccccCceEEEEEEEC-CCCEEEEEEecCCChhh---HHHHHHHHHH-hhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEV---DRGFERELEA-MGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|++|.||+|... +++.||+|.+.......   ...+..|... ....+|||++++++.+...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999874 57889999986543221   2234445444 3455899999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            999999963    35688999999999999999999998   999999999999999999999999998875433     


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ............. .  .   ...+
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-~--~---~~~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRRIN-W--P---EEVK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcccC-C--C---Cccc
Confidence            1223478899999999888899999999999999999999999964321      1111221111100 0  0   0112


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ...+..+.+++.+||+.||++|||+.++.+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            234578999999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-38  Score=275.69  Aligned_cols=243  Identities=25%  Similarity=0.293  Sum_probs=188.8

Q ss_pred             cCCCCCCcc--cccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVI--GSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.+  |+|+||.||++... ++..+++|.+........     |+.....+ +|||++++++.+...+..++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            456666665  99999999999864 577899998865322211     22222212 6999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccccC
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLME  224 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~  224 (351)
                      ||+++++|.+++..    ...+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++ .++++|||++....
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            99999999999973    34789999999999999999999998   999999999999999988 99999999987554


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ...     ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+. .....+.... . .        
T Consensus       162 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~-~--------  225 (267)
T PHA03390        162 TPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q-K--------  225 (267)
T ss_pred             CCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c-c--------
Confidence            322     2347889999999998899999999999999999999999997442221 1111121111 0 0        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPT-MTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~e~l~~  341 (351)
                       ....+...+..+.+++.+||+.+|.+||+ +++++++
T Consensus       226 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 -KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence             01123345578999999999999999996 5888753

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-38  Score=281.76  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=196.7

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |+..+.||+|+||.||++... ++..+++|.+....   ......+.+|+..++.++|||++++++++.+++..+++|||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667788999999999999864 57889999986432   23335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +.+ +|.+.+..   ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus       107 ~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         107 CLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            975 77777653   235588999999999999999999998   9999999999999999999999999988654322 


Q ss_pred             ccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          228 THVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                          ....+++.|+|||.+.   .+.++.++|+||||+++|+|++|..||......      ............      
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~------  242 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP------  242 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccCC------
Confidence                2234788999999873   467889999999999999999999998543111      111111111100      


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                        ...+...+..+.+++.+||+.+|.+||++.++++++..+
T Consensus       243 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         243 --TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             --CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence              011223446799999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.7e-39  Score=278.83  Aligned_cols=242  Identities=24%  Similarity=0.395  Sum_probs=194.1

Q ss_pred             ccccCceEEEEEEECC-CCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVND-STAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|+||.||++...+ ++.+++|.+.....   ...+.+.+|++.+++++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999864 88999999876543   3445688999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc-----
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-----  228 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----  228 (351)
                      .+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999973    34689999999999999999999998   999999999999999999999999999875433211     


Q ss_pred             --cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          229 --HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       229 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                        .......++..|+|||...+..++.++|+||||+++|+|++|..||.....      ........... ..       
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~-------  219 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGK-IE-------  219 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-cC-------
Confidence              112234578899999999888899999999999999999999999865421      11122211111 00       


Q ss_pred             CCCCHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          307 EGCPIN--EINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       307 ~~~~~~--~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                        .+..  .+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus       220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         220 --WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence              1111  257899999999999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-39  Score=290.97  Aligned_cols=263  Identities=22%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEec----CCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTS----SQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  141 (351)
                      ..+|+..+.||+|++|.||+|... ++..|++|++.....  ...+.+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999865 588999999875432  334567789999999999999999998753    3467


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+. ++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 58999886    345589999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCccccc---ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          222 LMEAEKTH---VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       222 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........   ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCCh
Confidence            65432221   1123457889999998765 5688999999999999999999999965322110   000000000000


Q ss_pred             ------------ccee------ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          298 ------------EEYV------IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       298 ------------~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                                  ....      .+..........+.++.+++.+||+.+|++|||+.+++.+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                        0000      00000001123457899999999999999999999998753

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-38  Score=283.43  Aligned_cols=258  Identities=19%  Similarity=0.275  Sum_probs=189.9

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      +.+|.|+++.|+++.. +++.+|+|++...  .....+.+.+|+..++.++||||+++++++.+.+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3344555555555443 5888999998764  334456789999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc-----
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-----  228 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----  228 (351)
                      .+++....  ...+++.....++.|+++||+|||+.   +++|+||||+||+++.++.++++|||.+........     
T Consensus        87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            99997542  34578889999999999999999998   999999999999999999999999998865432211     


Q ss_pred             -cccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh-----------
Q 018702          229 -HVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ-----------  294 (351)
Q Consensus       229 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  294 (351)
                       .......++..|+|||.+.+  ..++.++|+||+|+++|+|++|..||.......  ...........           
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence             11122346778999999865  458899999999999999999999997532111  00000000000           


Q ss_pred             -cCcc--------ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 -DKRE--------EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 -~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ....        ...........+...+.++.+++.+||+.||++|||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             0000        0000000012234456788999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.2e-39  Score=283.32  Aligned_cols=263  Identities=26%  Similarity=0.315  Sum_probs=197.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC------
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  139 (351)
                      ..+|+..+.||+|++|.||+|..+ +++.|++|.++....  .....+.+|+.+++.++|||++++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            457888999999999999999985 578899999875432  23345778999999999999999999987654      


Q ss_pred             ----eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          140 ----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       140 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                          ..++++||+++ ++..++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence                78999999976 777777532   34689999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      |||.+...............++..|+|||.+.+ ..++.++||||||+++|+|++|++||......   .....+.....
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~  235 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCG  235 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence            999997654433222222235778999998764 45788999999999999999999999653211   11111111111


Q ss_pred             cCcccee-----------cc------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYV-----------ID------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~-----------~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .......           .+      ..........+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1100000           00      00000111235779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-40  Score=296.60  Aligned_cols=274  Identities=25%  Similarity=0.345  Sum_probs=208.5

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC------eeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------YNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~  142 (351)
                      -|...+.||+|+||.||+|++ ..|+.||||.+.... ....+...+|++++++++|||||++.++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355667899999999999995 568999999987643 334456789999999999999999999854433      458


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCC--ceEEeeec
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD--QNM--EARVSDFG  218 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~--~~~--~~kl~dfg  218 (351)
                      ++||||.||||...++... +...+++...+.+..++..||.|||++   +|+||||||.||++-  ++|  ..||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            9999999999999998665 567799999999999999999999998   999999999999994  233  37999999


Q ss_pred             cccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      .|+......  ......||+.|++||.... +.|+..+|.|||||++|+++||..||.............|....-....
T Consensus       170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            999765544  4566789999999999984 8899999999999999999999999976543332222333222222111


Q ss_pred             cceecccc---------CCCCC----HHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhccccccC
Q 018702          298 EEYVIDTS---------LEGCP----INEINDVFSIASMCLEPEPSKRP--TMTEVVKMLELIKSEKV  350 (351)
Q Consensus       298 ~~~~~~~~---------~~~~~----~~~~~~l~~li~~cl~~~p~~Rp--s~~e~l~~L~~~~~~~~  350 (351)
                      .....++.         ..+.|    ......+-..+..+|..+|++|.  ...+....+..+.+..|
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v  315 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV  315 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence            11111100         00122    22334456778889999999999  77777777777665544

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.3e-39  Score=286.71  Aligned_cols=262  Identities=23%  Similarity=0.296  Sum_probs=196.5

Q ss_pred             cCCC-CCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhh--------------HHHHHHHHHHhhcCCCCceeeeee
Q 018702           70 LKFS-SKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEV--------------DRGFERELEAMGDIKHRNIVTLHG  133 (351)
Q Consensus        70 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~  133 (351)
                      .+|. ..+.||+|+||.||+|... +++.||+|.+.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3554 3567999999999999865 68899999986543221              124678999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       134 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                      ++...+..+++|||+. |+|.+++.    ....+++.....++.|++.|++|||+.   +++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999996 59999986    345688999999999999999999998   999999999999999999999


Q ss_pred             EeeeccccccCccc-------------ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchh
Q 018702          214 VSDFGLATLMEAEK-------------THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFL  279 (351)
Q Consensus       214 l~dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  279 (351)
                      |+|||++.......             ........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999987654111             0111122367889999988764 468999999999999999999999965432


Q ss_pred             cccccHHHHHHHHHhcCccce---------------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          280 EEGTKLVTWVKAVMQDKREEY---------------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      .+   ................               .............+.++.+++.+||+.+|++|||++|++.+-
T Consensus       240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            11   1111111111110000               000000011123356789999999999999999999998753

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7e-39  Score=287.67  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=195.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecC--CeeE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSS--QYNL  142 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~  142 (351)
                      ..+|+..+.||+|+||.||+|... +++.+++|++...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            357888899999999999999975 5788999988542  223334577899999999 999999999998653  4679


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||++ ++|.+++..     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 599998853     2678889999999999999999998   999999999999999999999999999976


Q ss_pred             cCcccc----cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc-HHH--------H
Q 018702          223 MEAEKT----HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK-LVT--------W  288 (351)
Q Consensus       223 ~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~--------~  288 (351)
                      ......    .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......... ...        .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            543322    12223457889999998754 567889999999999999999999996432111000 000        0


Q ss_pred             HHHH---HhcCccceecc---ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          289 VKAV---MQDKREEYVID---TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       289 ~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....   ...........   ..........+..+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000   00000000000   00001111245789999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.1e-38  Score=282.34  Aligned_cols=255  Identities=22%  Similarity=0.349  Sum_probs=191.2

Q ss_pred             ccccc--CceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           77 VIGSG--GFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        77 ~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .||+|  +||+||++.+. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++++||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  89999999874 68999999986533  233467889999999999999999999999999999999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc-
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-  230 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-  230 (351)
                      +|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+.......... 
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999987542  34588889999999999999999998   99999999999999999999999998653222111100 


Q ss_pred             -----cccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC-------
Q 018702          231 -----STIVAGTFGYLAPEYFDTG--RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK-------  296 (351)
Q Consensus       231 -----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  296 (351)
                           .....++..|+|||++.+.  .++.++|+||||+++|+|++|..||........     .........       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~  234 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-----LLQKLKGPPYSPLDIT  234 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-----HHHHhcCCCCCCcccc
Confidence                 1112346679999998763  478999999999999999999999965421110     000000000       


Q ss_pred             ----------------------------ccceeccccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 ----------------------------REEYVIDTSL-EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 ----------------------------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                                  ......+... ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                        0000000000 11234466789999999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-39  Score=289.59  Aligned_cols=248  Identities=27%  Similarity=0.397  Sum_probs=207.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhh--HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEV--DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ...|.+.+.||+|.|+.|.++.+. .+..||+|.+.+.....  .+.+.+|+++|..++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            346888999999999999999864 68889999997754332  245889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+.+|.+.+++.+    ...+.+..+...+.|+.+|++|||++   +|+|||||++|||++.+.++||+|||++..+..
T Consensus       135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999984    44566688899999999999999999   999999999999999999999999999998763


Q ss_pred             ccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .  ....+.+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||.+.......      .++...+        
T Consensus       208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------~rvl~gk--------  271 (596)
T KOG0586|consen  208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------PRVLRGK--------  271 (596)
T ss_pred             c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------chheeee--------
Confidence            3  33456789999999999998766 57999999999999999999999765432211      1111111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        -..|...+.++.++++++|-.+|.+|++.+++.+.
T Consensus       272 --~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  272 --YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             --ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence              02344445778999999999999999999998765

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-38  Score=277.84  Aligned_cols=242  Identities=25%  Similarity=0.366  Sum_probs=188.2

Q ss_pred             cccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHH---HHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           77 VIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERE---LEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .||+|+||.||++... +++.||+|.+......   ....+..|   ...++..+|||++.+.+.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 5788999988654221   11223333   334555679999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      |++|.+++.    ....+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            999999886    345689999999999999999999998   999999999999999999999999999875433221 


Q ss_pred             ccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                        ....|+..|+|||.+.++ .++.++|+||+|+++|+|++|..||........   .. ........      +   ..
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~---~~-~~~~~~~~------~---~~  217 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-IDRMTLTM------A---VE  217 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch---HH-HHHHhhcc------C---CC
Confidence              233589999999998754 689999999999999999999999965421111   11 11111100      0   11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                      .+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            2333457899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=321.63  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=203.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+-+++....||.|.||.||.+.. ++|.-.|+|.+......  ....+.+|..++..++|||+|+++|+-.+.+..++.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            445778888999999999999886 45677899987654333  234678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      ||||++|+|.+.+..    ....++.....+..|++.|++|||+.   |||||||||+||+++.+|.+|++|||.+....
T Consensus      1313 MEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999973    33355666677889999999999999   99999999999999999999999999998776


Q ss_pred             ccccc---ccccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          225 AEKTH---VSTIVAGTFGYLAPEYFDTG---RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       225 ~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +....   ..+...||+.|||||++.+.   ...-+.||||+||++.||+||+.||.....+  ..++   -.+-...  
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIM---y~V~~gh-- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIM---YHVAAGH-- 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHH---hHHhccC--
Confidence            54311   22345799999999999653   4567899999999999999999998654221  1111   1111111  


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                             ....|...+.+-++++.+||..||..|+++.|++++
T Consensus      1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   123577788899999999999999999999998875

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=277.30  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=194.0

Q ss_pred             CCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChh--hHHHHHHHHHHhhcC---CCCceeeeeeEEecCCe-----
Q 018702           72 FSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTE--VDRGFERELEAMGDI---KHRNIVTLHGYYTSSQY-----  140 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  140 (351)
                      |+..+.||+|++|.||+|..+. ++.+|+|.+......  ....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567889999999999999864 889999999754322  233456677766555   69999999999987776     


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+++|||+++ +|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 8998886432  23589999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc-
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE-  299 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  299 (351)
                      .........  ....++..|+|||.+.+..++.++|+||||+++|+|++|.+||......+.  ............... 
T Consensus       155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  230 (287)
T cd07838         155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW  230 (287)
T ss_pred             eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence            765433221  223468899999999988999999999999999999999999865432111  111111000000000 


Q ss_pred             ------------eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 ------------YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                  ..............+..+.+++.+||+.||++||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                        000000011123345778999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-39  Score=284.62  Aligned_cols=262  Identities=21%  Similarity=0.300  Sum_probs=193.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-------  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  139 (351)
                      .+|+..+.||+|+||.||++... +++.||+|.+.....  .....+.+|+.++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            47888999999999999999975 578899998865322  22335678999999999999999999986554       


Q ss_pred             -eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          140 -YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       140 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                       ..+++|||+. ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence             4499999996 4888887532   24689999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCccccc---ccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          219 LATLMEAEKTH---VSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       219 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ++.........   ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........   .........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~~~  241 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQLCG  241 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence            99765432211   11223467889999988654 478899999999999999999999865432111   111111110


Q ss_pred             cCccce-------------eccccCC-C-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEY-------------VIDTSLE-G-----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~-------------~~~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......             ....... .     .+...+..+.+++.+||+.||.+|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000             0000000 0     011123567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=269.05  Aligned_cols=255  Identities=24%  Similarity=0.303  Sum_probs=200.7

Q ss_pred             HhcCCCCC-CcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEec----CCe
Q 018702           68 KTLKFSSK-DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTS----SQY  140 (351)
Q Consensus        68 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  140 (351)
                      .+++|++. ++||-|-.|.|..+..+ +++.+|+|++...     ....+|++.--.. .|||||.++++|.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            44566654 57999999999998865 5778999988642     2345777765555 59999999999764    346


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeee
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDF  217 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~df  217 (351)
                      +.+|||.++||.|.+.+...  ..+.+++.++..|++||+.|+.|||+.   +|.||||||+|+|.+.   |..+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            67899999999999999865  356799999999999999999999999   9999999999999975   556999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      |+++....  .....+.+-||.|.|||++....|+..+|+||+|+++|-|++|.+||.....   ..+..-.+..+....
T Consensus       209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ  283 (400)
T ss_pred             ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC
Confidence            99986543  2334556789999999999999999999999999999999999999976432   222222222222211


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      .++     ..+-+...+++..++|+.+|+.+|++|.|+.+++++=
T Consensus       284 y~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  284 YEF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             ccC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            111     1123567789999999999999999999999998753

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-38  Score=279.08  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=195.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTT-EVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|++|.||+|..++ ++.+|+|.+..... .....+..|+..+.+.. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            467888999999999999999875 78899999875432 33455677777776665 9999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+. ++|.++....   ...+++..+..++.|++.|++|||+.  .+++|+||+|+||++++++.++|+|||++......
T Consensus        95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            985 4777776532   34688999999999999999999973  28999999999999999999999999998765432


Q ss_pred             cccccccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGR----ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ...  ....++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||......     ..............   
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~---  238 (296)
T cd06618         169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEPPS---  238 (296)
T ss_pred             Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCCCC---
Confidence            221  2224678999999987553    788999999999999999999998542111     11122222211110   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                         . ......+.++.+++.+||..||++|||+.+++++-.
T Consensus       239 ---~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         239 ---L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             ---C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence               0 011123477999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-39  Score=267.66  Aligned_cols=272  Identities=22%  Similarity=0.316  Sum_probs=201.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC---C--CCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEec-C
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN---D--STAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTS-S  138 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~  138 (351)
                      +....|+....||+|+||.||++.-+   +  +..+|+|+++....  .......+|+..++.++|||++.+..++.+ +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34457899999999999999999532   2  33689999976532  223456799999999999999999999877 8


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----CceE
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSV-NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN----MEAR  213 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~----~~~k  213 (351)
                      ...++++||.+. +|...++-.+. ..+.++...+.++..||+.|+.|||++   -|.||||||.|||+..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence            899999999987 88888864332 345788889999999999999999999   89999999999999877    9999


Q ss_pred             EeeeccccccCccccc--ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc---HHH
Q 018702          214 VSDFGLATLMEAEKTH--VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK---LVT  287 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~  287 (351)
                      |+|||+++.+.+.-..  ....++.|.+|.|||.+.+ ..|+.+.|||++|||+.||++..+.|..........   ..+
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            9999999988765332  3445678999999998876 578999999999999999999988886533221111   000


Q ss_pred             HHH---HHHhcCccceecc-------------cc---CCCC--------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          288 WVK---AVMQDKREEYVID-------------TS---LEGC--------PINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       288 ~~~---~~~~~~~~~~~~~-------------~~---~~~~--------~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      .+.   +++.-.......+             ..   ...+        ...-++...+|+.+||..||-+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            111   1111110000000             00   0000        0001233889999999999999999999987


Q ss_pred             HH
Q 018702          341 ML  342 (351)
Q Consensus       341 ~L  342 (351)
                      +.
T Consensus       337 h~  338 (438)
T KOG0666|consen  337 HP  338 (438)
T ss_pred             cc
Confidence            64

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=303.38  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=208.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC----C----CCEEEEEEecCCChh-hHHHHHHHHHHhhcCC-CCceeeeeeEEecCCe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN----D----STAFAVKRLHRGTTE-VDRGFERELEAMGDIK-HRNIVTLHGYYTSSQY  140 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  140 (351)
                      +..+.+.||+|.||.|++|...    .    ...||||.++..... ..+.+..|+++|+.+. ||||+.++|+|...+.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            3455669999999999998742    1    346999999865444 4467899999999995 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCC---C-C------C--CCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 018702          141 NLLIYELMPNGSLDTFLHGKS---V-N------K--KNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ  208 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~---~-~------~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~  208 (351)
                      .++++||+..|+|.+|++..+   . .      .  ..++..+.+.++.||+.||+||++.   +++||||.++|||+++
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence            999999999999999998655   0 0      1  2388999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccccccCccccccccccc--ccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          209 NMEARVSDFGLATLMEAEKTHVSTIVA--GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       209 ~~~~kl~dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +..+||+|||+++..............  -+..|||||.+....|+.++||||||+++||+++ |..||.....  ... 
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~-  530 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE-  530 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH-
Confidence            999999999999865554444322222  3556999999999999999999999999999999 9999865210  111 


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                        . .+.+.+        ......|..++.++++++..||+.+|++||++.++.+.++..
T Consensus       531 --l-~~~l~~--------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 --L-LEFLKE--------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --H-HHHHhc--------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              1 112211        111234777779999999999999999999999999999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-38  Score=274.25  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=197.0

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCC-----ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRG-----TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     .......+..|+.+++.++|||++++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998653 344555555431     112233566789999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      +||+++++|.+++.........+++..+..++.|++.|+.|||+.   +++|+||+|+||++++ +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865433456789999999999999999999998   9999999999999975 569999999987653


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......+++.|+|||...+..++.++|+||||+++|+|++|..||....      ...........         
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~---------  220 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG---------  220 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC---------
Confidence            3221 1223457889999999988888999999999999999999999985421      11111111111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....+...+.++.+++.+||+.+|++||++.|++++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            1112344556789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.1e-38  Score=282.06  Aligned_cols=264  Identities=24%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec-CCe
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS-SQY  140 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  140 (351)
                      ++..+++|+..+.||+|+||.||++... ++..+|+|++....  ....+.+.+|+++++.++|||++++.+++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456778999999999999999999865 68889999886432  2334567889999999999999999999865 557


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .++++||+ +++|.+++.     ...++......++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||.+
T Consensus        85 ~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            88999998 568988885     34577888889999999999999998   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc---------HHHHHH
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK---------LVTWVK  290 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------~~~~~~  290 (351)
                      .......    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........         ..++..
T Consensus       156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            7543221    22346788999998765 578999999999999999999999996532211000         000111


Q ss_pred             HHHhcCccceeccccC-CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          291 AVMQDKREEYVIDTSL-EGCP-----INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ................ ...+     ...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000000000 0011     1234789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=286.82  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             hHHHHHHhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC
Q 018702           62 SDAIFKKTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS  138 (351)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  138 (351)
                      ...+...+.+|+..+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++++++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            445666778999999999999999999986 467889999987542  22345678899999999999999999987543


Q ss_pred             ------CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          139 ------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       139 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                            ...+++++++ +++|.+++.     ...+++..+..++.|+++|++|||+.   +++|+||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence                  3467888887 789988875     34588999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH-H----
Q 018702          213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL-V----  286 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~----  286 (351)
                      +|+|||++......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........... .    
T Consensus       160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999998754322    122357889999998765 5688999999999999999999999964321110000 0    


Q ss_pred             ----HHHHHHHhcCc------cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          287 ----TWVKAVMQDKR------EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       287 ----~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ...........      ................+..+.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                00000000000      00000000001111234678999999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=276.89  Aligned_cols=262  Identities=21%  Similarity=0.330  Sum_probs=195.8

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      |+..+.||+|++|+||+|... +++.+++|++...... ......+|+..+++++ |||++++++++...+..+++|||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566788999999999999985 4678999998654332 2234567899999999 999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                       +|+|.+++....  ...+++..+..++.|++.++.|||++   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             789999886432  34689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             cccccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc----------cHHHHHHHHHhcCc
Q 018702          229 HVSTIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT----------KLVTWVKAVMQDKR  297 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~~  297 (351)
                      .  ....++..|+|||.+. ...++.++|+||||+++++|++|++||......+..          ....|.........
T Consensus       155 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 Y--TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             c--CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            1  2234788999999874 456789999999999999999999998654221100          00001111110000


Q ss_pred             cceecccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTS----LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........    ........+.++.+++.+||+.+|++|||++|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000    001111224679999999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-38  Score=283.47  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=197.8

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-
Q 018702           64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-  139 (351)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  139 (351)
                      ++.....+|+..+.||+|+||.||++... ++..||+|++....  ......+.+|+.+++.++||||+++.+++..+. 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            34456678999999999999999999864 68889999986432  223456789999999999999999999987554 


Q ss_pred             -----eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          140 -----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       140 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                           ..+++|||+ +++|.+++.     ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+++
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl  159 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI  159 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence                 458999998 779988875     34688999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc---------c
Q 018702          215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT---------K  284 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------~  284 (351)
                      +|||++.......    ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.........         .
T Consensus       160 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         160 LDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             eecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999987543321    22346889999998865 46889999999999999999999999753211000         0


Q ss_pred             HHHHHHHHHhcCccce------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          285 LVTWVKAVMQDKREEY------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       285 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ...+............      .............+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000000000      0000000111234467899999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.9e-37  Score=275.43  Aligned_cols=244  Identities=29%  Similarity=0.435  Sum_probs=192.4

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |...+.||+|+||.||+|... ++..+++|.+.....   .....+.+|+..++.++|||++++.+++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555677999999999999874 578899999864322   2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +. +++.+++..   ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-  174 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-  174 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence            96 578777753   234688999999999999999999998   9999999999999999999999999988643221 


Q ss_pred             ccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          228 THVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                          ....++..|+|||.+.   ...++.++|+||||+++|+|++|..||.....      ..............     
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~~-----  239 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDSPT-----  239 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC-----
Confidence                2345788999999984   45688899999999999999999999855321      11111111111100     


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ......+..+.+++.+||+.+|.+||++.+++++
T Consensus       240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0112233568999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-38  Score=284.33  Aligned_cols=265  Identities=25%  Similarity=0.336  Sum_probs=195.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC------C
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS------Q  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  139 (351)
                      ..+|...+.||+|+||.||+|... +++.+|+|++....  ......+.+|+.+++.++||||+++.+++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468888999999999999999864 68899999986532  22334678999999999999999999998654      3


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..++++||+.. +|..+..      ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999864 7777652      3578899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH--------HHH
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT--------WVK  290 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~  290 (351)
                      +.......    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.............        .+.
T Consensus       164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            87543221    22346889999998865 468899999999999999999999997532111000000        000


Q ss_pred             HHHhcCc-cce------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcccc
Q 018702          291 AVMQDKR-EEY------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIKS  347 (351)
Q Consensus       291 ~~~~~~~-~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~~  347 (351)
                      ....... ...      .............+..+.+++.+||+.||.+|||+++++.+  ++.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000000 000      00000000011234678999999999999999999999965  555543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-38  Score=286.98  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=193.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC----------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS----------  138 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------  138 (351)
                      .+|+..+.||.|+||.||+|... ++..|++|.+........+.+.+|+++++.++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57889999999999999999875 5788999998776655566788999999999999999999776543          


Q ss_pred             ----CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceE
Q 018702          139 ----QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEAR  213 (351)
Q Consensus       139 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~k  213 (351)
                          ...+++|||++ ++|.+++.     ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++. ++.++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence                35789999996 58988884     34588999999999999999999998   9999999999999974 56789


Q ss_pred             EeeeccccccCcccccc--cccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH
Q 018702          214 VSDFGLATLMEAEKTHV--STIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      ++|||.+..........  .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........  ......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~  233 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILE  233 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            99999987654322111  122346889999997644 5688899999999999999999999965321110  000000


Q ss_pred             -----------HHHhcCccceeccccC-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          291 -----------AVMQDKREEYVIDTSL-----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       291 -----------~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                 ................     .......+.++.+++.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                       0000000000000000     00112244678999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.9e-38  Score=276.67  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=196.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .|+..+.||+|++|.||+|... ++..+++|.+...   .......+.+|+++++.++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666778999999999999975 5678999988642   22334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+. |++.+++..   ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 588777653   234578899999999999999999998   9999999999999999999999999998755432


Q ss_pred             cccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .     ...+++.|+|||.+.   ...++.++||||||+++|+|++|..||......      ............     
T Consensus       169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~-----  232 (308)
T cd06634         169 N-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-----  232 (308)
T ss_pred             c-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcCCC-----
Confidence            2     234788999999874   356788999999999999999999998543111      111111111100     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                         ...+...+..+.+++.+||+.+|.+||++.+++++.....
T Consensus       233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence               0112234577899999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.5e-39  Score=304.74  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=185.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEec----------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTS----------  137 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  137 (351)
                      .+|+..++||+||||.||+++++ ||+.||||++.... ......+.+|+..+.+++|||||+++..|.+          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            35677789999999999999976 89999999997754 2334568899999999999999998643200          


Q ss_pred             --------------------------------------------------------------------------------
Q 018702          138 --------------------------------------------------------------------------------  137 (351)
Q Consensus       138 --------------------------------------------------------------------------------  137 (351)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 018702          138 ---------------------S--------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH  188 (351)
Q Consensus       138 ---------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  188 (351)
                                           +        ...|+-||||+..++.+++..+....   .....++++++|++|+.|+|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHh
Confidence                                 0        12367788888877777776432111   466789999999999999999


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC--------------c---ccccccccccccccccCcccccCC--
Q 018702          189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME--------------A---EKTHVSTIVAGTFGYLAPEYFDTG--  249 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~--------------~---~~~~~~~~~~~~~~y~aPE~~~~~--  249 (351)
                      +   |++||||||.|||+++++.|||+|||+++...              .   ......+...||.-|+|||++.+.  
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            9   99999999999999999999999999998621              0   001122345699999999999764  


Q ss_pred             -CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCC
Q 018702          250 -RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPE  328 (351)
Q Consensus       250 -~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  328 (351)
                       .|+.|+|+||||++++||+.   ||.+...        -+.....-+ ...+..+  .....+..+.-.++|.+|++.|
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~iL~~LR-~g~iP~~--~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RASILTNLR-KGSIPEP--ADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHH--------HHHHHHhcc-cCCCCCC--cccccccchHHHHHHHHHhcCC
Confidence             49999999999999999986   4654321        111111111 1111111  1223333455678999999999


Q ss_pred             CCCCCCHHHHHH
Q 018702          329 PSKRPTMTEVVK  340 (351)
Q Consensus       329 p~~Rps~~e~l~  340 (351)
                      |.+||||.|+|+
T Consensus       859 P~kRPtA~eLL~  870 (1351)
T KOG1035|consen  859 PSKRPTATELLN  870 (1351)
T ss_pred             CccCCCHHHHhh
Confidence            999999999986

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=268.88  Aligned_cols=239  Identities=28%  Similarity=0.366  Sum_probs=194.3

Q ss_pred             ccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      ||+|++|.||++... +++.+++|.+.....   .....+..|+.+++.++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999975 478899999876432   2345788999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI  233 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  233 (351)
                      .+++..    ...+++.....++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT  152 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence            999973    34689999999999999999999998   999999999999999999999999999876543321 1223


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       234 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      ..++..|+|||...+...+.++|+||||+++|++++|..||.....      ...........          ...+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP----------LRFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC----------CCCCCCC
Confidence            4578899999999888889999999999999999999999954321      11111111110          1123333


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH---HHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPTM---TEVVK  340 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~---~e~l~  340 (351)
                      +..+.+++.+||..||++|||+   .++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            5788999999999999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=274.50  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      |+..+.||+|++|.||+|... +++.+++|.+....  ....+.+..|+..++.++|||++++.+++.+.+..++++||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999976 48899999987653  333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      + ++|.+++....   ..+++..+..++.|++.|+++||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 59999997431   4689999999999999999999998   999999999999999999999999999876544322


Q ss_pred             cccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc-cHH--------HHHHHHHhcCcc
Q 018702          229 HVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT-KLV--------TWVKAVMQDKRE  298 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~--------~~~~~~~~~~~~  298 (351)
                      . .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||......... .+.        ............
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            1 1223357789999998766 7899999999999999999999998654321110 000        000000000000


Q ss_pred             ceeccc----cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDT----SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......    .........+..+.+++.+||+.||++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000    0000011225679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.4e-38  Score=280.06  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=191.5

Q ss_pred             CCCCCCcccccCceEEEEEEECC---CCEEEEEEecCCC--hhhHHHHHHHHHHhhcC-CCCceeeeeeEEec----CCe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND---STAFAVKRLHRGT--TEVDRGFERELEAMGDI-KHRNIVTLHGYYTS----SQY  140 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  140 (351)
                      +|+..+.||+|+||.||++....   +..+|+|++....  ....+.+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            46777889999999999999753   6789999886532  22345678899999999 59999999987532    245


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+++++++. ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            688889885 68999886    345689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCccccc---ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc---------cHHH
Q 018702          221 TLMEAEKTH---VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT---------KLVT  287 (351)
Q Consensus       221 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------~~~~  287 (351)
                      .........   ......|++.|+|||...+ ..++.++|+||+|+++|+|++|.+||.........         ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            765432211   1123458899999998765 56899999999999999999999998653211100         0000


Q ss_pred             HHHHHHhcCccce------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          288 WVKAVMQDKREEY------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       288 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .............      .............+..+.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000000      00000001111234679999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-38  Score=284.89  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=196.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe---
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY---  140 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  140 (351)
                      ...++|+..+.||+|++|.||+|... ++..||+|++....  ....+.+.+|+.+++.++|||++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34568899999999999999999975 57889999886532  2233567789999999999999999988766554   


Q ss_pred             ---eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          141 ---NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       141 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                         .++++||+ +++|.+++.     ...+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence               89999998 679999985     35689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      |++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   ............
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~  235 (343)
T cd07851         163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTP  235 (343)
T ss_pred             ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCC
Confidence            998765432    122347889999998765 467899999999999999999999996432111   000000000000


Q ss_pred             c------------cceec------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 R------------EEYVI------DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 ~------------~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .            .....      ...........+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0            00000      000000111235789999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=266.33  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=197.0

Q ss_pred             CCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhh-cCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           73 SSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMG-DIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +....||.|+||+|++-.++ .|+..|||+++.... ...+++..|.+... .-++||||+++|.+-.++..|+.||.| 
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence            33557999999999998764 688899999987655 34456777887654 447999999999999999999999999 


Q ss_pred             CCCHHHhhcC-CCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          150 NGSLDTFLHG-KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       150 ~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      .-||+.+... .......+++...-.|+.....||.||....  .|+|||+||+|||++..|.+||||||.+..+..+..
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA  223 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA  223 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence            4588776642 1224566888888888888999999999874  999999999999999999999999999986654433


Q ss_pred             cccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          229 HVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .  +.-.|-..|+|||.+..  ..|+.+|||||||++++|+.||+.|++.-     ....+.+..+..........+.. 
T Consensus       224 k--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gdpp~l~~~~~-  295 (361)
T KOG1006|consen  224 K--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGDPPILLFDKE-  295 (361)
T ss_pred             h--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCCCCeecCccc-
Confidence            2  22357889999999854  45899999999999999999999998652     12333334444333332222211 


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ..+.+..+.+++.-||.+|.+.||+..++.++
T Consensus       296 ---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  296 ---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               23355789999999999999999999988753

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.7e-38  Score=278.66  Aligned_cols=263  Identities=23%  Similarity=0.285  Sum_probs=193.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCC------
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  139 (351)
                      ..+|+..+.||+|++|.||+|... +++.+++|++......  ....+.+|+++++.++||||+++++.+....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            357899999999999999999975 5788999988654322  2345678999999999999999999875433      


Q ss_pred             --eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          140 --YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       140 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                        ..++++||+.+ +|...+..   ....+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46999999965 77777653   234689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCccccc----------ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH
Q 018702          218 GLATLMEAEKTH----------VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV  286 (351)
Q Consensus       218 g~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  286 (351)
                      |++.........          ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||........   .
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~  236 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---L  236 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence            998754432211          1122346788999998765 4588999999999999999999999865322111   0


Q ss_pred             HHHHHHHhcCccc---------e----eccccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          287 TWVKAVMQDKREE---------Y----VIDTSLE----GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       287 ~~~~~~~~~~~~~---------~----~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .............         .    .......    .........+.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0111110000000         0    0000000    0011223678899999999999999999998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=305.58  Aligned_cols=252  Identities=26%  Similarity=0.354  Sum_probs=207.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ....+|.+.++||+|+||.|..+..+ .++.||+|++.+.   .......|..|-.+|..-+.+.|+++.-.|+++..+|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            34568999999999999999999975 5678999998762   2223345889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||++||+|-.++.+.    ..+++..+..++..+.-||.-||+.   |+|||||||+|||+|..|++||+|||.+-.
T Consensus       152 lVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             EEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence            999999999999999743    3799999999999999999999998   999999999999999999999999999988


Q ss_pred             cCcccccccccccccccccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh-cC
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFD----T-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ-DK  296 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~  296 (351)
                      ...+..-.+...+|||-|.+||++.    + +.|++.+|.||+|+++|||+.|..||.....-      ........ ..
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv------eTY~KIm~hk~  298 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV------ETYGKIMNHKE  298 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH------HHHHHHhchhh
Confidence            8777766677778999999999983    3 67999999999999999999999999764322      22222221 11


Q ss_pred             ccceeccccCCCCC--HHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 018702          297 REEYVIDTSLEGCP--INEINDVFSIASMCLEPEPSKRPT---MTEVVKM  341 (351)
Q Consensus       297 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps---~~e~l~~  341 (351)
                      ..         .+|  ...++.+.+||.+.+. +|+.|..   ++++-.+
T Consensus       299 ~l---------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  299 SL---------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hc---------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            11         122  3366889999999887 6777876   7666543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=271.66  Aligned_cols=259  Identities=23%  Similarity=0.302  Sum_probs=201.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCC--CC----ceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIK--HR----NIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~~~~~~~~~~~~  141 (351)
                      +.+|.+.+.+|+|+||.|..+.+.. +..||+|+++.- ....+...-|++++.++.  .|    -++++.++|+-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            5689999999999999999988654 578999988653 333344567899999994  23    388889999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--------------
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD--------------  207 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~--------------  207 (351)
                      |+|+|.+ |-|+.+|+..+  +..+++...++.++.|+++++++||+.   +++|-||||+|||+.              
T Consensus       167 Civfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999998 67999999876  567889999999999999999999999   999999999999993              


Q ss_pred             ------CCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc
Q 018702          208 ------QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE  281 (351)
Q Consensus       208 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  281 (351)
                            .+..++++|||.+++.....    .+...|..|.|||++.+-.++.++||||+||||.|+++|...|++....+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  13458999999998654444    34568999999999999999999999999999999999999998865322


Q ss_pred             cccHHHHHHHHHhcCc-----------------c-----------ceecccc-----CCCCCHHHHHHHHHHHHHhcCCC
Q 018702          282 GTKLVTWVKAVMQDKR-----------------E-----------EYVIDTS-----LEGCPINEINDVFSIASMCLEPE  328 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~  328 (351)
                      ..   ...........                 .           .++.+..     .....+.+...+++|+.+||..|
T Consensus       317 HL---aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  317 HL---AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             HH---HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            21   11111111100                 0           0000000     00233455677999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 018702          329 PSKRPTMTEVVKM  341 (351)
Q Consensus       329 p~~Rps~~e~l~~  341 (351)
                      |.+|+|+.|+|.+
T Consensus       394 P~~RiTl~EAL~H  406 (415)
T KOG0671|consen  394 PARRITLREALSH  406 (415)
T ss_pred             ccccccHHHHhcC
Confidence            9999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=243.31  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +|...++||+|+||+||+++.. .++-||+|+++.++.  .......+|+-+++.++|.|||++++....++..-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556678999999999999965 456799999876543  3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      |. .+|..|...   -++.++.+...+++.|+++|+.++|++   ++.|||+||.|.+++.+|.+|++|||+++.++-..
T Consensus        83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            95 488888764   356789999999999999999999999   99999999999999999999999999999877655


Q ss_pred             ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHh---cCccceec
Q 018702          228 THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ---DKREEYVI  302 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  302 (351)
                      ...+. ...|.+|.+|.++.+. -|++..|+||.||++.|+.. |++.|.+....+  ++...++..-.   +.......
T Consensus       156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCCcccc
Confidence            44333 3479999999998775 58899999999999999987 777776653322  22222222111   11111111


Q ss_pred             cccCCCCC------------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCP------------INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~------------~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      -+....+|            +.....-++++.+.|.-+|.+|.|+++.+++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            11111111            2222345789999999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=280.81  Aligned_cols=240  Identities=24%  Similarity=0.326  Sum_probs=194.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +..|.....+|.|+|+.|-.+.. .+++..++|++.....+    -.+|+.++... +|||++++.+.+.+....|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            55677788899999999988875 45778999999775222    34566666555 69999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-cCCCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL-DQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~-~~~~~~kl~dfg~~~~~~~  225 (351)
                      .+.|+-+.+-+..    .+... ..+..|+.+++.|+.|||++   |++||||||+|||+ ++.++++|+|||.++..++
T Consensus       397 ~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999888777752    22233 67778999999999999998   99999999999999 5889999999999987766


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      +    ..+.+-|..|.|||++....|++++|+||||++||+|++|+.||.....+     .+.... +...         
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~-i~~~---------  529 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTR-IQMP---------  529 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHh-hcCC---------
Confidence            5    33456789999999999999999999999999999999999999765322     111111 1111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ......+..+.+|+.+||+.||.+||++.++..+
T Consensus       530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence              1124556889999999999999999999998765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.4e-37  Score=262.25  Aligned_cols=219  Identities=23%  Similarity=0.246  Sum_probs=176.3

Q ss_pred             cCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcC
Q 018702           81 GGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHG  159 (351)
Q Consensus        81 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  159 (351)
                      |.+|.||++.+. +++.+|+|.+....     ...+|...+....|||++++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999874 67889999987643     223444555556799999999999999999999999999999999863


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccccccccc
Q 018702          160 KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG  239 (351)
Q Consensus       160 ~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  239 (351)
                          ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||.+.......    ....++..
T Consensus        79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  147 (237)
T cd05576          79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM  147 (237)
T ss_pred             ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence                34588999999999999999999998   99999999999999999999999999876543321    12335678


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHH
Q 018702          240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS  319 (351)
Q Consensus       240 y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  319 (351)
                      |+|||...+..++.++|+||+|+++|+|++|..|+.......            ...        .....|...+..+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~--------~~~~~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH--------TTLNIPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc--------cccCCcccCCHHHHH
Confidence            999999988889999999999999999999998874321100            000        000123344578999


Q ss_pred             HHHHhcCCCCCCCCCH
Q 018702          320 IASMCLEPEPSKRPTM  335 (351)
Q Consensus       320 li~~cl~~~p~~Rps~  335 (351)
                      ++.+||+.||++||++
T Consensus       208 li~~~l~~dp~~R~~~  223 (237)
T cd05576         208 LLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHccCCHHHhcCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=266.70  Aligned_cols=240  Identities=25%  Similarity=0.356  Sum_probs=196.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCCh---hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTT---EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|....+||+|+||+|.++..++ .+.+|||+++++..   +..+--+.|-++|... +.|.++++...|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            478888999999999999998764 45699999987532   1222235577777766 478999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||++||+|--.++    +-..+.+..+...+..|+-||-+||++   +|++||||..||+++.+|++||+|||+++.--
T Consensus       429 MEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999988776    345678888899999999999999999   99999999999999999999999999997422


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      - ......+.+|||.|+|||.+..++|+.+.|.||+|++||||+.|++||.+...++      .+......         
T Consensus       502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~aI~eh---------  565 (683)
T KOG0696|consen  502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQAIMEH---------  565 (683)
T ss_pred             c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHc---------
Confidence            1 2233457899999999999999999999999999999999999999997753322      11221111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRP  333 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  333 (351)
                       ...+|...+.++.+++...|.+.|.+|.
T Consensus       566 -nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 -NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence             1135777789999999999999999996

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.5e-36  Score=291.85  Aligned_cols=145  Identities=28%  Similarity=0.395  Sum_probs=129.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|.+.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.++..++||||+++++.+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            46888899999999999999976 67889999986542   223356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ||+.+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999963    34578889999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=268.87  Aligned_cols=254  Identities=24%  Similarity=0.394  Sum_probs=194.2

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhh-------HHHHHHHHHHhhcCCCCceeeeeeEEe-cCCee
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEV-------DRGFERELEAMGDIKHRNIVTLHGYYT-SSQYN  141 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~  141 (351)
                      +|-...+||+|+|+.||++.+ ...+.||+|+-.......       .+...+|..+-+.++||.||+++++|. +.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            555667899999999999985 456778998754332211       134678999999999999999999986 55688


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeec
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFG  218 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg  218 (351)
                      |-|+|||+|.+|+-||+    ..+.++++.++.|++||+.||.||... .+.|+|-||||.|||+-+   -|.+||+|||
T Consensus       544 CTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             eeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            99999999999999998    567799999999999999999999875 578999999999999943   5789999999


Q ss_pred             cccccCccccc------ccccccccccccCccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHH
Q 018702          219 LATLMEAEKTH------VSTIVAGTFGYLAPEYFD----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW  288 (351)
Q Consensus       219 ~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  288 (351)
                      +++....+...      ......||.+|+|||.+.    ...++.+.||||+|+|+|.++.|+.||......  .++.++
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqe  696 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQE  696 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhh
Confidence            99987654332      223356999999999873    345788999999999999999999999764322  111111


Q ss_pred             HHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 018702          289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV  339 (351)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l  339 (351)
                      .. .+......+       +.-+..+.++.++|++||+...++|....++.
T Consensus       697 NT-IlkAtEVqF-------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 NT-ILKATEVQF-------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hc-hhcceeccC-------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11 111111111       11123346789999999999999998887764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=276.12  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=204.7

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCE-EEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +++....||-|+||.|=++..+.... +|+|.+++.   +....+.+..|-.+|...+.|+||+++..|.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            44556679999999999988765443 888887654   34455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      -|-||.|...+.    ..+.++......++..+++|+.|||++   +|++|||||+|.+++.+|-+||.|||+++.....
T Consensus       501 aClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  501 ACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999998    567788888899999999999999999   9999999999999999999999999999987654


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      .  ...+++|||.|.|||.+.+...+.+.|.||||+++|||++|.+||+....-.      .....+..-        ..
T Consensus       574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILkGi--------d~  637 (732)
T KOG0614|consen  574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILKGI--------DK  637 (732)
T ss_pred             C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHhhh--------hh
Confidence            3  3467899999999999999999999999999999999999999997643211      111111110        01


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                      ...|........+|++++.+.+|.+|.-     +.++-++
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            1346666788999999999999999975     5555444

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=278.60  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=205.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEe-----cCCe
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYT-----SSQY  140 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~  140 (351)
                      .+..|.+.+.+|+|.+|.||++.. ++++..|+|+..... +..+++..|.++++.. +|||++.++|++.     .++.
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            445688889999999999999985 467788999876643 3456688899999988 5999999999975     3568


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      +|||||||.|||..+++++..  ...+.|..+..|++.++.|+.+||.+   .++|||+|-.|||++.++.||++|||.+
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeee
Confidence            899999999999999998664  67799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      ....... ....+..|||.|||||++..     ..|+..+|+||||++..||.-|.+|+-+...-      ..+-...+.
T Consensus       171 aQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raLF~IpRN  243 (953)
T KOG0587|consen  171 AQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRN  243 (953)
T ss_pred             eeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhhccCCCC
Confidence            7664432 33445679999999999965     35778999999999999999999998554221      111111111


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .      ++.+ .-|...++++-++|..||.+|-.+||+..+++++
T Consensus       244 P------PPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  244 P------PPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             C------Cccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            1      0111 2366777889999999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.9e-36  Score=283.74  Aligned_cols=264  Identities=16%  Similarity=0.203  Sum_probs=171.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECC-----CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeE------Ee
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVND-----STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY------YT  136 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  136 (351)
                      ..++|+..+.||+|+||.||+|.+.+     +..||+|++......  +....+  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            34678999999999999999999754     578999987643211  111111  1112222222222111      24


Q ss_pred             cCCeeEEEEEecCCCCHHHhhcCCCCC----------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 018702          137 SSQYNLLIYELMPNGSLDTFLHGKSVN----------------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIK  200 (351)
Q Consensus       137 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  200 (351)
                      .....++++||+.+++|.+++......                ........+..++.|++.||.|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            566789999999999999998643210                00112234567999999999999998   99999999


Q ss_pred             CCcEEEcC-CCceEEeeeccccccCcccccccccccccccccCcccccCC----------------------CCCchhhH
Q 018702          201 SSNILLDQ-NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG----------------------RATAKGDV  257 (351)
Q Consensus       201 p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv  257 (351)
                      |+|||+++ ++.+||+|||+++..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 68999999999986544433334456689999999965322                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCcchh-------cccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCC
Q 018702          258 YSFGVVLLELLTGKRPMDEAFL-------EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPS  330 (351)
Q Consensus       258 ~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  330 (351)
                      |||||++|||+++..|+.....       ..+.+...|........... .. .. ...........++|+.+||+.||+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~-~~-~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPD-LR-RG-FEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchh-hh-hh-hhhccccchHHHHHHHHHccCCcc
Confidence            9999999999997766533210       00111122211111100000 00 00 001111234567999999999999


Q ss_pred             CCCCHHHHHHH
Q 018702          331 KRPTMTEVVKM  341 (351)
Q Consensus       331 ~Rps~~e~l~~  341 (351)
                      +|||+.|++++
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=269.64  Aligned_cols=246  Identities=22%  Similarity=0.360  Sum_probs=197.6

Q ss_pred             CCcccccCceEEEEEEE-CCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           75 KDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .++||+|.||+||-|.. ++|+.||||++.+.  .......+.+|+.+|.+++||.||.+...|+..+..+.|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            47899999999999986 57899999998653  233345688999999999999999999999999999999999955 


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeeccccccCcccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +..+.+-..  ....+++..-..+..||+.||.|||.+   +|+|+||||+|||+.+   -.++||||||+++..+...-
T Consensus       648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            665555422  456688888888999999999999999   9999999999999965   35799999999998765432


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                        .....|||.|+|||++..+.|...-|+||.|+|+|--++|..||...     .++.+.    +++.  .+..++   .
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQ----IQNA--aFMyPp---~  786 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQ----IQNA--AFMYPP---N  786 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHH----hhcc--ccccCC---C
Confidence              34567999999999999999999999999999999999999999643     111111    1111  111111   1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      -..+.+..+.+||..+|+..-++|-|...-+.+-
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            2455667899999999999999999988876654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.2e-35  Score=251.12  Aligned_cols=238  Identities=29%  Similarity=0.395  Sum_probs=192.4

Q ss_pred             CceEEEEEEECC-CCEEEEEEecCCChhh-HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcC
Q 018702           82 GFGTVYRLTVND-STAFAVKRLHRGTTEV-DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHG  159 (351)
Q Consensus        82 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  159 (351)
                      +||.||++...+ +..+++|++....... .+.+.+|+..+++++|+|++++.+.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999864 8889999997765544 57889999999999999999999999999999999999999999999864


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccccccccccc
Q 018702          160 KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG  239 (351)
Q Consensus       160 ~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  239 (351)
                      .    ..+++..++.++.+++.++.+||+.   +++|+||+|+||++++++.++++|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            2    2388899999999999999999998   99999999999999999999999999998665432  2223457889


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHH
Q 018702          240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS  319 (351)
Q Consensus       240 y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  319 (351)
                      |++||...+..++.++|+||+|+++++|++|..||....     ................       .......+.++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPKPPF-------PPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCCCC-------ccccccCCHHHHH
Confidence            999999988889999999999999999999999986521     1111111111111000       0000004478999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 018702          320 IASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       320 li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ++.+||..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-38  Score=251.32  Aligned_cols=262  Identities=21%  Similarity=0.335  Sum_probs=193.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec--------CC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS--------SQ  139 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~  139 (351)
                      .|....++|+|.||.||++..+ +++.||+|++-.+.  ........+|+++|..+.|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555678999999999999864 56778888664321  1222346789999999999999999988743        23


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      .+++|+++|+. +|.-.+.+   ....++...+.+++.++..||.|+|..   .|+|||+||+|+||+.+|.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            58999999977 88888864   235688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCccccc---ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          220 ATLMEAEKTH---VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       220 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      ++.+...+..   .......|.+|.+||.+.+ ..|+++.|+|..||++.||+++.+.++............   .+...
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is---~LcGs  247 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS---QLCGS  247 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH---HHhcc
Confidence            9765433222   1233456999999998765 679999999999999999999999998765433222211   11111


Q ss_pred             Ccccee-----------c--cccCC---CC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          296 KREEYV-----------I--DTSLE---GC------PINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       296 ~~~~~~-----------~--~~~~~---~~------~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ...+.+           +  ++..+   ..      |-.-.++..+|+.++|..||.+|+++.+++.+-
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            000000           0  00000   00      111124688999999999999999999998764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.2e-35  Score=268.72  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=181.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-----------------CCCCEEEEEEecCCChhhHHH--------------HHHH
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-----------------NDSTAFAVKRLHRGTTEVDRG--------------FERE  116 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  116 (351)
                      ..++|+..++||+|+||.||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999864                 234679999987543322222              2346


Q ss_pred             HHHhhcCCCCce-----eeeeeEEec--------CCeeEEEEEecCCCCHHHhhcCCCC--------------------C
Q 018702          117 LEAMGDIKHRNI-----VTLHGYYTS--------SQYNLLIYELMPNGSLDTFLHGKSV--------------------N  163 (351)
Q Consensus       117 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~  163 (351)
                      +..+.+++|.++     ++++++|..        .+..++||||+++++|.+++.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777765544     667777643        3467999999999999999864211                    1


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCc
Q 018702          164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP  243 (351)
Q Consensus       164 ~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aP  243 (351)
                      ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12356778889999999999999998   999999999999999999999999999875433222211122347899999


Q ss_pred             ccccCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCcchhcc------cccHHHHHHHHHh
Q 018702          244 EYFDTGR--------------------A--TAKGDVYSFGVVLLELLTGKR-PMDEAFLEE------GTKLVTWVKAVMQ  294 (351)
Q Consensus       244 E~~~~~~--------------------~--~~~~Dv~slG~il~~l~~g~~-p~~~~~~~~------~~~~~~~~~~~~~  294 (351)
                      |.+....                    +  ..+.|+||+||++++|++|.. ||.......      ......|  +...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYK  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhhc
Confidence            9875322                    1  134799999999999999875 664321110      0111111  1111


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHHH
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEP---SKRPTMTEVVKML  342 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~Rps~~e~l~~L  342 (351)
                      ....    +.   ......++..++|+.+||..+|   .+|+|++|+|++-
T Consensus       458 ~~~~----~~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        458 GQKY----DF---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             ccCC----Cc---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            1111    10   1123345789999999999766   6899999999863

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=280.25  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=189.4

Q ss_pred             CCCCCcccccCceEE-EEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecC
Q 018702           72 FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V-~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      |...+++|.|+.|+| |+|... +++||||++-.+..   ....+|+..++.-+ ||||+++++.-.+.+..|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            444568999998764 788875 67899998865433   34678999999985 9999999999999999999999995


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCceEEeeeccccccC
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-----NMEARVSDFGLATLME  224 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~dfg~~~~~~  224 (351)
                       .+|+++++....+.........+.+..|+++|+++||+.   +|+||||||.||||+.     ...++|+|||+++...
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             599999986311111122245678899999999999998   9999999999999975     2568999999999887


Q ss_pred             cccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          225 AEKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       225 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ......  .....||.+|+|||++....-+.+.||||+||++|+.++ |..||.+....+ .++       ......-..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI-------l~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI-------LTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh-------hcCccceee
Confidence            665443  234569999999999999888899999999999999999 599997753221 111       111100000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          + ....++  ++.+||.+|+.++|..||||.+|+.+
T Consensus       735 ----L-~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  735 ----L-EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ----e-ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                0 111111  78999999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=230.20  Aligned_cols=201  Identities=25%  Similarity=0.395  Sum_probs=168.3

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEe
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .......||+|+||.|-+.++ .+|+..|+|.+..... +..++..+|+++..+. .+|++|.++|........++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            344456799999999988775 5788899999976543 3345678888876666 699999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      |. -||+.|...-......+++..+-+|+..+..||.|||++  ..++|||+||+|||++.+|++|+||||.+..+.++.
T Consensus       127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            94 499888765444678899999999999999999999998  599999999999999999999999999998765543


Q ss_pred             ccccccccccccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 018702          228 THVSTIVAGTFGYLAPEYFDT----GRATAKGDVYSFGVVLLELLTGKRPMDE  276 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~g~~p~~~  276 (351)
                      ....  ..|-..|+|||.+..    ..|+-++||||||+++.||.+++.||..
T Consensus       204 Akt~--daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  204 AKTM--DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             HHHH--hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            3221  247788999998854    4789999999999999999999999853

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=244.09  Aligned_cols=248  Identities=20%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++|...++||+|+|++|..+.++ +.+-+|+|++++.   ..+.......|-.+..+. +||.+|.+..+|+.+...++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            47888899999999999999875 4567899988764   233345566777777666 699999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      .||++||+|--++.    .+..++++.++.....|..||.|||++   ||++||||..|+|++..|++|++|+|+++.--
T Consensus       330 ieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999977776    456799999999999999999999999   99999999999999999999999999997432


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhc-ccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE-EGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      . ......+.+|||.|.|||.+.+..|....|.|+||++++||+.|+.||..-..+ .+.+-.+++-.++.++...    
T Consensus       403 ~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----  477 (593)
T KOG0695|consen  403 G-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----  477 (593)
T ss_pred             C-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----
Confidence            2 223345689999999999999999999999999999999999999999653322 2233334444444433332    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPT  334 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps  334 (351)
                           .|...+-.+-.+++..|++||.+|.-
T Consensus       478 -----iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 -----IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -----ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                 23334455678899999999999963

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=259.31  Aligned_cols=205  Identities=25%  Similarity=0.365  Sum_probs=172.2

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhh---HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      -|..++.||-|+||+|.++...| ...||+|.+++.+.-.   ...+..|-.+|..-+.+.||+++-.|++.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            35566789999999999987544 4568999987654322   2346789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc-
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-  225 (351)
                      |++||++-++|.+    ..-+.+..++.++..+.+|+++.|..   |++||||||+|||||.+|++||+|||++.-+.. 
T Consensus       710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999874    45678888889999999999999998   999999999999999999999999999964321 


Q ss_pred             --ccc--------------------------------------cccccccccccccCcccccCCCCCchhhHHHHHHHHH
Q 018702          226 --EKT--------------------------------------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLL  265 (351)
Q Consensus       226 --~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~  265 (351)
                        .++                                      .......||+.|+|||++....|+..+|.||.|+|||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence              000                                      0011346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCcchhccc
Q 018702          266 ELLTGKRPMDEAFLEEG  282 (351)
Q Consensus       266 ~l~~g~~p~~~~~~~~~  282 (351)
                      ||+.|++||-.....+.
T Consensus       863 em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHhhCCCCccCCCCCcc
Confidence            99999999987655443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5.4e-32  Score=225.93  Aligned_cols=211  Identities=33%  Similarity=0.583  Sum_probs=183.2

Q ss_pred             ccccCceEEEEEEECC-CCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018702           78 IGSGGFGTVYRLTVND-STAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDT  155 (351)
Q Consensus        78 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  155 (351)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 888999999765443 34578899999999999999999999999899999999999999999


Q ss_pred             hhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCcccccccccc
Q 018702          156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKTHVSTIV  234 (351)
Q Consensus       156 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~  234 (351)
                      ++....   ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            986421   4688999999999999999999998   9999999999999999 89999999999976544321 12223


Q ss_pred             cccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHH
Q 018702          235 AGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE  313 (351)
Q Consensus       235 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (351)
                      .+...|++||..... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            468889999999877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       ..+.+++.+|++.||++||++.++++.+
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             3478899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=237.85  Aligned_cols=264  Identities=23%  Similarity=0.333  Sum_probs=198.8

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----eeE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----YNL  142 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  142 (351)
                      +.+..+.||-|+||.||.+++ .+|+.|++|++..-.  ....+.+.+|++++...+|.|++..+++....+     ..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            456678899999999999987 478899999986532  233467899999999999999999988866543     457


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      .++|.+. .+|...+-    +.+.++...+.-+.+||++||.|||+.   +|.||||||.|.|+++|..+||||||+++.
T Consensus       134 V~TELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            7888884 47777775    667888889999999999999999998   999999999999999999999999999997


Q ss_pred             cCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH---------HHHHH
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT---------WVKAV  292 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~  292 (351)
                      ...+.....+....|..|.|||.+.+ ..|+.+.||||.|||+.||+..+-.|+....-...++..         .....
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            76665555555567899999999876 478999999999999999998887776533222211111         00000


Q ss_pred             HhcCccc----eeccccCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          293 MQDKREE----YVIDTSLE-----GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       293 ~~~~~~~----~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ....+..    ....++..     ..+.+...+...+..+++.+||+.|.+..+.+.++
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            0000000    01111111     22334445678899999999999999999887664

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.4e-34  Score=225.38  Aligned_cols=259  Identities=18%  Similarity=0.255  Sum_probs=193.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecC--CeeE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSS--QYNL  142 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~  142 (351)
                      ....+|++.+.+|+|.|++||.|.. .++..++||.++.   ...+.+.+|+.+|..+. ||||++++++..++  ....
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            3456788899999999999999984 5678899999874   34567899999999997 99999999998764  4568


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeecccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLAT  221 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~  221 (351)
                      +++||+++.+.....       +.++...++..+.+++.||.|+|+.   ||.|||+||.|++++. .-.++|+|+|++.
T Consensus       112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            999999998877765       3567788899999999999999999   9999999999999985 5679999999998


Q ss_pred             ccCcccccccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH------------H
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT------------W  288 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~  288 (351)
                      +..+......  ...+..|-.||.+ ....|+.+-|+|||||++..|+..+.||-....+.+ +++.            +
T Consensus       182 FYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  182 FYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAY  258 (338)
T ss_pred             hcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHH
Confidence            8765543321  2345667899977 456789999999999999999999999854222111 1111            1


Q ss_pred             HHHHHhc--Cccceeccc---------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          289 VKAVMQD--KREEYVIDT---------SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       289 ~~~~~~~--~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +....-.  +.-..+...         ...+...-.++++.+++.+.|..|-++|||++|.+.+
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1111000  000000000         0001111124779999999999999999999998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=235.84  Aligned_cols=263  Identities=25%  Similarity=0.308  Sum_probs=195.1

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC----
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS----  138 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  138 (351)
                      +..+.+|...+.+|.|.- .|..+.+ -.+++||+|+....  .....++..+|+..+..++|+|+++++.+|...    
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            445568999999999999 5555554 35788999987654  222345688999999999999999999998643    


Q ss_pred             --CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          139 --QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       139 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                        ...|+|||+|. .+|...+.      -.++-.....+..|+++|+.|||+.   +|+||||||+||+++.++.+||.|
T Consensus        92 ~~~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   92 EFQEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHHhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence              36799999995 48888875      2356677889999999999999998   999999999999999999999999


Q ss_pred             eccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc--------------
Q 018702          217 FGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG--------------  282 (351)
Q Consensus       217 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------  282 (351)
                      ||+++.-...  ...+....|..|.|||++.+..|.+.+||||+||++.||++|..-|.+...-+.              
T Consensus       162 fg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  162 FGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             chhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            9999854433  234456688899999999888899999999999999999999988864211110              


Q ss_pred             --ccHHHHHHHHHhcCcc-------ceeccccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          283 --TKLVTWVKAVMQDKRE-------EYVIDTSLE---GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       283 --~~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .++...+.........       +...|....   ..+......+++++.+||..||++|.|++++|++
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence              0011111111111000       001111111   1122334568999999999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.98  E-value=2.7e-33  Score=245.72  Aligned_cols=263  Identities=21%  Similarity=0.234  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC------CCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK------HRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~  142 (351)
                      .+|......|+|-|++|..|.+. .+..||||++...... .+.=..|+++|++|+      --++++++..|...+++|
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC  510 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC  510 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence            46777778899999999999864 4678999999875433 334568999999995      247899999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeecccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLAT  221 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~  221 (351)
                      ||+|-+ ..+|.+.|.+.. ..-.+....+..++.|++-||..|-..   +|+|.||||.|||++++ ..+||||||.+.
T Consensus       511 lVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  511 LVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             EEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence            999988 569999998765 456788899999999999999999998   99999999999999975 568999999987


Q ss_pred             ccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC-----
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK-----  296 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  296 (351)
                      .......   +.+..+..|.|||++.+.+|+...|+||.||+||||.||+..|.+...+....+...++..+..+     
T Consensus       586 ~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  586 FASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             ccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            6544332   22334667999999999999999999999999999999999998765444332222111111000     


Q ss_pred             -ccceecc--------------------------------------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 018702          297 -REEYVID--------------------------------------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE  337 (351)
Q Consensus       297 -~~~~~~~--------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e  337 (351)
                       -.....|                                      +.+..-.......+.+|+.+||..||+.|.|..+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence             0000000                                      0111112334556889999999999999999999


Q ss_pred             HHHH
Q 018702          338 VVKM  341 (351)
Q Consensus       338 ~l~~  341 (351)
                      +|.+
T Consensus       743 AL~H  746 (752)
T KOG0670|consen  743 ALKH  746 (752)
T ss_pred             HhcC
Confidence            9875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-31  Score=232.81  Aligned_cols=132  Identities=22%  Similarity=0.389  Sum_probs=111.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----C---CceeeeeeEEec---
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----H---RNIVTLHGYYTS---  137 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~---  137 (351)
                      .+|-..++||.|.|++||++-+. +.+-||+|+.+.. ....+....|+++|++++     |   ..||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            47778889999999999999864 5677999988653 333455778999999883     3   359999999874   


Q ss_pred             -CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          138 -SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       138 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                       +.+.|||+|+. |.+|..++...  ..+.++...+.+|++||+.||.|||.+|  +|+|-||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence             45889999999 77999999865  5678999999999999999999999997  999999999999994

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-33  Score=251.97  Aligned_cols=252  Identities=24%  Similarity=0.342  Sum_probs=204.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|.....+|+|+||.||++++. .++..|+|.++....+...-+.+|+-+++..+||||+.++|.+......+++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            47888999999999999999964 67889999999888887788889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      .||+|++..+    -..++++.++..+++..++|++|||+.   +=+|||||-.||++++.|.+|++|||.+-.+.....
T Consensus        95 gggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   95 GGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             CCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence            9999999877    567899999999999999999999998   989999999999999999999999999876544322


Q ss_pred             cccccccccccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          229 HVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       ....+.||+.|||||+.   ..+.|...+|+|++|+...|+-.-++|..+..      ..+...-.....    ..++.
T Consensus       168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------pmr~l~LmTkS~----~qpp~  236 (829)
T KOG0576|consen  168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------PMRALFLMTKSG----FQPPT  236 (829)
T ss_pred             -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------hHHHHHHhhccC----CCCCc
Confidence             23345699999999976   45789999999999999999988888743221      111111111111    11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ++ -+....+.+.++++.||.++|.+|||++.+|.
T Consensus       237 lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11 12233467889999999999999999988765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=243.17  Aligned_cols=199  Identities=25%  Similarity=0.431  Sum_probs=169.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhH--------HHHHHHHHHhhcCC---CCceeeeeeE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVD--------RGFERELEAMGDIK---HRNIVTLHGY  134 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~niv~~~~~  134 (351)
                      ++..+|+..+.||+|+||.|+.+.++. ...|++|.+.++.--..        -.+-.|+.+|..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            444568899999999999999999865 46689998866421111        12557999999997   9999999999


Q ss_pred             EecCCeeEEEEEec-CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          135 YTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       135 ~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                      |++++.+|++||-. +|.+|.++++    -.+.+++..+..|++|++.|+++||++   +|+|||||-+|+.++.+|-+|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEE
Confidence            99999999999976 4679999997    456789999999999999999999999   999999999999999999999


Q ss_pred             EeeeccccccCcccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 018702          214 VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMD  275 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~  275 (351)
                      |+|||.+.+..+   .......||..|.|||++.+..| ...-|||++|+++|.++....||.
T Consensus       711 lidfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999875533   33456789999999999998877 567899999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=7.6e-31  Score=221.61  Aligned_cols=198  Identities=32%  Similarity=0.476  Sum_probs=171.6

Q ss_pred             CCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      |...+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999999865 788999999876554 56778899999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCC-CChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          150 NGSLDTFLHGKSVNKKN-LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +++|.+++...    .. +++.....++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999999743    23 78899999999999999999998   999999999999999999999999999887654431


Q ss_pred             cccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 018702          229 HVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDE  276 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  276 (351)
                      .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122234577889999998 667788899999999999999999999944

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=212.52  Aligned_cols=251  Identities=21%  Similarity=0.334  Sum_probs=188.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeE-EecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGY-YTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e  146 (351)
                      +.|++.+.||+|.||.+-++.++ ..+.+++|-+.... ...++|.+|...--.+ .|.||+.-++. |+..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            35788889999999999999986 46779999887643 3346788998876666 48999987765 778888899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCceEEeeeccccccC
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD--QNMEARVSDFGLATLME  224 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~--~~~~~kl~dfg~~~~~~  224 (351)
                      |++.|+|.+-+.     ...+.+.....++.|+++|+.|+|+.   +++|||||.+||||-  +.-.+|+||||.++..+
T Consensus       103 ~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999999985     35678888889999999999999999   999999999999993  34589999999997654


Q ss_pred             cccccccccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTG-----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .-...    ...+..|.+||.....     ...+.+|+|.||++++.+++|+.|++.... .+.....|  ..+..+...
T Consensus       175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~--~~w~~rk~~  247 (378)
T KOG1345|consen  175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEW--EQWLKRKNP  247 (378)
T ss_pred             ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHH--HHHhcccCc
Confidence            33222    1235679999987543     246789999999999999999999985432 33333322  222222221


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .     +...-...++.+.++.++-|..+|.+|-...++-++
T Consensus       248 ~-----~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  248 A-----LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             c-----CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            1     111122234778999999999999999555554443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=6.6e-30  Score=219.70  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=193.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  142 (351)
                      ....|...++||.|.|++||++.+.    .+..||+|.+...  .....+..|++.|..+. +.||+++.+++...+...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3346888999999999999999853    4567999988653  33346889999999996 999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeecccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLAT  221 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~  221 (351)
                      +|+||+++....+++.       .++...+...++.++.||+++|++   ||+|||+||.|+|.+. .+.-.|.|||++.
T Consensus       112 ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence            9999999999999985       356788899999999999999999   9999999999999985 6788999999996


Q ss_pred             ccCccc-------------cc------------------------------ccccccccccccCccccc-CCCCCchhhH
Q 018702          222 LMEAEK-------------TH------------------------------VSTIVAGTFGYLAPEYFD-TGRATAKGDV  257 (351)
Q Consensus       222 ~~~~~~-------------~~------------------------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv  257 (351)
                      ......             ..                              ......||++|.|||++. ...-+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            211000             00                              001235999999999885 4567889999


Q ss_pred             HHHHHHHHHHHhCCCCCCcchhcccccHHHHHH--------H--HHhcC---------------------c-cceec--c
Q 018702          258 YSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK--------A--VMQDK---------------------R-EEYVI--D  303 (351)
Q Consensus       258 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~--~~~~~---------------------~-~~~~~--~  303 (351)
                      ||.|+|++.+++++.||-....+-+ .+...+.        .  .....                     . .+...  +
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999999865322211 1111000        0  00000                     0 00000  0


Q ss_pred             c---cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 T---SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .   ......+..+..+.+++.+||..||.+|.|+++.|++
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0   0011122234578999999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.1e-30  Score=255.19  Aligned_cols=196  Identities=18%  Similarity=0.235  Sum_probs=138.8

Q ss_pred             cCCC-CceeeeeeEE-------ecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 018702          122 DIKH-RNIVTLHGYY-------TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH  193 (351)
Q Consensus       122 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~  193 (351)
                      .++| +||.+++++|       .....++.++|++ +++|.+++...   ...+++..+..++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4455 5777788876       2334667888987 66999999642   35689999999999999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCc-------------------eEEeeeccccccCcccc---------------ccccccccccc
Q 018702          194 IIHRDIKSSNILLDQNME-------------------ARVSDFGLATLMEAEKT---------------HVSTIVAGTFG  239 (351)
Q Consensus       194 i~H~dlkp~Nil~~~~~~-------------------~kl~dfg~~~~~~~~~~---------------~~~~~~~~~~~  239 (351)
                      |+||||||+|||++..+.                   +|++|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999965444                   55555665543210000               00011347889


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHH
Q 018702          240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS  319 (351)
Q Consensus       240 y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  319 (351)
                      |+|||++.+..++.++|||||||++|||++|.+|+.....        .........     .++.    .........+
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--------~~~~~~~~~-----~~~~----~~~~~~~~~~  243 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--------TMSSLRHRV-----LPPQ----ILLNWPKEAS  243 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--------HHHHHHHhh-----cChh----hhhcCHHHHH
Confidence            9999999999999999999999999999999988643210        011111000     0000    0111234678


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHH
Q 018702          320 IASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       320 li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ++.+||+++|.+|||+.|++++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhc
Confidence            8999999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=7.5e-29  Score=201.64  Aligned_cols=170  Identities=20%  Similarity=0.248  Sum_probs=128.9

Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|.+++...   ...+++..++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6899998642   45699999999999999999999998   5      999999999999999  99987654322   


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                         ..||+.|+|||++.+..++.++||||||+++|||++|..||.....     ................   +.....+
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPADD---PRDRSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccCC---ccccccH
Confidence               1478999999999999999999999999999999999999854321     1111111111111100   0000112


Q ss_pred             HHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          311 INEIN--DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       311 ~~~~~--~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....  .+.+++.+||+.+|.+|||+.|+++++..+..+
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            23333  699999999999999999999999999877554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.2e-26  Score=202.29  Aligned_cols=166  Identities=22%  Similarity=0.173  Sum_probs=128.0

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEEC--CCCEEEEEEecCC-----ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLTVN--DSTAFAVKRLHRG-----TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS  138 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  138 (351)
                      .....+|+..+.||+|+||+||+|.+.  +++.+|+|++...     .......+.+|++++++++|+|+++.+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            344568999999999999999999864  4677899987532     12234568999999999999999853322   2


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCCceEEeee
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDI-KSSNILLDQNMEARVSDF  217 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl-kp~Nil~~~~~~~kl~df  217 (351)
                      +..++||||++|++|... .    ...      ...++.++++||.|||+.   +|+|||| ||+|||++.++.++|+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            457999999999999632 1    111      146788999999999998   9999999 999999999999999999


Q ss_pred             ccccccCcccccc-------cccccccccccCcccccC
Q 018702          218 GLATLMEAEKTHV-------STIVAGTFGYLAPEYFDT  248 (351)
Q Consensus       218 g~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~  248 (351)
                      |+++.........       .....+++.|.+||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9998765432111       124557888999999854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=5.1e-25  Score=195.79  Aligned_cols=260  Identities=18%  Similarity=0.273  Sum_probs=192.5

Q ss_pred             CCCCCCcccccCceEEEEEEECCC--CEEEEEEecCCChhhHHHHHHHHHHhhcCC----CCceeeeeeEE-ecCCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDS--TAFAVKRLHRGTTEVDRGFERELEAMGDIK----HRNIVTLHGYY-TSSQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~l  143 (351)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|.-..........+..|..++..+.    .+++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997654  468888766543332225667777777776    35888888888 47778899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-----CceEEeeec
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-----MEARVSDFG  218 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-----~~~kl~dfg  218 (351)
                      ||+.+ |.+|.++.....  .+.++......++.|++.+|.+||+.   |++||||||.|+++...     ..+.+.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99998 889999876543  57799999999999999999999998   99999999999999754     468999999


Q ss_pred             cccccC--cccc----cc---cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHH
Q 018702          219 LATLME--AEKT----HV---STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWV  289 (351)
Q Consensus       219 ~~~~~~--~~~~----~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  289 (351)
                      +++...  ....    ..   .....||..|+++....+...+.+.|+||++.++.++..|..|+........   ...+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKF  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHH
Confidence            998322  1111    11   1234599999999999999999999999999999999999999855422111   1111


Q ss_pred             HHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ...........        .....+..+.++...+-..+..++|....+...|.....
T Consensus       250 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  250 EKDPRKLLTDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHhhhhcccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            11111111100        111222456666666666899999999999888766543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-26  Score=185.90  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=188.0

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      ..+|.+...|+.|+|++.++. +++|++...  .....+.|..|.-.++-..||||+.++|.|..+.+..++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            346888999999999998655 677776443  23334578899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe--eeccccccCcccccc
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS--DFGLATLMEAEKTHV  230 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~--dfg~~~~~~~~~~~~  230 (351)
                      |...++..  ..-..+..++.+++.++++|++|||+.. +-|.---|++..+++|++.+.+|.  |--++....      
T Consensus       274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~------  344 (448)
T KOG0195|consen  274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV------  344 (448)
T ss_pred             HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeecc------
Confidence            99999854  2344677788999999999999999973 334455789999999999887764  433332111      


Q ss_pred             cccccccccccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRA---TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                        .....|.|++||.++..+-   -.++|+|||++++|||.|...||.+-..-+..     .+-.+.         ....
T Consensus       345 --gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----mkiale---------glrv  408 (448)
T KOG0195|consen  345 --GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----MKIALE---------GLRV  408 (448)
T ss_pred             --ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----hhhhhc---------cccc
Confidence              1124688999999976543   35799999999999999999999764322211     000111         1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ..|+..+..+..|+.-|++.||.+||.+..++-.|+.++
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            357777788999999999999999999999999888754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=1e-26  Score=220.40  Aligned_cols=247  Identities=20%  Similarity=0.195  Sum_probs=182.6

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh-hHHHH---HHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE-VDRGF---ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++...+.||++.|=+|.++.+.+|. |++|++-+..+. ..+.+   .+|++ ...++|||.+++..+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777788999999999999998887 999998654422 22333   33444 556689999999988778888899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc--C
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM--E  224 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~--~  224 (351)
                      |..+ +|.+.+.    .+.-+...+...++.|++.|+..+|..   ||+|||||.+||||+.-.-+.|+||...+..  +
T Consensus       102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9966 9999885    344567778889999999999999999   9999999999999999999999999876532  2


Q ss_pred             cccc----cccccccccccccCcccccCC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHH
Q 018702          225 AEKT----HVSTIVAGTFGYLAPEYFDTG-----------RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW  288 (351)
Q Consensus       225 ~~~~----~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~  288 (351)
                      .+..    ....+-..-.+|.|||.+...           ..+++.||||+||++.||++ |++||.-...-.-....  
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~--  251 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN--  251 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC--
Confidence            2211    122333456789999988431           15789999999999999988 89998654322110000  


Q ss_pred             HHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                                .......++..+   ...++.++..|++.||++|.|+++.|+.-
T Consensus       252 ----------~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  252 ----------ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             ----------ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence                      000000000011   13688999999999999999999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.6e-26  Score=216.59  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=185.9

Q ss_pred             CCCCcccccCceEEEEEEEC-CCCEEEEEEec----CC-Chh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH----RG-TTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ....++|.|++|.|+..... ....++.|.+.    .. ... ....+..|+.+-..+.|||++.....+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34568999999977776542 33334444332    11 111 1122667888889999999988877776666555569


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |||++ +|..++..    ...+....+..+++|++.|+.|+|+.   |+.|||+|++|++++.+|.+||+|||.+..+..
T Consensus       401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 99999873    34688889999999999999999999   999999999999999999999999999876653


Q ss_pred             ccc---cccccccccccccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          226 EKT---HVSTIVAGTFGYLAPEYFDTGRATA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       226 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...   ......+|...|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+...     ..  ........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~--~~~~~~~~  545 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KT--NNYSDQRN  545 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hh--hccccccc
Confidence            322   3445567999999999999999876 5899999999999999999997765443321     00  00000000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      ............+...+.++.+||+.||.+|.|++++++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            111111223334566889999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.8e-23  Score=186.75  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=196.4

Q ss_pred             CCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCC-ceeeeeeEEecCCeeEEEEEe
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKHR-NIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  147 (351)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|...+..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556678999999999999987  77899988765433   356789999999999988 799999999777778999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccccCcc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAE  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~  226 (351)
                      +.++++.+++...... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777633211 3688889999999999999999998   999999999999999988 7999999999755443


Q ss_pred             ccc-----ccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          227 KTH-----VSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       227 ~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ...     ......++..|++||.+.+   ..++...|+||+|++++++++|..||......  ................
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc
Confidence            322     2345679999999999987   57889999999999999999999996544221  0011111111111111


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .. ........+......+.+++..|+..+|..|.+..+....
T Consensus       234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00 0000000012223578899999999999999998876653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.7e-24  Score=178.77  Aligned_cols=170  Identities=14%  Similarity=0.197  Sum_probs=132.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHH---------HHHHHHHhhcCCCCceeeeeeEEecC-
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG---------FERELEAMGDIKHRNIVTLHGYYTSS-  138 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~-  138 (351)
                      ..+|...++||.|+||.||.... ++..+|+|.+..........         +.+|+..+.+++||+|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            46899999999999999999766 56679999997654333322         67899999999999999999885533 


Q ss_pred             -------CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc
Q 018702          139 -------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME  211 (351)
Q Consensus       139 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~  211 (351)
                             +..+++|||++|.+|.++..        ++.    ....+++.++..+|+.   |++|||++|+|++++++| 
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                   35789999999999988742        122    2456899999999999   999999999999999988 


Q ss_pred             eEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 018702          212 ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELL  268 (351)
Q Consensus       212 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~  268 (351)
                      ++++|||.......+....             ..+....+..++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            9999999886543222111             1233344667899999999877653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=7.7e-24  Score=180.08  Aligned_cols=232  Identities=22%  Similarity=0.312  Sum_probs=149.2

Q ss_pred             CCCCcccccCceEEEEEEECC-CCEEEEEEecCCChh---hHHHHHHHHHHhhcCC----------CCceeeeeeEEe--
Q 018702           73 SSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTE---VDRGFERELEAMGDIK----------HRNIVTLHGYYT--  136 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~----------h~niv~~~~~~~--  136 (351)
                      ...+.||.|+++.||.+.+.+ ++++|+|++......   ..+.+.+|.-....+.          |-.++-.++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            345689999999999999864 788999988543322   2344555554444422          212222222211  


Q ss_pred             -------cC---C-----eeEEEEEecCCCCHHHhhcC---CCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 018702          137 -------SS---Q-----YNLLIYELMPNGSLDTFLHG---KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRD  198 (351)
Q Consensus       137 -------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~d  198 (351)
                             ..   .     ..+++|+-+ .++|.+++..   .......+....++.+..|+++.+++||+.   |++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence                   11   1     236778877 4588887642   111123344556677889999999999999   999999


Q ss_pred             CCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccC--------CCCCchhhHHHHHHHHHHHHhC
Q 018702          199 IKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT--------GRATAKGDVYSFGVVLLELLTG  270 (351)
Q Consensus       199 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g  270 (351)
                      |+|+|++++.+|.++|+||+.....+.....    ...+..|.|||....        -.++.+.|.|+||+++|.|++|
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999999876644332221    224577999997744        2478899999999999999999


Q ss_pred             CCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 018702          271 KRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKR  332 (351)
Q Consensus       271 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  332 (351)
                      ..||...........                   ....|. +.++.+.+||..+|+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999976543332211                   345677 888999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.8e-23  Score=170.84  Aligned_cols=139  Identities=14%  Similarity=0.158  Sum_probs=107.9

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChh--h------------------------HHHHHHHHHHhhcCCCCce
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE--V------------------------DRGFERELEAMGDIKHRNI  128 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  128 (351)
                      ...||+|++|.||+|...+|++||+|+++.....  .                        ......|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999998754211  0                        1122458999999987776


Q ss_pred             eeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEEEc
Q 018702          129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL-HHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       129 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ........  ...++||||++|+++.....    ....++......++.|++.+|.++ |+.   +++||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333322  22389999999877765432    235688889999999999999999 687   999999999999998


Q ss_pred             CCCceEEeeecccccc
Q 018702          208 QNMEARVSDFGLATLM  223 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~  223 (351)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.6e-22  Score=165.95  Aligned_cols=141  Identities=16%  Similarity=0.192  Sum_probs=110.8

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhh--------------------------HHHHHHHHHHhhcCCCCce
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV--------------------------DRGFERELEAMGDIKHRNI  128 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni  128 (351)
                      .+.||+|++|.||+|...+|+.||+|++.......                          ......|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999998789999999987642210                          1123578899999999887


Q ss_pred             eeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEc
Q 018702          129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       129 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~  207 (351)
                      .....+....  .++||||++|+++.....    ....++......++.|++.++.++|+ .   |++||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            5554443332  489999999875543321    23456778889999999999999999 7   999999999999999


Q ss_pred             CCCceEEeeeccccccCc
Q 018702          208 QNMEARVSDFGLATLMEA  225 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~  225 (351)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3.8e-22  Score=167.15  Aligned_cols=199  Identities=22%  Similarity=0.326  Sum_probs=167.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..|.++++||+|.||..+.|.. -++++||||.=...  ....++..|....+.|. .++|...+-+-.++.+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4799999999999999999984 57899999954332  22335677888888885 78999999888888888999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-----CceEEeeeccccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-----MEARVSDFGLATL  222 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-----~~~kl~dfg~~~~  222 (351)
                      . |-||.++..-   ....++.+....+|.|++.-++|+|++   .+++|||||+|.||...     ..+.++|||+++.
T Consensus       106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            8 7799888764   356799999999999999999999999   99999999999999643     3589999999997


Q ss_pred             cCccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          223 MEAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       223 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      +......      ..+...||.+||+=-...+..-+.+-|+=|||-++.+.+-|..||++.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            7654332      244567999999998888888999999999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=7.8e-23  Score=164.07  Aligned_cols=258  Identities=20%  Similarity=0.225  Sum_probs=190.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC-CceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH-RNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|...+.||+|+||.+|.|.. .+|..||+|.=+..  .....+..|.++.+.+++ ..|..+.-+..+.....+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            45899999999999999999984 67899999975432  222356778888888874 677777777888888899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CceEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN---MEARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~  223 (351)
                      .. |-||.++..-   ....++.+..+-++-|++.-++|+|.+   +++||||||+|.|..-+   ..+.++|||+++.+
T Consensus        92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            98 7799988764   346688899999999999999999999   99999999999998543   46899999999876


Q ss_pred             Cccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          224 EAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       224 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      .+....      ......||.+|.+--...+..-+.+-|+=|+|.++.++--|..||++.......+..+...+.-....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            543322      12345699999998887777788899999999999999999999988644333222222221111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      .+        ..-...+.++.-.+..|-..--++-|...-+-+.+.
T Consensus       245 ie--------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  245 IE--------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HH--------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            11        111222356667777777777777777655544433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.3e-24  Score=191.60  Aligned_cols=225  Identities=26%  Similarity=0.359  Sum_probs=180.7

Q ss_pred             cccccCceEEEEEE----ECCCCEEEEEEecCCChhh--HHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecC
Q 018702           77 VIGSGGFGTVYRLT----VNDSTAFAVKRLHRGTTEV--DRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        77 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+|+||.|+.+.    .+.+..+++|.++......  ......|-.++...+ ||.++++.-.++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999865    2346678888876543221  113456777888887 9999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      ||.|...+.    ....+++.........++-++.++|+.   +++|+|+|++||+++.+|++++.|||.++..-..+..
T Consensus        81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999988886    445566677777778899999999999   9999999999999999999999999999865443332


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                           +||..|+|||++.  ....++|.||||+++++|++|..||...          .........          ...
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il~~~----------~~~  206 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRILKAE----------LEM  206 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHhhhc----------cCC
Confidence                 7999999999998  5788999999999999999999999761          111111111          134


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                      |...+..+.+++.+++..+|.+|.-.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            77778889999999999999999754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.4e-21  Score=158.16  Aligned_cols=185  Identities=16%  Similarity=0.114  Sum_probs=138.9

Q ss_pred             CCCcccccCceEEEEEEECCCCEEEEEEecCCChhhH----HHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEec
Q 018702           74 SKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD----RGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ....|++|+||+|+.+.. ++.+++.+.+........    ..+.+|+++|++++ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456799999999997665 677788887766443211    24789999999995 5889999886    3469999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCCceEEeeeccccccCccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDI-KSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl-kp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      .|.+|.+.+.     ..      ...++.|++.++.++|++   ||+|||| ||+|||++.++.++|+|||++.......
T Consensus        81 ~G~~L~~~~~-----~~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRPP-----RG------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhhh-----hh------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9999875432     11      134678999999999999   9999999 7999999999999999999998654332


Q ss_pred             cc----c--------cccccccccccCcccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          228 TH----V--------STIVAGTFGYLAPEYFDTG-RAT-AKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       228 ~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      ..    .        ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..|....
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            10    0        0112257777777754322 334 5678889999999999998886544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2e-22  Score=172.73  Aligned_cols=197  Identities=23%  Similarity=0.299  Sum_probs=140.8

Q ss_pred             CCCceeeeeeEEec---------------------------CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHH
Q 018702          124 KHRNIVTLHGYYTS---------------------------SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA  176 (351)
Q Consensus       124 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~  176 (351)
                      +|||||++.++|.+                           ....|+||...+. +|.+++-     ....+.-...-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence            59999999887632                           2356899988754 9999985     3344555667788


Q ss_pred             HHHHHHHHHHHhcCCCCeeecCCCCCcEEE--cCCC--ceEEeeeccccccCccc-----ccccccccccccccCccccc
Q 018702          177 VGAARGIAYLHHDCIPHIIHRDIKSSNILL--DQNM--EARVSDFGLATLMEAEK-----THVSTIVAGTFGYLAPEYFD  247 (351)
Q Consensus       177 ~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~--~~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~  247 (351)
                      .|+++|+.|||.+   |+.|||+|++|||+  ++|+  .+.++|||++---....     ....-...|+..-+|||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999999  3443  46889999875322211     11112245888999999986


Q ss_pred             CCC------CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHH
Q 018702          248 TGR------ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIA  321 (351)
Q Consensus       248 ~~~------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  321 (351)
                      ..+      .-.++|.|+.|.+.||++....||.... +...+...     .++        ..+...|+.++..+++++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~-----Yqe--------~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRT-----YQE--------SQLPALPSRVPPVARQLV  490 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhh-----hhh--------hhCCCCcccCChHHHHHH
Confidence            432      2358999999999999999999997621 11111000     000        112235666678899999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHh
Q 018702          322 SMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       322 ~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ...|+.||++|+|+.-....|+
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876666554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.9e-22  Score=193.16  Aligned_cols=249  Identities=22%  Similarity=0.191  Sum_probs=178.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  143 (351)
                      ....+|.+.+.+|+|+||+||.|...+++.||+|+-+.......   .=-..++.+|+   -+.|..+.....-.+..++
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            34457888889999999999999988899999998776654421   11122333333   2334444444455566799


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-------CCCceEEee
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-------QNMEARVSD  216 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~-------~~~~~kl~d  216 (351)
                      |+||.+.|+|.+++.    ..+.+++.....++.|++..+.+||..   +||||||||+|.+|.       ++..++|+|
T Consensus       772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            999999999999998    567899999999999999999999998   999999999999994       345689999


Q ss_pred             eccccccCcc-cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          217 FGLATLMEAE-KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       217 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      ||.+..+..- ........++|..+-.+|+..+..+++..|.|.++.+++-|+.|+..-   ...+...           
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---~~~g~~~-----------  910 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---VKNGSSW-----------  910 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH---hcCCcce-----------
Confidence            9998754321 112344567899999999999999999999999999999999987542   0000000           


Q ss_pred             CccceeccccCCCCCHHHH-HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          296 KREEYVIDTSLEGCPINEI-NDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           ..+..+   +.... +.+-+++..+|+.|-.-=|...++...++....
T Consensus       911 -----~~~~~~---~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  911 -----MVKTNF---PRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             -----eccccc---hhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence                 000001   11111 234467777788554444777777777766543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=5.5e-22  Score=179.27  Aligned_cols=218  Identities=27%  Similarity=0.443  Sum_probs=163.7

Q ss_pred             hhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 018702          120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDI  199 (351)
Q Consensus       120 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl  199 (351)
                      |+.+.|.|+.+++|.+.++...+.|++||..|+|.+.+..   ....+++.....+.++++.||+|||+.  +--+|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            4678999999999999999999999999999999999975   356688889999999999999999997  23399999


Q ss_pred             CCCcEEEcCCCceEEeeeccccccCcc-cccccccccccccccCcccccCC-------CCCchhhHHHHHHHHHHHHhCC
Q 018702          200 KSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYFDTG-------RATAKGDVYSFGVVLLELLTGK  271 (351)
Q Consensus       200 kp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~~l~~g~  271 (351)
                      ++.|++++....+|++|||+....... .........-..-|.|||.+...       ..+.++|+||||++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998765421 11111111235579999998653       1466799999999999999999


Q ss_pred             CCCCcchhcccc-cHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          272 RPMDEAFLEEGT-KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       272 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .||......... .+...+..   .....  ..+.+.... ...+++..++..||..+|.+||++.++-..++.+...
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~---~~~~~--~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK---GGSNP--FRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHHHHh---cCCCC--cCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            999775433322 22222221   11111  111111111 2334789999999999999999999999888877653

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.6e-21  Score=159.54  Aligned_cols=137  Identities=18%  Similarity=0.236  Sum_probs=106.2

Q ss_pred             CCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-----CCCceeeeeeEEecCC---e-eE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-----KHRNIVTLHGYYTSSQ---Y-NL  142 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~  142 (351)
                      +...+.||+|++|.||.  +.+....+||+.........+.+.+|+.+++.+     +||||++++|+++++.   . +.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            44567899999999995  443333479988765444556789999999999     5799999999998874   3 33


Q ss_pred             EEEEe--cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCcEEEcC----CCceEEe
Q 018702          143 LIYEL--MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI-AYLHHDCIPHIIHRDIKSSNILLDQ----NMEARVS  215 (351)
Q Consensus       143 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~~~~~i~H~dlkp~Nil~~~----~~~~kl~  215 (351)
                      +|+||  +.+++|.+++.+     ..+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  557999999963     234444  35577777777 999999   9999999999999974    3479999


Q ss_pred             eeccc
Q 018702          216 DFGLA  220 (351)
Q Consensus       216 dfg~~  220 (351)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.6e-20  Score=155.86  Aligned_cols=147  Identities=16%  Similarity=0.220  Sum_probs=112.9

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEE--ECCCCEEEEEEecCCChh------------------------hHHHHHHHHH
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLT--VNDSTAFAVKRLHRGTTE------------------------VDRGFERELE  118 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~  118 (351)
                      ..+...-|++.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|+.
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            34444468888999999999999998  467899999998754210                        1123567999


Q ss_pred             HhhcCCCC--ceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-ee
Q 018702          119 AMGDIKHR--NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH-II  195 (351)
Q Consensus       119 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-i~  195 (351)
                      .+.++.+.  .+.++++.    ...++||||++|.+|.....    ............++.|++.++++||+.   + ++
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~ii  171 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELV  171 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence            99999753  33444433    23489999999988876543    223455566788999999999999999   8 99


Q ss_pred             ecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          196 HRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       196 H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      |+||||+||+++ ++.++++|||.+...
T Consensus       172 H~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      172 HGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999999 889999999988743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.8e-19  Score=150.79  Aligned_cols=134  Identities=19%  Similarity=0.286  Sum_probs=112.1

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChh--------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE--------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      +.||+|++|.||+|.. .+..+++|+.......        ....+.+|+..+..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5699999999999987 5667899976543211        123577899999999999988877777777788999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|++|.+++...       .. .+..++.+++.++.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998532       11 7788999999999999998   999999999999999 78999999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.6e-19  Score=148.42  Aligned_cols=131  Identities=18%  Similarity=0.251  Sum_probs=105.8

Q ss_pred             cccccCceEEEEEEECCCCEEEEEEecCCCh---h-----hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           77 VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT---E-----VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .||+|++|.||+|.. ++..+++|.......   .     ....+.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 467799998654321   1     1245778999999999887665555555666779999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|++|.+++...    ..       .++.+++.++.+||+.   +++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999987521    10       7889999999999998   999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=3.4e-20  Score=176.31  Aligned_cols=208  Identities=25%  Similarity=0.323  Sum_probs=144.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|..++++..|+||.||.+.++. .+++|+|.-+. ..-     .+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~li-----lRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLI-----LRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc-chh-----hhc--cccccCCccee------------------
Confidence            3578889999999999999998764 56688853322 111     111  33333444444                  


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                         |+=...++.    .++++..        .+.+++|||+.   +|+|||+||+|.+|+.-|++|++|||+++......
T Consensus       136 ---gDc~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ---GDCATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ---chhhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence               333344432    2233322        26789999998   99999999999999999999999999987432110


Q ss_pred             ------------cc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          228 ------------TH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       228 ------------~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                                  .+  ..+..+||+.|.|||++....|....|+|++|+|+|+.+-|..||.....++..      ..++
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~vi  271 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVI  271 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhh
Confidence                        00  122358999999999999999999999999999999999999999776544321      2222


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP  333 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  333 (351)
                      .+...       +.+-....+.++.+++.++|+.+|..|.
T Consensus       272 sd~i~-------wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  272 SDDIE-------WPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhcc-------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            11111       0011222236799999999999999996

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=5.3e-19  Score=146.25  Aligned_cols=144  Identities=18%  Similarity=0.176  Sum_probs=110.9

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh----------------------hHHHHHHHHHHhhc
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE----------------------VDRGFERELEAMGD  122 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~  122 (351)
                      +.+....|...+.||+|+||.||++...+++.+|+|++......                      .......|...+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333347788999999999999999888999999987643211                      01125678888888


Q ss_pred             CCCC--ceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 018702          123 IKHR--NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIK  200 (351)
Q Consensus       123 l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  200 (351)
                      +.|+  .+...++.    ...+++|||++|++|......          .....++.+++.++.++|+.   +++|+||+
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence            8776  34444432    345899999999998765420          23467889999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEeeeccccccCc
Q 018702          201 SSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       201 p~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1e-18  Score=165.69  Aligned_cols=136  Identities=17%  Similarity=0.252  Sum_probs=110.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEE-ecCCC--h-----hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKR-LHRGT--T-----EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~--~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      ..|...+.||+|+||.||++.+.+.. +++|+ .....  .     ...+.+.+|++++..++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566789999999999999876554 34443 22111  1     1234578999999999999998888777777778


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||++|++|.+++.            ....++.+++.++.+||+.   +++|||+||+||++ +++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999999874            3467899999999999998   99999999999999 67799999999997


Q ss_pred             c
Q 018702          222 L  222 (351)
Q Consensus       222 ~  222 (351)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=3e-20  Score=165.18  Aligned_cols=174  Identities=25%  Similarity=0.453  Sum_probs=128.3

Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..++.|++|...+|.+|+.... .....++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4689999999999999997544 33456778889999999999999   5   999999999999999999999999999


Q ss_pred             ccccCccc-----ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHH
Q 018702          220 ATLMEAEK-----THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       220 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      ........     ........||..||+||.+.+..|+.++||||||++++||+. =..++....             ..
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-------------t~  469 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-------------TL  469 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-------------hh
Confidence            87654433     222334569999999999999999999999999999999987 222221110             00


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV  338 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~  338 (351)
                      .+-+...+........     +.-..|+.+++.+.|.+||++.+.
T Consensus       470 ~d~r~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 TDIRDGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhcCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence            0101111100111111     345689999999999999955443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=5.6e-17  Score=128.11  Aligned_cols=134  Identities=21%  Similarity=0.237  Sum_probs=112.4

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC--CceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH--RNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|...+..++|  +++++++++....+..++++||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999865 6799998866443  4568889999999976  588999988888788999999998877


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +..+           +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543           4456677889999999999996444799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=4.8e-17  Score=133.39  Aligned_cols=135  Identities=19%  Similarity=0.230  Sum_probs=96.6

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhH--HH----------------------HHHHHHHhhcCCCC--ce
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD--RG----------------------FERELEAMGDIKHR--NI  128 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~--ni  128 (351)
                      .+.||+|+||.||+|...+++.||+|++........  ..                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988899999999875422111  11                      12455555555433  24


Q ss_pred             eeeeeEEecCCeeEEEEEecCCCCHHHh-hcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEE
Q 018702          129 VTLHGYYTSSQYNLLIYELMPNGSLDTF-LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILL  206 (351)
Q Consensus       129 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~  206 (351)
                      .++++.    ...+++|||++++++... +...     ... .....++.+++.++.++|+ .   +++|+||+|+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            444433    235899999998543221 1110     001 5678899999999999999 7   99999999999999


Q ss_pred             cCCCceEEeeecccccc
Q 018702          207 DQNMEARVSDFGLATLM  223 (351)
Q Consensus       207 ~~~~~~kl~dfg~~~~~  223 (351)
                      + ++.++++|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 889999999999644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=1.1e-16  Score=135.55  Aligned_cols=135  Identities=19%  Similarity=0.230  Sum_probs=103.7

Q ss_pred             CCccc-ccCceEEEEEEECCCCEEEEEEecCCC-------------hhhHHHHHHHHHHhhcCCCCce--eeeeeEEecC
Q 018702           75 KDVIG-SGGFGTVYRLTVNDSTAFAVKRLHRGT-------------TEVDRGFERELEAMGDIKHRNI--VTLHGYYTSS  138 (351)
Q Consensus        75 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  138 (351)
                      ...|| .|+.|+||.+... +..+++|.+....             ......+.+|++++..++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999998875 5668999875321             1223457889999999998774  6677664332


Q ss_pred             C----eeEEEEEecCC-CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          139 Q----YNLLIYELMPN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       139 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                      .    ..++|||+++| .+|.+++..     ..++..    .+.+++.++.+||+.   ||+|+||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    22599999997 699988853     234433    356899999999998   999999999999999989999


Q ss_pred             Eeeeccccc
Q 018702          214 VSDFGLATL  222 (351)
Q Consensus       214 l~dfg~~~~  222 (351)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1e-18  Score=165.21  Aligned_cols=254  Identities=23%  Similarity=0.306  Sum_probs=188.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC--CEEEEEEecCCC--hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS--TAFAVKRLHRGT--TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  144 (351)
                      ..|...+.||+|+++.|-.......  ..++.|.+....  .........|..+-..+. |+|++.+++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            3577778899999999988775433  345556554432  223334555777777776 99999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATL  222 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~  222 (351)
                      +++..|+++.+-+...  .....+....-..+.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..++.|||++..
T Consensus       100 ~~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999998888311  2224566677788999999999999 76   999999999999999999 999999999987


Q ss_pred             cCc-c-cccccccccc-cccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          223 MEA-E-KTHVSTIVAG-TFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       223 ~~~-~-~~~~~~~~~~-~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +.. . ........+| ++.|.|||...+ ....+..|+||.|+++..+++|..|+....... .....|....      
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~------  247 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK------  247 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc------
Confidence            765 2 2223344567 999999999987 456788999999999999999999986653322 1111111110      


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV  339 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l  339 (351)
                          ................+++.+++..+|..|.+.+++-
T Consensus       248 ----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 ----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ----cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                0001122344456788999999999999999988764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=9e-17  Score=135.10  Aligned_cols=211  Identities=23%  Similarity=0.329  Sum_probs=147.8

Q ss_pred             HHHHHhhcCCCCceeeeeeEEecCC-----eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc
Q 018702          115 RELEAMGDIKHRNIVTLHGYYTSSQ-----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD  189 (351)
Q Consensus       115 ~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~  189 (351)
                      .-+..+-.+.|.|+++++.++.+.+     ...+++||+..|++.+||++.....+.+....-.+|+.||+.||.|||+.
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            3445566677999999999986543     56899999999999999998777788888888999999999999999995


Q ss_pred             CCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc----cccccccccccccccCcccccCCCCCchhhHHHHHHHHH
Q 018702          190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE----KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLL  265 (351)
Q Consensus       190 ~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~  265 (351)
                       .|.++|+++..+.|++..+|-+|++--.-.. ....    .........+.++|.+||.=...+.+-++|||+||....
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence             5789999999999999999888885322111 1111    011111223678999999876667778999999999999


Q ss_pred             HHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          266 ELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       266 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      +|..|..--...  +.....    .+... .....+-+           ..-+.++.+|++..|..||++++++.+.-.+
T Consensus       274 emailEiq~tns--eS~~~~----ee~ia-~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  274 EMAILEIQSTNS--ESKVEV----EENIA-NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             HHHHheeccCCC--cceeeh----hhhhh-hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            998765432111  000000    00000 00000000           1124688999999999999999998765433

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.61  E-value=5e-15  Score=136.09  Aligned_cols=142  Identities=19%  Similarity=0.269  Sum_probs=99.3

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHH----------------------------------------HHH
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR----------------------------------------GFE  114 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~  114 (351)
                      .+.||.|++|.||+|...+|+.||||+.+........                                        .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3579999999999999999999999998654211100                                        133


Q ss_pred             HHHHHhhcCC-----CCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHH-HHHHHHh
Q 018702          115 RELEAMGDIK-----HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR-GIAYLHH  188 (351)
Q Consensus       115 ~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~  188 (351)
                      +|...+.++.     ++++.-..-+....+..+++|||++|++|.++....   ....   ....++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHh
Confidence            4555444442     344332222223344569999999999998876421   1111   23455666655 4678888


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      .   |++|+|++|.||++++++.++++|||++.....
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7   999999999999999999999999999976654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.57  E-value=1.1e-13  Score=127.21  Aligned_cols=230  Identities=16%  Similarity=0.220  Sum_probs=156.4

Q ss_pred             ECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChH
Q 018702           91 VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP  170 (351)
Q Consensus        91 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  170 (351)
                      ..++.++.|...+...........+.++.++.++||||+++++.++.++..|+|+|.+.  -|..++..       ++..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence            34677888888877666445567888999999999999999999999999999999874  56666653       2245


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccCCC
Q 018702          171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR  250 (351)
Q Consensus       171 ~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  250 (351)
                      ....-+.||+.||.+||+.+  +++|+++....|+++..|..||++|..+.....-.. ........-.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            55667889999999999774  999999999999999999999999987754322211 111112233466777654322


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCcchhccccc----HHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcC
Q 018702          251 ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK----LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLE  326 (351)
Q Consensus       251 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  326 (351)
                        -..|.|.|||++++++.|..+-.......+..    +.-+.+.+...              +...+. ..+++..|..
T Consensus       182 --~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~--------------~~~r~n-~~~~~~~~~~  244 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGAT--------------ELKRPN-KLRFILECRL  244 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccc--------------cccccc-hhhHHHHHHh
Confidence              35699999999999999933321111111110    00111111111              111112 5677777777


Q ss_pred             CCCCCCCCHHHHHHHHhcccccc
Q 018702          327 PEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       327 ~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ..+--|=.+-+++..|++++-++
T Consensus       245 ~~gff~n~fvd~~~fLeel~lks  267 (690)
T KOG1243|consen  245 LGGFFRNDFVDTLLFLEELRLKS  267 (690)
T ss_pred             ccccccchHHHHHHHHHhcccCc
Confidence            77777777888888888776554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=9.9e-15  Score=132.61  Aligned_cols=246  Identities=24%  Similarity=0.321  Sum_probs=178.6

Q ss_pred             CCCCCCcccc--cCceEEEEEEE---CCCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeE
Q 018702           71 KFSSKDVIGS--GGFGTVYRLTV---NDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        71 ~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  142 (351)
                      .+.....+|.  |.+|.||.+..   .++..+|+|+-+....  .....=.+|+...+.++ |+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566678999  99999999876   3567789987544322  33334457777777775 999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeee
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR----GIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDF  217 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~df  217 (351)
                      +-+|++ +.+|.++....   ...++....+....+..+    |+.++|+.   +++|-|+||.||+..++ ...+++||
T Consensus       195 iqtE~~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeccc-cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            999999 46888887642   233666677777777878    99999998   99999999999999999 88999999


Q ss_pred             ccccccCccccc----ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          218 GLATLMEAEKTH----VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       218 g~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      |+...+......    ......+...|++||... +-++.+.|+|++|.++.+-.++..+........      |     
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W-----  335 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W-----  335 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c-----
Confidence            998766544311    112234778899999876 467889999999999999988776643321110      0     


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV  339 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l  339 (351)
                      ...+..++.+    ++-...+.++...+.+|++.+|..|++++.+.
T Consensus       336 ~~~r~~~ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  336 SQLRQGYIPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccccccCch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            0011111111    11112234566699999999999999997654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.51  E-value=2.1e-14  Score=133.50  Aligned_cols=145  Identities=17%  Similarity=0.232  Sum_probs=93.2

Q ss_pred             CCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhh----------------------------------HHH---
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEV----------------------------------DRG---  112 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~---  112 (351)
                      .|+. +.||+|++|.||+|..++ |+.||||+.++.....                                  .+.   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 689999999999999987 9999999997542110                                  011   


Q ss_pred             ---HHHHHHHhhcCC----CCceeeeeeEE-ecCCeeEEEEEecCCCCHHHhh--cCCCCCCCCCChHHHHHHHHHHHHH
Q 018702          113 ---FERELEAMGDIK----HRNIVTLHGYY-TSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARG  182 (351)
Q Consensus       113 ---~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~i~~~i~~~  182 (351)
                         +.+|...+.+++    +.+.+.+-.++ .-.+..+++|||++|+.+.++-  .....+.+.+.......++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence               334444444442    33333322222 2245568999999999998752  2111111122222333334443   


Q ss_pred             HHHHHhcCCCCeeecCCCCCcEEEcCCC----ceEEeeeccccccCcc
Q 018702          183 IAYLHHDCIPHIIHRDIKSSNILLDQNM----EARVSDFGLATLMEAE  226 (351)
Q Consensus       183 l~~Lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg~~~~~~~~  226 (351)
                          ...   |++|+|+||.||+++.+|    .++++|||+....+..
T Consensus       277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                344   999999999999999888    9999999999766543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=3.1e-13  Score=108.90  Aligned_cols=129  Identities=22%  Similarity=0.171  Sum_probs=93.4

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCcee-eeeeEEecCCeeEEEEEecCCCCHH
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV-TLHGYYTSSQYNLLIYELMPNGSLD  154 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L~  154 (351)
                      +.|+.|..+.||++... +..+++|....... ....+..|+..++.+.+.+++ +++...  ....++||||++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46889999999998875 66799998765432 122356788888888654443 444443  23458999999998775


Q ss_pred             HhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          155 TFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC--IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       155 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ..-         .   .....+.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            430         0   11245678999999999982  12369999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=1.9e-12  Score=105.03  Aligned_cols=135  Identities=13%  Similarity=0.134  Sum_probs=96.3

Q ss_pred             CcccccCceEEEEEEECC-------CCEEEEEEecCCC----------------------hhhHHH----HHHHHHHhhc
Q 018702           76 DVIGSGGFGTVYRLTVND-------STAFAVKRLHRGT----------------------TEVDRG----FERELEAMGD  122 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~e~~~l~~  122 (351)
                      ..||.|-.+.||.|...+       +..+|+|+.+...                      ....+.    ..+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4789999763210                      011122    3379999988


Q ss_pred             CCC--CceeeeeeEEecCCeeEEEEEecCCCCHHH-hhcCCCCCCCCCChHHHHHHHHHHHHHHHHH-HhcCCCCeeecC
Q 018702          123 IKH--RNIVTLHGYYTSSQYNLLIYELMPNGSLDT-FLHGKSVNKKNLDWPSRYKIAVGAARGIAYL-HHDCIPHIIHRD  198 (351)
Q Consensus       123 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~i~H~d  198 (351)
                      +..  -++..++++    ...++||||+.+..+.. .+.     ...++......+..+++.+|..+ |+.   +++|||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            853  455666654    45589999997654422 222     22344455667789999999998 777   999999


Q ss_pred             CCCCcEEEcCCCceEEeeecccccc
Q 018702          199 IKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       199 lkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      |++.||+++ ++.+.++|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.43  E-value=6.6e-12  Score=109.76  Aligned_cols=265  Identities=15%  Similarity=0.168  Sum_probs=167.0

Q ss_pred             CCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeE------EecCC-eeEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGY------YTSSQ-YNLLI  144 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~~-~~~lv  144 (351)
                      ...+.||+|+.+.+|..-.-.+  .+.|+.............   ..|... .||-+-.-+.|      --+.+ ..-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchhhc--hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3456799999999996432222  467877766554433222   223333 45533321111      01222 25678


Q ss_pred             EEecCCC-CHHHhhcC--CCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          145 YELMPNG-SLDTFLHG--KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       145 ~e~~~~g-~L~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      |+.+.+. -...++.-  .+.+....+|...++.++.++.+.+.||..   |.+-||++++|+|+++++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            8887764 33334331  122445688999999999999999999998   99999999999999999999998865433


Q ss_pred             ccCcccccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCcchhccccc--HH-HHHHHH
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTG-KRPMDEAFLEEGTK--LV-TWVKAV  292 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g-~~p~~~~~~~~~~~--~~-~~~~~~  292 (351)
                      ...+...  ..-..|...|.+||.-.     +..-+...|-|.||+++++++.| +.||.+.....+..  .. ......
T Consensus       166 i~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         166 INANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            2222211  12235889999999764     33456789999999999999885 99998754332211  10 000000


Q ss_pred             H---hcCccceeccccCCCCC-HHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHHHhcccccc
Q 018702          293 M---QDKREEYVIDTSLEGCP-INEINDVFSIASMCLE--PEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       293 ~---~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~--~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      .   .+........+ . ..| .-.+.++..|..+|+.  .++.-|||++-++..|.+++++.
T Consensus       244 f~ya~~~~~g~~p~P-~-~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         244 FAYASDQRRGLKPPP-R-SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eeechhccCCCCCCC-C-CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            0   01111111111 0 112 2234678899999996  34789999999999999998764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=5.8e-12  Score=98.31  Aligned_cols=144  Identities=19%  Similarity=0.278  Sum_probs=105.1

Q ss_pred             CCCcccccCceEEEEEEECCCCEEEEEE-ecCC----Chh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           74 SKDVIGSGGFGTVYRLTVNDSTAFAVKR-LHRG----TTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~----~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ...++-||+.+.|+++.+.+ +...||. +.+.    ..+   ..++..+|.+.+.++.--.|....-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            45678899999999999874 4455553 3221    111   2245678999999987656666666677777779999


Q ss_pred             EecCC-CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc---eEEeeecccc
Q 018702          146 ELMPN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLAT  221 (351)
Q Consensus       146 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~  221 (351)
                      ||++| .++.+|+...-  ...........+++.|-+.+.-||.+   +++||||..+||++.+++.   +.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99977 47888876431  22223333478899999999999999   9999999999999976543   4899999987


Q ss_pred             cc
Q 018702          222 LM  223 (351)
Q Consensus       222 ~~  223 (351)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            44

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=9e-12  Score=97.68  Aligned_cols=131  Identities=23%  Similarity=0.307  Sum_probs=99.5

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCC---ChhhH-----HHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRG---TTEVD-----RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+++|+.+.++.+.+.+.. +++|.=.+.   .++..     .+-.+|..++.+++--.|....-+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775444 566643221   11211     2456799999888765665555566677778899999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|-.|.+++...           ...++..+-..+.-||..   +|+||||.++||.+.+++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999898632           245677888888999998   999999999999998764 99999999974

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.36  E-value=1.3e-11  Score=104.04  Aligned_cols=142  Identities=20%  Similarity=0.253  Sum_probs=107.0

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCC--CceeeeeeEEecC---CeeEEEEEecC
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKH--RNIVTLHGYYTSS---QYNLLIYELMP  149 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  149 (351)
                      +.|+.|..+.||++...+|..+++|....... .....+..|.+++..+.+  .++.+++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999887767899998765432 134467889999999875  4456677776553   25689999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC---------------------------------------  190 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------------  190 (351)
                      |.++.+.+.     ...++......++.++++++..||+..                                       
T Consensus        84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            988877552     134566667777788888888887521                                       


Q ss_pred             --------------CCCeeecCCCCCcEEEcC--CCceEEeeeccccc
Q 018702          191 --------------IPHIIHRDIKSSNILLDQ--NMEARVSDFGLATL  222 (351)
Q Consensus       191 --------------~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~  222 (351)
                                    ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246799999999999998  66789999987763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.35  E-value=4.3e-11  Score=107.23  Aligned_cols=218  Identities=17%  Similarity=0.258  Sum_probs=156.0

Q ss_pred             CceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe----cCCeeEEEEEecCC-CCHHH
Q 018702           82 GFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT----SSQYNLLIYELMPN-GSLDT  155 (351)
Q Consensus        82 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~  155 (351)
                      ...+.|++.. .||..|++|+++............-++.++++.|+|+|++..++.    .+...++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4467788875 478999999996544444444556688999999999999999876    34577999999985 68877


Q ss_pred             hhcCCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          156 FLHGKS-----------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       156 ~l~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      +.....           .+....++..+|.++.|+..||.++|+.   |+.-+-|.|.+|+++.+.+++|...|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            654322           1234567789999999999999999998   99999999999999999999998888776554


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .+...               -+   .--.+-|.=.||.++..|.+|...-...     .......               
T Consensus       445 ~d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~-----d~~~~s~---------------  486 (655)
T KOG3741|consen  445 EDPTE---------------PL---ESQQQNDLRDLGLLLLALATGTENSNRT-----DSTQSSH---------------  486 (655)
T ss_pred             CCCCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccccccc-----cchHHHH---------------
Confidence            43311               01   1123578889999999999986441110     0000000               


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       ........+.++++++......++++ -++.+++.++
T Consensus       487 -~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  487 -LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence             01123445577888888888888887 7777777654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.2e-12  Score=117.55  Aligned_cols=246  Identities=18%  Similarity=0.253  Sum_probs=173.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CCCEEEEEEecCCChhhHHH--HHHHHHHhhcCC-CCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--DSTAFAVKRLHRGTTEVDRG--FERELEAMGDIK-HRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|.....||.|.|+.|+....+  ++..|++|.+.........+  -..|+.+...+. |.++++....|......++=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            36777788999999999987643  56779999887654433322  245666666664 88888888777777777888


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeecccccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLM  223 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~  223 (351)
                      -|||+++++.....    ....++....+++..|++.++.++|+.   .++|+|++|+||++..+ +..+++|||++..+
T Consensus       345 ~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             hhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence            99999998877663    334567778899999999999999997   99999999999999876 78899999998642


Q ss_pred             Cccccccccccccccccc--CcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTHVSTIVAGTFGYL--APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .-...    ......++.  +|+......+..+.|++|||..+.+.+++..--... ..       |          ..+
T Consensus       418 ~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~-------~----------~~i  475 (524)
T KOG0601|consen  418 AFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ-------S----------LTI  475 (524)
T ss_pred             ceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccc-cc-------c----------eee
Confidence            21111    111233444  455556667888999999999999999877542211 00       0          000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ........+. ....+..+...+...++..||++.++..+....
T Consensus       476 ~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  476 RSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            1111111222 226778889999999999999998877655443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.19  E-value=6e-12  Score=120.96  Aligned_cols=248  Identities=19%  Similarity=0.220  Sum_probs=168.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ...+.+.+-+.+|.++.++.+.-.. +.-.+.|.....   .....+....+-.++-..++|.++...-.+......+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            3456666778889999998765322 222233322111   111112233334444444567777666556667788999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      ++|.++++|...+++.    ...+..-.+.....+.++.++||+.   .+.|+|++|.|.+...+++.+++|||......
T Consensus       883 ~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence            9999999999998743    3445555566677788999999997   79999999999999999999999998322110


Q ss_pred             ---------------------ccc---------ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 018702          225 ---------------------AEK---------THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM  274 (351)
Q Consensus       225 ---------------------~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  274 (351)
                                           ...         ........+|+.|.+||...+......+|.|+.|+++++.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                                 000         00112345899999999999999999999999999999999999999


Q ss_pred             CcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 018702          275 DEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMT  336 (351)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  336 (351)
                      .....+...      .....       .+..+..-+...+....+++...+..+|.+|..+.
T Consensus      1036 na~tpq~~f------~ni~~-------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF------ENILN-------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhhhh------hcccc-------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            765433211      11111       11112233455567789999999999999997665

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.18  E-value=3.1e-10  Score=94.46  Aligned_cols=134  Identities=21%  Similarity=0.189  Sum_probs=97.4

Q ss_pred             CCCCCcccccCceEEEEEEECCCCEEEEEEecCCC----------------------hhhHHHHHHHHHHhhcCCCC--c
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT----------------------TEVDRGFERELEAMGDIKHR--N  127 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n  127 (351)
                      ..++..||-|-.+.||.|...+|.++++|.=+...                      .-......+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999432110                      00112356899999999755  6


Q ss_pred             eeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       128 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      +.+.+++    +...+|||+++|-.|...-         ++......++..|++-+.-+-..   |++|||+++-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            7777765    5568999999886654431         12233344455555555555555   999999999999999


Q ss_pred             CCCceEEeeecccc
Q 018702          208 QNMEARVSDFGLAT  221 (351)
Q Consensus       208 ~~~~~kl~dfg~~~  221 (351)
                      ++|.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999996554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=2.6e-10  Score=92.26  Aligned_cols=125  Identities=22%  Similarity=0.270  Sum_probs=82.0

Q ss_pred             EEEEEEECCCCEEEEEEecCCC--------------------------hhhHHHHHHHHHHhhcCCCC--ceeeeeeEEe
Q 018702           85 TVYRLTVNDSTAFAVKRLHRGT--------------------------TEVDRGFERELEAMGDIKHR--NIVTLHGYYT  136 (351)
Q Consensus        85 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  136 (351)
                      .||.|...++..+|+|..+...                          ........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999889999999863210                          00113456899999999754  466666542 


Q ss_pred             cCCeeEEEEEecC--CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          137 SSQYNLLIYELMP--NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       137 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                         ..++||||++  |..+..+...      .++......++.+++..+.. +|..   |++||||++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3489999998  6555444321      11134456677788886555 5676   99999999999999988 999


Q ss_pred             Eeeecccccc
Q 018702          214 VSDFGLATLM  223 (351)
Q Consensus       214 l~dfg~~~~~  223 (351)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.13  E-value=1.4e-09  Score=93.34  Aligned_cols=140  Identities=17%  Similarity=0.161  Sum_probs=96.8

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChh-hH----------HHHHHHHHHhhcCCCCc--eeeeeeEEec-----
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE-VD----------RGFERELEAMGDIKHRN--IVTLHGYYTS-----  137 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~n--iv~~~~~~~~-----  137 (351)
                      +.+-......|.++.. +|+.+++|........ ..          ..+.+|...+.++...+  .+.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444445666655 4668999977443211 11          13678888887774322  2233444332     


Q ss_pred             CCeeEEEEEecCCC-CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------C
Q 018702          138 SQYNLLIYELMPNG-SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-------N  209 (351)
Q Consensus       138 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-------~  209 (351)
                      ....++|||++++. +|.+++....  ..+.+......++.+++..+.-||..   |++|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23568999999875 8999885321  23445667788999999999999999   9999999999999975       4


Q ss_pred             CceEEeeecccc
Q 018702          210 MEARVSDFGLAT  221 (351)
Q Consensus       210 ~~~kl~dfg~~~  221 (351)
                      +.+.++||+.+.
T Consensus       182 ~~~~LIDl~r~~  193 (268)
T PRK15123        182 LKLSVIDLHRAQ  193 (268)
T ss_pred             ceEEEEECCccc
Confidence            678999999875

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=6.9e-11  Score=109.50  Aligned_cols=149  Identities=20%  Similarity=0.364  Sum_probs=103.3

Q ss_pred             HHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc--------ccccccccccCcccccCC
Q 018702          178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--------TIVAGTFGYLAPEYFDTG  249 (351)
Q Consensus       178 ~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~  249 (351)
                      +++.|+.++|..  ++++|++|.|++|.++.++..||++|+++...........        .-......|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344899999998  6999999999999999999999999998865433111110        111245689999999988


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCC
Q 018702          250 RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPE  328 (351)
Q Consensus       250 ~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  328 (351)
                      ..+.++|+||+|+++|.+.. |+.-+....     ....+......       .+........+.+.++++=+.+++..+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-----~~~~~~~~~~~-------~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANG-----GLLSYSFSRNL-------LNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccC-----Ccchhhhhhcc-------cccccccccccCcHHHHHHHHHHhcCC
Confidence            88999999999999999995 444432211     00111111111       111111233455678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 018702          329 PSKRPTMTEVVK  340 (351)
Q Consensus       329 p~~Rps~~e~l~  340 (351)
                      +.-||++.+++.
T Consensus       253 ~~~rp~~~~l~~  264 (700)
T KOG2137|consen  253 SAVRPTLDLLLS  264 (700)
T ss_pred             cccCcchhhhhc
Confidence            999997766543

>PRK09902 hypothetical protein; Provisional

Probab=98.99  E-value=1e-08  Score=83.52  Aligned_cols=137  Identities=15%  Similarity=0.104  Sum_probs=100.7

Q ss_pred             ccccCceEEEEEEECCCCEEEEEEecCCC------hhhHHHHHHHHHHhhcCCC--CceeeeeeEEe---c--CCeeEEE
Q 018702           78 IGSGGFGTVYRLTVNDSTAFAVKRLHRGT------TEVDRGFERELEAMGDIKH--RNIVTLHGYYT---S--SQYNLLI  144 (351)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~---~--~~~~~lv  144 (351)
                      -|+||.+.|+.....+. .+.+|+.....      +.....|.+|+..+..+..  -.+.++. ++.   .  .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36799999998776544 69999875211      2234568999999988852  2244444 322   1  1235799


Q ss_pred             EEecCC-CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc--eEEeeecccc
Q 018702          145 YELMPN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME--ARVSDFGLAT  221 (351)
Q Consensus       145 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~  221 (351)
                      +|-+.| -+|.+++....  ..+.+...+..+..+++..+.-||+.   |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997754 68999886432  23457777889999999999999999   9999999999999986667  9999997665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.98  E-value=1.7e-09  Score=100.44  Aligned_cols=141  Identities=19%  Similarity=0.250  Sum_probs=93.7

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhH------------------------------HH----------HHH
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD------------------------------RG----------FER  115 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~~----------~~~  115 (351)
                      +.|+.++-|.||+|.+++|+.||||+.+++.....                              ++          +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57999999999999999999999998754321110                              01          224


Q ss_pred             HHHHhhcC-----CCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHH-HHHHHhc
Q 018702          116 ELEAMGDI-----KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG-IAYLHHD  189 (351)
Q Consensus       116 e~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~-l~~Lh~~  189 (351)
                      |...+.++     +.|++.-..=+++-.+...++|||++|-.+.+....   .....+.+.+   +..++++ +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~i---a~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKEL---AELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHH---HHHHHHHHHHHHHhc
Confidence            55555444     245544444444555677999999999888887422   1233443322   2222221 2222223


Q ss_pred             CCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       190 ~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                         |++|.|.+|.||+++.+|.+.+.|||+......
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               999999999999999999999999999876654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=8.2e-09  Score=85.65  Aligned_cols=105  Identities=26%  Similarity=0.295  Sum_probs=79.8

Q ss_pred             HHHHHHHHHhhcCCC--CceeeeeeEEecC----CeeEEEEEecCC-CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHH
Q 018702          111 RGFERELEAMGDIKH--RNIVTLHGYYTSS----QYNLLIYELMPN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI  183 (351)
Q Consensus       111 ~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  183 (351)
                      ....+|...+..+..  -.....+++....    ...++|+|++++ .+|.+++...    ...+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            356778877777742  2244445554432    245899999987 4899998742    2256667788999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCcEEEcCCC---ceEEeeeccccc
Q 018702          184 AYLHHDCIPHIIHRDIKSSNILLDQNM---EARVSDFGLATL  222 (351)
Q Consensus       184 ~~Lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~  222 (351)
                      +-||..   |++|+|+++.|||++.++   .+.++||+-++.
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   999999999999999887   899999987764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.85  E-value=6.7e-08  Score=79.92  Aligned_cols=155  Identities=16%  Similarity=0.191  Sum_probs=105.1

Q ss_pred             ccCChHHHHHHhcCCCCCC---cccccCceEEEEEEECCCCEEEEEEecCCChhh------------------------H
Q 018702           58 HSLQSDAIFKKTLKFSSKD---VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV------------------------D  110 (351)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~  110 (351)
                      ...+...+.....+..+..   .|++|..+.||+|...++..+|+|+++......                        .
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3444455555555554444   466899999999998889999999985432111                        1


Q ss_pred             HHHHHHHHHhhcCC--CCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 018702          111 RGFERELEAMGDIK--HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH  188 (351)
Q Consensus       111 ~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  188 (351)
                      ....+|+..|+++.  +-.+.+.+++..    ..|+|||+....    ......+.-++.......+..++++.+.-|-.
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH
Confidence            12446888888874  455566666533    379999995431    11111123333444567778888888888877


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      .  .+++|+||+.-|||+. ++.+.++|||-+...
T Consensus       185 ~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         185 E--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             h--cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            4  3999999999999999 779999999988643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.80  E-value=1.4e-07  Score=79.32  Aligned_cols=140  Identities=18%  Similarity=0.206  Sum_probs=84.4

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc--eeeeeeEEecCCeeEEEEEecCCCC-
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHGYYTSSQYNLLIYELMPNGS-  152 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~-  152 (351)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+.++.+..-.  +.+.+++....+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            46899999999984   24457888876533  2345688999998886332  4667777777777889999998863 


Q ss_pred             HHHhhcC-------------------CCCCCCCCChHHHH-HHHH----------HHHH-HHHHHHhc-CCCCeeecCCC
Q 018702          153 LDTFLHG-------------------KSVNKKNLDWPSRY-KIAV----------GAAR-GIAYLHHD-CIPHIIHRDIK  200 (351)
Q Consensus       153 L~~~l~~-------------------~~~~~~~~~~~~~~-~i~~----------~i~~-~l~~Lh~~-~~~~i~H~dlk  200 (351)
                      +...+..                   ........+..... .+..          .+.. ...+|.+. ..+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            2111110                   00000011111100 0000          0111 12222221 12467999999


Q ss_pred             CCcEEEcCCCceEEeeecccc
Q 018702          201 SSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       201 p~Nil~~~~~~~kl~dfg~~~  221 (351)
                      |.||++++++ +.++||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999998775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=1.5e-07  Score=76.95  Aligned_cols=137  Identities=16%  Similarity=0.246  Sum_probs=90.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHH---------HHHHHhhcCC---CCc-----eeee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE---------RELEAMGDIK---HRN-----IVTL  131 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~n-----iv~~  131 (351)
                      ..+|...+++-......|.+...+ +..+++|..+.......+.+.         +.+..+.+++   .-.     ++.-
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            346777777777777777766654 577999988765444333322         3344333332   222     2222


Q ss_pred             eeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc
Q 018702          132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME  211 (351)
Q Consensus       132 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~  211 (351)
                      .-.+.-....+++|||++|..|.++..        ++.    .++..+.+++.-||+.   |++|||.+|.|++++++ .
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-c
Confidence            222333445579999999988876642        222    2445677889999998   99999999999999865 4


Q ss_pred             eEEeeeccccc
Q 018702          212 ARVSDFGLATL  222 (351)
Q Consensus       212 ~kl~dfg~~~~  222 (351)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.55  E-value=1.5e-06  Score=74.25  Aligned_cols=140  Identities=21%  Similarity=0.196  Sum_probs=83.6

Q ss_pred             ccccCc-eEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018702           78 IGSGGF-GTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSLDT  155 (351)
Q Consensus        78 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  155 (351)
                      |..|.+ +.||+.... +..+++|......   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 888988765 4678999876543   334667888877774 3446667777766667799999999987764


Q ss_pred             hhc-------------------CCCCCCCCCChH--HHHHHHH--------------------HHHHHHHHHHh----cC
Q 018702          156 FLH-------------------GKSVNKKNLDWP--SRYKIAV--------------------GAARGIAYLHH----DC  190 (351)
Q Consensus       156 ~l~-------------------~~~~~~~~~~~~--~~~~i~~--------------------~i~~~l~~Lh~----~~  190 (351)
                      ...                   .......+....  .......                    .+......|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                   100000011100  0000000                    01111222211    12


Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          191 IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       191 ~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      .+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3469999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.53  E-value=6.4e-09  Score=95.88  Aligned_cols=190  Identities=19%  Similarity=0.175  Sum_probs=135.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc-eeeeeeEEecCCeeEEEE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-IVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  145 (351)
                      .++..+....-+++|++++++|.+-...+....+.+...     ....-++++|.+++||| .+..++-++.+...++.+
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            333444455568899999999877544444455555432     23455789999999999 777777777788889999


Q ss_pred             EecCCC-CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          146 ELMPNG-SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       146 e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      +++.++ +-..-..   ...-.+...+...+.+.-.++++++|+.   .=+|+|    ||+.++ +..+..||+....+.
T Consensus       314 ~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  314 RICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             hhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccC
Confidence            999776 2211110   1222233344455666677889999986   557888    777765 578999999887665


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM  274 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  274 (351)
                      +..  ......+++.++|||+.....+....|+|++|.-..++.-|.+|-
T Consensus       383 ~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  383 RTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            443  234456899999999999999999999999998777777777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=1.7e-06  Score=73.23  Aligned_cols=143  Identities=20%  Similarity=0.238  Sum_probs=82.5

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCC--ceeeeeeEEe---cCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR--NIVTLHGYYT---SSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~  150 (351)
                      +.++.|..+.||++...+ ..+++|.....  .....+.+|..+++.+...  .+.+++....   .....+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468899999999999887 58999987654  4456677888888777422  3455555432   23356899999999


Q ss_pred             CCHHH----------------hhc---CCCCCCCCCChHHH---------HHH------------HHHHHH-HHHHHHhc
Q 018702          151 GSLDT----------------FLH---GKSVNKKNLDWPSR---------YKI------------AVGAAR-GIAYLHHD  189 (351)
Q Consensus       151 g~L~~----------------~l~---~~~~~~~~~~~~~~---------~~i------------~~~i~~-~l~~Lh~~  189 (351)
                      ..+..                .+.   ..............         ...            ...+.. .+..+++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                111   11001111111100         000            011222 23333321


Q ss_pred             ----CCCCeeecCCCCCcEEEc-CCCceEEeeecccc
Q 018702          190 ----CIPHIIHRDIKSSNILLD-QNMEARVSDFGLAT  221 (351)
Q Consensus       190 ----~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~  221 (351)
                          ....++|+|+.|.||+++ +++.+-++||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                234799999999999999 56666799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.49  E-value=6.4e-06  Score=67.01  Aligned_cols=103  Identities=17%  Similarity=0.166  Sum_probs=81.0

Q ss_pred             HHHHHhhcCCC-CceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 018702          115 RELEAMGDIKH-RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH  193 (351)
Q Consensus       115 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~  193 (351)
                      .|.-++..+++ +++++++|+|-.    ++++||...+++...... -..--..+|..+.++|.++++.+.+|++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47778888875 699999999844    789999987655421000 001123689999999999999999999976557


Q ss_pred             eeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          194 IIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       194 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +.-+|++|+|+-+++++++|++|.+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99999999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.48  E-value=6.6e-06  Score=67.24  Aligned_cols=129  Identities=22%  Similarity=0.306  Sum_probs=88.8

Q ss_pred             CCCcccccCceEEEEEEECCCCEEEEEEecCCC----------------hhhHHHHHHHHHHhhcCC------CCceeee
Q 018702           74 SKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT----------------TEVDRGFERELEAMGDIK------HRNIVTL  131 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~  131 (351)
                      ....||+|+.-.||  .++++....||+.....                ....++..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            45679999999999  45566667899887655                112234455555444443      7889999


Q ss_pred             eeEEecCCeeEEEEEecCC------CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 018702          132 HGYYTSSQYNLLIYELMPN------GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL  205 (351)
Q Consensus       132 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  205 (351)
                      +|+.+++....+|+|.+.+      -+|.+++.     .+.++. ...   ..+-+-..||-+.   +|+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEE
Confidence            9999999999999998643      26778874     333444 333   3333445677777   9999999999999


Q ss_pred             EcCC--C--ceEEee
Q 018702          206 LDQN--M--EARVSD  216 (351)
Q Consensus       206 ~~~~--~--~~kl~d  216 (351)
                      +..+  +  .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532  2  466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=1.3e-06  Score=81.10  Aligned_cols=141  Identities=18%  Similarity=0.240  Sum_probs=88.5

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhh-------------------------------HH------HHHHHHH
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-------------------------------DR------GFERELE  118 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~~  118 (351)
                      +.||..+.|.|++|+.++|+.||||+.++.....                               .+      .|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999875532211                               00      1233444


Q ss_pred             HhhcC----CCCc------eeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 018702          119 AMGDI----KHRN------IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH  188 (351)
Q Consensus       119 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  188 (351)
                      ...+.    .|-+      |.+++  +.-.....|+|||++|..+.+.-.-   ....++...   ++..+.++..  +.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~---i~~~l~~~~~--~q  316 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHD---ILNKLVEAYL--EQ  316 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHH---HHHHHHHHHH--HH
Confidence            33333    3444      22222  3344567999999999877654211   123344443   3333333222  22


Q ss_pred             cCCCCeeecCCCCCcEEEcC----CCceEEeeeccccccCcc
Q 018702          189 DCIPHIIHRDIKSSNILLDQ----NMEARVSDFGLATLMEAE  226 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~~----~~~~kl~dfg~~~~~~~~  226 (351)
                      ....|++|+|-+|.||+++.    ++.+.+.|||+.......
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            12229999999999999983    678999999998765443

>PLN02876 acyl-CoA dehydrogenase

Probab=98.35  E-value=9.8e-06  Score=81.22  Aligned_cols=79  Identities=15%  Similarity=0.304  Sum_probs=56.9

Q ss_pred             CCcccccCceEEEEEEECCC---CEEEEEEecCCCh-hhHHHHHHHHHHhhcCC-CCce--eeeeeEEecC---CeeEEE
Q 018702           75 KDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTT-EVDRGFERELEAMGDIK-HRNI--VTLHGYYTSS---QYNLLI  144 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  144 (351)
                      .+.++.|.++.+|+....++   ..+++|+...... .....+.+|+++++.+. |+++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688999999999876654   3678887654321 22346889999999985 6654  7777777664   467899


Q ss_pred             EEecCCCCH
Q 018702          145 YELMPNGSL  153 (351)
Q Consensus       145 ~e~~~~g~L  153 (351)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.30  E-value=9.8e-06  Score=63.65  Aligned_cols=129  Identities=17%  Similarity=0.197  Sum_probs=87.1

Q ss_pred             CCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      ...+.|++|+.|.||++.+.++ .+|+|+-+.+++  ...+..|.+++..++-.++.+=+-.+..+   ++.|||.+|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-eEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcc
Confidence            3456799999999999998754 689998765433  34688899999998866655433222222   45599999988


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCcEEEcCCCceEEeeecccc
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIK-SSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk-p~Nil~~~~~~~kl~dfg~~~  221 (351)
                      |.++-...       +.++..    .+++.---|...   ||-|+.|+ |...++..++.+.|+||..++
T Consensus        99 L~~~~~~~-------~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          99 LGKLEIGG-------DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhcc-------cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            88775311       223333    344443334444   99999998 444444445599999998876

>PRK10593 hypothetical protein; Provisional

Probab=98.26  E-value=3.1e-05  Score=68.01  Aligned_cols=78  Identities=13%  Similarity=0.098  Sum_probs=56.3

Q ss_pred             CCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC---CceeeeeeEEec---CCeeEEEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH---RNIVTLHGYYTS---SQYNLLIYE  146 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e  146 (351)
                      ...+.||.|..+.||.....+++ +++|..+.  ......+..|.+.++.+.-   ..+.++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34567999999999998766664 77777543  1123467889988888852   357778877654   366899999


Q ss_pred             ecCCCCH
Q 018702          147 LMPNGSL  153 (351)
Q Consensus       147 ~~~~g~L  153 (351)
                      +++|.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=1.8e-05  Score=67.19  Aligned_cols=73  Identities=12%  Similarity=0.209  Sum_probs=44.2

Q ss_pred             CcccccCce-EEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCC---ceeeeeeEEecC---CeeEEEEEec
Q 018702           76 DVIGSGGFG-TVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR---NIVTLHGYYTSS---QYNLLIYELM  148 (351)
Q Consensus        76 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~  148 (351)
                      +.++.|+.. .||+..    ..+++|..+..  .....+.+|.+.+..+...   .+...++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRLG----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEcC----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457766665 588752    34778865432  2234678888888777421   234444433322   2347899999


Q ss_pred             CCCCHH
Q 018702          149 PNGSLD  154 (351)
Q Consensus       149 ~~g~L~  154 (351)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.19  E-value=1.5e-05  Score=68.68  Aligned_cols=140  Identities=12%  Similarity=0.107  Sum_probs=77.4

Q ss_pred             cccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCce-eeeeeEEecCCeeEEEEEecCCCCHHH
Q 018702           77 VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-VTLHGYYTSSQYNLLIYELMPNGSLDT  155 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~  155 (351)
                      .+..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ .+++....    .++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356788889998874 466788987654322211124667888877753222 33333322    268999999876532


Q ss_pred             h-----------------hcCCCCCCCCCChHHH-HHHHHHH---------HHHHHHHHhc-----CCCCeeecCCCCCc
Q 018702          156 F-----------------LHGKSVNKKNLDWPSR-YKIAVGA---------ARGIAYLHHD-----CIPHIIHRDIKSSN  203 (351)
Q Consensus       156 ~-----------------l~~~~~~~~~~~~~~~-~~i~~~i---------~~~l~~Lh~~-----~~~~i~H~dlkp~N  203 (351)
                      -                 ++.......+++.... .....++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 1111111122222211 1111111         1112222111     12368999999999


Q ss_pred             EEEcCCCceEEeeeccccc
Q 018702          204 ILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       204 il~~~~~~~kl~dfg~~~~  222 (351)
                      |++++++ +.++||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.13  E-value=1.3e-05  Score=79.51  Aligned_cols=196  Identities=19%  Similarity=0.253  Sum_probs=135.2

Q ss_pred             HHHHHHHhhcCCCCceeeeeeEEecCCeeE----EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 018702          113 FERELEAMGDIKHRNIVTLHGYYTSSQYNL----LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH  188 (351)
Q Consensus       113 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  188 (351)
                      ..-|++.+....|+|++.++.+-......-    +..+++..-++...+.    .-...+....+.+..+..+|+.++|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            445777888889999999998865543322    3346777777777775    44567888889999999999999999


Q ss_pred             cCCCCeeecCCCCC---cEEEcCCCceEEe--eeccccccCcccccccccccccccccCcccccCCCCCc--hhhHHHHH
Q 018702          189 DCIPHIIHRDIKSS---NILLDQNMEARVS--DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA--KGDVYSFG  261 (351)
Q Consensus       189 ~~~~~i~H~dlkp~---Nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Dv~slG  261 (351)
                      .   ...|.-+..+   +--.+..+.+..+  ||+.+............  ..+..+.+||.......+.  ..|+|.+|
T Consensus       305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHHH
Confidence            7   5555555554   4445566677777  89888766544433222  2355677888776655544  47999999


Q ss_pred             HHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          262 VVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       262 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....+..|..+-......         ..              +.  +........+...+|+..++++|+++.+++.+
T Consensus       380 ll~~~~~~~~~i~~~~~~~---------~~--------------~l--~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVP---------VS--------------LL--DVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHhhhhhcCcccccccch---------hh--------------hh--ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999999877663211000         00              00  11111257789999999999999999999876


Q ss_pred             H
Q 018702          342 L  342 (351)
Q Consensus       342 L  342 (351)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            4

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.12  E-value=4.5e-05  Score=64.71  Aligned_cols=73  Identities=21%  Similarity=0.231  Sum_probs=46.6

Q ss_pred             CcccccCceEEEEEEECC--CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc-eeeeeeEEecCCeeEEEEEecCCCC
Q 018702           76 DVIGSGGFGTVYRLTVND--STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-IVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      +.|..|-...+|++...+  +..+++|........ .....+|..+++.+.... ..++++.+.  +  .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            457788889999988764  677899976543222 122346777777774322 334444332  2  48999999876


Q ss_pred             H
Q 018702          153 L  153 (351)
Q Consensus       153 L  153 (351)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.99  E-value=0.0002  Score=58.16  Aligned_cols=125  Identities=22%  Similarity=0.406  Sum_probs=86.8

Q ss_pred             cCCCCCCcccccCc-eEEEEEEECCCCEEEEEEecC---CCh------------------hhHHHHHHHHHHhhcCC---
Q 018702           70 LKFSSKDVIGSGGF-GTVYRLTVNDSTAFAVKRLHR---GTT------------------EVDRGFERELEAMGDIK---  124 (351)
Q Consensus        70 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---  124 (351)
                      .+++..+.||.|.. |.||++... |..+|+|.+..   ...                  .....|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            57888999999999 999999987 45899999321   000                  11124778888877775   


Q ss_pred             CCce--eeeeeEEecC------------------CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHH
Q 018702          125 HRNI--VTLHGYYTSS------------------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA  184 (351)
Q Consensus       125 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~  184 (351)
                      +.++  ++++||..-.                  ..+.+|.||.+...             .+..    .-+.++.+-+.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence            4456  8999986321                  12356777665422             1222    23456667788


Q ss_pred             HHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       185 ~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89998   9999999999986     3489999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.98  E-value=0.00011  Score=64.72  Aligned_cols=144  Identities=17%  Similarity=0.162  Sum_probs=83.0

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCC--ceeeeeeE------EecCCeeEEEEE
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR--NIVTLHGY------YTSSQYNLLIYE  146 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e  146 (351)
                      .+.+..|....+|+....++ .+++|+....   ....+..|+.++..+.+-  .+.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677888899999876544 6899987642   233456677766666322  23444331      123456689999


Q ss_pred             ecCCCCHHH----hh----------cC----CCCC---CCCCChHHHH----------HHHHHHHHHHHHHHh----cCC
Q 018702          147 LMPNGSLDT----FL----------HG----KSVN---KKNLDWPSRY----------KIAVGAARGIAYLHH----DCI  191 (351)
Q Consensus       147 ~~~~g~L~~----~l----------~~----~~~~---~~~~~~~~~~----------~i~~~i~~~l~~Lh~----~~~  191 (351)
                      +++|..+..    ..          +.    ....   .....|....          .....+..++.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    00          00    0000   0111111110          011122334444443    123


Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          192 PHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       192 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      .+++|+|+.|.|+++++++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999987778999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.95  E-value=0.00034  Score=62.35  Aligned_cols=142  Identities=19%  Similarity=0.204  Sum_probs=75.1

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-----CCCceeeee-e--EEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-----KHRNIVTLH-G--YYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e~  147 (351)
                      +.++.|....+|.....++ .+++|++.....   +.+..|...+..+     ..|.++.-. |  +....+..+++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567788889999887655 589998752222   2233344444443     234433211 1  12234567899999


Q ss_pred             cCCCCHH-----------Hhh---cCCC--C-----CCCCCCh-HHHHH------------HH-HHHHHHHHHHHh----
Q 018702          148 MPNGSLD-----------TFL---HGKS--V-----NKKNLDW-PSRYK------------IA-VGAARGIAYLHH----  188 (351)
Q Consensus       148 ~~~g~L~-----------~~l---~~~~--~-----~~~~~~~-~~~~~------------i~-~~i~~~l~~Lh~----  188 (351)
                      ++|..+.           +.+   +...  .     ....+.+ .....            .. ..+...+..+.+    
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            9887431           111   0000  0     0011111 11110            11 111112223321    


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ....+++|+|+.|.||+++++...-++||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            123489999999999999876556899999875

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00029  Score=63.96  Aligned_cols=75  Identities=16%  Similarity=0.174  Sum_probs=52.3

Q ss_pred             CcccccCceEEEEEEECCC-CEEEEEEecCC-----C--hhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEEE
Q 018702           76 DVIGSGGFGTVYRLTVNDS-TAFAVKRLHRG-----T--TEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  144 (351)
                      +.||.|....||++...+| +.++||.-...     .  +...++...|.+.|..+.   ..++.+++.+  ++...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998877 48999974321     1  123345667777777763   3456667766  44557899


Q ss_pred             EEecCCCC
Q 018702          145 YELMPNGS  152 (351)
Q Consensus       145 ~e~~~~g~  152 (351)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.91  E-value=0.00048  Score=61.02  Aligned_cols=144  Identities=18%  Similarity=0.184  Sum_probs=80.1

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC--CceeeeeeE------EecCCeeEEEEE
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH--RNIVTLHGY------YTSSQYNLLIYE  146 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~------~~~~~~~~lv~e  146 (351)
                      .+.++.|....+|+....++ .+++|.......  ...+..|.+++..+..  -.+.+++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677788889999876555 588897754221  2234455666655531  113333332      122456789999


Q ss_pred             ecCCCCHHH-----------h---hcC----CCCCCC----CCChHHHH------------HHHHHHHHHHHHHHh----
Q 018702          147 LMPNGSLDT-----------F---LHG----KSVNKK----NLDWPSRY------------KIAVGAARGIAYLHH----  188 (351)
Q Consensus       147 ~~~~g~L~~-----------~---l~~----~~~~~~----~~~~~~~~------------~i~~~i~~~l~~Lh~----  188 (351)
                      |++|..+..           .   ++.    ......    ...|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854321           0   111    000000    01111100            011122334444532    


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ....+++|+|+++.|+++++++...++||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223589999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.88  E-value=0.00018  Score=63.26  Aligned_cols=138  Identities=17%  Similarity=0.276  Sum_probs=95.3

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCC--------------------------hhhHHHHHHHHHHhhcCCCCcee
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--------------------------TEVDRGFERELEAMGDIKHRNIV  129 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~niv  129 (351)
                      ..|..|-.+.||.+...+|..+|||+++-..                          ....-....|+..|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4688999999999999999999999863210                          11122355788888888644433


Q ss_pred             eeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC
Q 018702          130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN  209 (351)
Q Consensus       130 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~  209 (351)
                      -..-+..  ....|||+|+....-.    ......-.++...+..+-.+++.-|.-|.+.|  ++||.||+--|+|+- +
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence            2221111  2337999998532111    11113445666678888888999999998886  999999999999996 4


Q ss_pred             CceEEeeeccccc
Q 018702          210 MEARVSDFGLATL  222 (351)
Q Consensus       210 ~~~kl~dfg~~~~  222 (351)
                      |.+.++|.+-+..
T Consensus       301 G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 GKLYIIDVSQSVE  313 (520)
T ss_pred             CEEEEEEcccccc
Confidence            5899999887753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.82  E-value=1.8e-05  Score=68.17  Aligned_cols=134  Identities=18%  Similarity=0.162  Sum_probs=92.4

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCC------------------Ch-hh---HHHHHHHHHHhhcCC-CC-
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG------------------TT-EV---DRGFERELEAMGDIK-HR-  126 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~-~~---~~~~~~e~~~l~~l~-h~-  126 (351)
                      -+..++.||-|..+.||.+...+|++.++|.=+..                  .. +.   .-...+|+..|+.+. |. 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            35678899999999999999999999998842110                  00 00   012456888888885 32 


Q ss_pred             ceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 018702          127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL  206 (351)
Q Consensus       127 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~  206 (351)
                      -+.+.+++    +..++|||++.|..|...-+       ..+.   ..+...+..-+.-|..+   |++|||.+-=||++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~---~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDP---PTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee-------cCCh---HHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence            24445543    45689999998877755432       1112   23344444455667777   99999999999999


Q ss_pred             cCCCceEEeeecccc
Q 018702          207 DQNMEARVSDFGLAT  221 (351)
Q Consensus       207 ~~~~~~kl~dfg~~~  221 (351)
                      ++++.++++||--..
T Consensus       236 ~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMV  250 (465)
T ss_pred             ecCCCEEEeechHhh
Confidence            999999999996443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.77  E-value=0.00022  Score=62.96  Aligned_cols=73  Identities=25%  Similarity=0.347  Sum_probs=46.1

Q ss_pred             cccccCceEEEEEEECC-------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc-eeeeeeEEecCCeeEEEEEec
Q 018702           77 VIGSGGFGTVYRLTVND-------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-IVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+..|-...+|+....+       ++.+++|...... .......+|.+++..+.... ..++++.+. +   ..|++|+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence            46667778999888655       4779999875543 22234567777777774222 234455443 2   3689999


Q ss_pred             CCCCHH
Q 018702          149 PNGSLD  154 (351)
Q Consensus       149 ~~g~L~  154 (351)
                      +|..+.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.65  E-value=0.0008  Score=58.44  Aligned_cols=31  Identities=23%  Similarity=0.501  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCcEEEcCCCc-eEEeeeccccc
Q 018702          192 PHIIHRDIKSSNILLDQNME-ARVSDFGLATL  222 (351)
Q Consensus       192 ~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~  222 (351)
                      +.++|+|++|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            46899999999999997555 46999998763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.62  E-value=0.00061  Score=59.29  Aligned_cols=74  Identities=20%  Similarity=0.309  Sum_probs=47.0

Q ss_pred             CCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEEEEEecCC
Q 018702           74 SKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      ..+.++.|.-..+|+.. .+++.+.+|.-..   .....+..|.+-|+.+.   .-.+.+.+++....+..++++||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34568889999999877 6678899998762   22345777887777773   45677888887777777999999977


Q ss_pred             C
Q 018702          151 G  151 (351)
Q Consensus       151 g  151 (351)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.61  E-value=0.0014  Score=57.47  Aligned_cols=133  Identities=20%  Similarity=0.269  Sum_probs=79.7

Q ss_pred             ccCceEEEEEEECCCCEEEEEEecC--CChhhHHHHHHHHHHhhcCCC--CceeeeeeEEecCC--eeEEEEEecCCCCH
Q 018702           80 SGGFGTVYRLTVNDSTAFAVKRLHR--GTTEVDRGFERELEAMGDIKH--RNIVTLHGYYTSSQ--YNLLIYELMPNGSL  153 (351)
Q Consensus        80 ~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~g~L  153 (351)
                      .|....+|..... +++++++ ...  ..........+|+.+++.+.-  .-+...++.|.++.  ..+.||+|++|..+
T Consensus        35 ~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~  112 (321)
T COG3173          35 GGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV  112 (321)
T ss_pred             CCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence            3444444544433 7778888 331  223334456677888777752  33455666776665  67999999988543


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHH-HHHHHHHHHH---------------------------------------------
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAV-GAARGIAYLH---------------------------------------------  187 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~-~i~~~l~~Lh---------------------------------------------  187 (351)
                      .+.+....     ..    .+++. .++..|+.||                                             
T Consensus       113 ~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         113 WSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             cCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            33221100     00    11111 3333333333                                             


Q ss_pred             -----hc-----CCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          188 -----HD-----CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       188 -----~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                           .+     ..+.++|||+.+.|+++++++.+-+.||+++..-
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                 32     1257999999999999999888999999998754

>PLN02236 choline kinase

Probab=97.34  E-value=0.003  Score=56.76  Aligned_cols=141  Identities=16%  Similarity=0.223  Sum_probs=78.0

Q ss_pred             cccccCceEEEEEEECC-----CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCce-eeeeeEEecCCeeEEEEEecCC
Q 018702           77 VIGSGGFGTVYRLTVND-----STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-VTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      .|..|-...+|++...+     ++.+++|........... -.+|..++..+..-++ .++++.+...    .+++|+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45557788889887532     357899987654322222 2567777777753222 2345554332    58999987


Q ss_pred             CCHHHh-----------------hcCCCCC--CCCCChHHHHHHHHHH-----------------HHHHHHH----Hh-c
Q 018702          151 GSLDTF-----------------LHGKSVN--KKNLDWPSRYKIAVGA-----------------ARGIAYL----HH-D  189 (351)
Q Consensus       151 g~L~~~-----------------l~~~~~~--~~~~~~~~~~~i~~~i-----------------~~~l~~L----h~-~  189 (351)
                      .++..-                 ++.....  .....+.....+..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 1111100  1111122222322111                 1112222    21 1


Q ss_pred             CCCCeeecCCCCCcEEEcC-CCceEEeeeccccc
Q 018702          190 CIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATL  222 (351)
Q Consensus       190 ~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~  222 (351)
                      ....++|+|+++.||++++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2347899999999999986 57899999988763

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.32  E-value=3e-05  Score=78.99  Aligned_cols=162  Identities=10%  Similarity=-0.004  Sum_probs=118.9

Q ss_pred             HHHHHHHhhcCCCCceeeeeeEEe--cCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 018702          113 FERELEAMGDIKHRNIVTLHGYYT--SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC  190 (351)
Q Consensus       113 ~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~  190 (351)
                      ...|.+.++...|+++.....-..  +...-+..++++.+|.+.+.+.+.......++..-.....++...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            445666667778988776655433  233558899999999999998876545555555544444444355556666543


Q ss_pred             C--CCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 018702          191 I--PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELL  268 (351)
Q Consensus       191 ~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~  268 (351)
                      .  ...+|.+||+-|.+|..+-.++++++|+.+..++..... ....+++-|+.|+..+.-.++.++|+|..|+-+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~-Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF-GLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhh-hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            2  247899999999999999999999999998444433332 3345778899999998888999999999999999998


Q ss_pred             hCCCCCC
Q 018702          269 TGKRPMD  275 (351)
Q Consensus       269 ~g~~p~~  275 (351)
                      -|..+|.
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            8888863

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.27  E-value=0.0063  Score=53.93  Aligned_cols=31  Identities=19%  Similarity=0.301  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          191 IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       191 ~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ..+++|+|+.+.|+++++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3489999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.16  E-value=0.0063  Score=54.31  Aligned_cols=79  Identities=13%  Similarity=0.086  Sum_probs=49.2

Q ss_pred             cccccCceEEEEEEECCC-CEEEEEEecC-------CChhhHHHHHHHHHHhhcCC--CC-ceeeeeeEEecCCeeEEEE
Q 018702           77 VIGSGGFGTVYRLTVNDS-TAFAVKRLHR-------GTTEVDRGFERELEAMGDIK--HR-NIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|.|...-||++...++ +.++||.-..       +-+-...+..-|.+.|+...  .| .+.+++.+  ++....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999998654 5799996421       11222344556677776653  45 34445543  555667999


Q ss_pred             EecCC-CCHHHhh
Q 018702          146 ELMPN-GSLDTFL  157 (351)
Q Consensus       146 e~~~~-g~L~~~l  157 (351)
                      |+++. ..|...|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            99854 3343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.08  E-value=0.011  Score=52.56  Aligned_cols=140  Identities=20%  Similarity=0.290  Sum_probs=82.8

Q ss_pred             ccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC---CCc---eeeeeeEE--ecC--CeeEEEEEe
Q 018702           78 IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---HRN---IVTLHGYY--TSS--QYNLLIYEL  147 (351)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~~~~~~--~~~--~~~~lv~e~  147 (351)
                      |.+ ....+|+....++.. ++|.....  ....++..|...+..+.   .+=   +...-|-.  .-.  ...+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 677889988887775 88988765  44455677777777773   111   22222221  112  367888999


Q ss_pred             cCCCCHHH-h-----------h-------cCC----CCCCCCCChHH-------------HHHHHHHHHHHHHHHHhc--
Q 018702          148 MPNGSLDT-F-----------L-------HGK----SVNKKNLDWPS-------------RYKIAVGAARGIAYLHHD--  189 (351)
Q Consensus       148 ~~~g~L~~-~-----------l-------~~~----~~~~~~~~~~~-------------~~~i~~~i~~~l~~Lh~~--  189 (351)
                      ++|..+.. -           +       +..    +.......|..             ......++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99887762 1           0       111    01111223320             011233444444444443  


Q ss_pred             --CCCC---eeecCCCCCcEEEcCCCc-eEEeeecccc
Q 018702          190 --CIPH---IIHRDIKSSNILLDQNME-ARVSDFGLAT  221 (351)
Q Consensus       190 --~~~~---i~H~dlkp~Nil~~~~~~-~kl~dfg~~~  221 (351)
                        ....   ++|+|+.|.||+++++.. .-+.||+.+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              1123   999999999999998875 8899999775

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.01  E-value=0.0071  Score=54.69  Aligned_cols=74  Identities=15%  Similarity=0.135  Sum_probs=47.8

Q ss_pred             CCcccccCceEEEEEEECC-CCEEEEEEecC------CChhhHHHHHHHHHHhhcCC--CC-ceeeeeeEEecCCeeEEE
Q 018702           75 KDVIGSGGFGTVYRLTVND-STAFAVKRLHR------GTTEVDRGFERELEAMGDIK--HR-NIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv  144 (351)
                      .+.||.|.-.-||++...+ ++.++||.-..      +-+-..++..-|.+.|+...  .| .+.+++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3468999999999999743 56799986421      11223345566777777663  45 45555544  55556788


Q ss_pred             EEecCC
Q 018702          145 YELMPN  150 (351)
Q Consensus       145 ~e~~~~  150 (351)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.99  E-value=0.03  Score=50.99  Aligned_cols=73  Identities=14%  Similarity=0.153  Sum_probs=48.5

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCCh-------hhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEEE
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT-------EVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+.||.|....||+.... +..++||.-.....       ....+...|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            456899999999998865 45699997642111       12233444566666553   347778888766  345789


Q ss_pred             EEecCC
Q 018702          145 YELMPN  150 (351)
Q Consensus       145 ~e~~~~  150 (351)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.90  E-value=0.066  Score=47.79  Aligned_cols=94  Identities=12%  Similarity=0.116  Sum_probs=55.4

Q ss_pred             cccCChHHHHHHhcCCCCC---C-cccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC---CCcee
Q 018702           57 IHSLQSDAIFKKTLKFSSK---D-VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---HRNIV  129 (351)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv  129 (351)
                      ..+++++.+......+-..   + ..-.+....||.....++..+++|..+.. ......+..|...+..+.   -| ++
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gip-v~   85 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIP-VV   85 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCC-CC
Confidence            3456777776655555321   1 22245678899988888888999987533 223445666776666553   22 22


Q ss_pred             ee---ee--EEecCCeeEEEEEecCCCC
Q 018702          130 TL---HG--YYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus       130 ~~---~~--~~~~~~~~~lv~e~~~~g~  152 (351)
                      ..   -|  ....++..+.++++++|..
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            21   12  1223456788999998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.87  E-value=0.0099  Score=53.18  Aligned_cols=141  Identities=21%  Similarity=0.287  Sum_probs=75.5

Q ss_pred             cccccCceEEEEEEECC----CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCce-eeeeeEEecCCeeEEEEEecCCC
Q 018702           77 VIGSGGFGTVYRLTVND----STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-VTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .|..|-...+|+....+    +..|++|......... -.-.+|..+++.+..-++ .++++++. .+   ++.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            45557778888886543    2378999875543221 123467777777754333 34455542 22   588998776


Q ss_pred             CHHH--h-----h----------cCCCCC-CC-CCChHHHHHHHHHH----------------------HHHHHHHHh--
Q 018702          152 SLDT--F-----L----------HGKSVN-KK-NLDWPSRYKIAVGA----------------------ARGIAYLHH--  188 (351)
Q Consensus       152 ~L~~--~-----l----------~~~~~~-~~-~~~~~~~~~i~~~i----------------------~~~l~~Lh~--  188 (351)
                      +|..  +     +          +..... .. ..-+.....+..++                      ..-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            5521  0     1          111100 11 11122222222111                      111111111  


Q ss_pred             --c-CCCCeeecCCCCCcEEEcC-CCceEEeeeccccc
Q 018702          189 --D-CIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATL  222 (351)
Q Consensus       189 --~-~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~  222 (351)
                        . ...-.+|+|+.+.||++++ ++.++++||..+..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              1 1224899999999999975 57899999988753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.83  E-value=0.041  Score=48.73  Aligned_cols=29  Identities=38%  Similarity=0.460  Sum_probs=25.5

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          192 PHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       192 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      .+++|||+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 678999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.69  E-value=0.055  Score=44.94  Aligned_cols=75  Identities=23%  Similarity=0.348  Sum_probs=51.5

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC---CCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI---KHRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      +.+.-|.--..|...+ +..++.+|.-..   .....|..|+.-|..+   +--++.+.+.+-.+.++.|+|+||.+-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3455566666665543 456799996543   3334577777666666   34567788888888889999999998766


Q ss_pred             HH
Q 018702          153 LD  154 (351)
Q Consensus       153 L~  154 (351)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>PRK06148 hypothetical protein; Provisional

Probab=96.55  E-value=0.053  Score=55.93  Aligned_cols=144  Identities=18%  Similarity=0.237  Sum_probs=78.8

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-------CCCceeeee-e----EEec-CC--e
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-------KHRNIVTLH-G----YYTS-SQ--Y  140 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~-~----~~~~-~~--~  140 (351)
                      +.|+ |..-.+|+....++..+++|+.......  .....|...+..+       ..|.+++-. |    .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3454 4568889988888888999998764322  2333344444333       344444422 1    1111 22  4


Q ss_pred             eEEEEEecCCCCHHHhhc---------------------CC--CCCCCCCChHH-----------------HHHHHHHHH
Q 018702          141 NLLIYELMPNGSLDTFLH---------------------GK--SVNKKNLDWPS-----------------RYKIAVGAA  180 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~---------------------~~--~~~~~~~~~~~-----------------~~~i~~~i~  180 (351)
                      .+-+++|.+|..+.+...                     ..  ......+.|..                 ...++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            567899999977754110                     00  00111122211                 122222333


Q ss_pred             HHHHH----HHhcCCCCeeecCCCCCcEEEcCCC--ceE-Eeeeccccc
Q 018702          181 RGIAY----LHHDCIPHIIHRDIKSSNILLDQNM--EAR-VSDFGLATL  222 (351)
Q Consensus       181 ~~l~~----Lh~~~~~~i~H~dlkp~Nil~~~~~--~~k-l~dfg~~~~  222 (351)
                      ....-    .......+++|+|+++.||+++.++  .+. |+|||.+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            32221    1112234899999999999999875  555 999998764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.27  E-value=0.031  Score=46.09  Aligned_cols=115  Identities=14%  Similarity=0.104  Sum_probs=68.9

Q ss_pred             CceEEEEEEECCCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCC
Q 018702           82 GFGTVYRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK  160 (351)
Q Consensus        82 ~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  160 (351)
                      +.++.-.+..+-| +..+|++...... ....+..+.+++.+++-  |+++..  .+...+-++.|+|..-..       
T Consensus        74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~N--Dn~~~yGvIlE~Cy~~~i-------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKN--DNNYKYGVILERCYKIKI-------  141 (308)
T ss_pred             CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeec--CCCceeEEEEeeccCccc-------
Confidence            3344433333322 3455555443333 33456777888877753  566552  234455688998843111       


Q ss_pred             CCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          161 SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       161 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                            ..    ..++..=+.+|.-.|+. ..+..|||-.|+||+-|..|-+||.|-+.
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence                  00    11122114567778854 25899999999999999999999999864

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.18  E-value=0.025  Score=50.89  Aligned_cols=60  Identities=17%  Similarity=0.142  Sum_probs=41.0

Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..++-+|.+|.++..++.     .+..+++....++.--..|+-.+---  .+.+|.|++|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence            356777888999999985     34445555555555555554432222  2899999999999995

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.17  E-value=0.046  Score=48.57  Aligned_cols=102  Identities=17%  Similarity=0.215  Sum_probs=68.2

Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..|++|++. |+++..        .+...+++...++.+.+..+.-+....  ..=|||+.-.||+|+ +|++.|+||-+
T Consensus       300 y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         300 YLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             EEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence            445666664 444422        233567888999999888888888774  789999999999999 99999999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHH
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSF  260 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  260 (351)
                      ++....... .     ...+.-.|-.+.| .-+.+-|||-+
T Consensus       368 sRl~~~q~~-i-----sy~rldhp~lF~G-~dd~QFeIYrl  401 (488)
T COG5072         368 SRLSYSQGI-I-----SYNRLDHPDLFNG-VDDYQFEIYRL  401 (488)
T ss_pred             eecccCCce-e-----eccccCchhhhcC-ccceeeeHHHH
Confidence            984322211 1     1222334555553 23566677754

>PTZ00384 choline kinase; Provisional

Probab=96.11  E-value=0.068  Score=48.71  Aligned_cols=74  Identities=14%  Similarity=0.202  Sum_probs=42.7

Q ss_pred             CcccccCceEEEEEEECCC--CE-----EEEEEecCCChhhHHHHHHHHHHhhcCCCCce-eeeeeEEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVNDS--TA-----FAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-VTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  147 (351)
                      +.|..|-...+|++...++  ..     |.++.... ..+..-.-.+|+.+++.+...++ .++++.+..    +++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            3455678889999875433  22     34443211 11111123467888888864443 445555432    699999


Q ss_pred             cCCCCHH
Q 018702          148 MPNGSLD  154 (351)
Q Consensus       148 ~~~g~L~  154 (351)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987664

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.02  E-value=0.0049  Score=56.82  Aligned_cols=47  Identities=13%  Similarity=0.246  Sum_probs=37.1

Q ss_pred             HHHHHHHHHhhcCCCCceeeeeeEEecC-CeeEEEEEecCCCCHHHhhc
Q 018702          111 RGFERELEAMGDIKHRNIVTLHGYYTSS-QYNLLIYELMPNGSLDTFLH  158 (351)
Q Consensus       111 ~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~  158 (351)
                      ..+.-....++.++|+|...++++-... ....+|+|++ +.||.+.+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            3466677889999999999999886543 3467889998 569999886

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.64  E-value=0.11  Score=44.44  Aligned_cols=79  Identities=19%  Similarity=0.134  Sum_probs=53.4

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec-CCCCH
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM-PNGSL  153 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~g~L  153 (351)
                      ...+..|..+.|+.+...+|++.++|......... .+. .....|+.-+=...|++++.  +.....+++|.+ ++-+|
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E~-~g~~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L   82 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HEA-RGEAALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSL   82 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hhh-hHHhHhheeCCCCceeeecc--ccccchhhhhhccCCCch
Confidence            34466799999999999999999999876432211 111 11244666676667888876  334557888988 45577


Q ss_pred             HHhh
Q 018702          154 DTFL  157 (351)
Q Consensus       154 ~~~l  157 (351)
                      .+..
T Consensus        83 ~~~~   86 (253)
T PF04655_consen   83 ASLP   86 (253)
T ss_pred             hhcc
Confidence            6655

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	351
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-64
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-63
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-42
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-38
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-28
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-26
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-26
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-25
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-25
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-25
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-25
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-25
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-25
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-25
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-25
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-25
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-25
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-25
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-24
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-24
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-24
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-24
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-24
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-24
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-24
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-24
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-24
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-24
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-24
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-23
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-23
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-23
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-23
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-23
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-23
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-23
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-23
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-23
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-23
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-22
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-22
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-22
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-22
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-22
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-22
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-22
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-21
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-20
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-18
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-12
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-10
3soa_A	444	Full-Length Human Camkii Length = 444		3e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-08
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  241 bits (616), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 120/276 (43%), Positives = 180/276 (65%), Gaps = 4/276 (1%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEAMGDIKHRNIVT 130
           FS+K+++G GGFG VY+  + D T  AVKRL     +  +  F+ E+E +    HRN++ 
Sbjct: 40  FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLR 99
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G+  +    LL+Y  M NGS+ + L  +  ++  LDWP R +IA+G+ARG+AYLH  C
Sbjct: 100 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
            P IIHRD+K++NILLD+  EA V DFGLA LM+ +  HV   V GT G++APEY  TG+
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK 219
Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFL--EEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           ++ K DV+ +GV+LLEL+TG+R  D A L  ++   L+ WVK ++++K+ E ++D  L+G
Sbjct: 220 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 279
Query: 309 C-PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                E+  +  +A +C +  P +RP M+EVV+MLE
Sbjct: 280 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  238 bits (608), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 118/276 (42%), Positives = 178/276 (64%), Gaps = 4/276 (1%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEAMGDIKHRNIVT 130
           F +K+++G GGFG VY+  + D    AVKRL    T+  +  F+ E+E +    HRN++ 
Sbjct: 32  FXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G+  +    LL+Y  M NGS+ + L  +  ++  LDWP R +IA+G+ARG+AYLH  C
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
            P IIHRD+K++NILLD+  EA V DFGLA LM+ +  HV   V G  G++APEY  TG+
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK 211
Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFL--EEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           ++ K DV+ +GV+LLEL+TG+R  D A L  ++   L+ WVK ++++K+ E ++D  L+G
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271
Query: 309 C-PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                E+  +  +A +C +  P +RP M+EVV+MLE
Sbjct: 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/308 (34%), Positives = 164/308 (53%), Gaps = 14/308 (4%)
Query: 41  TDSVSGGKMVMFRS---PLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAF 97
            D++S   +V F S   PL+       + + T  F  K +IG G FG VY+  + D    
Sbjct: 13  NDALSSSYLVPFESYRVPLVD------LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 98  AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL 157
           A+KR    +++    FE E+E +   +H ++V+L G+       +LIY+ M NG+L   L
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 158 HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF 217
           +G  +   ++ W  R +I +GAARG+ YLH      IIHRD+KS NILLD+N   +++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 218 GLATL-MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
           G++    E ++TH+  +V GT GY+ PEYF  GR T K DVYSFGVVL E+L  +  + +
Sbjct: 184 GISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSL-EGCPINEINDVFSIASMCLEPEPSKRPTM 335
           +   E   L  W      + + E ++D +L +      +      A  CL      RP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 336 TEVVKMLE 343
            +V+  LE
Sbjct: 304 GDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 107/308 (34%), Positives = 163/308 (52%), Gaps = 14/308 (4%)
Query: 41  TDSVSGGKMVMFRS---PLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAF 97
            D++S   +V F S   PL+       + + T  F  K +IG G FG VY+  + D    
Sbjct: 13  NDALSSSYLVPFESYRVPLVD------LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 98  AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL 157
           A+KR    +++    FE E+E +   +H ++V+L G+       +LIY+ M NG+L   L
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 158 HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF 217
           +G  +   ++ W  R +I +GAARG+ YLH      IIHRD+KS NILLD+N   +++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 218 GLATL-MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
           G++    E  +TH+  +V GT GY+ PEYF  GR T K DVYSFGVVL E+L  +  + +
Sbjct: 184 GISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSL-EGCPINEINDVFSIASMCLEPEPSKRPTM 335
           +   E   L  W      + + E ++D +L +      +      A  CL      RP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 336 TEVVKMLE 343
            +V+  LE
Sbjct: 304 GDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 153/271 (56%), Gaps = 12/271 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHR----GTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G GGFG VY+  VN++T  AVK+L       T E+ + F++E++ M   +H N+V L G
Sbjct: 39  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           + +      L+Y  MPNGSL   L         L W  R KIA GAA GI +LH +   H
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---H 153
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            IHRDIKS+NILLD+   A++SDFGLA   E   +T + + + GT  Y+APE    G  T
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEIT 212
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D+YSFGVVLLE++TG   +DE   E    L    +   ++K  E  ID  +      
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            +  ++S+AS CL  + +KRP + +V ++L+
Sbjct: 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 152/271 (56%), Gaps = 12/271 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHR----GTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G GGFG VY+  VN++T  AVK+L       T E+ + F++E++ M   +H N+V L G
Sbjct: 39  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           + +      L+Y  MPNGSL   L         L W  R KIA GAA GI +LH +   H
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---H 153
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            IHRDIKS+NILLD+   A++SDFGLA   E   +T +   + GT  Y+APE    G  T
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEIT 212
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D+YSFGVVLLE++TG   +DE   E    L    +   ++K  E  ID  +      
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            +  ++S+AS CL  + +KRP + +V ++L+
Sbjct: 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 109/272 (40%), Positives = 152/272 (55%), Gaps = 14/272 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHR----GTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G GGFG VY+  VN++T  AVK+L       T E+ + F++E++ M   +H N+V L G
Sbjct: 33  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           + +      L+Y  MPNGSL   L         L W  R KIA GAA GI +LH +   H
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---H 147
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLME--AEKTHVSTIVAGTFGYLAPEYFDTGRA 251
            IHRDIKS+NILLD+   A++SDFGLA   E  A+      IV GT  Y+APE    G  
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIV-GTTAYMAPEAL-RGEI 205
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           T K D+YSFGVVLLE++TG   +DE   E    L    +   ++K  E  ID  +     
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 264
Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             +  ++S+AS CL  + +KRP + +V ++L+
Sbjct: 265 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 147/271 (54%), Gaps = 14/271 (5%)
Query: 79  GSGGFGTVYRLTVNDSTAFAVKRLHR----GTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           G GGFG VY+  VN++T  AVK+L       T E+ + F++E++     +H N+V L G+
Sbjct: 31  GEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            +      L+Y   PNGSL   L         L W  R KIA GAA GI +LH +   H 
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLD-GTPPLSWHXRCKIAQGAANGINFLHEN---HH 145
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME--AEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           IHRDIKS+NILLD+   A++SDFGLA   E  A+    S IV GT  Y APE    G  T
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIV-GTTAYXAPEAL-RGEIT 203
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D+YSFGVVLLE++TG   +DE   E    L    +   ++K  E  ID         
Sbjct: 204 PKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADST 262
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            +   +S+AS CL  + +KRP + +V ++L+
Sbjct: 263 SVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 99/276 (35%), Positives = 137/276 (49%), Gaps = 21/276 (7%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEAMGDIKHRNIVTLH 132
           K+ IG+G FGTV+R   + S   AVK L       +R   F RE+  M  ++H NIV   
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G  T      ++ E +  GSL   LH KS  ++ LD   R  +A   A+G+ YLH+   P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            I+HRD+KS N+L+D+    +V DFGL+ L +A     S   AGT  ++APE      + 
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K DVYSFGV+L EL T ++P        G      V A +  K +   I       P N
Sbjct: 218 EKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFKCKRLEI-------PRN 263
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKS 347
               V +I   C   EP KRP+   ++ +L  LIKS
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 137/276 (49%), Gaps = 21/276 (7%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEAMGDIKHRNIVTLH 132
           K+ IG+G FGTV+R   + S   AVK L       +R   F RE+  M  ++H NIV   
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G  T      ++ E +  GSL   LH KS  ++ LD   R  +A   A+G+ YLH+   P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            I+HR++KS N+L+D+    +V DFGL+ L +A     S   AGT  ++APE      + 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K DVYSFGV+L EL T ++P        G      V A +  K +   I       P N
Sbjct: 218 EKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFKCKRLEI-------PRN 263
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKS 347
               V +I   C   EP KRP+   ++ +L  LIKS
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 132/288 (45%), Gaps = 37/288 (12%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHR 126
           + + +++IG GGFG VYR   + D  A    R H    ++ +  E   +E +    +KH 
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAAR-HDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNL-DWPSRYKIAVGAARGIAY 185
           NI+ L G         L+ E    G L+  L GK +    L +W      AV  ARG+ Y
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNY 120
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEA--------RVSDFGLATLMEAEKTHVSTIVAGT 237
           LH + I  IIHRD+KSSNIL+ Q +E         +++DFGLA   E  +T      AG 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRT-TKMSAAGA 177
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
           + ++APE       +   DV+S+GV+L ELLTG+ P        G   +     V  +K 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVAMNKL 231
Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +  T    CP         +   C  P+P  RP+ T ++  L  I
Sbjct: 232 ALPIPST----CP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 73  SSKDVIGSGGFGTVYRLTVNDSTA-----FAVKRLHRGTTEVDR-GFERELEAMGDIKHR 126
           + + VIG+G FG VY+  +  S+       A+K L  G TE  R  F  E   MG   H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY- 185
           NI+ L G  +  +  ++I E M NG+LD FL  K      L         VG  RGIA  
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ-------LVGMLRGIAAG 159
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAP 243
           + +    + +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + AP
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E     + T+  DV+SFG+V+ E++T G+RP  E    E          VM+   + + +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------VMKAINDGFRL 269
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            T ++ CP    + ++ +   C + E ++RP   ++V +L+
Sbjct: 270 PTPMD-CP----SAIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 138/295 (46%), Gaps = 33/295 (11%)
Query: 55  PLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG 112
           P    L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-A 225
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F +E + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P  
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQL 282
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +     
Sbjct: 283 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
                  + APE    GR T K DV+SFG++L EL T  R             V +   V
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMV 386
Query: 293 MQDKREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            ++     V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 387 NRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 138/295 (46%), Gaps = 33/295 (11%)
Query: 55  PLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG 112
           P    L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-A 225
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F +E + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P  
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQL 282
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +     
Sbjct: 283 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
                  + APE    GR T K DV+SFG++L EL T  R             V +   V
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMV 386
Query: 293 MQDKREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            ++     V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 387 NRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 138/295 (46%), Gaps = 33/295 (11%)
Query: 55  PLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG 112
           P    L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-A 225
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F +E + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P  
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVGEYMSKGSLLDFLKGET--GKYLRLPQL 282
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +     
Sbjct: 283 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
                  + APE    GR T K DV+SFG++L EL T  R             V +   V
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMV 386
Query: 293 MQDKREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            ++     V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 387 NRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 134/283 (47%), Gaps = 31/283 (10%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +E + M  ++
Sbjct: 5   IPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLR 61
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+    S +   ++ E M  GSL  FL G++   K L  P    +A   A G+A
Sbjct: 62  HEKLVQLYAV-VSEEPIXIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMA 118
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +            + APE
Sbjct: 119 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 175
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               GR T K DV+SFG++L EL T  R             V +   V ++     V+D 
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE-----VLDQ 217
Query: 305 SLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 218 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 137/290 (47%), Gaps = 33/290 (11%)
Query: 60  LQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFEREL 117
           L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +E 
Sbjct: 1   LAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEA 57
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P    +A 
Sbjct: 58  QVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAA 114
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +          
Sbjct: 115 QIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
             + APE    GR T K DV+SFG++L EL T  R             V +   V ++  
Sbjct: 172 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE-- 216
Query: 298 EEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 217 ---VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 137/280 (48%), Gaps = 37/280 (13%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVD-------RGFERELEAMGDIKHRNIV 129
           IG GGFG V++   V D +  A+K L  G +E +       + F+RE+  M ++ H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L+G   +     ++ E +P G L   L  K+     + W  + ++ +  A GI Y+ + 
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 190 CIPHIIHRDIKSSNILL---DQNME--ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
             P I+HRD++S NI L   D+N    A+V+DFGL+     +  H  + + G F ++APE
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 245 YFDTGRA--TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
                    T K D YSF ++L  +LTG+ P DE +     K +  +       REE + 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIKFINMI-------REEGLR 248
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            T  E CP    N    +  +C   +P KRP  + +VK L
Sbjct: 249 PTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 138/295 (46%), Gaps = 33/295 (11%)
Query: 55  PLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG 112
           P    L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  
Sbjct: 252 PQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-A 308
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F +E + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P  
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQL 365
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +     
Sbjct: 366 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
                  + APE    GR T K DV+SFG++L EL T  R             V +   V
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMV 469
Query: 293 MQDKREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            ++     V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 470 NRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 137/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 3   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 59
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P    +
Sbjct: 60  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGET--GKYLRLPQLVDM 116
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           +   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 117 SAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAK 173
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 220
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 221 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 137/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 3   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 59
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  GSL  FL G++   K L  P    +
Sbjct: 60  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGET--GKYLRLPQLVDM 116
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           +   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 117 SAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 173
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 220
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   EP +RPT   +   LE
Sbjct: 221 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+   +     ++I E M  GSL  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 136/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  I+H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +
Sbjct: 63  EAQVMKKIRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++LK   K  +G+G FG V+  T N  T  AVK +  G+  V+  F  E   M  ++
Sbjct: 12  IPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQ 68
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH   T      +I E M  GSL  FL     +K+ L  P     +   A G+A
Sbjct: 69  HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMA 125
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           ++      + IHRD++++NIL+  ++  +++DFGLA ++E  +            + APE
Sbjct: 126 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 182
Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             + G  T K DV+SFG++L+E++T G+ P        G      ++A+ +  R      
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYP------GMSNPEVIRALERGYRM----- 231
Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              E CP     ++++I   C +  P +RPT   +  +L+
Sbjct: 232 PRPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 37/280 (13%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVD-------RGFERELEAMGDIKHRNIV 129
           IG GGFG V++   V D +  A+K L  G +E +       + F+RE+  M ++ H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L+G   +     ++ E +P G L   L  K+     + W  + ++ +  A GI Y+ + 
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 190 CIPHIIHRDIKSSNILL---DQNME--ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
             P I+HRD++S NI L   D+N    A+V+DF L+     +  H  + + G F ++APE
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 245 YFDTGRA--TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
                    T K D YSF ++L  +LTG+ P DE +     K +  +       REE + 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIKFINMI-------REEGLR 248
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            T  E CP    N    +  +C   +P KRP  + +VK L
Sbjct: 249 PTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+   +     ++I E M  GSL  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 37/280 (13%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVD-------RGFERELEAMGDIKHRNIV 129
           IG GGFG V++   V D +  A+K L  G +E +       + F+RE+  M ++ H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L+G   +     ++ E +P G L   L  K+     + W  + ++ +  A GI Y+ + 
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 190 CIPHIIHRDIKSSNILL---DQNME--ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
             P I+HRD++S NI L   D+N    A+V+DFG +     +  H  + + G F ++APE
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 245 YFDTGRA--TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
                    T K D YSF ++L  +LTG+ P DE +     K +  +       REE + 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIKFINMI-------REEGLR 248
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            T  E CP    N    +  +C   +P KRP  + +VK L
Sbjct: 249 PTIPEDCPPRLRN----VIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 133/283 (46%), Gaps = 31/283 (10%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +E + M  ++
Sbjct: 6   IPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLR 62
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +A   A G+A
Sbjct: 63  HEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMA 119
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +            + APE
Sbjct: 120 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 176
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               GR T K DV+SFG++L EL T  R             V +   V ++     V+D 
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE-----VLDQ 218
Query: 305 SLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 219 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 133/283 (46%), Gaps = 31/283 (10%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +E + M  ++
Sbjct: 4   IPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLR 60
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +A   A G+A
Sbjct: 61  HEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMA 117
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +            + APE
Sbjct: 118 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 174
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               GR T K DV+SFG++L EL T  R             V +   V ++     V+D 
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE-----VLDQ 216
Query: 305 SLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 217 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 135/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           VIG+G FG V     +L        A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI-AYLHHDC 190
            G  T S+  +++ E M NGSLDTFL      KKN D        VG  RGI A + +  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL------KKN-DGQFTVIQLVGMLRGISAGMKYLS 141
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + APE    
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+V+ E+++ G+RP  E   ++  K V           E Y + + ++
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV----------EEGYRLPSPMD 251
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + E + RP   E+V ML+
Sbjct: 252 -CPAA----LYQLMLDCWQKERNSRPKFDEIVNMLD 282

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 130/267 (48%), Gaps = 22/267 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V+    N+ST  AVK L  GT  V + F  E   M  ++H  +V L+   T 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M  GSL  FL      K  L  P     +   A G+AY+      + IHR
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIHR 134
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D++++N+L+ +++  +++DFGLA ++E  +            + APE  + G  T K DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFG++L E++T GK P        G      + A+ Q  R   V     E CP    ++
Sbjct: 195 WSFGILLYEIVTYGKIPY------PGRTNADVMTALSQGYRMPRV-----ENCP----DE 239
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKMLE 343
           ++ I  MC + +  +RPT   +  +L+
Sbjct: 240 LYDIMKMCWKEKAEERPTFDYLQSVLD 266

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 137/280 (48%), Gaps = 24/280 (8%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I ++++K   K  +G+G FG V+    N+ST  AVK L  GT  V + F  E   M  ++
Sbjct: 9   IPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQ 65
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V L+   T  +   +I E M  GSL  FL      K  L  P     +   A G+A
Sbjct: 66  HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMA 123
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y+      + IHRD++++N+L+ +++  +++DFGLA ++E  +            + APE
Sbjct: 124 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 180
Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             + G  T K +V+SFG++L E++T GK P        G      + A+ Q  R      
Sbjct: 181 AINFGCFTIKSNVWSFGILLYEIVTYGKIPY------PGRTNADVMSALSQGYRM----- 229
Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             +E CP    ++++ I  MC + +  +RPT   +  +L+
Sbjct: 230 PRMENCP----DELYDIMKMCWKEKAEERPTFDYLQSVLD 265

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 135/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  GSL  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD+ ++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 135/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  G L  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++LK   K  +G+G FG V+  T N  T  AVK +  G+  V+  F  E   M  ++
Sbjct: 185 IPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQ 241
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH   T      +I E M  GSL  FL     +K+ L  P     +   A G+A
Sbjct: 242 HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMA 298
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           ++      + IHRD++++NIL+  ++  +++DFGLA ++E  +            + APE
Sbjct: 299 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             + G  T K DV+SFG++L+E++T G+ P        G      ++A+ +  R      
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYP------GMSNPEVIRALERGYRM----- 404
Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              E CP     ++++I   C +  P +RPT   +  +L+
Sbjct: 405 PRPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 135/292 (46%), Gaps = 33/292 (11%)
Query: 58  HSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER 115
             L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  GT   +  F +
Sbjct: 6   QGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQ 62
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E + M  ++H  +V L+    S +   ++ E M  G L  FL G+    K L  P    +
Sbjct: 63  EAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEM--GKYLRLPQLVDM 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +        
Sbjct: 120 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE    GR T K DV+SFG++L EL T  R             V +   V ++
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMVNRE 223
Query: 296 KREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 224 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 135/295 (45%), Gaps = 33/295 (11%)
Query: 55  PLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG 112
           P    L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  G    +  
Sbjct: 170 PQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE-A 226
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F +E + M  ++H  +V L+    S +   ++ E M  GSL  FL G+    K L  P  
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQL 283
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGL  L+E  +     
Sbjct: 284 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ 340
Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
                  + APE    GR T K DV+SFG++L EL T  R             V +   V
Sbjct: 341 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-------------VPYPGMV 387
Query: 293 MQDKREEYVIDTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            ++     V+D    G    CP      +  +   C   +P +RPT   +   LE
Sbjct: 388 NRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 12  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 69  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 125
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 231
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 232 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 13  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 69
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 70  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 126
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 127 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 183
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 232
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 233 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 14  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 70
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 71  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 127
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 128 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 184
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 233
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 234 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAV-KRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +V+G G FG   ++T  ++    V K L R   E  R F +E++ M  ++H N++   G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
               +    I E +  G+L   +  KS++ +   W  R   A   A G+AYLH     +I
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII--KSMDSQ-YPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI-------------VAGTFGYL 241
           IHRD+ S N L+ +N    V+DFGLA LM  EKT    +             V G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           APE  +      K DV+SFG+VL E++ G+   D  +L         V+  +    + Y 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFL----DRY- 243
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
                  CP N     F I   C + +P KRP+  ++   LE ++
Sbjct: 244 -------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 21  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 77
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 78  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 134
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 135 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 191
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 240
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 241 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGLA ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 135
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 245
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 246 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 12  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 69  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 125
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 231
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 232 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 135
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 245
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 246 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 12  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 69  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 125
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 231
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 232 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 18  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 75  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 131
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 188
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 237
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 238 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 152
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 213 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 262
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 263 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 20  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 76
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 77  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 133
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 134 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 190
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 239
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 240 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 17  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 73
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 74  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 130
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 131 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 187
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 236
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 237 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 18  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 75  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 131
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 188
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 237
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 238 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 7   RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 63
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 64  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 120
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 121 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 177
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 226
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 227 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 22  RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 78
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 79  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 135
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 136 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 192
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 241
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 242 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 162
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 222
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 223 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 272
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 273 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 303

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 23/267 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V+  T N +T  A+K L  GT   +  F  E + M  +KH  +V L+    S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAV-VS 74
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   ++ E M  GSL  FL  K    + L  P+   +A   A G+AY+      + IHR
Sbjct: 75  EEPIYIVTEYMNKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 129
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D++S+NIL+   +  +++DFGLA L+E  +            + APE    GR T K DV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFG++L EL+T G+ P       E          V++     Y +    + CPI+    
Sbjct: 190 WSFGILLTELVTKGRVPYPGMNNRE----------VLEQVERGYRMPCP-QDCPIS---- 234
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +  +   C + +P +RPT   +   LE
Sbjct: 235 LHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 133/276 (48%), Gaps = 31/276 (11%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           V+G+G FG V     +L      + A+K L  G TE  R  F  E   MG   H NI+ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY-LHHDC 190
            G  T S+  +++ E M NGSLD+FL         +         VG  RGIA  + +  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGMKYLS 164
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYFDT 248
               +HRD+ + NIL++ N+  +VSDFGL  ++E +     T   G     + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + T+  DV+S+G+VL E+++ G+RP    + E   + V  +KAV +  R    +D    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDV--IKAVDEGYRLPPPMD---- 274
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP      ++ +   C + + + RP   ++V +L+
Sbjct: 275 -CPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 139/292 (47%), Gaps = 38/292 (13%)
Query: 66  FKKTLKFSS---KDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFEREL 117
           F K L  S    + VIG+G FG V     +L      A A+K L  G TE  R  F  E 
Sbjct: 36  FAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKI 175
             MG   H N+V L G  T  +  +++ E M NG+LD FL  H        L        
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL-------- 147
Query: 176 AVGAARGIAY-LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
            VG  RGIA  + +      +HRD+ + NIL++ N+  +VSDFGL+ ++E +   V T  
Sbjct: 148 -VGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTT 206
Query: 235 AGTFG--YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
            G     + APE     + T+  DV+S+G+V+ E+++ G+RP    + +   + V  +KA
Sbjct: 207 GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMSNQDV--IKA 260
Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           + +  R    +D     CP      +  +   C + E ++RP   ++V +L+
Sbjct: 261 IEEGYRLPAPMD-----CPAG----LHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 135/278 (48%), Gaps = 35/278 (12%)
Query: 77  VIGSGGFGTVY--RLTV--NDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           VIG G FG V   RL V        A+K L  G T+  R  F  E   MG   H NI+ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAY-LHH 188
            G  T  +  ++I E M NGSLD FL      +KN     R+ +   VG  RGI   + +
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFL------RKN---DGRFTVIQLVGMLRGIGSGMKY 125
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYF 246
                 +HRD+ + NIL++ N+  +VSDFG++ ++E +     T   G     + APE  
Sbjct: 126 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
              + T+  DV+S+G+V+ E+++ G+RP    + +   + V  +KA+ +  R    +D  
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMSNQDV--IKAIEEGYRLPPPMD-- 237
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              CPI     +  +   C + E S RP   ++V ML+
Sbjct: 238 ---CPIA----LHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 146/310 (47%), Gaps = 36/310 (11%)
Query: 49  MVMFRSPLIHSLQSDAI--FKKTLKFSS---KDVIGSGGFGTV----YRLTVNDSTAFAV 99
           M +F  P      ++A+  F K +  S    + VIG+G FG V     +L        A+
Sbjct: 7   MKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI 66
Query: 100 KRLHRGTTEVDR-GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH 158
           K L  G TE  R  F  E   MG   H N++ L G  T S   ++I E M NGSLD+FL 
Sbjct: 67  KTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 126
Query: 159 GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG 218
               N           +  G A G+ YL      + +HRD+ + NIL++ N+  +VSDFG
Sbjct: 127 Q---NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFG 180
Query: 219 LATLME---AEKTHVSTIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP 273
           L+  +E   ++ T+ S +       + APE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 181 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240
Query: 274 MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP 333
               + +   + V  + A+ QD R    +D     CP    + +  +   C + + + RP
Sbjct: 241 ----YWDMTNQDV--INAIEQDYRLPPPMD-----CP----SALHQLMLDCWQKDRNHRP 285
Query: 334 TMTEVVKMLE 343
              ++V  L+
Sbjct: 286 KFGQIVNTLD 295

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 135/278 (48%), Gaps = 35/278 (12%)
Query: 77  VIGSGGFGTVY--RLTV--NDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           VIG G FG V   RL V        A+K L  G T+  R  F  E   MG   H NI+ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAY-LHH 188
            G  T  +  ++I E M NGSLD FL      +KN     R+ +   VG  RGI   + +
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFL------RKN---DGRFTVIQLVGMLRGIGSGMKY 131
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYF 246
                 +HRD+ + NIL++ N+  +VSDFG++ ++E +     T   G     + APE  
Sbjct: 132 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
              + T+  DV+S+G+V+ E+++ G+RP    + +   + V  +KA+ +  R    +D  
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMSNQDV--IKAIEEGYRLPPPMD-- 243
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              CPI     +  +   C + E S RP   ++V ML+
Sbjct: 244 ---CPIA----LHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 8   RETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 64
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 65  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 121
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHR+++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 122 EER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 178
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 227
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 228 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 135/278 (48%), Gaps = 35/278 (12%)
Query: 77  VIGSGGFGTVY--RLTV--NDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTL 131
           VIG G FG V   RL V        A+K L  G T+  R  F  E   MG   H NI+ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAY-LHH 188
            G  T  +  ++I E M NGSLD FL      +KN     R+ +   VG  RGI   + +
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFL------RKN---DGRFTVIQLVGMLRGIGSGMKY 146
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPEYF 246
                 +HRD+ + NIL++ N+  +VSDFG++ ++E +     T   G     + APE  
Sbjct: 147 LSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
              + T+  DV+S+G+V+ E+++ G+RP    + +   + V  +KA+ +  R    +D  
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMSNQDV--IKAIEEGYRLPPPMD-- 258
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              CPI     +  +   C + E S RP   ++V ML+
Sbjct: 259 ---CPIA----LHQLMLDCWQKERSDRPKFGQIVNMLD 289

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 137/279 (49%), Gaps = 31/279 (11%)
Query: 75  KDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           ++VIG+G FG V R  +       +  A+K L  G TE  R  F  E   MG  +H NI+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T+S   +++ E M NG+LD+FL    +N           +  G A G+ YL   
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME---AEKTHVSTIVAG-TFGYLAPEY 245
                +HRD+ + NIL++ N+  +VSDFGL+  +E   ++ T+ S++       + APE 
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 246 FDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               + T+  D +S+G+V+ E+++ G+RP    + +   + V  + A+ QD R     D 
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP----YWDMSNQDV--INAIEQDYRLPPPPD- 245
Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               CP +    +  +   C + + + RP   +VV  L+
Sbjct: 246 ----CPTS----LHQLMLDCWQKDRNARPRFPQVVSALD 276

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 75  KDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           + +IGSG  G V     R+        A+K L  G TE  R  F  E   MG   H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGI-AYL 186
            L G  T  +  +++ E M NGSLDTFL  H        L         VG  RG+ A +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---------VGMLRGVGAGM 164
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPE 244
            +      +HRD+ + N+L+D N+  +VSDFGL+ ++E +     T   G     + APE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW---VKAVMQDKREEY 300
                  ++  DV+SFGVV+ E+L  G+RP              W    + V+    E Y
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPY-------------WNMTNRDVISSVEEGY 271
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKSEK 349
            +   + GCP    + +  +   C   + ++RP  +++V +L+ LI+S +
Sbjct: 272 RLPAPM-GCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 144/305 (47%), Gaps = 44/305 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 7   ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 121
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 122 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 179 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 229
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 230 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 285
Query: 344 LIKSE 348
            I+ +
Sbjct: 286 QIRDQ 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 144/305 (47%), Gaps = 44/305 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 40  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 154
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 212 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 262
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 263 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 318
Query: 344 LIKSE 348
            I+ +
Sbjct: 319 QIRDQ 323

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 134/282 (47%), Gaps = 39/282 (13%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++LK   K  +G+G FG V+  T N  T  AVK +  G+  V+  F  E   M  ++
Sbjct: 179 IPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQ 235
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH   T      +I E M  GSL  FL     +K+ L  P     +   A G+A
Sbjct: 236 HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMA 292
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLA 242
           ++      + IHRD++++NIL+  ++  +++DFGLA             V   F   + A
Sbjct: 293 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIKWTA 337
Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           PE  + G  T K DV+SFG++L+E++T G+ P        G      ++A+ +  R    
Sbjct: 338 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY------PGMSNPEVIRALERGYRM--- 388
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                E CP     ++++I   C +  P +RPT   +  +L+
Sbjct: 389 --PRPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 12  ERHLKFLRQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK---HKERIDHIKLLQYTSQI 126
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 184 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 234
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 344 LIKS 347
            I+ 
Sbjct: 291 QIRD 294

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 25/278 (8%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           ++TLK   +  +G+G  G V+    N  T  AVK L +G+   D  F  E   M  ++H+
Sbjct: 12  RETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L+   T      +I E M NGSL  FL   S  K  ++      +A   A G+A++
Sbjct: 69  RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI 125
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI 182
Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           + G  T K DV+SFG++L E++T G+ P       E          V+Q+    Y +   
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRM-VR 231
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            + CP     +++ +  +C +  P  RPT   +  +LE
Sbjct: 232 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 13  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 127
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 128 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 185 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 235
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 236 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 291
Query: 344 LIKS 347
            I+ 
Sbjct: 292 QIRD 295

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 8   ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 122
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 123 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 180 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 230
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 231 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 286
Query: 344 LIKS 347
            I+ 
Sbjct: 287 QIRD 290

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 27  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 141
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 142 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 199 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 249
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 250 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 344 LIKS 347
            I+ 
Sbjct: 306 QIRD 309

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 9   ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 123
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 181 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 231
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 344 LIKS 347
            I+ 
Sbjct: 288 QIRD 291

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 75  KDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           + +IGSG  G V     R+        A+K L  G TE  R  F  E   MG   H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGI-AYL 186
            L G  T  +  +++ E M NGSLDTFL  H        L         VG  RG+ A +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---------VGMLRGVGAGM 164
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--YLAPE 244
            +      +HRD+ + N+L+D N+  +VSDFGL+ ++E +     T   G     + APE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW---VKAVMQDKREEY 300
                  ++  DV+SFGVV+ E+L  G+RP              W    + V+    E Y
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPY-------------WNMTNRDVISSVEEGY 271
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKSEK 349
            +   + GCP    + +  +   C   + ++RP  +++V +L+ LI+S +
Sbjct: 272 RLPAPM-GCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 15  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 129
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 130 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 187 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 237
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 238 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 293
Query: 344 LIKS 347
            I+ 
Sbjct: 294 QIRD 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 27  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 141
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 142 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 199 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 249
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 250 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 344 LIKS 347
            I+ 
Sbjct: 306 QIRD 309

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 9   ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 123
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 181 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 231
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 344 LIKS 347
            I+ 
Sbjct: 288 QIRD 291

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 16  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 130
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 131 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 188 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 238
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 239 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 294
Query: 344 LIKS 347
            I+ 
Sbjct: 295 QIRD 298

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 9   ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 123
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 181 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 231
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 344 LIKS 347
            I+ 
Sbjct: 288 QIRD 291

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 14  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 128
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 129 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 186 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 236
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 237 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 292
Query: 344 LIKS 347
            I+ 
Sbjct: 293 QIRD 296

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 12  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 126
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 184 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 234
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 344 LIKS 347
            I+ 
Sbjct: 291 QIRD 294

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 136/279 (48%), Gaps = 31/279 (11%)
Query: 75  KDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           ++VIG+G FG V R  +       +  A+K L  G TE  R  F  E   MG  +H NI+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T+S   +++ E M NG+LD+FL    +N           +  G A G+ YL   
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME---AEKTHVSTIVAG-TFGYLAPEY 245
                +HRD+ + NIL++ N+  +VSDFGL+  +E   ++ T  S++       + APE 
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 246 FDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               + T+  D +S+G+V+ E+++ G+RP    + +   + V  + A+ QD R     D 
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP----YWDMSNQDV--INAIEQDYRLPPPPD- 247
Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               CP +    +  +   C + + + RP   +VV  L+
Sbjct: 248 ----CPTS----LHQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVN---KKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            Q   ++ +     SL   LH        KK +D      IA   ARG+ YLH   I   
Sbjct: 80  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLID------IARQTARGMDYLHAKSI--- 129
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGR 250
           IHRD+KS+NI L ++   ++ DFGLAT+      +H    ++G+  ++APE     D+  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 251 ATAKGDVYSFGVVLLELLTGKRP 273
            + + DVY+FG+VL EL+TG+ P
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLP 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 144/304 (47%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 10  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L     +K+ +D     +     
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQI 124
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHR++ + NIL++     ++ DFGL  ++  +K +      G   
Sbjct: 125 CKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 182 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 232
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 233 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 288
Query: 344 LIKS 347
            I+ 
Sbjct: 289 QIRD 292

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 142/304 (46%), Gaps = 44/304 (14%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E + 
Sbjct: 12  ERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            ++H NIV   G  Y++ + NL LI E +P GSL  +L   +   + +D     +     
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHA---ERIDHIKLLQYTSQI 126
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G   
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQD 295
            F Y APE     + +   DV+SFGVVL EL T        ++E+  +    +++ +  D
Sbjct: 184 IFWY-APESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGND 234
Query: 296 KREEYVIDTSLE------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           K+ + ++   +E            GCP    ++++ I + C     ++RP+  ++   ++
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 344 LIKS 347
            I+ 
Sbjct: 291 QIRD 294

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 77
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 132
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 239
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 240 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 276

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 243
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
               V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 244 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 77
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 132
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 239
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 240 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 276

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 78
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 133
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 241 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 277

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 131
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
               V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 239 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 243
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
               V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 244 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 132/277 (47%), Gaps = 40/277 (14%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTLHG 133
           ++V+G G FG V +     +   A+K++    +E +R  F  EL  +  + H NIV L+G
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA-------ARGIAYL 186
              +     L+ E    GSL   LHG          P  Y  A  A       ++G+AYL
Sbjct: 70  ACLNPV--CLVMEYAEGGSLYNVLHGAE--------PLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           H      +IHRD+K  N+LL       ++ DFG A  ++   TH+ T   G+  ++APE 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THM-TNNKGSAAWMAPEV 175
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
           F+    + K DV+S+G++L E++T ++P DE     G      + AV    R   +    
Sbjct: 176 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEI----GGPAFRIMWAVHNGTRPPLI---- 227
Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                 N    + S+ + C   +PS+RP+M E+VK++
Sbjct: 228 -----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           ++V+G G FG V +     +   A+K++   +    + F  EL  +  + H NIV L+G 
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA-------ARGIAYLH 187
             +     L+ E    GSL   LHG          P  Y  A  A       ++G+AYLH
Sbjct: 70  CLNPV--CLVMEYAEGGSLYNVLHGAE--------PLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
                 +IHRD+K  N+LL       ++ DFG A  ++   TH+ T   G+  ++APE F
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THM-TNNKGSAAWMAPEVF 175
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
           +    + K DV+S+G++L E++T ++P DE     G      + AV    R   +     
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI----GGPAFRIMWAVHNGTRPPLI----- 226
Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                N    + S+ + C   +PS+RP+M E+VK++
Sbjct: 227 ----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 89
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 144
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 251
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 252 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 288

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T+
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVN---KKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            Q   ++ +     SL   LH        KK +D      IA   ARG+ YLH   I   
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLID------IARQTARGMDYLHAKSI--- 141
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGR 250
           IHRD+KS+NI L ++   ++ DFGLAT       +H    ++G+  ++APE     D+  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 251 ATAKGDVYSFGVVLLELLTGKRP 273
            + + DVY+FG+VL EL+TG+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 78
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 133
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 241 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 277

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 78
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 133
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 241 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 277

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 243
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
               V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 244 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 135
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 242
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
               V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 243 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 243
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 244 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 280

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 123/271 (45%), Gaps = 23/271 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 131
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               V+ +   C +  PS RP+  E+ +  E
Sbjct: 239 --EKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVN---KKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            Q   ++ +     SL   LH        KK +D      IA   ARG+ YLH   I   
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLID------IARQTARGMDYLHAKSI--- 141
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGR 250
           IHRD+KS+NI L ++   ++ DFGLAT       +H    ++G+  ++APE     D+  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 251 ATAKGDVYSFGVVLLELLTGKRP 273
            + + DVY+FG+VL EL+TG+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 239 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 239 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 239 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 239 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T+
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q  + + +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 128
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 136
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 243
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 244 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 280

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 133/279 (47%), Gaps = 31/279 (11%)
Query: 75  KDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           + VIG+G FG V     +L        A+K L  G TE  R  F  E   MG   H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T S   ++I E M NGSLD+FL     N           +  G A G+ YL   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD- 127
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME---AEKTHVSTIVAG-TFGYLAPEY 245
              + +HR + + NIL++ N+  +VSDFGL+  +E   ++ T+ S +       + APE 
Sbjct: 128 --MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 246 FDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
               + T+  DV+S+G+V+ E+++ G+RP    + +   + V  + A+ QD R    +D 
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMTNQDV--INAIEQDYRLPPPMD- 238
Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               CP    + +  +   C + + + RP   ++V  L+
Sbjct: 239 ----CP----SALHQLMLDCWQKDRNHRPKFGQIVNTLD 269

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 130
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 191 QSDVYAFGIVLYELMTGQLP 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G FG VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 74
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 129
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G       + + +D R E       EGCP  
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYP------GIDPSQVYELLEKDYRME-----RPEGCP-- 236
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 237 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q  + + +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 128
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 133
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 133
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 155
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 216 QSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 156
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     D    + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 74
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 129
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G       + + +D R E       EGCP  
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYP------GIDPSQVYELLEKDYRME-----RPEGCP-- 236
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 237 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 273

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 128
Query: 198 DIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT       +H    ++G+  ++APE     D    + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 15  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 74
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 75  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 133
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 134 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEX 187
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 188 XSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 248 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 292
Query: 345 IKS 347
           I S
Sbjct: 293 IFS 295

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 74
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 129
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G       + + +D R E       EGCP  
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYP------GIDPSQVYELLEKDYRME-----RPEGCP-- 236
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 237 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 273

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 92/335 (27%), Positives = 155/335 (46%), Gaps = 34/335 (10%)
Query: 25  ISVLLYRRWKRKNMVYTDSVSGGKMVMFRSP-LIHSLQSDAIFKKTLKFSSKDVIGSGGF 83
           +S  LY++   +N+ +  + +    +   +P L+ ++Q   I   +L     +VIG G F
Sbjct: 43  LSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHF 102
Query: 84  GTVYRLTVNDSTA----FAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           G VY  T+ D+       AVK L+R T   EV + F  E   M D  H N+++L G    
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLR 161
Query: 138 SQYN-LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
           S+ + L++   M +G L  F+  ++ N    D        +  A+G+ +L        +H
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFLASK---KFVH 215
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLM---EAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           RD+ + N +LD+    +V+DFGLA  M   E +  H  T       ++A E   T + T 
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV+SFGV+L EL+T G  P  +    + T  +   + ++Q            E CP  
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-----------EYCP-- 322
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
             + ++ +   C  P+   RP+ +E+V  +  I S
Sbjct: 323 --DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 96  PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 148
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT       +H    ++G+  ++APE     D    + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 209 QSDVYAFGIVLYELMTGQLP 228

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  D+   FA K + +         E+   E+     + H+++V  HG
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++  + +  ++ EL    SL   LH +   +K L  P           G  YLH +    
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKR---RKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L++++E ++ DFGLAT +E +     T+  GT  Y+APE       + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 196
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G ++  LL GK P + + L+E     T+++     K+ EY I           
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYSIP--------KH 239
Query: 314 INDV-FSIASMCLEPEPSKRPTMTEVV 339
           IN V  S+    L+ +P+ RPT+ E++
Sbjct: 240 INPVAASLIQKMLQTDPTARPTINELL 266

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 322
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ ++      +A   +  + YL      +
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 377
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHR++ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 484
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 485 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 521

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 8   LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 67
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 68  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 126
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 127 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 180
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 181 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 240
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 241 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 285
Query: 345 IKS 347
           I S
Sbjct: 286 IFS 288

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  D+   FA K + +         E+   E+     + H+++V  HG
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++  + +  ++ EL    SL   LH +   +K L  P           G  YLH +    
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKR---RKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L++++E ++ DFGLAT +E +     T+  GT  Y+APE       + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 196
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G ++  LL GK P + + L+E     T+++     K+ EY I           
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYSIP--------KH 239
Query: 314 INDV-FSIASMCLEPEPSKRPTMTEVV 339
           IN V  S+    L+ +P+ RPT+ E++
Sbjct: 240 INPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  D+   FA K + +         E+   E+     + H+++V  HG
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++  + +  ++ EL    SL   LH +   +K L  P           G  YLH +    
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKR---RKALTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L++++E ++ DFGLAT +E +      ++ GT  Y+APE       + 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKGHSF 194
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G ++  LL GK P + + L+E     T+++     K+ EY I           
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYSIP--------KH 237
Query: 314 INDV-FSIASMCLEPEPSKRPTMTEVV 339
           IN V  S+    L+ +P+ RPT+ E++
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELL 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+   GY T 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            Q   ++ +     SL   LH   + +   +      IA   A+G+ YLH   I   IHR
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHR 156
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYF---DTGRATA 253
           D+KS+NI L +++  ++ DFGLAT       +H    ++G+  ++APE     D    + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 254 KGDVYSFGVVLLELLTGKRP 273
           + DVY+FG+VL EL+TG+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  D+   FA K + +         E+   E+     + H+++V  HG
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++  + +  ++ EL    SL   LH +   +K L  P           G  YLH +    
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKR---RKALTEPEARYYLRQIVLGCQYLHRN---R 141
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L++++E ++ DFGLAT +E +     T+  GT  Y+APE       + 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 200
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G ++  LL GK P + + L+E     T+++     K+ EY I           
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYSIP--------KH 243
Query: 314 INDV-FSIASMCLEPEPSKRPTMTEVV 339
           IN V  S+    L+ +P+ RPT+ E++
Sbjct: 244 INPVAASLIQKMLQTDPTARPTINELL 270

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 35  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 94
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 95  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 153
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 154 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 207
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 208 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 267
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 268 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 312
Query: 345 IKS 347
           I S
Sbjct: 313 IFS 315

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 13  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 73  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 132 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 185
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 186 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 246 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
Query: 345 IKS 347
           I S
Sbjct: 291 IFS 293

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 16  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 75
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 76  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 135 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 189 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 249 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 293
Query: 345 IKS 347
           I S
Sbjct: 294 IFS 296

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 15  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 74
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 75  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 133
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 134 L---IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 187
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 188 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 248 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 292
Query: 345 IKS 347
           I S
Sbjct: 293 IFS 295

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 11  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 70
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 71  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 130 L---IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 244 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 288
Query: 345 IKS 347
           I S
Sbjct: 289 IFS 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 14  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 73
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 74  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 132
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 133 L---IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 186
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 187 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 247 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 291
Query: 345 IKS 347
           I S
Sbjct: 292 IFS 294

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 16  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 75
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 76  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 135 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 189 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 249 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 293
Query: 345 IKS 347
           I S
Sbjct: 294 IFS 296

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 140/303 (46%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 16  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 75
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 76  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 135 L---IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
           +  H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 189 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 249 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 293
Query: 345 IKS 347
           I S
Sbjct: 294 IFS 296

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 34  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 93
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 94  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 152
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 153 L---IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 206
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
              H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 207 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 266
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 267 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 311
Query: 345 IKS 347
           I S
Sbjct: 312 IFS 314

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 140/303 (46%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 16  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 75
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 76  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 135 L---IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
           +  H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 189 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 249 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 293
Query: 345 IKS 347
           I S
Sbjct: 294 IFS 296

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  D+   FA K + +         E+   E+     + H+++V  HG
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++  + +  ++ EL    SL   LH +   +K L  P           G  YLH +    
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKR---RKALTEPEARYYLRQIVLGCQYLHRN---R 159
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L++++E ++ DFGLAT +E +      ++ GT  Y+APE       + 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKGHSF 218
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G ++  LL GK P + + L+E     T+++     K+ EY I           
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYSIP--------KH 261
Query: 314 INDV-FSIASMCLEPEPSKRPTMTEVV 339
           IN V  S+    L+ +P+ RPT+ E++
Sbjct: 262 INPVAASLIQKMLQTDPTARPTINELL 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 140/303 (46%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 17  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 76
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 77  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 135
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 136 L---IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 189
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
           +  H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 190 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 249
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 250 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 294
Query: 345 IKS 347
           I S
Sbjct: 295 IFS 297

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 140/303 (46%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 21  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 80
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 81  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 139
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 140 L---IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 193
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
           +  H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 194 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 253
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 254 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 298
Query: 345 IKS 347
           I S
Sbjct: 299 IFS 301

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 140/303 (46%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 14  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 73
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 74  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 132
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 133 L---IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 186
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
           +  H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 187 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 247 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 291
Query: 345 IKS 347
           I S
Sbjct: 292 IFS 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 140/303 (46%), Gaps = 33/303 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT--EV 109
           L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   EV
Sbjct: 17  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 76
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNLD 168
            + F  E   M D  H N+++L G    S+ + L++   M +G L  F+  ++ N    D
Sbjct: 77  SQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 135
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EA 225
                   +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  M   E 
Sbjct: 136 L---IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF 189
Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
           +  H  T       ++A E   T + T K DV+SFGV+L EL+T G  P  +    + T 
Sbjct: 190 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 249
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
            +   + ++Q            E CP    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 250 YLLQGRRLLQP-----------EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 294
Query: 345 IKS 347
           I S
Sbjct: 295 IFS 297

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  D+   FA K + +         E+   E+     + H+++V  HG
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++  + +  ++ EL    SL   LH +   +K L  P           G  YLH +    
Sbjct: 109 FFEDNDFVFVVLELCRRRSL-LELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---R 161
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L++++E ++ DFGLAT +E +      ++ GT  Y+APE       + 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKGHSF 220
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G ++  LL GK P + + L+E     T+++     K+ EY I           
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYSIP--------KH 263
Query: 314 INDV-FSIASMCLEPEPSKRPTMTEVV 339
           IN V  S+    L+ +P+ RPT+ E++
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELL 290

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 283
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHR++ + N L+ +N   +V+DFGL+ LM  +             + APE     + + 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P        G  L    + + +D R E       EGCP  
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME-----RPEGCP-- 445
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
               V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 446 --EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FGTVY+   +   A  + ++   T E  + F  E+  +   +H NI+   GY T 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 138 SQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
              NL I      GS L   LH   V +          IA   A+G+ YLH     +IIH
Sbjct: 104 D--NLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLH---AKNIIH 155
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLME----AEKTHVSTIVAGTFGYLAPEYF---DTG 249
           RD+KS+NI L + +  ++ DFGLAT+      +++    T   G+  ++APE     D  
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAPEVIRMQDNN 212
Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
             + + DVYS+G+VL EL+TG+ P
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 21  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G +   L   S      D           A  ++Y H     
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLS----KFDEQRTATYITELANALSYCHSK--- 132
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 189
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D    +V + + +     
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD----- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 241 -------LISRLLKHNPSQRPMLREVLE 261

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 21  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 132
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEXIEGRXHD 189
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 241 -------LISRLLKHNPSQRPXLREVLE 261

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 128/293 (43%), Gaps = 37/293 (12%)
Query: 78  IGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG V+       L   D    AVK L   +    + F+RE E +  ++H++IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLH-----------GKSVNKKNLDWPSRYKIAVGAA 180
            G  T  +  L+++E M +G L+ FL            G+ V    L       +A   A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFG 239
            G+ YL      H +HRD+ + N L+ Q +  ++ DFG++  +   +   V         
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           ++ PE     + T + DV+SFGVVL E+ T GK+P  +    E    +T  + + + +  
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR-- 260
Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                     CP     +V++I   C + EP +R ++ +V   L+ +     V
Sbjct: 261 ---------ACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 15  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 73
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 74  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 126
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 127 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 183
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 234
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 235 -------LISRLLKHNPSQRPMLREVLE 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 128/293 (43%), Gaps = 37/293 (12%)
Query: 78  IGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG V+       L   D    AVK L   +    + F+RE E +  ++H++IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLH-----------GKSVNKKNLDWPSRYKIAVGAA 180
            G  T  +  L+++E M +G L+ FL            G+ V    L       +A   A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFG 239
            G+ YL      H +HRD+ + N L+ Q +  ++ DFG++  +   +   V         
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           ++ PE     + T + DV+SFGVVL E+ T GK+P  +    E    +T  + + + +  
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR-- 254
Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                     CP     +V++I   C + EP +R ++ +V   L+ +     V
Sbjct: 255 ---------ACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 19  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 130
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 187
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLE 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 21  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 132
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 189
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 241 -------LISRLLKHNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 19  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 130
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 187
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLE 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 118/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 17  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 128
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T ++GT  YL PE  +     
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGTLDYLPPEMIEGRMHD 185
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 236
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 237 -------LISRLLKHNPSQRPMLREVLE 257

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 20  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 131
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 132 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 188
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 239
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 240 -------LISRLLKHNPSQRPMLREVLE 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 33  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 91
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 92  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 144
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 201
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D    +V + + +     
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD----- 252
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 253 -------LISRLLKHNPSQRPMLREVLE 273

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 128/293 (43%), Gaps = 37/293 (12%)
Query: 78  IGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG V+       L   D    AVK L   +    + F+RE E +  ++H++IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLH-----------GKSVNKKNLDWPSRYKIAVGAA 180
            G  T  +  L+++E M +G L+ FL            G+ V    L       +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFG 239
            G+ YL      H +HRD+ + N L+ Q +  ++ DFG++  +   +   V         
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           ++ PE     + T + DV+SFGVVL E+ T GK+P  +    E    +T  + + + +  
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR-- 283
Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                     CP     +V++I   C + EP +R ++ +V   L+ +     V
Sbjct: 284 ---------ACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 42  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 153
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 210
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D    +V + + +     
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD----- 261
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 262 -------LISRLLKHNPSQRPMLREVLE 282

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 38/291 (13%)
Query: 75  KDVIGSGGFGTV-----YRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K  +G G FG V     Y L+   D    AVK L   T    + F+RE E + +++H +I
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSV----------NKKNLDWPSRYKIA 176
           V  +G        ++++E M +G L+ FL  HG              K  L       IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVA 235
              A G+ YL      H +HRD+ + N L+  N+  ++ DFG++  +   +   V     
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
               ++ PE     + T + DV+SFGV+L E+ T GK+P  +    E  + +T  + + +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 256
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
            +            CP     +V+ +   C + EP +R  + E+ K+L  +
Sbjct: 257 PRV-----------CP----KEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 21  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 132
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHD 189
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 241 -------LISRLLKHNPSQRPMLREVLE 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 17  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 128
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHD 185
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 236
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 237 -------LISRLLKHNPSQRPMLREVLE 257

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L       F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 13  LGKGKFGNVY-LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 71
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 72  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 124
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 181
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 232
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 233 -------LISRLLKHNPSQRPMLREVLE 253

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 18  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 129
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E ++++FG +    + +    T + GT  YL PE  +     
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 186
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 237
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 238 -------LISRLLKHNPSQRPMLREVLE 258

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 118/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 21  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G +   L   S      D           A  ++Y H     
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLS----KFDEQRTATYITELANALSYCHSK--- 132
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXGTLDYLPPEMIEGRMHD 189
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D    +V + + +     
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD----- 240
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 241 -------LISRLLKHNPSQRPMLREVLE 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 23/269 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G+   D  F  E E M  + H  +V L+G    
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
                L++E M +G L  +L      +      +   + +    G+AYL   C+   IHR
Sbjct: 94  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHR 147
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R ++K DV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ + GK P +     E          V++D    + +       P      
Sbjct: 208 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLYK-----PRLASTH 252
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           V+ I + C +  P  RP  + +++ L  I
Sbjct: 253 VYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 19  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 130
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E ++++FG +    + +    T + GT  YL PE  +     
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 187
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLE 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 18  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 129
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPPEMIEGRMHD 186
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 237
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 238 -------LISRLLKHNPSQRPMLREVLE 258

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 118/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 17  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 128
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +  + A  +   T+  GT  YL PE  +     
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTL-CGTLDYLPPEMIEGRMHD 185
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 236
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 237 -------LISRLLKHNPSQRPMLREVLE 257

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 19  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 130
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPPEMIEGRMHD 187
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLE 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 19  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 130
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPPEMIEGRMHD 187
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLE 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L    ++ F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  S    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDSTRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    ++  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 16  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 127
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPPEMIEGRMHD 184
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 235
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLE 256

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 23/266 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L+G    
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
                L++E M +G L  +L      +      +   + +    G+AYL   C+   IHR
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHR 125
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R ++K DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ + GK P +     E          V++D    + +       P      
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLYK-----PRLASTH 230
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKML 342
           V+ I + C +  P  RP  + +++ L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 23/266 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L+G    
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
                L++E M +G L  +L      +      +   + +    G+AYL   C+   IHR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHR 127
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R ++K DV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ + GK P +     E          V++D    + +       P      
Sbjct: 188 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLYK-----PRLASTH 232
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKML 342
           V+ I + C +  P  RP  + +++ L
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 23/269 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L+G    
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
                L++E M +G L  +L      +      +   + +    G+AYL   C+   IHR
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHR 130
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R ++K DV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ + GK P +     E          V++D    + +       P      
Sbjct: 191 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLYK-----PRLASTH 235
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           V+ I + C    P  RP  + +++ L  I
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 75  KDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY  +    S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 95
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      ++ E MP G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLEKK---N 150
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE       + 
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 254 KGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
           K DV++FGV+L E+ T G  P     L +   L+           + Y ++   EGCP  
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLL----------EKGYRMEQP-EGCPPK 259
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               V+ +   C +  P+ RP+  E  +  E
Sbjct: 260 ----VYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 19  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 130
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPPEMIEGRMHD 187
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D         
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--------- 238
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLE 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 42  LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK--- 153
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPPEMIEGRMHD 210
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            K D++S GV+  E L GK P +    +E  K ++ V+    D    +V + + +     
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD----- 261
Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                  + S  L+  PS+RP + EV++
Sbjct: 262 -------LISRLLKHNPSQRPMLREVLE 282

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +GSG FG V           AVK +  G+   D  F+ E + M  + H  +V  +G  + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKLVKFYGVCSK 74
Query: 138 SQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
                ++ E + NG L  +L  HGK +    L      ++      G+A+L        I
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFI 126
Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HRD+ + N L+D+++  +VSDFG+   +  ++   S        + APE F   + ++K 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 256 DVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEI 314
           DV++FG+++ E+ + GK P D   L   +++V  V    +  R     DT          
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD---LYTNSEVVLKVSQGHRLYRPHLASDT---------- 233
Query: 315 NDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
             ++ I   C    P KRPT  +++  +E ++ +
Sbjct: 234 --IYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 234
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 235 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 273

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 234
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 235 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 273

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   Y +T  D+   FA K + +         E+   E+     + + ++V  HG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++    +  ++ E+    SL   LH +   +K +  P          +G+ YLH++    
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKR---RKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L+ +M+ ++ DFGLAT +E +     T+  GT  Y+APE       + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVLCKKGHSF 221
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + D++S G +L  LL GK P + + L+E     T+++     K+ EY +           
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKE-----TYIRI----KKNEYSVP--------RH 264
Query: 314 INDVFS-IASMCLEPEPSKRPTMTEVV 339
           IN V S +    L  +P+ RP++ E++
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 76  DVIGSGGFGTVY--RLTVNDSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLH 132
           + IG G FG V+  RL   D+T  AVK        ++   F +E   +    H NIV L 
Sbjct: 120 EQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           G  T  Q   ++ EL+  G   TFL   G  +  K L      ++   AA G+ YL   C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAAGMEYLESKC 233
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST--IVAGTFGYLAPEYFDT 248
               IHRD+ + N L+ +    ++SDFG++   EA+  + ++  +      + APE  + 
Sbjct: 234 C---IHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
           GR +++ DV+SFG++L E  + G  P                  +   +  E+V      
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPN---------------LSNQQTREFVEKGGRL 334
Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
            CP    + VF +   C   EP +RP+ + + + L+ I+
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 105/221 (47%), Gaps = 29/221 (13%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLH--------RGTTEVDRGFERELEAM 120
           K+  KDVIG G   +V R  V+ +T   FAVK +             EV     RE   +
Sbjct: 95  KYDPKDVIGRG-VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 121 GDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
             +  H +I+TL   Y SS +  L+++LM  G L  +L      K  L       I    
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSL 209
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTF 238
              +++LH +   +I+HRD+K  NILLD NM+ R+SDFG +  +E  EK      + GT 
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTP 263
Query: 239 GYLAPEYFDTG-RATAKG-----DVYSFGVVLLELLTGKRP 273
           GYLAPE        T  G     D+++ GV+L  LL G  P
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 126/295 (42%), Gaps = 47/295 (15%)
Query: 78  IGSGGFGTVYR------LTVNDSTAFAVKRL-HRGTTEVDRGFERELEAMGDIKHRNIVT 130
           IG G FG V++      L     T  AVK L    + ++   F+RE   M +  + NIV 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHG--------------------KSVNKKNLDWP 170
           L G     +   L++E M  G L+ FL                       S     L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTH 229
            +  IA   A G+AYL        +HRD+ + N L+ +NM  +++DFGL+  +  A+   
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW 288
                A    ++ PE     R T + DV+++GVVL E+ + G +P      EE    V +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----VIY 287
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                      YV D ++  CP N   +++++  +C    P+ RP+   + ++L+
Sbjct: 288 -----------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 82  IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 239
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 74  IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 231
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 105 IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 158
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 159 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 218 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 262
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 263 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 301

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 79  IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 133 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 192 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 236
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 237 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 275

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 80  IGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 133
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 134 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 237
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 238 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 276

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 78  IGSGGFGTVYRLTV-----NDSTAFAVKRL--HRGTTEVDRGFERELEAMGDIKHRNIVT 130
           +G G FG V          N     AVK L    G   +    ++E+E + ++ H NIV 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVK 87
Query: 131 LHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             G  T    N   LI E +P+GSL  +L     NK  ++   + K AV   +G+ YL  
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVAGTFGYLAPEYF 246
                 +HRD+ + N+L++   + ++ DFGL   +E +K    V         + APE  
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 247 DTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
              +     DV+SFGV L ELLT       PM   FL    K++      M   R   ++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPM-ALFL----KMIGPTHGQMTVTR---LV 253
Query: 303 DTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           +T  EG    CP N  ++V+ +   C E +PS R +   +++  E +
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 23/269 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L+G    
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
                L+ E M +G L  +L      +      +   + +    G+AYL   C+   IHR
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHR 128
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R ++K DV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ + GK P +     E          V++D    + +       P      
Sbjct: 189 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLYK-----PRLASTH 233
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           V+ I + C    P  RP  + +++ L  I
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 78  IGSGGFGTVYRLTV-----NDSTAFAVKRL--HRGTTEVDRGFERELEAMGDIKHRNIVT 130
           +G G FG V          N     AVK L    G   +    ++E+E + ++ H NIV 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVK 75
Query: 131 LHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             G  T    N   LI E +P+GSL  +L     NK  ++   + K AV   +G+ YL  
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVAGTFGYLAPEYF 246
                 +HRD+ + N+L++   + ++ DFGL   +E +K    V         + APE  
Sbjct: 133 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 247 DTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
              +     DV+SFGV L ELLT       PM   FL    K++      M   R   ++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPM-ALFL----KMIGPTHGQMTVTR---LV 241
Query: 303 DTSLEG----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
           +T  EG    CP N  ++V+ +   C E +PS R +   +++  E +
Sbjct: 242 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 288

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 76  DVIGSGGFGTVY--RLTVNDSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLH 132
           + IG G FG V+  RL   D+T  AVK        ++   F +E   +    H NIV L 
Sbjct: 120 EQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           G  T  Q   ++ EL+  G   TFL   G  +  K L      ++   AA G+ YL   C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAAGMEYLESKC 233
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG-------YLAP 243
               IHRD+ + N L+ +    ++SDFG++      +     + A + G       + AP
Sbjct: 234 C---IHRDLAARNCLVTEKNVLKISDFGMS------REEADGVXAASGGLRQVPVKWTAP 284
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E  + GR +++ DV+SFG++L E  + G  P                  +   +  E+V 
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPN---------------LSNQQTREFVE 329
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
                 CP    + VF +   C   EP +RP+ + + + L+ I+
Sbjct: 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME      ++       ++APE  +  R 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 234
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 235 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 273

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 23/271 (8%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L+G    
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
                L++E M +G L  +L      +      +   + +    G+AYL       +IHR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHR 127
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R ++K DV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 258 YSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIND 316
           +SFGV++ E+ + GK P +     E          V++D    + +       P      
Sbjct: 188 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLYK-----PRLASTH 232
Query: 317 VFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
           V+ I + C +  P  RP  + +++ L  I +
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQLAAIAA 263

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 135/306 (44%), Gaps = 28/306 (9%)
Query: 57  IHSLQSDAIFK-KTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVD 110
           +++ Q   IF+ + LK+ S+  +G G FG+V       L  N     AVK+L     +  
Sbjct: 11  LYACQDPTIFEERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ 68
Query: 111 RGFERELEAMGDIKHRNIVTLHG--YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
           R F+RE++ +  +    IV   G  Y    Q   L+ E +P+G L  FL     ++  LD
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLD 125
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +    +G+ YL        +HRD+ + NIL++     +++DFGLA L+  +K 
Sbjct: 126 ASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
Query: 229 HVSTIVAGT---FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLEE 281
           +      G    F Y APE       + + DV+SFGVVL EL T       P  E     
Sbjct: 183 YYVVREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
           G +      + + +  EE     +   CP     +V  +  +C  P P  RP+ + +   
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPA----EVHELMKLCWAPSPQDRPSFSALGPQ 297
Query: 342 LELIKS 347
           L+++ S
Sbjct: 298 LDMLWS 303

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 25/226 (11%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDRGFE 114
           S+Q+  I +KT  F   +V+GSG F  V+    RLT      FA+K + +     D   E
Sbjct: 1   SMQTTNI-RKTFIFM--EVLGSGAFSEVFLVKQRLT---GKLFALKCIKKSPAFRDSSLE 54
Query: 115 RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY 173
            E+  +  IKH NIVTL   Y S+ +  L+ +L+  G L D  L      +K+       
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---- 110
Query: 174 KIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHV 230
            +       + YLH +    I+HRD+K  N+L    ++N +  ++DFGL+ +   E+  +
Sbjct: 111 -VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGI 163
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
            +   GT GY+APE       +   D +S GV+   LL G  P  E
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   Y +T  D+   FA K + +         E+   E+     + + ++V  HG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++    +  ++ E+    SL   LH +   +K +  P          +G+ YLH++    
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKR---RKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L+ +M+ ++ DFGLAT +E +       + GT  Y+APE       + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAPEVLCKKGHSF 221
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + D++S G +L  LL GK P + + L+E     T+++     K+ EY +           
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKE-----TYIRI----KKNEYSVP--------RH 264
Query: 314 INDVFS-IASMCLEPEPSKRPTMTEVV 339
           IN V S +    L  +P+ RP++ E++
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELL 291

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 614
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   Y +T  D+   FA K + +         E+   E+     + + ++V  HG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++    +  ++ E+    SL   LH +   +K +  P          +G+ YLH++    
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKR---RKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L+ +M+ ++ DFGLAT +E +      +  GT  Y+APE       + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVLCKKGHSF 221
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + D++S G +L  LL GK P + + L+E     T+++     K+ EY +           
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKE-----TYIRI----KKNEYSVP--------RH 264
Query: 314 INDVFS-IASMCLEPEPSKRPTMTEVV 339
           IN V S +    L  +P+ RP++ E++
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 30/267 (11%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLHG 133
           +G GGF   Y +T  D+   FA K + +         E+   E+     + + ++V  HG
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++    +  ++ E+    SL   LH +   +K +  P          +G+ YLH++    
Sbjct: 94  FFEDDDFVYVVLEICRRRSL-LELHKR---RKAVTEPEARYFMRQTIQGVQYLHNN---R 146
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +IHRD+K  N+ L+ +M+ ++ DFGLAT +E +      +  GT  Y+APE       + 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVLCKKGHSF 205
Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + D++S G +L  LL GK P + + L+E     T+++     K+ EY +           
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETSCLKE-----TYIRI----KKNEYSVP--------RH 248
Query: 314 INDVFS-IASMCLEPEPSKRPTMTEVV 339
           IN V S +    L  +P+ RP++ E++
Sbjct: 249 INPVASALIRRMLHADPTLRPSVAELL 275

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 61  QSDAIFK-KTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFE 114
           Q   IF+ + LK+ S+  +G G FG+V       L  N     AVK+L     +  R F+
Sbjct: 2   QDPTIFEERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ 59
Query: 115 RELEAMGDIKHRNIVTLHG--YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           RE++ +  +    IV   G  Y    Q   L+ E +P+G L  FL     ++  LD    
Sbjct: 60  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRL 116
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
              +    +G+ YL        +HRD+ + NIL++     +++DFGLA L+  +K +   
Sbjct: 117 LLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 173
Query: 233 IVAGT---FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWV 289
              G    F Y APE       + + DV+SFGVVL EL T        + ++        
Sbjct: 174 REPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFT--------YCDKSCSPSAEF 224
Query: 290 KAVMQDKREEYVID------------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE 337
             +M  +R+   +              +   CP     +V  +  +C  P P  RP+ + 
Sbjct: 225 LRMMGSERDVPALSRLLELLEEGQRLPAPPACPA----EVHELMKLCWAPSPQDRPSFSA 280
Query: 338 VVKMLELIKS 347
           +   L+++ S
Sbjct: 281 LGPQLDMLWS 290

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 35/286 (12%)
Query: 75  KDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K  +G G FG V+           D    AVK L   +    + F RE E + +++H +I
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSV-------NKKNLDWPSRYKIAVGA 179
           V  +G        ++++E M +G L+ FL  HG              L       IA   
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTF 238
           A G+ YL      H +HRD+ + N L+ +N+  ++ DFG++  +   +   V        
Sbjct: 138 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
            ++ PE     + T + DV+S GVVL E+ T GK+P  +    E  + +T  + V+Q  R
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPR 253
Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                      CP     +V+ +   C + EP  R  +  +  +L+
Sbjct: 254 T----------CP----QEVYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           V+G G +G VY    +++    A+K +    +   +    E+     +KH+NIV   G +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGK----SVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           + + +  +  E +P GSL   L  K      N++ + + ++  +      G+ YLH +  
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 141
Query: 192 PHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG- 249
             I+HRDIK  N+L++      ++SDFG +  +        T   GT  Y+APE  D G 
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGP 199
Query: 250 RATAK-GDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           R   K  D++S G  ++E+ TGK P    F E G       K  M     E     S E 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP----FYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                    F +   C EP+P KR    +++
Sbjct: 256 -------KAFILK--CFEPDPDKRACANDLL 277

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 126/296 (42%), Gaps = 52/296 (17%)
Query: 72  FSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           +  ++VIGSG    V   Y     +  A     L +  T +D    +E++AM    H NI
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNI 70
Query: 129 VTLHGYYTSSQYNLLIYELMPNGS-LDTFLH--GKSVNKKN-LDWPSRYKIAVGAARGIA 184
           V+ +  +       L+ +L+  GS LD   H   K  +K   LD  +   I      G+ 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG----LATLMEAEKTHVSTIVAGTFGY 240
           YLH +     IHRD+K+ NILL ++   +++DFG    LAT  +  +  V     GT  +
Sbjct: 131 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 241 LAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPM---------------DEAFLEEGTK 284
           +APE  +  R    K D++SFG+  +EL TG  P                D   LE G  
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG-- 245
Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                   +QDK        S              + S+CL+ +P KRPT  E+++
Sbjct: 246 --------VQDKEMLKKYGKSFR-----------KMISLCLQKDPEKRPTAAELLR 282

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 20  LGKGKFGNVY-LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLS----RFDEQRTATYITELANALSYCHSK--- 131
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL  N E +++DFG +    + +    T + GT  YL PE  +     
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHD 188
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
            K D++S GV+  E L G  P +    +E  + ++ V+    D
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 30/271 (11%)
Query: 77  VIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           V+G G +G VY    +++    A+K +    +   +    E+     +KH+NIV   G +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGK----SVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           + + +  +  E +P GSL   L  K      N++ + + ++  +      G+ YLH +  
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 127
Query: 192 PHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG- 249
             I+HRDIK  N+L++      ++SDFG +  +        T   GT  Y+APE  D G 
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGP 185
Query: 250 RATAK-GDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           R   K  D++S G  ++E+ TGK P    F E G       K  M     E     S E 
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPP----FYELGEPQAAMFKVGMFKVHPEIPESMSAEA 241
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                     +    C EP+P KR    +++
Sbjct: 242 K---------AFILKCFEPDPDKRACANDLL 263

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 19/240 (7%)
Query: 45  SGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVY----RLTVNDSTAFAVK 100
           SG + + F+ P +    S AIF  + ++  + V+G G FG V     ++T  +     + 
Sbjct: 9   SGRENLYFQGPGMFVQHSTAIF--SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 66
Query: 101 RLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK 160
           +             RE++ +  + H NI+ L+ ++    Y  L+ E+   G     L  +
Sbjct: 67  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDE 122
Query: 161 SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDF 217
            +++K        +I      GI Y+H +    I+HRD+K  N+LL+   ++   R+ DF
Sbjct: 123 IISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF 179
Query: 218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA 277
           GL+T  EA K     I  GT  Y+APE    G    K DV+S GV+L  LL+G  P + A
Sbjct: 180 GLSTHFEASKKMKDKI--GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA 236

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 24/282 (8%)
Query: 72  FSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           +  ++VIGSG    V   Y     +  A     L +  T +D    +E++AM    H NI
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNI 75
Query: 129 VTLHGYYTSSQYNLLIYELMPNGS-LDTFLH--GKSVNKKN-LDWPSRYKIAVGAARGIA 184
           V+ +  +       L+ +L+  GS LD   H   K  +K   LD  +   I      G+ 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG----LATLMEAEKTHVSTIVAGTFGY 240
           YLH +     IHRD+K+ NILL ++   +++DFG    LAT  +  +  V     GT  +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 241 LAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           +APE  +  R    K D++SFG+  +EL TG  P  +       K++           E 
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY---PPMKVLMLTLQNDPPSLET 249
Query: 300 YVIDTSLEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
            V D  +    + +    F  + S+CL+ +P KRPT  E+++
Sbjct: 250 GVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+      ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 131 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 234
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 235 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 273

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 28/302 (9%)
Query: 61  QSDAIFK-KTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFE 114
           Q   IF+ + LK+ S+  +G G FG+V       L  N     AVK+L     +  R F+
Sbjct: 3   QDPTIFEERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ 60
Query: 115 RELEAMGDIKHRNIVTLHG--YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           RE++ +  +    IV   G  Y    Q   L+ E +P+G L  FL     ++  LD    
Sbjct: 61  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRL 117
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
              +    +G+ YL        +HRD+ + NIL++     +++DFGLA L+  +K +   
Sbjct: 118 LLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 174
Query: 233 IVAGT---FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLEEGTKL 285
              G    F Y APE       + + DV+SFGVVL EL T       P  E     G + 
Sbjct: 175 REPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 233
Query: 286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  + +  EE     +   CP     +V  +  +C  P P  RP+ + +   L+++
Sbjct: 234 DVPALCRLLELLEEGQRLPAPPACPA----EVHELMKLCWAPSPQDRPSFSALGPQLDML 289
Query: 346 KS 347
            S
Sbjct: 290 WS 291

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 25/239 (10%)
Query: 45  SGGKMVMFRSPLIHSLQSDAIFKKTLK--FSSKDVIGSGGFGTVY-RLTVNDSTAFAVKR 101
           +GG+    + P +  L     FK   +  FS    IG G FG VY    V +S   A+K+
Sbjct: 31  AGGRAGSLKDPDVAEL----FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 102 LHRGTTEVDRGFE---RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH 158
           +     + +  ++   +E+  +  ++H N +   G Y       L+ E     + D    
Sbjct: 87  MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL-- 144
Query: 159 GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG 218
              V+KK L       +  GA +G+AYLH     ++IHRD+K+ NILL +    ++ DFG
Sbjct: 145 --EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199
Query: 219 LATLMEAEKTHVSTIVAGTFGYLAPEY---FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            A++M      V     GT  ++APE     D G+   K DV+S G+  +EL   K P+
Sbjct: 200 SASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 114/242 (47%), Gaps = 30/242 (12%)
Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELE 118
           L ++ ++ +++     +V   G FG V++  + N+  A  +  +    +  +   E E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQN---EYEVY 70
Query: 119 AMGDIKHRNIVTLHGYY---TSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
           ++  +KH NI+   G     TS   +L LI      GSL  FL    V+     W     
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-----WNELCH 125
Query: 175 IAVGAARGIAYLHHDCI-------PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
           IA   ARG+AYLH D         P I HRDIKS N+LL  N+ A ++DFGLA   EA K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 228 THVSTI-VAGTFGYLAPEYFDTG-----RATAKGDVYSFGVVLLELLT----GKRPMDEA 277
           +   T    GT  Y+APE  +        A  + D+Y+ G+VL EL +       P+DE 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 278 FL 279
            L
Sbjct: 246 ML 247

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 11/216 (5%)
Query: 64  AIFKKTLKFSSKDVIGSGGFGTVYRL-TVNDSTAFAVKRLHRGT---TEVDRGFERELEA 119
            I +K   F   +++G G F  VYR  +++     A+K + +       + +  + E++ 
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
              +KH +I+ L+ Y+  S Y  L+ E+  NG ++ +L  K+  K   +  +R+ +    
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QI 121
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
             G+ YLH   I   +HRD+  SN+LL +NM  +++DFGLAT ++       T+  GT  
Sbjct: 122 ITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           Y++PE         + DV+S G +   LL G+ P D
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 128/294 (43%), Gaps = 51/294 (17%)
Query: 74  SKDVIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTTEVDR--GFERELEAMGDIKHRN 127
           S  VIG G FG VY     D        A+K L R  TE+ +   F RE   M  + H N
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPN 83
Query: 128 IVTLHGYYTSSQ---YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           ++ L G     +   + LL Y  M +G L  F+     N    D  S     +  ARG+ 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGME 138
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFG--YL 241
           YL        +HRD+ + N +LD++   +V+DFGLA  +++ E   V           + 
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP----MDE----AFLEEGTKLVTWVKAVM 293
           A E   T R T K DV+SFGV+L ELLT   P    +D      FL +G +L        
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------- 247
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
              + EY        CP    + ++ +   C E +P+ RPT   +V  +E I S
Sbjct: 248 --PQPEY--------CP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 72  FSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           FS    IG G FG VY    V +S   A+K++     + +  ++   +E+  +  ++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            +   G Y       L+ E     + D       V+KK L       +  GA +G+AYLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY-- 245
                ++IHRD+K+ NILL +    ++ DFG A++M      V     GT  ++APE   
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 246 -FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             D G+   K DV+S G+  +EL   K P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 16/223 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    ++H NI+ L+
Sbjct: 20  LGKGKFGNVY-LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY+  +    LI E  P G++   L   S      D           A  ++Y H     
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLS----RFDEQRTATYITELANALSYCHSK--- 131
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL  N E +++DFG +  + A  +   T+  GT  YL PE  +     
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTL-CGTLDYLPPEMIEGRMHD 188
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
            K D++S GV+  E L G  P +    +E  + ++ V+    D
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 77  VIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V    Y    N + A A+K     T++ V   F +E   M    H +IV L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T +    +I EL   G L +FL    V K +LD  S    A   +  +AYL     
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRDI + N+L+      ++ DFGL+  ME    + ++       ++APE  +  R 
Sbjct: 511 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 252 TAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
           T+  DV+ FGV + E+L  G +P       +G K    +  +   +R            P
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPF------QGVKNNDVIGRIENGERLPM---------P 614
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
            N    ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 48/298 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +DVIG G FG V +  +         A+KR+    ++ D R F  ELE +  + H  NI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAV 177
            L G      Y  L  E  P+G+L  FL    V                L        A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             ARG+ YL        IHRD+ + NIL+ +N  A+++DFGL+   E         V  T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 238 FG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
            G     ++A E  +    T   DV+S+GV+L E+++ G  P        G       + 
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEK 253
Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
           + Q  R E          P+N  ++V+ +   C   +P +RP+  +++  L  +  E+
Sbjct: 254 LPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 48/298 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +DVIG G FG V +  +         A+KR+    ++ D R F  ELE +  + H  NI+
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAV 177
            L G      Y  L  E  P+G+L  FL    V                L        A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             ARG+ YL        IHRD+ + NIL+ +N  A+++DFGL+   E         V  T
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 189
Query: 238 FG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
            G     ++A E  +    T   DV+S+GV+L E+++ G  P        G       + 
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEK 243
Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
           + Q  R E          P+N  ++V+ +   C   +P +RP+  +++  L  +  E+
Sbjct: 244 LPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 292

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HRD+ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 244
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P+ RPT  E+V +L+
Sbjct: 245 VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 248
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 249 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HRD+ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 244
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P  RPT  E+V +L+
Sbjct: 245 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HRD+ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 241
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P  RPT  E+V +L+
Sbjct: 242 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 131/299 (43%), Gaps = 58/299 (19%)
Query: 70  LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           + F   ++IGSGGFG V++     D   + +KR+     +     ERE++A+  + H NI
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNI 66
Query: 129 VTLHGYYTSSQYN----------------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           V  +G +    Y+                 +  E    G+L+ ++  +   K  LD    
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
            ++     +G+ Y+H      +I+RD+K SNI L    + ++ DFGL T ++ +     +
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS 181
Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
              GT  Y++PE   +     + D+Y+ G++L ELL      D AF  E +K  T ++  
Sbjct: 182 --KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAF--ETSKFFTDLRDG 234
Query: 293 MQDKREEYVIDTSLEGCPINEINDVF-----SIASMCLEPEPSKRPTMTEVVKMLELIK 346
           +                    I+D+F     ++    L  +P  RP  +E+++ L + K
Sbjct: 235 I--------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 27/295 (9%)
Query: 67  KKTLKFSSKDVIGSGGFGTVY-----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMG 121
           ++ LK+ S+  +G G FG+V       L  N     AVK+L     +  R F+RE++ + 
Sbjct: 6   ERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 122 DIKHRNIVTLHGY-YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            +    IV   G  Y   +  L L+ E +P+G L  FL     ++  LD       +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQI 120
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-- 237
            +G+ YL        +HRD+ + NIL++     +++DFGLA L+  +K        G   
Sbjct: 121 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 238 -FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT----GKRPMDEAFLEEGTKLVTWVKAV 292
            F Y APE       + + DV+SFGVVL EL T       P  E     G +        
Sbjct: 178 IFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCR 236
Query: 293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
           + +  EE     +   CP     +V  +  +C  P P  RP+ + +   L+++ S
Sbjct: 237 LLELLEEGQRLPAPPACPA----EVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 287

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 48/298 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +DVIG G FG V +  +         A+KR+    ++ D R F  ELE +  + H  NI+
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAV 177
            L G      Y  L  E  P+G+L  FL    V                L        A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             ARG+ YL        IHR++ + NIL+ +N  A+++DFGL+   E         V  T
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 196
Query: 238 FG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
            G     ++A E  +    T   DV+S+GV+L E+++ G  P        G       + 
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEK 250
Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
           + Q  R E          P+N  ++V+ +   C   +P +RP+  +++  L  +  E+
Sbjct: 251 LPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 299

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDXXKK 208
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 266 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGT-TEVDRGFERELE 118
           I K+T +     V+GSG FGTVY+ + V +        A+K L+  T  + +  F  E  
Sbjct: 34  ILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKI 175
            M  + H ++V L G   S    L + +LMP+G L  ++H    N  +   L+W      
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------ 145
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+E  EK + +   
Sbjct: 146 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E     + T + DV+S+GV + EL+T G +P D          LE+G +L
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 261

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 247
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 248 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 144 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 245
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 246 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 201
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 258
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 259 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHG---KSVNKKNLDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L        N   L  PS  K+   A   A G+A
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 143 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 244
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 245 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 247
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 248 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 208
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 266 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGT-TEVDRGFERELE 118
           I K+T +     V+GSG FGTVY+ + V +        A+K L+  T  + +  F  E  
Sbjct: 11  ILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKI 175
            M  + H ++V L G   S    L + +LMP+G L  ++H    N  +   L+W      
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+E  EK + +   
Sbjct: 123 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E     + T + DV+S+GV + EL+T G +P D          LE+G +L
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 238

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 208
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 266 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HRD+ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 244
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P  RPT  E+V +L+
Sbjct: 245 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 200
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 257
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 258 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 248
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 249 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 117/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +  + H+NIV 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 284
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 285 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 175 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 276
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 277 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 197
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 254
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 255 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHG---KSVNKKNLDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L        N   L  PS  K+   A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 254
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 140 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 241
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 242 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 117/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +  + H+NIV 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK------ 269
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 270 -----NCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN------------KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +               ++ L        
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 193
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 250
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 251 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 254
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +F +  MC +  P  RP+  E++
Sbjct: 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 30/282 (10%)
Query: 78  IGSGGFGTVYRLT---VNDSTA--FAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG V        ND T    AVK L  G   ++  G++RE+E +  + H +IV  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 132 HGYY--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            G       +   L+ E +P GSL  +L    V    L        A     G+AYLH  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 130
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG---TFGYLAPEYF 246
              H IHR + + N+LLD +   ++ DFGLA  +     +      G    F Y APE  
Sbjct: 131 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECL 186
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID--- 303
              +     DV+SFGV L ELLT     +++   + T+L+   +  M   R   +++   
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT-YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 245
Query: 304 --TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                + CP     +++ +   C E E S RPT   +V +L+
Sbjct: 246 RLPRPDRCPC----EIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HRD+ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 243
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P  RPT  E+V +L+
Sbjct: 244 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN------------KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +               ++ L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 208
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 266 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 115/223 (51%), Gaps = 23/223 (10%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLH 132
           +G G FG+V    YR+        A+K L +GT + D     RE + M  + +  IV L 
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G    ++  +L+ E+   G L  FL GK   ++ +   +  ++    + G+ YL      
Sbjct: 77  GV-CQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF--GYLAPEYFDTGR 250
           + +HRD+ + N+LL     A++SDFGL+  + A+ ++ +   AG +   + APE  +  +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEGTKL 285
            +++ DV+S+GV + E L+ G++P  +       AF+E+G ++
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 125/283 (44%), Gaps = 32/283 (11%)
Query: 78  IGSGGFGTV----YRLTVNDSTA--FAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVT 130
           +G G FG V    Y  T ND T    AVK L  G   ++  G++RE+E +  + H +IV 
Sbjct: 17  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 131 LHGYY--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             G       +   L+ E +P GSL  +L    V    L        A     G+AYLH 
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHA 130
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG---TFGYLAPEY 245
               H IHR + + N+LLD +   ++ DFGLA  +     +      G    F Y APE 
Sbjct: 131 Q---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 186
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID-- 303
               +     DV+SFGV L ELLT     +++   + T+L+   +  M   R   +++  
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT-YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG 245
Query: 304 ---TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                 + CP     +++ +   C E E S RPT   +V +L+
Sbjct: 246 ERLPRPDRCPC----EIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 269
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 270 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 269
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 270 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+TL G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 261
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 262 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 300

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N ++ ++   ++ DFG+   + E +             +++P
Sbjct: 138 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 239
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +  +  MC +  P  RP+  E++
Sbjct: 240 EGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG--Y 240
           +AYL+       +HRD+ + N ++  +   ++ DFG+   +  E  +      G     +
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVRW 198
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           +APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLK 243
Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +V+D      P N    V  +  MC +  P  RPT  E+V +L+
Sbjct: 244 FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 124/265 (46%), Gaps = 33/265 (12%)
Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVTL 131
            IG G FG V  +  ND+   +A+K +++       EV R   +EL+ M  ++H  +V L
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV-RNVFKELQIMQGLEHPFLVNL 80
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA-ARGIAYLHHDC 190
              +   +   ++ +L+  G L   L  ++V+ K        K+ +      + YL +  
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKE----ETVKLFICELVMALDYLQNQ- 134
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              IIHRD+K  NILLD++    ++DF +A ++  E T ++T+ AGT  Y+APE F + +
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTM-AGTKPYMAPEMFSSRK 190
Query: 251 ATAKG---DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                   D +S GV   ELL G+RP               +++    K   +  +T++ 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYH-------------IRSSTSSKEIVHTFETTVV 237
Query: 308 GCPINEINDVFSIASMCLEPEPSKR 332
             P     ++ S+    LEP P +R
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR 262

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLAT-LMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 270
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 271 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK------ 275
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 276 -----NCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 315

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 284
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 285 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 54  SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEV 109
           +P +    S AIF    ++  + V+G G FG V     ++T  +     + +        
Sbjct: 12  TPGMFVQHSTAIFSD--RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDW 169
                RE++ +  + H NI+ L+ ++    Y  L+ E+   G     L  + +++K    
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSE 125
Query: 170 PSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLMEAE 226
               +I      GI Y+H +    I+HRD+K  N+LL+   ++   R+ DFGL+T  EA 
Sbjct: 126 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA 277
           K     I  GT  Y+APE    G    K DV+S GV+L  LL+G  P + A
Sbjct: 183 KKMKDKI--GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGA 230

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK------ 285
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 286 -----NCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 325

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   R++DFGLA  +     +  T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK------ 269
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 270 -----NCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK------ 295
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 296 -----NCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 335

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +   N  T  AVK L    TE D      E+E M  I KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +       S N     ++ L        
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
           A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     H+     
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 249
Query: 236 GTFG-----YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
            T G     ++APE       T + DV+SFGV+L E+ T G  P     +EE  KL+   
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 306
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                  +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 307 -------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 24/273 (8%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIV 129
           F  K  +GSG FG V+ +    S     +K +++  ++V     E E+E +  + H NI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +   +       ++ E    G L   +       K L      ++       +AY H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 190 CIPHIIHRDIKSSNILLDQ---NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
              H++H+D+K  NIL      +   ++ DFGLA L ++++   ST  AGT  Y+APE F
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVF 198
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                T K D++S GVV+  LLTG  P     LEE  +  T+       K   Y ++   
Sbjct: 199 KRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-------KEPNYAVECR- 249
Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
              P+        +    L  +P +RP+  +V+
Sbjct: 250 ---PLTP--QAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HR++ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 245
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P+ RPT  E+V +L+
Sbjct: 246 VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/312 (23%), Positives = 133/312 (42%), Gaps = 71/312 (22%)
Query: 70  LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           + F   ++IGSGGFG V++     D   + ++R+     +     ERE++A+  + H NI
Sbjct: 12  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNI 67
Query: 129 VTLHGYYT--------------SSQYN---------------LLIYELMPNGSLDTFLHG 159
           V  +G +               SS Y+                +  E    G+L+ ++  
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 160 KSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL 219
           +   K  LD     ++     +G+ Y+H      +IHRD+K SNI L    + ++ DFGL
Sbjct: 128 RRGEK--LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGL 182
Query: 220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL 279
            T ++ +     +   GT  Y++PE   +     + D+Y+ G++L ELL      D AF 
Sbjct: 183 VTSLKNDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAF- 236
Query: 280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVF-----SIASMCLEPEPSKRPT 334
            E +K  T ++  +                    I+D+F     ++    L  +P  RP 
Sbjct: 237 -ETSKFFTDLRDGI--------------------ISDIFDKKEKTLLQKLLSKKPEDRPN 275
Query: 335 MTEVVKMLELIK 346
            +E+++ L + K
Sbjct: 276 TSEILRTLTVWK 287

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 310
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 311 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY     D       T  AVK ++   +  +R  F  E   M      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR--------YKIAVGAARG 182
           L G  +  Q  L++ ELM +G L ++L  +S+  +  + P R         ++A   A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           +AYL+       +HR++ + N ++  +   ++ DFG+   + E +             ++
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE    G  T   D++SFGVVL E+ +  ++P                + +  ++  ++
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQVLKF 244
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V+D      P N    V  +  MC +  P+ RPT  E+V +L+
Sbjct: 245 VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 284
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 285 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIV 234
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +   +    +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIV 234
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +   +    +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 78  IGSGGFGTVYRLTV----NDSTAF--AVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY   V    ND +    AVK L    +E D   F  E   +    H+NIV 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVS---DFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
            +   H IHRDI + N LL      RV+   DFG+A  +  A              ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E F  G  T+K D +SFGV+L E+ + G  P      +E  + VT    +   K      
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN----- 287
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
                 CP      V+ I + C + +P  RP    +++ +E    +  V
Sbjct: 288 ------CP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 326

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 54  SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEV 109
           +P +    S AIF    ++  + V+G G FG V     ++T  +     + +        
Sbjct: 35  TPGMFVQHSTAIFSD--RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 92
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDW 169
                RE++ +  + H NI+ L+ ++    Y  L+ E+   G     L  + +++K    
Sbjct: 93  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSE 148
Query: 170 PSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLMEAE 226
               +I      GI Y+H +    I+HRD+K  N+LL+   ++   R+ DFGL+T  EA 
Sbjct: 149 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA 277
           K     I  GT  Y+APE    G    K DV+S GV+L  LL+G  P + A
Sbjct: 206 KKMKDKI--GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGA 253

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 54  SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEV 109
           +P +    S AIF    ++  + V+G G FG V     ++T  +     + +        
Sbjct: 36  TPGMFVQHSTAIFSD--RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 93
Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDW 169
                RE++ +  + H NI+ L+ ++    Y  L+ E+   G     L  + +++K    
Sbjct: 94  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSE 149
Query: 170 PSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLMEAE 226
               +I      GI Y+H +    I+HRD+K  N+LL+   ++   R+ DFGL+T  EA 
Sbjct: 150 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA 277
           K     I  GT  Y+APE    G    K DV+S GV+L  LL+G  P + A
Sbjct: 207 KKMKDKI--GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGA 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     + +T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-----FER---ELEAMGD 122
           FS   +IG GGFG VY     D+   +A+K L +   ++ +G      ER    L + GD
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 123 IKHRNIVTL-HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
                IV + + ++T  + + ++ +LM  G L   L    V        S   +   AA 
Sbjct: 251 CPF--IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVF-------SEADMRFYAAE 300
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            I  L H     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 242 APEYFDTGRA-TAKGDVYSFGVVLLELLTGKRP 273
           APE    G A  +  D +S G +L +LL G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-----FER---ELEAMGD 122
           FS   +IG GGFG VY     D+   +A+K L +   ++ +G      ER    L + GD
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 123 IKHRNIVTL-HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
                IV + + ++T  + + ++ +LM  G L   L    V        S   +   AA 
Sbjct: 251 CPF--IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVF-------SEADMRFYAAE 300
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            I  L H     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 242 APEYFDTGRA-TAKGDVYSFGVVLLELLTGKRP 273
           APE    G A  +  D +S G +L +LL G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 5   IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 118
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 227
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 228 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 9   IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 66
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 122
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 231
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 232 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 5   IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 118
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 227
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 228 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 5   IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 118
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 227
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 228 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 9   IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 66
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 122
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 231
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 232 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 261
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 262 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 259
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 260 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IG G FG V  L        AVK +    T   + F  E   M  ++H N+V L G    
Sbjct: 201 IGKGEFGDVM-LGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 138 SQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
            +  L ++ E M  GSL  +L  +S  +  L      K ++     + YL  +   + +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RD+ + N+L+ ++  A+VSDFGL    EA  T  +  +     + APE     + + K D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 368
Query: 257 VYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN 315
           V+SFG++L E+ + G+ P     L          K V+    + Y +D   +GCP     
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPL----------KDVVPRVEKGYKMDAP-DGCP----P 413
Query: 316 DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
            V+ +   C   + + RPT  ++ + LE I++ ++
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IG G FG V  L        AVK +    T   + F  E   M  ++H N+V L G    
Sbjct: 14  IGKGEFGDVM-LGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 138 SQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
            +  L ++ E M  GSL  +L  +S  +  L      K ++     + YL  +   + +H
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 125
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RD+ + N+L+ ++  A+VSDFGL    EA  T  +  +     + APE     + + K D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181
Query: 257 VYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN 315
           V+SFG++L E+ + G+ P     L          K V+    + Y +D   +GCP     
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPL----------KDVVPRVEKGYKMDAP-DGCP----P 226
Query: 316 DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
            V+ +   C   + + RP+  ++ + LE IK+ ++
Sbjct: 227 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 261

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-----FER---ELEAMGD 122
           FS   +IG GGFG VY     D+   +A+K L +   ++ +G      ER    L + GD
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 123 IKHRNIVTL-HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
                IV + + ++T  + + ++ +LM  G L   L    V        S   +   AA 
Sbjct: 251 CPF--IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVF-------SEADMRFYAAE 300
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            I  L H     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 242 APEYFDTGRA-TAKGDVYSFGVVLLELLTGKRP 273
           APE    G A  +  D +S G +L +LL G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-----FER---ELEAMGD 122
           FS   +IG GGFG VY     D+   +A+K L +   ++ +G      ER    L + GD
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 123 IKHRNIVTL-HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
                IV + + ++T  + + ++ +LM  G L   L    V        S   +   AA 
Sbjct: 250 CPF--IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVF-------SEADMRFYAAE 299
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            I  L H     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+
Sbjct: 300 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 356
Query: 242 APEYFDTGRA-TAKGDVYSFGVVLLELLTGKRP 273
           APE    G A  +  D +S G +L +LL G  P
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 264
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 265 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 15  IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 128
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 237
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 238 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 318
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 319 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR---GTTEVDRGFEREL 117
           I +K L+   K  +G G FG V R         + + AVK L        E    F RE+
Sbjct: 15  IGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            AM  + HRN++ L+G   +    + + EL P GSL   L  K      L   SRY  AV
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRY--AV 128
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVA 235
             A G+ YL        IHRD+ + N+LL      ++ DFGL   +     H  +     
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
             F + APE   T   +   D + FGV L E+ T G+ P        G++++  +     
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKI----- 237
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           DK  E +     E CP     D++++   C   +P  RPT   +   L
Sbjct: 238 DKEGERL--PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IG G FG V  L        AVK +    T   + F  E   M  ++H N+V L G    
Sbjct: 29  IGKGEFGDVM-LGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 138 SQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
            +  L ++ E M  GSL  +L  +S  +  L      K ++     + YL  +   + +H
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RD+ + N+L+ ++  A+VSDFGL    EA  T  +  +     + APE     + + K D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 196
Query: 257 VYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN 315
           V+SFG++L E+ + G+ P     L          K V+    + Y +D   +GCP     
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPL----------KDVVPRVEKGYKMDAP-DGCP----P 241
Query: 316 DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
            V+ +   C   + + RP+  ++ + LE IK+ ++
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 126/253 (49%), Gaps = 26/253 (10%)
Query: 51  MFRSPL--IHSLQSDAIFKKTLKFSSKDV-IGSGGFGTV----YRLTVNDSTAFAVKRLH 103
           +F SP      L+   +F K       D+ +G G FG+V    YR+        A+K L 
Sbjct: 314 VFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLK 372
Query: 104 RGTTEVD-RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV 162
           +GT + D     RE + M  + +  IV L G    ++  +L+ E+   G L  FL GK  
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGK-- 429
Query: 163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
            ++ +   +  ++    + G+ YL      + +HR++ + N+LL     A++SDFGL+  
Sbjct: 430 -REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKA 485
Query: 223 MEAEKTHVSTIVAGTFG--YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDE--- 276
           + A+ ++ +   AG +   + APE  +  + +++ DV+S+GV + E L+ G++P  +   
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 277 ----AFLEEGTKL 285
               AF+E+G ++
Sbjct: 546 PEVMAFIEQGKRM 558

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I E    G+L  +L  +             V ++ + +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 136/319 (42%), Gaps = 42/319 (13%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV----YRLTVNDSTA--FAV 99
           G   V+F+ P         +F K      +D +G G FG V    Y  T ND T    AV
Sbjct: 13  GALEVLFQGP-----GDPTVFHKRYLKKIRD-LGEGHFGKVSLYCYDPT-NDGTGEMVAV 65
Query: 100 KRLHRGTTEVDR-GFERELEAMGDIKHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTF 156
           K L        R G+++E++ +  + H +I+   G    +      L+ E +P GSL  +
Sbjct: 66  KALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           L   S+    L        A     G+AYLH     H IHRD+ + N+LLD +   ++ D
Sbjct: 126 LPRHSIGLAQL-----LLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD 177
Query: 217 FGLATLMEA--EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT---GK 271
           FGLA  +    E   V         + APE     +     DV+SFGV L ELLT     
Sbjct: 178 FGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
Query: 272 RPMDEAFLE-----EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLE 326
           +     FLE     +G   V  +  +++  R E +     + CP     +V+ +   C E
Sbjct: 238 QSPPTKFLELIGIAQGQMTVLRLTELLE--RGERL--PRPDKCPA----EVYHLMKNCWE 289
Query: 327 PEPSKRPTMTEVVKMLELI 345
            E S RPT   ++ +L+ +
Sbjct: 290 TEASFRPTFENLIPILKTV 308

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 78  IGSGGFGTVY----RLTVNDS--TAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG VY    +  V D   T  A+K ++   +  +R  F  E   M +    ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN---LDWPSRYKIAVGA---ARGIA 184
           L G  +  Q  L+I ELM  G L ++L       +N   L  PS  K+   A   A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAP 243
           YL+ +     +HRD+ + N  + ++   ++ DFG+   + E +             +++P
Sbjct: 140 YLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E    G  T   DV+SFGVVL E+ T  ++P                + +  ++   +V+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLRFVM 241
Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +  L   P N  + +  +  MC +  P  RP+  E++
Sbjct: 242 EGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           IG G FG V  L        AVK +    T   + F  E   M  ++H N+V L G    
Sbjct: 20  IGKGEFGDVM-LGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 138 SQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
            +  L ++ E M  GSL  +L  +S  +  L      K ++     + YL  +   + +H
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 131
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RD+ + N+L+ ++  A+VSDFGL    EA  T  +  +     + APE       + K D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 257 VYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEIN 315
           V+SFG++L E+ + G+ P     L          K V+    + Y +D   +GCP     
Sbjct: 188 VWSFGILLWEIYSFGRVPYPRIPL----------KDVVPRVEKGYKMDAP-DGCP----P 232
Query: 316 DVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
            V+ +   C   + + RP+  ++ + LE IK+ ++
Sbjct: 233 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 267

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 76  DVIGSGGFGTVY---RLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           D +G GG  TVY      +N   A  A+    R   E  + FERE+     + H+NIV++
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                      L+ E +   +L  ++  HG       L   +          GI + H  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP------LSVDTAINFTNQILDGIKHAHD- 129
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               I+HRDIK  NIL+D N   ++ DFG+A  +       +  V GT  Y +PE    G
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA-KG 186
Query: 250 RATAK-GDVYSFGVVLLELLTGKRPMD 275
            AT +  D+YS G+VL E+L G+ P +
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVND----STAFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 12  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 123
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 124 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 239

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 15  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 126
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 127 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 125
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVND----STAFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 5   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 116
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 21  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 132
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 133 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 248

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 124
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 62  SDAIFKKTLKFSSKDVIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDRGFEREL 117
           S AIF  + ++  + V+G G FG V     ++T  +     + +             RE+
Sbjct: 20  STAIF--SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           + +  + H NI  L+ ++    Y  L+ E+   G     L  + +++K        +I  
Sbjct: 78  QLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIR 133
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLMEAEKTHVSTIV 234
               GI Y H +    I+HRD+K  N+LL+   ++   R+ DFGL+T  EA K     I 
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI- 189
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA 277
            GT  Y+APE    G    K DV+S GV+L  LL+G  P + A
Sbjct: 190 -GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGA 230

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 19/228 (8%)
Query: 75  KDVIGSGGFGTV-----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           ++ +G G FG V     Y+     +  F  ++L +  +++    ERE+  +  ++H +I+
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHII 72
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L+   T+    +++ E       D  +  K + +   D   R+   +  A  I Y H  
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE---DEGRRFFQQIICA--IEYCHRH 127
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               I+HRD+K  N+LLD N+  +++DFGL+ +M  +   + T   G+  Y APE  + G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKT-SCGSPNYAAPEVIN-G 181
Query: 250 R--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
           +  A  + DV+S G+VL  +L G+ P D+ F+    K V     VM D
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 125
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 77  VIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTL 131
           ++G G FG VY     +        AVK   +  T +    F  E   M ++ H +IV L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DC 190
            G     +   +I EL P G L  +L     NK +L   +    ++   + +AYL   +C
Sbjct: 75  IGI-IEEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
           +    HRDI   NIL+      ++ DFGL+  +E E  + +++      +++PE  +  R
Sbjct: 131 V----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            T   DV+ F V + E+L+ GK+P    F  E   ++     V++        D     C
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQPF---FWLENKDVI----GVLEKGDRLPKPDL----C 235
Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           P      ++++ + C + +PS RP  TE+V
Sbjct: 236 P----PVLYTLMTRCWDYDPSDRPRFTELV 261

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 12  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNW------ 123
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 124 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 124
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 125
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 118/258 (45%), Gaps = 23/258 (8%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLH-RGTTEVDRG-FERELEAMGDIKHRNIVTLHGY 134
           IG G F TVY+ L    +   A   L  R  T+ +R  F+ E E +  ++H NIV  +  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 135 YTSS----QYNLLIYELMPNGSLDTFLHGKSVNKKNL--DWPSRYKIAVGAARGIAYLHH 188
           + S+    +  +L+ EL  +G+L T+L    V K  +   W  +        +G+ +LH 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQFLHT 147
Query: 189 DCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
              P IIHRD+K  NI +       ++ D GLATL  A     +  V GT  + APE ++
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFXAPEXYE 203
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEA--FLEEGTKLVTWVKAVMQDKREEYVIDTS 305
             +     DVY+FG   LE  T + P  E     +   ++ + VK    DK     +   
Sbjct: 204 E-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 306 LEGCPINEINDVFSIASM 323
           +EGC     ++ +SI  +
Sbjct: 263 IEGCIRQNKDERYSIKDL 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L       F  A+K L +   E   V+    RE+E    ++H NI+ ++
Sbjct: 22  LGKGKFGNVY-LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
            Y+   +   L+ E  P G L   L  HG+   +++  +          A  + Y H   
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 133
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              +IHRDIK  N+L+    E +++DFG +    + +      + GT  YL PE  +   
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLDYLPPEMIEGKT 188
Query: 251 ATAKGDVYSFGVVLLELLTGKRPMD 275
              K D++  GV+  E L G  P D
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 18  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 129
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 125
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 17  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 128
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 129 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 244

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +     +   +A K     RL      V R   ERE+  + +I+H NI+T
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +    +LI EL+  G L  FL      K++L      +       G+ YLH   
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSKR 135
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFG+A  +EA     +  + GT  ++APE  
Sbjct: 136 IAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIV 190
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREEYVIDTS 305
           +      + D++S GV+   LL+G  P    FL E   + +T + AV  D  EEY  +TS
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP----FLGETKQETLTNISAVNYDFDEEYFSNTS 246

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 77  VIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTL 131
           ++G G FG VY     +        AVK   +  T +    F  E   M ++ H +IV L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DC 190
            G     +   +I EL P G L  +L     NK +L   +    ++   + +AYL   +C
Sbjct: 79  IGI-IEEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
           +    HRDI   NIL+      ++ DFGL+  +E E  + +++      +++PE  +  R
Sbjct: 135 V----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            T   DV+ F V + E+L+ GK+P    F  E   ++     V++        D     C
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPF---FWLENKDVI----GVLEKGDRLPKPDL----C 239
Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           P      ++++ + C + +PS RP  TE+V
Sbjct: 240 P----PVLYTLMTRCWDYDPSDRPRFTELV 265

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 111/250 (44%), Gaps = 26/250 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRN 127
           +  K+ +G+GGFG V R    D+    A+K+  +  +  +R  ER   E++ M  + H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPN 73
Query: 128 IVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           +V+        Q        LL  E    G L  +L+         + P R  ++   + 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISS 132
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
            + YLH +    IIHRD+K  NI+L    Q +  ++ D G A   E ++  + T   GT 
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTL 187
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
            YLAPE  +  + T   D +SFG +  E +TG RP    FL    + V W   V +   E
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FL-PNWQPVQWHGKVREKSNE 242
Query: 299 EYVIDTSLEG 308
             V+   L G
Sbjct: 243 HIVVYDDLTG 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I      G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 77  VIGSGGFGTVYRLTVNDSTA----FAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTL 131
           ++G G FG VY     +        AVK   +  T +    F  E   M ++ H +IV L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DC 190
            G     +   +I EL P G L  +L     NK +L   +    ++   + +AYL   +C
Sbjct: 91  IGI-IEEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
           +    HRDI   NIL+      ++ DFGL+  +E E  + +++      +++PE  +  R
Sbjct: 147 V----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 202
Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            T   DV+ F V + E+L+ GK+P    F  E   ++     V++        D     C
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQPF---FWLENKDVI----GVLEKGDRLPKPDL----C 251
Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           P      ++++ + C + +PS RP  TE+V
Sbjct: 252 P----PVLYTLMTRCWDYDPSDRPRFTELV 277

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 111/250 (44%), Gaps = 26/250 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRN 127
           +  K+ +G+GGFG V R    D+    A+K+  +  +  +R  ER   E++ M  + H N
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPN 74
Query: 128 IVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           +V+        Q        LL  E    G L  +L+         + P R  ++   + 
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISS 133
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
            + YLH +    IIHRD+K  NI+L    Q +  ++ D G A   E ++  + T   GT 
Sbjct: 134 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTL 188
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
            YLAPE  +  + T   D +SFG +  E +TG RP    FL    + V W   V +   E
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FL-PNWQPVQWHGKVREKSNE 243
Query: 299 EYVIDTSLEG 308
             V+   L G
Sbjct: 244 HIVVYDDLTG 253

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +     +   +A K     RL      V R   ERE+  + +I+H NI+T
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +    +LI EL+  G L  FL      K++L      +       G+ YLH   
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSKR 149
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFG+A  +EA     +  + GT  ++APE  
Sbjct: 150 IAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIV 204
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREEYVIDTS 305
           +      + D++S GV+   LL+G  P    FL E   + +T + AV  D  EEY  +TS
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASP----FLGETKQETLTNISAVNYDFDEEYFSNTS 260

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +     +   +A K     RL      V R   ERE+  + +I+H NI+T
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +    +LI EL+  G L  FL      K++L      +       G+ YLH   
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFG+A  +EA     +  + GT  ++APE  
Sbjct: 129 IAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIV 183
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREEYVIDTS 305
           +      + D++S GV+   LL+G  P    FL E   + +T + AV  D  EEY  +TS
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP----FLGETKQETLTNISAVNYDFDEEYFSNTS 239

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L       F  A+K L +   E   V+    RE+E    ++H NI+ ++
Sbjct: 23  LGKGKFGNVY-LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
            Y+   +   L+ E  P G L   L  HG+   +++  +          A  + Y H   
Sbjct: 82  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 134
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              +IHRDIK  N+L+    E +++DFG +    + +      + GT  YL PE  +   
Sbjct: 135 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLDYLPPEMIEGKT 189
Query: 251 ATAKGDVYSFGVVLLELLTGKRPMD 275
              K D++  GV+  E L G  P D
Sbjct: 190 HDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 36  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 147
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 148 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 78  IGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHRN 127
           +G G FG V         +    ++   AVK L    TE D      E+E M  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKI 175
           I+ L G  T      +I      G+L  +L  +             V ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +  T   
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                ++APE       T + DV+SFGV++ E+ T G  P     +EE  KL+       
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 272
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              +E + +D      P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 273 ---KEGHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 8   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 119
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 120 CVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 235

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 118/284 (41%), Gaps = 20/284 (7%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLH---RGTTEVDRGFE 114
           +L+ D  +     F  +  IG G F  VYR   + D    A+K++        +      
Sbjct: 21  ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 115 RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
           +E++ +  + H N++  +  +       ++ EL   G L   +      K+ +   + +K
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
             V     + ++H      ++HRDIK +N+ +      ++ D GL     ++ T   ++V
Sbjct: 141 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ 294
            GT  Y++PE         K D++S G +L E+   + P    F  +   L +  K + Q
Sbjct: 198 -GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKIEQ 252
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                   D   E        ++  + +MC+ P+P KRP +T V
Sbjct: 253 CDYPPLPSDHYSE--------ELRQLVNMCINPDPEKRPDVTYV 288

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 78  IGSGGFGTV----YRLTVNDSTA--FAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG V    Y  T ND T    AVK L        R G+++E++ +  + H +I+ 
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 131 LHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             G           L+ E +P GSL  +L   S+    L        A     G+AYLH 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHS 135
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG---TFGYLAPEY 245
               H IHR++ + N+LLD +   ++ DFGLA  +     +      G    F Y APE 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 246 FDTGRATAKGDVYSFGVVLLELLT---GKRPMDEAFLE-----EGTKLVTWVKAVMQDKR 297
               +     DV+SFGV L ELLT     +     FLE     +G   V  +  +++  R
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE--R 249
Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
            E +     + CP     +V+ +   C E E S RPT   ++ +L+ +
Sbjct: 250 GERL--PRPDKCPC----EVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + V      A+++++            E+  M + K+ NIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 20/226 (8%)
Query: 77  VIGSGGFGTVY---RLTVNDSTA-FAVKRLHRGTTEV-DR---GFERELEAMGDIKHRNI 128
           V+G G FG V+   ++T  DS   +A+K L + T +V DR     ER++  + D+ H  +
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI--LADVNHPFV 92
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V LH  + +     LI + +  G L T L  K V     D   ++ +A   A G+ +LH 
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEED--VKFYLA-ELALGLDHLHS 148
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYLAPEYFD 247
             I   I+RD+K  NILLD+    +++DFGL+   ++ EK   S    GT  Y+APE  +
Sbjct: 149 LGI---IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVN 203
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
               +   D +S+GV++ E+LTG  P      +E   L+   K  M
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGM 249

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 78  IGSGGFGTV----YRLTVNDSTA--FAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
           +G G FG V    Y  T ND T    AVK L        R G+++E++ +  + H +I+ 
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 131 LHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             G           L+ E +P GSL  +L   S+    L        A     G+AYLH 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHA 135
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG---TFGYLAPEY 245
               H IHR++ + N+LLD +   ++ DFGLA  +     +      G    F Y APE 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 246 FDTGRATAKGDVYSFGVVLLELLT---GKRPMDEAFLE-----EGTKLVTWVKAVMQDKR 297
               +     DV+SFGV L ELLT     +     FLE     +G   V  +  +++  R
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE--R 249
Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
            E +     + CP     +V+ +   C E E S RPT   ++ +L+ +
Sbjct: 250 GERL--PRPDKCPC----EVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 39/295 (13%)
Query: 67  KKTLKFSSKDVIGSGGFG-----TVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEA 119
           +  L+F     +G+G FG     T + L   D+      ++ + T   D       EL+ 
Sbjct: 37  RNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS---VNKKN---LDWPSR 172
           M  + +H NIV L G  T     L+I E    G L  FL  K+   ++K++   L+    
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
              +   A+G+A+L      + IHRD+ + N+LL     A++ DFGLA  +  +  +   
Sbjct: 155 LHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--- 208
Query: 233 IVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW 288
           IV G       ++APE       T + DV+S+G++L E+ +               L  +
Sbjct: 209 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY 255
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              ++  K  + V D      P     +++SI   C   EP+ RPT  ++   L+
Sbjct: 256 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 138/293 (47%), Gaps = 33/293 (11%)
Query: 71  KFSSKDVIGSGGFGTVYRL-TVNDSTAFAVKRL---HRGTTE--VDRGFERELEAMGDIK 124
           ++   D +G G F TVY+    N +   A+K++   HR   +  ++R   RE++ + ++ 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI-AVGAARGI 183
           H NI+ L   +       L+++ M    L+  +   S+    +  PS  K   +   +G+
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGL 125
Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLA 242
            YLH   I   +HRD+K +N+LLD+N   +++DFGLA +     + +   +V  T  Y A
Sbjct: 126 EYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRA 180
Query: 243 PEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM--DEAFLEEGTKLVTWVKAVMQDK--- 296
           PE     R    G D+++ G +L ELL  + P    ++ L++ T++   +    +++   
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 297 ---REEYVIDTSLEGCPINEI-----NDVFSIASMCLEPEPSKRPTMTEVVKM 341
                +YV   S  G P++ I     +D+  +        P  R T T+ +KM
Sbjct: 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLH-RGTTEVDRGFERELEAMGDIKHRNIV 129
           F+  + IG G FG V++   N +    A+K +      +     ++E+  +       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARGIAYL 186
             +G Y       +I E +  GS    L     ++        ++IA       +G+ YL
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE--------FQIATMLKEILKGLDYL 136
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H +     IHRDIK++N+LL +  + +++DFG+A  +   +   +T V   F ++APE  
Sbjct: 137 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 192
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                 +K D++S G+  +EL  G+ P  +                M   R  ++I  + 
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPPNSD----------------MHPMRVLFLIPKNN 236
Query: 307 EGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
               + +    F      CL  +PS RPT  E++K   ++K+ K
Sbjct: 237 PPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSK 280

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 76  DVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           D +G G FG V    + LT +      + R    + +V     RE++ +   +H +I+ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           +   ++     ++ E +  G L  ++         LD     ++      G+ Y H   +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPEYFDTGR 250
              +HRD+K  N+LLD +M A+++DFGL+ +M + E    S    G+  Y APE   +GR
Sbjct: 138 ---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVI-SGR 190
Query: 251 --ATAKGDVYSFGVVLLELLTGKRPMDE 276
             A  + D++S GV+L  LL G  P D+
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 15  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 126
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFG A L+ A EK + +   
Sbjct: 127 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVND----STAFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+  L   T+ + ++    E  
Sbjct: 45  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 156
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 157 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 272

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 39/295 (13%)
Query: 67  KKTLKFSSKDVIGSGGFG-----TVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEA 119
           +  L+F     +G+G FG     T + L   D+      ++ + T   D       EL+ 
Sbjct: 45  RNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS---VNKKN---LDWPSR 172
           M  + +H NIV L G  T     L+I E    G L  FL  K+   ++K++   L+    
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
              +   A+G+A+L      + IHRD+ + N+LL     A++ DFGLA  +  +  +   
Sbjct: 163 LHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--- 216
Query: 233 IVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW 288
           IV G       ++APE       T + DV+S+G++L E+ +               L  +
Sbjct: 217 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY 263
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              ++  K  + V D      P     +++SI   C   EP+ RPT  ++   L+
Sbjct: 264 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH   I   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIGI--- 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRL-HRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V ++    S     ++L H       R    REL+ + +     IV  +G +
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 136 TSSQYNLLIYELMPNGSLDTFL-HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            S     +  E M  GSLD  L   K + ++ L      K+++   RG+AYL       I
Sbjct: 84  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREKH--QI 136
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y+APE       + 
Sbjct: 137 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERLQGTHYSV 192
Query: 254 KGDVYSFGVVLLELLTGKRPM 274
           + D++S G+ L+EL  G+ P+
Sbjct: 193 QSDIWSMGLSLVELAVGRYPI 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 28/281 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIV 129
           F+  + IG G FG V++   N +    A+K +      +     ++E+  +       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 130 TLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             +G Y       +I E +  GS LD    G       LD      I     +G+ YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
           +     IHRDIK++N+LL ++ E +++DFG+A  +   +   +T V   F ++APE    
Sbjct: 123 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQ 178
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
               +K D++S G+  +EL  G+ P  E         +  +K +    +       +LEG
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSE---------LHPMKVLFLIPKNN---PPTLEG 226
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
              N    +      CL  EPS RPT  E++K   ++++ K
Sbjct: 227 ---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+ SG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 11  ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 28/281 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIV 129
           F+  + IG G FG V++   N +    A+K +      +     ++E+  +       + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 130 TLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             +G Y       +I E +  GS LD    G       LD      I     +G+ YLH 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 142
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
           +     IHRDIK++N+LL ++ E +++DFG+A  +   +   +T V   F ++APE    
Sbjct: 143 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQ 198
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
               +K D++S G+  +EL  G+ P  E         +  +K +    +       +LEG
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSE---------LHPMKVLFLIPKNN---PPTLEG 246
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
              N    +      CL  EPS RPT  E++K   ++++ K
Sbjct: 247 ---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 284

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH   I   
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIGI--- 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+ SG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 18  ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 129
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
           +  +DV+G+G F  V  L  +  T    A+K + +   E   G  E E+  +  IKH NI
Sbjct: 20  YDFRDVLGTGAFSEVI-LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           V L   Y S  +  LI +L+  G L D  +      +++    SR    V  A  + YLH
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQVLDA--VKYLH 133
Query: 188 HDCIPHIIHRDIKSSNIL---LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
                 I+HRD+K  N+L   LD++ +  +SDFGL+  ME   + +ST   GT GY+APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLST-ACGTPGYVAPE 188
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                  +   D +S GV+   LL G  P    F +E        K   Q  + EY  D+
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDEND-----AKLFEQILKAEYEFDS 239
Query: 305 SLEGCPINEIND-VFSIASMCLEPEPSKRPTMTEVVK 340
                  ++I+D         +E +P KR T  + ++
Sbjct: 240 PY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
           +  +DV+G+G F  V  L  +  T    A+K + +   E   G  E E+  +  IKH NI
Sbjct: 20  YDFRDVLGTGAFSEVI-LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           V L   Y S  +  LI +L+  G L D  +      +++    SR    V  A  + YLH
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQVLDA--VKYLH 133
Query: 188 HDCIPHIIHRDIKSSNIL---LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
                 I+HRD+K  N+L   LD++ +  +SDFGL+  ME   + +ST   GT GY+APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLST-ACGTPGYVAPE 188
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                  +   D +S GV+   LL G  P    F +E        K   Q  + EY  D+
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDEND-----AKLFEQILKAEYEFDS 239
Query: 305 SLEGCPINEIND-VFSIASMCLEPEPSKRPTMTEVVK 340
                  ++I+D         +E +P KR T  + ++
Sbjct: 240 PY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
           +  +DV+G+G F  V  L  +  T    A+K + +   E   G  E E+  +  IKH NI
Sbjct: 20  YDFRDVLGTGAFSEVI-LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           V L   Y S  +  LI +L+  G L D  +      +++    SR    V  A  + YLH
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQVLDA--VKYLH 133
Query: 188 HDCIPHIIHRDIKSSNIL---LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
                 I+HRD+K  N+L   LD++ +  +SDFGL+  ME   + +ST   GT GY+APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLST-ACGTPGYVAPE 188
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                  +   D +S GV+   LL G  P    F +E        K   Q  + EY  D+
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDEND-----AKLFEQILKAEYEFDS 239
Query: 305 SLEGCPINEIND-VFSIASMCLEPEPSKRPTMTEVVK 340
                  ++I+D         +E +P KR T  + ++
Sbjct: 240 PY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 45/300 (15%)
Query: 67  KKTLKFSSKDVIGSGGFG-----TVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEA 119
           +  L+F     +G+G FG     T + L   D+      ++ + T   D       EL+ 
Sbjct: 45  RNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS----------VNKKNLD 168
           M  + +H NIV L G  T     L+I E    G L  FL  KS          +    L 
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + N+LL     A++ DFGLA  +  +  
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 229 HVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGT 283
           +   IV G       ++APE       T + DV+S+G++L E+ + G  P          
Sbjct: 220 Y---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---------- 266
Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               +   ++  K  + V D      P     +++SI   C   EP+ RPT  ++   L+
Sbjct: 267 ----YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 128/272 (47%), Gaps = 31/272 (11%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 125
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 181
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            + D++S G+ L+E+  G+ P+     +E ++    +  ++     +Y+++      P  
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELL-----DYIVNEPPPKLP-- 234
Query: 313 EINDVFSI-----ASMCLEPEPSKRPTMTEVV 339
             + VFS+      + CL   P++R  + +++
Sbjct: 235 --SGVFSLEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 13  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 124
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 124
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFG A L+ A EK + +   
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNW------ 124
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFG A L+ A EK + +   
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFER-----------------ELEAM 120
           +  G F  +  L   D+  +A+K+  +   E  R F +                 EL+ +
Sbjct: 39  LNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV--- 177
            DIK+   +T  G  T+     +IYE M N S+  F     V  KN  +     I V   
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKC 155
Query: 178 ---GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
                    +Y+H++   +I HRD+K SNIL+D+N   ++SDFG +  M  +K   S   
Sbjct: 156 IIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 235 AGTFGYLAPEYF--DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            GT+ ++ PE+F  ++    AK D++S G+ L  +     P 
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 122
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFG A L+ A EK + +   
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+ SG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 18  ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 129
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+ A EK + +   
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + V      A+++++            E+  M + K+ NIV
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 136
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHR+IKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 137 ---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 192
Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
           +  +DV+G+G F  V  L  +  T    A+K + +   E   G  E E+  +  IKH NI
Sbjct: 20  YDFRDVLGTGAFSEVI-LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           V L   Y S  +  LI +L+  G L D  +      +++    SR    V  A  + YLH
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA---SRLIFQVLDA--VKYLH 133
Query: 188 HDCIPHIIHRDIKSSNIL---LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
                 I+HRD+K  N+L   LD++ +  +SDFGL+  ME   + +ST   GT GY+APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLST-ACGTPGYVAPE 188
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                  +   D +S GV+   LL G  P    F +E        K   Q  + EY  D+
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDEND-----AKLFEQILKAEYEFDS 239
Query: 305 SLEGCPINEIND-VFSIASMCLEPEPSKRPTMTEVVK 340
                  ++I+D         +E +P KR T  + ++
Sbjct: 240 PY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 18  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 129
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFG A L+ A EK + +   
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + V      A+++++            E+  M + K+ NIV
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 136
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  S +V GT  ++APE     
Sbjct: 137 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRK 192
Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+ L + +        A+K L   T+ + ++    E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNL-DWPSRYKI 175
            M  + + ++  L G   +S   L I +LMP G L  ++  H  ++  + L +W      
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 124
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIV 234
            V  A+G+ YL       ++HRD+ + N+L+      +++DFG A L+ A EK + +   
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E       T + DV+S+GV + EL+T G +P D        + LE+G +L
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + V      A+++++            E+  M + K+ NIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  S +V GT  ++APE     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRK 191
Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH   I   
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIGI--- 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKK 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY  + V      A+++++            E+  M + K+ NIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL        V +  +D      +     + + +LH +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDV-----VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  S +V GT  ++APE     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRK 191
Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
               K D++S G++ +E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 67  KKTLKFSSKDVIGSGGFG-----TVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEA 119
           +  L+F     +G+G FG     T + L   D+      ++ + T   D       EL+ 
Sbjct: 45  RNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
           M  + +H NIV L G  T     L+I E    G L  FL  KS   + L+    + IA  
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS---RVLETDPAFAIANS 159
Query: 179 AA-------------RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
            A             +G+A+L      + IHRD+ + N+LL     A++ DFGLA  +  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 226 EKTHVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE 281
           +  +   IV G       ++APE       T + DV+S+G++L E+ +            
Sbjct: 217 DSNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------------ 261
Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
              L  +   ++  K  + V D      P     +++SI   C   EP+ RPT  ++   
Sbjct: 262 -LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
Query: 342 LE 343
           L+
Sbjct: 321 LQ 322

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 76  DVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           ++   G FG V++  + ND  A  +  L    +      ERE+ +   +KH N++     
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQS---EREIFSTPGMKHENLLQFIAA 77
Query: 135 YTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                 NL     LI      GSL  +L G  +      W     +A   +RG++YLH D
Sbjct: 78  EKRGS-NLEVELWLITAFHDKGSLTDYLKGNIIT-----WNELCHVAETMSRGLSYLHED 131
Query: 190 CI--------PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI-VAGTFGY 240
                     P I HRD KS N+LL  ++ A ++DFGLA   E  K    T    GT  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 241 LAPEYFDTG-----RATAKGDVYSFGVVLLELLT----GKRPMDEAFL 279
           +APE  +        A  + D+Y+ G+VL EL++       P+DE  L
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYML 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 92/217 (42%), Gaps = 16/217 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG VY L     + F  A+K L +   E   V+    RE+E    + H NI+ L+
Sbjct: 31  LGKGKFGNVY-LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLY 89
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
            Y+   +   LI E  P G L   L          D      I    A  + Y H     
Sbjct: 90  NYFYDRRRIYLILEYAPRGELYKELQKSCT----FDEQRTATIMEELADALMYCHGK--- 142
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  +     
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR---RKTMCGTLDYLPPEMIEGRMHN 199
Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWV 289
            K D++  GV+  ELL G  P + A   E  + +  V
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV 236

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 71  KFSSKDVIGSGGFGTVY---RLTVNDSTA-FAVKRLHRGTTEV-DR---GFERELEAMGD 122
           +F    V+G G FG V+   +++ +D+   +A+K L + T +V DR     ER++  + +
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVE 83
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H  IV LH  + +     LI + +  G L T L  K V     D   ++ +A   A  
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEED--VKFYLA-ELALA 139
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYL 241
           + +LH   I   I+RD+K  NILLD+    +++DFGL+   ++ EK   S    GT  Y+
Sbjct: 140 LDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 194
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           APE  +    T   D +SFGV++ E+LTG  P
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 71  KFSSKDVIGSGGFGTVY---RLTVNDSTA-FAVKRLHRGTTEV-DR---GFERELEAMGD 122
           +F    V+G G FG V+   +++ +D+   +A+K L + T +V DR     ER++  + +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVE 82
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H  IV LH  + +     LI + +  G L T L  K V     D   ++ +A   A  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEED--VKFYLA-ELALA 138
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYL 241
           + +LH   I   I+RD+K  NILLD+    +++DFGL+   ++ EK   S    GT  Y+
Sbjct: 139 LDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           APE  +    T   D +SFGV++ E+LTG  P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 28/281 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIV 129
           F+  + IG G FG V++   N +    A+K +      +     ++E+  +       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 130 TLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             +G Y       +I E +  GS LD    G       LD      I     +G+ YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
           +     IHRDIK++N+LL ++ E +++DFG+A  +   +   +  V   F ++APE    
Sbjct: 123 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQ 178
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
               +K D++S G+  +EL  G+ P  E         +  +K +    +       +LEG
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSE---------LHPMKVLFLIPKNN---PPTLEG 226
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
              N    +      CL  EPS RPT  E++K   ++++ K
Sbjct: 227 ---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 20/213 (9%)
Query: 71  KFSSKDVIGSGGFGTVY---RLTVNDSTA-FAVKRLHRGTTEV-DR---GFERELEAMGD 122
           +F    V+G G FG V+   +++ +D+   +A+K L + T +V DR     ER++  + +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVE 82
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H  IV LH  + +     LI + +  G L T L  K V     D   ++ +A   A  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEED--VKFYLA-ELALA 138
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-LMEAEKTHVSTIVAGTFGYL 241
           + +LH   I   I+RD+K  NILLD+    +++DFGL+   ++ EK   S    GT  Y+
Sbjct: 139 LDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE  +    T   D +SFGV++ E+LTG  P 
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-----VTL 131
           +G G +G V ++  V      AVKR+ R T  V+   ++ L    DI  R +     VT 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI-RAT--VNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHD 189
           +G         +  ELM + SLD F   K V  K    P     KIAV   + + +LH  
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY---- 245
               +IHRD+K SN+L++   + ++ DFG++  +    +   TI AG   Y+APE     
Sbjct: 173 L--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPE 228
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
            +    + K D++S G+ ++EL   + P D           +W     Q K+   V++  
Sbjct: 229 LNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQ---VVEEP 274
Query: 306 LEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
               P ++ +  F    S CL+    +RPT  E+++
Sbjct: 275 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
           F     +G+G  G V++++   S    A K +H       R    REL+ + +     IV
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLH 187
             +G + S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL 
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                 I+HRD+K SNIL++   E ++ DFG++  +  E   ++    GT  Y++PE   
Sbjct: 125 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSPERLQ 179
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
               + + D++S G+ L+E+  G+ P
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 22/227 (9%)
Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G  G V +L VN  T  A AVK +  +   +     ++E+     + H N+V  +G+
Sbjct: 14  LGEGAAGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L  E    G L   +         +  P   +       G+ YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GI 125
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
            HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE        A
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 254 KG-DVYSFGVVLLELLTGKRPMDEA---------FLEEGTKLVTWVK 290
           +  DV+S G+VL  +L G+ P D+          + E+ T L  W K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 72  FSSKDV-----IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKH 125
           F+++D+     IG G +G+V ++    S    AVKR+    + VD   +++L    D+  
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVM 75
Query: 126 RN-----IVTLHGYYTSSQYNLLIYELMPNGSLDTFL-HGKSVNKKNLDWPSRYKIAVGA 179
           R+     IV  +G         +  ELM + S D F  +  SV    +      KI +  
Sbjct: 76  RSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
            + + +L  +    IIHRDIK SNILLD++   ++ DFG++   +   +   T  AG   
Sbjct: 135 VKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRP 190
Query: 240 YLAPEYFDTGRA----TAKGDVYSFGVVLLELLTGKRPMDE--AFLEEGTKLVTWVKAVM 293
           Y+APE  D   +      + DV+S G+ L EL TG+ P  +  +  ++ T++V      +
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            +  EE     S     IN +N       +CL  + SKRP   E++K
Sbjct: 251 SNS-EEREFSPSF----INFVN-------LCLTKDESKRPKYKELLK 285

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 72  FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           F     +G GGFG V+      D   +A+KR+     E+ R    RE++A+  ++H  IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 130 TLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNL-DW-------PSRYK-----I 175
               Y+ +        +L P+   +  ++  +   K+NL DW         R +     I
Sbjct: 67  R---YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---EAEKTHVST 232
            +  A  + +LH      ++HRD+K SNI    +   +V DFGL T M   E E+T ++ 
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 233 IVA--------GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELL 268
           + A        GT  Y++PE       + K D++S G++L ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 77  VIGSGGFGTVYRLTV-NDSTAFAVKRLH------RGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V  + + N    FA+K L+      R  T   R  ER++   GD K   I 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-ERDVLVNGDSKW--IT 137
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAYLH 187
           TLH  +       L+ +    G L T L       +  +  +R+ +A  V A   +  LH
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
           +      +HRDIK  NIL+D N   R++DFG    +  + T  S++  GT  Y++PE   
Sbjct: 196 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 248 T-----GRATAKGDVYSFGVVLLELLTGKRPM 274
                 GR   + D +S GV + E+L G+ P 
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 28/281 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIV 129
           F+  + IG G FG V++   N +    A+K +      +     ++E+  +       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 130 TLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             +G Y       +I E +  GS LD    G       LD      I     +G+ YLH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 137
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
           +     IHRDIK++N+LL ++ E +++DFG+A  +   +   +  V   F ++APE    
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQ 193
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
               +K D++S G+  +EL  G+ P  E    +   L+                  +LEG
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------PTLEG 241
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
              N    +      CL  EPS RPT  E++K   ++++ K
Sbjct: 242 ---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTE-VDRGFERELEAMGDIKHRNI 128
           F  K+ +G+G F  V  L    +T   FAVK + +   +  +   E E+  +  IKH NI
Sbjct: 24  FEFKETLGTGAFSEVV-LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENI 82
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           V L   Y S  +  L+ +L+  G L D  +      +K+     R  +       + YLH
Sbjct: 83  VALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVL-----DAVYYLH 137
Query: 188 HDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
                 I+HRD+K  N+L    D+  +  +SDFGL+  ME  K  V +   GT GY+APE
Sbjct: 138 R---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEG-KGDVMSTACGTPGYVAPE 192
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                  +   D +S GV+   LL G  P    + E  +KL        Q  + EY  D+
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDSKLFE------QILKAEYEFDS 243
Query: 305 SLEGCPINEIND-VFSIASMCLEPEPSKRPTMTEVVK 340
                  ++I+D         +E +P+KR T  +  +
Sbjct: 244 PY----WDDISDSAKDFIRNLMEKDPNKRYTCEQAAR 276

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +G     + F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 125
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 181
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 125
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 181
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +G     + F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 152
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 208
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 93  YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREK--HK 144
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 200
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 127
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 128 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 182
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 238
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 239 YFSNTS 244

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 125
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 181
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +G     + F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 125
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 181
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH   +   IH
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQGV---IH 148
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 207
Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 127
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 128 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 182
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 238
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 239 YFSNTS 244

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH   +   IH
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQGV---IH 139
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 198
Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 24/243 (9%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           ++ + +++  VIG+G FG V++  + +S   A+K++ +     D+ F+ REL+ M  +KH
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKH 91
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            N+V L  ++ S+       +  L+ E +P        H   + K+ +            
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL-KQTMPMLLIKLYMYQL 150
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD      ++ DFG A ++ A + +VS I +   
Sbjct: 151 LRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY- 206
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT-KLVTWVKAVMQDK 296
            Y APE  F     T   D++S G V+ EL+ G+ P+     E G  +LV  +K +    
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPG--ESGIDQLVEIIKVLGTPS 262
Query: 297 REE 299
           RE+
Sbjct: 263 REQ 265

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH   +   IH
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQGV---IH 150
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 209
Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLHGYY 135
           +G+G  G V++++   S    A K +H       R    REL+ + +     IV  +G +
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCIPH 193
            S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL       
Sbjct: 136 YSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 187
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           I+HRD+K SNIL++   E ++ DFG++  L+++    ++    GT  Y++PE       +
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 243
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            + D++S G+ L+E+  G+ P+
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH   +   IH
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQGV---IH 143
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 202
Query: 257 VYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK-REEYVIDTSLEGCPINEIN 315
           ++S G++++E++ G+ P    F E   K +  ++  +  + +  + +  SL+G       
Sbjct: 203 IWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG------- 252
Query: 316 DVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
                    L  +P++R T  E++K   L K+
Sbjct: 253 ----FLDRLLVRDPAQRATAAELLKHPFLAKA 280

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 126/294 (42%), Gaps = 56/294 (19%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYK----------IAVG 178
            L G  T     L+ I E    G+L T+L  +S   + + +   YK           +  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
            A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +V    A   
Sbjct: 153 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA- 268
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P     +++     C   EPS+RPT +E+V+ L
Sbjct: 269 ---------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 12/222 (5%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTEVDRGFE-RELEAMGDIKHRN 127
           +F   + +G+G + TVY+  +N +T    A+K +   + E       RE+  M ++KH N
Sbjct: 6   QFKQLEKLGNGTYATVYK-GLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNK--KNLDWPSRYKIAVGAARGIAY 185
           IV L+    +     L++E M N  L  ++  ++V    + L+            +G+A+
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
            H +    I+HRD+K  N+L+++  + ++ DFGLA          S+ V  T  Y AP+ 
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDV 179
Query: 246 FDTGRATAKG-DVYSFGVVLLELLTGKRPMDEAFLEEGTKLV 286
               R  +   D++S G +L E++TGK        EE  KL+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 22/210 (10%)
Query: 76  DVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           D +G G FG V    ++LT +      + R    + +V    +RE++ +   +H +I+ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
           +   ++     ++ E +  G L  ++  HG+    + ++    ++  + A   + Y H  
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRV---EEMEARRLFQQILSA---VDYCHRH 130
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPEYFDT 248
            +   +HRD+K  N+LLD +M A+++DFGL+ +M + E    S    G+  Y APE   +
Sbjct: 131 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVI-S 183
Query: 249 GR--ATAKGDVYSFGVVLLELLTGKRPMDE 276
           GR  A  + D++S GV+L  LL G  P D+
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 123/292 (42%), Gaps = 52/292 (17%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGK--------SVNKKNLDWPSRYKIAVGAA 180
            L G  T     L+ I E    G+L T+L  K         + K  L        +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-TFG 239
           +G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +V    A     
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTWVK 290
           ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++     
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRM----- 266
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                              P     +++     C   EPS+RPT +E+V+ L
Sbjct: 267 -----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 67  KKTLKFSSKDVIGSGGFG-----TVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEA 119
           +  L+F     +G+G FG     T + L   D+      ++ + T   D       EL+ 
Sbjct: 45  RNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------SVN-----KKN 166
           M  + +H NIV L G  T     L+I E    G L  FL  K       S N     ++ 
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 167 LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE 226
           L        +   A+G+A+L      + IHRD+ + N+LL     A++ DFGLA  +  +
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 227 KTHVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG 282
             +   IV G       ++APE       T + DV+S+G++L E+ +             
Sbjct: 220 SNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------------- 263
Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
             L  +   ++  K  + V D      P     +++SI   C   EP+ RPT  ++   L
Sbjct: 264 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323
Query: 343 E 343
           +
Sbjct: 324 Q 324

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 19  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 73
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 132
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 133 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 188
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 189 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 243
Query: 296 KREE 299
            RE+
Sbjct: 244 TREQ 247

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 22  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 76
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 135
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 136 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 191
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 192 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 246
Query: 296 KREE 299
            RE+
Sbjct: 247 TREQ 250

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 139
Query: 177 ------VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +V
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LE 280
               A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           EGT++                        P     +++     C   EPS+RPT +E+V+
Sbjct: 257 EGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 341 ML 342
            L
Sbjct: 295 HL 296

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-----VTL 131
           +G G +G V ++  V      AVKR+ R T  V+   ++ L    DI  R +     VT 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI-RAT--VNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHD 189
           +G         +  ELM + SLD F   K V  K    P     KIAV   + + +LH  
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY---- 245
               +IHRD+K SN+L++   + ++ DFG++  +  +      I AG   Y+APE     
Sbjct: 129 L--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPE 184
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
            +    + K D++S G+ ++EL   + P D           +W     Q K+   V++  
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQ---VVEEP 230
Query: 306 LEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
               P ++ +  F    S CL+    +RPT  E+++
Sbjct: 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 84
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 143
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 199
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 254
Query: 296 KREE 299
            RE+
Sbjct: 255 TREQ 258

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 72
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 131
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 242
Query: 296 KREE 299
            RE+
Sbjct: 243 TREQ 246

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 128/303 (42%), Gaps = 70/303 (23%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 139
Query: 177 ------VGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
                    A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +  +
Sbjct: 140 HLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 230 VSTIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---L 279
           V    A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255
Query: 280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +EGT++                        P     +++     C   EPS+RPT +E+V
Sbjct: 256 KEGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293
Query: 340 KML 342
           + L
Sbjct: 294 EHL 296

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 77  VIGSGGFGTVYRLTV-NDSTAFAVK------RLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V  + + N    +A+K       L R  T   R  ER++   GD +   I 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFRE-ERDVLVNGDCQW--IT 137
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAYLH 187
            LH  +    +  L+ +    G L T L  K  +K   D  +R+ I   V A   I  LH
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGGDLLTLL-SKFEDKLPEDM-ARFYIGEMVLAIDSIHQLH 195
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
           +      +HRDIK  N+LLD N   R++DFG    M  + T  S++  GT  Y++PE   
Sbjct: 196 Y------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 248 T-----GRATAKGDVYSFGVVLLELLTGKRPM 274
                 G+   + D +S GV + E+L G+ P 
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDR------GFERELEAMGDIK 124
           + + + +GSG F  V +     +   +A K + +  T+  R        ERE+  + +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H N++TLH  Y +    +LI EL+  G L  FL      K++L      +       G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVY 128
Query: 185 YLHHDCIPHIIHRDIKSSNI-LLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           YLH   I H    D+K  NI LLD+N+     ++ DFGLA  ++      +  + GT  +
Sbjct: 129 YLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREE 299
           +APE  +      + D++S GV+   LL+G  P    FL +   + +  V AV  +  +E
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 239
Query: 300 YVIDTS 305
           Y  +TS
Sbjct: 240 YFSNTS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 128/303 (42%), Gaps = 70/303 (23%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 185
Query: 177 ------VGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
                    A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +  +
Sbjct: 186 HLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 230 VSTIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---L 279
           V    A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L
Sbjct: 242 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301
Query: 280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +EGT++                        P     +++     C   EPS+RPT +E+V
Sbjct: 302 KEGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELV 339
Query: 340 KML 342
           + L
Sbjct: 340 EHL 342

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 26  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 80
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 139
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 195
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 196 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 250
Query: 296 KREE 299
            RE+
Sbjct: 251 TREQ 254

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 148
Query: 177 ------VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +V
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LE 280
               A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           EGT++                        P     +++     C   EPS+RPT +E+V+
Sbjct: 266 EGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 341 ML 342
            L
Sbjct: 304 HL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 127/303 (41%), Gaps = 70/303 (23%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 139
Query: 177 ------VGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
                    A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +   
Sbjct: 140 HLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 230 VSTIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---L 279
           V    A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255
Query: 280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +EGT++                        P     +++     C   EPS+RPT +E+V
Sbjct: 256 KEGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293
Query: 340 KML 342
           + L
Sbjct: 294 EHL 296

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 84
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 143
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 199
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 254
Query: 296 KREE 299
            RE+
Sbjct: 255 TREQ 258

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 37  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 91
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 150
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 206
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 207 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 261
Query: 296 KREE 299
            RE+
Sbjct: 262 TREQ 265

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 18/241 (7%)
Query: 40  YTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFA 98
           Y DS+   + + ++      L+   + K T  F    V+G GGFG V    V  +   +A
Sbjct: 161 YLDSIYFNRFLQWKW-----LERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 99  VKRLHRGTTEVDRGFE---RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDT 155
            K+L +   +  +G      E + +  +  R +V+L   Y +     L+  LM  G L  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK- 272
Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS 215
             H   + +           A     G+  LH +    I++RD+K  NILLD +   R+S
Sbjct: 273 -FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS 328
Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           D GLA  +   +T    +  GT GY+APE     R T   D ++ G +L E++ G+ P  
Sbjct: 329 DLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
Query: 276 E 276
           +
Sbjct: 387 Q 387

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 63/313 (20%)
Query: 71  KFSSKDVIGSGGFG-----TVYRLTVNDST-AFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           + S    +G+G FG     T Y L  +D+    AVK L       +R     EL+ +  +
Sbjct: 42  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 101
Query: 124 -KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------SVNKKNLD 168
             H NIV L G  T     L+I E    G L  FL  K                ++  LD
Sbjct: 102 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 161
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +  
Sbjct: 162 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218
Query: 229 HVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAF 278
           +V   V G       ++APE       T + DV+S+G+ L EL +         P+D  F
Sbjct: 219 YV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 275
Query: 279 ---LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
              ++EG ++++                      P +   +++ I   C + +P KRPT 
Sbjct: 276 YKMIKEGFRMLS----------------------PEHAPAEMYDIMKTCWDADPLKRPTF 313
Query: 336 TEVVKMLELIKSE 348
            ++V+++E   SE
Sbjct: 314 KQIVQLIEKQISE 326

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 29/239 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDST----AFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +     V+GSG FGTVY+ + + D        A+K L   T+ + ++    E  
Sbjct: 13  ILKET-ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKI 175
            M  +    +  L G   +S   L + +LMP G L   +    G+  ++  L+W      
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNW------ 124
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            +  A+G++YL       ++HRD+ + N+L+      +++DFGLA L++ ++T       
Sbjct: 125 CMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 181
Query: 236 GT-FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKL 285
                ++A E     R T + DV+S+GV + EL+T G +P D          LE+G +L
Sbjct: 182 KVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL 240

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 35/270 (12%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+  M  + H NIV L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFE 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y H    
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFRQIVSA---VQYCHQK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K+ N+LLD +M  +++DFG +   E    +      G+  Y APE F   + 
Sbjct: 133 -FIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 252 TA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
              + DV+S GV+L  L++G  P D   L+E  + V          R +Y I       P
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI-------P 233
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                D  ++    L   PSKR T+ +++K
Sbjct: 234 FYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 35/270 (12%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+  M  + H NIV L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFE 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y H    
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFRQIVSA---VQYCHQK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K+ N+LLD +M  +++DFG +   E    +      G+  Y APE F   + 
Sbjct: 133 -FIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 252 TA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
              + DV+S GV+L  L++G  P D   L+E  + V          R +Y I       P
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI-------P 233
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                D  ++    L   PSKR T+ +++K
Sbjct: 234 FYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 72  FSSKDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
           +  +  IG G F  V    + LT  +     + +     T + + F RE+  M  + H N
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF-REVRIMKILNHPN 75
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           IV L     + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFRQIVSA---VQY 129
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
            H     +I+HRD+K+ N+LLD +M  +++DFG +   E    +      G+  Y APE 
Sbjct: 130 CHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSN--EFTVGNKLDTFCGSPPYAAPEL 184
Query: 246 FDTGRATA-KGDVYSFGVVLLELLTGKRPMDEAFLEE 281
           F   +    + DV+S GV+L  L++G  P D   L+E
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 63/313 (20%)
Query: 71  KFSSKDVIGSGGFG-----TVYRLTVNDST-AFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           + S    +G+G FG     T Y L  +D+    AVK L       +R     EL+ +  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 124 -KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------SVNKKNLD 168
             H NIV L G  T     L+I E    G L  FL  K                ++  LD
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +  
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 229 HVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAF 278
           +V   V G       ++APE       T + DV+S+G+ L EL +         P+D  F
Sbjct: 201 YV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 279 ---LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
              ++EG ++++                      P +   +++ I   C + +P KRPT 
Sbjct: 258 YKMIKEGFRMLS----------------------PEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 336 TEVVKMLELIKSE 348
            ++V+++E   SE
Sbjct: 296 KQIVQLIEKQISE 308

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 63/313 (20%)
Query: 71  KFSSKDVIGSGGFG-----TVYRLTVNDST-AFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           + S    +G+G FG     T Y L  +D+    AVK L       +R     EL+ +  +
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 124 -KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------SVNKKNLD 168
             H NIV L G  T     L+I E    G L  FL  K                ++  LD
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +  
Sbjct: 167 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223
Query: 229 HVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAF 278
           +V   V G       ++APE       T + DV+S+G+ L EL +         P+D  F
Sbjct: 224 YV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 279 ---LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
              ++EG ++++                      P +   +++ I   C + +P KRPT 
Sbjct: 281 YKMIKEGFRMLS----------------------PEHAPAEMYDIMKTCWDADPLKRPTF 318
Query: 336 TEVVKMLELIKSE 348
            ++V+++E   SE
Sbjct: 319 KQIVQLIEKQISE 331

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +     T + + F RE+  M  + H NIV L  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 78
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   LI E    G +  +L  HG+   K   +  S+++  V A   + Y H    
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFRQIVSA---VQYCHQK-- 130
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K+ N+LLD +M  +++DFG +   E           G+  Y APE F   + 
Sbjct: 131 -RIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 252 TA-KGDVYSFGVVLLELLTGKRPMDEAFLEE 281
              + DV+S GV+L  L++G  P D   L+E
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 218

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 127/303 (41%), Gaps = 70/303 (23%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 139
Query: 177 ------VGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
                    A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +   
Sbjct: 140 HLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 230 VSTIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---L 279
           V    A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255
Query: 280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +EGT++                        P     +++     C   EPS+RPT +E+V
Sbjct: 256 KEGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293
Query: 340 KML 342
           + L
Sbjct: 294 EHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 126/302 (41%), Gaps = 68/302 (22%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 148
Query: 177 ------VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +   V
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LE 280
               A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           EGT++                        P     +++     C   EPS+RPT +E+V+
Sbjct: 266 EGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 341 ML 342
            L
Sbjct: 304 HL 305

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 63/313 (20%)
Query: 71  KFSSKDVIGSGGFG-----TVYRLTVNDST-AFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           + S    +G+G FG     T Y L  +D+    AVK L       +R     EL+ +  +
Sbjct: 40  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 99
Query: 124 -KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------SVNKKNLD 168
             H NIV L G  T     L+I E    G L  FL  K                ++  LD
Sbjct: 100 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 159
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +  
Sbjct: 160 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216
Query: 229 HVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAF 278
           +V   V G       ++APE       T + DV+S+G+ L EL +         P+D  F
Sbjct: 217 YV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 279 ---LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
              ++EG ++++                      P +   +++ I   C + +P KRPT 
Sbjct: 274 YKMIKEGFRMLS----------------------PEHAPAEMYDIMKTCWDADPLKRPTF 311
Query: 336 TEVVKMLELIKSE 348
            ++V+++E   SE
Sbjct: 312 KQIVQLIEKQISE 324

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH   +   IH
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQGV---IH 193
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 252
Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 35/270 (12%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+  M  + H NIV L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFE 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y H    
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFRQIVSA---VQYCHQK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K+ N+LLD +M  +++DFG +   E    +      G+  Y APE F   + 
Sbjct: 133 -FIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 252 TA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
              + DV+S GV+L  L++G  P D   L+E  + V          R +Y I       P
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI-------P 233
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                D  ++    L   PSKR T+ +++K
Sbjct: 234 FYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 29/294 (9%)
Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTE--VDRGFERELEAMGD 122
           F+   K+ +  ++G G +G V +    D+    A+K+      +  V +   RE++ +  
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           ++H N+V L       +   L++E + +  LD       +    LD+    K       G
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL----ELFPNGLDYQVVQKYLFQIING 136
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           I + H     +IIHRDIK  NIL+ Q+   ++ DFG A  + A        VA T  Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 243 PEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM--DEAFLEEGTKLVTWVKAVMQDKREE 299
           PE         K  DV++ G ++ E+  G+ P+   ++ +++   ++  +  ++   +E 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 300 YVIDTSLEGCPINEIND--------------VFSIASMCLEPEPSKRPTMTEVV 339
           +  +    G  + EI +              V  +A  CL  +P KRP   E++
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 77  VIGSGGFGTVYRLTV-NDSTAFAVK------RLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V  + + N    +A+K       L R  T   R  ER++   GD +   I 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFRE-ERDVLVNGDCQW--IT 153
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIAYLH 187
            LH  +    +  L+ +    G L T L  K  +K   D  +R+ I   V A   I  LH
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGGDLLTLL-SKFEDKLPEDM-ARFYIGEMVLAIDSIHQLH 211
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
           +      +HRDIK  N+LLD N   R++DFG    M  + T  S++  GT  Y++PE   
Sbjct: 212 Y------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 248 T-----GRATAKGDVYSFGVVLLELLTGKRPM 274
                 G+   + D +S GV + E+L G+ P 
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGK----------SVNKKNLDWPSRYKIAVG 178
            L G  T     L+ I E    G+L T+L  K           + K  L        +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
            A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +   V    A   
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA- 272
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P     +++     C   EPS+RPT +E+V+ L
Sbjct: 273 ---------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 71  KFSSKD-----VIGSGGFGTVYRL-TVNDSTAFAVKRLHRGTT----EVDRGFERELEAM 120
           K+S +D      +G+G FG V+ + + ++   +A+K L +       +V+   +  L  +
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-ML 60
Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
             + H  I+ + G +  +Q   +I + +  G L + L  KS    N   P     A    
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPN---PVAKFYAAEVC 116
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
             + YLH      II+RD+K  NILLD+N   +++DFG A  +      V+  + GT  Y
Sbjct: 117 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDY 169
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +APE   T       D +SFG+++ E+L G  P 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 63/313 (20%)
Query: 71  KFSSKDVIGSGGFG-----TVYRLTVNDST-AFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           + S    +G+G FG     T Y L  +D+    AVK L       +R     EL+ +  +
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 124 -KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------SVNKKNLD 168
             H NIV L G  T     L+I E    G L  FL  K                ++  LD
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +  
Sbjct: 167 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223
Query: 229 HVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT------GKRPMDEAF 278
           +V   V G       ++APE       T + DV+S+G+ L EL +         P+D  F
Sbjct: 224 YV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 279 ---LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
              ++EG ++++                      P +   +++ I   C + +P KRPT 
Sbjct: 281 YKMIKEGFRMLS----------------------PEHAPAEMYDIMKTCWDADPLKRPTF 318
Query: 336 TEVVKMLELIKSE 348
            ++V+++E   SE
Sbjct: 319 KQIVQLIEKQISE 331

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   TV  S    AVK++     +       E+  M D +H N+V ++  Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   + ++ LH   +   IH
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQGV---IH 270
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 329
Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 106
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 165
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 221
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 276
Query: 296 KREE 299
            RE+
Sbjct: 277 TREQ 280

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 31  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 85
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 144
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 200
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 201 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 255
Query: 296 KREE 299
            RE+
Sbjct: 256 TREQ 259

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 127/308 (41%), Gaps = 52/308 (16%)
Query: 67  KKTLKFSSKDVIGSGGFG-----TVYRLTVNDSTAFAVKRLHRGTTEVDR--GFERELEA 119
           +  L+F     +G+G FG     T + L   D+      ++ + T   D       EL+ 
Sbjct: 30  RNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS----------------V 162
           M  + +H NIV L G  T     L+I E    G L  FL  K+                +
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 163 NKKN---LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL 219
           +K++   L+       +   A+G+A+L      + IHRD+ + N+LL     A++ DFGL
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 220 ATLMEAEKTHVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           A  +  +  +   IV G       ++APE       T + DV+S+G++L E+ +      
Sbjct: 205 ARDIMNDSNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------ 255
Query: 276 EAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
                    L  +   ++  K  + V D      P     +++SI   C   EP+ RPT 
Sbjct: 256 -------LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 308
Query: 336 TEVVKMLE 343
            ++   L+
Sbjct: 309 QQICSFLQ 316

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 76  DVIGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           D +G G FG V    ++LT +      + R    + +V    +RE++ +   +H +I+ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
           +   ++     ++ E +  G L  ++  HG+    + ++    ++  + A   + Y H  
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRV---EEMEARRLFQQILSA---VDYCHRH 130
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
            +   +HRD+K  N+LLD +M A+++DFGL+ +M   +    +   G+  Y APE   +G
Sbjct: 131 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVI-SG 184
Query: 250 R--ATAKGDVYSFGVVLLELLTGKRPMDE 276
           R  A  + D++S GV+L  LL G  P D+
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 123/296 (41%), Gaps = 57/296 (19%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGK-----------SVNKKNLDWPSRYKIAV 177
            L G  T     L+ I E    G+L T+L  K            + K  L        + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 178 GAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
             A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +   V    A 
Sbjct: 156 QVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 237 -TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLV 286
               ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++ 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                  P     +++     C   EPS+RPT +E+V+ L
Sbjct: 272 A----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +     T + + F RE+  M  + H NIV L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   LI E    G +  +L  HG+   K   +  S+++  V A   + Y H    
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFRQIVSA---VQYCHQK-- 133
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K+ N+LLD +M  +++DFG +   E           G   Y APE F   + 
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 252 TA-KGDVYSFGVVLLELLTGKRPMDEAFLEE 281
              + DV+S GV+L  L++G  P D   L+E
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 123/296 (41%), Gaps = 56/296 (18%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGK------------SVNKKNLDWPSRYKIA 176
            L G  T     L+ I E    G+L T+L  K             + K  L        +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
              A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +V    A 
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 237 -TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLV 286
               ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++ 
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 273
Query: 287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                  P     +++     C   EPS+RPT +E+V+ L
Sbjct: 274 A----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 18/241 (7%)
Query: 40  YTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFA 98
           Y DS+   + + ++      L+   + K T  F    V+G GGFG V    V  +   +A
Sbjct: 161 YLDSIYFNRFLQWKW-----LERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 99  VKRLHRGTTEVDRGFE---RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDT 155
            K+L +   +  +G      E + +  +  R +V+L   Y +     L+  LM  G L  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK- 272
Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS 215
             H   + +           A     G+  LH +    I++RD+K  NILLD +   R+S
Sbjct: 273 -FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS 328
Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           D GLA  +   +T    +  GT GY+APE     R T   D ++ G +L E++ G+ P  
Sbjct: 329 DLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
Query: 276 E 276
           +
Sbjct: 387 Q 387

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 39/272 (14%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+  M  + H NIV L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFE 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y H    
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFRQIVSA---VQYCHQK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--GTFGYLAPEYFDTG 249
             I+HRD+K+ N+LLD +M  +++DFG +     E T  + + A  G   Y APE F   
Sbjct: 133 -FIVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 250 RATA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           +    + DV+S GV+L  L++G  P D   L+E  + V          R +Y I      
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI------ 232
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            P     D  ++    L   PSKR T+ +++K
Sbjct: 233 -PFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 42/300 (14%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYR--LTVNDSTAF--AVKRLHRGTTEVDRGFERELE 118
           D +  + L    K ++G G FG+V    L   D T+   AVK     T ++D   +RE+E
Sbjct: 28  DVVIDRNLLILGK-ILGEGEFGSVMEGNLKQEDGTSLKVAVK-----TMKLDNSSQREIE 81
Query: 119 -------AMGDIKHRNIVTLHGYY--TSSQ---YNLLIYELMPNGSLDTFLHGKSVN--K 164
                   M D  H N++ L G     SSQ     ++I   M  G L T+L    +    
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 165 KNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLM 223
           K++   +  K  V  A G+ YL +    + +HRD+ + N +L  +M   V+DFGL+  + 
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT 283
             +      I      ++A E       T+K DV++FGV + E+               T
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI--------------AT 244
Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           + +T    V   +  +Y++       P + +++++ I   C   +P  RPT + +   LE
Sbjct: 245 RGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 15  RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 73
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 74  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 127
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 128 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 239
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 240 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K+   + IG G +G VY+   N    FA+K  RL +    +     RE+  + ++KH NI
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L+    + +  +L++E + +  L   L    V +  L+  +     +    GIAY H 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF- 246
                ++HRD+K  N+L+++  E +++DFGLA       + +   IV  T  Y AP+   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLM 173
Query: 247 DTGRATAKGDVYSFGVVLLELLTG 270
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IG G  G V   T   +    AVK++     +       E+  M D  H N+V ++  Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E +  G+L   +    +N++ +       + +   R ++YLH+  +   IH
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQGV---IH 164
Query: 197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGD 256
           RDIKS +ILL  +   ++SDFG    +  E      +V GT  ++APE         + D
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEVD 223
Query: 257 VYSFGVVLLELLTGKRP 273
           ++S G++++E++ G+ P
Sbjct: 224 IWSLGIMVIEMIDGEPP 240

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 3   RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 61
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 62  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 115
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 116 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 227
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 228 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 258

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 25  RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 83
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 84  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 137
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 249
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 250 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 25  RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 83
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 84  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 137
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 249
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 250 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 5   RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 64  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 117
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 229
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 230 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 9   RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 67
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 68  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 121
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 122 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 233
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 234 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 23  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 77
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 136
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 137 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 192
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 193 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 247
Query: 296 KREE 299
            RE+
Sbjct: 248 TREQ 251

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 39/272 (14%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+  M  + H NIV L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFE 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y H    
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFRQIVSA---VQYCHQK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGYLAPEYFDTG 249
             I+HRD+K+ N+LLD +M  +++DFG +     E T  + +    G+  Y APE F   
Sbjct: 133 -FIVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDEFCGSPPYAAPELFQGK 187
Query: 250 RATA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           +    + DV+S GV+L  L++G  P D   L+E  + V          R +Y I      
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI------ 232
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            P     D  ++    L   PSKR T+ +++K
Sbjct: 233 -PFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 36/282 (12%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           ++IG G FG VY    +   A  +  + R   +  + F+RE+ A    +H N+V   G  
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
            S  +  +I  L    +L + +    +    LD     +IA    +G+ YLH      I+
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 196 HRDIKSSNILLDQNMEARVSDFGL----ATLMEAEKTHVSTIVAGTFGYLAPEYF----- 246
           H+D+KS N+  D N +  ++DFGL      L    +     I  G   +LAPE       
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 247 ----DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV-MQDKREEYV 301
               D    +   DV++ G +  EL   + P    F  +  + + W     M+    +  
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +          EI+D+      C   E  +RPT T+++ MLE
Sbjct: 268 MG--------KEISDILLF---CWAFEQEERPTFTKLMDMLE 298

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 126/302 (41%), Gaps = 68/302 (22%)
Query: 78  IGSGGFGTVYRLTVN--DSTA----FAVKRLHRGTTEVD-RGFERELEAMGDIKHR-NIV 129
           +G G FG V        D TA     AVK L  G T  + R    EL+ +  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 TLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA------------ 176
            L G  T     L+ I E    G+L T+L     +K+N   P  YK+A            
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLR----SKRNEFVP--YKVAPEDLYKDFLTLE 148
Query: 177 ------VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +   V
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LE 280
               A     ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           EGT++                        P     +++     C   EPS+RPT +E+V+
Sbjct: 266 EGTRMRA----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 341 ML 342
            L
Sbjct: 304 HL 305

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 32/282 (11%)
Query: 66  FKKTLKFSSKDVIGSGGFG-TVYRLTVNDSTAFAVKRLH--RGTTEVDRGFERELEAMGD 122
           F+   K+     IG G FG  +   +  D   + +K ++  R +++      RE+  + +
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS----VNKKNLDWPSRYKIAVG 178
           +KH NIV     +  +    ++ +    G L   ++ +        + LDW       V 
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQ 133
Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
               + ++H      I+HRDIKS NI L ++   ++ DFG+A ++ +    ++    GT 
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTP 189
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
            YL+PE  +      K D+++ G VL EL T    +  AF E G+     +K        
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCT----LKHAF-EAGSMKNLVLK-------- 236
Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
             +I  S     ++   D+ S+ S   +  P  RP++  +++
Sbjct: 237 --IISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 77  VIGSGGFGTVYRLTVND---STAFAVKRLHRGTTEVD--RGFERELEAMGDIKHRNIVTL 131
           ++G G FG V  L   D      +AVK +++ + +        RE+E +  + H NI+ L
Sbjct: 29  MLGKGSFGEV--LKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
                 S    ++ EL   G L      + + +K        +I      GI Y+H    
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 192 PHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
            +I+HRD+K  NILL   +++ + ++ DFGL+T  +        I  GT  Y+APE    
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL-R 196
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPM 274
           G    K DV+S GV+L  LL+G  P 
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 46  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 100
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 159
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 215
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 216 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 270
Query: 296 KREE 299
            RE+
Sbjct: 271 TREQ 274

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 77  VIGSGGFGTVYRLTVND---STAFAVKRLHRGTTEVD--RGFERELEAMGDIKHRNIVTL 131
           ++G G FG V  L   D      +AVK +++ + +        RE+E +  + H NI+ L
Sbjct: 29  MLGKGSFGEV--LKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
                 S    ++ EL   G L      + + +K        +I      GI Y+H    
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 192 PHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
            +I+HRD+K  NILL   +++ + ++ DFGL+T  +        I  GT  Y+APE    
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL-R 196
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPM 274
           G    K DV+S GV+L  LL+G  P 
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 106
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 165
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 276
Query: 296 KREE 299
            RE+
Sbjct: 277 TREQ 280

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 23  RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 81
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 82  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 135
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 136 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 247
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 248 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 54  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 108
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 167
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 168 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 223
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 224 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 278
Query: 296 KREE 299
            RE+
Sbjct: 279 TREQ 282

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 97  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 151
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 210
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 211 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 266
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 267 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 321
Query: 296 KREE 299
            RE+
Sbjct: 322 TREQ 325

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K+   + IG G +G VY+   N    FA+K  RL +    +     RE+  + ++KH NI
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L+    + +  +L++E + +  L   L    V +  L+  +     +    GIAY H 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF- 246
                ++HRD+K  N+L+++  E +++DFGLA       + +   +V  T  Y AP+   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLM 173
Query: 247 DTGRATAKGDVYSFGVVLLELLTG 270
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K+   + IG G +G VY+   N    FA+K  RL +    +     RE+  + ++KH NI
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L+    + +  +L++E + +  L   L    V +  L+  +     +    GIAY H 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF- 246
                ++HRD+K  N+L+++  E +++DFGLA       + +   +V  T  Y AP+   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLM 173
Query: 247 DTGRATAKGDVYSFGVVLLELLTG 270
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 78  IGSGGFGTVYRLT-----VNDSTAFAVKRLHRGTTE-VDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +       +  +  F  KR  R +   V R   ERE+  +  + H N++T
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  Y +    +LI EL+  G L  FL      K++L              G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFGLA   E E       + GT  ++APE  
Sbjct: 136 IAHF---DLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREEYVIDTS 305
           +      + D++S GV+   LL+G  P    FL +   + +  + AV  D  EE+   TS
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANITAVSYDFDEEFFSQTS 246

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH-RNIVT 130
           F   +++G+G +G VY+     +   A  ++   T + +   ++E+  +    H RNI T
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 131 LHGYYTSSQYN------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
            +G +             L+ E    GS+   +     N    +W +   I     RG++
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 143
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           +LH      +IHRDIK  N+LL +N E ++ DFG++  ++      +T + GT  ++APE
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 199
Query: 245 YF---DTGRATA--KGDVYSFGVVLLELLTGKRPM 274
                +   AT   K D++S G+  +E+  G  P+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGF--ERELEAMGDIKHRNI----- 128
           ++IG G +G VY+ ++ D    AVK       +    F  E+ +  +  ++H NI     
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIV 74
Query: 129 ----VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
               VT  G     +Y LL+ E  PNGSL  +L   +      DW S  ++A    RG+A
Sbjct: 75  GDERVTADG---RMEY-LLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLA 125
Query: 185 YLHHDCI------PHIIHRDIKSSNILLDQNMEARVSDFGLATLM-------EAEKTHVS 231
           YLH +        P I HRD+ S N+L+  +    +SDFGL+  +         E+ + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 232 TIVAGTFGYLAPEYF-------DTGRATAKGDVYSFGVVLLELL 268
               GT  Y+APE         D   A  + D+Y+ G++  E+ 
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE-RELEAMGDIKH 125
           + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  + H
Sbjct: 56  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 110
Query: 126 RNIVTLHGYYTSSQ------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            NIV L  ++ SS       Y  L+ + +P        H  S  K+ L            
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL 169
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKTHVSTIVAGTF 238
            R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I +   
Sbjct: 170 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 225
Query: 239 GYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR--PMDEAFLEEGTKLVTWVKAVMQD 295
            Y APE  F     T+  DV+S G VL ELL G+   P D        +LV  +K +   
Sbjct: 226 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP 280
Query: 296 KREE 299
            RE+
Sbjct: 281 TREQ 284

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 78  IGSGGFGTVYRLT-----VNDSTAFAVKRLHRGTTE-VDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +       +  +  F  KR  R +   V R   ERE+  +  + H N++T
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  Y +    +LI EL+  G L  FL      K++L              G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFGLA   E E       + GT  ++APE  
Sbjct: 136 IAHF---DLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREEYVIDTS 305
           +      + D++S GV+   LL+G  P    FL +   + +  + AV  D  EE+   TS
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANITAVSYDFDEEFFSQTS 246

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 77  VIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVD--RGFERELEAMGDIKHRNIVT 130
           ++G G FG V     R+T  +   +AVK +++ + +        RE+E +  + H NI+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQE---YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L      S    ++ EL   G L      + + +K        +I      GI Y+H   
Sbjct: 86  LFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK-- 139
Query: 191 IPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
             +I+HRD+K  NILL   +++ + ++ DFGL+T  +        I  GT  Y+APE   
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL- 195
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
            G    K DV+S GV+L  LL+G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 78  IGSGGFGTVYRLTVNDS-----TAFAVKRLHRGTTEVDRG-----FERELEAMGDIKHRN 127
           +GSG F  V +     +       F  KR  R +    RG      ERE+  +  + H N
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR---RGVCREEIEREVSILRQVLHPN 76
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           I+TLH  Y +    +LI EL+  G L  FL      K++L              G+ YLH
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 188 HDCIPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
              I H    D+K  NI LLD+N+     ++ DFGLA   E E       + GT  ++AP
Sbjct: 133 TKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAP 187
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL-EEGTKLVTWVKAVMQDKREEYVI 302
           E  +      + D++S GV+   LL+G  P    FL +   + +  + AV  D  EE+  
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANITAVSYDFDEEFFS 243
Query: 303 DTS 305
            TS
Sbjct: 244 QTS 246

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H NI+ L   Y ++ +  L+++LM  G L  +L      K  L      KI       I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 138
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
            LH     +I+HRD+K  NILLD +M  +++DFG +  ++  +   S  V GT  YLAPE
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSYLAPE 193
Query: 245 YFDTGRAT------AKGDVYSFGVVLLELLTGKRPM 274
             +            + D++S GV++  LL G  P 
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 35/270 (12%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+  M  + H NIV L  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFE 73
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG    K   +  ++++  V A   + Y H    
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK---EARAKFRQIVSA---VQYCHQK-- 125
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K+ N+LLD +M  +++DFG +   E    +      G+  Y APE F   + 
Sbjct: 126 -FIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 252 TA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
              + DV+S GV+L  L++G  P D   L+E  + V          R +Y I       P
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI-------P 226
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                D  ++    L   PSKR T+ +++K
Sbjct: 227 FYMSTDCENLLKKFLILNPSKRGTLEQIMK 256

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 41/301 (13%)
Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTLH 132
           + +G G +G V+R L   +S A  +      ++  ++ + RE E    +  +H NI+   
Sbjct: 14  ECVGKGRYGEVWRGLWHGESVAVKI-----FSSRDEQSWFRETEIYNTVLLRHDNILGFI 68
Query: 133 GYYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
               +S+ +     LI     +GSL  FL      ++ L+     ++AV AA G+A+LH 
Sbjct: 69  ASDMTSRNSSTQLWLITHYHEHGSLYDFLQ-----RQTLEPHLALRLAVSAACGLAHLHV 123
Query: 189 DCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV---STIVAGTFGY 240
           +       P I HRD KS N+L+  N++  ++D GLA +      ++   +    GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 241 LAPEYFDTGRAT------AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL---VTWVKA 291
           +APE  D    T         D+++FG+VL E+   +R +    +E+       V     
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNGIVEDYRPPFYDVVPNDP 241
Query: 292 VMQDKREEYVIDTSLEGCPINEIND--VFSIASM---CLEPEPSKRPTMTEVVKMLELIK 346
             +D ++   +D      P     D  +  +A M   C  P PS R T   + K L+ I 
Sbjct: 242 SFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKIS 301
Query: 347 S 347
           +
Sbjct: 302 N 302

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 47/295 (15%)
Query: 78  IGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVT 130
           +G G FG V + T          T  AVK L    +  + R    E   +  + H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH------------GKSVNKKNLDWPSRYKIAVG 178
           L+G  +     LLI E    GSL  FL             G S N  +LD P    + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 179 --------AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    ++G+ YL       ++HRD+ + NIL+ +  + ++SDFGL+  +  E ++V
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW 288
                     ++A E       T + DV+SFGV+L E++T G  P      E   +L   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---RLFNL 264
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +K   + +R            P N   +++ +   C + EP KRP   ++ K LE
Sbjct: 265 LKTGHRMER------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF---ERELEAMGDIKHR 126
           +  K+ +G G F  V R  V+ +T   FA K ++       R F   ERE      ++H 
Sbjct: 8   YDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHP 65
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NIV LH       ++ L+++L+  G L   +    V ++                 IAY 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYC 121
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           H +    I+HR++K  N+LL    +    +++DFGLA  +E   +      AGT GYL+P
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSP 176
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
           E       +   D+++ GV+L  LL G  P    + E+  +L   +KA   D
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQHRLYAQIKAGAYD 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF---ERELEAMGDIKHR 126
           +  K+ +G G F  V R  V+ +T   FA K ++       R F   ERE      ++H 
Sbjct: 8   YDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHP 65
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NIV LH       ++ L+++L+  G L   +    V ++                 IAY 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYC 121
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           H +    I+HR++K  N+LL    +    +++DFGLA  +E   +      AGT GYL+P
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSP 176
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
           E       +   D+++ GV+L  LL G  P    + E+  +L   +KA   D
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQHRLYAQIKAGAYD 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF---ERELEAMGDIKHR 126
           +  K+ +G G F  V R  V+ +T   FA K ++       R F   ERE      ++H 
Sbjct: 7   YDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHP 64
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NIV LH       ++ L+++L+  G L   +    V ++                 IAY 
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYC 120
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           H +    I+HR++K  N+LL    +    +++DFGLA  +E   +      AGT GYL+P
Sbjct: 121 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSP 175
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
           E       +   D+++ GV+L  LL G  P    + E+  +L   +KA   D
Sbjct: 176 EVLKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQHRLYAQIKAGAYD 224

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 9   RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 67
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 68  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 121
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-- 238
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++        G +  
Sbjct: 122 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 233
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 234 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 36/207 (17%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGY 134
           DV G G F           +A  V+ L   T        +E++ +  +  H NI+ L   
Sbjct: 38  DVTGGGSF-----------SAEEVQELREATL-------KEVDILRKVSGHPNIIQLKDT 79
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
           Y ++ +  L+++LM  G L  +L      K  L      KI       I  LH     +I
Sbjct: 80  YETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHK---LNI 132
Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPEYFDTGRAT- 252
           +HRD+K  NILLD +M  +++DFG +  ++  EK      V GT  YLAPE  +      
Sbjct: 133 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDN 189
Query: 253 -----AKGDVYSFGVVLLELLTGKRPM 274
                 + D++S GV++  LL G  P 
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGF 113
           ++  L  ++I + T  +  K+ IG G + +V +  ++ +T   FAVK + +      R  
Sbjct: 9   IVQQLHRNSI-QFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSK----RDP 62
Query: 114 ERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPS 171
             E+E +    +H NI+TL   Y   +Y  ++ ELM  G L D  L  K  +++      
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--- 119
Query: 172 RYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL-LDQ--NMEA-RVSDFGLATLMEAEK 227
              +     + + YLH   +   +HRD+K SNIL +D+  N E+ R+ DFG A  + AE 
Sbjct: 120 --AVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             + T    T  ++APE  +     A  D++S GV+L  +LTG  P 
Sbjct: 175 GLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 111/246 (45%), Gaps = 26/246 (10%)
Query: 62  SDAIFKKTLKFSS----KDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF-- 113
           S+ +   + KFS     K+ +G G F +V R  V+ +T   FA K ++       R F  
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQK 74
Query: 114 -ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
            ERE      ++H NIV LH       ++ L+++L+  G L   +    V ++       
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADA 130
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTH 229
                     IAY H +    I+HR++K  N+LL    +    +++DFGLA  +E   + 
Sbjct: 131 SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSE 185
Query: 230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWV 289
                AGT GYL+PE       +   D+++ GV+L  LL G  P    + E+  +L   +
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQHRLYAQI 242
Query: 290 KAVMQD 295
           KA   D
Sbjct: 243 KAGAYD 248

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 78  IGSGGFGTVYRLT-----VNDSTAFAVKRLHRGTTE-VDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +       +  +  F  KR  R +   V R   ERE+  +  + H N++T
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  Y +    +LI EL+  G L  FL      K++L              G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFGLA   E E       + GT  ++APE  
Sbjct: 136 IAHF---DLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +      + D++S GV+   LL+G  P 
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           V+G GGFG V+   +  +   +A K+L++   +  +G++    E + +  +  R IV+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + +     L+  +M  G +   ++    +      P           G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           +II+RD+K  N+LLD +   R+SD GLA  ++A +T      AGT G++APE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYD 367
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
              D ++ GV L E++  + P 
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHR 126
           K+   + +G G +G VY+   +     A+KR+       D G      RE+  + ++ H 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHP 79
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV-GAARGIAY 185
           NIV+L     S +   L++E M    L   L     NK  L   S+ KI +    RG+A+
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFM-EKDLKKVL---DENKTGLQ-DSQIKIYLYQLLRGVAH 134
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE 244
            H      I+HRD+K  N+L++ +   +++DFGLA       +++   +V  T  Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPD 189
Query: 245 YF-DTGRATAKGDVYSFGVVLLELLTGK 271
               + + +   D++S G +  E++TGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHR 126
           K+   + +G G +G VY+   +     A+KR+       D G      RE+  + ++ H 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHP 79
Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV-GAARGIAY 185
           NIV+L     S +   L++E M    L   L     NK  L   S+ KI +    RG+A+
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFM-EKDLKKVL---DENKTGLQ-DSQIKIYLYQLLRGVAH 134
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE 244
            H      I+HRD+K  N+L++ +   +++DFGLA       +++   +V  T  Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPD 189
Query: 245 YF-DTGRATAKGDVYSFGVVLLELLTGK 271
               + + +   D++S G +  E++TGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 78  IGSGGFGTVYRLT-----VNDSTAFAVKRLHRGTTE-VDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +       +  +  F  KR  R +   V R   ERE+  +  + H N++T
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  Y +    +LI EL+  G L  FL      K++L              G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFGLA   E E       + GT  ++APE  
Sbjct: 136 IAHF---DLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +      + D++S GV+   LL+G  P 
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 47/295 (15%)
Query: 78  IGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVT 130
           +G G FG V + T          T  AVK L    +  + R    E   +  + H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH------------GKSVNKKNLDWPSRYKIAVG 178
           L+G  +     LLI E    GSL  FL             G S N  +LD P    + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 179 --------AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    ++G+ YL    +   +HRD+ + NIL+ +  + ++SDFGL+  +  E + V
Sbjct: 151 DLISFAWQISQGMQYLAEMSL---VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW 288
                     ++A E       T + DV+SFGV+L E++T G  P      E   +L   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---RLFNL 264
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +K   + +R            P N   +++ +   C + EP KRP   ++ K LE
Sbjct: 265 LKTGHRMER------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 135/304 (44%), Gaps = 46/304 (15%)
Query: 66  FKKTLK--FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           F+++LK    S+ ++G G  GTV           AVKR+     ++    E +L    D 
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL-MEIKLLTESD- 66
Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK---IAVGAA 180
            H N++  +   T+ ++  +  EL  N +L   +  K+V+ +NL     Y    +    A
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLD-------------QNMEARVSDFGLATLMEAEK 227
            G+A+LH      IIHRD+K  NIL+              +N+   +SDFGL   +++ +
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 228 THVSTIV---AGTFGYLAPEYFDTG-------RATAKGDVYSFGVVLLELLT-GKRPMDE 276
           +   T +   +GT G+ APE  +         R T   D++S G V   +L+ GK P  +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMT 336
            +  E       ++ +      + + D SL       I +   + S  ++ +P KRPT  
Sbjct: 243 KYSRES----NIIRGIFSLDEMKCLHDRSL-------IAEATDLISQMIDHDPLKRPTAM 291
Query: 337 EVVK 340
           +V++
Sbjct: 292 KVLR 295

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H NI+ L   Y ++ +  L+++LM  G L  +L      K  L      KI       I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 138
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAP 243
            LH     +I+HRD+K  NILLD +M  +++DFG +  ++  EK      V GT  YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAP 192
Query: 244 EYFDTGRAT------AKGDVYSFGVVLLELLTGKRPM 274
           E  +            + D++S GV++  LL G  P 
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           V+G GGFG V+   +  +   +A K+L++   +  +G++    E + +  +  R IV+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + +     L+  +M  G +   ++    +      P           G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           +II+RD+K  N+LLD +   R+SD GLA  ++A +T      AGT G++APE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYD 367
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
              D ++ GV L E++  + P 
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           V+G GGFG V+   +  +   +A K+L++   +  +G++    E + +  +  R IV+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + +     L+  +M  G +   ++    +      P           G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           +II+RD+K  N+LLD +   R+SD GLA  ++A +T      AGT G++APE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYD 367
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
              D ++ GV L E++  + P 
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           V+G GGFG V+   +  +   +A K+L++   +  +G++    E + +  +  R IV+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + +     L+  +M  G +   ++    +      P           G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
           +II+RD+K  N+LLD +   R+SD GLA  ++A +T      AGT G++APE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYD 367
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
              D ++ GV L E++  + P 
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 47/295 (15%)
Query: 78  IGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVT 130
           +G G FG V + T          T  AVK L    +  + R    E   +  + H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLH------------GKSVNKKNLDWPSRYKIAVG 178
           L+G  +     LLI E    GSL  FL             G S N  +LD P    + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 179 --------AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
                    ++G+ YL       ++HRD+ + NIL+ +  + ++SDFGL+  +  E + V
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 231 STIVAG-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW 288
                     ++A E       T + DV+SFGV+L E++T G  P      E   +L   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---RLFNL 264
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +K   + +R            P N   +++ +   C + EP KRP   ++ K LE
Sbjct: 265 LKTGHRMER------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 78  IGSGGFGTVYRLT-----VNDSTAFAVKRLHRGTTE-VDRG-FERELEAMGDIKHRNIVT 130
           +GSG F  V +       +  +  F  KR  R +   V R   ERE+  +  + H N++T
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  Y +    +LI EL+  G L  FL      K++L              G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 191 IPHIIHRDIKSSNI-LLDQNM---EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I H    D+K  NI LLD+N+     ++ DFGLA   E E       + GT  ++APE  
Sbjct: 136 IAHF---DLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +      + D++S GV+   LL+G  P 
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 115/258 (44%), Gaps = 34/258 (13%)
Query: 99  VKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLLIYELMPNGSLDTF 156
           V ++   +T   R F  E   +    H N++ + G   S  + +  LI   MP GSL   
Sbjct: 40  VLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV 99
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           LH  +     +D     K A+  ARG+A+LH    P I    + S ++++D++M AR+S 
Sbjct: 100 LHEGT--NFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISM 156
Query: 217 FGLA-TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM- 274
             +  +     + +    VA       PE  DT R +A  D++SF V+L EL+T + P  
Sbjct: 157 ADVKFSFQSPGRMYAPAWVAPEALQKKPE--DTNRRSA--DMWSFAVLLWELVTREVPFA 212
Query: 275 DEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC----PINEINDVFSIASMCLEPEPS 330
           D + +E G K+                   +LEG     P      V  +  +C+  +P+
Sbjct: 213 DLSNMEIGMKV-------------------ALEGLRPTIPPGISPHVSKLMKICMNEDPA 253
Query: 331 KRPTMTEVVKMLELIKSE 348
           KRP    +V +LE ++ +
Sbjct: 254 KRPKFDMIVPILEKMQDK 271

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 31/241 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V     V      AVK+L R    +    R + REL  +
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLL 104
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 158
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 159 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 211
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
             T  Y APE   +        D++S G ++ ELLTG+       L  GT  +  ++ +M
Sbjct: 212 VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT------LFPGTDHINQLQQIM 265
Query: 294 Q 294
           +
Sbjct: 266 R 266

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
           K+   + IG G +GTV++    ++    A    RL      V     RE+  + ++KH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV LH    S +   L++E       D   +  S N  +LD            +G+ + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YF 246
                +++HRD+K  N+L+++N E +++DFGLA          S  V  T  Y  P+  F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
                +   D++S G +  EL    RP+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E+  M D +H N+V ++  Y   +   ++ E +  G+L   +    +N++ +       +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-----ATV 146
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
                + +AYLH      +IHRDIKS +ILL  +   ++SDFG    +  +      +V 
Sbjct: 147 CEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV- 202
Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           GT  ++APE         + D++S G++++E++ G+ P
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 37/243 (15%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR- 104
           G  M   R        +  I++   ++ +   +GSG +G+V         AF  K  HR 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRV 70
Query: 105 GTTEVDRGFE---------RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMP 149
              ++ R F+         REL  +  +KH N++ L   +T +    ++N   L+  LM 
Sbjct: 71  AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM- 129
Query: 150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN 209
              L+  +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++
Sbjct: 130 GADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 210 MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELL 268
            E ++ DFGLA   + E T        T  Y APE   +        D++S G ++ ELL
Sbjct: 182 CELKILDFGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 269 TGK 271
           TG+
Sbjct: 238 TGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 37/243 (15%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR- 104
           G  M   R        +  I++   ++ +   +GSG +G+V         AF  K  HR 
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRV 69
Query: 105 GTTEVDRGFE---------RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMP 149
              ++ R F+         REL  +  +KH N++ L   +T +    ++N   L+  LM 
Sbjct: 70  AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM- 128
Query: 150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN 209
              L+  +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++
Sbjct: 129 GADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 180
Query: 210 MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELL 268
            E ++ DFGLA   + E T        T  Y APE   +        D++S G ++ ELL
Sbjct: 181 CELKILDFGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236
Query: 269 TGK 271
           TG+
Sbjct: 237 TGR 239

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTA-FAVKRLH--RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G F  V R      T  +A K ++  + +    +  ERE      +KH NIV LH  
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HDCIPH 193
            +   ++ L+++L+  G L   +  +    +       ++I       + ++H HD    
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI----LESVNHIHQHD---- 150
Query: 194 IIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
           I+HRD+K  N+LL    +    +++DFGLA  ++ E+       AGT GYL+PE      
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFGFAGTPGYLSPEVLRKDP 209
Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
                D+++ GV+L  LL G  P    + E+  KL   +KA   D         + E   
Sbjct: 210 YGKPVDIWACGVILYILLVGYPPF---WDEDQHKLYQQIKAGAYDFPSPEWDTVTPEA-- 264
Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            N IN + +I        P+KR T  + +K
Sbjct: 265 KNLINQMLTI-------NPAKRITADQALK 287

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T
Sbjct: 129 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
                   T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 181 G----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 65
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 124
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T
Sbjct: 125 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
                   T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 177 G----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 75  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 189 WAFGVLMWEIYSLGKMPYE 207

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 41/299 (13%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTLHG 133
           + +G G +G V+R +       AVK     ++  ++ + RE E    +  +H NI+    
Sbjct: 14  ECVGKGRYGEVWRGSWQGENV-AVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 134 YYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
              +S+++     LI      GSL  +L   +     LD  S  +I +  A G+A+LH +
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIE 124
Query: 190 CI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI----VAGTFGY 240
                  P I HRD+KS NIL+ +N +  ++D GLA +M ++ T+   +      GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 241 LAPEYFDTG------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL---VTWVKA 291
           +APE  D         +  + D+++FG+VL E+   +R +    +E+       V     
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 292 VMQDKREEYVIDTSLEGCPINEIND--VFSIASM---CLEPEPSKRPTMTEVVKMLELI 345
             +D R+   +D      P    +D  + S+A +   C    PS R T   + K L  I
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 71  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 185 WAFGVLMWEIYSLGKMPYE 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 16/230 (6%)
Query: 50  VMFRSP---LIHSLQSDAIFKKTLK-FSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHR 104
           V  R+P    +  L  D++ K+  + F   + +G G +G+VY+    ++    A+K++  
Sbjct: 5   VQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-- 62
Query: 105 GTTEVD-RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN 163
              E D +   +E+  M      ++V  +G Y  +    ++ E    GS+   +    + 
Sbjct: 63  -PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LR 118
Query: 164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM 223
            K L       I     +G+ YLH       IHRDIK+ NILL+    A+++DFG+A  +
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             +       V GT  ++APE           D++S G+  +E+  GK P
Sbjct: 176 -TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHGYYT 136
           +G G FG VY+    ++ A A  ++    +E +   +  E+E +    H  IV L G Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E  P G++D  +       + L  P    +       + +LH      IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 197 RDIKSSNILLDQNMEARVSDFGL-ATLMEAEKTHVSTIVAGTFGYLAPEYF--DTGRATA 253
           RD+K+ N+L+    + R++DFG+ A  ++  +   S I  GT  ++APE    +T + T 
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTP 190
Query: 254 ---KGDVYSFGVVLLELLTGKRPMDE 276
              K D++S G+ L+E+   + P  E
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPPHHE 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHGYYT 136
           +G G FG VY+    ++ A A  ++    +E +   +  E+E +    H  IV L G Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                 ++ E  P G++D  +       + L  P    +       + +LH      IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 197 RDIKSSNILLDQNMEARVSDFGL-ATLMEAEKTHVSTIVAGTFGYLAPEYF--DTGRATA 253
           RD+K+ N+L+    + R++DFG+ A  ++  +   S I  GT  ++APE    +T + T 
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTP 198
Query: 254 ---KGDVYSFGVVLLELLTGKRPMDE 276
              K D++S G+ L+E+   + P  E
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHE 224

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 41/299 (13%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTLHG 133
           + +G G +G V+R +       AVK     ++  ++ + RE E    +  +H NI+    
Sbjct: 14  ECVGKGRYGEVWRGSWQGENV-AVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 134 YYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
              +S+++     LI      GSL  +L   +     LD  S  +I +  A G+A+LH +
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIE 124
Query: 190 CI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI----VAGTFGY 240
                  P I HRD+KS NIL+ +N +  ++D GLA +M ++ T+   +      GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 241 LAPEYFDTG------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL---VTWVKA 291
           +APE  D         +  + D+++FG+VL E+   +R +    +E+       V     
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 292 VMQDKREEYVIDTSLEGCPINEIND--VFSIASM---CLEPEPSKRPTMTEVVKMLELI 345
             +D R+   +D      P    +D  + S+A +   C    PS R T   + K L  I
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 40/278 (14%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIV 129
           F+  D IG G FG VY+   N +    A+K +      +     ++E+  +       I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
              G Y  S    +I E +  GS    L    + +  +       I     +G+ YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 135
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
                IHRDIK++N+LL +  + +++DFG+A  +   +   +  V   F ++APE     
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQS 191
Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI----DTS 305
               K D++S G+  +EL  G+ P  +                +   R  ++I      +
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSD----------------LHPMRVLFLIPKNSPPT 235
Query: 306 LEGC---PINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           LEG    P  E          CL  +P  RPT  E++K
Sbjct: 236 LEGQHSKPFKE------FVEACLNKDPRFRPTAKELLK 267

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 367 RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 425
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 426 QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 479
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG- 239
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 480 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 240 -YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 591
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 592 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 91  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 205 WAFGVLMWEIYSLGKMPYE 223

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 17/218 (7%)
Query: 63  DAIFKKTLKFSSKD-VIGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFERELEAM 120
           D+ F +      KD  +G G F    +     S  AFAVK +   +  ++   ++E+ A+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITAL 59
Query: 121 GDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
              + H NIV LH  +    +  L+ EL+  G L      +   KK+        I    
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKL 115
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
              ++++H      ++HRD+K  N+L    + N+E ++ DFG A L   +   + T    
Sbjct: 116 VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF- 171
Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           T  Y APE  +        D++S GV+L  +L+G+ P 
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 190 WAFGVLMWEIYSLGKMPYE 208

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 37/285 (12%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRL-----HRGTTEVDRGFERELE 118
           IFK+T +     V+GSG FGTV++ + + +  +  +         +   +  +     + 
Sbjct: 9   IFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKI 175
           A+G + H +IV L G    S   L + + +P GSL   +    G    +  L+W      
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW------ 120
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            V  A+G+ YL    +   +HR++ + N+LL    + +V+DFG+A L+  +   +    A
Sbjct: 121 GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177
Query: 236 GT-FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
            T   ++A E    G+ T + DV+S+GV + EL+T G  P     L E   L+       
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL------- 230
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
             ++ E +    +  C I    DV+ +   C   + + RPT  E+
Sbjct: 231 --EKGERLAQPQI--CTI----DVYMVMVKCWMIDENIRPTFKEL 267

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 36/292 (12%)
Query: 71  KFSSKDVIGSGGFGTV--YRLTVNDST--AFAVKRLHR---GTTEVDRGFERELEAMGDI 123
           +F+   ++G G FG+V   +L   D +    AVK L      +++++  F RE   M + 
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEF 82
Query: 124 KHRNIVTLHGYYTSSQYN------LLIYELMPNGSLDTFLHGKSV--NKKNLDWPSRYKI 175
            H ++  L G    S+        ++I   M +G L  FL    +  N  NL   +  + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            V  A G+ YL      + IHRD+ + N +L ++M   V+DFGL+  + +   +     +
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 236 G-TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
                +LA E       T   DV++FGV + E++T G+ P                  + 
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---------------YAGIE 244
Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
             +   Y+I  +    P   + +V+ +   C   +P +RP+ T +   LE I
Sbjct: 245 NAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 79
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 138
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T
Sbjct: 139 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 190
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
                   T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 191 G----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 66  FKKTLK--FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           F+++LK    S+ ++G G  GTV           AVKR+     ++    E +L    D 
Sbjct: 27  FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL-MEIKLLTESD- 84
Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK---IAVGAA 180
            H N++  +   T+ ++  +  EL  N +L   +  K+V+ +NL     Y    +    A
Sbjct: 85  DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLD-------------QNMEARVSDFGLATLMEAEK 227
            G+A+LH      IIHRD+K  NIL+              +N+   +SDFGL   +++ +
Sbjct: 144 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 228 THVSTIV---AGTFGYLAPEYFDTG---RATAKGDVYSFGVVLLELLT-GKRPMDEAFLE 280
                 +   +GT G+ APE  +     R T   D++S G V   +L+ GK P  + +  
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           E       ++ +      + + D SL       I +   + S  ++ +P KRPT  +V++
Sbjct: 261 ES----NIIRGIFSLDEMKCLHDRSL-------IAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 75
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 134
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T
Sbjct: 135 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 186
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
                   T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 187 G----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 82  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 196 WAFGVLMWEIYSLGKMPYE 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 41/299 (13%)
Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTLHG 133
           + +G G +G V+R +       AVK     ++  ++ + RE E    +  +H NI+    
Sbjct: 43  ECVGKGRYGEVWRGSWQGENV-AVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 134 YYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
              +S+++     LI      GSL  +L   +     LD  S  +I +  A G+A+LH +
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIE 153
Query: 190 CI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI----VAGTFGY 240
                  P I HRD+KS NIL+ +N +  ++D GLA +M ++ T+   +      GT  Y
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRY 212
Query: 241 LAPEYFDTG------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL---VTWVKA 291
           +APE  D         +  + D+++FG+VL E+   +R +    +E+       V     
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVPNDP 270
Query: 292 VMQDKREEYVIDTSLEGCPINEIND--VFSIASM---CLEPEPSKRPTMTEVVKMLELI 345
             +D R+   +D      P    +D  + S+A +   C    PS R T   + K L  I
Sbjct: 271 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-DRGFERELEA----MG 121
           +K L    K+ +GSG FGTV +             +     E  D   + EL A    M 
Sbjct: 368 RKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 426
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAA 180
            + +  IV + G   +  + +L+ E+   G L+ +L   + V  KN+      ++    +
Sbjct: 427 QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 480
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG- 239
            G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G +  
Sbjct: 481 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 240 -YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD-------EAFLEEGTKLVTWVK 290
            + APE  +  + ++K DV+SFGV++ E  + G++P          A LE+G ++     
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 592
Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                            GCP     +++ + ++C   +   RP    V
Sbjct: 593 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 623

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E  
Sbjct: 129 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 178
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
            ++  VA T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 179 -MAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E  
Sbjct: 129 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 178
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
            ++  VA T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 179 -MAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 190 WAFGVLMWEIYSLGKMPYE 208

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 66  FKKTLK--FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           F+++LK    S+ ++G G  GTV           AVKR+     ++    E +L    D 
Sbjct: 27  FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL-MEIKLLTESD- 84
Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK---IAVGAA 180
            H N++  +   T+ ++  +  EL  N +L   +  K+V+ +NL     Y    +    A
Sbjct: 85  DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLD-------------QNMEARVSDFGLATLMEAEK 227
            G+A+LH      IIHRD+K  NIL+              +N+   +SDFGL   +++ +
Sbjct: 144 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 228 THVSTIV---AGTFGYLAPEYFDTG---RATAKGDVYSFGVVLLELLT-GKRPMDEAFLE 280
                 +   +GT G+ APE  +     R T   D++S G V   +L+ GK P  + +  
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           E       ++ +      + + D SL       I +   + S  ++ +P KRPT  +V++
Sbjct: 261 ES----NIIRGIFSLDEMKCLHDRSL-------IAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS 137
           +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L+G  T 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHR 197
            +   +I E M NG L  +L      +         ++       + YL        +HR
Sbjct: 91  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 198 DIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDV 257
           D+ + N L++     +VSDFGL+  +  ++   S        +  PE     + ++K D+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 258 YSFGVVLLELLT-GKRPMD 275
           ++FGV++ E+ + GK P +
Sbjct: 205 WAFGVLMWEIYSLGKMPYE 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 65
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 124
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E  
Sbjct: 125 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
            ++  VA T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 175 -MAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 78  IGSGGFGTV---YRLTVNDSTAFAV-KRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G G FG V   Y  T     A  +  +     +++    ERE+  +  ++H +I+ L+ 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
              S    +++ E   N   D  +    ++++      R+   + +A  + Y H      
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE---ARRFFQQIISA--VEYCHRH---K 123
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR--A 251
           I+HRD+K  N+LLD+++  +++DFGL+ +M  +   + T   G+  Y APE   +G+  A
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKT-SCGSPNYAAPEVI-SGKLYA 180
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDE 276
             + DV+S GV+L  +L  + P D+
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRG 105
           G M   R        +  I++   ++ +   +GSG +G+V            AVK+L R 
Sbjct: 1   GPMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 106 TTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTF 156
              +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  
Sbjct: 61  FQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 118
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D
Sbjct: 119 VKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 170
Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           FGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 171 FGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR---LTVNDSTAFAV--KRLH-RGTTEVDRGFERELE 118
           IFK+T +     V+GSG FGTV++   +   +S    V  K +  +   +  +     + 
Sbjct: 27  IFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 85
Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKI 175
           A+G + H +IV L G    S   L + + +P GSL   +    G    +  L+W      
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW------ 138
Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            V  A+G+ YL    +   +HR++ + N+LL    + +V+DFG+A L+  +   +    A
Sbjct: 139 GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 195
Query: 236 GT-FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP 273
            T   ++A E    G+ T + DV+S+GV + EL+T G  P
Sbjct: 196 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 58/250 (23%)
Query: 71  KFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE--------------- 114
           +++ KD IG G +G V      ND+T +A+K L +       GF                
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 115 -----------RELEAMGDIKHRNIVTLHGYYTSSQYNLL--IYELMPNGSLDTFLHGKS 161
                      +E+  +  + H N+V L         + L  ++EL+  G +        
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------- 125
Query: 162 VNKKNLDWPSRYKIAVGAAR--------GIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR 213
                ++ P+   ++   AR        GI YLH+     IIHRDIK SN+L+ ++   +
Sbjct: 126 -----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIK 177
Query: 214 VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG---DVYSFGVVLLELLTG 270
           ++DFG++   +     +S  V GT  ++APE     R    G   DV++ GV L   + G
Sbjct: 178 IADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 271 KRP-MDEAFL 279
           + P MDE  +
Sbjct: 237 QCPFMDERIM 246

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRG 105
           G M   R        +  I++   ++ +   +GSG +G+V            AVK+L R 
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 106 TTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTF 156
              +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  
Sbjct: 61  FQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 118
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D
Sbjct: 119 VKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 170
Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           FGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 171 FGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 78  IGSGGFGTV---YRLTVNDSTAFAV-KRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G G FG V   Y  T     A  +  +     +++    ERE+  +  ++H +I+ L+ 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
              S    +++ E   N   D  +    ++++      R+   + +A  + Y H      
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE---ARRFFQQIISA--VEYCHRH---K 132
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR--A 251
           I+HRD+K  N+LLD+++  +++DFGL+ +M  +   + T   G+  Y APE   +G+  A
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKT-SCGSPNYAAPEVI-SGKLYA 189
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDE 276
             + DV+S GV+L  +L  + P D+
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 72  FSSKDVIGSGGFGTVYRL-TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           F    V+G G FG V +     DS  +A+K++ R T E       E+  +  + H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 131 LHGYY------------TSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            +  +               +  L I  E   NG+L   +H +++N++  ++   +++  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---WRLFR 123
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-------LMEAEKTHV 230
                ++Y+H   I   IHRD+K  NI +D++   ++ DFGLA        +++ +  ++
Sbjct: 124 QILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 231 S------TIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELL 268
                  T   GT  Y+A E  D TG    K D+YS G++  E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 78  IGSGGFGTV---YRLTVNDSTAFAV-KRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G G FG V   Y  T     A  +  +     +++    ERE+  +  ++H +I+ L+ 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
              S    +++ E   N   D  +    ++++      R+   + +A  + Y H      
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE---ARRFFQQIISA--VEYCHRH---K 133
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR--A 251
           I+HRD+K  N+LLD+++  +++DFGL+ +M  +   + T   G+  Y APE   +G+  A
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKT-SCGSPNYAAPEVI-SGKLYA 190
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDE 276
             + DV+S GV+L  +L  + P D+
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 77  VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG----FERELEAMGDIKHRNIVTLH 132
           VIG G FG V  +    S      +L      + R     F  E + M       +V L 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             +   +Y  ++ E MP G L   +    V +K   W   Y   V  A  +  +H     
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WAKFYTAEVVLA--LDAIHS---M 193
Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPEYFDT--- 248
            +IHRD+K  N+LLD++   +++DFG    M E    H  T V GT  Y++PE   +   
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGG 252
Query: 249 -GRATAKGDVYSFGVVLLELLTGKRPM 274
            G    + D +S GV L E+L G  P 
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 65
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +    +   ++ 
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCAKLTDDHVQ 124
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T
Sbjct: 125 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
                   T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 177 G----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 78  IGSGGFGTV---YRLTVNDSTAFAV-KRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G G FG V   Y  T     A  +  +     +++    ERE+  +  ++H +I+ L+ 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
              S    +++ E   N   D  +    ++++      R+   + +A  + Y H      
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE---ARRFFQQIISA--VEYCHRH---K 127
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR--A 251
           I+HRD+K  N+LLD+++  +++DFGL+ +M  +   + T   G+  Y APE   +G+  A
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKT-SCGSPNYAAPEVI-SGKLYA 184
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDE 276
             + DV+S GV+L  +L  + P D+
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 78  IGSGGFGTVYRLTV----NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G+G FG V+R+T     N+  A  V   H    E  R   +E++ M  ++H  +V LH 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHD 221
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            +      ++IYE M  G L   +     NK + D    Y   V   +G+ ++H +   +
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQV--CKGLCHMHEN---N 275
Query: 194 IIHRDIKSSNILL--DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
            +H D+K  NI+    ++ E ++ DFGL   ++ +++    +  GT  + APE  +    
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPV 333
Query: 252 TAKGDVYSFGVVLLELLTGKRPM 274
               D++S GV+   LL+G  P 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPF 356

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 77  VIGSGGFGTVYRLTVNDST--AFAVKRLHRGT--TEVDRGF---ERELEAMGDIKHRNIV 129
           VIG G FG V +L  + ST   +A+K L +       D  F   ER++ A  +     +V
Sbjct: 81  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW--VV 137
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK----IAVGAARGIAY 185
            L   +   +Y  ++ E MP G L   +    V +K   W   Y     +A+ A   + +
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALDAIHSMGF 194
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
                    IHRD+K  N+LLD++   +++DFG    M  E         GT  Y++PE 
Sbjct: 195 ---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 246 FDT----GRATAKGDVYSFGVVLLELLTGKRPM 274
             +    G    + D +S GV L E+L G  P 
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 43/284 (15%)
Query: 78  IGSGGFGTVYRLTV------NDSTAFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVT 130
           +G   FG VY+  +        + A A+K L  +    +   F  E      ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN------------KKNLDWPSRYKIAVG 178
           L G  T  Q   +I+    +G L  FL  +S +            K  L+ P    +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
            A G+ YL      H++H+D+ + N+L+   +  ++SD GL    E        ++  + 
Sbjct: 154 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLGNSL 208
Query: 239 ---GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
               ++APE    G+ +   D++S+GVVL E+ + G +P    +     + V        
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCGYSNQDVV------- 257
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
               E + +  +  CP +    V+++   C    PS+RP   ++
Sbjct: 258 ----EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 43/284 (15%)
Query: 78  IGSGGFGTVYRLTV------NDSTAFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNIVT 130
           +G   FG VY+  +        + A A+K L  +    +   F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVN------------KKNLDWPSRYKIAVG 178
           L G  T  Q   +I+    +G L  FL  +S +            K  L+ P    +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
            A G+ YL      H++H+D+ + N+L+   +  ++SD GL    E        ++  + 
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLGNSL 191
Query: 239 ---GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ 294
               ++APE    G+ +   D++S+GVVL E+ + G +P    +     + V        
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCGYSNQDVV------- 240
Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
               E + +  +  CP +    V+++   C    PS+RP   ++
Sbjct: 241 ----EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 78  IGSGGFGTVY-----------RLTVNDSTAFAVKRLHRGTTEVDRGFER---ELEAMGDI 123
           +GSG +G V             + V   + F   R       +++  E    E+  +  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
            H NI+ L   +   +Y  L+ E    G L      + +N+   D      I      GI
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSGI 159
Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQN---MEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
            YLH     +I+HRDIK  NILL+     +  ++ DFGL++     K +      GT  Y
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTAYY 214
Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +APE     +   K DV+S GV++  LL G  P 
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRG 105
           G M   R        +  I++   ++ +   +GSG +G+V            AVK+L R 
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 70
Query: 106 TTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTF 156
              +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  
Sbjct: 71  FQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 128
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D
Sbjct: 129 VKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 180
Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           FGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 181 FGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 30/211 (14%)
Query: 78  IGSGGFGTVYRLTVNDST-AFAVKRLHR-GTTEVDRGFERELEAMGDIKHRN---IVTLH 132
           +GSG  G V+++    +    AVK++ R G  E ++    +L+ +  +K  +   IV   
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV--LKSHDCPYIVQCF 90
Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI----AVGAARGIAYLHH 188
           G + ++    +  ELM  G+    L      KK +  P   +I     V   + + YL  
Sbjct: 91  GTFITNTDVFIAMELM--GTCAEKL------KKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 189 DCIPH-IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               H +IHRD+K SNILLD+  + ++ DFG++  +  +K    +  AG   Y+APE  D
Sbjct: 143 K---HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERID 197
Query: 248 TGRATA-----KGDVYSFGVVLLELLTGKRP 273
               T      + DV+S G+ L+EL TG+ P
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRG 105
           G M   R        +  I++   ++ +   +GSG +G+V            AVK+L R 
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 70
Query: 106 TTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTF 156
              +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  
Sbjct: 71  FQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 128
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D
Sbjct: 129 VKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 180
Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           FGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 181 FGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 78  IGSGGFGTVYRLTV----NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G+G FG V+R+T     N+  A  V   H    E  R   +E++ M  ++H  +V LH 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHD 115
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
            +      ++IYE M  G L   +     NK + D    Y   V   +G+ ++H +   +
Sbjct: 116 AFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQV--CKGLCHMHEN---N 169
Query: 194 IIHRDIKSSNILL--DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
            +H D+K  NI+    ++ E ++ DFGL   ++ +++    +  GT  + APE  +    
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPV 227
Query: 252 TAKGDVYSFGVVLLELLTGKRPM 274
               D++S GV+   LL+G  P 
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR- 104
           G  M   R        +  I++   ++ +   +GSG +G+V         AF  K  HR 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRV 70
Query: 105 GTTEVDRGFE---------RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMP 149
              ++ R F+         REL  +  +KH N++ L   +T +    ++N   L+  LM 
Sbjct: 71  AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM- 129
Query: 150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN 209
              L+  +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++
Sbjct: 130 GADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 210 MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELL 268
            E ++ DFGLA   + E   +   VA T  Y APE   +        D++S G ++ ELL
Sbjct: 182 CELKILDFGLARHTDDE---MXGXVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 269 TGK 271
           TG+
Sbjct: 238 TGR 240

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 77  VIGSGGFGTVYRLTVNDST--AFAVKRLHRGT--TEVDRGF---ERELEAMGDIKHRNIV 129
           VIG G FG V +L  + ST   +A+K L +       D  F   ER++ A  +     +V
Sbjct: 76  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW--VV 132
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK----IAVGAARGIAY 185
            L   +   +Y  ++ E MP G L   +    V +K   W   Y     +A+ A   + +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALDAIHSMGF 189
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
                    IHRD+K  N+LLD++   +++DFG    M  E         GT  Y++PE 
Sbjct: 190 ---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 246 FDT----GRATAKGDVYSFGVVLLELLTGKRPM 274
             +    G    + D +S GV L E+L G  P 
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHR 104
           G  M   R        +  I++   ++ +   +GSG +G+V            AVK+L R
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 77
Query: 105 GTTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDT 155
               +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+ 
Sbjct: 78  PFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 135
Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS 215
            +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ 
Sbjct: 136 IVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 187
Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           DFGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 188 DFGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   IGSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 80
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 134
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG----Y 187
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 80  YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 132
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      GT  Y+ PE   D   +
Sbjct: 133 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +   +     ++ + A++    E   
Sbjct: 191 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE--- 242
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 243 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 275

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           D +G G + TVY+    LT N      ++  H           RE+  + D+KH NIVTL
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTL 65
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
           H    + +   L++E + +  L  +L   G  +N  N+             RG+AY H  
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL-----FLFQLLRGLAYCHRQ 119
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME-AEKTHVSTIVAGTFGYLAPE-YFD 247
               ++HRD+K  N+L+++  E +++DFGLA       KT+ + +V  T  Y  P+    
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLG 174
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPM 274
           +   + + D++  G +  E+ TG RP+
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATG-RPL 200

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  FSSKDVIGSGGFGTVY---RLTVNDSTA-FAVKRLHRGT-------TEVDRGFERELEAM 120
           F    V+G+G +G V+   +++ +D+   +A+K L + T       TE  R   + LE +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
              +   +VTLH  + +     LI + +  G L T L  +       +  + +++ +   
Sbjct: 116 R--QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVG 166
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
             +  L H     II+RDIK  NILLD N    ++DFGL+    A++T  +    GT  Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 241 LAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +AP+     D+G   A  D +S GV++ ELLTG  P 
Sbjct: 227 MAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPF 262

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 113/247 (45%), Gaps = 30/247 (12%)
Query: 36  KNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDS 94
           +N+ +  + S  +   +R  L     +  I++   ++ +   +GSG +G+V         
Sbjct: 16  ENLYFQSNASQERPTFYRQEL-----NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG 70
Query: 95  TAFAVKRLHRGTTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIY 145
              AVK+L R    +    R + REL  +  +KH N++ L   +T +    ++N   L+ 
Sbjct: 71  LRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL 205
            LM    L+  +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ 
Sbjct: 130 HLM-GADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLA 180
Query: 206 LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVL 264
           ++++ E ++ DFGLA   + E          T  Y APE   +        D++S G ++
Sbjct: 181 VNEDCELKILDFGLARHTDDEMXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 236
Query: 265 LELLTGK 271
            ELLTG+
Sbjct: 237 AELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHR 104
           G  M   R        +  I++   ++ +   +GSG +G+V            AVK+L R
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 76
Query: 105 GTTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDT 155
               +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+ 
Sbjct: 77  PFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 134
Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS 215
            +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ 
Sbjct: 135 IVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 186
Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           DFGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 187 DFGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 133/304 (43%), Gaps = 46/304 (15%)
Query: 66  FKKTLK--FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           F+++LK    S+ ++G G  GTV           AVKR+     ++    E +L    D 
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL-MEIKLLTESD- 66
Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK---IAVGAA 180
            H N++  +   T+ ++  +  EL  N +L   +  K+V+ +NL     Y    +    A
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLD-------------QNMEARVSDFGLATLMEAEK 227
            G+A+LH      IIHRD+K  NIL+              +N+   +SDFGL   +++ +
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 228 THVSTIV---AGTFGYLAPEYFDTG-------RATAKGDVYSFGVVLLELLT-GKRPMDE 276
                 +   +GT G+ APE  +         R T   D++S G V   +L+ GK P  +
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMT 336
            +  E       ++ +      + + D SL       I +   + S  ++ +P KRPT  
Sbjct: 243 KYSRES----NIIRGIFSLDEMKCLHDRSL-------IAEATDLISQMIDHDPLKRPTAM 291
Query: 337 EVVK 340
           +V++
Sbjct: 292 KVLR 295

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 96  YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 148
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      GT  Y+ PE   D   +
Sbjct: 149 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +  + + +KL     A++    E   
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKL----HAIIDPNHE--- 258
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 259 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 291

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFERELEA 119
           ++ L+F    V+GSG FG V   T         S   AVK L       +R     EL+ 
Sbjct: 44  RENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 120 MGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV----------NKKNLD 168
           M  +  H NIV L G  T S    LI+E    G L  +L  K            N+K L+
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 169 WPSRYKI---------AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL 219
                 +         A   A+G+ +L        +HRD+ + N+L+      ++ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 220 ATLMEAEKTHVSTIVAGT----FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT 269
           A  + ++  +V   V G       ++APE    G  T K DV+S+G++L E+ +
Sbjct: 219 ARDIMSDSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTL- 131
           ++ IG G FG V+R         AVK     ++  +R + RE E    +  +H NI+   
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 132 ------HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                 +G +T      L+ +   +GSL  +L+  +V  + +      K+A+  A G+A+
Sbjct: 64  AADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 115
Query: 186 LHHDCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGT 237
           LH + +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 238 FGYLAPEYFDTG------RATAKGDVYSFGVVLLEL 267
             Y+APE  D         +  + D+Y+ G+V  E+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRG 105
           G M   R        +  I++   ++ +   +GSG +G+V            AVK+L R 
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 106 TTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTF 156
              +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  
Sbjct: 61  FQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 118
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D
Sbjct: 119 VKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILD 170
Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           FGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 171 FGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           F    ++G G FG V+      +  F A+K L +    +D   E     M + +  ++  
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKRVLSLAW 76
Query: 131 LHGYYT------SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
            H + T       ++ NL       NG  D   H +S +K +L   + Y  A     G+ 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGG-DLMYHIQSCHKFDLSRATFY--AAEIILGLQ 133
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLA 242
           +LH   I   ++RD+K  NILLD++   +++DFG+    ++   KT+      GT  Y+A
Sbjct: 134 FLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE---FCGTPDYIA 187
Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           PE     +     D +SFGV+L E+L G+ P 
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 77  VIGSGGFGTVYRLTVNDST--AFAVKRLHRGT--TEVDRGF---ERELEAMGDIKHRNIV 129
           VIG G FG V +L  + ST   +A+K L +       D  F   ER++ A  +     +V
Sbjct: 81  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW--VV 137
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK----IAVGAARGIAY 185
            L   +   +Y  ++ E MP G L   +    V +K   W   Y     +A+ A   + +
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALDAIHSMGF 194
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
                    IHRD+K  N+LLD++   +++DFG    M  E         GT  Y++PE 
Sbjct: 195 ---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 246 FDT----GRATAKGDVYSFGVVLLELLTGKRPM 274
             +    G    + D +S GV L E+L G  P 
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 76  YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 128
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      GT  Y+ PE   D   +
Sbjct: 129 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +   +     ++ + A++    E   
Sbjct: 187 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE--- 238
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 239 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 271

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 78  IGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEV--DRGFERELEAMGDIKHRNIVTLH 132
           +GSG +G+V   +  D+      AVK+L R    +   R   REL  +  +KH N++ L 
Sbjct: 28  VGSGAYGSV--CSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 133 GYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
             +T +          L+  LM    L+  +  ++++ +++ +     +     RG+ Y+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 139
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-Y 245
           H   I   IHRD+K SN+ ++++ E R+ DFGLA   + E T        T  Y APE  
Sbjct: 140 HSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQADEEMTG----YVATRWYRAPEIM 192
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ 294
            +        D++S G ++ ELL GK       L  G+  +  +K +M+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKA------LFPGSDYIDQLKRIME 235

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLH--RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G F  V R + +     +A K ++  + +    +  ERE      +KH NIV LH  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            +   ++ L+++L+  G L   +  +       ++ S    +    + +  ++H  +  I
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILESVNHCHLNGI 124
Query: 195 IHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
           +HRD+K  N+LL    +    +++DFGLA  ++ ++       AGT GYL+PE       
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLRKDPY 183
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
               D+++ GV+L  LL G  P    + E+  +L   +KA   D         + E   +
Sbjct: 184 GKPVDMWACGVILYILLVGYPPF---WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVK 340
             IN + +I        P+KR T +E +K
Sbjct: 241 --INKMLTI-------NPAKRITASEALK 260

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 30/237 (12%)
Query: 46  GGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHR 104
           G +   +R  L     +  I++   ++ +   +GSG +G+V            AVK+L R
Sbjct: 1   GSRPTFYRQEL-----NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 55
Query: 105 GTTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDT 155
               +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+ 
Sbjct: 56  PFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 113
Query: 156 FLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS 215
            +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ 
Sbjct: 114 IVKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 165
Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           DFGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 166 DFGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 77  VIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           ++G G FG V+      +  F A+K L +    +D   E     M + +  ++   H + 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKRVLSLAWEHPFL 80
Query: 136 T------SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
           T       ++ NL       NG  D   H +S +K +L   + Y  A     G+ +LH  
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGG-DLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHSK 137
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPEYFD 247
            I   ++RD+K  NILLD++   +++DFG+    ++   KT+      GT  Y+APE   
Sbjct: 138 GI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNX---FCGTPDYIAPEILL 191
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPM 274
             +     D +SFGV+L E+L G+ P 
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLH--RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G F  V R + +     +A K ++  + +    +  ERE      +KH NIV LH  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            +   ++ L+++L+  G L   +  +       ++ S    +    + +  ++H  +  I
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILESVNHCHLNGI 124
Query: 195 IHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
           +HRD+K  N+LL    +    +++DFGLA  ++ ++       AGT GYL+PE       
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLRKDPY 183
Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
               D+++ GV+L  LL G  P    + E+  +L   +KA   D         + E   +
Sbjct: 184 GKPVDMWACGVILYILLVGYPPF---WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVK 340
             IN + +I        P+KR T +E +K
Sbjct: 241 --INKMLTI-------NPAKRITASEALK 260

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----X 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 36/274 (13%)
Query: 78  IGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           IG G F  V R   L      A  +    + +    +  ERE      +KH NIV LH  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI-----AYLHHD 189
            +   ++ L+++L+  G L   +  +            Y     A+  I     A LH  
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVARE-----------YYSEADASHCIQQILEAVLHCH 120
Query: 190 CIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
            +  ++HRD+K  N+LL    +    +++DFGLA  ++ ++       AGT GYL+PE  
Sbjct: 121 QMG-VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVL 178
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                    D+++ GV+L  LL G  P    + E+  KL   +KA   D         + 
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPF---WDEDQHKLYQQIKAGAYDFPSPEWDTVTP 235
Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           E    N IN + +I        P+KR T  E +K
Sbjct: 236 EA--KNLINQMLTI-------NPAKRITAHEALK 260

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 80
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 134
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 187
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 74
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 128
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 129 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 181
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 182 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLH--RGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G F  V R + V     +A K ++  + +    +  ERE      +KH NIV LH  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI-----AYLHHD 189
            +   ++ LI++L+  G L   +  +            Y     A+  I     A LH  
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVARE-----------YYSEADASHCIQQILEAVLHCH 138
Query: 190 CIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
            +  ++HRD+K  N+LL   ++    +++DFGLA  +E E+       AGT GYL+PE  
Sbjct: 139 QMG-VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVL 196
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                    D+++ GV+L  LL G  P    + E+  +L   +KA   D         + 
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF---WDEDQHRLYQQIKAGAYDFPSPEWDTVTP 253
Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           E   +  IN + +I        PSKR T  E +K
Sbjct: 254 EAKDL--INKMLTI-------NPSKRITAAEALK 278

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 80
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 134
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG----Y 187
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 82
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 136
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 189
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTL- 131
           ++ IG G FG V+R         AVK     ++  +R + RE E    +  +H NI+   
Sbjct: 9   QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 64
Query: 132 ------HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                 +G +T      L+ +   +GSL  +L+  +V  + +      K+A+  A G+A+
Sbjct: 65  AADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 116
Query: 186 LHHDCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGT 237
           LH + +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 238 FGYLAPEYFDTG------RATAKGDVYSFGVVLLEL 267
             Y+APE  D         +  + D+Y+ G+V  E+
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 72
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 126
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 127 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 179
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 72
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 126
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 127 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 179
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
           K+   + IG G +GTV++    ++    A    RL      V     RE+  + ++KH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV LH    S +   L++E       D   +  S N  +LD            +G+ + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YF 246
                +++HRD+K  N+L+++N E ++++FGLA          S  V  T  Y  P+  F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
                +   D++S G +  EL    RP+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 78  IGSGGFGTVYRLTVNDST-----AFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLH 132
           +GSG +G V  L   D       A  + R    +T  +     E+  +  + H NI+ L+
Sbjct: 45  LGSGAYGEV--LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 133 GYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            ++   +   L+ E    G L D  +H    N+  +D     K  +    G+ YLH    
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--VDAAVIIKQVLS---GVTYLHK--- 154
Query: 192 PHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
            +I+HRD+K  N+LL   +++   ++ DFGL+ + E +K     +  GT  Y+APE    
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL-R 211
Query: 249 GRATAKGDVYSFGVVLLELLTGKRP 273
            +   K DV+S GV+L  LL G  P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTL- 131
           ++ IG G FG V+R         AVK     ++  +R + RE E    +  +H NI+   
Sbjct: 11  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 66
Query: 132 ------HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                 +G +T      L+ +   +GSL  +L+  +V  + +      K+A+  A G+A+
Sbjct: 67  AADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 118
Query: 186 LHHDCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGT 237
           LH + +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 238 FGYLAPEYFDTG------RATAKGDVYSFGVVLLEL 267
             Y+APE  D         +  + D+Y+ G+V  E+
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 80
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 134
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 187
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 39/272 (14%)
Query: 78  IGSGGFGTV----YRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           IG G F  V    + LT  +     + +    ++ + + F RE+     + H NIV L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIXKVLNHPNIVKLFE 80
Query: 134 YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +   L+ E    G +  +L  HG+   K   +  ++++  V A   + Y H    
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK---EARAKFRQIVSA---VQYCHQK-- 132
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--GTFGYLAPEYFDTG 249
             I+HRD+K+ N+LLD +   +++DFG +     E T  + + A  G   Y APE F   
Sbjct: 133 -FIVHRDLKAENLLLDADXNIKIADFGFSN----EFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 250 RATAKG-DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
           +      DV+S GV+L  L++G  P D   L+E  + V          R +Y I      
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------RGKYRI------ 232
Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            P     D  ++    L   PSKR T+ ++ K
Sbjct: 233 -PFYXSTDCENLLKKFLILNPSKRGTLEQIXK 263

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTL- 131
           ++ IG G FG V+R         AVK     ++  +R + RE E    +  +H NI+   
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 132 ------HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                 +G +T      L+ +   +GSL  +L+  +V  + +      K+A+  A G+A+
Sbjct: 103 AADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 154
Query: 186 LHHDCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGT 237
           LH + +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 238 FGYLAPEYFDTG------RATAKGDVYSFGVVLLEL 267
             Y+APE  D         +  + D+Y+ G+V  E+
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 71
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 125
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 178
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTL- 131
           ++ IG G FG V+R         AVK     ++  +R + RE E    +  +H NI+   
Sbjct: 34  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 89
Query: 132 ------HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                 +G +T      L+ +   +GSL  +L+  +V  + +      K+A+  A G+A+
Sbjct: 90  AADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 141
Query: 186 LHHDCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGT 237
           LH + +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 238 FGYLAPEYFDTG------RATAKGDVYSFGVVLLEL 267
             Y+APE  D         +  + D+Y+ G+V  E+
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 77  YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 129
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      GT  Y+ PE   D   +
Sbjct: 130 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +   +     ++ + A++    E   
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE--- 239
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 240 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 272

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 63  DAIFKKTLKFSSKDV-IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTEVDRGFERELEA 119
           D  +++ + +++  + +G G FG V+R+  +  T F  AVK++     EV R    EL A
Sbjct: 85  DYEYREEVHWATHQLRLGRGSFGEVHRME-DKQTGFQCAVKKVR---LEVFRA--EELMA 138
Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
              +    IV L+G      +  +  EL+  GSL     G+ V ++      R    +G 
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLVKEQGCLPEDRALYYLGQ 193
Query: 180 A-RGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI---- 233
           A  G+ YLH      I+H D+K+ N+LL  +   A + DFG A  ++ +    S +    
Sbjct: 194 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAF 278
           + GT  ++APE        AK DV+S   ++L +L G  P  + F
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFF 295

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTL- 131
           ++ IG G FG V+R         AVK     ++  +R + RE E    +  +H NI+   
Sbjct: 14  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 69
Query: 132 ------HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                 +G +T      L+ +   +GSL  +L+  +V  + +      K+A+  A G+A+
Sbjct: 70  AADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 121
Query: 186 LHHDCI-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGT 237
           LH + +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 238 FGYLAPEYFDTG------RATAKGDVYSFGVVLLEL 267
             Y+APE  D         +  + D+Y+ G+V  E+
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 86
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 140
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 141 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG----Y 193
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGF 113
           ++  L  ++I + T  +  K+ IG G + +V +  ++ +T   FAVK + +      R  
Sbjct: 9   IVQQLHRNSI-QFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSK----RDP 62
Query: 114 ERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPS 171
             E+E +    +H NI+TL   Y   +Y  ++ EL   G L D  L  K  +++      
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREAS--- 119
Query: 172 RYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL-LDQ--NMEA-RVSDFGLATLMEAEK 227
              +     + + YLH   +   +HRD+K SNIL +D+  N E+ R+ DFG A  + AE 
Sbjct: 120 --AVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             + T    T  ++APE  +     A  D++S GV+L   LTG  P 
Sbjct: 175 GLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 81
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 135
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 188
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 77
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 131
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 184
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 86
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 140
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 141 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 193
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 32/240 (13%)
Query: 44  VSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS---TAFAVK 100
           +SG +   +R  L     +  +++   +      +GSG +G+V   +  D+      AVK
Sbjct: 7   MSGPRAGFYRQEL-----NKTVWEVPQRLQGLRPVGSGAYGSV--CSAYDARLRQKVAVK 59
Query: 101 RLHRGTTEV--DRGFERELEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGS 152
           +L R    +   R   REL  +  +KH N++ L   +T +          L+  LM    
Sbjct: 60  KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GAD 118
Query: 153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA 212
           L+  +  ++++ +++ +     +     RG+ Y+H   I   IHRD+K SN+ ++++ E 
Sbjct: 119 LNNIVKSQALSDEHVQF-----LVYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDSEL 170
Query: 213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           R+ DFGLA   + E T        T  Y APE   +        D++S G ++ ELL GK
Sbjct: 171 RILDFGLARQADEEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 98
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 152
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 153 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 205
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 71  KFSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGF----ERELEAMGDIKH 125
           ++   +++G GG   V+    + D    AVK L R     D  F     RE +    + H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNH 71
Query: 126 RNIVTLH----GYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGA 179
             IV ++        +     ++ E +   +L   +H  G    K+ ++      +   A
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADA 125
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--GT 237
            + + + H + I   IHRD+K +NIL+      +V DFG+A  +      V    A  GT
Sbjct: 126 CQALNFSHQNGI---IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 33/260 (12%)
Query: 78  IGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHG 133
           +GSG +G V       + A  A+K+L+R         R + REL  +  ++H N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLD 91
Query: 134 YYTSSQY---NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
            +T  +        Y +MP    D    GK +  + L       +     +G+ Y+H   
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDL---GKLMKHEKLGEDRIQFLVYQMLKGLRYIH--- 145
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY-FDTG 249
              IIHRD+K  N+ ++++ E ++ DFGLA   +A+      +V  T  Y APE   +  
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVV--TRWYRAPEVILNWM 201
Query: 250 RATAKGDVYSFGVVLLELLTGKR---------PMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           R T   D++S G ++ E++TGK           + E     GT    +V+ +  D+ + Y
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 301 VIDTSLEGCPINEINDVFSI 320
                ++G P  E  D  SI
Sbjct: 262 -----MKGLPELEKKDFASI 276

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGF-ERELEAMGDIKHRNIV-----TL 131
           IG G +G V+ +        AVK     TTE    F E E+     ++H NI+      +
Sbjct: 45  IGKGRYGEVW-MGKWRGEKVAVKVFF--TTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  + +Q   LI +   NGSL  +L   +++ K++      K+A  +  G+ +LH +  
Sbjct: 102 KGTGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLHTEIF 155
Query: 192 -----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS---TIVAGTFGYLAP 243
                P I HRD+KS NIL+ +N    ++D GLA    ++   V        GT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 244 EYFDTG------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEE 281
           E  D        ++    D+YSFG++L E+   +R +    +EE
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEE 257

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 71  KFSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGF----ERELEAMGDIKH 125
           ++   +++G GG   V+    + D    AVK L R     D  F     RE +    + H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNH 71
Query: 126 RNIVTLH----GYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGA 179
             IV ++        +     ++ E +   +L   +H  G    K+ ++      +   A
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADA 125
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--GT 237
            + + + H + I   IHRD+K +NI++      +V DFG+A  +      V+   A  GT
Sbjct: 126 CQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 71  KFSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGF----ERELEAMGDIKH 125
           ++   +++G GG   V+    + D    AVK L R     D  F     RE +    + H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNH 71
Query: 126 RNIVTLH----GYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGA 179
             IV ++        +     ++ E +   +L   +H  G    K+ +      ++   A
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADA 125
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--GT 237
            + + + H + I   IHRD+K +NI++      +V DFG+A  +      V+   A  GT
Sbjct: 126 CQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 81
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 135
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG----Y 188
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRG 105
           G M   R        +  I++   ++ +   +GSG +G+V            AVK+L + 
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKP 70
Query: 106 TTEV---DRGFERELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTF 156
              +    R + REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  
Sbjct: 71  FQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 128
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
           +  + +   ++ +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D
Sbjct: 129 VKCQKLTDDHVQF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 180
Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           FGLA   + E T        T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 181 FGLARHTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 81
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 135
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T      
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----Y 188
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 124 YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 176
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      GT  Y+ PE   D   +
Sbjct: 177 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +   +     ++ + A++    E   
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE--- 286
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 287 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 319

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 32/240 (13%)
Query: 44  VSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS---TAFAVK 100
           +SG +   +R  L     +  +++   +      +GSG +G+V   +  D+      AVK
Sbjct: 7   MSGPRAGFYRQEL-----NKTVWEVPQRLQGLRPVGSGAYGSV--CSAYDARLRQKVAVK 59
Query: 101 RLHRGTTEV--DRGFERELEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGS 152
           +L R    +   R   REL  +  +KH N++ L   +T +          L+  LM    
Sbjct: 60  KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GAD 118
Query: 153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA 212
           L+  +  ++++ +++ +     +     RG+ Y+H   I   IHRD+K SN+ ++++ E 
Sbjct: 119 LNNIVKCQALSDEHVQF-----LVYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDSEL 170
Query: 213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           R+ DFGLA   + E T        T  Y APE   +        D++S G ++ ELL GK
Sbjct: 171 RILDFGLARQADEEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 82
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 136
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA     E T      
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----Y 189
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 82
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 136
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA     E T      
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----Y 189
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 82
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 136
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA     E T      
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----Y 189
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 17/169 (10%)
Query: 113 FERELEAMGDIKHRNIVTLHGY----YTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKN 166
           F RE +    + H  IV ++        +     ++ E +   +L   +H  G    K+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 167 LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE 226
           ++      +   A + + + H + I   IHRD+K +NI++      +V DFG+A  +   
Sbjct: 119 IE------VIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 227 KTHVSTIVA--GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
              V+   A  GT  YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 17/169 (10%)
Query: 113 FERELEAMGDIKHRNIVTLH----GYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKN 166
           F RE +    + H  IV ++        +     ++ E +   +L   +H  G    K+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 167 LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE 226
           ++      +   A + + + H + I   IHRD+K +NI++      +V DFG+A  +   
Sbjct: 119 IE------VIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 227 KTHVSTIVA--GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
              V+   A  GT  YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 71  KFSSKDVIGSGGFGTVY---RLTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKH 125
           ++   +++G GG   V+    L ++   A  V R  L R  +   R F RE +    + H
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNH 88
Query: 126 RNIVTLH----GYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIAVGA 179
             IV ++        +     ++ E +   +L   +H  G    K+ ++      +   A
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADA 142
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--GT 237
            + + + H + I   IHRD+K +NI++      +V DFG+A  +      V+   A  GT
Sbjct: 143 CQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR-GTTEVDRGFE--------- 114
           I++   ++ +   +GSG +G+V         AF  K  HR    ++ R F+         
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 115 RELEAMGDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLD 168
           REL  +  +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ 
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
           +     +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DF LA   + E T
Sbjct: 129 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT 180
Query: 229 HVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
                   T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 181 G----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D+GLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGL    + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 124 YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 176
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      GT  Y+ PE   D   +
Sbjct: 177 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +   +     ++ + A++    E   
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE--- 286
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 287 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 319

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 23/225 (10%)
Query: 63  DAIFKKTLKFSSKDV-IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTEVDRGFERELEA 119
           D  +++ + +++  + +G G FG V+R+  +  T F  AVK++     EV R    EL A
Sbjct: 66  DYEYREEVHWATHQLRLGRGSFGEVHRME-DKQTGFQCAVKKVR---LEVFRA--EELMA 119
Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
              +    IV L+G      +  +  EL+  GSL     G+ V ++      R    +G 
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLVKEQGCLPEDRALYYLGQ 174
Query: 180 A-RGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI---- 233
           A  G+ YLH      I+H D+K+ N+LL  +   A + DFG A  ++ +      +    
Sbjct: 175 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAF 278
           + GT  ++APE        AK DV+S   ++L +L G  P  + F
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFF 276

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 96  YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 148
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ +   V      GT  Y+ PE   D   +
Sbjct: 149 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +  + + +KL     A++    E   
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKL----HAIIDPNHE--- 258
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 259 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 291

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 67  KKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGD 122
           K+   F    ++G G F TV     +  S  +A+K L +     +       RE + M  
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H   V L+  +   +          NG L  ++  + +   +      Y   + +A  
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA-- 121
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYL 241
           + YLH   I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y+
Sbjct: 122 LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +PE      A    D+++ G ++ +L+ G  P 
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 67  KKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGD 122
           K+   F    ++G G F TV     +  S  +A+K L +     +       RE + M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H   V L+  +   +          NG L  ++  + +   +      Y   + +A  
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA-- 120
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYL 241
           + YLH   I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y+
Sbjct: 121 LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +PE      A    D+++ G ++ +L+ G  P 
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 67  KKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGD 122
           K+   F    ++G G F TV     +  S  +A+K L +     +       RE + M  
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H   V L+  +   +          NG L  ++  + +   +      Y   + +A  
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA-- 119
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYL 241
           + YLH   I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y+
Sbjct: 120 LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +PE      A    D+++ G ++ +L+ G  P 
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 37/276 (13%)
Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-----VTL 131
           +G G +G V +   V      AVKR+ R T  V+   ++ L    DI  R +     VT 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI-RAT--VNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHD 189
           +G         +  EL  + SLD F   K V  K    P     KIAV   + + +LH  
Sbjct: 99  YGALFREGDVWICXELX-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 155
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY---- 245
               +IHRD+K SN+L++   + +  DFG++  +  +      I AG   Y APE     
Sbjct: 156 L--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA--KDIDAGCKPYXAPERINPE 211
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
            +    + K D++S G+  +EL   + P D           +W     Q K+   V++  
Sbjct: 212 LNQKGYSVKSDIWSLGITXIELAILRFPYD-----------SWGTPFQQLKQ---VVEEP 257
Query: 306 LEGCPINEINDVF-SIASMCLEPEPSKRPTMTEVVK 340
               P ++ +  F    S CL+    +RPT  E+ +
Sbjct: 258 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           +G G FG V+R+  +  T F  AVK++      V+     EL A   +    IV L+G  
Sbjct: 82  VGRGSFGEVHRMK-DKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 135
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA-RGIAYLHHDCIPHI 194
               +  +  EL+  GSL     G+ + +       R    +G A  G+ YLH      I
Sbjct: 136 REGPWVNIFMELLEGGSL-----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRI 187
Query: 195 IHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI----VAGTFGYLAPEYFDTG 249
           +H D+K+ N+LL  +   A + DFG A  ++ +    S +    + GT  ++APE     
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAF 278
              AK D++S   ++L +L G  P  + F
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPWTQYF 276

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHRGT-TEVDRG-FERELEAMGDIKHRNIVTLHG 133
            IG+G +G   ++   +D      K L  G+ TE ++     E+  + ++KH NIV    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR--- 69
Query: 134 YYTS--SQYNLLIY---ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           YY     + N  +Y   E    G L + +   +  ++ LD     ++       +   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 189 --DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
             D    ++HRD+K +N+ LD     ++ DFGLA ++  + +   T V GT  Y++PE  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQM 188
Query: 247 DTGRATAKGDVYSFGVVLLEL 267
           +      K D++S G +L EL
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 67  KKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGD 122
           K+   F    ++G G F TV     +  S  +A+K L +     +       RE + M  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H   V L+  +   +          NG L  ++  + +   +      Y   + +A  
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA-- 122
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYL 241
           + YLH   I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y+
Sbjct: 123 LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           +PE      A    D+++ G ++ +L+ G  P 
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           +G G FG V+R+  +  T F  AVK++      V+     EL A   +    IV L+G  
Sbjct: 66  VGRGSFGEVHRMK-DKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 119
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA-RGIAYLHHDCIPHI 194
               +  +  EL+  GSL     G+ + +       R    +G A  G+ YLH      I
Sbjct: 120 REGPWVNIFMELLEGGSL-----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRI 171
Query: 195 IHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI----VAGTFGYLAPEYFDTG 249
           +H D+K+ N+LL  +   A + DFG A  ++ +    S +    + GT  ++APE     
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAF 278
              AK D++S   ++L +L G  P  + F
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 72  FSSKDVIGSGGFGTVYRL-TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           F    V+G G FG V +     DS  +A+K++ R T E       E+  +  + H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 131 LHGYY------------TSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            +  +               +  L I  E   N +L   +H +++N++  ++   +++  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY---WRLFR 123
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-------LMEAEKTHV 230
                ++Y+H   I   IHRD+K  NI +D++   ++ DFGLA        +++ +  ++
Sbjct: 124 QILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 231 S------TIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELL 268
                  T   GT  Y+A E  D TG    K D+YS G++  E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 112/262 (42%), Gaps = 48/262 (18%)
Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRG------TTEVDRG 112
            Q  ++ +   K+  K  IG G +G V     N + A  A+K +++         +V+R 
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER- 74
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG----SLDTFL----------- 157
            + E+  M  + H NI  L+  Y   QY  L+ EL   G     L+ F+           
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 158 -----------HGKSVN------KKNLDWPSRYKIAVGAARGI-AYLHHDCIPHIIHRDI 199
                      + +++N      +++LD+  R K+     R I + LH+     I HRDI
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 200 KSSNILLDQN--MEARVSDFGLAT---LMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT-- 252
           K  N L   N   E ++ DFGL+     +   + +  T  AGT  ++APE  +T   +  
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 253 AKGDVYSFGVVLLELLTGKRPM 274
            K D +S GV+L  LL G  P 
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPF 276

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           +G G FG V+R+  +  T F  AVK++      V+     EL A   +    IV L+G  
Sbjct: 80  LGRGSFGEVHRMK-DKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 133
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA-RGIAYLHHDCIPHI 194
               +  +  EL+  GSL     G+ + +       R    +G A  G+ YLH      I
Sbjct: 134 REGPWVNIFMELLEGGSL-----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRI 185
Query: 195 IHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI----VAGTFGYLAPEYFDTG 249
           +H D+K+ N+LL  +   A + DFG A  ++ +    S +    + GT  ++APE     
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAF 278
              AK D++S   ++L +L G  P  + F
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHPWTQYF 274

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 60  LQSDAIFKKTLKFSS----KDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGF 113
           L ++ ++ +++ FS     K+ IG G +    R  V+ +T   +AVK + +      R  
Sbjct: 13  LGTENLYFQSMVFSDGYVVKETIGVGSYSECKR-CVHKATNMEYAVKVIDKSK----RDP 67
Query: 114 ERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPS 171
             E+E +    +H NI+TL   Y   ++  L+ ELM  G  LD  L  K  +++   +  
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-- 125
Query: 172 RYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL-LDQ--NMEA-RVSDFGLATLMEAEK 227
              +     + + YLH      ++HRD+K SNIL +D+  N E  R+ DFG A  + AE 
Sbjct: 126 ---VLHTIGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             + T    T  ++APE           D++S G++L  +L G  P
Sbjct: 180 GLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 50/279 (17%)
Query: 77  VIGSGGFGTVY---RLTVNDSTAFAVKRLHR----GTTEVDRGFERELEAMGDIK----- 124
           ++G GGFGTV+   RLT  D    A+K + R    G + +       LE     K     
Sbjct: 38  LLGKGGFGTVFAGHRLT--DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 125 -HRNIVTLHGYYTSSQYNLLIYE-LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
            H  ++ L  ++ + +  +L+ E  +P   L  ++  K    +    PSR        + 
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG---PSRCFFG----QV 148
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           +A + H     ++HRDIK  NIL+D +   A++ DFG   L+  E     T   GT  Y 
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TDFDGTRVYS 205
Query: 242 APEYFDTGRATA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
            PE+    +  A    V+S G++L +++ G  P +                     R++ 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE---------------------RDQE 244
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +++  L   P +   D  ++   CL P+PS RP++ E++
Sbjct: 245 ILEAELH-FPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 131
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 132 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 189 TEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 36/274 (13%)
Query: 78  IGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G F  V R   +      A  +    + +    +  ERE      +KH NIV LH  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI-----AYLHHD 189
            +   ++ LI++L+  G L   +  +            Y     A+  I     A LH  
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVARE-----------YYSEADASHCIQQILEAVLHCH 127
Query: 190 CIPHIIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
            +  ++HR++K  N+LL   ++    +++DFGLA  +E E+       AGT GYL+PE  
Sbjct: 128 QMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVL 185
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                    D+++ GV+L  LL G  P    + E+  +L   +KA   D         + 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPF---WDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           E   +  IN + +I        PSKR T  E +K
Sbjct: 243 EAKDL--INKMLTI-------NPSKRITAAEALK 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 94/232 (40%), Gaps = 16/232 (6%)
Query: 51  MFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTE 108
           M R+P+        I   + ++     IGSG FG V RL  +  T    AVK + RG   
Sbjct: 1   MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKYIERGAA- 58
Query: 109 VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
           +D   +RE+     ++H NIV       +  +  +I E    G L    + +  N     
Sbjct: 59  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFS 114
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR--VSDFGLATLMEAE 226
                        G++Y H      I HRD+K  N LLD +   R  + DFG +      
Sbjct: 115 EDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 227 KTHVSTIVAGTFGYLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMDEA 277
               ST+  GT  Y+APE         K  DV+S GV L  +L G  P ++ 
Sbjct: 172 SQPKSTV--GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 55/311 (17%)
Query: 70  LKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRN 127
           L+   + V+  GGF  VY    V     +A+KRL     E +R   +E+  M  +  H N
Sbjct: 28  LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 128 IVTLHGYYT-------SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
           IV      +       + Q   L+   +  G L  FL  K  ++  L   +  KI     
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTC 146
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT----------------LME 224
           R + ++H    P IIHRD+K  N+LL      ++ DFG AT                L+E
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 225 AEKTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE 281
            E T  +T +     Y  PE  D         K D+++ G +L  L   + P      E+
Sbjct: 206 EEITRNTTPM-----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----FED 255
Query: 282 GTKL-VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           G KL +   K  +     +Y +  SL             I +M L+  P +R ++ EVV 
Sbjct: 256 GAKLRIVNGKYSIPPHDTQYTVFHSL-------------IRAM-LQVNPEERLSIAEVVH 301
Query: 341 MLELIKSEKVV 351
            L+ I + + V
Sbjct: 302 QLQEIAAARNV 312

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 147 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 148 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR------GTTEVD 110
           +L+ + I  KTL        GSG  G V +L     T    A+K + +         E D
Sbjct: 7   ALRDEYIMSKTL--------GSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREAD 57
Query: 111 RGF--ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
                E E+E +  + H  I+ +  ++ +  Y  ++ ELM  G L      K V  K L 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----FDKVVGNKRLK 112
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEA 225
             +           + YLH +    IIHRD+K  N+LL    E    +++DFG + ++  
Sbjct: 113 EATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 226 EKTHVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
            +T +   + GT  YLAPE      T       D +S GV+L   L+G  P  E
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 150 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 154
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 155 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 212 TEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 38/278 (13%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHG 133
           IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L+ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y  + QY   IY +M  G++D  L+     KK++D   R          +  +H   I  
Sbjct: 124 YEITDQY---IYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI-- 176
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV-STIVAGTFGYLAPEYF-DTGRA 251
            +H D+K +N L+   M  ++ DFG+A  M+ + T V      G   Y+ PE   D   +
Sbjct: 177 -VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 252 TAKG----------DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
              G          DV+S G +L  +  GK P  +   +     ++ + A++    E   
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHE--- 286
Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
                   P  ++ DV      CL+ +P +R ++ E++
Sbjct: 287 --IEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELL 319

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++  FGLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 148 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 150 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 150 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A+   D+++ G ++ +L+ G  P 
Sbjct: 207 TEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 148 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGT-VYRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F T V    +  S  +A+K L +     +       RE + M  + H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 148 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 150 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 152
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 153 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 210 TEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 151 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR------GTTEVD 110
           +L+ + I  KTL        GSG  G V +L     T    A+K + +         E D
Sbjct: 7   ALRDEYIMSKTL--------GSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREAD 57
Query: 111 RGF--ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
                E E+E +  + H  I+ +  ++ +  Y  ++ ELM  G L      K V  K L 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----FDKVVGNKRLK 112
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEA 225
             +           + YLH +    IIHRD+K  N+LL    E    +++DFG + ++  
Sbjct: 113 EATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 226 EKTHVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
            +T +   + GT  YLAPE      T       D +S GV+L   L+G  P  E
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR------GTTEVD 110
           +L+ + I  KTL        GSG  G V +L     T    A+K + +         E D
Sbjct: 6   ALRDEYIMSKTL--------GSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREAD 56
Query: 111 RGF--ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
                E E+E +  + H  I+ +  ++ +  Y  ++ ELM  G L      K V  K L 
Sbjct: 57  PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----FDKVVGNKRLK 111
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEA 225
             +           + YLH +    IIHRD+K  N+LL    E    +++DFG + ++  
Sbjct: 112 EATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 166
Query: 226 EKTHVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
            +T +   + GT  YLAPE      T       D +S GV+L   L+G  P  E
Sbjct: 167 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 147 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 75  KDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTL 131
           K+ IG G +    R  V+ +T   +AVK + +      R    E+E +    +H NI+TL
Sbjct: 32  KETIGVGSYSECKR-CVHKATNMEYAVKVIDKS----KRDPSEEIEILLRYGQHPNIITL 86
Query: 132 HGYYTSSQYNLLIYELMPNGS-LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
              Y   ++  L+ ELM  G  LD  L  K  +++   +     +     + + YLH   
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHSQG 141
Query: 191 IPHIIHRDIKSSNIL-LDQ--NMEA-RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
              ++HRD+K SNIL +D+  N E  R+ DFG A  + AE   + T    T  ++APE  
Sbjct: 142 ---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVL 197
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRP 273
                    D++S G++L  +L G  P
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR------GTTEVD 110
           +L+ + I  KTL        GSG  G V +L     T    A+K + +         E D
Sbjct: 7   ALRDEYIMSKTL--------GSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREAD 57
Query: 111 RGF--ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
                E E+E +  + H  I+ +  ++ +  Y  ++ ELM  G L      K V  K L 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----FDKVVGNKRLK 112
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEA 225
             +           + YLH +    IIHRD+K  N+LL    E    +++DFG + ++  
Sbjct: 113 EATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 226 EKTHVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
            +T +   + GT  YLAPE      T       D +S GV+L   L+G  P  E
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D GLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 72/266 (27%)
Query: 72  FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIV 129
           F     +G GGFG V+      D   +A+KR+     E+ R    RE++A+  ++H  IV
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 130 TLHGYY-------------------TSSQYNL-----------------------LIYEL 147
                +                    S+ + L                        + +L
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 148 MPNGS-LDTFLHGKSVNKKNL-DWPSR------------YKIAVGAARGIAYLHHDCIPH 193
            P+   +  ++  +   K+NL DW +R              I +  A  + +LH   +  
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL-- 185
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLM---EAEKTHVSTIVA--------GTFGYLA 242
            +HRD+K SNI    +   +V DFGL T M   E E+T ++ + A        GT  Y++
Sbjct: 186 -MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 243 PEYFDTGRATAKGDVYSFGVVLLELL 268
           PE       + K D++S G++L ELL
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 150 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 59  SLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHR------GTTEVD 110
           +L+ + I  KTL        GSG  G V +L     T    A+K + +         E D
Sbjct: 13  ALRDEYIMSKTL--------GSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREAD 63
Query: 111 RGF--ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
                E E+E +  + H  I+ +  ++ +  Y  ++ ELM  G L      K V  K L 
Sbjct: 64  PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----FDKVVGNKRLK 118
Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEA 225
             +           + YLH +    IIHRD+K  N+LL    E    +++DFG + ++  
Sbjct: 119 EATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 173
Query: 226 EKTHVSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
            +T +   + GT  YLAPE      T       D +S GV+L   L+G  P  E
Sbjct: 174 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHRGT-TEVDRG-FERELEAMGDIKHRNIVTLHG 133
            IG+G +G   ++   +D      K L  G+ TE ++     E+  + ++KH NIV    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR--- 69
Query: 134 YYTS--SQYNLLIY---ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           YY     + N  +Y   E    G L + +   +  ++ LD     ++       +   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 189 --DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
             D    ++HRD+K +N+ LD     ++ DFGLA ++  + +     V GT  Y++PE  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQM 188
Query: 247 DTGRATAKGDVYSFGVVLLEL 267
           +      K D++S G +L EL
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
            V L+  +   +          NG L  ++  + +   +      Y   + +A  + YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYF 246
              I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE  
Sbjct: 150 GKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
               A    D+++ G ++ +L+ G  P 
Sbjct: 207 TEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D GLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 72  FSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRN 127
           F    ++G G F TV     +  S  +A+K L +     +       RE + M  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 128 IVTLHGYYTSSQYNLLIYEL--MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            V L  Y+T      L + L    NG L  ++  + +   +      Y   + +A  + Y
Sbjct: 95  FVKL--YFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEY 148
Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE 244
           LH   I   IHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y++PE
Sbjct: 149 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
                 A    D+++ G ++ +L+ G  P 
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L TF+   ++    L     Y   +   +G+A+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 124
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLT 269
              Y+ T       D++S G +  E++T
Sbjct: 180 GCKYYSTAV-----DIWSLGCIFAEMVT 202

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 62  SDAIFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHR---GTTEVDRGF 113
           +D+ F    ++     IGSG  G V       L +N     AVK+L R     T   R +
Sbjct: 16  ADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGIN----VAVKKLSRPFQNQTHAKRAY 71
Query: 114 ERELEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNL 167
            REL  +  + H+NI++L   +T        Q   L+ ELM + +L   +H +      L
Sbjct: 72  -RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME------L 123
Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
           D      +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACT 178
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
             + T    T  Y APE        A  D++S G ++ EL+ G
Sbjct: 179 NFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHRGT-TEVDRG-FERELEAMGDIKHRNIVTLHG 133
            IG+G +G   ++   +D      K L  G+ TE ++     E+  + ++KH NIV    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR--- 69
Query: 134 YYTS--SQYNLLIY---ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           YY     + N  +Y   E    G L + +   +  ++ LD     ++       +   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 189 --DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
             D    ++HRD+K +N+ LD     ++ DFGLA ++  ++      V GT  Y++PE  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQM 188
Query: 247 DTGRATAKGDVYSFGVVLLEL 267
           +      K D++S G +L EL
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTV-YRLTVNDSTAFAVKRLHRGTTEV---DRGFERELEAM 120
           I++   ++ +   +GSG +G+V            AVK+L R    +    R + REL  +
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLL 75
Query: 121 GDIKHRNIVTLHGYYTSS----QYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
             +KH N++ L   +T +    ++N   L+  LM    L+  +  + +   ++ +     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 129
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ Y+H      IIHRD+K SN+ ++++ E ++ D GLA   + E T      
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTG----Y 182
Query: 235 AGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE   +        D++S G ++ ELLTG+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE---------RELEAMG 121
           +++    IG G +G V       S+A+   R  R   +    FE         RE++ + 
Sbjct: 44  RYTQLQYIGEGAYGMV-------SSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILL 96
Query: 122 DIKHRNIVTLHGYYTSSQY----NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
             +H N++ +     +S      ++ I + +    L   L  + ++  ++ +   Y+I  
Sbjct: 97  RFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-FLYQIL- 154
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVA 235
              RG+ Y+H     +++HRD+K SN+L++   + ++ DFGLA + + E  H    T   
Sbjct: 155 ---RGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 236 GTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
            T  Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 32/264 (12%)
Query: 31  RRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLK--FSSKDVIGSGGFGTVYR 88
           RR    N     S+S  K+ +F      ++   +++ K L+  +     +GSG  G V +
Sbjct: 111 RRPLNNNSEIALSLSRNKVFVF---FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV-K 166
Query: 89  LTVNDSTAFAV-------KRLHRGTT-EVDRGF--ERELEAMGDIKHRNIVTLHGYYTSS 138
           L     T   V       ++   G+  E D     E E+E +  + H  I+ +  ++ + 
Sbjct: 167 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 226
Query: 139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRD 198
            Y  ++ ELM  G L      K V  K L   +           + YLH +    IIHRD
Sbjct: 227 DY-YIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRD 278
Query: 199 IKSSNILLDQNME---ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF---DTGRAT 252
           +K  N+LL    E    +++DFG + ++   +T +   + GT  YLAPE      T    
Sbjct: 279 LKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYN 336
Query: 253 AKGDVYSFGVVLLELLTGKRPMDE 276
              D +S GV+L   L+G  P  E
Sbjct: 337 RAVDCWSLGVILFICLSGYPPFSE 360

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 96
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNK----KNLDWPSRYKIAV 177
             +H NI+ ++    +        E M +  L T L G  + K    ++L          
Sbjct: 97  RFRHENIIGINDIIRAP-----TIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 151
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVA 235
              RG+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T   
Sbjct: 152 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 236 GTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
            T  Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 32/264 (12%)
Query: 31  RRWKRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLK--FSSKDVIGSGGFGTVYR 88
           RR    N     S+S  K+ +F      ++   +++ K L+  +     +GSG  G V +
Sbjct: 97  RRPLNNNSEIALSLSRNKVFVF---FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV-K 152
Query: 89  LTVNDSTAFAV-------KRLHRGTT-EVDRGF--ERELEAMGDIKHRNIVTLHGYYTSS 138
           L     T   V       ++   G+  E D     E E+E +  + H  I+ +  ++ + 
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212
Query: 139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRD 198
            Y  ++ ELM  G L      K V  K L   +           + YLH +    IIHRD
Sbjct: 213 DY-YIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRD 264
Query: 199 IKSSNILLDQNMEA---RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF---DTGRAT 252
           +K  N+LL    E    +++DFG + ++   +T +   + GT  YLAPE      T    
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322
Query: 253 AKGDVYSFGVVLLELLTGKRPMDE 276
              D +S GV+L   L+G  P  E
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSE 346

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTE--VDRGFERELEAMGDIKHRN 127
           K+     IG G +G V++    D+    A+K+      +  + +   RE+  +  +KH N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +V L   +   +   L++E   +    T LH     ++ +       I     + + + H
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 188 -HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
            H+CI    HRD+K  NIL+ ++   ++ DFG A L+     +    VA T  Y +PE  
Sbjct: 120 KHNCI----HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELL 174
Query: 247 --DTGRATAKGDVYSFGVVLLELLTG 270
             DT +     DV++ G V  ELL+G
Sbjct: 175 VGDT-QYGPPVDVWAIGCVFAELLSG 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 72  FSSKDVIGSGGFGTVYRL-TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           F    V+G G FG V +     DS  +A+K++ R T E       E+  +  + H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 131 LHGYY------------TSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
            +  +               +  L I  E   N +L   +H +++N++  ++   +++  
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY---WRLFR 123
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT-------LMEAEKTHV 230
                ++Y+H   I   IHR++K  NI +D++   ++ DFGLA        +++ +  ++
Sbjct: 124 QILEALSYIHSQGI---IHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 231 S------TIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELL 268
                  T   GT  Y+A E  D TG    K D YS G++  E +
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 77  VIGSGGFGTVYRLT----VNDSTAFAVKRLHRGT---TEVDRGFER-ELEAMGDIKHRNI 128
           V+G GG+G V+++      N    FA+K L +        D    + E   + ++KH  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L   + +     LI E +  G L   L  + +  +  D    Y   +  A G  +LH 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME--DTACFYLAEISMALG--HLHQ 139
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGTFGYLAPEY 245
             I   I+RD+K  NI+L+     +++DFGL      E  H  T+     GT  Y+APE 
Sbjct: 140 KGI---IYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDGTVTHTFCGTIEYMAPEI 192
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
                     D +S G ++ ++LTG  P
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 77  VIGSGGFGTVYRLT----VNDSTAFAVKRLHRGT---TEVDRGFER-ELEAMGDIKHRNI 128
           V+G GG+G V+++      N    FA+K L +        D    + E   + ++KH  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L   + +     LI E +  G L   L  + +  +  D    Y   +  A G  +LH 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME--DTACFYLAEISMALG--HLHQ 139
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV---AGTFGYLAPEY 245
             I   I+RD+K  NI+L+     +++DFGL      E  H  T+     GT  Y+APE 
Sbjct: 140 KGI---IYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDGTVTHXFCGTIEYMAPEI 192
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
                     D +S G ++ ++LTG  P
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 70  LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNI 128
           + F  KDV+G G  GT+    + D+   AVKR+     E     +RE++ + +  +H N+
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNV 80
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           +         Q+  +  EL    +L  ++  K      L+      +      G+A+LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS 136
Query: 189 DCIPHIIHRDIKSSNILLDQ-----NMEARVSDFGLATLMEAEKTHVS--TIVAGTFGYL 241
               +I+HRD+K  NIL+        ++A +SDFGL   +   +   S  + V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 242 APEYFDTG---RATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVK-AVMQDK 296
           APE          T   D++S G V   +++ G  P  ++   +   L+       +  +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           + E VI   L       I  + ++       +P KRP+   V+K
Sbjct: 254 KHEDVIAREL-------IEKMIAM-------DPQKRPSAKHVLK 283

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 76
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 135
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 136 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 120
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 176 GCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRG-TTEV--DRGFERELEAMGDIKHRNIVTLHG 133
           +GSG +G+V   +        A+K+L R   +E+   R + REL  +  ++H N++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 108
Query: 134 YYT--SSQYNLL-IYELMPNGSLD-TFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +T  SS  N    Y +MP    D   + G   +++ + +     +     +G+ Y+H  
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHSA 163
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
            +   +HRD+K  N+ ++++ E ++ DFGLA   +AE T        T  Y APE   + 
Sbjct: 164 GV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSW 216
Query: 250 RATAKG-DVYSFGVVLLELLTGK 271
               +  D++S G ++ E+LTGK
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 26  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 84
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 143
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 144 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 76
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 135
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 136 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 74
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 133
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 134 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 78
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 137
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 138 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 74
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 133
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 134 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 120
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 176 GCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 81
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 140
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 141 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 24  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 82
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 141
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 142 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 15  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 73
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 132
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 133 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 80
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 139
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L TF+   ++    L     Y   +   +G+A+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 120
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 176 GCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTL-HGYY 135
           +G G FG VY+    +++  A  ++    +E +   +  E++ +    H NIV L   +Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAAR---GIAYLHHDCI 191
             +   +LI E    G++D  +         L+ P +  +I V   +    + YLH +  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVM-------LELERPLTESQIQVVCKQTLDALNYLHDN-- 154
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTG 249
             IIHRD+K+ NIL   + + +++DFG++           + + GT  ++APE    +T 
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETS 212
Query: 250 RATA---KGDVYSFGVVLLELLTGKRPMDE 276
           +      K DV+S G+ L+E+   + P  E
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHE 242

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 120
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 176 GCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 76
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 135
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 136 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 80
Query: 122 DIKHRNIVTLHGYYTS----SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
             +H NI+ ++    +       ++ I + +    L   L  + ++  ++ +   Y+I  
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-FLYQIL- 138
Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVA 235
              RG+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T   
Sbjct: 139 ---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 236 GTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
            T  Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 78
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 137
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 138 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRG-TTEV--DRGFERELEAMGDIKHRNIVTLHG 133
           +GSG +G+V   +        A+K+L R   +E+   R + REL  +  ++H N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90
Query: 134 YYT--SSQYNLL-IYELMPNGSLD-TFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +T  SS  N    Y +MP    D   + G   +++ + +     +     +G+ Y+H  
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHSA 145
Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
            +   +HRD+K  N+ ++++ E ++ DFGLA   +AE T        T  Y APE   + 
Sbjct: 146 GV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSW 198
Query: 250 RATAKG-DVYSFGVVLLELLTGK 271
               +  D++S G ++ E+LTGK
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 120
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 176 GCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 96
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 155
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 156 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE-VDRGFERELEAMGDIKHRNI 128
           ++ ++ IG G +G V ++ V   T    A K++ +   E VDR F++E+E M  + H NI
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNI 68
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           + L+  +  +    L+ EL   G     L  + V+K+        +I       +AY H 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 189 DCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
               ++ HRD+K  N L      +   ++ DFGLA   +  K   + +  GT  Y++P+ 
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQV 179
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            + G    + D +S GV++  LL G  P 
Sbjct: 180 LE-GLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 128
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 129 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLT 269
              Y+ T       D++S G +  E++T
Sbjct: 184 GCKYYSTAV-----DIWSLGCIFAEMVT 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 120
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 176 GCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 177
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 178 GCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYFD 247
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 248 TGRATAKG-DVYSFGVVLLELLTGK 271
             +  +   D++S G +  E++T +
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTL-HGYY 135
           +G G FG VY+    +++  A  ++    +E +   +  E++ +    H NIV L   +Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAAR---GIAYLHHDCI 191
             +   +LI E    G++D  +         L+ P +  +I V   +    + YLH +  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVM-------LELERPLTESQIQVVCKQTLDALNYLHDN-- 154
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTG 249
             IIHRD+K+ NIL   + + +++DFG++           + + GT  ++APE    +T 
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETS 212
Query: 250 RATA---KGDVYSFGVVLLELLTGKRPMDE 276
           +      K DV+S G+ L+E+   + P  E
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHE 242

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 80
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 139
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 123
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 179 GCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 125
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 126 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 180
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLT 269
              Y+ T       D++S G +  E++T
Sbjct: 181 GCKYYSTAV-----DIWSLGCIFAEMVT 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 124
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 180 GCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 123
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 179 GCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 128
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYFD 247
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 129 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 248 TGRATAKG-DVYSFGVVLLELLT 269
             +  +   D++S G +  E++T
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 51/239 (21%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN--------------DSTAFAVKRLHRGTTEVD 110
           ++  +  F  K ++G G +G V   T                D   FA++ L        
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------- 57
Query: 111 RGFERELEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKK 165
               RE++ +   KH NI+T+        +       +I ELM      T LH     + 
Sbjct: 58  ----REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQM 108
Query: 166 NLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
             D   +Y I     R +  LH     ++IHRD+K SN+L++ N + +V DFGLA +++ 
Sbjct: 109 LSDDHIQYFI-YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 226 EKTHVS---------TIVAGTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
                S         T    T  Y APE   T    ++  DV+S G +L EL   +RP+
Sbjct: 165 SAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 124
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLT 269
              Y+ T       D++S G +  E++T
Sbjct: 180 GCKYYSTAV-----DIWSLGCIFAEMVT 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 125
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 126 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 180
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 181 GCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 178 GCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTL-HGYY 135
           +G G FG VY+    +++  A  ++    +E +   +  E++ +    H NIV L   +Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAAR---GIAYLHHDCI 191
             +   +LI E    G++D  +         L+ P +  +I V   +    + YLH +  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVM-------LELERPLTESQIQVVCKQTLDALNYLHDN-- 154
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTG 249
             IIHRD+K+ NIL   + + +++DFG++               GT  ++APE    +T 
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 250 RATA---KGDVYSFGVVLLELLTGKRPMDE 276
           +      K DV+S G+ L+E+   + P  E
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHE 242

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 123 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 178 GCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 123
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 124 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 179 GCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 76
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 135
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 136 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 178 GCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 80
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 139
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H   +     T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 81
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 140
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H   +     T  
Sbjct: 141 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 111/253 (43%), Gaps = 39/253 (15%)
Query: 58  HSLQ-SDAIFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHR---GTTE 108
           +S+Q +D+ F    ++     IGSG  G V       L +N     AVK+L R     T 
Sbjct: 9   YSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGIN----VAVKKLSRPFQNQTH 64
Query: 109 VDRGFERELEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSV 162
             R + REL  +  + H+NI++L   +T        Q   L+ ELM + +L   +H +  
Sbjct: 65  AKRAY-RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME-- 120
Query: 163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
               LD      +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA  
Sbjct: 121 ----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 173
Query: 223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG 282
             A    + T    T  Y APE           D++S G ++ EL+ G      + + +G
Sbjct: 174 --ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG------SVIFQG 225
Query: 283 TKLV-TWVKAVMQ 294
           T  +  W K + Q
Sbjct: 226 TDHIDQWNKVIEQ 238

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAF--AVKRLHRGTTE-VDRGFERELEAMGDIKHRNI 128
           ++ ++ IG G +G V ++ V   T    A K++ +   E VDR F++E+E M  + H NI
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNI 85
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           + L+  +  +    L+ EL   G     L  + V+K+        +I       +AY H 
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHK 141
Query: 189 DCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
               ++ HRD+K  N L      +   ++ DFGLA   +  K   + +  GT  Y++P+ 
Sbjct: 142 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQV 196
Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            + G    + D +S GV++  LL G  P 
Sbjct: 197 LE-GLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 102/246 (41%), Gaps = 34/246 (13%)
Query: 106 TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLLIYELMPNGSLDTFLHGKSVN 163
           +T   R F  E   +    H N++ + G   S  + +  LI    P GSL   LH  +  
Sbjct: 47  STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGT-- 104
Query: 164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TL 222
              +D     K A+  ARG A+LH    P I    + S ++ +D++  AR+S   +  + 
Sbjct: 105 NFVVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSF 163
Query: 223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM-DEAFLEE 281
               + +    VA       PE  DT R +A  D +SF V+L EL+T + P  D +  E 
Sbjct: 164 QSPGRXYAPAWVAPEALQKKPE--DTNRRSA--DXWSFAVLLWELVTREVPFADLSNXEI 219
Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGC----PINEINDVFSIASMCLEPEPSKRPTMTE 337
           G K+                   +LEG     P      V  +  +C   +P+KRP    
Sbjct: 220 GXKV-------------------ALEGLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDX 260
Query: 338 VVKMLE 343
           +V +LE
Sbjct: 261 IVPILE 266

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 51/239 (21%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN--------------DSTAFAVKRLHRGTTEVD 110
           ++  +  F  K ++G G +G V   T                D   FA++ L        
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------- 57
Query: 111 RGFERELEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKK 165
               RE++ +   KH NI+T+        +       +I ELM      T LH     + 
Sbjct: 58  ----REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQM 108
Query: 166 NLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
             D   +Y I     R +  LH     ++IHRD+K SN+L++ N + +V DFGLA +++ 
Sbjct: 109 LSDDHIQYFI-YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 226 EKTHVS---------TIVAGTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
                S         T    T  Y APE   T    ++  DV+S G +L EL   +RP+
Sbjct: 165 SAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 37/174 (21%)
Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
           A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +  +V    A   
Sbjct: 203 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA- 317
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P     +++     C   EPS+RPT +E+V+ L
Sbjct: 318 ---------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 124
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 125 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 180 GCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 35/173 (20%)
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-TF 238
           A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +V    A    
Sbjct: 201 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTWV 289
            ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++    
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-- 315
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                               P     +++     C   EPS+RPT +E+V+ L
Sbjct: 316 --------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 122
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 123 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 178 GCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 76
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 135
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 136 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG----FERELEAMGDIKHRN 127
           F    VIG G F  V  + +  +      ++      + RG    F  E + + +   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLH--GKSVNKKNLDWPSRYKIA--VGAARGI 183
           I  LH  +    Y  L+ E    G L T L   G+ +  +     +R+ +A  V A   +
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM----ARFYLAEIVMAIDSV 178
Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
             L +      +HRDIK  NILLD+    R++DFG    + A+ T  S +  GT  YL+P
Sbjct: 179 HRLGY------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 244 EYFDT-------GRATAKGDVYSFGVVLLELLTGKRPM 274
           E           G    + D ++ GV   E+  G+ P 
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILL 78
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 137
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 138 GLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 74  SKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTL 131
            +DV+G G    V   + +  S  +AVK + +    +     RE+E +   + HRN++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
             ++       L++E M  GS+ + +H     +++ +      +    A  + +LH+   
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK-- 130
Query: 192 PHIIHRDIKSSNILLD---QNMEARVSDFGLAT--LMEAEKTHVST----IVAGTFGYLA 242
             I HRD+K  NIL +   Q    ++ DFGL +   +  + + +ST       G+  Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 243 PEYFDTGRATA-----KGDVYSFGVVLLELLTGKRPM 274
           PE  +     A     + D++S GV+L  LL+G  P 
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A+K++      T   R   RE++ + 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL-REIKILL 80
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 139
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 124
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 180 GCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/78 (41%), Positives = 41/78 (52%)
Query: 196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKG 255
           HRD+K  NIL+  +  A + DFG+A+    EK        GT  Y APE F    AT + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 256 DVYSFGVVLLELLTGKRP 273
           D+Y+   VL E LTG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 37/174 (21%)
Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
           A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +  +V    A   
Sbjct: 208 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA- 322
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P     +++     C   EPS+RPT +E+V+ L
Sbjct: 323 ---------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 37/174 (21%)
Query: 180 ARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG-T 237
           A+G+ +L    CI    HRD+ + NILL +    ++ DFGLA  +  +  +V    A   
Sbjct: 210 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTW 288
             ++APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EGT++   
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA- 324
Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                                P     +++     C   EPS+RPT +E+V+ L
Sbjct: 325 ---------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 123
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 179 GCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLH--RGTTEVDRGFERELEAMG 121
           +F    ++++   IG G +G V     N +    A++++      T   R   RE++ + 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL-REIKILL 80
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H NI+ ++    +     +    +    ++T L+ K +  ++L             R
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILR 139
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS--TIVAGTFG 239
           G+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H    T    T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
           Y APE     +   K  D++S G +L E+L+  RP+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 51/239 (21%)
Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVN--------------DSTAFAVKRLHRGTTEVD 110
           ++  +  F  K ++G G +G V   T                D   FA++ L        
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------- 57
Query: 111 RGFERELEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKK 165
               RE++ +   KH NI+T+        +       +I ELM      T LH     + 
Sbjct: 58  ----REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQM 108
Query: 166 NLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
             D   +Y I     R +  LH     ++IHRD+K SN+L++ N + +V DFGLA +++ 
Sbjct: 109 LSDDHIQYFI-YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 226 EKTHVSTIVAGTFG---------YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPM 274
                S       G         Y APE   T    ++  DV+S G +L EL   +RP+
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 72  FSSKDVIGSGGFGTVYRL---TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+++ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLSFCHS 121
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y+ T       D++S G +  E++T +
Sbjct: 177 GCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFER-ELEAMGDIKHRNIV 129
           F  +  +G G    VYR     +   +A+K L +    VD+   R E+  +  + H NI+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLSHPNII 111
Query: 130 TLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR----GIA 184
            L   + +     L+ EL+  G L D  +     ++++         A  A +     +A
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD---------AADAVKQILEAVA 162
Query: 185 YLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           YLH +    I+HRD+K  N+L      +   +++DFGL+ ++E +   +   V GT GY 
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYC 217
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE         + D++S G++   LL G  P 
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVK--RLHRG------TTEVDRGFERELEA 119
           T ++     IG G +GTVY+     S  F A+K  R+  G      +T  +    R LEA
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 120 MGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
               +H N+V L     +S+ +      L++E + +  L T+L         L   +   
Sbjct: 63  ---FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKD 116
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ +LH +CI   +HRD+K  NIL+      +++DFGLA +   +      +V
Sbjct: 117 LMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV 173
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE           D++S G +  E+   K
Sbjct: 174 --TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 11/200 (5%)
Query: 78  IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVTLHGYYT 136
           +GSG FG V+R     +    V +       +D+   + E+  M  + H  ++ LH  + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH 196
                +LI E +  G L   +  +       +  +  +    A  G+ ++H   I   +H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR---QACEGLKHMHEHSI---VH 172
Query: 197 RDIKSSNILLDQNMEARVS--DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAK 254
            DIK  NI+ +    + V   DFGLAT +  ++  +  +   T  + APE  D       
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFY 230
Query: 255 GDVYSFGVVLLELLTGKRPM 274
            D+++ GV+   LL+G  P 
Sbjct: 231 TDMWAIGVLGYVLLSGLSPF 250

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E M P   L  F+  +   ++ L   S +   + A 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 127
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 128 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 178
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVK--RLHRG------TTEVDRGFERELEA 119
           T ++     IG G +GTVY+     S  F A+K  R+  G      +T  +    R LEA
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 120 MGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
               +H N+V L     +S+ +      L++E + +  L T+L         L   +   
Sbjct: 63  ---FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKD 116
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ +LH +CI   +HRD+K  NIL+      +++DFGLA +   +      +V
Sbjct: 117 LMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV 173
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE           D++S G +  E+   K
Sbjct: 174 --TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 15/213 (7%)
Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEA-----MG 121
           K   F    VIG G FG V          F AVK L +    + +  E+ + +     + 
Sbjct: 36  KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI-LKKKEEKHIMSERNVLLK 94
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           ++KH  +V LH  + ++     + + +  G L  F H +   +  L+  +R+  A   A 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQR-ERCFLEPRARF-YAAEIAS 150
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH     +I++RD+K  NILLD      ++DFGL      E    ++   GT  YL
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYL 206
Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE           D +  G VL E+L G  P 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANL--XQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 78  IGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +GSG +G V     +LT  +     +K+    TT        E+  +  + H NI+ L+ 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++   +   L+ E+   G L      + + ++         I      G  YLH     +
Sbjct: 89  FFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH---N 141
Query: 194 IIHRDIKSSNILLD---QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
           I+HRD+K  N+LL+   ++   ++ DFGL+   E        +  GT  Y+APE     +
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEVLRK-K 198
Query: 251 ATAKGDVYSFGVVLLELLTGKRPM 274
              K DV+S GV+L  LL G  P 
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPPF 222

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 72  FSSKDVIGSGGFGTVYRLT---VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           F   + IG G +G VY+       +  A    RL   T  V     RE+  + ++ H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L     +     L++E + +  L  F+   ++    L     Y   +   +G+A+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHS 124
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPE--- 244
                ++HRD+K  N+L++     +++DFGLA       +T+   +V  T  Y APE   
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLT 269
              Y+ T       D++S G +  E++T
Sbjct: 180 GCKYYSTAV-----DIWSLGCIFAEMVT 202

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 76  DVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLH 132
           D++G G    V+R     +   FA+K  +  +    VD    RE E +  + H+NIV L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLF 73
Query: 133 GYY--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
                T++++ +LI E  P GSL T L   S N   L       +      G+ +L  + 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 191 IPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I   +HR+IK  NI+     D     +++DFG A  +E ++  VS  + GT  YL P+ +
Sbjct: 133 I---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMY 187
Query: 247 DTG--------RATAKGDVYSFGVVLLELLTGKRPM 274
           +          +  A  D++S GV      TG  P 
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 29/234 (12%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRG---TTE 108
           L+ +   D  F    ++   + IG+G +G V     RLT       A+K++       T 
Sbjct: 41  LLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLT---GQQVAIKKIPNAFDVVTN 97
Query: 109 VDRGFERELEAMGDIKHRNIVTLHGY------YTSSQYNLLIYELMPNGSLDTFLHGKSV 162
             R   REL+ +   KH NI+ +         Y   +   ++ +LM    L   +H  S 
Sbjct: 98  AKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIH--SS 153
Query: 163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
               L+   RY +     RG+ Y+H      +IHRD+K SN+L+++N E ++ DFG+A  
Sbjct: 154 QPLTLEH-VRYFL-YQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 208
Query: 223 M---EAEKTHVSTIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR 272
           +    AE  +  T    T  Y APE        T   D++S G +  E+L  ++
Sbjct: 209 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IGSG FG    +    S    AVK + RG  ++D   +RE+     ++H NIV       
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 137 SSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
           +  +  ++ E    G L +   +    ++    +  +  I+     G++Y H      + 
Sbjct: 85  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 136
Query: 196 HRDIKSSNILLDQNMEAR--VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           HRD+K  N LLD +   R  + DFG +          ST+  GT  Y+APE         
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDG 194
Query: 254 K-GDVYSFGVVLLELLTGKRPMDE 276
           K  DV+S GV L  +L G  P ++
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFED 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVY--RLTVNDSTAFAVKRLHRGTTEVDRGFE--R 115
           ++ D + +   ++     IG G +G V+  R   N     A+KR+   T E        R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 116 E---LEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNL 167
           E   L  +   +H N+V L    T S+ +      L++E + +  L T+L    V +  +
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGV 117
Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
              +   +     RG+ +LH      ++HRD+K  NIL+  + + +++DFGLA +   + 
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
              S +V  T  Y APE           D++S G +  E+   K
Sbjct: 175 ALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 25/226 (11%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF-----ER 115
           D +F+   +    +VIG G F +V R  +N  T   FAVK +         G      +R
Sbjct: 19  DVLFEDVYELC--EVIGKGAF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E      +KH +IV L   Y+S     +++E M    L  F   + V + +  +     +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-CF---EIVKRADAGFVYSEAV 131
Query: 176 AVGAARGI----AYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKT 228
           A    R I     Y H +   +IIHRD+K  N+LL   + +   ++ DFG+A  +  E  
Sbjct: 132 ASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESG 187
Query: 229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            V+    GT  ++APE           DV+  GV+L  LL+G  P 
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 66
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANL--XQVIQMELDHE 119
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 120 RMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFM 174
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 29/234 (12%)
Query: 56  LIHSLQSDAIFKKTLKFSSKDVIGSGGFGTV----YRLTVNDSTAFAVKRLHRG---TTE 108
           L+ +   D  F    ++   + IG+G +G V     RLT       A+K++       T 
Sbjct: 40  LLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLT---GQQVAIKKIPNAFDVVTN 96
Query: 109 VDRGFERELEAMGDIKHRNIVTLHGY------YTSSQYNLLIYELMPNGSLDTFLHGKSV 162
             R   REL+ +   KH NI+ +         Y   +   ++ +LM    L   +H  S 
Sbjct: 97  AKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIH--SS 152
Query: 163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
               L+   RY +     RG+ Y+H      +IHRD+K SN+L+++N E ++ DFG+A  
Sbjct: 153 QPLTLEH-VRYFL-YQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207
Query: 223 M---EAEKTHVSTIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGKR 272
           +    AE  +  T    T  Y APE        T   D++S G +  E+L  ++
Sbjct: 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 20/203 (9%)
Query: 77  VIGSGGFGTV---YRLTVNDSTAFAV----KRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V   Y   V+   A  +    KR HR   E  R  E  L         N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILE-HLRKQDKDNTMNVI 162
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +   +T   +  + +EL+   S++ +   K    +    P   K A    + +  LH +
Sbjct: 163 HMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 190 CIPHIIHRDIKSSNILLDQNMEA--RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               IIH D+K  NILL Q   +  +V DFG +     E   V T +   F Y APE   
Sbjct: 220 ---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTXIQSRF-YRAPEVIL 272
Query: 248 TGRATAKGDVYSFGVVLLELLTG 270
             R     D++S G +L ELLTG
Sbjct: 273 GARYGMPIDMWSLGCILAELLTG 295

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANL--XQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVK--RLHRG------TTEVDRGFERELEA 119
           T ++     IG G +GTVY+     S  F A+K  R+  G      +T  +    R LEA
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 120 MGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
               +H N+V L     +S+ +      L++E + +  L T+L         L   +   
Sbjct: 63  ---FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKD 116
Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     RG+ +LH +CI   +HRD+K  NIL+      +++DFGLA +   +      +V
Sbjct: 117 LMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
             T  Y APE           D++S G +  E+   K
Sbjct: 174 --TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVY--RLTVNDSTAFAVKRLHRGTTEVDRGFE--R 115
           ++ D + +   ++     IG G +G V+  R   N     A+KR+   T E        R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 116 E---LEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNL 167
           E   L  +   +H N+V L    T S+ +      L++E + +  L T+L    V +  +
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGV 117
Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
              +   +     RG+ +LH      ++HRD+K  NIL+  + + +++DFGLA +   + 
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
              S +V  T  Y APE           D++S G +  E+   K
Sbjct: 175 ALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVY--RLTVNDSTAFAVKRLHRGTTEVDRGFE--R 115
           ++ D + +   ++     IG G +G V+  R   N     A+KR+   T E        R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 116 E---LEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNL 167
           E   L  +   +H N+V L    T S+ +      L++E + +  L T+L    V +  +
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGV 117
Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
              +   +     RG+ +LH      ++HRD+K  NIL+  + + +++DFGLA +   + 
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
              S +V  T  Y APE           D++S G +  E+   K
Sbjct: 175 ALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 20/203 (9%)
Query: 77  VIGSGGFGTV---YRLTVNDSTAFAV----KRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V   Y   V+   A  +    KR HR   E  R  E  L         N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILE-HLRKQDKDNTMNVI 162
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +   +T   +  + +EL+   S++ +   K    +    P   K A    + +  LH +
Sbjct: 163 HMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 190 CIPHIIHRDIKSSNILLDQNMEA--RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               IIH D+K  NILL Q   +  +V DFG +     E   V T +   F Y APE   
Sbjct: 220 ---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTXIQSRF-YRAPEVIL 272
Query: 248 TGRATAKGDVYSFGVVLLELLTG 270
             R     D++S G +L ELLTG
Sbjct: 273 GARYGMPIDMWSLGCILAELLTG 295

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 73  SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLH-----RGTTEVDRGFERELEAMGDIKHRN 127
           S  +++G G FG V++    + TA  +K        RG  + +   + E+  M  + H N
Sbjct: 92  SKTEILGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKDKEE-VKNEISVMNQLDHAN 147
Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           ++ L+  + S    +L+ E +  G L   +  +S N   LD     K       GI ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMH 204
Query: 188 HDCIPHIIHRDIKSSNILLDQNMEAR---VSDFGLATLMEA-EKTHVSTIVAGTFGYLAP 243
                +I+H D+K  NIL   N +A+   + DFGLA   +  EK  V+    GT  +LAP
Sbjct: 205 Q---MYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAP 257
Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           E  +    +   D++S GV+   LL+G  P
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANL--XQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 40/279 (14%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFER--------ELEAMG 121
           K+S+   +GSG FG V+     + +    VK + +     D   E         E+  + 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
            ++H NI+ +   + +  +  L+ E   +G LD F          LD P    I      
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFID--RHPRLDEPLASYIFRQLVS 141
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YL    +  IIHRDIK  NI++ ++   ++ DFG A  +E  K   +    GT  Y 
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYC 196
Query: 242 APEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           APE          + +++S GV L  L+  + P  E  LEE       V+A +      Y
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEET------VEAAIHPP---Y 245
Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           ++   L            S+ S  L+P P +R T+ ++V
Sbjct: 246 LVSKEL-----------MSLVSGLLQPVPERRTTLEKLV 273

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 78  IGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +GSG +G V     +LT  +     +K+    TT        E+  +  + H NI+ L+ 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           ++   +   L+ E+   G L      + + ++         I      G  YLH     +
Sbjct: 72  FFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HN 124
Query: 194 IIHRDIKSSNILLD---QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
           I+HRD+K  N+LL+   ++   ++ DFGL+   E        +  GT  Y+APE     +
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEVL-RKK 181
Query: 251 ATAKGDVYSFGVVLLELLTGKRP 273
              K DV+S GV+L  LL G  P
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPP 204

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 78  IGSGGFGTVYRLTVNDSTA---FAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G VY+    D      +A+K++    T +     RE+  + ++KH N+++L   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 135 YTSSQ----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHH 188
           + S      + L  Y       +  F      NKK +  P      +      GI YLH 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 189 DCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGYLA 242
           + +   +HRD+K +NIL+     +    +++D G A L  +    ++ +  V  TF Y A
Sbjct: 147 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 243 PEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
           PE     R   K  D+++ G +  ELLT +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDST---AFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V  +   D+      A+K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIV--VAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL--SQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S GV++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL--SQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S GV++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 67
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 68  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 120
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 121 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 175
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 67
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 68  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 120
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 121 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 175
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 66
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 119
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 120 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 174
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 35/173 (20%)
Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST-IVAGTF 238
           ARG+ +L        IHRD+ + NILL +N   ++ DFGLA  +     +V         
Sbjct: 209 ARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEGTKLVTWV 289
            ++APE       + K DV+S+GV+L E+ + G  P     MDE F   L EG ++    
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRA-- 323
Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                               P     +++ I   C   +P +RP   E+V+ L
Sbjct: 324 --------------------PEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 74  SKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTL 131
            +DV+G G    V   + +  S  +AVK + +    +     RE+E +   + HRN++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
             ++       L++E M  GS+ + +H     +++ +      +    A  + +LH+   
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK-- 130
Query: 192 PHIIHRDIKSSNILLD---QNMEARVSDFGLAT--LMEAEKTHVST----IVAGTFGYLA 242
             I HRD+K  NIL +   Q    ++ DF L +   +  + + +ST       G+  Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 243 PEYFDTGRATA-----KGDVYSFGVVLLELLTGKRPM 274
           PE  +     A     + D++S GV+L  LL+G  P 
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 74
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 75  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 127
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 182
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 16  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 72
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 73  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 125
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 126 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 180
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 181 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 74
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 75  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 127
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 182
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG------------TTEVDRGFERE 116
           T ++     IG G +GTVY+     S  F   +  R             +T  +    R 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 117 LEAMGDIKHRNIVTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPS 171
           LEA    +H N+V L     +S+ +      L++E + +  L T+L         L   +
Sbjct: 68  LEA---FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAET 121
Query: 172 RYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS 231
              +     RG+ +LH +CI   +HRD+K  NIL+      +++DFGLA +   +     
Sbjct: 122 IKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            +V  T  Y APE           D++S G +  E+   K
Sbjct: 179 VVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 111
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 164
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFM 219
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   ++ + A  +K+L R     T   R + RE
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVA--IKKLSRPFQNQTHAKRAY-RE 111
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI++L   +T        Q   L+ ELM     D  L    V +  LD  
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHE 164
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 219
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 128
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 129 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 179
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 115/282 (40%), Gaps = 48/282 (17%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 123
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 124 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPM--DEAFLEEGTKLVTWVKAVMQDK 296
           Y  PE+    R   +   V+S G++L +++ G  P   DE  +         V +  Q  
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ-- 232
Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                                  +   CL   PS RPT  E+
Sbjct: 233 ----------------------HLIRWCLALRPSDRPTFEEI 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 126
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 127 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 177
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 27/241 (11%)
Query: 47  GKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRG 105
           G  V+F+ P  H  + + +     ++    ++GSGGFG+VY  + V+D+   A+K + + 
Sbjct: 13  GLEVLFQGP--HMKEKEPL---ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 67
Query: 106 TT----EVDRGFERELEAMGDIK----HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTF 156
                 E+  G    +E +   K       ++ L  ++      +LI E   P   L  F
Sbjct: 68  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 127
Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVS 215
           +  +   ++ L   S +   + A R      H+C   ++HRDIK  NIL+D N  E ++ 
Sbjct: 128 ITERGALQEELA-RSFFWQVLEAVRHC----HNC--GVLHRDIKDENILIDLNRGELKLI 180
Query: 216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPM 274
           DFG   L+   K  V T   GT  Y  PE+    R   +   V+S G++L +++ G  P 
Sbjct: 181 DFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237
Query: 275 D 275
           +
Sbjct: 238 E 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 128
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 129 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 179
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 123
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 124 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFE-----RELEAMGDIKHRNIVT 130
           V+G G FG V       +   +A+K L +     D   E     + + A+ D K   +  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD-KPPFLTQ 84
Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +      + E +  G  D   H + V K     P     A   + G+ +LH   
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGG--DLMYHIQQVGK--FKEPQAVFYAAEISIGLFFLHKR- 139
Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLAPEYFDT 248
              II+RD+K  N++LD     +++DFG+    +M+   T       GT  Y+APE    
Sbjct: 140 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRE---FCGTPDYIAPEIIAY 194
Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMD 275
                  D +++GV+L E+L G+ P D
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 127
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 128 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 178
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 66  FKKTLKFSSKDVIGSGGFGTVY-RLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           F+   K +S +++G G +  V   +++ +   +AVK + +          RE+E +   +
Sbjct: 10  FEDMYKLTS-ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQ 68
Query: 125 -HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
            ++NI+ L  ++       L++E +  GS+   +      +K+ +     ++    A  +
Sbjct: 69  GNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQ----KQKHFNEREASRVVRDVAAAL 124
Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEAEKTHVS------TIV 234
            +LH      I HRD+K  NIL +   +    ++ DF L + M+   +         T  
Sbjct: 125 DFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 235 AGTFGYLAPEYFD--TGRAT---AKGDVYSFGVVLLELLTGKRPM 274
            G+  Y+APE  +  T +AT    + D++S GVVL  +L+G  P 
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 76  DVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLH 132
           D++G G    V+R     +   FA+K  +  +    VD    RE E +  + H+NIV L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLF 73
Query: 133 GYY--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
                T++++ +LI E  P GSL T L   S N   L       +      G+ +L  + 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 191 IPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           I   +HR+IK  NI+     D     +++DFG A  +E ++  V   + GT  YL P+ +
Sbjct: 133 I---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMY 187
Query: 247 DTG--------RATAKGDVYSFGVVLLELLTGKRPM 274
           +          +  A  D++S GV      TG  P 
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 170
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 171 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 221
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 142
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 143 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 193
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 35/255 (13%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 155
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 156 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPM--DEAFLE-----------EGTKL 285
           Y  PE+    R   +   V+S G++L +++ G  P   DE  +            E   L
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 266
Query: 286 VTWVKAVMQDKREEY 300
           + W  A+    R  +
Sbjct: 267 IRWCLALRPSDRPTF 281

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 156
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 157 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 155
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 156 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 155
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 156 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 128
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 129 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 179
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     IG+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E MP G  D F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 142
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 143 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 193
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 143
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 144 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 194
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 155
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 156 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 156
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 157 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 156
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 157 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     IG+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E MP G  D F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL--SQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 156
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 157 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 143
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 144 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 194
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 132/316 (41%), Gaps = 61/316 (19%)
Query: 48  KMVMFRSPLIHSLQS--------DAIFKKTLKFSSKDVIGSGGFGTVYRL-TVNDSTAFA 98
           + V FR     +LQS        ++ F+++ +  S+  +G G +G V+++ +  D   +A
Sbjct: 29  RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSR--LGHGSYGEVFKVRSKEDGRLYA 86
Query: 99  VKR---LHRGTTEVDRGFERELEAMGD----IKHRNIVTLHGYYTSSQYNLLIYELMPNG 151
           VKR     RG    DR   R+L  +G      +H   V L   +       ++Y      
Sbjct: 87  VKRSMSPFRGPK--DRA--RKLAEVGSHEKVGQHPCCVRLEQAWEEGG---ILY------ 133
Query: 152 SLDTFLHGKSVNKKNLDWPSRYKIAV--GAAR----GIAYLHHDCIPHIIHRDIKSSNIL 205
            L T L G S+ +    W +    A   G  R     +A+LH      ++H D+K +NI 
Sbjct: 134 -LQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIF 189
Query: 206 LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLL 265
           L      ++ DFGL  L+E        +  G   Y+APE       TA  DV+S G+ +L
Sbjct: 190 LGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGSYGTA-ADVFSLGLTIL 246
Query: 266 ELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCL 325
           E+      M+     EG     W     Q  R+ Y+      G      +++ S+  M L
Sbjct: 247 EVACN---MELPHGGEG-----W-----QQLRQGYLPPEFTAGL----SSELRSVLVMML 289
Query: 326 EPEPSKRPTMTEVVKM 341
           EP+P  R T   ++ +
Sbjct: 290 EPDPKLRATAEALLAL 305

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 35/255 (13%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 175
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 176 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 226
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPM--DEAFLE-----------EGTKL 285
           Y  PE+    R   +   V+S G++L +++ G  P   DE  +            E   L
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHL 286
Query: 286 VTWVKAVMQDKREEY 300
           + W  A+    R  +
Sbjct: 287 IRWCLALRPSDRPTF 301

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 143
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 144 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 194
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 20/203 (9%)
Query: 77  VIGSGGFGTV---YRLTVNDSTAFAV----KRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           VIG G FG V   Y   V+   A  +    KR HR   E  R  E  L         N++
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILE-HLRKQDKDNTMNVI 162
Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +   +T   +  + +EL+   S++ +   K    +    P   K A    + +  LH +
Sbjct: 163 HMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 190 CIPHIIHRDIKSSNILLDQNMEA--RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               IIH D+K  NILL Q   +  +V DFG +     E   V   +   F Y APE   
Sbjct: 220 ---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYXXIQSRF-YRAPEVIL 272
Query: 248 TGRATAKGDVYSFGVVLLELLTG 270
             R     D++S G +L ELLTG
Sbjct: 273 GARYGMPIDMWSLGCILAELLTG 295

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 19  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 75
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 76  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 128
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA         V
Sbjct: 129 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMV 185
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
             +V  T  Y APE           D++S G ++ E++ G
Sbjct: 186 PFVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL--SQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 162
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 163 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 213
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L   S +   + A 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-RSFFWQVLEAV 170
Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R      H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  
Sbjct: 171 RHC----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 221
Query: 240 YLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
           Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL--SQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 78  IGSGGFGTVYRLTVNDSTA---FAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           IG+G FG V RL + D  A    AVK + RG  ++D   +RE+     ++H NIV     
Sbjct: 27  IGAGNFG-VARL-MRDKQANELVAVKYIERG-EKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 135 YTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             +  +  ++ E    G L +   +    ++    +  +  I+     G++Y H      
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYAH---AMQ 135
Query: 194 IIHRDIKSSNILLDQNMEAR--VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
           + HRD+K  N LLD +   R  ++DFG +          S +  GT  Y+APE       
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV--GTPAYIAPEVLLKKEY 193
Query: 252 TAK-GDVYSFGVVLLELLTGKRPMDE 276
             K  DV+S GV L  +L G  P ++
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL--SQVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 74
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 127
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFM 182
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IGSG FG    +    S    AVK + RG  ++D   +RE+     ++H NIV       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 137 SSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
           +  +  ++ E    G L +   +    ++    +  +  I+     G++Y H      + 
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 137
Query: 196 HRDIKSSNILLDQNMEAR--VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           HRD+K  N LLD +   R  +  FG +          ST+  GT  Y+APE         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDG 195
Query: 254 K-GDVYSFGVVLLELLTGKRPMDEA 277
           K  DV+S GV L  +L G  P ++ 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 181
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG 270
            T    T  Y APE           D++S G ++ E++ G
Sbjct: 182 MTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--- 123
           K+  +F  + + G G FGTV +L    ST  +V    +   +  R   REL+ M D+   
Sbjct: 20  KEMDRFQVERMAGQGTFGTV-QLGKEKSTGMSVAI--KKVIQDPRFRNRELQIMQDLAVL 76
Query: 124 KHRNIVTLHGY-YTSSQ------YNLLIYELMPNGSLDTFLHGKSVN---KKNLDWPSRY 173
            H NIV L  Y YT  +      Y  ++ E +P    DT LH    N   ++    P   
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQVAPPPILI 131
Query: 174 KIAV-GAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKTHVS 231
           K+ +    R I  LH   + ++ HRDIK  N+L+++ +   ++ DFG A  +   + +V+
Sbjct: 132 KVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 232 TIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
            I +    Y APE  F     T   D++S G +  E++ G+
Sbjct: 191 YICSRY--YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 129/301 (42%), Gaps = 56/301 (18%)
Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVY---RLTVND-----STAFAVKRLHRGTTEVDRG 112
             D IF ++L        G G F  ++   R  V D      T   +K L +        
Sbjct: 7   NEDLIFNESL--------GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES 58
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F      M  + H+++V  +G       N+L+ E +  GSLDT+L  K+ N  N+ W  +
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILW--K 115
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA--------RVSDFGLA-TLM 223
            ++A   A  + +L  +    +IH ++ + NILL +  +         ++SD G++ T++
Sbjct: 116 LEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 224 EAEKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLT-GKRPMDEAFLEE 281
             +      I+     ++ PE  +  +      D +SFG  L E+ + G +P+  + L+ 
Sbjct: 173 PKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDS 224
Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
             KL        +D+ +           P  +  ++ ++ + C++ EP  RP+   +++ 
Sbjct: 225 QRKL-----QFYEDRHQ----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269
Query: 342 L 342
           L
Sbjct: 270 L 270

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IGSG FG    +    S    AVK + RG  ++    +RE+     ++H NIV       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERG-EKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 137 SSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
           +  +  ++ E    G L +   +    ++    +  +  I+     G++Y H      + 
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 137
Query: 196 HRDIKSSNILLDQNMEAR--VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           HRD+K  N LLD +   R  + DFG +          ST+  GT  Y+APE         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDG 195
Query: 254 K-GDVYSFGVVLLELLTGKRPMDEA 277
           K  DV+S GV L  +L G  P ++ 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIK- 124
           ++    ++GSGGFG+VY  + V+D+   A+K + +       E+  G    +E +   K 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 125 ---HRNIVTLHGYYTSSQYNLLIYELM-PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
                 ++ L  ++      +LI E   P   L  F+  +   ++ L            A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------A 112
Query: 181 RGIAYLHHDCIPH-----IIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIV 234
           R   +   + + H     ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T  
Sbjct: 113 RSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 169
Query: 235 AGTFGYLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
            GT  Y  PE+    R   +   V+S G++L +++ G  P +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH +   ++++RD+K  N++LD++   +++DFGL      +   + T   GT  YL
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYL 316
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 317 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH +   ++++RD+K  N++LD++   +++DFGL      +   + T   GT  YL
Sbjct: 263 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYL 319
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 320 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 352

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 109/244 (44%), Gaps = 29/244 (11%)
Query: 78  IGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLH---- 132
           +G GG G V+    ND     A+K++     +  +   RE++ +  + H NIV +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 133 ----------GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
                     G  T      ++ E M     +    G  + +    +   Y++     RG
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF--MYQLL----RG 132
Query: 183 IAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVSTIVAG--TFG 239
           + Y+H     +++HRD+K +N+ ++ +++  ++ DFGLA +M+   +H   +  G  T  
Sbjct: 133 LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 240 YLAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPMDEAF-LEEGTKLVTWVKAVMQDKR 297
           Y +P    +     K  D+++ G +  E+LTGK     A  LE+   ++  +  V ++ R
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 298 EEYV 301
           +E +
Sbjct: 250 QELL 253

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/310 (21%), Positives = 133/310 (42%), Gaps = 56/310 (18%)
Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVY---RLTVND-----STAFAVKRLHRGTTEVDRG 112
             D IF ++L        G G F  ++   R  V D      T   +K L +        
Sbjct: 7   NEDLIFNESL--------GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES 58
Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F      M  + H+++V  +G       N+L+ E +  GSLDT+L  K+ N  N+ W  +
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK-KNKNCINILW--K 115
Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA--------RVSDFGLA-TLM 223
            ++A   A  + +L  +    +IH ++ + NILL +  +         ++SD G++ T++
Sbjct: 116 LEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 224 EAEKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLT-GKRPMDEAFLEE 281
             +      I+     ++ PE  +  +      D +SFG  L E+ + G +P+  + L+ 
Sbjct: 173 PKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDS 224
Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
             KL        +D+ +           P  +  ++ ++ + C++ EP  RP+   +++ 
Sbjct: 225 QRKL-----QFYEDRHQ----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269
Query: 342 LELIKSEKVV 351
           L  + +  +V
Sbjct: 270 LNSLFTPDLV 279

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 67
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 68  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 120
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 121 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 175
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 22  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 78
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 79  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 131
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  + +
Sbjct: 132 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 186
Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            T    T  Y APE           D++S G ++ E++  K
Sbjct: 187 MTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   + T   GT  YL
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYL 172
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 173 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 205

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 16/205 (7%)
Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT 136
           IGSG FG    +    S    AVK + RG  ++D   +RE+     ++H NIV       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 137 SSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII 195
           +  +  ++ E    G L +   +    ++    +  +  I+     G++Y H      + 
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVC 137
Query: 196 HRDIKSSNILLDQNMEAR--VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           HRD+K  N LLD +   R  +  FG +           T+  GT  Y+APE         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTPAYIAPEVLLKKEYDG 195
Query: 254 K-GDVYSFGVVLLELLTGKRPMDEA 277
           K  DV+S GV L  +L G  P ++ 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 78  IGSGGFGTVYRLTVNDSTA--FAVKRLH---RGTTEVDRGFERELEAMGDIK-HRNIVTL 131
           +G G +G V++ +++  T    AVK++    + +T+  R F RE+  + ++  H NIV L
Sbjct: 17  LGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNL 74
Query: 132 HGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV-GAARGIAYLHH 188
                +       L+++ M     +T LH  +V + N+  P   +  V    + I YLH 
Sbjct: 75  LNVLRADNDRDVYLVFDYM-----ETDLH--AVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-------------TLMEAEKTH------ 229
             +   +HRD+K SNILL+     +V+DFGL+              L   E T       
Sbjct: 128 GGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 230 -VSTIVAGTFGYLAPEYFDTGRATAKG-DVYSFGVVLLELLTGK 271
            + T    T  Y APE         KG D++S G +L E+L GK
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   + T   GT  YL
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYL 172
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 173 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   + T   GT  YL
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYL 175
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 176 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 208

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH  + +      + E +  G  D   H +   K   +    Y   +  A  + 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLA--LN 167
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YLH   I   I+RD+K  N+LLD     +++D+G+           ST   GT  Y+APE
Sbjct: 168 YLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAPE 223
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
                      D ++ GV++ E++ G+ P D
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   FA+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   FA+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   FA+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 12/153 (7%)
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH  + +      + E +  G  D   H +   K   +    Y   +  A  + 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLA--LN 135
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLA 242
           YLH   I   I+RD+K  N+LLD     +++D+G+    L   + T   +   GT  Y+A
Sbjct: 136 YLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 189
Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           PE           D ++ GV++ E++ G+ P D
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT------LME 224
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA       +ME
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMME 183
Query: 225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            E          T  Y APE           D++S G ++ E++  K
Sbjct: 184 PEVV--------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     IG+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 12/153 (7%)
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH  + +      + E +  G  D   H +   K   +    Y   +  A  + 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLA--LN 120
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLA 242
           YLH   I   I+RD+K  N+LLD     +++D+G+    L   + T   +   GT  Y+A
Sbjct: 121 YLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 174
Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           PE           D ++ GV++ E++ G+ P D
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 77  VIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFE------RELEAMGDIKHRNI 128
           V+G G FG V  L+    T   +AVK L +     D   E      R L   G  K   +
Sbjct: 27  VLGKGSFGKVM-LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             LH  + +      + E +  G  D   H + V +     P     A   A G+ +L  
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGG--DLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQS 139
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST-IVAGTFGYLAPEYFD 247
                II+RD+K  N++LD     +++DFG+    E     V+T    GT  Y+APE   
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMD 275
                   D ++FGV+L E+L G+ P +
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 90/227 (39%), Gaps = 23/227 (10%)
Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDI----KHRNIVTL 131
           V+G G FG V    V ++   +AVK L +     D   E  +     +     H  +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
              + +      + E +  G L  F   KS   +  D       A      + +LH    
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDL-MFHIQKS---RRFDEARARFYAAEIISALMFLHDK-- 143
Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV-AGTFGYLAPEYFDTGR 250
             II+RD+K  N+LLD     +++DFG+    E     V+T    GT  Y+APE      
Sbjct: 144 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 251 ATAKGDVYSFGVVLLELLTGKRPMD--------EAFLEEGTKLVTWV 289
                D ++ GV+L E+L G  P +        EA L +     TW+
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 12/153 (7%)
Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH  + +      + E +  G  D   H +   K   +    Y   +  A  + 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLA--LN 124
Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT--LMEAEKTHVSTIVAGTFGYLA 242
           YLH   I   I+RD+K  N+LLD     +++D+G+    L   + T   +   GT  Y+A
Sbjct: 125 YLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 178
Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           PE           D ++ GV++ E++ G+ P D
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 94
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 150
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 203
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 87
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 88  FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 143
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEII 196
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTV---YRLTVNDSTAFAVKRLHR---GTTEVDRGFERE 116
           D+ F    ++ +   IGSG  G V   Y   +  + A  +K+L R     T   R + RE
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA--IKKLSRPFQNQTHAKRAY-RE 73
Query: 117 LEAMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
           L  M  + H+NI+ L   +T        Q   ++ ELM     D  L    V +  LD  
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC--QVIQMELDHE 126
Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT------LME 224
               +      GI +LH      IIHRD+K SNI++  +   ++ DFGLA       +ME
Sbjct: 127 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMME 183
Query: 225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
            E          T  Y APE           D++S G ++ E++  K
Sbjct: 184 PEVV--------TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS-TIVAGTFGY 240
            + YLH +   ++++RD+K  N++LD++   +++DFGL    E  K   +     GT  Y
Sbjct: 121 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 176
Query: 241 LAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           LAPE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 177 LAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS-TIVAGTFGY 240
            + YLH +   ++++RD+K  N++LD++   +++DFGL    E  K   +     GT  Y
Sbjct: 120 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 175
Query: 241 LAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           LAPE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 176 LAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 209

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS-TIVAGTFGY 240
            + YLH +   ++++RD+K  N++LD++   +++DFGL    E  K   +     GT  Y
Sbjct: 122 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 177
Query: 241 LAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           LAPE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 178 LAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 211

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 94
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 150
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 203
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   +     GT  YL
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYL 177
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 178 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 210

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   +     GT  YL
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYL 172
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 173 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 205

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFGLA  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF-----ER 115
           D +F+   +    +VIG G F +V R  +N  T   FAVK +         G      +R
Sbjct: 19  DVLFEDVYELC--EVIGKGPF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E      +KH +IV L   Y+S     +++E M    L  F   + V + +  +     +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-CF---EIVKRADAGFVYSEAV 131
Query: 176 AVGAARGI----AYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKT 228
           A    R I     Y H +   +IIHRD+K   +LL   + +   ++  FG+A  +  E  
Sbjct: 132 ASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESG 187
Query: 229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            V+    GT  ++APE           DV+  GV+L  LL+G  P 
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 77  VIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFE------RELEAMGDIKHRNI 128
           V+G G FG V  L+    T   +AVK L +     D   E      R L   G  K   +
Sbjct: 348 VLGKGSFGKVM-LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             LH  + +      + E +  G  D   H + V +     P     A   A G+ +L  
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGG--DLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQS 460
Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST-IVAGTFGYLAPE--- 244
                II+RD+K  N++LD     +++DFG+    E     V+T    GT  Y+APE   
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIA 515
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMD 275
           Y   G++    D ++FGV+L E+L G+ P +
Sbjct: 516 YQPYGKSV---DWWAFGVLLYEMLAGQAPFE 543

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   +     GT  YL
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYL 172
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 173 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 205

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 122
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 178
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 231
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGF-----ER 115
           D +F+   +    +VIG G F +V R  +N  T   FAVK +         G      +R
Sbjct: 21  DVLFEDVYELC--EVIGKGPF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 77
Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E      +KH +IV L   Y+S     +++E M    L  F   + V + +  +     +
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-CF---EIVKRADAGFVYSEAV 133
Query: 176 AVGAARGI----AYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKT 228
           A    R I     Y H +   +IIHRD+K   +LL   + +   ++  FG+A  +  E  
Sbjct: 134 ASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESG 189
Query: 229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            V+    GT  ++APE           DV+  GV+L  LL+G  P 
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            + YLH      +++RDIK  N++LD++   +++DFGL     ++   +     GT  YL
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYL 172
Query: 242 APEYF---DTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D GRA    D +  GVV+ E++ G+ P 
Sbjct: 173 APEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLPF 205

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFGLA  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  +AGT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 71  KFSSKDVIGSGGFGTVYRL--TVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           K+   + +G G FG V+R   T +  T  A     +GT +V    ++E+  +   +HRNI
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--LVKKEISILNIARHRNI 63
Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV--GAARGIAYL 186
           + LH  + S +  ++I+E +    LD F   + +N    +   R  ++        + +L
Sbjct: 64  LHLHESFESMEELVMIFEFI--SGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEA--RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           H   I H    DI+  NI+      +  ++ +FG A  ++          A    Y APE
Sbjct: 119 HSHNIGHF---DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE--YYAPE 173
Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV 286
                  +   D++S G ++  LL+G  P    FL E  + +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQI 211

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 188 HDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H+C   ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  Y  PE+ 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 247 DTGRATAK-GDVYSFGVVLLELLTGKRPMD 275
              R   +   V+S G++L +++ G  P +
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 122
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 178
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLAPEII 231
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   ++   +A+K L +      +  E  L      +  N  
Sbjct: 43  QFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFP 102
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E  P G +  F H + + +     P     A        YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 130 TLHGYYTSSQYNLLIYELM---PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            L     S + N  +Y +M   P G +  F H + + +     P     A        YL
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 37  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 96
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 97  FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 152
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 153 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 205
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 206 LSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 130 TLHGYYTSSQYNLLIYELM---PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            L     S + N  +Y +M   P G +  F H + + +     P     A        YL
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           +F     +G+G FG V  +  +     +A+K L +      +  E  L     ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 130 TLHGYYTSSQYNLLIYELM---PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            L     S + N  +Y +M   P G +  F H + + +     P     A        YL
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 158
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+++DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FXEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FAEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           +F     +G+G FG V  +   +S   +A+K L +      +  E  L     ++  N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 128 -IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G +  F H + + +     P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR--FSEPHARFYAAQIVLTFEYL 157
Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEII 210
Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPM 274
            +       D ++ GV++ E+  G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           +I+RD+K  N+L+DQ    +V+DFG A  ++      +  + GT  YLAPE   +     
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNK 217
Query: 254 KGDVYSFGVVLLELLTGKRPM 274
             D ++ GV++ E+  G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	351
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-138
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-128
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-124
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-85
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-68
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-67
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-65
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-65
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-65
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-62
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-62
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-61
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-59
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-59
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-59
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-50
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-46
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-46
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-45
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-44
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-43
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-43
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-43
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-42
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-42
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-42
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-42
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-41
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-41
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-41
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-41
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-41
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-41
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-40
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-39
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-38
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-38
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-38
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-37
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-37
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-36
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-05
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  395 bits (1017), Expect = e-138
 Identities = 123/279 (44%), Positives = 185/279 (66%), Gaps = 4/279 (1%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRN 127
           +  FS+K+++G GGFG VY+  + D T  AVKRL    T+  +  F+ E+E +    HRN
Sbjct: 29  SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           ++ L G+  +    LL+Y  M NGS+ + L  +  ++  LDWP R +IA+G+ARG+AYLH
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
             C P IIHRD+K++NILLD+  EA V DFGLA LM+ + THV+T V GT G++APEY  
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFL--EEGTKLVTWVKAVMQDKREEYVIDTS 305
           TG+++ K DV+ +GV+LLEL+TG+R  D A L  ++   L+ WVK ++++K+ E ++D  
Sbjct: 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 268

Query: 306 LEGC-PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           L+G     E+  +  +A +C +  P +RP M+EVV+MLE
Sbjct: 269 LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  368 bits (947), Expect = e-128
 Identities = 102/277 (36%), Positives = 152/277 (54%), Gaps = 5/277 (1%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI 128
           T  F  K +IG G FG VY+  + D    A+KR    +++    FE E+E +   +H ++
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V+L G+       +LIY+ M NG+L   L+G  +   ++ W  R +I +GAARG+ YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPEYFD 247
                IIHRD+KS NILLD+N   +++DFG++    E ++TH+ST+V GT GY+ PEYF 
Sbjct: 158 RA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            GR T K DVYSFGVVL E+L  +  + ++   E   L  W      + + E ++D +L 
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274

Query: 308 G-CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                  +      A  CL      RP+M +V+  LE
Sbjct: 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  358 bits (922), Expect = e-124
 Identities = 102/288 (35%), Positives = 156/288 (54%), Gaps = 14/288 (4%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV----DRGFERELEAMG 121
           F +       + +G GGFG VY+  VN+ T  AVK+L            + F++E++ M 
Sbjct: 27  FDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85

Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
             +H N+V L G+ +      L+Y  MPNGSL   L         L W  R KIA GAA 
Sbjct: 86  KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAAN 144

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGY 240
           GI +LH +     IHRDIKS+NILLD+   A++SDFGLA    +  +T +++ + GT  Y
Sbjct: 145 GINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY 201

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE-E 299
           +APE    G  T K D+YSFGVVLLE++TG   +DE    +   L+   + +  +++  E
Sbjct: 202 MAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIE 258

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
             ID  +       +  ++S+AS CL  + +KRP + +V ++L+ + +
Sbjct: 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  259 bits (663), Expect = 4e-85
 Identities = 77/314 (24%), Positives = 123/314 (39%), Gaps = 41/314 (13%)

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGD 122
           + ++ +++     +V   G FG V++  + +    AVK       +  +  E E+ ++  
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQ-NEYEVYSLPG 74

Query: 123 IKHRNIVTLHGY-----YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           +KH NI+   G              LI      GSL  FL         + W     IA 
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANV-----VSWNELCHIAE 128

Query: 178 GAARGIAYLHHDCI-------PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
             ARG+AYLH D         P I HRDIKS N+LL  N+ A ++DFGLA   EA K+  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 231 STI-VAGTFGYLAPEYFDTG-----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
            T    GT  Y+APE  +        A  + D+Y+ G+VL EL +     D    E    
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 285 LVTWV----------KAVMQDKREEYVIDTSLEGCPINEINDVFS-IASMCLEPEPSKRP 333
               +          + V+  K+   + D        +    +       C + +   R 
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDY----WQKHAGMAMLCETIEECWDHDAEARL 304

Query: 334 TMTEVVKMLELIKS 347
           +   V + +  ++ 
Sbjct: 305 SAGCVGERITQMQR 318

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  221 bits (564), Expect = 2e-70
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 24/275 (8%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           ++V+G G FG V +         A+K++   +    + F  EL  +  + H NIV L+G 
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDV-AIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
             +     L+ E    GSL   LHG                 +  ++G+AYLH      +
Sbjct: 70  CLNPVC--LVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 195 IHRDIKSSNILLDQNME-ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           IHRD+K  N+LL       ++ DFG A  ++   T+      G+  ++APE F+    + 
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAAWMAPEVFEGSNYSE 182

Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           K DV+S+G++L E++T ++P    F E G      + AV    R    +    +  P   
Sbjct: 183 KCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPP--LI---KNLP--- 230

Query: 314 INDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
              + S+ + C   +PS+RP+M E+VK++  +   
Sbjct: 231 -KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (551), Expect = 2e-68
 Identities = 89/281 (31%), Positives = 127/281 (45%), Gaps = 30/281 (10%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLH 132
           K+ IG+G FGTV+R   + S   AVK L       E    F RE+  M  ++H NIV   
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G  T      ++ E +  GSL   LH KS  ++ LD   R  +A   A+G+ YLH+   P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            I+HR++KS N+L+D+    +V DFGL+ L  A     S   AGT  ++APE      + 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL-----E 307
            K DVYSFGV+L EL T ++P            +   + V        V           
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGN---------LNPAQVVAA------VGFKCKRLEIPR 262

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
                    V +I   C   EP KRP+   ++ +L  +   
Sbjct: 263 NLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  213 bits (544), Expect = 1e-67
 Identities = 82/287 (28%), Positives = 133/287 (46%), Gaps = 39/287 (13%)

Query: 75  KDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG-------TTEVDRGFERELEAMGDIKHR 126
           +  IG GGFG V++   V D +  A+K L  G         E  + F+RE+  M ++ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NIV L+G   +     ++ E +P G L   L  K      + W  + ++ +  A GI Y+
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138

Query: 187 HHDCIPHIIHRDIKSSNILLDQ-----NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            +   P I+HRD++S NI L        + A+V+DFGL+     +  H  + + G F ++
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWM 193

Query: 242 APEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM-QDKRE 298
           APE         T K D YSF ++L  +LTG+ P    F E     + ++  +  +  R 
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGLRP 249

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              I    E CP      + ++  +C   +P KRP  + +VK L  +
Sbjct: 250 T--IP---EDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  207 bits (530), Expect = 1e-65
 Identities = 83/283 (29%), Positives = 119/283 (42%), Gaps = 35/283 (12%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVT 130
           +++IG GGFG VYR         AVK          ++      +E +    +KH NI+ 
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G         L+ E    G L+  L       K +        AV  ARG+ YLH + 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 191 IPHIIHRDIKSSNILLDQ--------NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           I  IIHRD+KSSNIL+ Q        N   +++DFGLA      +T   +  AG + ++A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS-AAGAYAWMA 182

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           PE       +   DV+S+GV+L ELLTG+ P       +G  +   V   M         
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI---DGLAVAYGV--AMNKLALP--- 234

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                 CP         +   C  P+P  RP+ T ++  L  I
Sbjct: 235 --IPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  206 bits (527), Expect = 3e-65
 Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 43/291 (14%)

Query: 70  LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRN 127
           L F +K  +     G +++     +    VK L     +T   R F  E   +    H N
Sbjct: 12  LNFLTK--LNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 128 IVTLHGYYTSSQYNLL--IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           ++ + G   S        I   MP GSL   LH        +D     K A+  ARG+A+
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAF 126

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           LH    P I    + S ++++D++M AR+S   +    +      S        ++APE 
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEA 179

Query: 246 FD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
                        D++SF V+L EL+T + P  +         ++ ++  M+      V 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD---------LSNMEIGMK------VA 224

Query: 303 DTSL-----EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
              L      G        V  +  +C+  +P+KRP    +V +LE ++ +
Sbjct: 225 LEGLRPTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  207 bits (529), Expect = 4e-65
 Identities = 76/288 (26%), Positives = 117/288 (40%), Gaps = 33/288 (11%)

Query: 75  KDVIGSGGFGTVYRLTVNDST-AFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
            +V+G G FG   ++T  ++     +K L R   E  R F +E++ M  ++H N++   G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
                +    I E +  G+L   +           W  R   A   A G+AYLH     +
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH-------------VSTIVAGTFGY 240
           IIHRD+ S N L+ +N    V+DFGLA LM  EKT                  V G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           +APE  +      K DV+SFG+VL E++           +      T    +      + 
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------DPDYLPRTMDFGLNVRGFLDR 242

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
                   CP       F I   C + +P KRP+  ++   LE ++  
Sbjct: 243 YCP---PNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (508), Expect = 4e-62
 Identities = 77/280 (27%), Positives = 128/280 (45%), Gaps = 25/280 (8%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLH 132
              IGSG FGTVY+   +   A  VK L+    T +  + F+ E+  +   +H NI+   
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVA--VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           GY T+ Q   ++ +     SL   LH     +   +      IA   ARG+ YLH     
Sbjct: 87  GYSTAPQL-AIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHA---K 139

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPE---YFDT 248
            IIHRD+KS+NI L ++   ++ DFGLAT       +H    ++G+  ++APE     D+
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
              + + DVY+FG+VL EL+TG+ P               +  ++        +      
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIEMVGRGSLSPDLSKVRSN 253

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
           CP      +  + + CL+ +  +RP+   ++  +E +  E
Sbjct: 254 CP----KRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  199 bits (508), Expect = 7e-62
 Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 38/287 (13%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLH 132
            ++IG G FG VY    +   A  ++ +       +  + F+RE+ A    +H N+V   
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVA--IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G   S  +  +I  L    +L + +      K  LD     +IA    +G+ YLH     
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA---K 149

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLM----EAEKTHVSTIVAGTFGYLAPEYFDT 248
            I+H+D+KS N+  D N +  ++DFGL ++        +     I  G   +LAPE    
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 249 GRA---------TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
                       +   DV++ G +  EL   + P    F  +       +  +    +  
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----F--KTQPAEAIIWQMGTGMKPN 262

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
                S  G       ++  I   C   E  +RPT T+++ MLE + 
Sbjct: 263 ----LSQIGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  197 bits (502), Expect = 8e-61
 Identities = 66/315 (20%), Positives = 119/315 (37%), Gaps = 46/315 (14%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELE--AMGDIKHRNI 128
                ++IG G +G VY+ ++++    AVK     +    + F  E     +  ++H NI
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDERPV-AVKVF---SFANRQNFINEKNIYRVPLMEHDNI 69

Query: 129 VTLHGYYTSSQYN-----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
                       +     LL+ E  PNGSL  +L          DW S  ++A    RG+
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGL 124

Query: 184 AYLHHD------CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME-------AEKTHV 230
           AYLH +        P I HRD+ S N+L+  +    +SDFGL+  +         E+ + 
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 231 STIVAGTFGYLAPEYFD-------TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT 283
           +    GT  Y+APE  +          A  + D+Y+ G++  E+      +         
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGC----PINEINDVFSIASM------CLEPEPSKRP 333
           ++    +       E+  +  S E      P     +  ++ S+      C + +   R 
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304

Query: 334 TMTEVVKMLELIKSE 348
           T     + +  +   
Sbjct: 305 TAQXAEERMAELMMI 319

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  193 bits (491), Expect = 4e-59
 Identities = 69/312 (22%), Positives = 107/312 (34%), Gaps = 39/312 (12%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
              K ++   +  IG G +G V+          AVK     T E     E E+     ++
Sbjct: 34  TIAKQIQMVKQ--IGKGRYGEVWMGKWRGEK-VAVKVFFT-TEEASWFRETEIYQTVLMR 89

Query: 125 HRNIVTLHGYYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
           H NI+           +     LI +   NGSL  +L         LD  S  K+A  + 
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSV 144

Query: 181 RGIAYLH-----HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV---ST 232
            G+ +LH         P I HRD+KS NIL+ +N    ++D GLA    ++   V     
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 233 IVAGTFGYLAPE------YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV 286
              GT  Y+ PE        +  ++    D+YSFG++L E+             E  +L 
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV---EEYQLP 261

Query: 287 TWVKAVMQDKREEYVIDTSLEGC--PINEINDVFSIASM-------CLEPEPSKRPTMTE 337
                      E+      ++                         C    P+ R T   
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 338 VVKMLELIKSEK 349
           V K L  +   +
Sbjct: 322 VKKTLAKMSESQ 333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  191 bits (488), Expect = 5e-59
 Identities = 72/301 (23%), Positives = 115/301 (38%), Gaps = 49/301 (16%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY 135
           + +G G +G V+R +       AVK       E     E EL     ++H NI+      
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN-VAVKIF-SSRDEKSWFRETELYNTVMLRHENILGFIASD 71

Query: 136 TSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD-- 189
            +S+++     LI      GSL  +L         LD  S  +I +  A G+A+LH +  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 190 ---CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV---STIVAGTFGYLAP 243
                P I HRD+KS NIL+ +N +  ++D GLA +       +   +    GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 244 E------YFDTGRATAKGDVYSFGVVLLELLTGKRPMDE---------------AFLEEG 282
           E        D   +  + D+++FG+VL E+                           E+ 
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
            K+V      +  +R    I       P   +  +  +   C    PS R T   + K L
Sbjct: 247 RKVV-----CVDQQRPN--IPNRWFSDPT--LTSLAKLMKECWYQNPSARLTALRIKKTL 297

Query: 343 E 343
            
Sbjct: 298 T 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  192 bits (490), Expect = 7e-59
 Identities = 68/315 (21%), Positives = 115/315 (36%), Gaps = 45/315 (14%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELE--AMGD 122
              +T+       IG G FG V+R         AVK      +  +R + RE E      
Sbjct: 39  TIARTIVLQES--IGKGRFGEVWRGKWRGEE-VAVKIFS---SREERSWFREAEIYQTVM 92

Query: 123 IKHRNIVTLHGYYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
           ++H NI+                 L+ +   +GSL  +L+     +  +      K+A+ 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALS 147

Query: 179 AARGIAYLHHD-----CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--- 230
            A G+A+LH +       P I HRD+KS NIL+ +N    ++D GLA   ++    +   
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 231 STIVAGTFGYLAPE------YFDTGRATAKGDVYSFGVVLLELLTGKRPMD--------- 275
                GT  Y+APE            +  + D+Y+ G+V  E+                 
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 276 EAFLEEGTKLVTWVKAVMQDK-REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT 334
              +     +    K V + K R    I    + C    +  +  I   C     + R T
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPN--IPNRWQSCEA--LRVMAKIMRECWYANGAARLT 323

Query: 335 MTEVVKMLELIKSEK 349
              + K L  +  ++
Sbjct: 324 ALRIKKTLSQLSQQE 338

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  171 bits (435), Expect = 2e-50
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 27/279 (9%)

Query: 75  KDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTLH 132
            + IG G FG V+   +  D+T  AVK          +  F +E   +    H NIV L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G  T  Q   ++ EL+  G   TFL         L   +  ++   AA G+ YL      
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK--- 232

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEYFDTGR 250
             IHRD+ + N L+ +    ++SDFG++     +  + ++           APE  + GR
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            +++ DV+SFG++L E  + G  P                + V +  R         E C
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPY------PNLSNQQTREFVEKGGRLP-----CPELC 340

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
           P    + VF +   C   EP +RP+ + + + L+ I+  
Sbjct: 341 P----DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  159 bits (403), Expect = 3e-46
 Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 35/280 (12%)

Query: 75  KDVIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
           + +IGSG  G V     R+        A+K L  G TE  R  F  E   MG   H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T  +  +++ E M NGSLDTFL     +           +  G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL--APEYFD 247
                +HRD+ + N+L+D N+  +VSDFGL+ ++E +     T   G       APE   
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 248 TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
               ++  DV+SFGVV+ E+L  G+RP       +    V  + +V +  R        L
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----V--ISSVEEGYR--------L 273

Query: 307 ---EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               GCP    + +  +   C   + ++RP  +++V +L+
Sbjct: 274 PAPMGCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  159 bits (403), Expect = 3e-46
 Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 41/302 (13%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRGFERELEA 119
             ++ LK+ S+  +G G FG+V       L  N     AVK+L     +  R F+RE++ 
Sbjct: 20  FEERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77

Query: 120 MGDIKHRNIVTLHG--YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           +  +    IV   G  Y    Q   L+ E +P+G L  FL     ++  LD       + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSS 134

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
              +G+ YL        +HRD+ + NIL++     +++DFGLA L+  +K      V   
Sbjct: 135 QICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVRE 188

Query: 238 FGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW--- 288
            G       APE       + + DV+SFGVVL EL T   +    +              
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 289 -----VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                ++ + + +R       +   CP     +V  +  +C  P P  RP+ + +   L+
Sbjct: 249 ALSRLLELLEEGQRLP-----APPACPA----EVHELMKLCWAPSPQDRPSFSALGPQLD 299

Query: 344 LI 345
           ++
Sbjct: 300 ML 301

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  162 bits (412), Expect = 6e-46
 Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 25/286 (8%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDI 123
           + +  +    K  +G G +G VY       S   AVK L   T EV+  F +E   M +I
Sbjct: 217 MERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEI 273

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
           KH N+V L G  T      +I E M  G+L  +L  +  N++ +       +A   +  +
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAM 331

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
            YL      + IHR++ + N L+ +N   +V+DFGL+ LM  +             + AP
Sbjct: 332 EYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           E     + + K DV++FGV+L E+ T G  P        G  L    + + +D R E   
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDLSQVYELLEKDYRME--- 439

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
               EGCP      V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 440 --RPEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  155 bits (393), Expect = 4e-45
 Identities = 67/276 (24%), Positives = 125/276 (45%), Gaps = 29/276 (10%)

Query: 75  KDVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
              +G G FG+V +            A+K L +GT + D     RE + M  + +  IV 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G   +    +L+ E+   G L  FL G    ++ +   +  ++    + G+ YL    
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK- 129

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF--GYLAPEYFDT 248
             + +HRD+ + N+LL     A++SDFGL+  + A+ ++ +   AG +   + APE  + 
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + +++ DV+S+GV + E L+ G++P       +  K    +  + Q KR E        
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY------KKMKGPEVMAFIEQGKRME-----CPP 236

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP     +++++ S C   +   RP    V + + 
Sbjct: 237 ECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMR 268

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  157 bits (399), Expect = 4e-45
 Identities = 82/280 (29%), Positives = 129/280 (46%), Gaps = 35/280 (12%)

Query: 75  KDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
             V+G+G FG V      L      + A+K L  G TE  R  F  E   MG   H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T S+  +++ E M NGSLD+FL     +           +  G A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL--APEYFD 247
                +HRD+ + NIL++ N+  +VSDFGL  ++E +     T   G       +PE   
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 248 TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
             + T+  DV+S+G+VL E+++ G+RP  E   ++    V  +KAV +  R        L
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----V--IKAVDEGYR--------L 269

Query: 307 ---EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                CP      ++ +   C + + + RP   ++V +L+
Sbjct: 270 PPPMDCP----AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (395), Expect = 5e-45
 Identities = 73/285 (25%), Positives = 115/285 (40%), Gaps = 48/285 (16%)

Query: 76  DVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
            V+GSG FGTVY+              A+K L   T+         E   M  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G   +S    LI +LMP G L  ++     +K N+         V  A+G+ YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT---FGYLAPEYF 246
               ++HRD+ + N+L+      +++DFGLA L+ AE+        G      ++A E  
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191

Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEGTKLVTWVKAVMQDKRE 298
                T + DV+S+GV + EL+T G +P D        + LE+G +L             
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------- 238

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                     C I    DV+ I   C   +   RP   E++    
Sbjct: 239 -----PQPPICTI----DVYMIMRKCWMIDADSRPKFRELIIEFS 274

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  155 bits (395), Expect = 6e-45
 Identities = 84/278 (30%), Positives = 133/278 (47%), Gaps = 30/278 (10%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAF-----AVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
           + VIG+G FG VY+  +  S+       A+K L  G TE  R  F  E   MG   H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           + L G  +  +  ++I E M NG+LD FL                 +  G A G+ YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEYF 246
               + +HRD+ + NIL++ N+  +VSDFGL+ ++E +     T   G       APE  
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
              + T+  DV+SFG+V+ E++T G+RP  E    E    V  +KA+    R       +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----V--MKAINDGFRLP-----T 271

Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              CP    + ++ +   C + E ++RP   ++V +L+
Sbjct: 272 PMDCP----SAIYQLMMQCWQQERARRPKFADIVSILD 305

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (392), Expect = 9e-45
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 36/300 (12%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDR-GFERELE 118
             K+ LK      +G G FG V          N     AVK L   +        ++E+E
Sbjct: 18  FEKRFLKR--IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75

Query: 119 AMGDIKHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
            + ++ H NIV   G  T    N   LI E +P+GSL  +L     NK  ++   + K A
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYA 132

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
           V   +G+ YL        +HRD+ + N+L++   + ++ DFGL   +E +K + +     
Sbjct: 133 VQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189

Query: 237 TF--GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW----- 288
                + APE     +     DV+SFGV L ELLT          L       T      
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249

Query: 289 ---VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
              V  + + KR           CP     +V+ +   C E +PS R +   +++  E +
Sbjct: 250 TRLVNTLKEGKRLP-----CPPNCPD----EVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  153 bits (389), Expect = 1e-44
 Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 27/277 (9%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
              +GSG FG V           AVK +  G+   D  F +E + M  + H  +V  +G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGV 71

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            +      ++ E + NG L  +L     + K L+     ++      G+A+L        
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEYFDTGRAT 252
           IHRD+ + N L+D+++  +VSDFG+   +  ++   S      F     APE F   + +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKYS 183

Query: 253 AKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           +K DV++FG+++ E+ + GK P D     E    V  V  V Q  R              
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSE----V--VLKVSQGHRLY-----RPHLAS- 231

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
              + ++ I   C    P KRPT  +++  +E ++ +
Sbjct: 232 ---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  153 bits (390), Expect = 1e-44
 Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 32/301 (10%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRGFERELEA 119
             ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E 
Sbjct: 7   FEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64

Query: 120 MGDIKHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           +  ++H NIV   G   S+      LI E +P GSL  +L     +K+ +D     +   
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTS 121

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
              +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K        G 
Sbjct: 122 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 238 F--GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE     + +   DV+SFGVVL EL T          E    +    +  M  
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 296 KREEYVIDTSLEG--------CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
                +I+             CP     +++ I + C     ++RP+  ++   ++ I+ 
Sbjct: 239 FH---LIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

Query: 348 E 348
            
Sbjct: 292 N 292

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  153 bits (389), Expect = 2e-44
 Identities = 68/276 (24%), Positives = 110/276 (39%), Gaps = 40/276 (14%)

Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
              IG G F TVY+ L    +   A    +  + T    + F+ E E +  ++H NIV  
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 132 HGYYTS---SQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           +  + S    +  +++  ELM +G+L T+L       K +             +G+ +LH
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 188 HDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
               P IIHRD+K  NI +       ++ D GLATL  A        V GT  ++APE +
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMY 202

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
           +        DVY+FG+ +LE+ T + P  E               +       Y   TS 
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSEYPYSE---------CQNAAQI-------YRRVTS- 244

Query: 307 EGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
            G      + V           C+     +R ++ +
Sbjct: 245 -GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  155 bits (394), Expect = 2e-44
 Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 35/309 (11%)

Query: 49  MVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHR 104
           +      L+ ++Q   I   +L     +VIG G FG VY              AVK L+R
Sbjct: 68  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 127

Query: 105 GTTEVDRG-FERELEAMGDIKHRNIVTLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKSV 162
            T   +   F  E   M D  H N+++L G    S+ + L +   M +G L  F+     
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--- 184

Query: 163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
              N          +  A+G+ +L        +HRD+ + N +LD+    +V+DFGLA  
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 223 MEAEKTHVSTIVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDE 276
           M  ++    ++   T   L     A E   T + T K DV+SFGV+L EL+T G  P  +
Sbjct: 242 MYDKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299

Query: 277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMT 336
               +    +     ++Q +R         E CP    + ++ +   C  P+   RP+ +
Sbjct: 300 VNTFD----I--TVYLLQGRRLL-----QPEYCP----DPLYEVMLKCWHPKAEMRPSFS 344

Query: 337 EVVKMLELI 345
           E+V  +  I
Sbjct: 345 ELVSRISAI 353

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  153 bits (389), Expect = 2e-44
 Identities = 84/311 (27%), Positives = 127/311 (40%), Gaps = 49/311 (15%)

Query: 54  SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEV 109
           S L+  ++   I  + +   S  VIG G FG VY         +    A+K L R T   
Sbjct: 5   SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64

Query: 110 DRG-FERELEAMGDIKHRNIVTLHGYYTSSQ-YNLLIYELMPNGSLDTFLHGKSVNKKNL 167
               F RE   M  + H N++ L G     +    ++   M +G L  F+      ++N 
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNP 121

Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
                    +  ARG+ YL        +HRD+ + N +LD++   +V+DFGLA  +    
Sbjct: 122 TVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI--LD 176

Query: 228 THVSTIVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEA- 277
               ++       L     A E   T R T K DV+SFGV+L ELLT G  P   +D   
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

Query: 278 ---FLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT 334
              FL +G +L                     E CP    + ++ +   C E +P+ RPT
Sbjct: 237 LTHFLAQGRRL------------------PQPEYCP----DSLYQVMQQCWEADPAVRPT 274

Query: 335 MTEVVKMLELI 345
              +V  +E I
Sbjct: 275 FRVLVGEVEQI 285

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  153 bits (389), Expect = 2e-44
 Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 35/310 (11%)

Query: 48  KMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLH 103
            +      L+ ++Q   I   +L     +VIG G FG VY              AVK L+
Sbjct: 3   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62

Query: 104 RGTTEVDRG-FERELEAMGDIKHRNIVTLHGYYTSSQYNLL-IYELMPNGSLDTFLHGKS 161
           R T   +   F  E   M D  H N+++L G    S+ + L +   M +G L  F+    
Sbjct: 63  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-- 120

Query: 162 VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT 221
               N          +  A+G+ YL        +HRD+ + N +LD+    +V+DFGLA 
Sbjct: 121 -ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176

Query: 222 LMEAEKTHVSTIVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMD 275
            M  ++ +  ++   T   L     A E   T + T K DV+SFGV+L EL+T G  P  
Sbjct: 177 DMYDKEYY--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

Query: 276 EAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
           +    +    +     ++Q +R         E CP    + ++ +   C  P+   RP+ 
Sbjct: 235 DVNTFD----I--TVYLLQGRRLL-----QPEYCP----DPLYEVMLKCWHPKAEMRPSF 279

Query: 336 TEVVKMLELI 345
           +E+V  +  I
Sbjct: 280 SELVSRISAI 289

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  153 bits (389), Expect = 3e-44
 Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 32/301 (10%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRGFERELEA 119
             ++ LKF  +  +G G FG+V       L  N     AVK+L   T E  R FERE+E 
Sbjct: 38  FEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 95

Query: 120 MGDIKHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
           +  ++H NIV   G   S+      LI E +P GSL  +L     +K+ +D     +   
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTS 152

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
              +G+ YL        IHRD+ + NIL++     ++ DFGL  ++  +K +      G 
Sbjct: 153 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 238 F--GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
               + APE     + +   DV+SFGVVL EL T          E    +    +  M  
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 296 KREEYVIDTSLEG--------CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
                +I+             CP     +++ I + C     ++RP+  ++   ++ I+ 
Sbjct: 270 FH---LIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

Query: 348 E 348
           +
Sbjct: 323 Q 323

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  152 bits (386), Expect = 5e-44
 Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 39/299 (13%)

Query: 54  SPLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDR 111
           +P    L   +  I  K L F     +G+G FG V           A+K +  G+   D 
Sbjct: 8   APSTAGLGYGSWEIDPKDLTF--LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE 65

Query: 112 GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPS 171
            F  E + M ++ H  +V L+G  T  +   +I E M NG L  +L      +       
Sbjct: 66  -FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQ 121

Query: 172 RYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS 231
             ++       + YL        +HRD+ + N L++     +VSDFGL+  +  ++   S
Sbjct: 122 LLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178

Query: 232 TIVAGTFGYL------APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
                  G         PE     + ++K D+++FGV++ E+ + GK P +     E   
Sbjct: 179 V------GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--- 229

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                + + Q  R                   V++I   C   +  +RPT   ++  + 
Sbjct: 230 -T--AEHIAQGLRLY-----RPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNIL 276

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  152 bits (387), Expect = 6e-44
 Identities = 74/302 (24%), Positives = 115/302 (38%), Gaps = 36/302 (11%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDR-GFERELE 118
             K+ LK      +G G FG V                AVK L        R G+++E++
Sbjct: 28  FHKRYLKKIRD--LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85

Query: 119 AMGDIKHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
            +  + H +I+   G    +      L+ E +P GSL  +L   S+    L        A
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFA 140

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
                G+AYLH     H IHRD+ + N+LLD +   ++ DFGLA  +     +       
Sbjct: 141 QQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVR 194

Query: 237 TFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW-- 288
             G       APE     +     DV+SFGV L ELLT                 +    
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254

Query: 289 --VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
             V  + +       +    + CP     +V+ +   C E E S RPT   ++ +L+ + 
Sbjct: 255 MTVLRLTELLERGERLPRP-DKCPA----EVYHLMKNCWETEASFRPTFENLIPILKTVH 309

Query: 347 SE 348
            +
Sbjct: 310 EK 311

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  157 bits (398), Expect = 8e-44
 Identities = 87/292 (29%), Positives = 133/292 (45%), Gaps = 27/292 (9%)

Query: 55  PLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRG 112
           P    L  DA  I +++L+   +  +G G FG V+  T N +T  A+K L  GT   +  
Sbjct: 252 PQTQGLAKDAWEIPRESLRL--EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA- 308

Query: 113 FERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
           F +E + M  ++H  +V L+   +      ++ E M  GSL  FL  K    K L  P  
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFL--KGETGKYLRLPQL 365

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E  +     
Sbjct: 366 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422

Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA 291
                  + APE    GR T K DV+SFG++L EL T G+ P        G      +  
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLDQ 476

Query: 292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           V +  R           CP      +  +   C   EP +RPT   +   LE
Sbjct: 477 VERGYRMP-----CPPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  151 bits (383), Expect = 8e-44
 Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 27/272 (9%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
              IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L+G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGV 71

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
                   L+ E M +G L  +L      +      +   + +    G+AYL       +
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CV 125

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEYFDTGRAT 252
           IHRD+ + N L+ +N   +VSDFG+   +  ++   ST     F     +PE F   R +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFSRYS 183

Query: 253 AKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           +K DV+SFGV++ E+ + GK P +     E    V  V+ +    R              
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE----V--VEDISTGFRLY-----KPRLAS- 231

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+ I + C    P  RP  + +++ L 
Sbjct: 232 ---THVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  155 bits (393), Expect = 1e-43
 Identities = 88/299 (29%), Positives = 134/299 (44%), Gaps = 27/299 (9%)

Query: 48  KMVMFRSPLIHSLQSDA--IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG 105
            +     P    L  DA  I +++L+   K  +G G FG V+  T N +T  A+K L  G
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG 219

Query: 106 TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKK 165
           T   +  F +E + M  ++H  +V L+   +      ++ E M  GSL  FL  K    K
Sbjct: 220 TMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFL--KGETGK 275

Query: 166 NLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
            L  P    +A   A G+AY+      + +HRD++++NIL+ +N+  +V+DFGLA L+E 
Sbjct: 276 YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332

Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK 284
            +            + APE    GR T K DV+SFG++L EL T G+ P        G  
Sbjct: 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMV 386

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               +  V +  R           CP      +  +   C   EP +RPT   +   LE
Sbjct: 387 NREVLDQVERGYRMP-----CPPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  150 bits (382), Expect = 2e-43
 Identities = 83/281 (29%), Positives = 124/281 (44%), Gaps = 33/281 (11%)

Query: 75  KDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           K  +G G +G VY       S   AVK L   T EV+  F +E   M +IKH N+V L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
             T      +I E M  G+L  +L  +  N++ +       +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL-----APEYFDT 248
            IHRD+ + N L+ +N   +V+DFGL+ LM  +     T  A           APE    
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAY 186

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + + K DV++FGV+L E+ T G  P        G  L    + + +D R E       E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDLSQVYELLEKDYRME-----RPE 235

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
           GCP      V+ +   C +  PS RP+  E+ +  E +  E
Sbjct: 236 GCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  151 bits (383), Expect = 2e-43
 Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 36/295 (12%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            +     +G GGF  V  +  ++D   +A+KR+     +     +RE +      H NI+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 130 TLHGYYTSSQYN----LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            L  Y    +       L+      G+L   +         L       + +G  RG+  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA--------GT 237
           +H        HRD+K +NILL    +  + D G               +          T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 238 FGYLAPEYFDTGR---ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ 294
             Y APE F          + DV+S G VL  ++ G+ P D  F +  +       AV  
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV----ALAVQN 262

Query: 295 DKREEYVIDTSLEGCPINEI--NDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
               +  I       P +    + ++ + +  +  +P +RP +  ++  LE ++ 
Sbjct: 263 ----QLSI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  156 bits (396), Expect = 4e-43
 Identities = 66/276 (23%), Positives = 124/276 (44%), Gaps = 29/276 (10%)

Query: 75  KDVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
              +G G FG+V +            A+K L +GT + D     RE + M  + +  IV 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G   +    +L+ E+   G L  FL G    ++ +   +  ++    + G+ YL    
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK- 455

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEYFDT 248
             + +HR++ + N+LL     A++SDFGL+  + A+ ++ +   AG +     APE  + 
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 249 GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
            + +++ DV+S+GV + E L+ G++P       +  K    +  + Q KR E        
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY------KKMKGPEVMAFIEQGKRME-----CPP 562

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            CP     +++++ S C   +   RP    V + + 
Sbjct: 563 ECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  150 bits (382), Expect = 5e-43
 Identities = 73/285 (25%), Positives = 115/285 (40%), Gaps = 48/285 (16%)

Query: 76  DVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
            V+GSG FGTVY+              A+K L   T+         E   M  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G   +S    LI +LMP G L  ++     +K N+         V  A+G+ YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT---FGYLAPEYF 246
               ++HRD+ + N+L+      +++DFGLA L+ AE+        G      ++A E  
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191

Query: 247 DTGRATAKGDVYSFGVVLLELLT-GKRPMDE-------AFLEEGTKLVTWVKAVMQDKRE 298
                T + DV+S+GV + EL+T G +P D        + LE+G +L             
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------- 238

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                     C I    DV+ I   C   +   RP   E++    
Sbjct: 239 -----PQPPICTI----DVYMIMVKCWMIDADSRPKFRELIIEFS 274

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  149 bits (379), Expect = 5e-43
 Identities = 65/287 (22%), Positives = 122/287 (42%), Gaps = 32/287 (11%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRG--FERELEA 119
           + +K L    K  +GSG FGTV +            AVK L     +         E   
Sbjct: 13  LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 71

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           M  + +  IV + G   +  + +L+ E+   G L+ +L       +++   +  ++    
Sbjct: 72  MQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQV 126

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF- 238
           + G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +      G + 
Sbjct: 127 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 239 -GYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             + APE  +  + ++K DV+SFGV++ E  + G++P        G K       + + +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY------RGMKGSEVTAMLEKGE 237

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           R          GCP     +++ + ++C   +   RP    V   L 
Sbjct: 238 RMG-----CPAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLR 275

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  149 bits (377), Expect = 2e-42
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 34/279 (12%)

Query: 75  KDVIGSGGFGTVYR-----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
             V+GSG FGTV++        +      +K +   +           + A+G + H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L G    S    L+ + +P GSL   +     ++  L         V  A+G+ YL  
Sbjct: 78  VRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT---FGYLAPEY 245
                ++HR++ + N+LL    + +V+DFG+A L+  +   +    +       ++A E 
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALES 188

Query: 246 FDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
              G+ T + DV+S+GV + EL+T G  P     L E    V     + + +R       
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----V--PDLLEKGERLA----- 237

Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             + C I    DV+ +   C   + + RPT  E+     
Sbjct: 238 QPQICTI----DVYMVMVKCWMIDENIRPTFKELANEFT 272

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  147 bits (373), Expect = 3e-42
 Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 47/294 (15%)

Query: 75  KDVIGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRN 127
            + +G   FG VY+           + A A+K L        R  F  E      ++H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL------------HGKSVNKKNLDWPSRYKI 175
           +V L G  T  Q   +I+    +G L  FL                  K  L+ P    +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
               A G+ YL      H++H+D+ + N+L+   +  ++SD GL   + A          
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKL 186

Query: 236 GTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWV 289
                L     APE    G+ +   D++S+GVVL E+ + G +P      ++        
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------- 238

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             V++  R   V+    + CP      V+++   C    PS+RP   ++   L 
Sbjct: 239 --VVEMIRNRQVLP-CPDDCP----AWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (372), Expect = 4e-42
 Identities = 79/279 (28%), Positives = 118/279 (42%), Gaps = 38/279 (13%)

Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
             IG G FG V++       N + A A+K     T++  R  F +E   M    H +IV 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G  T +    +I EL   G L +FL      K +LD  S    A   +  +AYL    
Sbjct: 81  LIGVITENPV-WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK- 135

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL-----APEY 245
               +HRDI + N+L+  N   ++ DFGL+  ME       T    + G L     APE 
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPES 188

Query: 246 FDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
            +  R T+  DV+ FGV + E+L  G +P       +    V  +  +   +R       
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V--IGRIENGERLP----- 237

Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               CP      ++S+ + C   +PS+RP  TE+   L 
Sbjct: 238 MPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLS 272

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  147 bits (374), Expect = 6e-42
 Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 41/288 (14%)

Query: 75  KDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRN 127
              +G G FG VY             T  A+K ++   +  +R  F  E   M +    +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL------HGKSVNKKNLDWPSRYKIAVGAAR 181
           +V L G  +  Q  L+I ELM  G L ++L         +            ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           G+AYL+ +     +HRD+ + N ++ ++   ++ DFG+   +            G  G L
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGLL 202

Query: 242 -----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQD 295
                +PE    G  T   DV+SFGVVL E+ T  ++P      E+          V++ 
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----------VLRF 252

Query: 296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             E  ++D   + CP    + +F +  MC +  P  RP+  E++  ++
Sbjct: 253 VMEGGLLD-KPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (370), Expect = 8e-42
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 27/272 (9%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
            + +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+ +V L+  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 76

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
            T  +   +I E M NGSL  FL  K+ +   L       +A   A G+A++      + 
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEYFDTGRAT 252
           IHRD++++NIL+   +  +++DFGLA L+E  +          F     APE  + G  T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAINYGTFT 188

Query: 253 AKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
            K DV+SFG++L E++T G+ P       E    V  ++ + +  R         + CP 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPE----V--IQNLERGYRMV-----RPDNCP- 236

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               +++ +  +C +  P  RPT   +  +LE
Sbjct: 237 ---EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  146 bits (370), Expect = 8e-42
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 39/287 (13%)

Query: 75  KDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
             ++G G FG VY         +    AVK   +  T  ++  F  E   M ++ H +IV
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G         +I EL P G L  +L     NK +L   +    ++   + +AYL   
Sbjct: 77  KLIGIIEEEPT-WIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL-----APE 244
              + +HRDI   NIL+      ++ DFGL+  +E E          +   L     +PE
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIKWMSPE 184

Query: 245 YFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
             +  R T   DV+ F V + E+L+ GK+P      ++    V  +  + +  R      
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----V--IGVLEKGDRLP---- 234

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKSEK 349
              + CP      ++++ + C + +PS RP  TE+V  L  + + EK
Sbjct: 235 -KPDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (370), Expect = 9e-42
 Identities = 69/286 (24%), Positives = 109/286 (38%), Gaps = 31/286 (10%)

Query: 75  KDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRN 127
            + +G G FG V R         + + AVK L        E    F RE+ AM  + HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           ++ L+G   +     ++ EL P GSL   L     ++ +    +  + AV  A G+ YL 
Sbjct: 83  LIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE 138

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LAPEY 245
                  IHRD+ + N+LL      ++ DFGL   +     H          +   APE 
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 246 FDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
             T   +   D + FGV L E+ T G+ P       +    +      +           
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---------- 245

Query: 305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
             E CP     D++++   C   +P  RPT   +   L   +   +
Sbjct: 246 RPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  145 bits (369), Expect = 1e-41
 Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 31/277 (11%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
              IG G FG V       +   AVK +    T     F  E   M  ++H N+V L G 
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGV 82

Query: 135 YTSSQYNLLI-YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
               +  L I  E M  GSL  +L  +S  +  L      K ++     + YL  +   +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI-VAGTFGYLAPEYFDTGRAT 252
            +HRD+ + N+L+ ++  A+VSDFGL     +       + V  T    APE     + +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVKWT----APEALREKKFS 192

Query: 253 AKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
            K DV+SFG++L E+ + G+ P           L   V  V +  + +     + +GCP 
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVVPRVEKGYKMD-----APDGCP- 240

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
                V+ +   C   + + RP+  ++ + LE IK+ 
Sbjct: 241 ---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (371), Expect = 1e-41
 Identities = 64/298 (21%), Positives = 123/298 (41%), Gaps = 28/298 (9%)

Query: 58  HSLQSDAIFKKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAFAVK--RLHRGTTEVDRGF- 113
            +L+ D  +     F  +  IG G F  VYR   + D    A+K  ++        R   
Sbjct: 20  KALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79

Query: 114 ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSR 172
            +E++ +  + H N++  +  +      L I  EL   G L   +      K+ +   + 
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
           +K  V     + ++H      ++HRDIK +N+ +      ++ D GL     ++ T   +
Sbjct: 139 WKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195

Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
           +V GT  Y++PE         K D++S G +L E+   + P    F  +   L +  K +
Sbjct: 196 LV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKI 250

Query: 293 MQDKREEYVIDTSLEGCPINEIN---DVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
            Q               P+   +   ++  + +MC+ P+P KRP +T V  + + + +
Sbjct: 251 EQCDYP-----------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  147 bits (372), Expect = 1e-41
 Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 54/295 (18%)

Query: 75  KDVIGSGGFGTVYRLTVND---STAFAVKRLHRGTTEVDRG-FERELEAMGDI-KHRNIV 129
           +DVIG G FG V +  +         A+KR+    ++ D   F  ELE +  +  H NI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY------------KIAV 177
            L G      Y  L  E  P+G+L  FL    V + +  +                  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             ARG+ YL        IHRD+ + NIL+ +N  A+++DFGL+   E         V  T
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199

Query: 238 FGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAFLEEGTKLVTW 288
            G L     A E  +    T   DV+S+GV+L E+++ G  P   M              
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------- 246

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
              + +   + Y ++     C     ++V+ +   C   +P +RP+  +++  L 
Sbjct: 247 CAELYEKLPQGYRLE-KPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLN 296

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (378), Expect = 2e-41
 Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 35/279 (12%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
              IG G FG V       +   AVK +    T     F  E   M  ++H N+V L G 
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGV 254

Query: 135 YTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
               +  L ++ E M  GSL  +L  +S  +  L      K ++     + YL  +   +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT-FGY--LAPEYFDTGR 250
            +HRD+ + N+L+ ++  A+VSDFGL           S+            APE     +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKK 362

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            + K DV+SFG++L E+ + G+ P           L   V  V +  + +     + +GC
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVVPRVEKGYKMD-----APDGC 411

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
           P      V+ +   C   + + RPT  ++ + LE I++ 
Sbjct: 412 P----PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  149 bits (377), Expect = 3e-41
 Identities = 82/287 (28%), Positives = 135/287 (47%), Gaps = 29/287 (10%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
           I +++LK   K  +G+G FG V+  T N  T  AVK +  G+  V+  F  E   M  ++
Sbjct: 185 IPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQ 241

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           H  +V LH   T      +I E M  GSL  FL  KS        P     +   A G+A
Sbjct: 242 HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY--LA 242
           ++      + IHRD++++NIL+  ++  +++DFGLA ++E  +          F     A
Sbjct: 299 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTA 353

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           PE  + G  T K DV+SFG++L+E++T G+ P        G      ++A+ +  R    
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY------PGMSNPEVIRALERGYRMP-- 405

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
                E CP     ++++I   C +  P +RPT   +  +L+   + 
Sbjct: 406 ---RPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  145 bits (369), Expect = 3e-41
 Identities = 70/301 (23%), Positives = 111/301 (36%), Gaps = 56/301 (18%)

Query: 75  KDVIGSGGFGTVYRLTVND----STAFAVKRLHRGTTEVDRG--FERELEAMGDIKHRNI 128
             ++G G FG+V    +          AVK L            F RE   M +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 129 VTLHG------YYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAA 180
             L G              ++I   M +G L  FL       N  NL   +  +  V  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
            G+ YL      + IHRD+ + N +L ++M   V+DFGL+  + +   +      G    
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200

Query: 241 L-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEA----FLEEGTKLVT 287
           L     A E       T   DV++FGV + E++T G+ P   ++ A    +L  G +L  
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-- 258

Query: 288 WVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
                                C      +V+ +   C   +P +RP+ T +   LE I  
Sbjct: 259 ----------------KQPPECM----EEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298

Query: 348 E 348
            
Sbjct: 299 H 299

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  148 bits (375), Expect = 4e-41
 Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 43/296 (14%)

Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAM 120
           ++  +    + F  KDV+G G  GT+    + D+   AVKR+     E     +RE++ +
Sbjct: 15  ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLL 71

Query: 121 GDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
            +  +H N++         Q+  +  EL    +L  ++  K      L+      +    
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQT 127

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILL-----DQNMEARVSDFGLATLMEAEKTHVSTI- 233
             G+A+LH     +I+HRD+K  NIL+        ++A +SDFGL   +   +   S   
Sbjct: 128 TSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 234 -VAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTW 288
            V GT G++APE          T   D++S G V   +++ G  P  ++   +       
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------- 237

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIA----SMCLEPEPSKRPTMTEVVK 340
                        +D       ++       IA       +  +P KRP+   V+K
Sbjct: 238 ----ANILLGACSLD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  145 bits (368), Expect = 6e-41
 Identities = 79/288 (27%), Positives = 112/288 (38%), Gaps = 41/288 (14%)

Query: 77  VIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
            +G G FG VY   V+           AVK L    +E D   F  E   +    H+NIV
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYL 186
              G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARV---SDFGLATLMEAEKTHVSTIVAGTFGYL-- 241
             +   H IHRDI + N LL      RV    DFG+A  +       S    G    L  
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLPV 209

Query: 242 ---APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
               PE F  G  T+K D +SFGV+L E+ + G  P      +E          V++   
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------VLEFVT 259

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
               +D   + CP      V+ I + C + +P  RP    +++ +E  
Sbjct: 260 SGGRMD-PPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  144 bits (366), Expect = 8e-41
 Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 55/297 (18%)

Query: 75  KDVIGSGGFGTVYRLTVND----STAFAVKRLHRG-TTEVDRG-FERELEAMGDIKHRNI 128
             ++G G FG+V    +      S   AVK +    +++ +   F  E   M D  H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 129 VTLHGYYTSSQ-----YNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAAR 181
           + L G             ++I   M  G L T+L         K++   +  K  V  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           G+ YL +    + +HRD+ + N +L  +M   V+DFGL+  + +   +      G    +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211

Query: 242 -----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEA----FLEEGTKLVTW 288
                A E       T+K DV++FGV + E+ T G  P   +       +L  G +L   
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--- 268

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                             E C     ++++ I   C   +P  RPT + +   LE +
Sbjct: 269 ---------------KQPEDCL----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 2e-40
 Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 45/290 (15%)

Query: 77  VIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
            +G G FG V+    ++          AVK L   +    + F+RE E +  ++H++IV 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFL-----------HGKSVNKKNLDWPSRYKIAVGA 179
             G  T  +  L+++E M +G L+ FL            G+ V    L       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           A G+ YL      H +HRD+ + N L+ Q +  ++ DFG++  + +          G   
Sbjct: 168 AAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGGRT 220

Query: 240 YL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
            L      PE     + T + DV+SFGVVL E+ T GK+P  +    E           +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----------AI 270

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               +   ++     CP     +V++I   C + EP +R ++ +V   L+
Sbjct: 271 DCITQGRELERP-RACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  149 bits (378), Expect = 2e-40
 Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 28/274 (10%)

Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVT 130
             IG G FG V++       N + A A+K     T++  R  F +E   M    H +IV 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G  T +    +I EL   G L +FL      K +LD  S    A   +  +AYL    
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK- 510

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
               +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            T+  DV+ FGV + E+L  G +P       +    V  +  +   +R           C
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V--IGRIENGERLP-----MPPNC 617

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           P      ++S+ + C   +PS+RP  TE+   L 
Sbjct: 618 P----PTLYSLMTKCWAYDPSRRPRFTELKAQLS 647

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  144 bits (364), Expect = 4e-40
 Identities = 78/288 (27%), Positives = 111/288 (38%), Gaps = 41/288 (14%)

Query: 77  VIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIV 129
            +G G FG VY   V+           AVK L    +E D   F  E   +    H+NIV
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLH---GKSVNKKNLDWPSRYKIAVGAARGIAYL 186
              G    S    ++ ELM  G L +FL     +     +L       +A   A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARV---SDFGLATLMEAEKTHVSTIVAGTFGYL-- 241
             +   H IHRDI + N LL      RV    DFG+A  +            G    L  
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPV 250

Query: 242 ---APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
               PE F  G  T+K D +SFGV+L E+ + G  P      +E          V++   
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------VLEFVT 300

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
               +D   + CP      V+ I + C + +P  RP    +++ +E  
Sbjct: 301 SGGRMDPP-KNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (360), Expect = 1e-39
 Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 28/276 (10%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVK--RLHRGTTEVDRGFERELEAMGDIKHRN 127
           K+     IG G FG      +  D   + +K   + R +++      RE+  + ++KH N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV     +  +    ++ +    G L   +   +               V     + ++H
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                 I+HRDIKS NI L ++   ++ DFG+A ++ +        + GT  YL+PE  +
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                 K D+++ G VL EL T K      F  E   +   V  ++              
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA----F--EAGSMKNLVLKIISGSFP--------- 243

Query: 308 GCPINEI--NDVFSIASMCLEPEPSKRPTMTEVVKM 341
             P++     D+ S+ S   +  P  RP++  +++ 
Sbjct: 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  140 bits (355), Expect = 2e-39
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 46/290 (15%)

Query: 78  IGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
           +G G FG V+     +          AVK L   T    + F+RE E + +++H +IV  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFL------------HGKSVNKKNLDWPSRYKIAVGA 179
           +G        ++++E M +G L+ FL                  K  L       IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           A G+ YL      H +HRD+ + N L+  N+  ++ DFG++  + +   +      G   
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195

Query: 240 YL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM 293
            L      PE     + T + DV+SFGV+L E+ T GK+P  +    E          V+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----------VI 245

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +   +  V++     CP     +V+ +   C + EP +R  + E+ K+L 
Sbjct: 246 ECITQGRVLE-RPRVCP----KEVYDVMLGCWQREPQQRLNIKEIYKILH 290

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  140 bits (356), Expect = 3e-39
 Identities = 77/302 (25%), Positives = 122/302 (40%), Gaps = 56/302 (18%)

Query: 75  KDVIGSGGFGTVYR--------LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDI-K 124
              +G G FG V              ++   AVK L    TE D      E+E M  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL------------HGKSVNKKNLDWPSR 172
           H+NI+ L G  T      +I E    G+L  +L                V ++ + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
                  ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +   
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213

Query: 233 IVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAFLEEGT 283
               T G L     APE       T + DV+SFGV++ E+ T G  P   +         
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------- 264

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+ + +  +E + +D     C     N+++ +   C    PS+RPT  ++V+ L+
Sbjct: 265 -----VEELFKLLKEGHRMD-KPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

Query: 344 LI 345
            I
Sbjct: 315 RI 316

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (350), Expect = 7e-39
 Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 58/300 (19%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           F   ++IGSGGFG V++     D   + +KR+     +     ERE++A+  + H NIV 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68

Query: 131 LHGYYTSSQY---------------NLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
            +G +    Y                L I  E    G+L+ ++  +    + LD     +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALE 126

Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
           +     +G+ Y+H      +I+RD+K SNI L    + ++ DFGL T ++ +     +  
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182

Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ 294
            GT  Y++PE   +     + D+Y+ G++L ELL       E                  
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------------SKFFT 229

Query: 295 DKREEYVIDTSLEGCPINEINDVFS-----IASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
           D R+               I+D+F      +    L  +P  RP  +E+++ L + K   
Sbjct: 230 DLRD-------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  137 bits (348), Expect = 2e-38
 Identities = 55/294 (18%), Positives = 113/294 (38%), Gaps = 60/294 (20%)

Query: 75  KDVIGSGGFGTVYR--------LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
            + +G G F  +++              T   +K L +        F      M  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           ++V  +G       N+L+ E +  GSLDT+L     NK  ++   + ++A   A  + +L
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFL 129

Query: 187 HHDCIPHIIHRDIKSSNILLDQ--------NMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
             +    +IH ++ + NILL +            ++SD G++  +  +      I     
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI----- 181

Query: 239 GYLAPEYFDTGRA-TAKGDVYSFGVVLLELLT-GKRP---MDEA----FLEEGTKLVTWV 289
            ++ PE  +  +      D +SFG  L E+ + G +P   +D      F E+  +L    
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL---- 237

Query: 290 KAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                          + +   +       ++ + C++ EP  RP+   +++ L 
Sbjct: 238 --------------PAPKAAEL------ANLINNCMDYEPDHRPSFRAIIRDLN 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  138 bits (349), Expect = 2e-38
 Identities = 77/302 (25%), Positives = 116/302 (38%), Gaps = 59/302 (19%)

Query: 75  KDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FERELEAMGDI-KHR 126
              +G+G FG V   T         +   AVK L       +R     EL+ +  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR-------------- 172
           NIV L G  T     L+I E    G L  FL  K  +                       
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
              +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +    S 
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND----SN 200

Query: 233 IVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAFLEE 281
            V      L     APE       T + DV+S+G+ L EL + G  P     +D  F   
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258

Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
                   K + +  R       S E  P     +++ I   C + +P KRPT  ++V++
Sbjct: 259 --------KMIKEGFRML-----SPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 342 LE 343
           +E
Sbjct: 302 IE 303

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (347), Expect = 2e-38
 Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 27/280 (9%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLH-RGTTEVDRGF-ERELEAMGDIKHRN 127
            +     IG+G +G   ++   +D      K L     TE ++     E+  + ++KH N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 128 IVTLHGYYTSSQYNLL--IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           IV  +          L  + E    G L + +   +  ++ LD     ++       +  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 186 LH--HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
            H   D    ++HRD+K +N+ LD     ++ DFGLA ++  + +   T V GT  Y++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
           E  +      K D++S G +L EL     P    F             + + K       
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP----F--TAFSQKELAGKIREGKFR----- 234

Query: 304 TSLEGCPINEI--NDVFSIASMCLEPEPSKRPTMTEVVKM 341
                  I     +++  I +  L  +   RP++ E+++ 
Sbjct: 235 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  139 bits (352), Expect = 2e-38
 Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 56/300 (18%)

Query: 75  KDVIGSGGFGTVYR--------LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDI-K 124
              +G G FG V              ++   AVK L    TE D      E+E M  I K
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL------------HGKSVNKKNLDWPSR 172
           H+NI+ L G  T      +I E    G+L  +L                V ++ + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
                  ARG+ YL        IHRD+ + N+L+ +N   +++DFGLA  +     +   
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259

Query: 233 IVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAFLEEGT 283
               T G L     APE       T + DV+SFGV++ E+ T G  P   +         
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------- 310

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+ + +  +E + +D     C     N+++ +   C    PS+RPT  ++V+ L+
Sbjct: 311 -----VEELFKLLKEGHRMD-KPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLD 360

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  137 bits (347), Expect = 6e-38
 Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 30/268 (11%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHR---GTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  +    FA K + +              E+     + H+++V  HG
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAARGIAYLHHDCIP 192
           ++  + +  ++ EL    SL          +K L  P +RY +      G  YLH +   
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYL-RQIVLGCQYLHRN--- 160

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRD+K  N+ L++++E ++ DFGLAT +E +      +  GT  Y+APE       +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGHS 219

Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            + DV+S G ++  LL GK P + + L+E     T+++     K+ EY         P +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYS-------IPKH 263

Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                 S+    L+ +P+ RPT+ E++ 
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLN 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (345), Expect = 6e-38
 Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 46/295 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNI 128
            F     +G GGFG V+      D   +A+KR+     E+ R    RE++A+  ++H  I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 129 VTLHGYY---------TSSQYNLLIY---ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
           V     +           S   + +Y   +L    +L  +++G+    +  +      I 
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIF 124

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA- 235
           +  A  + +LH      ++HRD+K SNI    +   +V DFGL T M+ ++   + +   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 236 ----------GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL 285
                     GT  Y++PE       + K D++S G++L ELL         F  +  ++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------PFSTQMERV 234

Query: 286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            T        +  ++            +    + +    L P P +RP    +++
Sbjct: 235 RTLTDV----RNLKFPPL------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  137 bits (348), Expect = 1e-37
 Identities = 79/300 (26%), Positives = 121/300 (40%), Gaps = 56/300 (18%)

Query: 75  KDVIGSGGFGTVYRLTV--------NDSTAFAVKRLHRGTTEVDRG-FERELEAMGDI-K 124
              +G G FG V             N  T  AVK L    TE D      E+E M  I K
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL------------HGKSVNKKNLDWPSR 172
           H+NI+ L G  T      +I E    G+L  +L            +     ++ L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
              A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     +   
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247

Query: 233 IVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAFLEEGT 283
               T G L     APE       T + DV+SFGV+L E+ T G  P   +         
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------- 298

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V+ + +  +E + +D     C     N+++ +   C    PS+RPT  ++V+ L+
Sbjct: 299 -----VEELFKLLKEGHRMD-KPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  137 bits (346), Expect = 1e-37
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 55/302 (18%)

Query: 75  KDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRN 127
              IG G FG V++            T  AVK L    +   +  F+RE   M +  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL--------------------HGKSVNKKNL 167
           IV L G     +   L++E M  G L+ FL                       S     L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
               +  IA   A G+AYL        +HRD+ + N L+ +NM  +++DFGL+  + +  
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 228 THVSTIVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEE 281
            +     A     +      PE     R T + DV+++GVVL E+ + G +P      EE
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284

Query: 282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM 341
                     V+   R+  ++    E CP     +++++  +C    P+ RP+   + ++
Sbjct: 285 ----------VIYYVRDGNILA-CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRI 329

Query: 342 LE 343
           L+
Sbjct: 330 LQ 331

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  135 bits (342), Expect = 1e-37
 Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 30/268 (11%)

Query: 78  IGSGGFGTVYRLT-VNDSTAFAVKRLHR---GTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G GGF   + ++  +    FA K + +              E+     + H+++V  HG
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAARGIAYLHHDCIP 192
           ++  + +  ++ EL    SL          +K L  P +RY +      G  YLH +   
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYL-RQIVLGCQYLHRN--- 134

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
            +IHRD+K  N+ L++++E ++ DFGLAT +E +      +  GT  Y+APE       +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGHS 193

Query: 253 AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPIN 312
            + DV+S G ++  LL GK P + + L+E     T+++     K+ EY         P +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI----KKNEYS-------IPKH 237

Query: 313 EINDVFSIASMCLEPEPSKRPTMTEVVK 340
                 S+    L+ +P+ RPT+ E++ 
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLN 265

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  135 bits (343), Expect = 2e-37
 Identities = 67/312 (21%), Positives = 121/312 (38%), Gaps = 62/312 (19%)

Query: 75  KDVIGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRN 127
              +G G FG V +            T  AVK L    +  +      E   +  + H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFL--------------------HGKSVNKKNL 167
           ++ L+G  +     LLI E    GSL  FL                         +++ L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
                   A   ++G+ YL       ++HRD+ + NIL+ +  + ++SDFGL+  +  E 
Sbjct: 148 TMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 228 THVSTIVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAF 278
           ++    V  + G +     A E       T + DV+SFGV+L E++T G  P   +    
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP--- 257

Query: 279 LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
            E           +    +  + ++   + C      +++ +   C + EP KRP   ++
Sbjct: 258 PER----------LFNLLKTGHRME-RPDNCS----EEMYRLMLQCWKQEPDKRPVFADI 302

Query: 339 VKMLE-LIKSEK 349
            K LE ++   +
Sbjct: 303 SKDLEKMMVKRR 314

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (345), Expect = 2e-37
 Identities = 34/308 (11%), Positives = 80/308 (25%), Gaps = 48/308 (15%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLH---RGTTEVDRGFERELEAMGD 122
           +   K    + +  G    V+ +  V     FA+K        +            A   
Sbjct: 59  QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118

Query: 123 IKHRNIVTL-------------------------HGYYTSSQYNLLIYELMPNGSLDTF- 156
           +   +                              G    +  N L+     +  L+   
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178

Query: 157 --LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV 214
             L    V + +    + + +     R  A L       ++H      N+ +  +    +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLML 235

Query: 215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA--TAKGDVYSFGVVLLELLTGKR 272
            D         +        +    Y   E+ +   A  T   + +  G+ +  +     
Sbjct: 236 GDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291

Query: 273 PMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKR 332
           P     L       +W +  ++    + +   S    P    + V ++    L  +  +R
Sbjct: 292 PFG---LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP----DFVKTLIGRFLNFDRRRR 344

Query: 333 PTMTEVVK 340
               E ++
Sbjct: 345 LLPLEAME 352

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (343), Expect = 3e-37
 Identities = 73/298 (24%), Positives = 114/298 (38%), Gaps = 55/298 (18%)

Query: 75  KDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVDRG-FERELEAMGDI-KHR 126
              +G+G FG V   T       +     AVK L       ++     EL+ M  + +H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY----------KIA 176
           NIV L G  T     L+I E    G L  FL  KS   +     +              +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
              A+G+A+L      + IHRD+ + N+LL     A++ DFGLA  +  +    S  +  
Sbjct: 171 SQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVK 223

Query: 237 TFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAFLEEGTKL 285
               L     APE       T + DV+S+G++L E+ + G  P     ++  F       
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY------ 277

Query: 286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
               K V    +            P     +++SI   C   EP+ RPT  ++   L+
Sbjct: 278 ----KLVKDGYQMA-----QPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  135 bits (341), Expect = 5e-37
 Identities = 75/304 (24%), Positives = 119/304 (39%), Gaps = 47/304 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNI 128
           +   + V+  GGF  VY    V     +A+KRL     E +R   +E+  M  +  H NI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 129 VTLHGYYT-------SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           V      +       + Q   L+   +  G L  FL  K  ++  L   +  KI     R
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCR 147

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA------ 235
            + ++H    P IIHRD+K  N+LL      ++ DFG AT +     +  +         
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 236 -----GTFGYLAPEYFDTGR---ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT 287
                 T  Y  PE  D         K D+++ G +L  L   + P    F E+G KL  
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----F-EDGAKL-- 259

Query: 288 WVKAVMQDKREEYVIDTSLEGCPINEI--NDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
               ++  K   Y I       P ++       S+    L+  P +R ++ EVV  L+ I
Sbjct: 260 ---RIVNGK---YSI-------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

Query: 346 KSEK 349
            + +
Sbjct: 307 AAAR 310

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  134 bits (339), Expect = 6e-37
 Identities = 73/299 (24%), Positives = 113/299 (37%), Gaps = 54/299 (18%)

Query: 75  KDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FERELEAMGDI-KHR 126
              +G G FG V                 AVK L  G T  +      EL+ +  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 127 NIVTLHGYYT-SSQYNLLIYELMPNGSLDTFL------------HGKSVNKKNLDWPSRY 173
           N+V L G  T      ++I E    G+L T+L              + + K  L      
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 174 KIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI 233
             +   A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +       
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDY 204

Query: 234 VAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP---MDEAFLEEGTK 284
           V      L     APE       T + DV+SFGV+L E+ + G  P   +     EE   
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE--- 259

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                    +  +E   +  + +        +++     C   EPS+RPT +E+V+ L 
Sbjct: 260 -------FCRRLKEGTRMR-APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLG 306

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (335), Expect = 1e-36
 Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 52/282 (18%)

Query: 75  KDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           + V+G G +G VY    +++    A+K +    +   +    E+     +KH+NIV   G
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 134 YYTSSQYNLLIY-ELMPNGSLDTFL---HGKSVNKKNLDWPSRYKIAVGAA---RGIAYL 186
            ++ + + + I+ E +P GSL   L    G   + +         I         G+ YL
Sbjct: 87  SFSENGF-IKIFMEQVPGGSLSALLRSKWGPLKDNEQT-------IGFYTKQILEGLKYL 138

Query: 187 HHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           H +    I+HRDIK  N+L++  +   ++SDFG +  +        T   GT  Y+APE 
Sbjct: 139 HDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEI 194

Query: 246 FDTGR--ATAKGDVYSFGVVLLELLTGKRP---MDEAFLEEGTKLVTWVKAVMQDKREEY 300
            D G        D++S G  ++E+ TGK P   + E              A M      +
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------------AAM------F 236

Query: 301 VIDTSLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
            +    +  P  EI +  S         C EP+P KR    +
Sbjct: 237 KVGMF-KVHP--EIPESMSAEAKAFILKCFEPDPDKRACAND 275

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  132 bits (334), Expect = 2e-36
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 39/273 (14%)

Query: 78  IGSGGFGTVYRLTVNDS-TAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHG 133
           +G G F  VYR     +    A+K + +       + +  + E++    +KH +I+ L+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
           Y+  S Y  L+ E+  NG ++ +L  +   K   +  +R+ +      G+ YLH      
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMH-QIITGMLYLHSH---G 132

Query: 194 IIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATA 253
           I+HRD+  SN+LL +NM  +++DFGLAT ++       T+  GT  Y++PE         
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPEIATRSAHGL 191

Query: 254 KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINE 313
           + DV+S G +   LL G+ P D   ++     V            +Y         P   
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---------VLADYE-------MPSF- 234

Query: 314 INDVFS------IASMCLEPEPSKRPTMTEVVK 340
                S      I  + L   P+ R +++ V+ 
Sbjct: 235 ----LSIEAKDLIHQL-LRRNPADRLSLSSVLD 262

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  132 bits (335), Expect = 4e-36
 Identities = 71/315 (22%), Positives = 118/315 (37%), Gaps = 62/315 (19%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDRG-FEREL 117
             ++ L+F    V+GSG FG V   T         S   AVK L       +R     EL
Sbjct: 42  FPRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99

Query: 118 EAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRY- 173
           + M  +  H NIV L G  T S    LI+E    G L  +L    +  ++  +++ ++  
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159

Query: 174 ----------------KIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF 217
                             A   A+G+ +L        +HRD+ + N+L+      ++ DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDF 216

Query: 218 GLATLMEAEKTHVSTIVAGTFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GK 271
           GLA  + ++    S  V      L     APE    G  T K DV+S+G++L E+ + G 
Sbjct: 217 GLARDIMSD----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272

Query: 272 RP---MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPE 328
            P   +                   +  +  + +D            +++ I   C   +
Sbjct: 273 NPYPGIPVD--AN----------FYKLIQNGFKMD-QPFYAT----EEIYIIMQSCWAFD 315

Query: 329 PSKRPTMTEVVKMLE 343
             KRP+   +   L 
Sbjct: 316 SRKRPSFPNLTSFLG 330

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 6e-36
 Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 23/208 (11%)

Query: 76  DVIGSGGFGTVYRLTVNDST---AFAVKRLHRGTTE----VDRGFERELEAMGDIKHRNI 128
            ++G GG G VY     D+      A+K +    +       R  +RE    G ++  ++
Sbjct: 40  RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHV 96

Query: 129 VTLH--GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           V +H  G      Y  +   L+    L   L  +      L  P    I       +   
Sbjct: 97  VPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAA 150

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK-THVSTIVAGTFGYLAPEY 245
           H        HRD+K  NIL+  +  A + DFG+A+    EK T +   V GT  Y+APE 
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPER 206

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
           F    AT + D+Y+   VL E LTG  P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (332), Expect = 1e-35
 Identities = 65/281 (23%), Positives = 103/281 (36%), Gaps = 49/281 (17%)

Query: 72  FSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
            + +  +G G FG V+R          AVK++      ++     EL A   +    IV 
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVP 114

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L+G      +  +  EL+  GSL   +         L           A  G+ YLH   
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR- 169

Query: 191 IPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI----VAGTFGYLAPEY 245
              I+H D+K+ N+LL  +   A + DFG A  ++ +    S +    + GT  ++APE 
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK----AVMQDKREEYV 301
                  AK D++S   ++L +L G  P              W +     +         
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP--------------WTQYFRGPLC------LK 267

Query: 302 IDTSLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
           I +  E  PI EI    +          L  EP  R +  E
Sbjct: 268 IAS--EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  136 bits (343), Expect = 1e-35
 Identities = 42/207 (20%), Positives = 73/207 (35%), Gaps = 26/207 (12%)

Query: 76  DVIGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTL 131
             I  GG G +Y      VN      +K L        +     E + + ++ H +IV +
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 132 H--GYYTSSQYNLLIY---ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
                +T    + + Y   E +   SL      K      L         +     ++YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYL 198

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +++ D+K  NI+L +  + ++ D G  + +         +  GT G+ APE  
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEI- 248

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRP 273
                T   D+Y+ G  L  L      
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPT 275

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  132 bits (333), Expect = 4e-35
 Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 46/296 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIV 129
              S+ ++G G  GTV           AVKR+     ++      E++ + +   H N++
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI---ALMEIKLLTESDDHPNVI 72

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARGIAYL 186
             +   T+ ++  +  EL  N +L   +  K+V+ +NL     Y         A G+A+L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 187 HHDCIPHIIHRDIKSSNILLD-------------QNMEARVSDFGLATLMEAEKTHVSTI 233
           H      IIHRD+K  NIL+              +N+   +SDFGL   +++ ++   T 
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 234 ---VAGTFGYLAPEYFD-------TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEG 282
               +GT G+ APE  +         R T   D++S G V   +L+ GK P  + +  E 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                         R  + +D        + I +   + S  ++ +P KRPT  +V
Sbjct: 248 ----------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  130 bits (329), Expect = 4e-35
 Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 43/294 (14%)

Query: 76  DVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGF-ERELEAMGDIKHRNIVTLHG 133
             +G+G  G V++++        A K +H       R    REL+ + +     IV  +G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAARGIAYLHHDCI 191
            + S     +  E M  GSLD  L      KK    P +   K+++   +G+ YL     
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREKH- 151

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I+HRD+K SNIL++   E ++ DFG++   +   +  ++ V GT  Y++PE       
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHY 207

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS------ 305
           + + D++S G+ L+E+  G+ P+     +E   +          +               
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 306 -----------------LEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
                            +   P    + VFS+      + CL   P++R  + +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (327), Expect = 6e-35
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 43/296 (14%)

Query: 77  VIGSGGFGTVYRLTVNDSTAFAVKRLHR-----------------GTTEVDRGFERELEA 119
            +  G F  +  L   D+  +A+K+  +                         F+ EL+ 
Sbjct: 38  TLNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           + DIK+   +T  G  T+     +IYE M N S+  F     V  KN       ++    
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 180 AR----GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
            +      +Y+H++   +I HRD+K SNIL+D+N   ++SDFG +  M  +K   S    
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211

Query: 236 GTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
           GT+ ++ PE+F        AK D++S G+ L  +     P    F  + + +  +     
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVELFNNIRT 267

Query: 294 QDKR---EEYVIDTSLEGCPINEINDVFS------IASMCLEPEPSKRPTMTEVVK 340
           ++     +       L        N+  S      +    L   P++R T  + +K
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-LRKNPAERITSEDALK 322

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (320), Expect = 2e-34
 Identities = 73/269 (27%), Positives = 111/269 (41%), Gaps = 32/269 (11%)

Query: 77  VIGSGGFGTVYRLTVNDSTAF--AVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTL 131
            +G G FG VY L     + F  A+K L +       V+    RE+E    ++H NI+ L
Sbjct: 16  PLGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           +GY+  +    LI E  P G++   L          D           A  ++Y H    
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK-- 128

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             +IHRDIK  N+LL    E +++DFG +    + +     +  GT  YL PE  +    
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DLC-GTLDYLPPEMIEGRMH 184

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
             K D++S GV+  E L GK P    F E  T   T+ +    +              P 
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP----F-EANTYQETYKRISRVEFT-----------FPD 228

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                   + S  L+  PS+RP + EV++
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREVLE 257

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  128 bits (323), Expect = 2e-34
 Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 40/285 (14%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKH--R 126
            +S    IGSGG   V+++       +A+K   L     +    +  E+  +  ++    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            I+ L+ Y  + QY  ++ E   N  L+++L      KK++D   R          +  +
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--STIVAGTFGYLAPE 244
           H      I+H D+K +N L+   M  ++ DFG+A  M+ + T V   + V GT  Y+ PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE 179

Query: 245 -----------YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
                           + + K DV+S G +L  +  GK P  +         ++ + A++
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAII 234

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
                 + I+      P     D+  +   CL+ +P +R ++ E+
Sbjct: 235 DPN---HEIE-----FPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (320), Expect = 2e-34
 Identities = 55/300 (18%), Positives = 111/300 (37%), Gaps = 53/300 (17%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            F    V+G G FG V +     DS  +A+K++     ++      E+  +  + H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST-ILSEVMLLASLNHQYVV 65

Query: 130 TLHGYYTSSQYNLL----------IY---ELMPNGSL-DTFLHGKSVNKKNLDWPSRYKI 175
             +  +   +  +           ++   E   NG+L D         +++  W    ++
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RL 121

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
                  ++Y+H      IIHRD+K  NI +D++   ++ DFGLA  +      +     
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 236 -------------GTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE 281
                        GT  Y+A E    TG    K D+YS G++  E++       E     
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME----- 233

Query: 282 GTKLVTWVKAVMQD-KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                     +++  +          +   +     +  I  + ++ +P+KRP    ++ 
Sbjct: 234 -------RVNILKKLRSVSIEFPPDFDDNKMKVEKKI--IRLL-IDHDPNKRPGARTLLN 283

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (320), Expect = 3e-34
 Identities = 63/280 (22%), Positives = 120/280 (42%), Gaps = 40/280 (14%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRN--IVTL 131
             IGSGG   V+++       +A+K   L     +    +  E+  +  ++  +  I+ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           + Y  + QY  ++ E   N  L+++L      KK++D   R          +  +H    
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 146

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--STIVAGTFGYLAPE----- 244
             I+H D+K +N L+   M  ++ DFG+A  M+ + T V   + V GT  Y+ PE     
Sbjct: 147 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDM 203

Query: 245 ------YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
                      + + K DV+S G +L  +  GK P    F ++    ++ + A++     
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----F-QQIINQISKLHAIIDPN-- 256

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
            + I+      P     D+  +   CL+ +P +R ++ E+
Sbjct: 257 -HEIE-----FPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (323), Expect = 4e-34
 Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 40/295 (13%)

Query: 61  QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKR--LHRGTTEVDRGFERELE 118
            ++ I  K   +S    IGSGG   V+++       +A+K   L     +    +  E+ 
Sbjct: 47  ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106

Query: 119 AMGDIKH--RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
            +  ++     I+ L+ Y  + QY  ++ E   N  L+++L      KK++D   R    
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL----KKKKSIDPWERKSYW 161

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--STIV 234
                 +  +H      I+H D+K +N L+   M  ++ DFG+A  M+ + T V   + V
Sbjct: 162 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV 217

Query: 235 AGTFGYLAPE-----------YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT 283
            G   Y+ PE                + + K DV+S G +L  +  GK P  +       
Sbjct: 218 -GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----I 271

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
             ++ + A++     E       E        D+  +   CL+ +P +R ++ E+
Sbjct: 272 NQISKLHAIIDPN-HEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPEL 318

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  127 bits (320), Expect = 1e-33
 Identities = 39/320 (12%), Positives = 87/320 (27%), Gaps = 76/320 (23%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG---TTEVDRGFERELEAMGD 122
           ++        V+G          T      +F V   +      +   +  + E+  +  
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 123 IK-------------------------HRNIVTLHGYYTSSQYNLLIYELMP-----NGS 152
           ++                          + ++ +        + L  + L P       +
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE-RDMWVLSRFFLYPRMQSNLQT 188

Query: 153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA 212
               L   S   K+L   +R ++ +   R +A LHH     ++H  ++  +I+LDQ    
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGV 245

Query: 213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-----------GRATAKGDVYSFG 261
            ++ F       A         + + G+  PE                  T   D ++ G
Sbjct: 246 FLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 262 VVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP-INEINDVFSI 320
           +V+  +     P                             +     C  I +   V ++
Sbjct: 301 LVIYWIWCADLP----I---------------TKDAALGGSEWIFRSCKNIPQ--PVRAL 339

Query: 321 ASMCLEPEPSKRPTMTEVVK 340
               L      R    + ++
Sbjct: 340 LEGFLRYPKEDRLLPLQAME 359

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 1e-33
 Identities = 67/311 (21%), Positives = 113/311 (36%), Gaps = 39/311 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHR-GTTEVDRGFERELEAMGDIKHRNI 128
           +   D++G G    V+    +  T   FA+K  +            RE E +  + H+NI
Sbjct: 11  WLLSDILGQGATANVF-RGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 129 VTLHGYY--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           V L      T++++ +LI E  P GSL T L   S N   L       +      G+ +L
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHL 128

Query: 187 HHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
             +    I+HR+IK  NI+     D     +++DFG A  +E +     ++  GT  YL 
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183

Query: 243 PEYFDTGRA--------TAKGDVYSFGVVLLELLTGKRP--------MDEAFLEEGTKLV 286
           P+ ++             A  D++S GV      TG  P         ++  + +     
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFS------IASMCLEPEPSKRPTMTEVVK 340
                    K E   ID S +      ++          +A++ LE +  K     +   
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-LEADQEKCWGFDQFFA 302

Query: 341 MLELIKSEKVV 351
               I      
Sbjct: 303 ETSDILHRGNS 313

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  124 bits (314), Expect = 1e-33
 Identities = 67/298 (22%), Positives = 116/298 (38%), Gaps = 40/298 (13%)

Query: 69  TLKFSSKD-----VIGSGGFGTVYR-LTVNDSTAFAVKRLHR-GTTEVDRGFERELE-AM 120
           +++  + D      +G G +G V +   V      AVKR+     ++  +    +L+ +M
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 121 GDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
             +     VT +G         +  ELM + SLD F        + +      KIAV   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           + + +LH      +IHRD+K SN+L++   + ++ DFG++            I AG   Y
Sbjct: 120 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPY 175

Query: 241 LAPEYFDTGRA----TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK 296
           +APE  +        + K D++S G+ ++EL   + P D                  Q  
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW------------GTPFQ-- 221

Query: 297 REEYVIDTSLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTEVVKMLELIKSEK 349
                +   +E        D FS       S CL+    +RPT  E+++       E 
Sbjct: 222 ----QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  124 bits (313), Expect = 2e-33
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 76  DVIGSGGFGTVY-----RL--TVNDSTAFAVKRLHRGTTE----VDRGFERELEAMGDIK 124
           D +G GG  TVY      L   V      A+K +     E    + R FERE+     + 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKV------AIKAIFIPPREKEETLKR-FEREVHNSSQLS 69

Query: 125 HRNIVTLH--GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           H+NIV++          Y  L+ E +   +L  ++     +   L   +          G
Sbjct: 70  HQNIVSMIDVDEEDDCYY--LVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDG 123

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYL 241
           I + H      I+HRDIK  NIL+D N   ++ DFG+A  L E   T  + ++ GT  Y 
Sbjct: 124 IKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYF 179

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           +PE           D+YS G+VL E+L G+ P
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  123 bits (312), Expect = 5e-33
 Identities = 66/305 (21%), Positives = 104/305 (34%), Gaps = 37/305 (12%)

Query: 43  SVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKR 101
           S  G      +SP     + ++ F++   F     +G G +G V++  +  D   +AVKR
Sbjct: 32  SFRGEASETLQSPGYDPSRPESFFQQ--SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89

Query: 102 L---HRGTTEVDRGF--ERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTF 156
                RG  +  R        E +G   H   V L   +       L  EL    SL   
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQ--HPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146

Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
                    +L     +         +A+LH      ++H D+K +NI L      ++ D
Sbjct: 147 C---EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGD 200

Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE 276
           FGL   +            G   Y+APE    G      DV+S G+ +LE+         
Sbjct: 201 FGLLVEL-GTAGAGEVQE-GDPRYMAPELL-QGSYGTAADVFSLGLTILEVACNMELPHG 257

Query: 277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMT 336
                      W +        E+    S E           S+  M LEP+P  R T  
Sbjct: 258 GE--------GWQQLRQGYLPPEFTAGLSSELR---------SVLVMMLEPDPKLRATAE 300

Query: 337 EVVKM 341
            ++ +
Sbjct: 301 ALLAL 305

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (315), Expect = 7e-33
 Identities = 68/311 (21%), Positives = 116/311 (37%), Gaps = 39/311 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNI 128
           +   D++G G    V+    +  T   FA+K  +  +         RE E +  + H+NI
Sbjct: 11  WLLSDILGQGATANVF-RGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 129 VTLHGYY--TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           V L      T++++ +LI E  P GSL T L   S N   L       +      G+ +L
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHL 128

Query: 187 HHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
             +    I+HR+IK  NI+     D     +++DFG A  +E +     ++  GT  YL 
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183

Query: 243 PEYFDTGRA--------TAKGDVYSFGVVLLELLTGKRP--------MDEAFLEEGTKLV 286
           P+ ++             A  D++S GV      TG  P         ++  + +     
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFS------IASMCLEPEPSKRPTMTEVVK 340
                    K E   ID S +      ++          +A++ LE +  K     +   
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-LEADQEKCWGFDQFFA 302

Query: 341 MLELIKSEKVV 351
               I    V+
Sbjct: 303 ETSDILHRMVI 313

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (311), Expect = 3e-32
 Identities = 34/314 (10%), Positives = 78/314 (24%), Gaps = 65/314 (20%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH 125
           ++        V+G          T      +F V   +          ++  E +  ++ 
Sbjct: 75  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134

Query: 126 --------------------------------RNIVTLHGYYTSSQYNLLIYELMPNGSL 153
                                           R  +     +  S++ L         + 
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194

Query: 154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR 213
              L   S   K+L   +R ++ +   R +A LHH     ++H  ++  +I+LDQ     
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVF 251

Query: 214 VSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-----YFDTGRATAKGDVYSFGVVLLELL 268
           ++ F       A                A              T   D ++ G+ +  + 
Sbjct: 252 LTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 269 TGKRPMDEAFLEEGTKLVTWVKAVMQDKRE--EYVIDTSLEGCPINEINDVFSIASMCLE 326
               P            +   + + +  +   + V                  +    L 
Sbjct: 312 CADLP----N--TDDAALGGSEWIFRSCKNIPQPVRA----------------LLEGFLR 349

Query: 327 PEPSKRPTMTEVVK 340
                R    + ++
Sbjct: 350 YPKEDRLLPLQAME 363

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (305), Expect = 4e-32
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 35/217 (16%)

Query: 76  DVIGSGGFGTVY-----RL--TVNDSTAFAVKRLHRGTTE----VDRGFERELEAMGDIK 124
           +++G GG   V+     R    V      AVK L            R F RE +    + 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDV------AVKVLRADLARDPSFYLR-FRREAQNAAALN 70

Query: 125 HRNIVTLH------GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
           H  IV ++             Y  ++ E +   +L   +H     +  +      ++   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPY--IVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIAD 124

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--STIVAG 236
           A + + + H +    IIHRD+K +NI++      +V DFG+A  +      V  +  V G
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           T  YL+PE        A+ DVYS G VL E+LTG+ P
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (302), Expect = 6e-32
 Identities = 63/271 (23%), Positives = 98/271 (36%), Gaps = 36/271 (13%)

Query: 77  VIGSGGFGTVYRLTVNDSTAF--AVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTL 131
            +G G FG VY L       F  A+K L +       V+    RE+E    ++H NI+ +
Sbjct: 21  PLGKGKFGNVY-LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           + Y+   +   L+ E  P G L   L          D           A  + Y H    
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER-- 133

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             +IHRDIK  N+L+    E +++DFG +    + +        GT  YL PE  +    
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPEMIEGKTH 189

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK--REEYVIDTSLEGC 309
             K D++  GV+  E L G  P D     E              +    +          
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----------THRRIVNVDLK-------F 231

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           P    +    + S  L   P +R  +  V++
Sbjct: 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  120 bits (304), Expect = 8e-32
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 13/209 (6%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRG-FERELE-AMGDIKHRNIVTLH 132
             IG G +G+V + +        AVKR+     E ++     +L+  M       IV  +
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLH-GKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           G         +  ELM + S D F     SV    +      KI +   + + +L  +  
Sbjct: 88  GALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             IIHRDIK SNILLD++   ++ DFG++   +   +   T  AG   Y+APE  D   +
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 252 ----TAKGDVYSFGVVLLELLTGKRPMDE 276
                 + DV+S G+ L EL TG+ P  +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPK 231

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (294), Expect = 1e-30
 Identities = 51/297 (17%), Positives = 99/297 (33%), Gaps = 56/297 (18%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGT-TEVDRGF----ERELEAMGDIK 124
           +F   + IGSG FG+V++ +   D   +A+KR  +     VD             +G   
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ-- 69

Query: 125 HRNIVTLHGYYTSSQYNLLIY-ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
           H ++V     +    + +LI  E    GSL   +                 + +   RG+
Sbjct: 70  HSHVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVS-------------------DFGLATLME 224
            Y+H      ++H DIK SNI + +      +                   D G  T + 
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 225 AEKTHVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT 283
           + +        G   +LA E   +      K D+++  + ++     +            
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                   + Q +         +      E  ++     + + P+P +RP+   +VK
Sbjct: 237 -----WHEIRQGRLPR------IPQVLSQEFTELL---KVMIHPDPERRPSAMALVK 279

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  116 bits (293), Expect = 2e-30
 Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 38/275 (13%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDR-GFERELEA-MGDIKHRNIVTLH 132
             +GSG  G V++          AVK++ R   + +      +L+  +       IV   
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
           G + ++    +  ELM     +     K   +  +      K+ V   + + YL      
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK--H 144

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA- 251
            +IHRD+K SNILLD+  + ++ DFG++  +           AG   Y+APE  D     
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 252 ----TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                 + DV+S G+ L+EL TG+ P             T  + + +  +EE        
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYK--------NCKTDFEVLTKVLQEE-------- 246

Query: 308 GCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
             P+   +  FS         CL  +  KRP   +
Sbjct: 247 -PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (302), Expect = 3e-30
 Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 41/291 (14%)

Query: 75  KDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNIVTL 131
           K+ +G+GGFG V    ++  T    A+K+  +  +  +R  +  E++ M  + H N+V+ 
Sbjct: 19  KERLGTGGFGYVL-RWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 132 H------GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
                       +   LL  E    G L  +L+ +  N   L       +    +  + Y
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRY 136

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEAR---VSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           LH +    IIHRD+K  NI+L    +     + D G A  ++ +    +  V GT  YLA
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLA 191

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
           PE  +  + T   D +SFG +  E +TG RP    +       V W    +++K  E+++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHG-KVREKSNEHIV 245

Query: 303 DTSLEGCPINEINDVFS---------------IASMCLEPEPSKRPTMTEV 338
                   +   + + +               +  M L     +R T  + 
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM-LMWHQRQRGTDPQN 295

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (287), Expect = 1e-29
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 46/303 (15%)

Query: 51  MFRSPLIHSLQSDAIFKK--TLKFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKR--LHRG 105
           M  SP+   L      K      F+  + IG G FG V++ +        A+K   L   
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60

Query: 106 TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKK 165
             E++   ++E+  +       +   +G Y       +I E +  GS    L    +++ 
Sbjct: 61  EDEIE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET 119

Query: 166 NLDWPSRYKIAV---GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
                   +IA       +G+ YLH +     IHRDIK++N+LL ++ E +++DFG+A  
Sbjct: 120 --------QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168

Query: 223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG 282
           +   +   +T V GT  ++APE        +K D++S G+  +EL  G+ P  E      
Sbjct: 169 LTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE------ 221

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
                     +   +  ++I  +        +   +S         CL  EPS RPT  E
Sbjct: 222 ----------LHPMKVLFLIPKN----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 267

Query: 338 VVK 340
           ++K
Sbjct: 268 LLK 270

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  115 bits (289), Expect = 8e-29
 Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 40/296 (13%)

Query: 57  IHSLQSDAIFKKTLKFSSK----DVIGSGGFGTVYRLTVNDS-TAFAVKRLHRG--TTEV 109
           + +     I  K    S        +GSG +G V       +    A+K + +   +T  
Sbjct: 20  LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79

Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLD 168
           +     E+  +  + H NI+ L+ ++   +   L+ E    G L D     + +++   +
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD-----EIIHRMKFN 134

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEA 225
                 I      G+ YLH     +I+HRD+K  N+LL   +++   ++ DFGL+ +   
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-- 189

Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL 285
           E         GT  Y+APE     +   K DV+S GV+L  LL G  P    F  +  + 
Sbjct: 190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP----FGGQTDQE 244

Query: 286 VTWVKAVMQDK---REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
           +  ++ V + K         + S          D+  I  M L+ +  +R +  + 
Sbjct: 245 I--LRKVEKGKYTFDSPEWKNVS------EGAKDL--IKQM-LQFDSQRRISAQQA 289

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (285), Expect = 1e-28
 Identities = 57/313 (18%), Positives = 97/313 (30%), Gaps = 54/313 (17%)

Query: 71  KFSSKDVIGSG--GFGTVYR-LTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKH 125
            +    VIG G     TV             V+R  L   + E+    + EL       H
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARG 182
            NIV     + +     ++   M  GS    +   +     ++  +   IA    G  + 
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELA---IAYILQGVLKA 140

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI------VAG 236
           + Y+HH      +HR +K+S+IL+  + +  +S       M +       +         
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 237 TFGYLAPEYFDTGRA--TAKGDVYSFGVVLLELLTGKRPM-------------------- 274
              +L+PE          AK D+YS G+   EL  G  P                     
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 275 -----DEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIA-----SMC 324
                  A     +   +   + + D         S    P +  +  FS         C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 325 LEPEPSKRPTMTE 337
           L+  P  RP+ + 
Sbjct: 318 LQRNPDARPSAST 330

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (288), Expect = 1e-28
 Identities = 76/296 (25%), Positives = 119/296 (40%), Gaps = 39/296 (13%)

Query: 57  IHSLQSDAIFKKTLKFSSK----DVIGSGGFGTVYRLTVNDS-TAFAVKRLHR---GTTE 108
           +H+     +   T  FS +     V+G G FG V       +    AVK + +       
Sbjct: 9   LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT 68

Query: 109 VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNL 167
                 RE++ +  + H NI+ L+ ++    Y  L+ E+   G L D     + +++K  
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD-----EIISRKRF 123

Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLME 224
                 +I      GI Y+H +    I+HRD+K  N+LL    ++   R+ DFGL+T   
Sbjct: 124 SEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF- 179

Query: 225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
            E +       GT  Y+APE    G    K DV+S GV+L  LL+G  P    F      
Sbjct: 180 -EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP----FNGANEY 233

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPI--NEINDVFSIASMCLEPEPSKRPTMTEV 338
            +  +K V + K         L           D+  I  M L   PS R +  + 
Sbjct: 234 DI--LKKVEKGK-----YTFELPQWKKVSESAKDL--IRKM-LTYVPSMRISARDA 279

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  110 bits (277), Expect = 5e-28
 Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 48/295 (16%)

Query: 74  SKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVT 130
            +DV+G G    V    +N  T   +AVK + +    +     RE+E +   + HRN++ 
Sbjct: 17  QEDVLGEGAHARVQT-CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAAR----GIA 184
           L  ++       L++E M  GS+ + +H +            +    A    +     + 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----------HFNELEASVVVQDVASALD 125

Query: 185 YLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVS------TIVA 235
           +LH+     I HRD+K  NIL    +Q    ++ DF L + ++                 
Sbjct: 126 FLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 236 GTFGYLAPEYFDTGRATAKG-----DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK 290
           G+  Y+APE  +     A       D++S GV+L  LL+G  P    F+        W +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGSDCGWDR 238

Query: 291 AVMQDKREEYVIDTSLEGC---PINEINDVFSIA----SMCLEPEPSKRPTMTEV 338
                  +  + ++  EG    P  +   +   A    S  L  +  +R +  +V
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 6e-28
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 42/291 (14%)

Query: 72  FSSKDVIGSGGFGTVYR-LTVNDSTAFAVKR--LHRGTTEVDRGFERELEAMGDIKHRNI 128
           +  ++VIGSG    V            A+KR  L +  T +D    +E++AM    H NI
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNI 75

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAV---GAARGIA 184
           V+ +  +       L+ +L+  GS+   +       ++         IA        G+ 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF-G---Y 240
           YLH +     IHRD+K+ NILL ++   +++DFG++  +          V  TF G   +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 241 LAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           +APE  +  R    K D++SFG+  +EL TG  P  +       K       V+      
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK---YPPMK-------VL------ 236

Query: 300 YVIDTS----LEG-CPINEINDVFSIA-----SMCLEPEPSKRPTMTEVVK 340
            +   +    LE      E+   +  +     S+CL+ +P KRPT  E+++
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (277), Expect = 8e-28
 Identities = 40/222 (18%), Positives = 70/222 (31%), Gaps = 22/222 (9%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDST------AFAVKRLHRGTTEVDRGFERELEAMGDIK 124
                 ++G G F  VY  T  D         F +K              + +E +    
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL-HGKSVNKKNLDWPSRYKIAVGAARGI 183
               +  +  +     ++L+ EL   G+L   +   K+  +K +        A+     I
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 184 AYLHHDCIPHIIHRDIKSSNILL-----------DQNMEARVSDFGLATLMEA-EKTHVS 231
             +H      IIH DIK  N +L           D +    + D G +  M+   K  + 
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           T    T G+   E         + D +     +  +L G   
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (281), Expect = 1e-27
 Identities = 75/295 (25%), Positives = 120/295 (40%), Gaps = 40/295 (13%)

Query: 58  HSLQSDAIFKKTLKFSSK----DVIGSGGFGTVYRLTVNDS-TAFAVKRLHRG--TTEVD 110
           H             F+ +     ++G G FG V +     +   +AVK +++     +  
Sbjct: 6   HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 111 RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDW 169
               RE+E +  + H NI+ L      S    ++ EL   G L D     + + +K    
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD-----EIIKRKRFSE 120

Query: 170 PSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAE 226
               +I      GI Y+H     +I+HRD+K  NILL   +++ + ++ DFGL+T    +
Sbjct: 121 HDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--Q 175

Query: 227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV 286
           +        GT  Y+APE    G    K DV+S GV+L  LL+G  P    F  +    +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP----FYGKNEYDI 230

Query: 287 TWVKAVMQDK---REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
             +K V   K           S      ++  D+  I  M L   PS R T T+ 
Sbjct: 231 --LKRVETGKYAFDLPQWRTIS------DDAKDL--IRKM-LTFHPSLRITATQC 274

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (274), Expect = 3e-27
 Identities = 66/299 (22%), Positives = 112/299 (37%), Gaps = 38/299 (12%)

Query: 54  SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVK----RLHRGTTE 108
             ++     D +F+    +   +VIG G F  V R    ++   FAVK         +  
Sbjct: 10  GGILDMADDDVLFED--VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG 67

Query: 109 VDR-GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKN 166
           +     +RE      +KH +IV L   Y+S     +++E M    L       + V + +
Sbjct: 68  LSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF-----EIVKRAD 122

Query: 167 LDWPSRYKIAVGAAR----GIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGL 219
             +     +A    R     + Y H +   +IIHRD+K   +LL   + +   ++  FG+
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179

Query: 220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL 279
           A  +          V GT  ++APE           DV+  GV+L  LL+G  P    F 
Sbjct: 180 AIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FY 234

Query: 280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
               +L   +               S          D+  +  M L  +P++R T+ E 
Sbjct: 235 GTKERLFEGIIKGKYKMNPRQWSHISESA------KDL--VRRM-LMLDPAERITVYEA 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (278), Expect = 3e-27
 Identities = 73/307 (23%), Positives = 118/307 (38%), Gaps = 51/307 (16%)

Query: 57  IHSLQSDAIFKKTLKFSSK----DVIGSGGFGTVYRLTVNDS-TAFAVKRLHR------- 104
           I       + KK  K          +GSG +G V      +  +  A+K + +       
Sbjct: 19  IAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR 78

Query: 105 ------GTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFL 157
                    +       E+  +  + H NI+ L   +   +Y  L+ E    G L +   
Sbjct: 79  YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE--- 135

Query: 158 HGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARV 214
             + +N+   D      I      GI YLH     +I+HRDIK  NILL   +  +  ++
Sbjct: 136 --QIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI 190

Query: 215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
            DFGL++     K +      GT  Y+APE     +   K DV+S GV++  LL G  P 
Sbjct: 191 VDFGLSSFF--SKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP- 246

Query: 275 DEAFLEEGTKLVTWVKAVMQDK---REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSK 331
              F  +  + +  +K V + K         + S      +E  ++  I  M L  + +K
Sbjct: 247 ---FGGQNDQDI--IKKVEKGKYYFDFNDWKNIS------DEAKEL--IKLM-LTYDYNK 292

Query: 332 RPTMTEV 338
           R T  E 
Sbjct: 293 RCTAEEA 299

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (275), Expect = 3e-27
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 29/216 (13%)

Query: 75  KDVIGSGGFGTVYRLTVNDST--AFAVKRLHR--------GTTEVDRGFERELEAMGDIK 124
              +GSG  G V  L     T    A++ + +           +     E E+E +  + 
Sbjct: 140 SKTLGSGACGEVK-LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
           H  I+ +  ++ +  Y + + ELM  G L D     K V  K L   +           +
Sbjct: 199 HPCIIKIKNFFDAEDYYI-VLELMEGGELFD-----KVVGNKRLKEATCKLYFYQMLLAV 252

Query: 184 AYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
            YLH +    IIHRD+K  N+LL   +++   +++DFG + ++  E + + T+  GT  Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTY 307

Query: 241 LAPEYFDTGRATAKG---DVYSFGVVLLELLTGKRP 273
           LAPE   +          D +S GV+L   L+G  P
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (268), Expect = 5e-27
 Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 28/296 (9%)

Query: 51  MFRSPLIHSLQSDAIFKKTLK--FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTT 107
           M       S + +  F+ T+   F  K  +GSG FG V+ +    S     +K +++  +
Sbjct: 1   MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60

Query: 108 EVDR-GFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN 166
           +V     E E+E +  + H NI+ +   +       ++ E    G L   +       K 
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120

Query: 167 LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLM 223
           L      ++       +AY H     H++H+D+K  NIL      +   ++ DFGLA L 
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177

Query: 224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT 283
           ++++    T  AGT  Y+APE F     T K D++S GVV+  LLTG  P    F     
Sbjct: 178 KSDEHS--TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP----FTGTSL 230

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPI-NEINDVFSIASMCLEPEPSKRPTMTEV 338
           + V   +     +      + ++E  P+  +  D+  +  M L  +P +RP+  +V
Sbjct: 231 EEV--QQKATYKE-----PNYAVECRPLTPQAVDL--LKQM-LTKDPERRPSAAQV 276

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  108 bits (272), Expect = 7e-27
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 36/223 (16%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIK 124
            ++ + +++  VIG+G FG V++  + +S   A+K++ +     D+ F+ REL+ M  +K
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVK 90

Query: 125 HRNIVTLHGYYTSSQYNL------LIYELMPNGSLDTFLHG--KSVNKKNLDWPSR---- 172
           H N+V L  ++ S+          L+ E +P       ++   +   K     P      
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKL 145

Query: 173 --YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTH 229
             Y++     R +AY+H      I HRDIK  N+LLD      ++ DFG A ++ A + +
Sbjct: 146 YMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 230 VSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           VS I   +  Y APE  F     T   D++S G V+ EL+ G+
Sbjct: 199 VSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 1e-26
 Identities = 46/230 (20%), Positives = 91/230 (39%), Gaps = 36/230 (15%)

Query: 132 HGYYTSSQYNLLIY---ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
            G    S   + +Y   +L    +L  +++ +  + ++ +      I +  A  + +LH 
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA-----------GT 237
                ++HRD+K SNI    +   +V DFGL T M+ ++   + +             GT
Sbjct: 183 K---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
             Y++PE       + K D++S G++L ELL       E               ++ D R
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------------RVRIITDVR 287

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
                    +  P         +    L P P++RP  T++++   + ++
Sbjct: 288 NLKFPLLFTQKYP-----QEHMMVQDMLSPSPTERPEATDIIEN-AIFEN 331

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.9 bits (101), Expect = 7e-05
 Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 2/98 (2%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
            F     +G GGFG V+      D   +A+KR+     E+ R    RE++A+  ++H  I
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKN 166
           V     +  +       E+      D        +   
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (265), Expect = 2e-26
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 39/281 (13%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
              F   + +G G +G+VY+    ++    A+K++        +   +E+  M      +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARGIA 184
           +V  +G Y  +    ++ E    GS+   +    +  K L      +IA       +G+ 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTED---EIATILQSTLKGLE 139

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YLH       IHRDIK+ NILL+    A+++DFG+A  +       +T++ GT  ++APE
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPE 195

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                      D++S G+  +E+  GK P  +                +   R  ++I T
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYAD----------------IHPMRAIFMIPT 239

Query: 305 SLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTEVVK 340
           +    P     +++S         CL   P +R T T++++
Sbjct: 240 N--PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 2e-26
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 39/276 (14%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY      +    A+++++            E+  M + K+ NIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARGIAYL 186
                Y       ++ E +  GSL   +    +++         +IA       + + +L
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQALEFL 132

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H +    +IHRDIKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE  
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                  K D++S G++ +E++ G+ P               ++A+       Y+I T+ 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---------ENPLRAL-------YLIATN- 231

Query: 307 EGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
            G P  +  +  S       + CLE +  KR +  E
Sbjct: 232 -GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (265), Expect = 2e-26
 Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 39/278 (14%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN 127
            L   S   IG G  G V       S    AVK +     +       E+  M D +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARGIA 184
           +V ++  Y   +   ++ E +  G+L   +    +N++        +IA       + +A
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE--------QIATVCEAVLQALA 155

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YLH      +IHRDIKS +ILL  +   ++SDFG    +  +     ++V GT  ++APE
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE 211

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                    + D++S G++++E++ G+ P             + V+A+         +  
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFS---------DSPVQAM-------KRLRD 255

Query: 305 SLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTE 337
           S    P  + +   S          L  +P +R T  E
Sbjct: 256 S--PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  105 bits (265), Expect = 5e-26
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 31/224 (13%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
            K+  +F  + + G G FGTV       +  + A+K++ +     +R   + ++ +  + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLH 77

Query: 125 HRNIVTLHGYYTSSQ-------YNLLIYELMPNGSLDTFLHG--KSVNKKNLDWPSR--- 172
           H NIV L  Y+ +         Y  ++ E +P       LH   ++  ++ +  P     
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIK 132

Query: 173 ---YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKT 228
              +++     R I  LH   + ++ HRDIK  N+L++  +   ++ DFG A  +   + 
Sbjct: 133 VFLFQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 229 HVSTIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           +V+ I   +  Y APE  F     T   D++S G +  E++ G+
Sbjct: 188 NVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (262), Expect = 6e-26
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            F   +V+GSG F  V+ +    +   FA+K + +     D   E E+  +  IKH NIV
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69

Query: 130 TLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR----G 182
           TL   Y S+ +  L+ +L+  G L D     + + +        Y  K A    +     
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFD-----RILERG------VYTEKDASLVIQQVLSA 118

Query: 183 IAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           + YLH +    I+HRD+K  N+L    ++N +  ++DFGL+ + +       +   GT G
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPG 172

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           Y+APE       +   D +S GV+   LL G  P
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  104 bits (261), Expect = 6e-26
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 30/222 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDST--AFAVK---------RLHRGTTEVDRGFERELEA 119
            +  K+++G G    V    ++  T   +AVK                E+     +E++ 
Sbjct: 18  NYEPKEILGRGVSSVVR-RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 120 MGDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAV 177
           +  +  H NI+ L   Y ++ +  L+++LM  G L D         K  L      KI  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-----YLTEKVTLSEKETRKIMR 131

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
                I  LH     +I+HRD+K  NILLD +M  +++DFG +  ++  +  +  +  GT
Sbjct: 132 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GT 186

Query: 238 FGYLAPEYFDTGRATAKG------DVYSFGVVLLELLTGKRP 273
             YLAPE  +              D++S GV++  LL G  P
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  105 bits (263), Expect = 7e-26
 Identities = 60/262 (22%), Positives = 91/262 (34%), Gaps = 56/262 (21%)

Query: 65  IFKKTLKFSSK----DVIGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDRGFE 114
                L+   K      IG G +G V     N +    A+K     ++ +   +     +
Sbjct: 17  QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76

Query: 115 RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
            E+  M  + H NI  L+  Y   QY  L+ EL   G L   L+    +          K
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 175 IAVG-----------------------------AAR-------GIAYLHHDCIPHIIHRD 198
             +                               +         + YLH+     I HRD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRD 193

Query: 199 IKSSNILL--DQNMEARVSDFGLATLMEAEKT---HVSTIVAGTFGYLAPEYFDTGRA-- 251
           IK  N L   +++ E ++ DFGL+           +  T  AGT  ++APE  +T     
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253

Query: 252 TAKGDVYSFGVVLLELLTGKRP 273
             K D +S GV+L  LL G  P
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVP 275

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (261), Expect = 9e-26
 Identities = 64/297 (21%), Positives = 116/297 (39%), Gaps = 43/297 (14%)

Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELE 118
           ++    ++          +G G F    +     S  AFAVK + +    ++   ++E+ 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEIT 57

Query: 119 AMGDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--K 174
           A+   + H NIV LH  +    +  L+ EL+  G L +     +   KK+      +   
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE-----RIKKKKH------FSET 106

Query: 175 IAVGAAR----GIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEK 227
            A    R     ++++H      ++HRD+K  N+L    + N+E ++ DFG A L   + 
Sbjct: 107 EASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163

Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT 287
             + T    T  Y APE  +        D++S GV+L  +L+G+ P    F      L  
Sbjct: 164 QPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP----FQSHDRSLTC 218

Query: 288 WVKAVMQDKREEYVIDTSLEGCPINEINDVFSIA----SMCLEPEPSKRPTMTEVVK 340
                +  K ++                +V   A       L  +P+KR  M+ +  
Sbjct: 219 TSAVEIMKKIKKGDFS-----FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  102 bits (257), Expect = 2e-25
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 30/211 (14%)

Query: 75  KDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHG 133
           ++ IG G +G V       +    A K++ +   E    F++E+E M  + H NI+ L+ 
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 134 YYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR-------GIAY 185
            +  +    L+ EL   G L +  +H +   + +            AAR        +AY
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESD------------AARIMKDVLSAVAY 121

Query: 186 LHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
            H     ++ HRD+K  N L      +   ++ DFGLA   +  K        GT  Y++
Sbjct: 122 CHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVS 176

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           P+  + G    + D +S GV++  LL G  P
Sbjct: 177 PQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 2e-25
 Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 42/284 (14%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            +     +G G FG VY+          A K +   + E    +  E+E +    H  IV
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 79

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAARGIAYL 186
            L G Y       ++ E  P G++D  +       + L  P   +I V        + +L
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIML---ELDRGLTEP---QIQVVCRQMLEALNFL 133

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-- 244
           H      IIHRD+K+ N+L+    + R++DFG++           + + GT  ++APE  
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189

Query: 245 ---YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
                       K D++S G+ L+E+   + P  E                +   R    
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE----------------LNPMRVLLK 233

Query: 302 IDTSLEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTEVVK 340
           I  S    P       +S+       + L+  P  RP+  ++++
Sbjct: 234 IAKS--DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (262), Expect = 2e-25
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE-RELEAMGDI 123
             + + ++   VIG+G FG VY+  + DS    A+K++ +     D+ F+ REL+ M  +
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 104

Query: 124 KHRNIVTLHGYYTSSQYNL------LIYELMPNGSLDTFLHG--KSVNKKNLDWPSR--- 172
            H NIV L  ++ SS          L+ + +P       ++   +  ++     P     
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVK 159

Query: 173 ---YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-RVSDFGLATLMEAEKT 228
              Y++     R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + 
Sbjct: 160 LYMYQLF----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 229 HVSTIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           +VS I   +  Y APE  F     T+  DV+S G VL ELL G+
Sbjct: 213 NVSYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 4e-25
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 24/228 (10%)

Query: 58  HSLQSDAIFKKTLKFSSK----DVIGSGGFGTVYRLTVNDST--AFAVKRLHRG--TTEV 109
           H             F+ +     ++G G FG V     +  T   +AVK +++     + 
Sbjct: 6   HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVL-KCKDRITQQEYAVKVINKASAKNKD 64

Query: 110 DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLD 168
                RE+E +  + H NI+ L      S    ++ EL   G L D     + + +K   
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD-----EIIKRKRFS 119

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEA 225
                +I      GI Y+H     +I+HRD+K  NILL   +++ + ++ DFGL+T  + 
Sbjct: 120 EHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
                     GT  Y+APE    G    K DV+S GV+L  LL+G  P
Sbjct: 177 NTKM--KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (258), Expect = 4e-25
 Identities = 67/232 (28%), Positives = 96/232 (41%), Gaps = 51/232 (21%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR--------GTTEVDRGFERELEAMG 121
           K+  KDVIG G    V R     +   FAVK +             EV     RE   + 
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 122 DIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG-- 178
            +  H +I+TL   Y SS +  L+++LM  G L              D    Y       
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-------------FD----YLTEKVAL 197

Query: 179 ----AAR-------GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
                          +++LH +   +I+HRD+K  NILLD NM+ R+SDFG +  +E  +
Sbjct: 198 SEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254

Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKG------DVYSFGVVLLELLTGKRP 273
             +  +  GT GYLAPE                 D+++ GV+L  LL G  P
Sbjct: 255 K-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  102 bits (256), Expect = 4e-25
 Identities = 58/280 (20%), Positives = 102/280 (36%), Gaps = 50/280 (17%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHR------GTTEVDRGFERELEAM----GDIKH 125
           ++G GGFGTV+    + D    A+K + R                 E+  +        H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 126 RNIVTLHGYYTSSQYNLLIYEL-MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
             ++ L  ++ + +  +L+ E  +P   L  ++      K  L               I 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           + H      ++HRDIK  NIL+D     A++ DFG   L+  E         GT  Y  P
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPP 207

Query: 244 EYFDTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK--REEY 300
           E+    +       V+S G++L +++ G  P +                    +    E 
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFER-----------------DQEILEAEL 250

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                +         D  ++   CL P+PS RP++ E++ 
Sbjct: 251 HFPAHVS-------PDCCALIRRCLAPKPSSRPSLEEILL 283

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (255), Expect = 7e-25
 Identities = 69/272 (25%), Positives = 107/272 (39%), Gaps = 39/272 (14%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLH 132
           IG G F  V +L  +  T    A+K + +     T + +   RE+  M  + H NIV L 
Sbjct: 23  IGKGNFAKV-KLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKLF 80

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
               + +   LI E    G +  +L    V    +               + Y H     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQK--- 133

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLM---EAEKTHVSTIVAGTFGYLAPEYF-DT 248
            I+HRD+K+ N+LLD +M  +++DFG +                  G   Y APE F   
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAAPELFQGK 188

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
                + DV+S GV+L  L++G  P D   L+E  + V          R +Y I      
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV---------LRGKYRI------ 233

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            P     D  ++    L   P KR T+ +++K
Sbjct: 234 -PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 9e-25
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 58/294 (19%)

Query: 72  FSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIV 129
           F   +++G+G +G VY+   V      A+K +     E +   ++E+  +     HRNI 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKYSHHRNIA 84

Query: 130 TLHGYY-----TSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAA 180
           T +G +           L L+ E    GS+   +     N    +W     IA       
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREIL 139

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           RG+++LH      +IHRDIK  N+LL +N E ++ DFG++  ++      +T + GT  +
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 195

Query: 241 LAPE-----YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
           +APE              K D++S G+  +E+  G  P+ +                M  
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD----------------MHP 239

Query: 296 KREEYVIDTS----LEGCPINEINDVFSIA-----SMCLEPEPSKRPTMTEVVK 340
            R  ++I  +    L+          +S         CL    S+RP   +++K
Sbjct: 240 MRALFLIPRNPAPRLKS-------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (254), Expect = 9e-25
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 29/211 (13%)

Query: 77  VIGSGGFGTVYRLTVNDST--AFAVKRLHR--------GTTEVDRGFERELEAMGDIKHR 126
            +GSG  G V  L     T    A+K + +           +     E E+E +  + H 
Sbjct: 17  TLGSGACGEVK-LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            I+ +  ++ +  Y + + ELM  G L D     K V  K L   +           + Y
Sbjct: 76  CIIKIKNFFDAEDYYI-VLELMEGGELFD-----KVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 186 LHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           LH +    IIHRD+K  N+LL   +++   +++DFG + ++  E + + T+  GT  YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLA 184

Query: 243 PEYFDTGRATAKG---DVYSFGVVLLELLTG 270
           PE   +          D +S GV+L   L+G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 1e-24
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 28/212 (13%)

Query: 75  KDVIGSGGFGTVYRLTVNDS-TAFAVKRL--HRGTTEVDRGFERELEAMGDIKHRNIVTL 131
            + +G G F  V R     +   +A   +   + +    +  ERE      +KH NIV L
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 132 HGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR----GIA 184
           H   +   ++ LI++L+  G L +       V ++       Y    A    +     + 
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFE-----DIVARE------YYSEADASHCIQQILEAVL 124

Query: 185 YLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           + H      ++HR++K  N+LL    +    +++DFGLA  +E E+        GT GYL
Sbjct: 125 HCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYL 180

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           +PE           D+++ GV+L  LL G  P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  103 bits (259), Expect = 1e-24
 Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 37/278 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            +   + +G+G FG V+R+T   +   FA K +            +E++ M  ++H  +V
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRY--KIAVGAAR----GI 183
            LH  +      ++IYE M  G L  F       +K  D  ++     AV   R    G+
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGEL--F-------EKVADEHNKMSEDEAVEYMRQVCKGL 268

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHVSTIVAGTFGYL 241
            ++H +   + +H D+K  NI+        +   DFGL   ++ ++     +  GT  + 
Sbjct: 269 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFA 323

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE-GTKLVTWVKAVMQDKREEY 300
           APE  +        D++S GV+   LL+G  P    F  E   + +  VK+   +  +  
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSA 379

Query: 301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
               S +G       D   I  + L  +P+ R T+ + 
Sbjct: 380 FSGISEDG------KDF--IRKL-LLADPNTRMTIHQA 408

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (251), Expect = 1e-24
 Identities = 31/280 (11%), Positives = 73/280 (26%), Gaps = 67/280 (23%)

Query: 76  DVIGSGGFGTVYR-----L--TVNDSTAFAVKRLH----RGTTEVDRGFERELEAMGDIK 124
              G       ++     L   V      A+  +          +          +  I 
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQV------ALTFVDPQGVLPDDVLQE-TLSRTLRLSRID 89

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
              +  +     +    L++ E +  GSL            +       +     A    
Sbjct: 90  KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAAD 143

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
             H      +       S +         VS  G              +V      +   
Sbjct: 144 AAHRA---GVALSIDHPSRVR--------VSIDG-------------DVVLAYPATMPD- 178

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
                 A  + D+   G  L  LL  + P+ EA +  G      +    +D   + +   
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG------LAPAERDTAGQPIEPA 226

Query: 305 SLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            ++   P      + ++A+  ++ +   R   + ++ +++
Sbjct: 227 DIDRDIP----FQISAVAARSVQGDGGIRSA-STLLNLMQ 261

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (252), Expect = 1e-24
 Identities = 59/284 (20%), Positives = 109/284 (38%), Gaps = 50/284 (17%)

Query: 76  DVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFE----RELEAMGDIKHRNIV 129
           D++G G +G V    ++  T    AVK L +         E    +E++ +  ++H+N++
Sbjct: 11  DLLGEGSYGKVK-EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 130 TLHG--YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR------ 181
            L    Y    Q   ++ E    G  +             D     +  V  A       
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEML-----------DSVPEKRFPVCQAHGYFCQL 118

Query: 182 --GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTF 238
             G+ YLH      I+H+DIK  N+LL      ++S  G+A  +             G+ 
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 239 GYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK 296
            +  PE  +     +  K D++S GV L  + TG  P +   + +  + +          
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI---------G 226

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           +  Y I           ++D+  +  M LE EP+KR ++ ++ +
Sbjct: 227 KGSYAIPGDCG----PPLSDL--LKGM-LEYEPAKRFSIRQIRQ 263

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =   99 bits (250), Expect = 2e-24
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 75  KDVIGSGGFGTVYRLTVNDST--AFAVKRLH--RGTTEVDRGFERELEAMGDIKHRNIVT 130
           K+ +G G F  V    V+ +T   FA K ++  + +    +  ERE      ++H NIV 
Sbjct: 11  KEELGKGAFSVVR-RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 131 LHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR----GI 183
           LH       ++ L+++L+  G L +       V ++       Y    A    +     I
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFE-----DIVARE------FYSEADASHCIQQILESI 118

Query: 184 AYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
           AY H +    I+HR++K  N+LL    +    +++DFGLA  +           AGT GY
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGY 173

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           L+PE       +   D+++ GV+L  LL G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  101 bits (254), Expect = 2e-24
 Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 43/281 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            +   + +GSG FG V+R     +   F  K ++          + E+  M  + H  ++
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 111

Query: 130 TLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR----GIA 184
            LH  +      +LI E +  G L D       +  ++          +   R    G+ 
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDR------IAAEDYKMSEAE--VINYMRQACEGLK 163

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHVSTIVAGTFGYLA 242
           ++H      I+H DIK  NI+ +    + V   DFGLAT +  ++  +  +   T  + A
Sbjct: 164 HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAA 218

Query: 243 PEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQDKREEYV 301
           PE  D        D+++ GV+   LL+G  P    F  E   + +  VK    +  E+  
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDWEFDEDAF 274

Query: 302 IDTSLEGCPINEINDVFSIA----SMCLEPEPSKRPTMTEV 338
              S E             A       L+ EP KR T+ + 
Sbjct: 275 SSVSPE-------------AKDFIKNLLQKEPRKRLTVHDA 302

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (251), Expect = 2e-24
 Identities = 59/277 (21%), Positives = 102/277 (36%), Gaps = 46/277 (16%)

Query: 77  VIGSGGFGTVYRLT-VNDSTAFAVKRLHR------GTTEVDRGFERELEAMGDIKHR--N 127
           ++GSGGFG+VY    V+D+   A+K + +      G          E+  +  +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           ++ L  ++      +LI E  P    D F       +  L               + + H
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQDLF--DFITERGALQEELARSFFWQVLEAVRHCH 166

Query: 188 HDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           +     ++HRDIK  NIL+D N  E ++ DFG   L++           GT  Y  PE+ 
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWI 220

Query: 247 DTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK--REEYVID 303
              R       V+S G++L +++ G  P +                   ++  R +    
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-----------------DEEIIRGQVFFR 263

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
             +        ++   +   CL   PS RPT  E+  
Sbjct: 264 QRVS-------SECQHLIRWCLALRPSDRPTFEEIQN 293

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  100 bits (252), Expect = 2e-24
 Identities = 74/300 (24%), Positives = 132/300 (44%), Gaps = 36/300 (12%)

Query: 53  RSPLIHSLQSDAIFKKTLKFSS----KDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGT 106
           ++  +HS+    + + +++F+     K+ IG G +    R  ++ +T   FAVK + +  
Sbjct: 2   QTVGVHSIVQ-QLHRNSIQFTDGYEVKEDIGVGSYSVCKR-CIHKATNMEFAVKIIDKSK 59

Query: 107 TEVDRGFERELEAMG-DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNK 164
            +       E+E +    +H NI+TL   Y   +Y  ++ ELM  G L D     K + +
Sbjct: 60  RDP----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLD-----KILRQ 110

Query: 165 KNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEA-RVSDFGLA 220
           K         +     + + YLH      ++HRD+K SNIL      N E+ R+ DFG A
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167

Query: 221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE 280
             + AE   + T    T  ++APE  +     A  D++S GV+L  +LTG  P      +
Sbjct: 168 KQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

Query: 281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
              +++  + +        Y    S      +   D+  ++ M L  +P +R T   V++
Sbjct: 227 TPEEILARIGSGKFSLSGGYWNSVS------DTAKDL--VSKM-LHVDPHQRLTAALVLR 277

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 3e-24
 Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 77/309 (24%)

Query: 75  KDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGF------------------- 113
           KD IG G +G V  L  N++    +A+K L +       GF                   
Sbjct: 18  KDEIGKGSYGVVK-LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76

Query: 114 -------ERELEAMGDIKHRNIVTLHG-YYTSSQYNL-LIYELMPNGSLDTFLHGKSVNK 164
                   +E+  +  + H N+V L       ++ +L +++EL+  G +           
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------- 125

Query: 165 KNLDWPSRYKIAVGAAR--------GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
             ++ P+   ++   AR        GI YLH+     IIHRDIK SN+L+ ++   +++D
Sbjct: 126 --MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 217 FGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT---AKGDVYSFGVVLLELLTGKRP 273
           FG++   +     +S    GT  ++APE     R        DV++ GV L   + G+ P
Sbjct: 181 FGVSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

Query: 274 MDEAFLEEGTKLVTWVKAVMQDK--REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSK 331
             +  +             +  K   +        +     ++ D+  I  M L+  P  
Sbjct: 240 FMDERIMC-----------LHSKIKSQALEFPDQPDIAE--DLKDL--ITRM-LDKNPES 283

Query: 332 RPTMTEVVK 340
           R  + E+  
Sbjct: 284 RIVVPEIKL 292

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  100 bits (252), Expect = 3e-24
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 33/244 (13%)

Query: 43  SVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKR 101
           S++GG+ +   S  + +  +   F     +  K+ +G G F  V R     +   FA K 
Sbjct: 6   SMTGGQQMGRGSEFMMNASTK--FSD--NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 102 LH--RGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLH 158
           ++  + +    +  ERE      ++H NIV LH       ++ L+++L+  G L +    
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE---- 117

Query: 159 GKSVNKKNLDWPSRY--KIAVGAAR----GIAYLHHDCIPHIIHRDIKSSNILL---DQN 209
              V ++       Y    A    +     IAY H +    I+HR++K  N+LL    + 
Sbjct: 118 -DIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 167

Query: 210 MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT 269
              +++DFGLA  +   +       AGT GYL+PE       +   D+++ GV+L  LL 
Sbjct: 168 AAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 270 GKRP 273
           G  P
Sbjct: 226 GYPP 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (251), Expect = 3e-24
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 29/214 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            F  +  +G G    VYR     +   +A+K L +  T   +    E+  +  + H NI+
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNII 111

Query: 130 TLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR----G 182
            L   + +     L+ EL+  G L D     + V K        Y  + A  A +     
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFD-----RIVEKG------YYSERDAADAVKQILEA 160

Query: 183 IAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           +AYLH +    I+HRD+K  N+L      +   +++DFGL+ ++E +       V GT G
Sbjct: 161 VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPG 215

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           Y APE         + D++S G++   LL G  P
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.8 bits (247), Expect = 4e-24
 Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 48/279 (17%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V  L VN  T  A AVK +      +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEVQ-LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR--------GIAYL 186
                   L  E    G L  F   +              +    A+        G+ YL
Sbjct: 74  RREGNIQYLFLEYCSGGEL--F--DRIEPDI--------GMPEPDAQRFFHQLMAGVVYL 121

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT--HVSTIVAGTFGYLAPE 244
           H      I HRDIK  N+LLD+    ++SDFGLAT+         ++ +  GT  Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177

Query: 245 YFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
                R       DV+S G+VL  +L G+ P D+   +   +   W +       + Y+ 
Sbjct: 178 LL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEK------KTYLN 229

Query: 303 DTSLEGCPINEI-NDVFSIASMCLEPEPSKRPTMTEVVK 340
                  P  +I +   ++    L   PS R T+ ++ K
Sbjct: 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (250), Expect = 5e-24
 Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 43/286 (15%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIK 124
                  S  +++G G FG V++     +    A K +     +     + E+  M  + 
Sbjct: 85  VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD 144

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR-- 181
           H N++ L+  + S    +L+ E +  G L D  +       ++ +        +   +  
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRII------DESYNLTELD--TILFMKQI 196

Query: 182 --GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHVSTIVAGT 237
             GI ++H     +I+H D+K  NIL       ++   DFGLA   +  +  +     GT
Sbjct: 197 CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GT 251

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQDK 296
             +LAPE  +    +   D++S GV+   LL+G  P    FL +   + +  + A   D 
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP----FLGDNDAETLNNILACRWDL 307

Query: 297 REEYVIDTSLEGCPINEINDVFSIA----SMCLEPEPSKRPTMTEV 338
            +E   D S E             A    S  L  E S R + +E 
Sbjct: 308 EDEEFQDISEE-------------AKEFISKLLIKEKSWRISASEA 340

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 69  TLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIK 124
              FS    IG G FG VY      +    A+K++     + +  ++   +E+  +  ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV---GAAR 181
           H N +   G Y       L+ E     + D       V+KK L      +IA    GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEV---EIAAVTHGALQ 165

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           G+AYLH     ++IHRD+K+ NILL +    ++ DFG A++M    + V     GT  ++
Sbjct: 166 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 217

Query: 242 APE---YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           APE     D G+   K DV+S G+  +EL   K P+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.0 bits (247), Expect = 9e-24
 Identities = 70/307 (22%), Positives = 118/307 (38%), Gaps = 48/307 (15%)

Query: 49  MVMFRSPLIHSLQSDAIFKKTL--KFSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHR 104
           M +   P    L+  A  +     K+S+   +GSG FG V+   V+        VK + +
Sbjct: 1   MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVW-TAVDKEKNKEVVVKFIKK 59

Query: 105 GTTEVDRGFE--------RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTF 156
                D   E         E+  +  ++H NI+ +   + +  +  L+ E   +G LD F
Sbjct: 60  EKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLF 118

Query: 157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD 216
                     LD P    I       + YL       IIHRDIK  NI++ ++   ++ D
Sbjct: 119 --AFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173

Query: 217 FGLATLMEA-EKTHVSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRP 273
           FG A  +E  +  +      GT  Y APE    G      + +++S GV L  L+  + P
Sbjct: 174 FGSAAYLERGKLFYTF---CGTIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENP 229

Query: 274 MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP 333
             E            ++  +                P     ++ S+ S  L+P P +R 
Sbjct: 230 FCE------------LEETV---EAAIH-------PPYLVSKELMSLVSGLLQPVPERRT 267

Query: 334 TMTEVVK 340
           T+ ++V 
Sbjct: 268 TLEKLVT 274

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 42/276 (15%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGY 134
           +G G +G V  L VN  T  A AVK +      +     ++E+     + H N+V  +G+
Sbjct: 15  LGEGAYGEVQ-LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD-WPSRYK----IAVGAARGIAYLHHD 189
                   L  E    G L  F   +      +    ++      +A     G+ YLH  
Sbjct: 74  RREGNIQYLFLEYCSGGEL--F--DRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI 124

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT--HVSTIVAGTFGYLAPEYFD 247
               I HRDIK  N+LLD+    ++SDFGLAT+         ++ +  GT  Y+APE   
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL- 179

Query: 248 TGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
             R       DV+S G+VL  +L G+ P    + +       +       +++ Y+    
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYSDWK---EKKTYLN--- 229

Query: 306 LEGCPINEI-NDVFSIASMCLEPEPSKRPTMTEVVK 340
               P  +I +   ++    L   PS R T+ ++ K
Sbjct: 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 44/281 (15%)

Query: 75  KDVIGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDR-GFERELEAMGDIKHRN 127
            + +GSG F  V +     +   +A K     +       V R   ERE+  +  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR----G 182
           ++TLH  Y +    +LI EL+  G L D         K++L      + A    +    G
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFD-----FLAQKESL----SEEEATSFIKQILDG 127

Query: 183 IAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
           + YLH      I H D+K  NI+L          ++ DFGLA  +E         + GT 
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182

Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQDKR 297
            ++APE  +      + D++S GV+   LL+G  P    FL +   + +  + +V  D  
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANITSVSYDFD 238

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
           EE+   TS          D   I  + L  E  KR T+ E 
Sbjct: 239 EEFFSHTS------ELAKDF--IRKL-LVKETRKRLTIQEA 270

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 76/281 (27%), Positives = 115/281 (40%), Gaps = 44/281 (15%)

Query: 75  KDVIGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDR-GFERELEAMGDIKHRN 127
            + +GSG F  V +     +   +A K     +       V R   ERE+  +  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR----G 182
           I+TLH  Y +    +LI EL+  G L D         K++L      + A    +    G
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFD-----FLAQKESL----SEEEATSFIKQILDG 127

Query: 183 IAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
           + YLH      I H D+K  NI+L          ++ DFGLA  +E         + GT 
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182

Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE-GTKLVTWVKAVMQDKR 297
            ++APE  +      + D++S GV+   LL+G  P    FL +   + +  + AV  D  
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANITAVSYDFD 238

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
           EE+   TS          D   I  + L  E  KR T+ E 
Sbjct: 239 EEFFSQTS------ELAKDF--IRKL-LVKETRKRLTIQEA 270

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 43/213 (20%), Positives = 84/213 (39%), Gaps = 26/213 (12%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K+   + +G G FG V+R     S   +  K +    T+     ++E+  +   +HRNI+
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNIL 64

Query: 130 TLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR----G 182
            LH  + S +  ++I+E +    + +     +               +  V         
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFE-----RINTSA-----FELNEREIVSYVHQVCEA 114

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHVSTIVAGTFGY 240
           + +LH     +I H DI+  NI+      + +   +FG A  ++        ++     Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEY 169

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
            APE       +   D++S G ++  LL+G  P
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRNIVTLH 132
            IG G FG V  +  ND+   +A+K +++             +EL+ M  ++H  +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA-VGAARGIAYLHHDCI 191
             +   +   ++ +L+  G L    H +       +   +  I  +  A  + YL +   
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEET-VKLFICELVMA--LDYLQNQ-- 134

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             IIHRD+K  NILLD++    ++DF +A ++  E    +  +AGT  Y+APE F + + 
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKG 191

Query: 252 TAKG---DVYSFGVVLLELLTGKRP 273
                  D +S GV   ELL G+RP
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRP 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 75  KDVIGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDR-GFERELEAMGDIKHRN 127
            + +GSG F  V +     +   +A K     RL      V R   ERE+  + +I+H N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR----G 182
           I+TLH  + +    +LI EL+  G L D     +S+ +           A    +    G
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE---------ATQFLKQILDG 120

Query: 183 IAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
           + YLH      I H D+K  NI+L      N   ++ DFG+A  +EA       I  GT 
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-GTP 175

Query: 239 GYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
            ++APE  +      + D++S GV+   LL+G  P
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 77/286 (26%), Positives = 122/286 (42%), Gaps = 46/286 (16%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVK-----RLHRGTTEVDR-GFERELEAMGDI 123
            + + + +GSG F  V +     +   +A K     R       V R   ERE+  + +I
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRYKIAVGAAR- 181
           +H N++TLH  Y +    +LI EL+  G L D     +S+ ++          A    + 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE---------ATEFLKQ 122

Query: 182 ---GIAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLATLMEAEKTHVSTIV 234
              G+ YLH      I H D+K  NI+L          ++ DFGLA  ++         +
Sbjct: 123 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177

Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW--VKAV 292
            GT  ++APE  +      + D++S GV+   LL+G  P    FL + TK  T   V AV
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD-TKQETLANVSAV 232

Query: 293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEV 338
             +  +EY  +TS          D   I  + L  +P KR T+ + 
Sbjct: 233 NYEFEDEYFSNTS------ALAKDF--IRRL-LVKDPKKRMTIQDS 269

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 8e-23
 Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 48/277 (17%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHR---GTTEVDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG V  +  +  T    AVK L+R    + +V    +RE++ +   +H +I+ L+
Sbjct: 19  LGVGTFGKVK-IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR--------GIA 184
              ++     ++ E +  G L  ++                ++    AR         + 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYI----CKHG--------RVEEMEARRLFQQILSAVD 125

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y H      ++HRD+K  N+LLD +M A+++DFGL+ +M   +  + T   G+  Y APE
Sbjct: 126 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAAPE 180

Query: 245 YF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
                  A  + D++S GV+L  LL G  P D+  +    K +         +   +   
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI---------RGGVFY-- 229

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                 P      V ++    L+ +P KR T+ ++ +
Sbjct: 230 -----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 71/264 (26%), Positives = 110/264 (41%), Gaps = 31/264 (11%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGF-----ERE-LEAMGDIKHRNIV 129
           +IG GGFG VY     D+   +A+K L +   ++ +G      ER  L  +       IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +   + +      I +LM  G L    H       +      Y  A     G+ ++H+ 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFY--AAEIILGLEHMHNR 311

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +++RD+K +NILLD++   R+SD GLA     +K H    V GT GY+APE    G
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKG 365

Query: 250 RATAKG-DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
            A     D +S G +L +LL G  P    F +  TK    +  +      E     S E 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421

Query: 309 CPINEINDVFSIASMCLEPEPSKR 332
                     S+    L+ + ++R
Sbjct: 422 R---------SLLEGLLQRDVNRR 436

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 66/312 (21%), Positives = 110/312 (35%), Gaps = 55/312 (17%)

Query: 51  MFRSPLIHSLQSDAIFKKTLKFSSK-----DVIGSGGFGTVYRLTVNDS-TAFAVKRLH- 103
              S  +     +  F+    F++        +G G F  V +     +   +A K L  
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK 64

Query: 104 RGTTEVDRG-FERELEAMGDIKHR-NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKS 161
           R   +  R     E+  +   K    ++ LH  Y ++   +LI E    G + +    + 
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124

Query: 162 VNKKNLDWPSRY--KIAVGAAR----GIAYLHHDCIPHIIHRDIKSSNILL---DQNMEA 212
                            +   +    G+ YLH +   +I+H D+K  NILL       + 
Sbjct: 125 AE--------MVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173

Query: 213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKR 272
           ++ DFG++  +      +  I+ GT  YLAPE  +    T   D+++ G++   LLT   
Sbjct: 174 KIVDFGMSRKIG-HACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231

Query: 273 PMDEAFLEEGTKLVTW--VKAVMQDKREEYVIDTSLEGCPINEINDVFSIA----SMCLE 326
           P    F+ E     T+  +  V  D  EE     S               A       L 
Sbjct: 232 P----FVGE-DNQETYLNISQVNVDYSEETFSSVSQL-------------ATDFIQSLLV 273

Query: 327 PEPSKRPTMTEV 338
             P KRPT    
Sbjct: 274 KNPEKRPTAEIC 285

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 62/291 (21%), Positives = 107/291 (36%), Gaps = 60/291 (20%)

Query: 74  SKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVT 130
           SK V+G G  G V     +  T    A+K L+           +E++         +IV 
Sbjct: 33  SKQVLGLGVNGKVLECF-HRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVC 86

Query: 131 LHGYYTSSQYN----LLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR-- 181
           +   Y +  +     L+I E M  G L       +   + +      +  + A    R  
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFS-----RIQERGD----QAFTEREAAEIMRDI 137

Query: 182 --GIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
              I +LH     +I HRD+K  N+L    +++   +++DFG A         + T    
Sbjct: 138 GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-Y 191

Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK 296
           T  Y+APE     +     D++S GV++  LL G  P    F                  
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP----FYSNT-----------GQA 236

Query: 297 REEYVIDTSLEGC---PINEINDVFSIA----SMCLEPEPSKRPTMTEVVK 340
               +      G    P  E ++V   A     + L+ +P++R T+T+ + 
Sbjct: 237 ISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 94.9 bits (236), Expect = 8e-22
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 50/278 (17%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHR---GTTEVDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG V  +  ++ T    AVK L+R    + +V     RE++ +   +H +I+ L+
Sbjct: 24  LGVGTFGKVK-VGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR--------GIA 184
              ++     ++ E +  G L  ++                ++    +R        G+ 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI----CKNG--------RLDEKESRRLFQQILSGVD 130

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y H      ++HRD+K  N+LLD +M A+++DFGL+ +M   +  + T   G+  Y APE
Sbjct: 131 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE 185

Query: 245 YFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
              +GR  A  + D++S GV+L  LL G  P D+  +    K +             +  
Sbjct: 186 VI-SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI---------CDGIFYT 235

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
              L          V S+    L+ +P KR T+ ++ +
Sbjct: 236 PQYLN-------PSVISLLKHMLQVDPMKRATIKDIRE 266

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 73/361 (20%), Positives = 119/361 (32%), Gaps = 110/361 (30%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-GFEREL 117
             +  LK      +G G FG V                 AVK L  G T  +      EL
Sbjct: 19  FPRDRLKL--GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 76

Query: 118 EAMGDI-KHRNIVTLHGYYT-SSQYNLLIYELMPNGSLDTFLHGK--------------- 160
           + +  I  H N+V L G  T      ++I E    G+L T+L  K               
Sbjct: 77  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136

Query: 161 ----SVNKKNLDWPSRYKIAVGA----------ARGIAYLHHDCIPHIIHRDIKSSNILL 206
                V    +D   R      +           + ++ +  +  P  +++D  +   L+
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196

Query: 207 ------------------------------DQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
                                          +    ++ DFGLA  +  +  +    V  
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRK 252

Query: 237 TFGYL-----APEYFDTGRATAKGDVYSFGVVLLELLT-GKRP-----MDEAF---LEEG 282
               L     APE       T + DV+SFGV+L E+ + G  P     +DE F   L+EG
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
           T++                   + +        +++     C   EPS+RPT +E+V+ L
Sbjct: 313 TRM------------------RAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHL 350

Query: 343 E 343
            
Sbjct: 351 G 351

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 71/313 (22%), Positives = 115/313 (36%), Gaps = 62/313 (19%)

Query: 51  MFRSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTE 108
           M R+P+        I   + ++     IGSG FG    L  +  T    AVK + RG   
Sbjct: 1   MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVAR-LMRDKLTKELVAVKYIERGAAI 59

Query: 109 VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLD 168
            +   +RE+     ++H NIV       +  +  +I E    G L    + +  N     
Sbjct: 60  DEN-VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAG--- 111

Query: 169 WPSRYKIAVGAAR--------GIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR--VSDFG 218
                + +   AR        G++Y H      I HRD+K  N LLD +   R  + DFG
Sbjct: 112 -----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163

Query: 219 LATLMEAE---KTHVSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRP 273
            +         K+ V     GT  Y+APE     +       DV+S GV L  +L G  P
Sbjct: 164 YSKSSVLHSQPKSTV-----GTPAYIAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYP 217

Query: 274 MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS------IASMCLEP 327
            ++       +     K + +    +Y I   +            S      I+ +    
Sbjct: 218 FEDPEEPRDYR-----KTIQRILSVKYSIPDDIR----------ISPECCHLISRI-FVA 261

Query: 328 EPSKRPTMTEVVK 340
           +P+ R ++ E+  
Sbjct: 262 DPATRISIPEIKT 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.5 bits (230), Expect = 7e-21
 Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 25/261 (9%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE---RELEAMGDIKHRNIVTLH 132
           V+G GGFG V    V  +   +A K+L +   +  +G      E + +  +  R +V+L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP-SRYKIAVGAARGIAYLHHDCI 191
             Y +     L+  LM  G L    H   + +       + +  A     G+  LH +  
Sbjct: 251 YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRE-- 305

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             I++RD+K  NILLD +   R+SD GLA  +   +T +   V GT GY+APE     R 
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 362

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           T   D ++ G +L E++ G+ P    F +   K       + +++ E  V +   E    
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSP----FQQRKKK-------IKREEVERLVKEVPEE-YSE 410

Query: 312 NEINDVFSIASMCLEPEPSKR 332
                  S+ S  L  +P++R
Sbjct: 411 RFSPQARSLCSQLLCKDPAER 431

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 51/278 (18%)

Query: 78  IGSGGFGTVYRLTVNDST--AFAVKRLHR---GTTEVDRGFERELEAMGDIKHRNIVTLH 132
           +G G FG V  L  +  T    A+K + R     +++    ERE+  +  ++H +I+ L+
Sbjct: 17  LGEGSFGKVK-LATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR--------GIA 184
              T+    +++ E    G L  ++    V KK        ++     R         I 
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYI----VEKK--------RMTEDEGRRFFQQIICAIE 122

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           Y H      I+HRD+K  N+LLD N+  +++DFGL+ +M      + T   G+  Y APE
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPE 177

Query: 245 YFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI 302
               G+  A  + DV+S G+VL  +L G+ P D+ F+    K V             YV+
Sbjct: 178 VI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------NSCVYVM 227

Query: 303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
              L            S+    +  +P +R T+ E+ +
Sbjct: 228 PDFLS-------PGAQSLIRRMIVADPMQRITIQEIRR 258

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 37/216 (17%)

Query: 75  KDVIGSGGFGTVYRLTVNDST--AFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTL 131
             V+G G  G V ++  N  T   FA+K L            RE+E      +  +IV +
Sbjct: 67  SQVLGLGINGKVLQIF-NKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 120

Query: 132 HGYY----TSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSRY--KIAVGAAR--- 181
              Y       +  L++ E +  G L       +  ++ +      +  + A    +   
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFS-----RIQDRGD----QAFTEREASEIMKSIG 171

Query: 182 -GIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
             I YLH     +I HRD+K  N+L      N   +++DFG A    +  + ++T    T
Sbjct: 172 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YT 226

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             Y+APE     +     D++S GV++  LL G  P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 21/232 (9%)

Query: 54  SPLIHSLQSDAIFKKTLKFSSKD-----VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTT 107
            P   SLQ      +  K   +D     ++G G F TV       ++  +A+K L +   
Sbjct: 9   RPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI 68

Query: 108 EVDRGFE---RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNK 164
             +       RE + M  + H   V L+  +   +          NG L    + + +  
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGS 126

Query: 165 KNLDWPSRYKIA-VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--T 221
            +    +R+  A + +A  + YLH      IIHRD+K  NILL+++M  +++DFG A   
Sbjct: 127 FDET-CTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             E+++   ++ V GT  Y++PE      A    D+++ G ++ +L+ G  P
Sbjct: 181 SPESKQARANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 54/242 (22%), Positives = 90/242 (37%), Gaps = 51/242 (21%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFE-RELEAMGDIKHRNI 128
           K+S    +G+G FG V  +   +S   FA+K++ +     D  ++ REL+ M  + H NI
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNI 62

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR---------------- 172
           + L  Y+ ++          P+           VN  +                      
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 173 --YKIAVGAA-------------------RGIAYLHHDCIPHIIHRDIKSSNILLDQNM- 210
             +K+                        R + ++H      I HRDIK  N+L++    
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDN 179

Query: 211 EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLT 269
             ++ DFG A  +   +  V+ I   +  Y APE        T   D++S G V  EL+ 
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 270 GK 271
           GK
Sbjct: 238 GK 239

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.1 bits (221), Expect = 9e-20
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFE------RELEAMGDIKHRNIV 129
           V+G GGFG V+   +  +   +A K+L++   +  +G++      + L     +  R IV
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK---VHSRFIV 248

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWP---SRYKIAVGAARGIAYL 186
           +L   + +     L+  +M  G +    H  +V++ N  +    + +  A     G+ +L
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHL 305

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H     +II+RD+K  N+LLD +   R+SD GLA  ++A +T       GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELL 361

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRP 273
                    D ++ GV L E++  + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGFERELEAMGDIKHR 126
           F    VIG G FG V  + + ++   FA+K L++       E    F  E + + +   +
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSK 134

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGIA 184
            I TLH  +       L+ +    G L T L  K  ++   +  +R+ +A  V A   I 
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEM-ARFYLAEMVIA---ID 189

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
            +H     H +HRDIK  NIL+D N   R++DFG    +  + T  S++  GT  Y++PE
Sbjct: 190 SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 245 YFDTGRATAKG-----DVYSFGVVLLELLTGKRP 273
                           D +S GV + E+L G+ P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR---GTTEVDRGFERELE 118
           D+ F    ++ +   IGSG  G V            A+K+L R     T   R + REL 
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELV 76

Query: 119 AMGDIKHRNIVTLHGYYTSSQ--------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWP 170
            M  + H+NI+ L   +T  +        Y  ++ ELM     D  L    V +  LD  
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVY--IVMELM-----DANLC--QVIQMELD-H 126

Query: 171 SR-----YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA 225
            R     Y++      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A
Sbjct: 127 ERMSYLLYQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177

Query: 226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
             + + T    T  Y APE           D++S G ++ E++ G 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 34/219 (15%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTA-FAVKRLHRGT----TEVDRGFERELEAMGDIKHR 126
           +    VIG G FG V  +    +   +A+K L +      ++    F  E + M      
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSP 129

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR----- 181
            +V L   +   +Y  ++ E MP G L   +             S Y +    AR     
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAE 176

Query: 182 ---GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTF 238
               +  +H       IHRD+K  N+LLD++   +++DFG    M  E         GT 
Sbjct: 177 VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 239 GYLAPEYF-DTGRATAKG---DVYSFGVVLLELLTGKRP 273
            Y++PE     G     G   D +S GV L E+L G  P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 33/224 (14%)

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR---GTTEVDRGFERELE 118
           D+ F    ++ +   IGSG  G V            A+K+L R     T   R + REL 
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELV 113

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNL------LIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
            M  + H+NI++L   +T  +         L+ ELM     D  L    V +  L    R
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMEL-DHER 165

Query: 173 -----YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK 227
                Y++      GI +LH      IIHRD+K SNI++  +   ++ DFGLA    A  
Sbjct: 166 MSYLLYQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGT 216

Query: 228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
           + + T    T  Y APE           D++S G ++ E++  K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 25/217 (11%)

Query: 72  FSSKDVIGSGGFGTVY--RLTVNDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKH 125
           F    VIG G F  V   ++       +A+K +++       EV   F  E + + +   
Sbjct: 63  FEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDR 120

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA--VGAARGI 183
           R I  LH  +    Y  L+ E    G L          ++     +R+ +A  V A   I
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLAEIVMA---I 175

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
             +H       +HRDIK  NILLD+    R++DFG    + A+ T  S +  GT  YL+P
Sbjct: 176 DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

Query: 244 EYFDTGRATAKGDVY-------SFGVVLLELLTGKRP 273
           E             Y       + GV   E+  G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 52/231 (22%), Positives = 77/231 (33%), Gaps = 40/231 (17%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHR--GTTEVDRGFE-------- 114
           +      ++ +  I SG +G V     ++    A+KR+                      
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76

Query: 115 -RELEAMGDIKHRNIVTLHGYYTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLD 168
            RE+  +    H NI+ L   +   +        L+ ELM      T L    V      
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLA--QVIHDQRI 129

Query: 169 WPSR-------YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT 221
             S        Y I      G+  LH      ++HRD+   NILL  N +  + DF LA 
Sbjct: 130 VISPQHIQYFMYHI----LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR 182

Query: 222 LMEAEKTHVSTIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
             E       T       Y APE        T   D++S G V+ E+   K
Sbjct: 183 --EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 35/239 (14%)

Query: 49  MVMFRSPLIHSLQ-SDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR-- 104
           + + R    +    +   ++    + S   +GSG +G+V       S    A+K+L R  
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61

Query: 105 -GTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--------YNLLIYELMPNGSLDT 155
                  R + REL  +  ++H N++ L   +T +         Y  L+   M      T
Sbjct: 62  QSEIFAKRAY-RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY--LVMPFM-----QT 113

Query: 156 FLHGKSVNKKNLDWPSRYK-IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV 214
            L    +         + + +     +G+ Y+H      ++HRD+K  N+ ++++ E ++
Sbjct: 114 DLQ--KIMGLKFS-EEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKI 167

Query: 215 SDFGLATLMEAEKTH-VSTIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
            DFGLA   +AE T  V T       Y APE            D++S G ++ E+LTGK
Sbjct: 168 LDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVD--RGFERELEAMGDIKHRN 127
           ++++   IG G +G V     N +    A+K++     +    R   RE++ +   +H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHEN 86

Query: 128 IVTLHGYYTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLDWPSR-----YKIAV 177
           I+ ++    +          ++ +LM     +T L+ K +  ++L          Y+I  
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLY-KLLKTQHLS-NDHICYFLYQI-- 137

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI---V 234
              RG+ Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H   +   V
Sbjct: 138 --LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 235 AGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           A T  Y APE   ++   T   D++S G +L E+L+ +
Sbjct: 193 A-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 39/219 (17%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR---GTTEVDRGFERELEAMGDIKHR 126
            +     +GSG +G V       +    A+K+L+R         R + REL  +  ++H 
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHE 84

Query: 127 NIVTLHGYYTSSQ--------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR----YK 174
           N++ L   +T  +        Y  L+   M      T L  K +  + L         Y+
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFY--LVMPFM-----GTDLG-KLMKHEKLGEDRIQFLVYQ 136

Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTI 233
           +     +G+ Y+H      IIHRD+K  N+ ++++ E ++ DFGLA   ++E T +V T 
Sbjct: 137 ML----KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 189

Query: 234 VAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
                 Y APE   +  R T   D++S G ++ E++TGK
Sbjct: 190 W-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 33/216 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR---GTTEVDRGFERELEAMGDIKHR 126
           ++ +   +GSG +G+V       +    AVK+L R         R + REL  +  +KH 
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHE 88

Query: 127 NIVTLHGYYTSSQ--------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAV 177
           N++ L   +T ++        Y  L+  LM        L+   V  + L      + +  
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVY--LVTHLM-----GADLN-NIVKCQKLT-DDHVQFLIY 139

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAG 236
              RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA     E T +V+T    
Sbjct: 140 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-- 194

Query: 237 TFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
              Y APE   +        D++S G ++ ELLTG+
Sbjct: 195 ---YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKH 125
           +F   + +G+G + TVY+     +  + A+K +     + + G      RE+  M ++KH
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKH 62

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFL--HGKSVNKKNLDWPSRYKIAVGAARGI 183
            NIV L+    +     L++E M N  L  ++         + L+            +G+
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
           A+ H +    I+HRD+K  N+L+++  + ++ DFGLA          S+ V  T  Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177

Query: 244 EY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           +    +   +   D++S G +L E++TGK
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 27/212 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRG----TTEVDRGF-ERELEAMGDIKH 125
           F     +G+G FG V  +   +S   +A+K L +       +++    E+ +  +  +  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI--LQAVNF 100

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA-VGAARGIA 184
             +V L   +  +    ++ E +  G +  F H + + + +    +R+  A +       
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPH-ARFYAAQIVLT--FE 155

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YLH      +I+RD+K  N+L+DQ    +V+DFG A  ++  +T   T+  GT   LAPE
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTW--TLC-GTPEALAPE 208

Query: 245 YFDT---GRATAKGDVYSFGVVLLELLTGKRP 273
              +    +A    D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAV---DWWALGVLIYEMAAGYPP 237

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 53/246 (21%)

Query: 63  DAIFKKTLKFSSKDV----------IGSGGFGTVYR---LTVNDSTAFAVKRLHRGTTEV 109
           D  FK  L    + V          +G G +G VY+       D   +A+K++       
Sbjct: 4   DYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------ 57

Query: 110 DRGFE----RELEAMGDIKHRNIVTLHGYYTSSQYNL--LIYELMPN---GSLDTFLHGK 160
             G      RE+  + ++KH N+++L   + S       L+++   +     +      K
Sbjct: 58  GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK 117

Query: 161 SVNKKNLDWPSRYK-IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR----VS 215
           +  K         K +      GI YLH +    ++HRD+K +NIL+      R    ++
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 216 DFGLATLMEAEK---THVSTIVAGTFGYLAPE-------YFDTGRATAKGDVYSFGVVLL 265
           D G A L  +       +  +V  TF Y APE       Y      T   D+++ G +  
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFA 227

Query: 266 ELLTGK 271
           ELLT +
Sbjct: 228 ELLTSE 233

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFE----RE---LEAMG 121
           ++     IG G +G V++     +     A+KR+   T E   G      RE   L  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLE 69

Query: 122 DIKHRNIVTL----HGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA 176
             +H N+V L        T  +  L L++E +    L T+L    V +  +   +   + 
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMM 126

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
               RG+ +LH      ++HRD+K  NIL+  + + +++DFGLA +   +    S +V  
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 181

Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK 271
           T  Y APE           D++S G +  E+   K
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 74.1 bits (183), Expect = 3e-15
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 18/211 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKH 125
           K+   + IG G +GTV++    ++    A+KR+       D G      RE+  + ++KH
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIA 184
           +NIV LH    S +   L++E      L  +         +LD P   K       +G+ 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLD-PEIVKSFLFQLLKGLG 115

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           + H     +++HRD+K  N+L+++N E ++++FGLA          S  V  T  Y  P+
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171

Query: 245 Y-FDTGRATAKGDVYSFGVVLLELLTGKRPM 274
             F     +   D++S G +  EL    RP+
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 27/209 (12%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDR-GFE----RELEAMGDIKHRNIV 129
           D +G G F TVY+    N +   A+K++  G     + G      RE++ + ++ H NI+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIAYLHH 188
            L   +       L+++ M    L+  +   S+    L  PS  K   +   +G+ YLH 
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV---LT-PSHIKAYMLMTLQGLEYLHQ 130

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE---- 244
                I+HRD+K +N+LLD+N   +++DFGLA    +     +  V  T  Y APE    
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFG 186

Query: 245 --YFDTGRATAKGDVYSFGVVLLELLTGK 271
              +  G      D+++ G +L ELL   
Sbjct: 187 ARMYGVGV-----DMWAVGCILAELLLRV 210

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.1 bits (183), Expect = 4e-15
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHR 126
           K+   + +G G +G VY+   +     A+KR+       D G      RE+  + ++ H 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHP 79

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK-IAVGAARGIAY 185
           NIV+L     S +   L++E M    L   L      K  L   S+ K       RG+A+
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN---KTGLQ-DSQIKIYLYQLLRGVAH 134

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
            H      I+HRD+K  N+L++ +   +++DFGLA          +  V  T  Y AP+ 
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDV 190

Query: 246 -FDTGRATAKGDVYSFGVVLLELLTGK 271
              + + +   D++S G +  E++TGK
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 22/208 (10%)

Query: 78  IGSGGFGTVYRLTVNDSTAF-AVKRLHRGT-TEVDRGFE----RE---LEAMGDIKHRNI 128
           IG G +GTVY+     S  F A+K +          G      RE   L  +   +H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 129 VTL----HGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGI 183
           V L        T  +  + L++E +    L T+L         L   +   +     RG+
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGL 133

Query: 184 AYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
            +LH +    I+HRD+K  NIL+      +++DFGLA +   +      +V  T  Y AP
Sbjct: 134 DFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAP 188

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGK 271
           E           D++S G +  E+   K
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 34/223 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNI 128
           ++     +G GG G V+    ND     A+K++       V     RE++ +  + H NI
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNI 70

Query: 129 VTLHGYYTSSQYNL--------------LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
           V +      S   L              ++ E M     +T L    + +  L      +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLA-NVLEQGPLL-EEHAR 123

Query: 175 -IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVST 232
                  RG+ Y+H     +++HRD+K +N+ ++ +++  ++ DFGLA +M+   +H   
Sbjct: 124 LFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 233 I---VAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGK 271
           +   +  T  Y +P         T   D+++ G +  E+LTGK
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 38/224 (16%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVD--RGFERELEAMGDIKHRN 127
            F  K ++G G +G V   T   +    A+K++      +   R   RE++ +   KH N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHEN 70

Query: 128 IVTLHGYYTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLDWPSR-----YKIAV 177
           I+T+        +       +I ELM      T LH + ++ + L          Y+   
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELM-----QTDLH-RVISTQMLS-DDHIQYFIYQTL- 122

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
              R +  LH     ++IHRD+K SN+L++ N + +V DFGLA +++      S      
Sbjct: 123 ---RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 238 FG---------YLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
            G         Y APE    + + +   DV+S G +L EL   +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 17/207 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKH 125
            +   D +G G + TVY+     +    A+K +     E + G      RE+  + D+KH
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKH 59

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            NIVTLH    + +   L++E +    L  +L         ++  +         RG+AY
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI---INMHNVKLFLFQLLRGLAY 115

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
            H      ++HRD+K  N+L+++  E +++DFGLA             V  T  Y  P+ 
Sbjct: 116 CHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171

Query: 246 -FDTGRATAKGDVYSFGVVLLELLTGK 271
              +   + + D++  G +  E+ TG+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE----RELEAMGDIKHR 126
           K+   + IG G +G VY+   N    FA+K++       D G      RE+  + ++KH 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NIV L+    + +  +L++E +    L   L    V +  L+  +     +    GIAY 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY- 245
           H      ++HRD+K  N+L+++  E +++DFGLA          +  +  T  Y AP+  
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGK 271
             + + +   D++S G +  E++ G 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 49/230 (21%), Positives = 83/230 (36%), Gaps = 58/230 (25%)

Query: 60  LQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELE 118
           ++ +AI        +  V+G G  G V ++    +   FA+K L            RE+E
Sbjct: 10  IKKNAIIDD--YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVE 62

Query: 119 AMGDI-KHRNIVTLHGYY----TSSQYNLLIYELMPNGSL-DTFLHGKSVNKKNLDWPSR 172
                 +  +IV +   Y       +  L++ E +  G L       +  ++ +      
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS-----RIQDRGD----QA 113

Query: 173 Y--KIAVGAAR----GIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLM 223
           +  + A    +     I YLH     +I HRD+K  N+L      N   +++DFG A   
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170

Query: 224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             EK            Y               D++S GV++  LL G  P
Sbjct: 171 TGEK------------Y-----------DKSCDMWSLGVIMYILLCGYPP 197

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 26/230 (11%)

Query: 53  RSPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDR 111
            S  +     +  F+   K+ +  ++G G +G V +    D+    A+K+      + D+
Sbjct: 8   HSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDK 65

Query: 112 GFE----RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN---GSLDTFLHG--KSV 162
             +    RE++ +  ++H N+V L       +   L++E + +     L+ F +G    V
Sbjct: 66  MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV 125

Query: 163 NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL 222
            +K L     ++I      GI + H     +IIHRDIK  NIL+ Q+   ++ DFG A  
Sbjct: 126 VQKYL-----FQII----NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART 173

Query: 223 MEAEKTHVSTIVAGTFGYLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           + A        VA T  Y APE      +     DV++ G ++ E+  G+
Sbjct: 174 LAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 77  VIGSGGFGTVY----RLTVNDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHRNI 128
           V+G G FG V+        +    +A+K L + T      V    ER++  + ++ H  I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFI 88

Query: 129 VTLHGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA-VGAARGIAYL 186
           V LH Y   ++  L LI + +  G L  F           +   ++ +A +  A  + +L
Sbjct: 89  VKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEED-VKFYLAELALA--LDHL 142

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE 244
           H      II+RD+K  NILLD+    +++DFGL+  ++   +K +  +   GT  Y+APE
Sbjct: 143 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFC-GTVEYMAPE 196

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRP 273
             +    T   D +SFGV++ E+LTG  P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 17/204 (8%)

Query: 77  VIGSGGFGTVYRLTVNDSTA-FAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           ++G G FG V  +    +   +A+K L +              E   + + +H  +  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + +      + E    G L  F H       + D    Y   + +A  + YLH +   
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSA--LDYLHSEK-- 268

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE---YFDTG 249
           ++++RD+K  N++LD++   +++DFGL      +   + T   GT  YLAPE     D G
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEVLEDNDYG 327

Query: 250 RATAKGDVYSFGVVLLELLTGKRP 273
           RA    D +  GVV+ E++ G+ P
Sbjct: 328 RAV---DWWGLGVVMYEMMCGRLP 348

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 24/213 (11%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTA--FAVKRLHRGTTEVDRGFE----RELEAMGDIK 124
           ++     +G G +G VY+  ++  T    A+KR+       + G      RE+  + +++
Sbjct: 35  RYRRITKLGEGTYGEVYK-AIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
           HRNI+ L      +    LI+E       +  L        ++              G+ 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEAR-----VSDFGLATLMEAEKTHVSTIVAGTFG 239
           + H       +HRD+K  N+LL  +  +      + DFGLA          +  +  T  
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLW 202

Query: 240 YLAPEY-FDTGRATAKGDVYSFGVVLLELLTGK 271
           Y  PE    +   +   D++S   +  E+L   
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 52/245 (21%), Positives = 88/245 (35%), Gaps = 52/245 (21%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRG-TTEVD--RGFERELEAMG 121
                 +  K +IG G +G VY     ++    A+K+++R     +D  R   RE+  + 
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILN 80

Query: 122 DIKHRNIVTLHGYYTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLDWPSR---- 172
            +K   I+ L+               ++ E+      D+ L    + K  +         
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLK--KLFKTPIFLTEEHIKT 133

Query: 173 --YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV 230
             Y +      G  ++H      IIHRD+K +N LL+Q+   +V DFGLA  + +EK   
Sbjct: 134 ILYNLL----LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 231 STIVAGTFGYLAPEYFDTG------------RA----------TAKGDVYSFGVVLLELL 268
                       P   +              RA          T   D++S G +  ELL
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

Query: 269 TGKRP 273
              + 
Sbjct: 247 NMLQS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 58/236 (24%), Positives = 92/236 (38%), Gaps = 52/236 (22%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHR---GTTEVDRGFERE---LEAMGDI 123
           K+     +G G +G V++     +    AVK++      +T+  R F RE   L  +   
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSG- 67

Query: 124 KHRNIVTLHGYYTSSQYN--LLIYELMPNGSLDTFLHGKSVNKKNLDWPSR-----YKIA 176
            H NIV L     +       L+++ M     +T LH   +    L+ P       Y++ 
Sbjct: 68  -HENIVNLLNVLRADNDRDVYLVFDYM-----ETDLH-AVIRANILE-PVHKQYVVYQLI 119

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAG 236
               + I YLH      ++HRD+K SNILL+     +V+DFGL+      +   + I   
Sbjct: 120 ----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 237 TFGYLAPEYFDTG-----------RA----------TAKGDVYSFGVVLLELLTGK 271
                     D             RA          T   D++S G +L E+L GK
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 52/235 (22%), Positives = 91/235 (38%), Gaps = 60/235 (25%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGF----ERELEAMGDIKH 125
           K+     IG G FG V++     +    A+K++     E + GF     RE++ +  +KH
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKE-GFPITALREIKILQLLKH 75

Query: 126 RNIVTLHGYYTSSQYNL--------LIYELMPN---GSLDT----FLHG--KSVNKKNLD 168
            N+V L     +             L+++   +   G L      F     K V +  L 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL- 134

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                        G+ Y+H +    I+HRD+K++N+L+ ++   +++DFGLA      K 
Sbjct: 135 ------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 229 HVST-----IVAGTFGYLAPE-------YFDTGRATAKGDVYSFGVVLLELLTGK 271
                    +V  T  Y  PE       Y          D++  G ++ E+ T  
Sbjct: 180 SQPNRYTNRVV--TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.2 bits (165), Expect = 8e-13
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKH 125
           F     +G+G FG V+ +    +   +A+K L +       +V+    ER +  +  + H
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM--LSIVTH 65

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA-VGAARGIA 184
             I+ + G +  +Q   +I + +  G L  F   +   +      +++  A V  A  + 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNP-VAKFYAAEVCLA--LE 120

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           YLH      II+RD+K  NILLD+N   +++DFG A  +  + T+  T+  GT  Y+APE
Sbjct: 121 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY--TLC-GTPDYIAPE 173

Query: 245 YFDT---GRATAKGDVYSFGVVLLELLTGKRP 273
              T    ++    D +SFG+++ E+L G  P
Sbjct: 174 VVSTKPYNKSI---DWWSFGILIYEMLAGYTP 202

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.4 bits (163), Expect = 1e-12
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 48/223 (21%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAF-AVKRLHRGTTEVDRGFE----RELEAMGDIKH 125
           K+     IG G +G V++    D+    A+K+      E D   +    RE+  +  +KH
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKH 61

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA----- 180
            N+V L   +   +   L++E       D  +         LD   RY+  V        
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYC-----DHTV------LHELD---RYQRGVPEHLVKSI 107

Query: 181 -----RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
                + + + H     + IHRD+K  NIL+ ++   ++ DFG A L+     +    VA
Sbjct: 108 TWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164

Query: 236 GTFGYLAPE-------YFDTGRATAKGDVYSFGVVLLELLTGK 271
            T  Y +PE       Y          DV++ G V  ELL+G 
Sbjct: 165 -TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 32/166 (19%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRG-TTEVD--RGFERELEAMGDIKHR 126
           ++  + +IG+G +G V            A+K++ R     +D  R   RE+  +  + H 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHD 112

Query: 127 NIVTLHGYYTSSQYNL-----LIYELMPNGSLDTFLHGKSVNKKNLDWPSR------YKI 175
           ++V +                ++ E+      D+      + +  +           Y +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFK--KLFRTPVYLTELHIKTLLYNL 165

Query: 176 AVGAARGIAYLH-HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA 220
                 G+ Y+H       I+HRD+K +N L++Q+   +V DFGLA
Sbjct: 166 L----VGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 49/261 (18%)

Query: 42  DSVSGGKMVMFRSPLIHSLQSDAIFKKTLKFSSKD-----VIGSGGFGTVY----RLTVN 92
            S  GG        + H L++  +     K   ++     V+G+G +G V+        +
Sbjct: 21  TSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHD 80

Query: 93  DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH----RNI----------VTLHGYYTSS 138
               +A+K L +            ++     +H    R +          VTLH Y   +
Sbjct: 81  TGKLYAMKVLKK---------ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQT 130

Query: 139 QYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA-VGAARGIAYLHHDCIPHIIH 196
           +  L LI + +  G L  F H     +       +  +  +  A  + +LH      II+
Sbjct: 131 ETKLHLILDYINGGEL--FTHLSQRERFTEHE-VQIYVGEIVLA--LEHLHKL---GIIY 182

Query: 197 RDIKSSNILLDQNMEARVSDFGLA-TLMEAEKTHVSTIVAGTFGYLAPE---YFDTGRAT 252
           RDIK  NILLD N    ++DFGL+   +  E         GT  Y+AP+     D+G   
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDK 241

Query: 253 AKGDVYSFGVVLLELLTGKRP 273
           A  D +S GV++ ELLTG  P
Sbjct: 242 AV-DWWSLGVLMYELLTGASP 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 38/216 (17%)

Query: 77  VIGSGGFGTVY----RLTVNDSTAFAVKRLHRGTTEVDRGFERE--------LEAMGDIK 124
           V+G GG+G V+        N    FA+K L +    V    +          LE    +K
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEE---VK 79

Query: 125 HRNIVTLHGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIA-VGAARG 182
           H  IV L  Y   +   L LI E +  G L  F+  +       D  + + +A +  A  
Sbjct: 80  HPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDT-ACFYLAEISMA-- 133

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGY 240
           + +LH      II+RD+K  NI+L+     +++DFGL   ++ +   TH  T   GT  Y
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--TFC-GTIEY 187

Query: 241 LAPE---YFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           +APE        RA    D +S G ++ ++LTG  P
Sbjct: 188 MAPEILMRSGHNRAV---DWWSLGALMYDMLTGAPP 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKHRNIVT 130
           V+G G FG V       +   +AVK L +       +V+    E+ + A+   K   +  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQ 406

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +      + E +  G L    H + V +        Y   +  A G+ +L    
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEI--AIGLFFLQSK- 461

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE---Y 245
              II+RD+K  N++LD     +++DFG+    + +   T   T   GT  Y+APE   Y
Sbjct: 462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTF-CGTPDYIAPEIIAY 516

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
              G++    D ++FGV+L E+L G+ P
Sbjct: 517 QPYGKSV---DWWAFGVLLYEMLAGQAP 541

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.5 bits (158), Expect = 8e-12
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 22/206 (10%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFER---ELEAMGDIKHRNIVTLH 132
           ++G G FG V  +    +   +A+K L +              E   + + +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 133 GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIP 192
             + +      + E    G L  F H         +    Y   + +A  + YLH     
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSA--LEYLHSR--- 124

Query: 193 HIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE---YFD 247
            +++RDIK  N++LD++   +++DFGL    + +       T   GT  YLAPE     D
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC-GTPEYLAPEVLEDND 181

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
            GRA    D +  GVV+ E++ G+ P
Sbjct: 182 YGRAV---DWWGLGVVMYEMMCGRLP 204

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERE-LEAMGDIKHRNIV 129
           V+G G FG V       +   +AVK L +       +V+    E+  L   G  K   + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFLT 84

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            LH  + +      + E +  G L    H + V +        Y   +     + +L   
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIG--LFFLQSK 140

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE--- 244
               II+RD+K  N++LD     +++DFG+    + +   T   T   GT  Y+APE   
Sbjct: 141 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--TFC-GTPDYIAPEIIA 194

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRP 273
           Y   G++    D ++FGV+L E+L G+ P
Sbjct: 195 YQPYGKSV---DWWAFGVLLYEMLAGQAP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 31/211 (14%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKHRNIVT 130
           V+G G FG V    V ++   +AVK L +       +V+    E+ + ++    H  +  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 88

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR---GIAYLH 187
           L   + +      + E +  G L    H +   + +      Y     AA     + +LH
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY-----AAEIISALMFLH 141

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE- 244
                 II+RD+K  N+LLD     +++DFG+    +     T  +T   GT  Y+APE 
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIAPEI 195

Query: 245 --YFDTGRATAKGDVYSFGVVLLELLTGKRP 273
                 G A    D ++ GV+L E+L G  P
Sbjct: 196 LQEMLYGPAV---DWWAMGVLLYEMLCGHAP 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 45/225 (20%), Positives = 85/225 (37%), Gaps = 41/225 (18%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERE---LEAMG 121
           +     +     +G G +  V+    + ++    VK L        +  +RE   LE + 
Sbjct: 32  WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLR 88

Query: 122 DIKHRNIVTLH---GYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR---YKI 175
                NI+TL        S    L+   +      +T      + +   D+  R   Y+I
Sbjct: 89  G--GPNIITLADIVKDPVSRTPALVFEHVN-----NTDFK--QLYQTLTDYDIRFYMYEI 139

Query: 176 AVGAARGIAYLH-HDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKT---HV 230
                + + Y H       I+HRD+K  N+++D ++ + R+ D+GLA      +     V
Sbjct: 140 L----KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191

Query: 231 STIVAGTFGYLAPE-YFDTGRATAKGDVYSFGVVLLELLTGKRPM 274
           ++       +  PE   D        D++S G +L  ++  K P 
Sbjct: 192 ASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 77  VIGSGGFGTVY--RLTVNDSTAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKHRNIV 129
           ++G G FG V+        +  FA+K L +       +V+    E+ + ++   +H  + 
Sbjct: 24  MLGKGSFGKVFLAEF-KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT 81

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            +   + + +    + E +  G L    H +S +K +L   + Y   +     + +LH  
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILG--LQFLHSK 137

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               I++RD+K  NILLD++   +++DFG+    ++   KT  +T   GT  Y+APE   
Sbjct: 138 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFC-GTPDYIAPEILL 191

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRP 273
             +     D +SFGV+L E+L G+ P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 25/208 (12%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKHRNIVT 130
           VIG G FG V           +AVK L +       E      ER +    ++KH  +V 
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NVKHPFLVG 103

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + ++     + + +  G L  F H +          +R+  A   A  + YLH   
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPR-ARFYAA-EIASALGYLHSL- 158

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE---Y 245
             +I++RD+K  NILLD      ++DFGL    +     T  ST   GT  YLAPE    
Sbjct: 159 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFC-GTPEYLAPEVLHK 213

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
               R     D +  G VL E+L G  P
Sbjct: 214 QPYDRTV---DWWCLGAVLYEMLYGLPP 238

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERELEAMGDIKHRNIVT 130
           VIG G +  V  + +  +   +A+K + +       ++D    E+ +       H  +V 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 74

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           LH  + +      + E +  G L    H +   K   +    Y   +  A  + YLH   
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER- 129

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE---Y 245
              II+RD+K  N+LLD     +++D+G+    L   + T   T   GT  Y+APE    
Sbjct: 130 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--TFC-GTPNYIAPEILRG 184

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRP 273
            D G +    D ++ GV++ E++ G+ P
Sbjct: 185 EDYGFSV---DWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 40/271 (14%)

Query: 77  VIGSGGFGTVYRLTVNDS-TAFAVKRLHRGT----TEVDRGF-ERE-LEAMGDIKHRNIV 129
           VIG G +  V  + +  +   +A++ + +       ++D    E+   E      H  +V
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS--NHPFLV 116

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            LH  + +      + E +  G L    H +   K   +    Y   +  A  + YLH  
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER 172

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLA--TLMEAEKTHVSTIVAGTFGYLAPE--- 244
               II+RD+K  N+LLD     +++D+G+    L   + T   T   GT  Y+APE   
Sbjct: 173 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--TFC-GTPNYIAPEILR 226

Query: 245 YFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
             D G +    D ++ GV++ E++ G+ P    F   G+              E+Y+   
Sbjct: 227 GEDYGFSV---DWWALGVLMFEMMAGRSP----FDIVGS------SDNPDQNTEDYLFQV 273

Query: 305 SLEG---CPINEINDVFSIASMCLEPEPSKR 332
            LE     P +      S+    L  +P +R
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 55/313 (17%), Positives = 109/313 (34%), Gaps = 64/313 (20%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---------- 124
             +G G F TV+    + ++T  A+K + RG        E E++ +  +           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 125 -HRNIVTLHGYYTSSQYNL----LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
              +I+ L  ++     N     +++E++   +L   +  K    + +      +I+   
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI--KKYEHRGIPLIYVKQISKQL 140

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLD------QNMEARVSDFGLATLMEAEKTHVSTI 233
             G+ Y+H  C   IIH DIK  N+L++        ++ +++D G A        H +  
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNS 195

Query: 234 VAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKR--------------------- 272
           +     Y +PE           D++S   ++ EL+TG                       
Sbjct: 196 IQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 273 ----PMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE-------GCPINEINDVFSIA 321
                +    L  G    T+  +    +    +    LE           +E  ++    
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 322 SMCLEPEPSKRPT 334
           S  L+ +P KR  
Sbjct: 315 SPMLQLDPRKRAD 327

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 42/232 (18%), Positives = 75/232 (32%), Gaps = 50/232 (21%)

Query: 78  IGSGGFGTVY---------RLTVNDSTAFAVK------RLHRGTTEVDRGFE----RELE 118
                 G +Y           +      F++K      RL        R  +     + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 119 AMGDIKHRNIVTLHGY-YTSSQYNLLIYELMPNG-SLDTFLHGKSVNKKNLDWPSRYKIA 176
            +       I T  G+     +Y  L+   +  G SL + L      K  L   S  ++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL--DVSPKHVLSERSVLQVA 165

Query: 177 VGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHV---- 230
                 + +LH +     +H ++ + NI +D   +++V  + +G A        HV    
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 231 --STIVAGTFGYLAPEYFDTGRATAKG-------DVYSFGVVLLELLTGKRP 273
              +   G       E+        KG       D+ S G  +L+ L G  P
Sbjct: 223 GSRSPHEGD-----LEF--ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 22/206 (10%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVK------RLHR-GTTEVDRGFERELEAMGDIKHRN 127
            VIG G FG V +          A+K      R HR    E+       L         N
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR--ILEHLRKQDKDNTMN 160

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           ++ +   +T   +  + +EL+ + +L   +  K    +    P   K A    + +  LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEA--RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
                 IIH D+K  NILL Q   +  +V DFG +     E   V T +   F Y APE 
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQSRF-YRAPEV 270

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGK 271
               R     D++S G +L ELLTG 
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.3 bits (132), Expect = 1e-08
 Identities = 29/197 (14%), Positives = 51/197 (25%), Gaps = 45/197 (22%)

Query: 66  FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE----------- 114
              T K    + IG G FG V++ T+ D T  A+K +     ++  G             
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 115 ------RELEAMGDIKHRNIVTLH------GYYTSSQYNLLIYELMPNGSLDTFLHGKSV 162
                   L      +    + L+      G Y         +     GS +        
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 163 NK-------------------KNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSN 203
           ++                   K     +   I       +A           HRD+   N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192

Query: 204 ILLDQNMEARVSDFGLA 220
           +LL +    ++      
Sbjct: 193 VLLKKTSLKKLHYTLNG 209

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 20/206 (9%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVK------RLHR-GTTEVDRGFERELEAMGDIKHRN 127
            +IG G FG V +     +    A+K              EV       +          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR--LLELMNKHDTEMKYY 117

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV L  ++    +  L++E++ + +L   L  ++ N + +      K A      + +L 
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLL--RNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 188 HDCIPHIIHRDIKSSNILL--DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
              +  IIH D+K  NILL   +    ++ DFG +         +   +   F Y +PE 
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQSRF-YRSPEV 229

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGK 271
                     D++S G +L+E+ TG+
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 51/212 (24%), Positives = 79/212 (37%), Gaps = 30/212 (14%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIKHRNIVTLHGYY 135
           IGSG FG +Y    +  +   A+K  +  T      +E +    +       I  +  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG--IPNVRWFG 72

Query: 136 TSSQYNLLIYELM-PN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
               YN+L+ +L+ P+   L  F   K   K  L       +A      + ++H      
Sbjct: 73  VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEFVHSK---S 123

Query: 194 IIHRDIKSSNILLDQNMEAR---VSDFGLATLMEAEKTHV------STIVAGTFGYL--- 241
            +HRDIK  N L+     A    + DFGLA       TH       +  + GT  Y    
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
                +  R   + D+ S G VL+  L G  P
Sbjct: 184 THLGIEQSR---RDDLESLGYVLMYFLRGSLP 212

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 60/376 (15%), Positives = 129/376 (34%), Gaps = 110/376 (29%)

Query: 18  FVISKI----IISVLLYRRW-KRKNMVYTDSVSGGKMVMFRSPLIHSLQSDAIFKKTLKF 72
           F++S I        ++ R + ++++ +Y D+    K  + R      L+  A+ +  L+ 
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ-ALLE--LR- 148

Query: 73  SSKDVI--GSGGFG-TVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI- 128
            +K+V+  G  G G T   + +                +V   ++ +   M       I 
Sbjct: 149 PAKNVLIDGVLGSGKTW--VAL----------------DVCLSYKVQ-CKMDF----KIF 185

Query: 129 -VTLHGYYTSS-----QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
            + L     S          L+Y++ PN +               D  S  K+ + + + 
Sbjct: 186 WLNL-KNCNSPETVLEMLQKLLYQIDPNWT------------SRSDHSSNIKLRIHSIQA 232

Query: 183 -IAYL-----HHDCIPHIIHRDIKSSNILLDQNMEARV----SDFGLATLMEAEKTHVST 232
            +  L     + +C+  ++  +++++      N+  ++        +   + A  T   +
Sbjct: 233 ELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE---------------- 276
           +   +      E         K         LL      RP D                 
Sbjct: 291 LDHHSMTLTPDE--------VKS--------LLLKYLDCRPQDLPREVLTTNPRRLSIIA 334

Query: 277 AFLEEGTKLVTW--VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT 334
             + +G  L TW   K V  DK    +I++SL      E   +F    + + P  +  P 
Sbjct: 335 ESIRDG--LATWDNWKHVNCDKLTT-IIESSLNVLEPAEYRKMFD--RLSVFPPSAHIP- 388

Query: 335 MTEVVKML--ELIKSE 348
            T ++ ++  ++IKS+
Sbjct: 389 -TILLSLIWFDVIKSD 403

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 53/212 (25%), Positives = 78/212 (36%), Gaps = 30/212 (14%)

Query: 78  IGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIKHRNIVTLHGYY 135
           IGSG FG +Y    +      A+K     T       E +  + M       I T+    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG--IPTIRWCG 74

Query: 136 TSSQYNLLIYELM-PN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH 193
               YN+++ EL+ P+   L  F   K   K  L       +A      I Y+H     +
Sbjct: 75  AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL------LADQMISRIEYIHSK---N 125

Query: 194 IIHRDIKSSNILLDQNMEA---RVSDFGLATLMEAEKTHV------STIVAGTFGYL--- 241
            IHRD+K  N L+    +     + DFGLA      +TH       +  + GT  Y    
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRP 273
                +  R   + D+ S G VL+    G  P
Sbjct: 186 THLGIEQSR---RDDLESLGYVLMYFNLGSLP 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 47/233 (20%), Positives = 75/233 (32%), Gaps = 52/233 (22%)

Query: 78  IGSGGFGTVY------RLTVNDSTAFAVKRLHRGT----TEV-------DRGFERELEAM 120
           IG GGFG +Y        +V       VK          TE+            ++    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 121 GDIKHRNIVTLHGY----YTSSQYNLLIYELMPNG-SLDTFLHGKSVNKKNLDWPSRYKI 175
             +K+  +    G          Y  +I +    G  L         N K     +  ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRFSRKTVLQL 157

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHV--- 230
           ++     + Y+H       +H DIK+SN+LL+     +V   D+GLA     E  H    
Sbjct: 158 SLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214

Query: 231 ---STIVAGTFGYLAPEYFDTGRATAKG-------DVYSFGVVLLELLTGKRP 273
                   GT  +       T      G       D+   G  +++ LTG  P
Sbjct: 215 ADPKRCHDGTIEF-------TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 48/238 (20%), Positives = 80/238 (33%), Gaps = 65/238 (27%)

Query: 78  IGSGGFGTVY---RLTVNDSTAFAV------------------KRLHRGTTEVDRGFERE 116
           IGSGGFG +Y        +  A  V                  +R+ +          ++
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 117 LEAMGDIKHRNIVTLHGY----YTSSQYNLLIYELMPNG-SL-DTFLHGKSVNKKNLDWP 170
           L+ +G      I   +G     +    Y  ++ E +  G  L        +  K  +   
Sbjct: 105 LDYLG------IPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTV--- 153

Query: 171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKT 228
              ++ +     + Y+H +     +H DIK++N+LL      +V  +D+GL+        
Sbjct: 154 --LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

Query: 229 HV------STIVAGTFGYLAPEYFDTGRATAKG-------DVYSFGVVLLELLTGKRP 273
           H            GT      E+  T     KG       DV   G  +L  L GK P
Sbjct: 209 HKQYQENPRKGHNGT-----IEF--TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 30/165 (18%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIKHRNI 128
            F     IG G FG +     +  +   A+K     +       E R  + +G      I
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG--I 67

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR-------YKIAVGAAR 181
             ++ +    +YN ++ EL+          G S+     D   R         IA+    
Sbjct: 68  PQVYYFGPCGKYNAMVLELL----------GPSLEDL-FDLCDRTFSLKTVLMIAIQLIS 116

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS-----DFGLAT 221
            + Y+H     ++I+RD+K  N L+ +            DF LA 
Sbjct: 117 RMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 39/240 (16%), Positives = 57/240 (23%), Gaps = 87/240 (36%)

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILL----------------------------------- 206
           G+ YLH  C   IIH DIK  NILL                                   
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 207 --------------DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT 252
                          + ++ +++D G A  +    T        T  Y + E        
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYN 271

Query: 253 AKGDVYSFGVVLLELLTGKR-------------------------PMDEAFLEEGTKLVT 287
              D++S   +  EL TG                            +    +  G     
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331

Query: 288 WVKAVMQDKREEYVIDTSLE-------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           +       K    +    L             E           LE  P KR T  E ++
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 30/159 (18%), Positives = 60/159 (37%), Gaps = 18/159 (11%)

Query: 71  KFSSKDVIGSGGFGTVYR-LTVNDSTAFAVKRLHRGTTEVDRGFE-RELEAMGDIKHRNI 128
            +     IG G FG ++    + ++   A+K   R +       E R  + +       I
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--I 68

Query: 129 VTLHGYYTSSQYNLLIYELMPNG-SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
             ++ +     +N+L+ +L+  G SL+  L    +  +     +    A      +  +H
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEAR-----VSDFGLAT 221
                 +++RDIK  N L+ +          V DFG+  
Sbjct: 124 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 43/210 (20%), Positives = 68/210 (32%), Gaps = 66/210 (31%)

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-------------------RVSDFGLAT 221
             + +LH      + H D+K  NIL   +                      RV+DFG AT
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190

Query: 222 LMEAEKTHVSTIVAGTFGYLAPE-----YFDTGRATAKGDVYSFGVVLLELLTGKR---- 272
               +  H +TIVA    Y  PE      +         DV+S G +L E   G      
Sbjct: 191 F---DHEHHTTIVATRH-YRPPEVILELGWAQ-----PCDVWSIGCILFEYYRGFTLFQT 241

Query: 273 ---------------PMDEAFLEEGTKL-------VTWVKAVMQDKREEYVIDTSLEGCP 310
                          P+    +    K        + W +    D R        L+   
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE-NSSDGRYVKENCKPLKSYM 300

Query: 311 INEIND---VFSIASMCLEPEPSKRPTMTE 337
           + +  +   +F +    LE +P++R T+ E
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 43/209 (20%), Positives = 70/209 (33%), Gaps = 64/209 (30%)

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA-------------------RVSDFGLAT 221
           + + +LH      + H D+K  NIL  Q+                      +V DFG AT
Sbjct: 129 KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185

Query: 222 LMEAEKTHVSTIVAGTFGYLAPE-----YFDTGRATAKGDVYSFGVVLLELLTGKR---- 272
               +  H ST+V+    Y APE      +         DV+S G +L+E   G      
Sbjct: 186 Y---DDEHHSTLVSTRH-YRAPEVILALGWSQ-----PCDVWSIGCILIEYYLGFTVFPT 236

Query: 273 ---------------PMDEAFLEEGTK-------LVTWVKAVMQDKREEYVIDTSLE--G 308
                          P+ +  +++  K        + W +     +          E   
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTE 337
               E   +F +    LE +P+KR T+ E
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLRE 325

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 68/334 (20%), Positives = 108/334 (32%), Gaps = 94/334 (28%)

Query: 76  DVIGSGGFGTVYR-LTVNDSTAFAVK------RLHR-GTTEVDRGFERELEAMG--DIKH 125
             +G G FG V     +++   +AVK      +  R    E        L+ +   DI +
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEA-----DILKKIQNDDINN 95

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            NIV  HG +    +  LI+E +   SL   +     N             +   + + Y
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEII--TRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEA-------------------------RVSDFGLA 220
           L       + H D+K  NILLD                              ++ DFG A
Sbjct: 153 LR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 221 TLMEAEKTHVSTIVAGTFGYLAPE------YFDTGRATAKGDVYSFGVVLLELLTGK--- 271
           T    +  +  +I+     Y APE      +          D++SFG VL EL TG    
Sbjct: 210 TF---KSDYHGSIINTRQ-YRAPEVILNLGW------DVSSDMWSFGCVLAELYTGSLLF 259

Query: 272 ----------------RPMDEAFLEEGTK------------LVTWVKAVMQDKREEYVID 303
                           +P+ +  L E TK             + W +        ++V  
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE 337
             L    I +           L+ +P+ RP+  E
Sbjct: 320 -CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	351
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.54
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.18
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.14
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.13
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.81
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.73
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.59
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.57
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.44
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.26
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.96
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.58
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.91
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.98
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.98
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.66
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.72
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	85.89
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.41

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-61  Score=421.57  Aligned_cols=259  Identities=25%  Similarity=0.443  Sum_probs=216.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|...+.||+|+||+||+|.+.      ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..++|
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV   93 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   93 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            5777889999999999999864      3677999999887777778899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCC---------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          145 YELMPNGSLDTFLHGKS---------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      ||||++|+|.+++....         .....+++..++.++.||++||+|||++   +|+||||||+|||+++++.+||+
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence            99999999999997532         2345799999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHH
Q 018702          216 DFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       216 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      |||+|+........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |+.||.....      .+......
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~  244 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECIT  244 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH
Confidence            99999865543322 2334568999999999999999999999999999999998 8999965422      12222222


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ....         ...|..+++++.+|+.+||+.||++|||++|+++.|+++..
T Consensus       245 ~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          245 QGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2211         12345566889999999999999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-60  Score=421.76  Aligned_cols=259  Identities=27%  Similarity=0.449  Sum_probs=209.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      +|...+.||+|+||+||+|.+.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4566678999999999999864      3678999999887777778899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          145 YELMPNGSLDTFLHGKSV-----------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                      ||||++|+|.+++.....           ...++++..++.++.||++||+|||+.   +|+||||||+|||+++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEE
Confidence            999999999999975432           234699999999999999999999998   999999999999999999999


Q ss_pred             EeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHH
Q 018702          214 VSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       214 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      |+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.....      .+....
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~  272 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDC  272 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHHHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence            999999986644332 23344569999999999999999999999999999999999 8999965422      122222


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .......         ..|..+++++.+|+.+||+.||++|||++|++++|+.+.+
T Consensus       273 i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          273 ITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            2222111         2344556889999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.8e-60  Score=415.38  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=211.8

Q ss_pred             CCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++..+.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            455678999999999999863      45789999997543 33456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          145 YELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      ||||++|+|.++|.....            ....+++..+..++.||++||+|||++   +|+||||||+|||+++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence            999999999999964321            124689999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHH
Q 018702          213 RVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      ||+|||+++....... .......||+.|+|||++.++.|+.++|||||||++|||+| |..||.....      .+...
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~~~  258 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVE  258 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHHHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence            9999999986644332 22344579999999999999999999999999999999998 8999965432      12222


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ......         ..+.|.+++..+.+|+.+||+.||++|||++||+++|+.+.
T Consensus       259 ~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          259 MIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            222211         11245556688999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-59  Score=407.20  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=206.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+++..+.||+|+||+||+|.+++  .||||+++..  ..+..+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            467778899999999999998754  5899998653  33445679999999999999999999999865 567999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      |++|+|.+++...   ...+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus       113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999742   45699999999999999999999998   99999999999999999999999999998654332


Q ss_pred             -ccccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          228 -THVSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       228 -~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                       .......+||+.|+|||++.+   +.|+.++|||||||++|||+||+.||......      ...........    ..
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~----~~  256 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGY----AS  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTC----CC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC----CC
Confidence             223345679999999999853   46899999999999999999999999653211      11122221111    11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      +.....+.++++.+.+|+.+||+.||++|||+.|++++|+.++..
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            222234555668899999999999999999999999999988653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-59  Score=415.62  Aligned_cols=251  Identities=22%  Similarity=0.377  Sum_probs=205.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|+..+.||+|+||+||+|.+. +++.||||++....  ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999975 68899999997543  3344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      ||+||+|.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999643  244578899999999999999999999   9999999999999999999999999999866432


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      . ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....      .............         
T Consensus       179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~---------  242 (350)
T 4b9d_A          179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSF---------  242 (350)
T ss_dssp             H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC---------
T ss_pred             c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC---------
Confidence            2 12334679999999999999999999999999999999999999996542      2222333332221         


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12244456789999999999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.5e-59  Score=411.39  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=211.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888999999999999999975 68899999997655555566889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +||+|.+++.+     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.......
T Consensus       154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999963     4589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                       .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.....      .............       ...
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~-------~~~  291 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNLPP-------RLK  291 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSSCC-------CCS
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCCC-------CCC
Confidence             23456799999999999999999999999999999999999999965321      1122222211110       011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...++++.+|+.+||+.||++|||+.|++++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            234456889999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-59  Score=408.22  Aligned_cols=247  Identities=22%  Similarity=0.335  Sum_probs=210.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||+||+|... +++.||+|++....   ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999975 68899999996532   223457899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |||+||+|.+++.+    .+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999973    45799999999999999999999999   999999999999999999999999999987654


Q ss_pred             cc-ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EK-THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .. .....+.+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.....      ............       
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~-------  251 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEY-------  251 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC-------
Confidence            32 2334567899999999999999999999999999999999999999965321      222222222211       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV  339 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l  339 (351)
                         ..|...++++.+|+.+||++||++|||++|++
T Consensus       252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               13444567899999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.5e-59  Score=410.18  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=207.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..|+..+.||+|+||+||+|.+. +|+.||||+++....     ..+|+.+++.++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            35667778999999999999975 588999999976432     247999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccccCccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLMEAEK  227 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~  227 (351)
                      +||+|.+++..    .+.+++..+..++.||+.||+|||++   +|+||||||+|||++.+| .+||+|||+|+......
T Consensus       133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999973    45799999999999999999999999   999999999999999987 69999999998765432


Q ss_pred             cc----ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          228 TH----VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       228 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ..    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......   +.   .........     
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~i~~~~~~-----  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LC---LKIASEPPP-----  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CH---HHHHHSCCG-----
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHcCCCC-----
Confidence            21    1234579999999999999999999999999999999999999997643221   11   111111111     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                        ....+...++.+.+++.+||++||.+|||+.|++++|.....
T Consensus       275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence              112344556889999999999999999999999999876654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6e-58  Score=393.68  Aligned_cols=246  Identities=21%  Similarity=0.362  Sum_probs=194.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||+||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            48999999999999999999974 68899999997543   233457899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+ +|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 6799999873    45799999999999999999999999   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ..  ...+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||....      .............       
T Consensus       165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~-------  229 (275)
T 3hyh_A          165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVY-------  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCC-------
T ss_pred             CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCC-------
Confidence            32  2234679999999999988776 579999999999999999999996532      2222222222111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ..|...++++.+|+.+||+.||++|||++|++++
T Consensus       230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               1244456789999999999999999999999984

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=412.35  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=211.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46889999999999999999975 58899999998765555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +||+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.......
T Consensus       231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999963     4589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                       .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....      ..............       ..
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~~-------~~  368 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNLPPR-------LK  368 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC-------CS
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCCCC-------Cc
Confidence             23456799999999999999999999999999999999999999965321      11222222111100       01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...++++.+|+.+||+.||++|||+.|++++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            233445789999999999999999999999885

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-57  Score=392.86  Aligned_cols=245  Identities=27%  Similarity=0.433  Sum_probs=197.8

Q ss_pred             CCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEec----CCeeEEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS----SQYNLLIY  145 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  145 (351)
                      ...+.||+|+||+||+|.+. ++..||+|++...  .....+.+.+|++++++++|||||+++++|.+    ++..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45567999999999999975 5788999998653  23344678999999999999999999999865    35679999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEcC-CCceEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLDQ-NMEARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~  222 (351)
                      |||+||+|.+++.+    ...+++..+..++.||+.||+|||++   +  |+||||||+|||++. +|.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999999999973    45789999999999999999999998   7  999999999999984 89999999999975


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ....   ...+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....     ................   
T Consensus       182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~i~~~~~~~---  249 (290)
T 3fpq_A          182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVKPA---  249 (290)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCCCG---
T ss_pred             CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHHHHcCCCCC---
Confidence            4332   2345679999999999875 69999999999999999999999996431     1122222222211110   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ..+...++++.+|+.+||+.||++|||++|++++
T Consensus       250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0122234679999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2e-57  Score=398.90  Aligned_cols=267  Identities=24%  Similarity=0.304  Sum_probs=202.4

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC----eeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ----YNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  146 (351)
                      +|...+.||+|+||+||+|.++ |+.||||++..... ......+|+..+.+++|||||+++|+|.+++    ..++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            5677789999999999999984 78899999965322 2223445677778899999999999997654    5799999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD-----CIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      |+++|+|.+++..     .++++..+.+++.|++.||+|||++     +.++|+||||||+|||++.++.+||+|||+++
T Consensus        82 y~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           82 YHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999963     4589999999999999999999975     23589999999999999999999999999998


Q ss_pred             ccCccccc---ccccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCcchhcc---------cc
Q 018702          222 LMEAEKTH---VSTIVAGTFGYLAPEYFDTG------RATAKGDVYSFGVVLLELLTGKRPMDEAFLEE---------GT  283 (351)
Q Consensus       222 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~  283 (351)
                      ........   ......||+.|+|||++.+.      .++.++|||||||++|||+||.+||.......         ..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            66443322   12345799999999998754      36789999999999999999988775422111         11


Q ss_pred             cHHHHHHHHHhcCccceeccccCC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          284 KLVTWVKAVMQDKREEYVIDTSLE--GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ..............     ++.+.  ..+...++.+.+|+.+||+.||++|||+.|+++.|+++.+++
T Consensus       237 ~~~~~~~~~~~~~~-----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          237 SVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CHHHHHHHHTTSCC-----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHhcccC-----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            11222222222111     11111  112345678999999999999999999999999999998765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-57  Score=405.11  Aligned_cols=262  Identities=27%  Similarity=0.386  Sum_probs=213.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCChh-hHHHHHHHHHHhhcCCC-CceeeeeeEEecC-C
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTE-VDRGFERELEAMGDIKH-RNIVTLHGYYTSS-Q  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~-~  139 (351)
                      .++|+..+.||+|+||+||+|.+.+      ++.||+|.+...... ..+.+.+|++++.+++| ||||+++|+|.++ +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            4578889999999999999998643      257999999765443 34679999999999965 9999999998764 5


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..++|||||++|+|.++|.....            ....+++..+..++.||++||+|||++   +|+||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence            78999999999999999975321            234589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      +++.+||+|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||......     
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-----  294 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----  294 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence            9999999999999876544332 3344678999999999999999999999999999999998 99999653211     


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                       ..+........        ....|..+++++.+++.+||+.||++|||+.|++++|+.+.+
T Consensus       295 -~~~~~~i~~g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          295 -EEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             -HHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence             11122221111        112345556889999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-58  Score=399.74  Aligned_cols=248  Identities=26%  Similarity=0.358  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||+||+|...    .++.||+|++.....  .....+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999862    467899999875422  223357889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      |||||+||+|.+++.+    .+.+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999973    45799999999999999999999999   9999999999999999999999999999865


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ..... ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....      ............      
T Consensus       177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~------  243 (304)
T 3ubd_A          177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKL------  243 (304)
T ss_dssp             ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC------
T ss_pred             cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCC------
Confidence            43322 23346799999999999999999999999999999999999999965422      222222222211      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTM-----TEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~e~l~~  341 (351)
                          ..|...++++.+|+.+||+.||++|||+     +|++++
T Consensus       244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                2344556889999999999999999985     677753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-55  Score=385.14  Aligned_cols=250  Identities=25%  Similarity=0.450  Sum_probs=189.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCC---------
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQ---------  139 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  139 (351)
                      +|+..+.||+|+||+||+|... +++.||+|+++....+ ..+.+.+|++++++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5788899999999999999975 6889999999765433 3467899999999999999999999987544         


Q ss_pred             ---eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          140 ---YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       140 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                         ..|++||||++|+|.+++.... .....++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence               3689999999999999997532 223345667889999999999999999   999999999999999999999999


Q ss_pred             eccccccCccccc-----------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH
Q 018702          217 FGLATLMEAEKTH-----------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL  285 (351)
Q Consensus       217 fg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  285 (351)
                      ||+|+........           .....+||+.|+|||++.+..|+.++|||||||++|||++   ||.....     .
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----R  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----H
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----H
Confidence            9999876543221           1233579999999999999999999999999999999996   7754211     1


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...........         ....+...++.+.+|+.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~---------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 VRTLTDVRNLK---------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHHHTTC---------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhcCC---------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111111111         011122334567899999999999999999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-53  Score=383.62  Aligned_cols=261  Identities=21%  Similarity=0.322  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec------CCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS------SQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  140 (351)
                      ++|+..+.||+|+||+||+|.+. +|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47888999999999999999975 68899999997543  2334678899999999999999999998764      357


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .|+|||||+ |+|.+++.    ..+.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++
T Consensus       134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 68999997    456799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCccc---ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          221 TLMEAEK---THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       221 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      +......   .....+.+||+.|+|||++.+. .++.++||||+||++|||++|++||......+.   ...........
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCC
Confidence            8654322   2223456899999999998764 569999999999999999999999976432211   11111111110


Q ss_pred             ccceec-----------c--ccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 REEYVI-----------D--TSLEGC-----PINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 ~~~~~~-----------~--~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......           .  +.....     ....++++.+|+.+||+.||.+|||+.|+|++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000           0  000000     11235779999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-51  Score=366.15  Aligned_cols=279  Identities=36%  Similarity=0.610  Sum_probs=237.9

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           66 FKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ...+.+|+..+.||+|+||.||+|.+.+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            34567899999999999999999998889999999988776666778999999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999976554455799999999999999999999998   999999999999999999999999999976443


Q ss_pred             cc-ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EK-THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .. ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............|..............++
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            22 22233445899999999998889999999999999999999999999876655555666665555444443334444


Q ss_pred             cCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          305 SLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       305 ~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ... ..+...+..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            333 4677888999999999999999999999999999998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.5e-53  Score=377.43  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=197.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (351)
                      ..++|++.+.||+|+||+||+|..+    .++.||+|++....  ....+.+|+++++.+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3468999999999999999999863    35679999986543  234678999999998 6999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeecccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLAT  221 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~  221 (351)
                      +||||+++|+|.+++.       .+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+
T Consensus        97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999984       378999999999999999999999   99999999999999876 899999999997


Q ss_pred             ccCcccc---------------------------cccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCC
Q 018702          222 LMEAEKT---------------------------HVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRP  273 (351)
Q Consensus       222 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p  273 (351)
                      .......                           ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            5433211                           112234699999999998765 589999999999999999999999


Q ss_pred             CCcchhcccccHHHHHH-----------HHHhc----------------------C---ccceecc----ccCCCCCHHH
Q 018702          274 MDEAFLEEGTKLVTWVK-----------AVMQD----------------------K---REEYVID----TSLEGCPINE  313 (351)
Q Consensus       274 ~~~~~~~~~~~~~~~~~-----------~~~~~----------------------~---~~~~~~~----~~~~~~~~~~  313 (351)
                      |.....+.. .+.....           .....                      .   ......+    ..........
T Consensus       247 f~~~~~~~~-~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          247 FYKASDDLT-ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCHHH-HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            954321100 0000000           00000                      0   0000000    0000112234


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          314 INDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       314 ~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ++++.+|+.+||+.||++|||++|++++
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5779999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-52  Score=368.98  Aligned_cols=290  Identities=42%  Similarity=0.757  Sum_probs=242.9

Q ss_pred             cccCChHHHHHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEE
Q 018702           57 IHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYY  135 (351)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~  135 (351)
                      ...++..++.....+|+..+.||+|+||.||+|...+++.||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567788888899999999999999999999999888999999998765332 223688999999999999999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          136 TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       136 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      .+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++++||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998766566679999999999999999999999866699999999999999999999999


Q ss_pred             eeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhc--ccccHHHHHHHHH
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE--EGTKLVTWVKAVM  293 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~  293 (351)
                      |||++...............||+.|+|||.+.+..++.++||||||+++|+|++|..||......  .......|.....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99999876655444445556999999999998889999999999999999999999999754322  2334445555444


Q ss_pred             hcCccceeccccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          294 QDKREEYVIDTSLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       294 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .........+.... ..+...+..+.+++.+||+.||.+|||+.|++++|+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            44444444443333 567888899999999999999999999999999998643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.5e-52  Score=390.52  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHH---HHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDR---GFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.....   ....   ....++.+++.++|||||+++++|.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            46888899999999999999975 588999999864311   1112   2334567788889999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||++||+|.+++.+    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.+|++||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999973    45699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .....   ..+.+||+.|+|||++.. ..|+.++|+|||||++|||++|.+||.......   ............     
T Consensus       342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~-----  410 (689)
T 3v5w_A          342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMA-----  410 (689)
T ss_dssp             CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCC-----
T ss_pred             cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCC-----
Confidence            65433   234689999999999964 579999999999999999999999997643221   222222222111     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                           ...|...++++.+|+.+||+.||.+|++     ++|++++
T Consensus       411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                 1234556688999999999999999998     6777654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-51  Score=391.43  Aligned_cols=252  Identities=21%  Similarity=0.361  Sum_probs=211.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++||||++++++|.+.+..+++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            47888999999999999999975 68899999998776666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN--MEARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~--~~~kl~dfg~~~~~~~~  226 (351)
                      +||+|.+++..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.....
T Consensus       237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999864   235689999999999999999999999   99999999999999854  89999999999876543


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  ....+||+.|+|||++.+..|+.++||||+||++|+|++|.+||......      ............  ..+   
T Consensus       311 ~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~--~~~---  377 (573)
T 3uto_A          311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWN--MDD---  377 (573)
T ss_dssp             SE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC--CCS---
T ss_pred             Cc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCC--CCc---
Confidence            32  23457999999999999999999999999999999999999999654321      222222221110  001   


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ..+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       378 -~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 -SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1123345789999999999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.7e-50  Score=353.16  Aligned_cols=257  Identities=30%  Similarity=0.482  Sum_probs=214.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|...+.||+|+||.||++.+. ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46888899999999999999975 57889999997777777788999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999752   45689999999999999999999999   999999999999999999999999999986543322


Q ss_pred             cc-------------cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc---cHHHHHHHH
Q 018702          229 HV-------------STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT---KLVTWVKAV  292 (351)
Q Consensus       229 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~  292 (351)
                      ..             .....||+.|+|||.+.+..++.++||||||+++|+|++|..|+.........   ........ 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence            11             11356899999999999999999999999999999999999998654322211   11111110 


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                                     ..+...++.+.+++.+||+.||++|||+.++++.|+.++..
T Consensus       243 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          243 ---------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ---------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                           11233346799999999999999999999999999988753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.7e-49  Score=345.24  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=210.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|+..+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35799999999999999999986 56889999999766555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++|+|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999999963     3588999999999999999999999   99999999999999999999999999997665433


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .. .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      .............       .
T Consensus       171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~-------~  236 (297)
T 3fxz_A          171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-------L  236 (297)
T ss_dssp             CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-------C
T ss_pred             cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC-------C
Confidence            22 23456899999999999999999999999999999999999999653211      1111111111110       1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1244455789999999999999999999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-49  Score=342.90  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=215.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            46888899999999999999998888999999976543 34568999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           89 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999642   35689999999999999999999998   9999999999999999999999999999866544333


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||......      ...........         ..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~~~---------~~  227 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFR---------LY  227 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC---------CC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcCcc---------CC
Confidence            3334457888999999998999999999999999999999 99998653221      12222221111         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      .+...+..+.+++.+||+.||++|||+.+++++|+++....
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g  268 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  268 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence            23334578999999999999999999999999999987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.3e-48  Score=340.72  Aligned_cols=283  Identities=37%  Similarity=0.610  Sum_probs=229.1

Q ss_pred             cccCChHHHHHHhcCCCCC------CcccccCceEEEEEEECCCCEEEEEEecCCC----hhhHHHHHHHHHHhhcCCCC
Q 018702           57 IHSLQSDAIFKKTLKFSSK------DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHR  126 (351)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~  126 (351)
                      ...++..++...+.+|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4667888888888888776      8899999999999986 57889999986532    33456789999999999999


Q ss_pred             ceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 018702          127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL  206 (351)
Q Consensus       127 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~  206 (351)
                      ||+++++++.+.+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999999987532 245689999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH
Q 018702          207 DQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL  285 (351)
Q Consensus       207 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  285 (351)
                      +.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......  ..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence            99999999999999765433221 2233468999999998865 58899999999999999999999997643222  12


Q ss_pred             HHHHHHHHhc-CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQD-KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ..+....... .......+......+...++.+.+++.+||+.||.+|||+.+++++|+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2222222211 1112223334445678888999999999999999999999999999998864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-49  Score=342.21  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=214.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++...++..||+|++..... ..+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            47888899999999999999998888899999976443 34568999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.........
T Consensus        87 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           87 NGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999642   34589999999999999999999999   9999999999999999999999999999866554433


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......      ...........         ..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~  225 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHR---------LY  225 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC---------CC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCC---------CC
Confidence            3334456788999999998889999999999999999999 99998653221      11122211111         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      .+...++.+.+++.+||+.||++|||+.|++++|+.++.++
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            23334478999999999999999999999999999998763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.5e-49  Score=350.56  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|+||.||+|.+ .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4788999999999999999997 57889999998654  33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        95 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           95 YASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999963    35689999999999999999999998   9999999999999999999999999999765433


Q ss_pred             cccccccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRAT-AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .  .....+||+.|+|||.+.+..++ .++||||+|+++|+|++|+.||.....      ............        
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~--------  231 (328)
T 3fe3_A          168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKY--------  231 (328)
T ss_dssp             C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--------
T ss_pred             C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--------
Confidence            2  23445799999999999887765 799999999999999999999965422      222222222111        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ..|...+.++.+|+.+||+.||.+|||++|++++
T Consensus       232 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 --RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              1234455789999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-48  Score=342.90  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=208.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||++... ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            47899999999999999999975 67889999985532   334467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           91 EYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999973    35689999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..........||+.|+|||.+.+..++.++||||||+++|+|++|+.||......      .............. ..  
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~-~~--  234 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVPNV-TT--  234 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCCCH-HH--
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCCCc-ch--
Confidence            4433344456899999999999999999999999999999999999999654221      11122222111110 00  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhccccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP-TMTEVVKMLELIKSE  348 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~e~l~~L~~~~~~  348 (351)
                        ..+...++.+.+++.+||+.||.+|| +++++.+.|+.+..+
T Consensus       235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence              12233457899999999999999998 999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-48  Score=345.27  Aligned_cols=261  Identities=33%  Similarity=0.475  Sum_probs=204.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||+||+|.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            45788889999999999999987 47789999987653  3334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +  ++||||||+||+++.++.+||+|||+++...
T Consensus       115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999997432 122489999999999999999999998   8  9999999999999999999999999997543


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ...........       
T Consensus       191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~-------  256 (309)
T 3p86_A          191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCK-------  256 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCC-------
T ss_pred             cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC-------
Confidence            3221 223356899999999999999999999999999999999999999654221      11111111111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                       ....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       257 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          257 -RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence             11234455578999999999999999999999999999887643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3e-49  Score=345.15  Aligned_cols=259  Identities=22%  Similarity=0.368  Sum_probs=213.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..+|+..+.||+|+||.||++.+.++..||+|++...... .+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            4578888999999999999999998889999999765433 456889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            999999999742   35689999999999999999999998   999999999999999999999999999986654433


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......      ...........         .
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~~---------~  240 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLR---------L  240 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC---------C
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcccC---------C
Confidence            33333456788999999998899999999999999999998 99999654221      11122211111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ..+...++.+.+++.+||+.||.+|||+.+++++|+++..++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            123333478999999999999999999999999999998775

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=346.62  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=210.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|.+.    .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            46788899999999999999974    34469999997653 34456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999642   35689999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          225 AEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       225 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......      ...........    
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~----  272 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEGYR----  272 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCC----
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcCCC----
Confidence            43222  1222345778999999998899999999999999999999 99999654221      11222221111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                           ...+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       273 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                 112344557899999999999999999999999999987653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-48  Score=352.17  Aligned_cols=260  Identities=29%  Similarity=0.426  Sum_probs=212.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      .+|+..+.||+|+||.||+|.+.        ++..||+|+++.... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            46778889999999999999863        245699999976533 3346789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||++   +|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence            99999999999999999975421            234588999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......   .
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~  314 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L  314 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence            9999999999999865443221 2223346889999999999999999999999999999999 999997543221   1


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .   .......         ....+..++..+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus       315 ~---~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          315 F---KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             H---HHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---HHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1   1111111         112344455789999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-47  Score=339.24  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=208.0

Q ss_pred             CCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      |...+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            555678999999999999986 6899999999876666667789999999999999999999999999999999999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      ++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......... 
T Consensus       127 ~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  197 (321)
T 2c30_A          127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  197 (321)
T ss_dssp             CBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred             CCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-
Confidence            99999985     34689999999999999999999998   9999999999999999999999999999765543222 


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ..............      . ..+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~------~-~~~  264 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRDSPPPK------L-KNS  264 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSSCCC------C-TTG
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCCCC------c-Ccc
Confidence            2345689999999999999999999999999999999999999965321      11122222111110      0 112


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ...+..+.+++.+||+.||++|||+.|++++-.
T Consensus       265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            234578999999999999999999999998643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-48  Score=343.20  Aligned_cols=265  Identities=27%  Similarity=0.447  Sum_probs=210.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  142 (351)
                      .+|+..+.||+|+||.||++.+     .+++.||+|++........+.+.+|+.++++++||||+++++++..  ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            4788899999999999999984     3578899999987777767789999999999999999999999865  35689


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999743   34589999999999999999999998   999999999999999999999999999986


Q ss_pred             cCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc------c---ccHHHHHHH
Q 018702          223 MEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE------G---TKLVTWVKA  291 (351)
Q Consensus       223 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~---~~~~~~~~~  291 (351)
                      .......  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.......      .   .........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6443221  1223346788999999999999999999999999999999999986543210      0   000001111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....        .....+...++.+.+++.+||+.||++|||+.|+++.|+.++.+
T Consensus       244 ~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          244 LLKNN--------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHTT--------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcc--------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11111        11123445568899999999999999999999999999998765

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.6e-48  Score=344.44  Aligned_cols=248  Identities=21%  Similarity=0.316  Sum_probs=207.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            46888899999999999999975 58899999996532   223456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus        85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999873    45689999999999999999999999   999999999999999999999999999975432


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ... .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.....      ............        
T Consensus       158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~--------  222 (337)
T 1o6l_A          158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEI--------  222 (337)
T ss_dssp             TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--------
T ss_pred             CCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC--------
Confidence            221 23445799999999999999999999999999999999999999965321      122222222111        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                        ..|...+.++.+++.+||+.||.+||     +++|++++
T Consensus       223 --~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              12444557899999999999999999     89999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.6e-49  Score=355.81  Aligned_cols=259  Identities=27%  Similarity=0.431  Sum_probs=212.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|...+.||+|+||.||+|.+. +++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            346788899999999999999986 688999999876432 334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus       193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999742   34588999999999999999999999   9999999999999999999999999999764432


Q ss_pred             ccccc-ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          227 KTHVS-TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       227 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ..... ....+++.|+|||.+.++.++.++||||||+++|||++ |..||......      . .........       
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~-~~~~~~~~~-------  332 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------Q-TREFVEKGG-------  332 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------H-HHHHHHTTC-------
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCC-------
Confidence            22111 12235778999999998899999999999999999998 99999654221      1 111111110       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                       ....|..+++.+.+++.+||+.||++|||++++++.|++++..
T Consensus       333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence             1123444557899999999999999999999999999998754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-47  Score=345.39  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=206.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||++... +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            47888999999999999999975 5789999999764322      2467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----ceEEeeec
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM----EARVSDFG  218 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg  218 (351)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++    .+||+|||
T Consensus        92 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           92 LILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999996    345799999999999999999999998   999999999999998876    79999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||......      ............
T Consensus       165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~~~  236 (361)
T 2yab_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVSYD  236 (361)
T ss_dssp             SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC
T ss_pred             CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC
Confidence            9986554322  23456999999999999999999999999999999999999999654221      122222211100


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         .+.   ..+...++.+.+|+.+||..||.+|||+.|++++
T Consensus       237 ---~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          237 ---FDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ---CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               000   0112234779999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-48  Score=346.97  Aligned_cols=270  Identities=29%  Similarity=0.374  Sum_probs=209.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC----eeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ----YNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  144 (351)
                      ..+|+..+.||+|+||.||+|... ++.||+|++..... ......+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357889999999999999999876 68899999965432 3344667999999999999999999998754    46999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc-------CCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD-------CIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      |||+++|+|.+++..     ..+++..+..++.|++.||+|||+.       +.++++||||||+|||++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            999999999999963     4589999999999999999999985       1238999999999999999999999999


Q ss_pred             ccccccCccccc-ccccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc--------
Q 018702          218 GLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTG-----RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT--------  283 (351)
Q Consensus       218 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------  283 (351)
                      |+++........ ......||+.|+|||.+.+.     .++.++||||||+++|+|++|+.||.........        
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999766543322 22335689999999998763     4567899999999999999999999764322211        


Q ss_pred             --cHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          284 --KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       284 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                        ...................+ .  ..+...++.+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRD-Y--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCG-G--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccc-c--ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              11112222211111111000 0  01234567799999999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.4e-48  Score=361.12  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=212.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..+|+..+.||+|+||.||+|.++++..||+|+++... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            45678888999999999999999888899999997654 34567999999999999999999999987 56789999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus       265 ~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          265 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             TTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            999999999743  123578889999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......+|+.|+|||.+....++.++||||||+++|||++ |..||......      ...........         .
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~---------~  404 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYR---------M  404 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHHTCC---------C
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---------C
Confidence            22233346789999999998999999999999999999999 99999654221      11122211111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ..|..+++.+.+++.+||+.||++|||++++++.|+++...
T Consensus       405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            12444557899999999999999999999999999998653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.2e-48  Score=334.97  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=214.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++...++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            46888899999999999999998888999999976543 34578999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        87 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999742   35688999999999999999999999   9999999999999999999999999999866443322


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......      ...........         ..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~~~---------~~  225 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFR---------LY  225 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC---------CC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcCCc---------CC
Confidence            2333457889999999998899999999999999999999 89998653211      12222221111         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      .+...+..+.+++.+||+.||++|||+.+++++|+++....
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  266 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            23334578999999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.2e-48  Score=348.92  Aligned_cols=257  Identities=29%  Similarity=0.482  Sum_probs=200.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|...    ++..||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47899999999999999999864    46679999997653 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999742   34689999999999999999999998   99999999999999999999999999998665


Q ss_pred             cccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          225 AEKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       225 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......      ...........    
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~i~~~~~----  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKAVDEGYR----  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHHHHTTEE----
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC----
Confidence            432221  112235778999999999999999999999999999998 99999654221      11121111110    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           ...+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                 11233445789999999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-47  Score=338.38  Aligned_cols=261  Identities=27%  Similarity=0.394  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhc--CCCCceeeeeeEEec----CCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGD--IKHRNIVTLHGYYTS----SQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~l  143 (351)
                      ++|+..+.||+|+||+||+|.. +++.||+|++...   ....+.+|.+++..  ++||||+++++++..    ....++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            5788999999999999999988 5788999998653   23345556666555  789999999998654    356899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH--------HDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      +|||+++|+|.+++.     ...+++..++.++.|++.||+|||        +.   +++||||||+|||++.++.+||+
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            999999999999995     346899999999999999999999        76   99999999999999999999999


Q ss_pred             eeccccccCcccccc---cccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCc
Q 018702          216 DFGLATLMEAEKTHV---STIVAGTFGYLAPEYFDTG------RATAKGDVYSFGVVLLELLTG----------KRPMDE  276 (351)
Q Consensus       216 dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~  276 (351)
                      |||++..........   .....||+.|+|||.+.+.      .++.++||||||+++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997654332221   2234689999999999876      455799999999999999999          888765


Q ss_pred             chhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ...... ....................   ...+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  301 (301)
T 3q4u_A          236 VVPNDP-SFEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID  301 (301)
T ss_dssp             TSCSSC-CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cCCCCc-chhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence            432221 11111121111111111000   0123456788999999999999999999999999998763

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-47  Score=344.54  Aligned_cols=263  Identities=27%  Similarity=0.448  Sum_probs=213.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  140 (351)
                      ...+|+..+.||+|+||.||+|...+      ++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            34578999999999999999999753      3779999997653 3345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVN--------------------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIK  200 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  200 (351)
                      .++||||+++|+|.+++......                    ...+++..++.++.|++.||.|||+.   +++|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            99999999999999999753211                    25789999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcch
Q 018702          201 SSNILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAF  278 (351)
Q Consensus       201 p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  278 (351)
                      |+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999976543322 12233457899999999998899999999999999999999 999996532


Q ss_pred             hcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          279 LEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .      ...........         ....+...+..+.+++.+||+.||++|||+.+++++|+++..+
T Consensus       282 ~------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          282 H------EEVIYYVRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             H------HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             h------HHHHHHHhCCC---------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            2      11122221111         1123444557899999999999999999999999999988654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=336.42  Aligned_cols=267  Identities=23%  Similarity=0.271  Sum_probs=211.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC--eeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--YNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46888999999999999999986 478999999975432 33456789999999999999999999987655  779999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCceEEeeecccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLAT  221 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~~  221 (351)
                      ||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +++||||||+||++    +.++.+||+|||++.
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            9999999999997543 233489999999999999999999999   99999999999999    778889999999998


Q ss_pred             ccCcccccccccccccccccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFD--------TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      ........  ....||+.|+|||.+.        +..++.++||||||+++|+|++|..||........  .........
T Consensus       165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  240 (319)
T 4euu_A          165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKII  240 (319)
T ss_dssp             ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHH
T ss_pred             ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHh
Confidence            66543322  2345899999999885        57889999999999999999999999965322211  122222222


Q ss_pred             hcCccce---e---------cc---ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 018702          294 QDKREEY---V---------ID---TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL  344 (351)
Q Consensus       294 ~~~~~~~---~---------~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~  344 (351)
                      .......   .         .+   +.....+...+..+.+++.+||+.||++|||++|++++.++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            2211100   0         00   01113567788899999999999999999999999998875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-47  Score=339.96  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||+||+|.+.+++.||+|++.....  .....+.+|++++++++||||+++++++.+++..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            47889999999999999999998899999999875432  2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++ +|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus       101 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          101 MEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            975 88888764   235689999999999999999999998   99999999999999999999999999998654332


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc---
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID---  303 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  303 (351)
                      .. .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+   ...................   
T Consensus       174 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          174 RS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTT
T ss_pred             cc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhc
Confidence            22 223458999999999876 568999999999999999999999997643221   1222222211111100000   


Q ss_pred             ---------ccCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 ---------TSLE-----GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ---------~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                               ....     ......++++.+|+.+||+.||.+|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     0000     0112234678999999999999999999999984

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=349.40  Aligned_cols=261  Identities=28%  Similarity=0.400  Sum_probs=210.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||+|.+.      ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            46888899999999999999853      35679999996543 344457889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCC---CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---ceEEee
Q 018702          143 LIYELMPNGSLDTFLHGKS---VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---EARVSD  216 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~d  216 (351)
                      +||||+++|+|.+++....   .....+++..++.++.|+++||+|||++   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997532   1235689999999999999999999999   999999999999999655   499999


Q ss_pred             eccccccCccc-ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHh
Q 018702          217 FGLATLMEAEK-THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       217 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ||+++...... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....      .........
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i~~  301 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTS  301 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHT
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc
Confidence            99997543222 122233457899999999998999999999999999999998 9999965422      112222222


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ....         ..+...+..+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus       302 ~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          302 GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            1111         12334457799999999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-48  Score=338.32  Aligned_cols=257  Identities=30%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            478888999999999999998743    3469999987643 334567899999999999999999999985 4567999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999999742   34689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ..   ........      
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~---~~i~~~~~------  235 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIENGER------  235 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHHHTTCC------
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH---HHHHcCCC------
Confidence            443333333446789999999998899999999999999999997 999997543221   11   11111111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         ...+...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          236 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               112344557899999999999999999999999999988654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.2e-48  Score=361.71  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=215.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            457778899999999999999865 77899999976543 3567999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       299 ~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          299 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            999999999753  345689999999999999999999998   999999999999999999999999999987654433


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......   ....   .......         .
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~---~~~~~~~---------~  438 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE---LLEKDYR---------M  438 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH---HHHTTCC---------C
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHcCCC---------C
Confidence            33333446789999999998899999999999999999999 99999764322   1111   1111111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ..+..+++.+.+|+.+||+.||.+|||+.++++.|+.+..+.
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            234445578999999999999999999999999999986543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=346.82  Aligned_cols=261  Identities=29%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS  138 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  138 (351)
                      ..+|...+.||+|+||.||+|...        .+..||+|++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888899999999999999863        235699999976543 3346788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL  206 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~  206 (351)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            999999999999999999975431            134689999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhccccc
Q 018702          207 DQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK  284 (351)
Q Consensus       207 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~  284 (351)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999986544322 22233457889999999999999999999999999999999 9999865422     


Q ss_pred             HHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                       .............         ..+...+.++.+++.+||+.||++|||+.|++++|+.+..
T Consensus       300 -~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          300 -EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             -HHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             1222222221111         1233445789999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-47  Score=354.92  Aligned_cols=254  Identities=25%  Similarity=0.434  Sum_probs=209.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-eeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-YNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||+|.++ ++.||+|.++...  ..+.+.+|+.++++++||||+++++++...+ ..++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            46778889999999999999986 6689999997653  4567899999999999999999999987655 789999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...... 
T Consensus       270 ~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          270 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             TTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            999999999753  233478999999999999999999999   99999999999999999999999999997543221 


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                         ....+++.|+|||.+.+..++.++||||||+++|||++ |..||......   ...   ........         .
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~---~~i~~~~~---------~  405 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PRVEKGYK---------M  405 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THH---HHHHTTCC---------C
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCCC---------C
Confidence               12246889999999999999999999999999999998 99999754322   111   11111111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccccC
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV  350 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~~  350 (351)
                      ..|..++..+.+++.+||+.||.+|||+.++++.|+.+...++
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            2344556889999999999999999999999999999987664

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.9e-47  Score=329.48  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=207.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC--CeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|.++ ++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.  +..+++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46888899999999999999986 7789999997653  34446789999999999999999999999887  7889999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +  ++|+||||+||+++.++.++++|||++...
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999753  233689999999999999999999998   8  999999999999999999999999887643


Q ss_pred             CcccccccccccccccccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATA---KGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ...      ...+|+.|+|||.+.+..++.   ++||||||+++|+|++|..||......      ............  
T Consensus       164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~--  229 (271)
T 3kmu_A          164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLR--  229 (271)
T ss_dssp             SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCC--
T ss_pred             ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCC--
Confidence            222      234799999999998765544   899999999999999999999653221      111222211111  


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                            ...+...+..+.+++.+||+.||++|||++++++.|+.++++
T Consensus       230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~~  271 (271)
T 3kmu_A          230 ------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK  271 (271)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                  123444557899999999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-47  Score=330.57  Aligned_cols=253  Identities=32%  Similarity=0.473  Sum_probs=196.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh----hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT----EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|.+. ++.+|+|++.....    ...+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            46888899999999999999976 77899999865432    22456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--------CCceEEeee
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ--------NMEARVSDF  217 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~--------~~~~kl~df  217 (351)
                      ||+++++|.+++.     .+.+++..++.++.|++.|+.|||++...+++||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999984     456899999999999999999999981112999999999999986        778999999


Q ss_pred             ccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      |++........   ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......      ...........
T Consensus       161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~  231 (271)
T 3dtc_A          161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKL  231 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCC
T ss_pred             Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCC
Confidence            99976543322   2345899999999999899999999999999999999999999653211      11111111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      .        ...+...++.+.+++.+||+.||.+|||+.|++++|+.+
T Consensus       232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 A--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             C--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1        122344557899999999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.6e-48  Score=343.30  Aligned_cols=246  Identities=25%  Similarity=0.407  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|...+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4788899999999999999997 567899999986432   122356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+ +|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            999 7799998863    45689999999999999999999999   999999999999999999999999999986544


Q ss_pred             ccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ...  ....+||+.|+|||.+.+..+ ++++||||||+++|+|++|..||..........                ....
T Consensus       161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~~  222 (336)
T 3h4j_B          161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVNS  222 (336)
T ss_dssp             SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCCS
T ss_pred             Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHHc
Confidence            322  234569999999999988776 789999999999999999999996543221100                0111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....|...+..+.+++.+||+.||.+|||++|++++
T Consensus       223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1112345556889999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.6e-48  Score=357.07  Aligned_cols=258  Identities=31%  Similarity=0.473  Sum_probs=207.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..+|+..+.||+|+||.||+|.++++..||+|+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            346788889999999999999998888899999976543 34678999999999999999999999876 6789999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++.......
T Consensus       261 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          261 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             cCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999999642  224588999999999999999999998   999999999999999999999999999986654333


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......++..|+|||.+.++.++.++||||||+++|+|++ |..||......      ...........         .
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~---------~  400 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYR---------M  400 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC---------C
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---------C
Confidence            22233446789999999998999999999999999999999 99999654221      11222211111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ..|..+++.+.+++.+||+.||++|||++++++.|+.+...
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            23445567899999999999999999999999999987543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-47  Score=337.19  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||++... +++.||+|++.....   ...+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            46888899999999999999975 688999999865321   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999973    45689999999999999999999998   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .    ....+||+.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ............        
T Consensus       159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~--------  220 (318)
T 1fot_A          159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL--------  220 (318)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC--------
T ss_pred             c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--------
Confidence            2    2345699999999999999999999999999999999999999965321      122222222211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                        ..|...+.++.+++.+||+.||.+||     +++|++++
T Consensus       221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              12344557899999999999999999     88998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.6e-48  Score=345.75  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++....   ....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            357999999999999999999975 57889999997532   22345678899999988 69999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999973    45689999999999999999999999   9999999999999999999999999999753


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .... ......+||+.|+|||++.+..++.++|+||||+++|+|++|..||.....      ............      
T Consensus       175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~------  241 (353)
T 3txo_A          175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEV------  241 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC------
T ss_pred             ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC------
Confidence            3222 223445799999999999988899999999999999999999999965432      122222222211      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTM------TEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~e~l~~  341 (351)
                          ..|...+.++.+++.+||+.||.+||++      .|++++
T Consensus       242 ----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 ----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                1234455789999999999999999998      677653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=350.07  Aligned_cols=253  Identities=24%  Similarity=0.306  Sum_probs=205.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .++|+..+.||+|+||.||+|... +++.+|+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            347889999999999999999874 678899999876542  33456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCceEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~  222 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999873    45689999999999999999999999   999999999999998   467899999999976


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ....... .....||+.|+|||++.+..++.++||||+|+++|+|++|.+||.....      .............  ..
T Consensus       163 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~--~~  233 (444)
T 3soa_A          163 VEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAYD--FP  233 (444)
T ss_dssp             CCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCC--CC
T ss_pred             ecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCCC--CC
Confidence            6543322 2335699999999999999999999999999999999999999965321      1122222221111  01


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+    .....++++.+++.+||+.||.+|||+.|++++
T Consensus       234 ~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          234 SP----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11    122345789999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-47  Score=347.80  Aligned_cols=256  Identities=20%  Similarity=0.324  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+|+..+.||+|+||+||+|... +++.||+|+++....   ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357888999999999999999976 467899999975422   2234577899998877 89999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|..++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999999973    45689999999999999999999999   9999999999999999999999999999753


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc--cccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE--GTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||.......  .................   
T Consensus       204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  279 (396)
T 4dc2_A          204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  279 (396)
T ss_dssp             CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred             ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence            2222 22345679999999999999999999999999999999999999996432211  11111222222221111   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM------TEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~e~l~~  341 (351)
                            ..|...+.++.+|+.+||+.||.+||++      .|++++
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                  2344556889999999999999999996      566553

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-47  Score=344.49  Aligned_cols=255  Identities=22%  Similarity=0.277  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-----hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-----TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46889999999999999999875 57899999985421     1235678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc---eEEeeeccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLA  220 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~  220 (351)
                      ||||+++++|.+++.........+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            9999999999988865433445689999999999999999999999   9999999999999987655   999999999


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....       ............. 
T Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~~~~-  251 (351)
T 3c0i_A          181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGKYKM-  251 (351)
T ss_dssp             EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTCCCC-
T ss_pred             eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCCCCC-
Confidence            86654322 12334689999999999999999999999999999999999999975321       1112222111110 


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ....    ....++.+.+++.+||+.||++|||+.|++++
T Consensus       252 -~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          252 -NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0000    11234789999999999999999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=337.33  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||++... +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            36888899999999999999975 5789999998754322      3467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----ceEEeeec
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM----EARVSDFG  218 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg  218 (351)
                      +||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999996    346789999999999999999999998   999999999999999887    79999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ++........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ............
T Consensus       164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~  235 (326)
T 2y0a_A          164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE  235 (326)
T ss_dssp             TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTCCC
T ss_pred             CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcCCC
Confidence            9986643322  23346899999999999999999999999999999999999999653221      111111111100


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ..+.    .+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       236 --~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 --FEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --CCHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --cCcc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0000    011234678999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-47  Score=340.41  Aligned_cols=262  Identities=26%  Similarity=0.393  Sum_probs=213.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      ..+|...+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            35788889999999999999986      234789999997643 33446789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 018702          142 LLIYELMPNGSLDTFLHGKSV--------------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKS  201 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp  201 (351)
                      +++|||+++++|.+++.....                    ....+++..++.++.|++.||.|||++   +++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999975432                    123488899999999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchh
Q 018702          202 SNILLDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFL  279 (351)
Q Consensus       202 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~  279 (351)
                      +||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999865443322 1223346889999999998889999999999999999999 9999965432


Q ss_pred             cccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ..   ..   .......         ....+...++.+.+++.+||+.||++|||+.|++++|+.+..+
T Consensus       259 ~~---~~---~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ER---LF---NLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GG---HH---HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HH---HH---HHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            21   11   1111111         1112344557899999999999999999999999999988654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-47  Score=338.89  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=203.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            47889999999999999999976 688899999865433 2335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999997    445689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             -ccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          228 -THVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       228 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       ........||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....... .    ...........       
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~----~~~~~~~~~~~-------  227 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-Q----EYSDWKEKKTY-------  227 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-H----HHHHHHTTCTT-------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-H----HHHHHhccccc-------
Confidence             222334569999999999987765 778999999999999999999996542211 0    11111111000       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       .......+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       228 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence             011233457889999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=345.71  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999975 47889999986532   223456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+.||+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+|.+||+|||++.....
T Consensus        95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999997    345699999999999999999999999   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ..  .....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......   ...........       
T Consensus       168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~-------  235 (384)
T 4fr4_A          168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHTFETT-------  235 (384)
T ss_dssp             TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHHHHHC-------
T ss_pred             CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhhc-------
Confidence            32  2234579999999999864   468999999999999999999999996543222   11222221111       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPT-MTEVVK  340 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~e~l~  340 (351)
                         ....|...+..+.+++.+||+.||.+||+ ++++++
T Consensus       236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               11234455688999999999999999998 677664

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.6e-47  Score=341.73  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ..+|+..+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            347899999999999999999975 57899999997643  234467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CceEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN---MEARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~  222 (351)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||++..
T Consensus       108 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999987    345689999999999999999999999   99999999999999865   4599999999986


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ......  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....      ............. . .
T Consensus       181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~-~-~  250 (362)
T 2bdw_A          181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYD-Y-P  250 (362)
T ss_dssp             CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC-C-C
T ss_pred             ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC-C-C
Confidence            653322  2335689999999999999999999999999999999999999965321      1112222111110 0 0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .    ......+.++.+++.+||+.||.+|||+.|++++
T Consensus       251 ~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 S----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             T----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0    0112345789999999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-47  Score=334.62  Aligned_cols=259  Identities=29%  Similarity=0.434  Sum_probs=216.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|+..+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            3578888999999999999999864 7789999997643 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           91 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             CCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999754  345689999999999999999999999   99999999999999999999999999998766544


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ..   ........         
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~---~~~~~~~~---------  230 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY---ELLEKDYR---------  230 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH---HHHHTTCC---------
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHhccCC---------
Confidence            444444557889999999998999999999999999999999 999986543221   11   11111111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...+...++.+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            112344457899999999999999999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=342.02  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=208.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            47889999999999999999975 57889999998766666667899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ--NMEARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~  226 (351)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||++......
T Consensus       131 ~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          131 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998642   34689999999999999999999998   9999999999999974  577999999999876543


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....      .............   .+   
T Consensus       205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~---~~---  270 (387)
T 1kob_A          205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE---FD---  270 (387)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC---CC---
T ss_pred             cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CC---
Confidence            22  2234689999999999999999999999999999999999999965321      1112222211110   00   


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .......+.++.+++.+||+.||.+|||+.|++++
T Consensus       271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            11223345789999999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.9e-47  Score=331.03  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|+..+.||+|+||+||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999985 578899999975432  334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++ ++.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9976 56555543   346689999999999999999999999   9999999999999999999999999999866433


Q ss_pred             cccccccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee----
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV----  301 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  301 (351)
                      ... .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.....  ....................    
T Consensus       155 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             ccc-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence            222 23345899999999987765 89999999999999999998888533211  11111111111111110000    


Q ss_pred             ------------ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          302 ------------IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       302 ------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                  ............+..+.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                        0011112233456789999999999999999999999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.5e-47  Score=332.22  Aligned_cols=261  Identities=23%  Similarity=0.371  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|...+++.||+|++......  ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            468888999999999999999988999999999764332  235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            975 999988642   35689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce------
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY------  300 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  300 (351)
                      .. .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.......  .... ............      
T Consensus       155 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGG
T ss_pred             cc-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhc
Confidence            21 223458999999999865 458999999999999999999999997542211  1111 111111100000      


Q ss_pred             --ecccc--------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 --VIDTS--------LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 --~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ..++.        ........++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              00000        001122345789999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.5e-48  Score=349.80  Aligned_cols=268  Identities=27%  Similarity=0.375  Sum_probs=212.7

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEE
Q 018702           64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYY  135 (351)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~  135 (351)
                      .......+|+..+.||+|+||.||+|.+.      +++.||+|++..... ...+.+.+|++++.++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            33334568999999999999999999742      346899999976543 3346789999999999 799999999998


Q ss_pred             ecCC-eeEEEEEecCCCCHHHhhcCCCCC---------------------------------------------------
Q 018702          136 TSSQ-YNLLIYELMPNGSLDTFLHGKSVN---------------------------------------------------  163 (351)
Q Consensus       136 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------  163 (351)
                      .+.+ ..+++|||+++|+|.+++......                                                   
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8755 489999999999999999754311                                                   


Q ss_pred             -----------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc-ccc
Q 018702          164 -----------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-HVS  231 (351)
Q Consensus       164 -----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~  231 (351)
                                 ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........ ...
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                       12288999999999999999999999   999999999999999999999999999986543322 223


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCC
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP  310 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (351)
                      ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......      ..........        ....+
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~--------~~~~~  318 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT--------RMRAP  318 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTC--------CCCCC
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCC--------CCCCC
Confidence            34568899999999999999999999999999999998 999996542211      1111111111        11123


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       311 ~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...++.+.+++.+||+.||.+|||+.|++++|+++.+.
T Consensus       319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            34457899999999999999999999999999988653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-48  Score=343.02  Aligned_cols=263  Identities=28%  Similarity=0.446  Sum_probs=208.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecC--Cee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSS--QYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  141 (351)
                      .+|+..+.||+|+||.||+|.+     .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3578889999999999999984     3578899999975432 3346788999999999999999999999876  668


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999999954   235689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccc--cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhc--------ccccHHHHHHH
Q 018702          222 LMEAEKT--HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLE--------EGTKLVTWVKA  291 (351)
Q Consensus       222 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~  291 (351)
                      .......  .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+......        ...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            7654432  2223345788899999999889999999999999999999999986543211        00011111111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .....        .....+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       255 ~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEG--------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTT--------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcc--------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111        111234455688999999999999999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-47  Score=340.07  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=204.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||++..+ +++.||+|++....   ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888899999999999999986 57889999997542   33345678899999888 899999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999973    35689999999999999999999999   99999999999999999999999999997533


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc--cHHHHHHHHHhcCccceec
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT--KLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  302 (351)
                      ... ......+||+.|+|||.+.+..++.++|+|||||++|+|++|..||.........  ...............    
T Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  236 (345)
T 3a8x_A          162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  236 (345)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred             CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence            222 1233457999999999999999999999999999999999999999653211110  111111111111111    


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTM------TEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~e~l~~  341 (351)
                           ..|...+..+.+++.+||+.||.+||++      .|++++
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                 1344456789999999999999999996      566653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-46  Score=330.04  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=198.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|...+  .+|+|++....  ....+.+.+|+.+++.++||||+++++++ ..+..+++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            478999999999999999998653  59999987543  33446789999999999999999999965 45567999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc-
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-  226 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  226 (351)
                      +++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...... 
T Consensus       101 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          101 CEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             cCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999964   345689999999999999999999998   9999999999999999999999999999755432 


Q ss_pred             cccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||......     .. ..........    .
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~~----~  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQ-IIEMVGRGSL----S  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-----HH-HHHHHHHTSC----C
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhccccc----C
Confidence            122233456899999999986   567889999999999999999999999653211     11 1112111111    1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      +.....+...++.+.+++.+||+.||.+|||+.++++.|+++..|
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            111223344557899999999999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-47  Score=342.71  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=204.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (351)
                      ...+|...+.||+|+||.||+|..+ +++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4468999999999999999999985 57889999997532   22345577889888876 8999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||++||+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+++.
T Consensus        95 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999973    35689999999999999999999999   999999999999999999999999999975


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ..... ......+||+.|+|||++.+..++.++|+||||+++|+|++|..||.....      ...........      
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~------  234 (345)
T 1xjd_A          168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN------  234 (345)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC------
T ss_pred             cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC------
Confidence            43222 123446799999999999999999999999999999999999999965422      11222222211      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMT-EVVK  340 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-e~l~  340 (351)
                          ...|...+.++.+++.+||+.||++||++. ++++
T Consensus       235 ----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                112334557899999999999999999997 6654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2e-46  Score=327.93  Aligned_cols=252  Identities=30%  Similarity=0.541  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhH-------HHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVD-------RGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||+|.+. +++.||+|++........       +.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888999999999999999974 688899999865432211       56889999999999999999999987665  


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEcCCCc-----eEE
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLDQNME-----ARV  214 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~~~~~-----~kl  214 (351)
                      +++|||+++++|.+++..   ....+++..++.++.|++.|++|||+.   +  ++||||||+||+++.++.     +||
T Consensus        97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            799999999999998864   345789999999999999999999998   8  999999999999988776     999


Q ss_pred             eeeccccccCcccccccccccccccccCcccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF--DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      +|||++......    .....||+.|+|||.+  ....++.++||||||+++|+|++|..||......    ........
T Consensus       171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~  242 (287)
T 4f0f_A          171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----KIKFINMI  242 (287)
T ss_dssp             CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC----HHHHHHHH
T ss_pred             CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc----HHHHHHHH
Confidence            999999754332    2334689999999998  4456789999999999999999999999653221    11111222


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ......        ...+...++.+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       243 ~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLR--------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCC--------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111111        123444557899999999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.9e-47  Score=331.10  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=211.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+++++.++||||+++++++.. +..+++|||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            46888899999999999999998888899999976443 34678999999999999999999999874 45799999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++.........
T Consensus        91 ~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999642  123689999999999999999999998   9999999999999999999999999999876544333


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......      ...........         ..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~  230 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYR---------MV  230 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC---------CC
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHhcccC---------CC
Confidence            3333456889999999988889999999999999999999 99998653221      11122211111         11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .+...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            2334457899999999999999999999999999987653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.2e-47  Score=339.59  Aligned_cols=245  Identities=21%  Similarity=0.290  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||++... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46888899999999999999975 688999999865321   23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999973    35689999999999999999999998   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..    ...+||+.|+|||++.+..++.++|+||||+++|+|++|..||.....      ............        
T Consensus       194 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~--------  255 (350)
T 1rdq_E          194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV--------  255 (350)
T ss_dssp             CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--------
T ss_pred             Cc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCC--------
Confidence            32    335699999999999999999999999999999999999999965321      122222222211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                        ..|...+..+.+++.+||+.||.+||+     ++|++++
T Consensus       256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence              123445578999999999999999998     8888764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-47  Score=335.23  Aligned_cols=252  Identities=19%  Similarity=0.271  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            57888999999999999999976 56789999987543 33456889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ--NMEARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~  226 (351)
                      ++++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.  ++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999642   34689999999999999999999999   9999999999999987  789999999999876543


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....      ..............  ...  
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~--~~~--  225 (321)
T 1tki_A          158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTF--DEE--  225 (321)
T ss_dssp             CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC--CHH--
T ss_pred             Cc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCC--Chh--
Confidence            22  2334689999999999988899999999999999999999999965422      12222222211110  000  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                        .....+.++.+++.+||..||.+|||+.|++++-
T Consensus       226 --~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          226 --AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             --hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence              0112347799999999999999999999999854

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-47  Score=340.47  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=197.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCC----EEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee-
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDST----AFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-  141 (351)
                      ..+|+..+.||+|+||.||+|.+..+.    .||+|.+...  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            357999999999999999999865432    7999998764  234456789999999999999999999999877655 


Q ss_pred             -----EEEEEecCCCCHHHhhcCCCC--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          142 -----LLIYELMPNGSLDTFLHGKSV--NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       142 -----~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                           +++|||+++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence                 999999999999999864321  223689999999999999999999999   9999999999999999999999


Q ss_pred             eeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHH
Q 018702          215 SDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      +|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .   ....
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~---~~~~  252 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I---YNYL  252 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---HHHH
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H---HHHH
Confidence            999999865433221 2223346789999999999999999999999999999999 999997543221   1   1111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....         ...+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       253 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          253 IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11111         122344557899999999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-47  Score=339.20  Aligned_cols=260  Identities=18%  Similarity=0.234  Sum_probs=208.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.....  .+.+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            5788899999999999999997 4678899999875432  23578999999999 899999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc-----eEEeeeccccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME-----ARVSDFGLATL  222 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~dfg~~~~  222 (351)
                      + +++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||++..
T Consensus        87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           87 L-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             C-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9 99999999743   45799999999999999999999999   9999999999999998887     99999999986


Q ss_pred             cCccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          223 MEAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       223 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......   .............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~  236 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD---TLKERYQKIGDTK  236 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS---SHHHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc---cHHHHHHHHHhhh
Confidence            5433221      123456999999999999999999999999999999999999999764322   2222222111110


Q ss_pred             ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ... ..+.    .....+ ++.+++.+||+.||.+||++.++++.|+++..
T Consensus       237 ~~~-~~~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          237 RAT-PIEV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHS-CHHH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccC-CHHH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            000 0000    011123 79999999999999999999999999987754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-48  Score=345.25  Aligned_cols=265  Identities=26%  Similarity=0.418  Sum_probs=213.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe--cCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT--SSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  142 (351)
                      ++|+..+.||+|+||.||++.+     .++..||+|++........+.+.+|++++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4788899999999999999984     357789999998877777778999999999999999999999886  456789


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999999742   24589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc--------cccHHHHHHHH
Q 018702          223 MEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE--------GTKLVTWVKAV  292 (351)
Q Consensus       223 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~  292 (351)
                      .......  ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.......        ...........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543322  2233457888999999998889999999999999999999999986543221        00111111111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....        ....+...++.+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus       257 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          257 LEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             hhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11111        1123445568899999999999999999999999999988653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.1e-47  Score=332.48  Aligned_cols=262  Identities=16%  Similarity=0.202  Sum_probs=210.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++....  ..+.+.+|+..+..+ +|+|++++++++.+....+++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            4788999999999999999996 568889999986543  223578899999999 799999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc-----eEEeeeccccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME-----ARVSDFGLATL  222 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~dfg~~~~  222 (351)
                      + +++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.     +||+|||++..
T Consensus        88 ~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           88 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             c-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9 99999999743   34689999999999999999999998   9999999999999987776     99999999986


Q ss_pred             cCccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          223 MEAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       223 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221      1234568999999999999999999999999999999999999997643222111111111111111


Q ss_pred             ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...    .    .....++.+.+++.+||+.||++|||++++++.|+++..+
T Consensus       241 ~~~----~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          241 PLR----E----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             CHH----H----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cHH----H----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            100    0    1112347899999999999999999999999999987653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=331.07  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--------------------------hHHHHHHHHHHhhc
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--------------------------VDRGFERELEAMGD  122 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~  122 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++......                          ..+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57889999999999999999875 5788999998654321                          12458899999999


Q ss_pred             CCCCceeeeeeEEec--CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 018702          123 IKHRNIVTLHGYYTS--SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIK  200 (351)
Q Consensus       123 l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  200 (351)
                      ++||||+++++++.+  .+..++||||+++++|.+++.     ...+++..+..++.|++.||+|||++   +++|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            999999999999986  568899999999999988753     45789999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          201 SSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR---ATAKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       201 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      |+||+++.++.+||+|||++......... .....||+.|+|||.+.+..   ++.++||||||+++|+|++|..||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999999866543222 23346899999999997655   478899999999999999999999653


Q ss_pred             hhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          278 FLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..      ........... ...       ..+...++++.+++.+||+.||++|||+.|++++
T Consensus       244 ~~------~~~~~~~~~~~-~~~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RI------MCLHSKIKSQA-LEF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SH------HHHHHHHHHCC-CCC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cH------HHHHHHHhccc-CCC-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            21      11222221111 100       0112334779999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-47  Score=341.09  Aligned_cols=251  Identities=24%  Similarity=0.423  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC--------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--------  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  139 (351)
                      .+|+..+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46888899999999999999986 788999999975443 34567899999999999999999999986543        


Q ss_pred             -------------------------------------------------eeEEEEEecCCCCHHHhhcCCCCCCCCCChH
Q 018702          140 -------------------------------------------------YNLLIYELMPNGSLDTFLHGKSVNKKNLDWP  170 (351)
Q Consensus       140 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  170 (351)
                                                                       ..+++|||+++++|.+++.... .....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence                                                             3799999999999999997543 23445666


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc-----------ccccccccccc
Q 018702          171 SRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT-----------HVSTIVAGTFG  239 (351)
Q Consensus       171 ~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~~  239 (351)
                      .++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7899999999999999998   999999999999999999999999999987654321           11233468999


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHH
Q 018702          240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS  319 (351)
Q Consensus       240 y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  319 (351)
                      |+|||.+.+..++.++||||||+++|+|++|..|+....        ..........         ....+...+..+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~~~~~~---------~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITDVRNLK---------FPLLFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHHHHTTC---------CCHHHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHHhhccC---------CCcccccCChhHHH
Confidence            999999999999999999999999999999987753211        1111111110         01112334467899


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHH
Q 018702          320 IASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       320 li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ++.+||+.||.+|||+.|++++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCCCCcCCCHHHHhhc
Confidence            9999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9e-47  Score=336.09  Aligned_cols=248  Identities=24%  Similarity=0.335  Sum_probs=197.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE----CCCCEEEEEEecCCC----hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||++..    .+++.||+|++....    ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4788999999999999999987    468899999997643    22334578899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999973    35688999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....      ...........     
T Consensus       170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~-----  237 (327)
T 3a62_A          170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCK-----  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC-----
T ss_pred             ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-----
Confidence            5432221 22345689999999999999999999999999999999999999965422      11222222211     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                           ...|...+..+.+++.+||+.||.+||     ++.|++++
T Consensus       238 -----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 -----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                 112334457899999999999999999     77888764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.6e-47  Score=336.70  Aligned_cols=264  Identities=21%  Similarity=0.316  Sum_probs=210.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe----cCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT----SSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~l  143 (351)
                      ..+|+..+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            45799999999999999999997 568899999987766666778999999999999999999999986    3457899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|||+++|+|.+++.........+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999975443457799999999999999999999999   9999999999999999999999999998754


Q ss_pred             Cccccc--------ccccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          224 EAEKTH--------VSTIVAGTFGYLAPEYFDTGR---ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       224 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      ......        ......||+.|+|||.+.+..   ++.++||||||+++|+|++|..||........ ....    .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence            322111        012234799999999987554   68999999999999999999999965322211 1111    1


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ......        ...+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       260 ~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQNQLS--------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhccCC--------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            111000        011233447899999999999999999999999999988653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-47  Score=340.48  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=208.5

Q ss_pred             CCCCCcccccCceEEEEEEEC-----CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeEE
Q 018702           72 FSSKDVIGSGGFGTVYRLTVN-----DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLL  143 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  143 (351)
                      |+..+.||+|+||.||++.+.     +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999988642     577899999976543 345678999999999999999999999987  467899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++++|.+++..     ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            9999999999999963     3489999999999999999999999   9999999999999999999999999999876


Q ss_pred             Cccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc-----c-c--HHHHHHHHH
Q 018702          224 EAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-----T-K--LVTWVKAVM  293 (351)
Q Consensus       224 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~-~--~~~~~~~~~  293 (351)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||........     . .  .........
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543321  22334578889999999988999999999999999999999999865432100     0 0  000111111


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...        .....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.++
T Consensus       265 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          265 ERG--------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcc--------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            111        11123444557899999999999999999999999999988653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-47  Score=341.50  Aligned_cols=263  Identities=26%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  140 (351)
                      ..+|+..+.||+|+||.||+|...      ++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            457888999999999999999862      34579999997543 23346789999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCC-------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVN-------------------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKS  201 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp  201 (351)
                      .++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||+.   +++||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence            99999999999999999754211                   13478999999999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchh
Q 018702          202 SNILLDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFL  279 (351)
Q Consensus       202 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~  279 (351)
                      +||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            9999999999999999999865443222 2233457889999999988999999999999999999998 9999965422


Q ss_pred             cccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ..      ...........        ...+...++.+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus       281 ~~------~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          281 DA------NFYKLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SH------HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HH------HHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11      11112211111        112334457899999999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-47  Score=349.98  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=207.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChh---hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTE---VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||+||+|...+ ++.||+|++......   ....+.+|..++..++||||++++++|.+.+..++
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            45689999999999999999999864 678999998652211   12237889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       152 V~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             EECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            99999999999999742   45689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ...........+||+.|+|||++.     ...++.++||||||+++|||++|+.||......      ............
T Consensus       226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~  299 (437)
T 4aw2_A          226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKER  299 (437)
T ss_dssp             CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHH
T ss_pred             ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhhcccc
Confidence            554444444567999999999986     567899999999999999999999999654221      112222111100


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~  341 (351)
                       ...    .......++++.+|+.+||..+|++  ||+++|++++
T Consensus       300 -~~~----p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          300 -FQF----PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -CCC----CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -ccC----CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             000    1111224578999999999998888  9999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-46  Score=338.15  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=205.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+|+..+.||+|+||.||+|.... ++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            3578899999999999999999864 6789999987532   12345678899999988 79999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||++||+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+++..
T Consensus        99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999973    35689999999999999999999999   9999999999999999999999999999753


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||.....      ............      
T Consensus       172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~------  238 (353)
T 2i0e_A          172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV------  238 (353)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC------
T ss_pred             ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC------
Confidence            3222 123445799999999999999999999999999999999999999965321      122222222111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                          ..|...+.++.+++.+||+.||.+||+     +++++++
T Consensus       239 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                134445688999999999999999995     5777654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-46  Score=332.43  Aligned_cols=265  Identities=21%  Similarity=0.365  Sum_probs=204.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||.||+|.. .+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            345789999999999999999997 46889999999753   23445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999875433456789999999999999999999998   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....    .................    
T Consensus       187 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~----  257 (310)
T 2wqm_A          187 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQCDYPP----  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHHTTCSCC----
T ss_pred             cCCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHHhhcccCCC----
Confidence            433221 223458999999999999999999999999999999999999986532    11222222222111110    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                          ..+...+..+.+++.+||+.||.+|||+.++++.|+++++.
T Consensus       258 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          258 ----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             ----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                01123447899999999999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-47  Score=331.99  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC----CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS----TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|...+.||+|+||.||+|.+.++    ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.++ ..+++
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence            4788889999999999999986432    359999987653 34456789999999999999999999998754 56899


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        91 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           91 MELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999999642   34589999999999999999999998   99999999999999999999999999998665


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ...   .......      
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~---~~~~~~~------  232 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG---VLEKGDR------  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH---HHHHTCC------
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH---HHhcCCC------
Confidence            443333334457889999999998899999999999999999998 999996532221   111   1111111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                         ...+...++.+.+++.+||+.||++|||+.|++++|+++.+
T Consensus       233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          233 ---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence               11233345789999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5e-47  Score=337.90  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||+||+|.+. +++    +||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46888899999999999999964 333    36888876433 334567899999999999999999999998765 689


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +++|+.+|+|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999753   45689999999999999999999999   9999999999999999999999999999866


Q ss_pred             Cccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...   .......    
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~---~~~~~~~----  237 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS---ILEKGER----  237 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HHHTTCC----
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH---HHHcCCC----
Confidence            543322 2223346889999999999999999999999999999999 999996543221   111   1111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           ...+...+..+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus       238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 11234455789999999999999999999999999988754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.4e-47  Score=340.93  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|+..+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            458999999999999999999986 678899999976433 335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc--eEEeeeccccccCc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME--ARVSDFGLATLMEA  225 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  225 (351)
                      +++|+|.+++..    .+.+++..+..++.|++.||+|||+.   +++||||||+||+++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999863    45689999999999999999999998   9999999999999987765  99999999874322


Q ss_pred             ccccccccccccccccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAK-GDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ..  ......||+.|+|||.+.+..++.+ +||||||+++|+|++|+.||......  ................   .  
T Consensus       171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~---~--  241 (361)
T 3uc3_A          171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVKYS---I--  241 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTTCCC---C--
T ss_pred             cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcCCCC---C--
Confidence            21  1233468999999999988777665 89999999999999999999764322  2222222222221110   0  


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ..+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       242 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 ---PDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               0111234789999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-46  Score=342.61  Aligned_cols=266  Identities=19%  Similarity=0.266  Sum_probs=204.2

Q ss_pred             hcCCCCCCccccc--CceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSG--GFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+|+..+.||+|  +||.||++... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3579999999999  99999999986 68899999997543  3344678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999753  235689999999999999999999999   9999999999999999999999999988644


Q ss_pred             Ccccc------cccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          224 EAEKT------HVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       224 ~~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      .....      .......||+.|+|||.+.+  ..++.++|||||||++|+|++|+.||........  ...........
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence            22111      11122368999999999987  6799999999999999999999999965322110  00000000000


Q ss_pred             --------------------------------CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 --------------------------------KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 --------------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                                      .......+......+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                            0000000000011234456789999999999999999999999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-47  Score=349.55  Aligned_cols=255  Identities=23%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||+||+|... +++.||+|++.....   ...+.+.+|..++..++||||+++++++.+.+..++
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3467899999999999999999986 578899999864211   112347889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||++||+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.+|.+||+|||+++..
T Consensus       147 V~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             EECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            9999999999999863     3588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CcccccccccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGR----ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ...........+||+.|+|||++.+..    ++.++||||||+++|+|++|+.||.....      ..............
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL  292 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHC
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHhccccc
Confidence            554443444567999999999997655    78999999999999999999999965422      12222222111000


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSK--RPTMTEVVKML  342 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~e~l~~L  342 (351)
                      . .     ..+...+.++.+|+.+||+.+|.+  ||+++|++++-
T Consensus       293 ~-~-----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          293 T-F-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             C-C-----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             c-C-----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            0 0     001123478999999999999988  99999998763

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.4e-46  Score=332.02  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=191.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357899999999999999999875 5788999999765432 33568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          147 LMPNGSLDTFLHGKS--VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |++ |+|.+++....  .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 59999886432  1234689999999999999999999998   99999999999999999999999999998654


Q ss_pred             cccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec-
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI-  302 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (351)
                      ..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   .................. 
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence            33221 223458999999999876 468999999999999999999999997643221   111111111110000000 


Q ss_pred             -------cccCC-------------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 -------DTSLE-------------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 -------~~~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                             .....             ..+...+.++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                   00000             0111234689999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-46  Score=334.93  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=182.0

Q ss_pred             CCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           75 KDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      .+.||+|+||.||+|... +++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999985 5788999998643   3456788999999997 9999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---ceEEeeeccccccCccccc
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---EARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~  229 (351)
                      |.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++   .+||+|||++........ 
T Consensus        93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            9999973    46799999999999999999999998   999999999999998765   899999999986544322 


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc-ccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG-TKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||........ .............. ...  +   ..
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-~~~--~---~~  238 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-FSF--E---GE  238 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-CCC--C---SH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-CCC--C---cc
Confidence            22344689999999999999999999999999999999999999976433221 12222222222111 100  0   00


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .....++++.+|+.+||+.||.+|||++|++++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            112345789999999999999999999998865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.7e-47  Score=331.24  Aligned_cols=250  Identities=20%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-C-------CEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-S-------TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      ++|+..+.||+|+||.||+|.... +       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            468888999999999999998653 2       46999999776666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc--------eE
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME--------AR  213 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~--------~k  213 (351)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.        +|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999743   33489999999999999999999999   9999999999999998877        99


Q ss_pred             EeeeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCC-CCCcchhcccccHHHHHHH
Q 018702          214 VSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKR-PMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~-p~~~~~~~~~~~~~~~~~~  291 (351)
                      |+|||++......     ....+|+.|+|||.+.+ ..++.++||||||+++|+|++|.. |+.....      ......
T Consensus       162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~  230 (289)
T 4fvq_A          162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQF  230 (289)
T ss_dssp             ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHH
T ss_pred             eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHH
Confidence            9999998754332     22347889999999987 778999999999999999999554 4433211      111111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .....           ..+...+.++.+++.+||+.||.+|||+.|++++|+++.+
T Consensus       231 ~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 YEDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hhccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11110           1122223568999999999999999999999999998865

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.1e-46  Score=338.77  Aligned_cols=268  Identities=18%  Similarity=0.279  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCChhhHH-----------HHHHHHHHhhcCCCCceeee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTTEVDR-----------GFERELEAMGDIKHRNIVTL  131 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~~  131 (351)
                      ..+|+..+.||+|+||.||+|.+.+      ++.||+|++.........           .+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578999999999999999998764      367999998765432211           23456677888899999999


Q ss_pred             eeEEecC----CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          132 HGYYTSS----QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       132 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ++++...    ...++||||+ +++|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    4579999999 9999999974   236799999999999999999999999   999999999999999


Q ss_pred             --CCCceEEeeeccccccCcccccc------cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchh
Q 018702          208 --QNMEARVSDFGLATLMEAEKTHV------STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFL  279 (351)
Q Consensus       208 --~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  279 (351)
                        .++.+||+|||+++.........      .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998665432211      1234599999999999999999999999999999999999999975322


Q ss_pred             cccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          280 EEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .  ............... ....+..+.  +...+.++.+++.+||+.||.+|||+.++++.|+++..+
T Consensus       267 ~--~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          267 D--PKYVRDSKIRYRENI-ASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             C--HHHHHHHHHHHHHCH-HHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             C--HHHHHHHHHHhhhhH-HHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            1  111111111111111 111111110  122347899999999999999999999999999887543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-46  Score=348.44  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=206.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|...+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46888899999999999999975 688999999865321   23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        96 E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999997    345689999999999999999999998   999999999999999999999999999986544


Q ss_pred             ccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ..  .....+||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.....      ...........        
T Consensus       169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~--------  232 (476)
T 2y94_A          169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGI--------  232 (476)
T ss_dssp             TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTC--------
T ss_pred             cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCC--------
Confidence            32  2234569999999999988766 6899999999999999999999965321      11222222211        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ...|...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence              11233445789999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.3e-46  Score=334.60  Aligned_cols=261  Identities=28%  Similarity=0.426  Sum_probs=210.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS  138 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  138 (351)
                      ..+|+..+.||+|+||.||+|.+.        ++..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            357888999999999999999863        456799999976533 3446788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL  206 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~  206 (351)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            999999999999999999975432            123588999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhccccc
Q 018702          207 DQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTK  284 (351)
Q Consensus       207 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~  284 (351)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......    
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence            99999999999999866543221 1222346789999999988889999999999999999999 99998654221    


Q ss_pred             HHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                        ...........         ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus       267 --~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          267 --ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              12222211111         11233445789999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-46  Score=332.81  Aligned_cols=263  Identities=28%  Similarity=0.426  Sum_probs=213.2

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||+|..      .++..||+|.+..... ...+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4788899999999999999985      2456899999976543 3446789999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC--------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          142 LLIYELMPNGSLDTFLHGKSV--------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      +++|||+++|+|.+++.....              ....+++..++.++.|++.||+|||+.   +++||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence            999999999999999975421              123589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      .++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......    
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----  255 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----  255 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH----
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh----
Confidence            9999999999999866544322 2223457889999999988999999999999999999999 999986542211    


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                        ...........        ...+...+..+.+++.+||+.||.+|||+.|++++|+++..+.
T Consensus       256 --~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          256 --KFYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             --HHHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --HHHHHhccCCC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence              11111111111        0113334578999999999999999999999999999887653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=329.24  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=193.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||+||+|... +++.||+|++.....  ........|+..+..+ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46888999999999999999986 688999999865432  2333455555555555 8999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 67999988643   35689999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ...  .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.....         ...........      
T Consensus       210 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~~~~~------  271 (311)
T 3p1a_A          210 AGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQGYLPP------  271 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTTCCCH------
T ss_pred             CCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhccCCCc------
Confidence            322  233458999999999875 799999999999999999999776643211         11111111000      


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ..+...++.+.+++.+||+.||++|||+.|++++
T Consensus       272 --~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          272 --EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence              0112234789999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.3e-47  Score=358.49  Aligned_cols=257  Identities=31%  Similarity=0.475  Sum_probs=211.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ..+|+..+.||+|+||.||+|.++++..||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            346778889999999999999998888899999976543 34678999999999999999999999876 6789999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       344 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          344 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             TTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             cCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            999999999642  124588999999999999999999998   999999999999999999999999999986654322


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......      ...........         .
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~---------~  483 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYR---------M  483 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHHTTCC---------C
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---------C
Confidence            22223346789999999998999999999999999999999 99999654221      11222211111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ..+..++..+.+|+.+||+.||++|||++++++.|+.+..
T Consensus       484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            2344455789999999999999999999999999998754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=336.79  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             CCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           75 KDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      .+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            457999999999999874 6889999999887666677899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE--cCCCceEEeeeccccccCccccccc
Q 018702          154 DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL--DQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      .+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||+  ++++.+||+|||++........  .
T Consensus       174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~  245 (373)
T 2x4f_A          174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L  245 (373)
T ss_dssp             HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence            9988642   34588999999999999999999998   99999999999999  5678999999999986654322  2


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCH
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI  311 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ............  ..+.    ...
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~--~~~~----~~~  313 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD--LEDE----EFQ  313 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC--SCSG----GGT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC--CChh----hhc
Confidence            2345899999999999899999999999999999999999999654221      122222221111  0001    112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          312 NEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       312 ~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..++++.+|+.+||+.||.+|||+.|++++
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            334789999999999999999999999973

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-47  Score=341.83  Aligned_cols=264  Identities=27%  Similarity=0.406  Sum_probs=211.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      ...+|+..+.||+|+||.||+|....      ...||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            34578889999999999999999743      24799999976533 3456789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV----------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN  209 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~  209 (351)
                      ..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence            99999999999999999864211          134678999999999999999999998   99999999999999999


Q ss_pred             CceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHH
Q 018702          210 MEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVT  287 (351)
Q Consensus       210 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~  287 (351)
                      +.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......      
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------  274 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------  274 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------
Confidence            99999999999865433222 2223457889999999988899999999999999999998 999986542211      


Q ss_pred             HHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          288 WVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...........        ...+...++.+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus       275 ~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 KFYKLVKDGYQ--------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            11111111111        012333347899999999999999999999999999987654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-46  Score=329.05  Aligned_cols=261  Identities=22%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||.||++... +++.||+|++.....   ...+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3468999999999999999999975 678899999875432   234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            9999999999999973    35689999999999999999999999   9999999999999999999999999999766


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++|..||......       ............    
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----  253 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----
Confidence            544333333456899999999999999999999999999999999999999754321       111112111110    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRP-TMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~e~l~~L~~~~~~  348 (351)
                        ....+...+..+.+++.+||+.||++|| |++++++.|+++..+
T Consensus       254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence              0112333446799999999999999999 999999999877543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.3e-47  Score=334.93  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe----e
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY----N  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~  141 (351)
                      ++|+..+.||+|+||.||++.+ .+++.||+|++.....   .....+.+|+.++++++||||+++++++.....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            4789999999999999999997 5678899999976532   334568899999999999999999999876554    3


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        92 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            999999999999999973    35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ........  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......      .............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence            65443221  223346899999999999999999999999999999999999999654221      1112222111110


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVV-KMLEL  344 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l-~~L~~  344 (351)
                        ...    .+...+.++.+++.+||+.||.+||++.+++ +.+..
T Consensus       239 --~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 --PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             --HHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --ccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence              000    0122347799999999999999999766655 44433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=326.81  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=208.0

Q ss_pred             CCCCCC-cccccCceEEEEEEEC---CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKD-VIGSGGFGTVYRLTVN---DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      +|...+ .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            455555 8999999999999853   56789999997753 34456789999999999999999999999 455689999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           89 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999964   245689999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          226 EKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       226 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      .....  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......      ...........     
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~i~~~~~-----  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGKR-----  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTTCC-----
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHhcCCc-----
Confidence            33221  222346889999999988889999999999999999998 99999654221      11111111111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                          ...+...++.+.+++.+||+.||.+|||+.+++++|+++..+
T Consensus       232 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                123445557899999999999999999999999999987643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-46  Score=336.97  Aligned_cols=266  Identities=25%  Similarity=0.257  Sum_probs=205.3

Q ss_pred             ChHHHHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC-----ChhhHHHHHHHHHHhhcCCCCceeeeeeE
Q 018702           61 QSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG-----TTEVDRGFERELEAMGDIKHRNIVTLHGY  134 (351)
Q Consensus        61 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~  134 (351)
                      +...+.....+|+..+.||+|+||.||+|... ++..||+|++...     .....+.+.+|+.+++.++||||++++++
T Consensus        17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            34455666778999999999999999999974 5778999998643     23344678999999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHhhcCCCCC------------------------------------CCCCChHHHHHHHHH
Q 018702          135 YTSSQYNLLIYELMPNGSLDTFLHGKSVN------------------------------------KKNLDWPSRYKIAVG  178 (351)
Q Consensus       135 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~~  178 (351)
                      +.+.+..++||||+++|+|.+++......                                    ...+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            99999999999999999999998521100                                    112356678889999


Q ss_pred             HHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC--ceEEeeeccccccCcccc---cccccccccccccCcccccC--CCC
Q 018702          179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNM--EARVSDFGLATLMEAEKT---HVSTIVAGTFGYLAPEYFDT--GRA  251 (351)
Q Consensus       179 i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~  251 (351)
                      ++.||+|||+.   +++||||||+||+++.++  .+||+|||++........   .......||+.|+|||.+.+  ..+
T Consensus       177 i~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            99999999999   999999999999998776  899999999986543221   12334568999999999865  678


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 018702          252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSK  331 (351)
Q Consensus       252 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  331 (351)
                      +.++||||||+++|+|++|+.||......      .............  ..    ......++.+.+++.+||+.||.+
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--EN----PNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--TS----GGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--CC----cccccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999999999654321      1222222221110  00    011224578999999999999999


Q ss_pred             CCCHHHHHHH
Q 018702          332 RPTMTEVVKM  341 (351)
Q Consensus       332 Rps~~e~l~~  341 (351)
                      |||+.|++++
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999884

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=329.73  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=199.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||.||++... ++.||+|.+...  ...+.+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            46778889999999999999876 677999998643  344678999999999999999999998874  4799999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc-eEEeeeccccccCcccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME-ARVSDFGLATLMEAEKT  228 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~  228 (351)
                      +++|.+++.... ....+++..++.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++....... 
T Consensus        83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-  160 (307)
T 2eva_A           83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-  160 (307)
T ss_dssp             TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence            999999997532 2235788899999999999999999932229999999999999998886 7999999997543321 


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                         ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....    ...............         .
T Consensus       161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~---------~  224 (307)
T 2eva_A          161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVHNGTRP---------P  224 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHHTTCCC---------C
T ss_pred             ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHhcCCCC---------C
Confidence               223589999999999999999999999999999999999999964321    111111222111111         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            223344779999999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=335.11  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=191.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            356888899999999999999986 47789999997643  345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeeccccccC
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLATLME  224 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~~  224 (351)
                      +++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||++....
T Consensus       130 ~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          130 VTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999997    345689999999999999999999998   9999999999999975   8899999999998654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......     ............ . ... 
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~-~-~~~-  272 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEY-Y-FIS-  272 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCC-C-CCT-
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCC-c-cCC-
Confidence            322  123356899999999999999999999999999999999999999653211     111122221111 0 011 


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ......+.++.+++.+||+.||++|||+.|++++
T Consensus       273 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          273 ---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1223445789999999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-46  Score=331.86  Aligned_cols=257  Identities=30%  Similarity=0.507  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC-----CEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS-----TAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.....     ..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            4566778999999999999986432     3599999976533 334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999742   35689999999999999999999999   9999999999999999999999999999865


Q ss_pred             Ccccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          224 EAEKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       224 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      .......  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......      ...........   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~~~---  268 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFR---  268 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC---
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCCCc---
Confidence            4432211  122235788999999999999999999999999999999 99999653221      11122211111   


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                            ...+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       269 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  11233445789999999999999999999999999988754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-47  Score=345.47  Aligned_cols=256  Identities=24%  Similarity=0.290  Sum_probs=205.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||+||++..+ +++.||+|++.....   ...+.+.+|..++..++||||+++++++.+.+..++
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            4567999999999999999999985 688999999965321   122347889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++.+.   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+++..
T Consensus       139 VmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999999999742   24689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccccccccccccccccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFD-------TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      ...........+||+.|+|||++.       +..++.++|+|||||++|||++|+.||......      ..........
T Consensus       213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~  286 (412)
T 2vd5_A          213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGKIVHYK  286 (412)
T ss_dssp             CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHH
T ss_pred             cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhcc
Confidence            554433334467999999999986       457899999999999999999999999654221      1112221110


Q ss_pred             ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q 018702          297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKR---PTMTEVVKM  341 (351)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~e~l~~  341 (351)
                      ...     .....+...+.++.+|+.+||. +|.+|   |+++|++++
T Consensus       287 ~~~-----~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          287 EHL-----SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHC-----CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cCc-----CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            000     0011123345789999999999 99998   589998765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.7e-47  Score=336.42  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCE----EEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STA----FAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.+.. +..    |++|.+.... ......+.+|+.+++.++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            468888999999999999999753 433    7888875433 222345778999999999999999999986 456799


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence            99999999999999743   34688999999999999999999999   9999999999999999999999999999876


Q ss_pred             Cccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...... ......+|..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ..   ........    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~---~~~~~~~~----  235 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP---DLLEKGER----  235 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH---HHHHTTCB----
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH---HHHHcCCC----
Confidence            544322 2234457889999999998999999999999999999999 999997542211   11   11111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           ...+...+.++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       236 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 -----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 11223334568899999999999999999999999988754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=336.80  Aligned_cols=265  Identities=17%  Similarity=0.242  Sum_probs=200.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCChhh-----------HHHHHHHHHHhhcCCCCceeeeee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGTTEV-----------DRGFERELEAMGDIKHRNIVTLHG  133 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~  133 (351)
                      ..+|+..+.||+|+||.||+|...    ++..+|+|+........           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357899999999999999999985    46779999987654321           123567888999999999999999


Q ss_pred             EEec----CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC
Q 018702          134 YYTS----SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN  209 (351)
Q Consensus       134 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~  209 (351)
                      ++..    ....++||||+ +++|.+++..    ...+++..++.++.|++.||+|||+.   +++||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9887    67889999999 9999999974    33789999999999999999999998   99999999999999887


Q ss_pred             C--ceEEeeeccccccCccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc
Q 018702          210 M--EARVSDFGLATLMEAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE  281 (351)
Q Consensus       210 ~--~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  281 (351)
                      +  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999866433211      1234568999999999999999999999999999999999999996432111


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                        ..................... ..  +...++.+.+++.+||+.||++|||++++++.|+++.
T Consensus       268 --~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 --VAVQTAKTNLLDELPQSVLKW-AP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             --HHHHHHHHHHHHTTTHHHHHH-SC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             --HHHHHHHHhhcccccHHHHhh-cc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence              111111111111111100000 00  1133468999999999999999999999999999865

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=342.16  Aligned_cols=272  Identities=23%  Similarity=0.273  Sum_probs=215.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC--eeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--YNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  145 (351)
                      .+|...+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            47888999999999999999986 488999999975432 33456789999999999999999999988655  779999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCceEEeeecccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSDFGLAT  221 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~~  221 (351)
                      ||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++
T Consensus        89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            9999999999997543 233489999999999999999999999   99999999999999    778889999999998


Q ss_pred             ccCcccccccccccccccccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDT--------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      .......  .....||+.|+|||.+.+        ..++.++||||||+++|+|++|+.||.......  ..........
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~  240 (396)
T 4eut_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKII  240 (396)
T ss_dssp             ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHH
T ss_pred             EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHh
Confidence            6544332  233468999999999864        567889999999999999999999996532221  1122223333


Q ss_pred             hcCcccee-------------c-c-ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          294 QDKREEYV-------------I-D-TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       294 ~~~~~~~~-------------~-~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ........             . + +.....+...+..+.+++.+||+.||++|||+.|+++.++++....
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            22211100             0 0 0111345778889999999999999999999999999999887654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-46  Score=349.67  Aligned_cols=248  Identities=20%  Similarity=0.310  Sum_probs=197.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            46888899999999999999975 5789999998653   2233345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++...
T Consensus       228 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          228 EYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             CCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             eeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999973    4568999999999999999999998 7   99999999999999999999999999997543


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ............       
T Consensus       301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~-------  366 (446)
T 4ejn_A          301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEI-------  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-------
T ss_pred             CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCC-------
Confidence            3222 23345799999999999999999999999999999999999999965422      112222222111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                         ..|...+.++.+|+.+||+.||.+||     |++|++++
T Consensus       367 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 ---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence               12344557899999999999999999     99999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-46  Score=333.42  Aligned_cols=260  Identities=22%  Similarity=0.334  Sum_probs=199.4

Q ss_pred             cCCCCC-CcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSK-DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|++. +.||+|+||.||+|... +++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467774 78999999999999864 6889999999876656667789999999885 79999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc---eEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~  223 (351)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++...
T Consensus        92 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999973    35689999999999999999999999   9999999999999998776   999999998755


Q ss_pred             Ccccc------cccccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH-------
Q 018702          224 EAEKT------HVSTIVAGTFGYLAPEYFDT-----GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL-------  285 (351)
Q Consensus       224 ~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------  285 (351)
                      .....      .......||+.|+|||.+.+     ..++.++||||||+++|+|++|..||......+....       
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211      11223458999999999865     5688999999999999999999999976432211100       


Q ss_pred             -HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          286 -VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       286 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ............... ....    ....+..+.+++.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~i~~~~~~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEF-PDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCCCCC-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccCccc-Cchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             011111111111100 0000    01234679999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=334.07  Aligned_cols=266  Identities=27%  Similarity=0.441  Sum_probs=212.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-----CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC--ee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-----NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--YN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~  141 (351)
                      ..+|+..+.||+|+||.||++..     .+++.||+|++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            34688889999999999999984     357889999998776666778999999999999999999999987654  78


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999999753   34589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc------cc---cHHHHHH
Q 018702          222 LMEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE------GT---KLVTWVK  290 (351)
Q Consensus       222 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~---~~~~~~~  290 (351)
                      ........  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+......-      ..   .......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76543321  1223346788999999988889999999999999999999999976432110      00   0011111


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .......        ....+...+..+.+++.+||+.||++|||+.|+++.|++++.+
T Consensus       274 ~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          274 ELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhhcCC--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1111110        1122344557899999999999999999999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-46  Score=330.98  Aligned_cols=269  Identities=25%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC--CCCceeeeeeEEecC----Cee
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI--KHRNIVTLHGYYTSS----QYN  141 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~  141 (351)
                      ..++|+..+.||+|+||.||+|... ++.||+|++....   .....+|.+++...  +||||+++++++...    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3457999999999999999999986 7889999986432   23344555555554  899999999998877    788


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCcEEEcCCCceEEee
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC-----IPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                      ++||||+++|+|.+++..     ..+++..++.++.|++.||+|||+..     .++++||||||+||+++.++.+||+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            999999999999999963     35899999999999999999999851     23899999999999999999999999


Q ss_pred             eccccccCcccccc---cccccccccccCcccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCcc
Q 018702          217 FGLATLMEAEKTHV---STIVAGTFGYLAPEYFDTGRATAK------GDVYSFGVVLLELLTG----------KRPMDEA  277 (351)
Q Consensus       217 fg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~slG~il~~l~~g----------~~p~~~~  277 (351)
                      ||++..........   .....||+.|+|||.+.+..++.+      +||||||+++|+|++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            99997654433221   123468999999999987766654      9999999999999999          5666443


Q ss_pred             hhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          278 FLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      .... .. ...................  ...+..+++.+.+++.+||+.||++|||+.|++++|+.+..+.
T Consensus       266 ~~~~-~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          266 VPSD-PS-YEDMREIVCIKKLRPSFPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCSS-CC-HHHHHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCCC-Cc-hhhhHHHHhhhccCccccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            2211 11 1112222211111000000  0112367788999999999999999999999999999987653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.6e-46  Score=331.70  Aligned_cols=264  Identities=25%  Similarity=0.397  Sum_probs=213.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCC
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  139 (351)
                      ....+|+..+.||+|+||.||+|...      +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            34567899999999999999999864      357799999976433 33456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCC------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceE
Q 018702          140 YNLLIYELMPNGSLDTFLHGKS------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR  213 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~k  213 (351)
                      ..++||||+++|+|.+++....      .....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence            9999999999999999986421      1124578999999999999999999999   999999999999999999999


Q ss_pred             EeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHH
Q 018702          214 VSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      |+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......      .....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~  252 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRF  252 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHH
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHHHH
Confidence            9999999765433221 2223356889999999998899999999999999999999 89998653211      11222


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....         ....+...+..+.+++.+||+.||.+|||+.|++++|+++...
T Consensus       253 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          253 VMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            22111         1122344557899999999999999999999999999987543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-46  Score=328.53  Aligned_cols=259  Identities=30%  Similarity=0.439  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCC----CEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEE-ecCCeeE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDS----TAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYY-TSSQYNL  142 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~  142 (351)
                      ..+|+..+.||+|+||.||+|...++    ..+|+|.+..... ...+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            34678889999999999999986432    2589999876433 3446789999999999999999999985 4566889


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus       104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999974   245678999999999999999999998   999999999999999999999999999986


Q ss_pred             cCccccc---ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          223 MEAEKTH---VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       223 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      .......   ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......   ...   ........ 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~---~~~~~~~~-  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DIT---VYLLQGRR-  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THH---HHHHTTCC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHH---HHHhcCCC-
Confidence            5443221   1223457889999999999999999999999999999999 56666443211   111   11111111 


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                              ...+...+..+.+++.+||+.||++|||++|+++.|+.+..+
T Consensus       251 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          251 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    112333447899999999999999999999999999998765

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-46  Score=327.06  Aligned_cols=260  Identities=20%  Similarity=0.351  Sum_probs=209.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEe--cCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYT--SSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||++... +++.||+|.+....  ....+.+.+|+.++++++||||+++++++.  ..+..+++
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            47888999999999999999975 67889999997543  334567899999999999999999999874  46788999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCcEEEcCCCceEEeeecc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH-----IIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      |||+++++|.+++.........+++..++.++.|++.||+|||+.   +     ++|+||||+||+++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999975443455689999999999999999999998   7     99999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      +........ ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....      ............  
T Consensus       163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~--  233 (279)
T 2w5a_A          163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGKF--  233 (279)
T ss_dssp             HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC--
T ss_pred             heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHHhhccc--
Confidence            976543322 12234589999999999988999999999999999999999999965421      111122211111  


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                             ...+...+..+.+++.+||+.||.+|||+.|+++++..-.++
T Consensus       234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                   122334557899999999999999999999999988765543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.8e-46  Score=326.30  Aligned_cols=265  Identities=18%  Similarity=0.236  Sum_probs=205.6

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEE-ecCCeeEEE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY-TSSQYNLLI  144 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv  144 (351)
                      ....+|+..+.||+|+||.||+|.. .+++.||+|++.....  ...+.+|+.+++.++|++++..++.+ ...+..+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3446899999999999999999997 5678899998755332  23478899999999988777666655 667788999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCceEEeeecccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLAT  221 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~  221 (351)
                      |||+ +++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||++   ++++.+||+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 99999998642   35689999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccCcccc------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          222 LMEAEKT------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       222 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      .......      .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            6654322      1123456899999999999999999999999999999999999999765433333332222221111


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ....    .    .....++.+.+++.+||+.||++|||++++++.|+++..+
T Consensus       237 ~~~~----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          237 TPIE----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             SCHH----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             chhh----h----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            1100    0    0112246899999999999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-46  Score=325.40  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=208.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEE-ecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY-TSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||.||+|.. .+++.||+|++.....  .+.+.+|+.+++.++|++++..+..+ ...+..+++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            45789999999999999999997 5688999999876433  23588999999999988866666555 56778899999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCceEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~  223 (351)
                      |+ +++|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+||+++   +++.+||+|||++...
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 89999999642   35689999999999999999999999   999999999999994   7889999999999866


Q ss_pred             Cccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          224 EAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       224 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            543321      12345689999999999999999999999999999999999999976543333333222222111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...        .+...++.+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       239 ~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          239 IEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hHH--------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            000        0122347799999999999999999999999999988654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-46  Score=337.73  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=194.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHH-hhcCCCCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEA-MGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+|+..+.||+|+||.||++..+ ++..||+|++.....   .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357889999999999999999986 477899999975432   223456667776 577899999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||++||+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999973    35688999999999999999999998   9999999999999999999999999999753


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .... ......+||+.|+|||++.+..++.++|+||||+++|||++|..||.....      ............      
T Consensus       190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~------  256 (373)
T 2r5t_A          190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL------  256 (373)
T ss_dssp             BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCC------
T ss_pred             ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhccc------
Confidence            3222 223446799999999999999999999999999999999999999965322      122222222211      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE  337 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e  337 (351)
                          ..+...+..+.+++.+||+.||.+||++.+
T Consensus       257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                123344578999999999999999999854

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=335.32  Aligned_cols=252  Identities=24%  Similarity=0.425  Sum_probs=198.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCC--CceeeeeeEEecCCeeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKH--RNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  144 (351)
                      ..+|+..+.||+|+||.||++...+++.||+|++....  ....+.+.+|+.++..++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            34688899999999999999999889999999987543  3334678899999999976  9999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      || +.+++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||++....
T Consensus        88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99 457899999973    45789999999999999999999999   999999999999997 5789999999998665


Q ss_pred             ccccc-ccccccccccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          225 AEKTH-VSTIVAGTFGYLAPEYFDT-----------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       225 ~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      ..... ......||+.|+|||.+.+           ..++.++||||||+++|+|++|+.||....     .........
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~  233 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAI  233 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHH
Confidence            43322 2334569999999999864           678999999999999999999999996431     111122222


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ......        ...+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus       234 ~~~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          234 IDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hcCCcc--------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            211111        112333346799999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-46  Score=328.49  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             hcCCCCCC-cccccCceEEEEEEEC---CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           69 TLKFSSKD-VIGSGGFGTVYRLTVN---DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        69 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ..+|+..+ .||+|+||.||+|.+.   +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34677777 8999999999999642   357799999976432  3356789999999999999999999999 556789


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||+++++|.+++..    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999973    45689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCcccccc--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          223 MEAEKTHV--STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       223 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......      ..........   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~---  237 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGE---  237 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTC---
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC---
Confidence            65433221  122346788999999988889999999999999999999 99999654221      1111111111   


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                            ....+...+..+.+++.+||+.||.+|||+.++++.|+++-.+
T Consensus       238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                  1123444557899999999999999999999999999987543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3e-46  Score=332.96  Aligned_cols=259  Identities=29%  Similarity=0.463  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCE--EEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTA--FAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|... ++..  +++|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            47888899999999999999875 4443  4999887532 23345688999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          145 YELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      |||+++++|.+++....            .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997542            2235789999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHH
Q 018702          213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ||+|||++........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......      .....
T Consensus       182 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~  253 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK  253 (327)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH
T ss_pred             EEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHHH
Confidence            9999999874332211  122346889999999988889999999999999999998 99999654221      11111


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .....         ....+...+..+.+++.+||+.||.+|||+.|++++|+.+..+
T Consensus       254 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          254 LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11110         1122344557899999999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=327.00  Aligned_cols=261  Identities=21%  Similarity=0.304  Sum_probs=200.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            47888999999999999999985 488999999865433  334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999999886    345689999999999999999999999   9999999999999999999999999999865433


Q ss_pred             cccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc----------
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD----------  295 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  295 (351)
                      ... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+..   .........          
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHH
T ss_pred             ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhcccccccccccc
Confidence            222 233468999999999875 67899999999999999999999999764322211   111111100          


Q ss_pred             -C-ccc--eecccc-CC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 -K-REE--YVIDTS-LE---GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 -~-~~~--~~~~~~-~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       . ...  ...++. ..   ......+..+.+++.+||+.||.+|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0 000  000000 00   0012345679999999999999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=324.72  Aligned_cols=249  Identities=25%  Similarity=0.456  Sum_probs=185.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4688889999999999999997 4688999999865322   22356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999742   35689999999999999999999999   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........      ..    ....   .+  
T Consensus       165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~----~~~~---~~--  228 (278)
T 3cok_A          165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LN----KVVL---AD--  228 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCS---SC--
T ss_pred             CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HH----HHhh---cc--
Confidence            2221 2234589999999999988999999999999999999999999965432110      00    0000   00  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ...+...+.++.+++.+||+.||++|||+.+++++
T Consensus       229 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          229 -YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence             11234455789999999999999999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9e-46  Score=328.97  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||++... +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46888999999999999999975 5789999998764322      3467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----ceEEeeec
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM----EARVSDFG  218 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg  218 (351)
                      +||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++    .+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999997    345689999999999999999999998   999999999999999887    79999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ++........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ............
T Consensus       165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~  236 (321)
T 2a2a_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVSYD  236 (321)
T ss_dssp             TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC
T ss_pred             cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccc
Confidence            9986544322  23345899999999999999999999999999999999999999653221      112222111100


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         .+.   ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       237 ---~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          237 ---FDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ---CCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ---cCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000   0011234679999999999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-45  Score=321.66  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .++|+..+.||+|+||.||+|.... +..+|+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            3468889999999999999999764 668999999776555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCceEEeeeccccccC
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLME  224 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~  224 (351)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++....
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999863    45689999999999999999999999   99999999999999   788999999999997654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ....  .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||......      .............  ...
T Consensus       161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~~  229 (277)
T 3f3z_A          161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF--PEK  229 (277)
T ss_dssp             TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC--CHH
T ss_pred             Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC--Cch
Confidence            4322  233458999999999875 4999999999999999999999999654221      1111111111100  000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .    ....++.+.+++.+||+.||.+|||+.+++++
T Consensus       230 ~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          230 D----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             H----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             h----hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0    01234789999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.2e-46  Score=323.97  Aligned_cols=247  Identities=28%  Similarity=0.446  Sum_probs=202.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... ++..||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            46888899999999999999875 467899999865322   22456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           89 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999873    35689999999999999999999998   999999999999999999999999998865433


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..   .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||......      ..........         
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~---------  223 (279)
T 3fdn_A          162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVE---------  223 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC---------
T ss_pred             cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhCC---------
Confidence            22   12345899999999999999999999999999999999999999654221      1112111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       ...+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus       224 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             -CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             -CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence             112334457899999999999999999999999763

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-46  Score=338.55  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=192.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCC--ee
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQ--YN  141 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~  141 (351)
                      ...+|+..+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.+++.+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3468999999999999999999874 6789999998653  3344567889999999997 999999999997544  68


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++||||++ ++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999997 599999863     4688999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCcc--------------------cccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhc
Q 018702          222 LMEAE--------------------KTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLE  280 (351)
Q Consensus       222 ~~~~~--------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  280 (351)
                      .....                    .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                    1111233579999999999876 67899999999999999999999999764321


Q ss_pred             ccccHHHHHHHHHhcCccceec---------------------cccCCC-------------CCHHHHHHHHHHHHHhcC
Q 018702          281 EGTKLVTWVKAVMQDKREEYVI---------------------DTSLEG-------------CPINEINDVFSIASMCLE  326 (351)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~-------------~~~~~~~~l~~li~~cl~  326 (351)
                      ..  +.. ..............                     ......             .+...++++.+|+.+||+
T Consensus       238 ~~--~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQ--LER-IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HH--HHH-HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HH--HHH-HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            11  000 00111000000000                     000000             011334679999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 018702          327 PEPSKRPTMTEVVKM  341 (351)
Q Consensus       327 ~~p~~Rps~~e~l~~  341 (351)
                      .||++|||++|++++
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.1e-46  Score=331.13  Aligned_cols=265  Identities=28%  Similarity=0.414  Sum_probs=211.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS  138 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  138 (351)
                      ....+|+..+.||+|+||.||+|.+      .+++.||+|.+..... ...+.+.+|+.++.++ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            3456899999999999999999985      2457899999976543 3345788999999999 699999999998765


Q ss_pred             C-eeEEEEEecCCCCHHHhhcCCCCC------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 018702          139 Q-YNLLIYELMPNGSLDTFLHGKSVN------------KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNIL  205 (351)
Q Consensus       139 ~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  205 (351)
                      + ..+++|||+++++|.+++......            ...+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence            4 589999999999999999754321            22378899999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccc
Q 018702          206 LDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGT  283 (351)
Q Consensus       206 ~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~  283 (351)
                      ++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......  
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--  258 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--  258 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--
Confidence            99999999999999986543322 22233457889999999998999999999999999999998 999996532111  


Q ss_pred             cHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         ...........         ...+...+..+.+++.+||+.||.+|||+.|++++|+++.+.
T Consensus       259 ---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          259 ---EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             ---HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence               11111111111         112333457899999999999999999999999999988654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-46  Score=335.17  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=203.1

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----CCceeeeeeEEecCCe
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----HRNIVTLHGYYTSSQY  140 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~  140 (351)
                      ....+|+..+.||+|+||.||+|... +++.||+|++... ....+.+..|+.+++.++     ||||+++++++...+.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            34568999999999999999999974 6788999999753 344456778999999886     9999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC------------
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ------------  208 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~------------  208 (351)
                      .++||||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.            
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhc
Confidence            99999999 89999999754  234589999999999999999999998   9999999999999975            


Q ss_pred             -------------CCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 018702          209 -------------NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMD  275 (351)
Q Consensus       209 -------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  275 (351)
                                   ++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                         7899999999997644322    23468999999999999999999999999999999999999997


Q ss_pred             cchhcccccHHHHHHHHHhc------------CccceeccccCC-CCC--------------------HHHHHHHHHHHH
Q 018702          276 EAFLEEGTKLVTWVKAVMQD------------KREEYVIDTSLE-GCP--------------------INEINDVFSIAS  322 (351)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~-~~~--------------------~~~~~~l~~li~  322 (351)
                      .......   ..........            ............ ..|                    ....+.+.+|+.
T Consensus       261 ~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  337 (360)
T 3llt_A          261 THEHMEH---LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY  337 (360)
T ss_dssp             CSSHHHH---HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred             CCcHHHH---HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence            6432211   1111111100            000000000000 000                    011256889999


Q ss_pred             HhcCCCCCCCCCHHHHHHH
Q 018702          323 MCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       323 ~cl~~~p~~Rps~~e~l~~  341 (351)
                      +||+.||++|||+.|++++
T Consensus       338 ~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          338 SILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HHhcCChhhCCCHHHHhcC
Confidence            9999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-45  Score=321.38  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=205.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            357889999999999999999975 57889999986543  333467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc---eEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~  222 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999998863    45689999999999999999999999   9999999999999987655   99999999976


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ......  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ............ . .
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-~-~  227 (284)
T 3kk8_A          158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYD-Y-P  227 (284)
T ss_dssp             CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC-C-C
T ss_pred             cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhcccc-C-C
Confidence            544322  23346899999999999999999999999999999999999999653221      111111111110 0 0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .    ......++.+.+++.+||+.||++|||+.|++++
T Consensus       228 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 S----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             T----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             c----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0    1122344779999999999999999999999885

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.6e-46  Score=348.07  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=208.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|...+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            46777889999999999999985 588999999965322   22356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++||+|.+++.........+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999976544456799999999999999999999998   999999999999999999999999999986544


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .... ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||......  ..............         
T Consensus       342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~~~---------  409 (543)
T 3c4z_A          342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLEQA---------  409 (543)
T ss_dssp             TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHHCC---------
T ss_pred             CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhhcc---------
Confidence            3222 23357999999999999999999999999999999999999999764211  12222222222211         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTM-----TEVVK  340 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~e~l~  340 (351)
                       ...|...+..+.+++.+||+.||.+||++     .++++
T Consensus       410 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 -VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             12344556889999999999999999975     56654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-46  Score=326.43  Aligned_cols=258  Identities=30%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             CCCCCCcccccCceEEEEEEECC-C---CEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee-EEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVND-S---TAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  144 (351)
                      .|...+.||+|+||.||+|.+.+ +   ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45556889999999999998643 2   2699999876443 3446788999999999999999999999876655 999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+.+++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999974   245688999999999999999999999   99999999999999999999999999997654


Q ss_pred             cccc---cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          225 AEKT---HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       225 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+....  ......   ........    
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~---~~~~~~~~----  246 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLT---HFLAQGRR----  246 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHH---HHHHTTCC----
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHH---HHhhcCCC----
Confidence            3321   12223457899999999999999999999999999999999555543221  111111   11111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                           ...+...++.+.+++.+||+.||.+|||++++++.|+++...
T Consensus       247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 112334457899999999999999999999999999988654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=339.27  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=196.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CC--CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEe-cCCeeEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN--DS--TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYT-SSQYNLLI  144 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv  144 (351)
                      .|...+.||+|+||.||+|...  ++  ..+|+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556678999999999999864  22  358999886543 344567899999999999999999999865 45678999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999742   35578899999999999999999999   99999999999999999999999999998654


Q ss_pred             ccccc---ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          225 AEKTH---VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       225 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      .....   ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.....   .....   .......   
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~---~~~~~~~---  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV---YLLQGRR---  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHH---HHHTTCC---
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHH---HHHcCCC---
Confidence            33211   1223346789999999999999999999999999999999 7778765322   11111   1111111   


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                            ...|...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       315 ------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 ------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                  112334457899999999999999999999999999987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=332.21  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||.||+|.+. +++    +|++|.+... .....+.+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57888999999999999999964 343    3588877543 3344567899999999999999999999998765 789


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +++++.+|+|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999753   45689999999999999999999999   9999999999999999999999999999865


Q ss_pred             Cccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...   ......     
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---~~~~~~-----  236 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS---ILEKGE-----  236 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HHHTTC-----
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH---HHHcCC-----
Confidence            433222 1222346789999999999999999999999999999999 999997643221   111   111111     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                          ....+...+.++.+++.+||+.||.+|||+.|+++.|+.+..+
T Consensus       237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                1112344557899999999999999999999999999987643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-46  Score=349.80  Aligned_cols=253  Identities=26%  Similarity=0.360  Sum_probs=207.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            46888899999999999999975 68899999986532   123356789999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++||+|.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++.....
T Consensus       264 Ey~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          264 TLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             CCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999754  234589999999999999999999999   999999999999999999999999999986644


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ...  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ........... ..        
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~-~~--------  405 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKE-VP--------  405 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHH-CC--------
T ss_pred             Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhc-cc--------
Confidence            322  233469999999999999899999999999999999999999997643211  11111111111 11        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                       ...+...+.++.+|+.+||+.||.+||     +++|++++
T Consensus       406 -~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 -EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             112344558899999999999999999     78888865

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=334.06  Aligned_cols=243  Identities=26%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--------hHHHHHHHHHHhhcCCCCceeeeeeEEecCC
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  139 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++......        ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            457999999999999999999864 5788999999764311        2234678999999999999999999999999


Q ss_pred             eeEEEEEecCCC-CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          140 YNLLIYELMPNG-SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       140 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      ..++||||+.+| +|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999998766 9999997    345699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ++........  .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.......            ..  
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~--  239 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EA--  239 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TT--
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hh--
Confidence            9986654332  233568999999999988776 789999999999999999999996532110            00  


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                              ....+...++++.+++.+||+.||.+|||+.+++++-
T Consensus       240 --------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          240 --------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             --------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             --------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                    0011223457899999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-45  Score=330.04  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=208.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhc--CCCCceeeeeeEEecCC----e
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGD--IKHRNIVTLHGYYTSSQ----Y  140 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~  140 (351)
                      ....+|+..+.||+|+||.||+|... ++.||+|++...   ....+.+|.+++..  ++||||+++++++....    .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            34568999999999999999999984 788999998643   34457788888877  78999999999998776    7


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEEcCCCce
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH--------HDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      .+++|||+++|+|.+++..     ..+++..++.++.|++.||+|||        +.   +++||||||+||+++.++.+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred             eEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence            8999999999999999963     35899999999999999999999        66   99999999999999999999


Q ss_pred             EEeeeccccccCccccc---ccccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CCC
Q 018702          213 RVSDFGLATLMEAEKTH---VSTIVAGTFGYLAPEYFDTG------RATAKGDVYSFGVVLLELLTG----------KRP  273 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p  273 (351)
                      ||+|||++.........   ......||+.|+|||.+.+.      .++.++||||||+++|+|++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999765443322   12334689999999998765      234689999999999999999          677


Q ss_pred             CCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          274 MDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      |...... ......+..............+ .  ......+..+.+++.+||+.||++|||+.+++++|+.+..+.
T Consensus       267 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          267 YYDLVPS-DPSVEEMRKVVCEQKLRPNIPN-R--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTTTSCS-SCCHHHHHHHHTTSCCCCCCCG-G--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccccCcC-cccHHHHHHHHHHHHhCCCCcc-c--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            7553221 1122222222222111111000 0  012356678999999999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-45  Score=323.05  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|...+.||+|+||.||++... ++..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888999999999999999975 578899999876432 2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCceEEeeeccccccC
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLME  224 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~  224 (351)
                      +++++|.+++.........+++..+..++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999864433346789999999999999999999998   99999999999999   456789999999997654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ....  .....+|+.|+|||.+. +.++.++||||||+++|+|++|..||......      ............ .    
T Consensus       179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~-~----  244 (285)
T 3is5_A          179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPN-Y----  244 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC-C----
T ss_pred             Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCcc-c----
Confidence            3322  23346899999999886 57899999999999999999999999654321      111111111111 0    


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .......++.+.+++.+||+.||++|||+.|++++
T Consensus       245 --~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 --AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             --CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             --ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00011134678999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-46  Score=336.99  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||.||++..+ +++.||+|++......    ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457889999999999999999975 5788999999765433    34677788777 79999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----CceEEeeeccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN----MEARVSDFGLATL  222 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~----~~~kl~dfg~~~~  222 (351)
                      |+++|+|.+++.    ..+.+++..+..++.|++.||.|||+.   +|+||||||+|||+.++    +.+||+|||++..
T Consensus        97 ~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           97 LMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999997    345689999999999999999999999   99999999999998543    3599999999986


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ...... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.....   ................   .
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~~~~~~---~  242 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTPEEILARIGSGKFS---L  242 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCHHHHHHHHHHCCCC---C
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCHHHHHHHHccCCcc---c
Confidence            544322 22345689999999999888899999999999999999999999975321   1222222222222111   0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                         ....+...++++.+++.+||+.||++|||+.|++++-
T Consensus       243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence               0112334557899999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.3e-47  Score=328.86  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-CeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-QYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||.||++... ++.||+|.+....  ..+.+.+|+.++++++||||+++++++.+. +..+++|||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            47888999999999999999875 7789999987543  446788999999999999999999997544 5789999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++++|.+++...  ....+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++....... 
T Consensus        98 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           98 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             TTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999999643  122378889999999999999999998   99999999999999999999999999987543322 


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                         ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .   ........         ..
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~---~~~~~~~~---------~~  233 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V---VPRVEKGY---------KM  233 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H---HHHHTTTC---------CC
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHhcCC---------CC
Confidence               12346889999999998899999999999999999998 999996543221   1   11111111         01


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccccC
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV  350 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~~  350 (351)
                      ..+...++.+.+++.+||+.||.+|||+.|+++.|++++..++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            1234445789999999999999999999999999999987664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=328.76  Aligned_cols=262  Identities=22%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC-----hhhHHHHHHHHHHhhcC---CCCceeeeeeEEecCC
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT-----TEVDRGFERELEAMGDI---KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~  139 (351)
                      ..+|+..+.||+|+||+||+|.+ .+++.||+|++....     ......+.+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            45899999999999999999996 467889999986422     11223566777776666   4999999999987655


Q ss_pred             -----eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          140 -----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       140 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                           ..+++|||+. ++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence                 5799999996 5999999754  234489999999999999999999999   9999999999999999999999


Q ss_pred             eeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      +|||++........  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ..........
T Consensus       162 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~  236 (308)
T 3g33_A          162 ADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIG  236 (308)
T ss_dssp             CSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred             eeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence            99999986543322  234568999999999999999999999999999999999999996643221   1111111111


Q ss_pred             cCccceec-c-----ccCC--------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYVI-D-----TSLE--------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~~-~-----~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........ +     ....        ......++.+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11100000 0     0000        0112345779999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-46  Score=330.84  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=200.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECC----CCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC--
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ--  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  139 (351)
                      ...+|...+.||+|+||.||+|....    +..||+|.+....  ....+.+.+|+.++++++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            44578888999999999999998642    3479999987543  334467889999999999999999999987755  


Q ss_pred             ---eeEEEEEecCCCCHHHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          140 ---YNLLIYELMPNGSLDTFLHGKS--VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       140 ---~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                         ..+++|||+++++|.+++....  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence               3499999999999999985322  2346799999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHH
Q 018702          215 SDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       215 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      +|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .   ....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~  262 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M---YDYL  262 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H---HHHH
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHHH
Confidence            99999976543322 12223447889999999999999999999999999999999 889986543221   1   1111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .....         ...+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       263 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          263 LHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111         11233445789999999999999999999999999998864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-46  Score=346.50  Aligned_cols=265  Identities=21%  Similarity=0.267  Sum_probs=187.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEec-----CCe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS-----SQY  140 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  140 (351)
                      ..+|+..+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.+++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999875 6788999998653  23345678999999999999999999999843     357


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .|+||||+ +++|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 569999987    346699999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccc--------------------------cccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHh----
Q 018702          221 TLMEAEKT--------------------------HVSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLT----  269 (351)
Q Consensus       221 ~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~----  269 (351)
                      +.......                          ......+||+.|+|||++ .+..++.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            86542211                          112334689999999976 56679999999999999999999    


Q ss_pred             -------CCCCCCcchhccc-----------------ccHHHHHHHHHhcCccce------------------eccccCC
Q 018702          270 -------GKRPMDEAFLEEG-----------------TKLVTWVKAVMQDKREEY------------------VIDTSLE  307 (351)
Q Consensus       270 -------g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~------------------~~~~~~~  307 (351)
                             |+++|.+......                 .+................                  .....+.
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   5666644321000                 000000001110000000                  0000001


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......+.++.+|+.+||+.||.+|||++|++++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1122335789999999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.9e-46  Score=332.82  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++.....   ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3578888999999999999997 5678899999975432   23356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+. |+|.+++..   ....+++..+..++.|+++||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 588887753   245689999999999999999999999   999999999999999999999999999976543


Q ss_pred             ccccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      .     ....||+.|+|||.+.   ++.++.++||||||+++|+|++|..||.....      ..............   
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~~---  272 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESPA---  272 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC---
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC---
Confidence            2     2346899999999884   57789999999999999999999999865321      11222222221110   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                           ..+...++.+.+++.+||+.||++|||+.+++++..
T Consensus       273 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          273 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             -----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence                 112233477999999999999999999999987644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-45  Score=325.53  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            46888999999999999999975 68899999998765555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCceEEeeeccccccCc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~  225 (351)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||++   ++++.++|+|||++.....
T Consensus        89 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           89 SGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999863    35689999999999999999999998   99999999999999   7789999999999875433


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..   .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ............ .     
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~-~-----  226 (304)
T 2jam_A          162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYYE-F-----  226 (304)
T ss_dssp             BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCCC-C-----
T ss_pred             Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCC-C-----
Confidence            21   22345899999999999999999999999999999999999999654211      112222211110 0     


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            011223445789999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=337.74  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=206.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE----CCCCEEEEEEecCCC----hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV----NDSTAFAVKRLHRGT----TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  140 (351)
                      .+|+..+.||+|+||.||++..    .+++.||+|+++...    ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999997    367899999986532    12234567899999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999973    35689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +..............||+.|+|||.+.+  ..++.++||||||+++|+|++|..||......  ..............  
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~--  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE--  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCC--
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--chHHHHHHHHhccC--
Confidence            8665444444445679999999999975  35789999999999999999999999754221  12222222222211  


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHh
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKMLE  343 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~L~  343 (351)
                              ...+...+..+.+++.+||+.||.+||     |+.|++++..
T Consensus       283 --------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          283 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             --------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                    123444557899999999999999999     9999988653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.4e-46  Score=337.00  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCC--CCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIK--HRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||++...+++.||+|++....  ....+.+.+|+.+++.++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588999999999999999998889999999986543  334567899999999996  599999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      | +.+++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||++.....
T Consensus       136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 568899999974    34688889999999999999999998   999999999999995 57999999999987654


Q ss_pred             cccc-ccccccccccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          226 EKTH-VSTIVAGTFGYLAPEYFDT-----------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       226 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||....     ..........
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~  281 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHh
Confidence            3322 2334569999999999864           468899999999999999999999996432     1112222222


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......        ..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       282 ~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          282 DPNHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CTTSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccccC--------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            211110        1222234679999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=334.95  Aligned_cols=263  Identities=15%  Similarity=0.241  Sum_probs=206.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC---------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceee----------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND---------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT----------  130 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------  130 (351)
                      .+|+..+.||+|+||.||+|....         ++.||+|.+...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578999999999999999999764         778999998754     35778999999999999987          


Q ss_pred             -----eeeEEec-CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 018702          131 -----LHGYYTS-SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNI  204 (351)
Q Consensus       131 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  204 (351)
                           +++++.. .+..++||||+ +++|.+++...  ....+++..++.++.|++.||.|||++   +++||||||+||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  190 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI  190 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence                 5667665 67889999999 99999999743  236799999999999999999999999   999999999999


Q ss_pred             EEcCCC--ceEEeeeccccccCccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 018702          205 LLDQNM--EARVSDFGLATLMEAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDE  276 (351)
Q Consensus       205 l~~~~~--~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  276 (351)
                      +++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999866543221      11334689999999999999999999999999999999999999976


Q ss_pred             chhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          277 AFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ..... .......... ....... .+...  .....+..+.+++.+||+.||++|||++++++.|+++..+
T Consensus       271 ~~~~~-~~~~~~~~~~-~~~~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          271 CLPNT-EDIMKQKQKF-VDKPGPF-VGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             GTTCH-HHHHHHHHHH-HHSCCCE-ECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcCH-HHHHHHHHhc-cCChhhh-hhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            43111 1111111111 1111111 11000  0112247899999999999999999999999999988654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.4e-46  Score=326.42  Aligned_cols=247  Identities=21%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++....  ......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46888999999999999999986 68899999987642  33456788999999999 8999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----------------
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN----------------  209 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~----------------  209 (351)
                      ||+++++|.+++.........+++..++.++.|++.||+|||++   +++||||||+||+++.+                
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999999975432336689999999999999999999999   99999999999999844                


Q ss_pred             ---CceEEeeeccccccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH
Q 018702          210 ---MEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL  285 (351)
Q Consensus       210 ---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  285 (351)
                         ..+||+|||.+........     ..||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+.....      
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------
T ss_pred             CCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------
Confidence               4799999999986544322     3489999999999765 566899999999999999999987643211      


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                         ........         ....+...+..+.+++.+||+.||++|||+.|++++-
T Consensus       237 ---~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          237 ---WHEIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             ---HHHHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             ---HHHHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence               11111111         1123334457899999999999999999999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-45  Score=328.66  Aligned_cols=262  Identities=27%  Similarity=0.404  Sum_probs=206.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      ..+|+..+.||+|+||.||+|.+      .++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35789999999999999999984      346789999997543 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEe
Q 018702          142 LLIYELMPNGSLDTFLHGKSV---NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVS  215 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~  215 (351)
                      ++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432   224588999999999999999999998   9999999999999984   4469999


Q ss_pred             eeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHH
Q 018702          216 DFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       216 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      |||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......      .......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHHHh
Confidence            9999875433221 12223457889999999988899999999999999999998 99998653211      1112221


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ....         ...+...+..+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus       260 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          260 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            1111         112334457899999999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.3e-46  Score=323.74  Aligned_cols=248  Identities=26%  Similarity=0.478  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec-----------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS-----------  137 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----------  137 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|.+.....    .+.+|+++++.++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            46888999999999999999986 688999999976542    36689999999999999999998854           


Q ss_pred             -----CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          138 -----SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       138 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                           ....+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                 44579999999999999999743  235689999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      ||+|||++........  .....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+....        ......
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~~  231 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTDL  231 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHHH
T ss_pred             EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHHh
Confidence            9999999986654322  223458999999999999999999999999999999999999864321        111111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      . ...           .+...+..+.+++.+||+.||.+|||+.|++++|+.++..
T Consensus       232 ~-~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          232 R-DGI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             H-TTC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             h-ccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            1 110           1222346789999999999999999999999999988754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-45  Score=322.61  Aligned_cols=248  Identities=25%  Similarity=0.478  Sum_probs=206.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|...+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            47888999999999999999986 4678999998654   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999863    35689999999999999999999999   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .... .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||......      ..........         
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~---------  231 (294)
T 2rku_A          168 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNE---------  231 (294)
T ss_dssp             TTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC---------
T ss_pred             Cccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhcc---------
Confidence            2221 23346899999999999889999999999999999999999999654321      1111111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ...+...+..+.+++.+||+.||++|||++|++++
T Consensus       232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             01233445789999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.6e-46  Score=334.34  Aligned_cols=255  Identities=22%  Similarity=0.364  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||++.+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            46888899999999999999986 67889999997653 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.+  +++||||||+||+++.++.+||+|||++.......
T Consensus       113 ~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          113 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999973    346899999999999999999999841  89999999999999999999999999987543221


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH----------------------
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL----------------------  285 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----------------------  285 (351)
                         .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........                      
T Consensus       187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence               2234689999999999999999999999999999999999999975432211000                      


Q ss_pred             --------------HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          286 --------------VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       286 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                    ............        ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPP--------PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCC--------CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCCCcccchhhhhHHhccCC--------CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                          000000000000        001112245789999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.6e-45  Score=318.94  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46888999999999999999975 68899999986543 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+.......
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999986    345689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             c-cccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          228 T-HVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       228 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      . .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ..    ........ ..      
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~----~~~~~~~~-~~------  227 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QE----YSDWKEKK-TY------  227 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HH----HHHHHTTC-TT------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HH----HHHhhhcc-cc------
Confidence            1 22234568999999999987665 779999999999999999999996542211 01    11111111 00      


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       .......+..+.+++.+||+.||++|||+.|++++
T Consensus       228 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             01123345789999999999999999999999874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-45  Score=334.84  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=191.4

Q ss_pred             CCCCC-CcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHh-hcCCCCceeeeeeEEec----CCeeEE
Q 018702           71 KFSSK-DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAM-GDIKHRNIVTLHGYYTS----SQYNLL  143 (351)
Q Consensus        71 ~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~l  143 (351)
                      +|... +.||+|+||+||++... +++.||+|++...     ..+.+|+.++ +..+||||+++++++..    .+..++
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            45544 68999999999999975 5788999998642     3456788876 44589999999999875    567899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeeccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLA  220 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~  220 (351)
                      ||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999753  234689999999999999999999998   9999999999999987   788999999999


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccc-cHHHHHHHHHhcCccc
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT-KLVTWVKAVMQDKREE  299 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  299 (351)
                      +.......  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....   ..... ..
T Consensus       212 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~-~~  285 (400)
T 1nxk_A          212 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQ-YE  285 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTC-CC
T ss_pred             cccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCc-cc
Confidence            86543222  23456899999999999999999999999999999999999999764332211 11111   11111 00


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                       ...    ......+.++.+|+.+||+.||++|||+.|++++-
T Consensus       286 -~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          286 -FPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             -CCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -CCC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             000    11123457899999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=333.15  Aligned_cols=258  Identities=22%  Similarity=0.313  Sum_probs=196.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC-----
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ-----  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  139 (351)
                      ...+|+..+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3467999999999999999999974 6889999998653  2334467889999999999999999999987653     


Q ss_pred             -eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          140 -YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       140 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                       ..++||||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence             459999999 8899999863     4588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +++.....    .....+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||........   ............
T Consensus       174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~  246 (367)
T 1cm8_A          174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPP  246 (367)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred             cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC
Confidence            99865432    223468999999999876 6899999999999999999999999975432111   000000000000


Q ss_pred             c------------------ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 E------------------EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .                  ...............+..+.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0                  0000011112233445789999999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.9e-45  Score=319.84  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=204.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||.||++... +++.||+|.+......      ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            36888899999999999999986 5889999998654321      3567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----ceEEeeec
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM----EARVSDFG  218 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg  218 (351)
                      ++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999963    45689999999999999999999998   999999999999998877    89999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ++........  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......      ............
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~  229 (283)
T 3bhy_A          158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVNYD  229 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC
T ss_pred             cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcccC
Confidence            9986543322  22345899999999999999999999999999999999999999654221      111111111100


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcccc
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIKS  347 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~~  347 (351)
                       . ..    ..+...++.+.+++.+||+.||++|||+.|++++  ++.++.
T Consensus       230 -~-~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          230 -F-DE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             -C-CH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             -C-cc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence             0 00    0011234679999999999999999999999973  555443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=332.48  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhH-HHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||.||+|... +++.||+|++........ ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999986 678899999875432221 2355799999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      ++ |+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 5999988643   35689999999999999999999998   99999999999999999999999999997544322


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc---
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID---  303 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  303 (351)
                      . ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+   ...................   
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence            2 2223458999999999876 578999999999999999999999997643221   1111122111111100000   


Q ss_pred             --------------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 --------------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 --------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                    ..........+.++.+|+.+||+.||.+|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                          00000112345678999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-45  Score=345.98  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999975 68899999986542   334567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCceEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~  222 (351)
                      ||+.+|+|.+++.    ....+++..+..++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||++..
T Consensus       106 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          106 EVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             CCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999987    446789999999999999999999999   99999999999999   5678999999999986


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ......  .....||+.|+|||.+.+ .++.++||||+|+++|+|++|.+||.....      ............... .
T Consensus       179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~-~  248 (484)
T 3nyv_A          179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGKYTFE-L  248 (484)
T ss_dssp             BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC-S
T ss_pred             cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCCC-C
Confidence            644332  233468999999999875 699999999999999999999999965422      112222222211100 0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ..+...++.+.+++.+||+.||.+|||+.|++++
T Consensus       249 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          249 -----PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                 1123445789999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=350.92  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=200.7

Q ss_pred             cccccCceEEEEEEEC---CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018702           77 VIGSGGFGTVYRLTVN---DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGS  152 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  152 (351)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999864   45679999997653 3345779999999999999999999999976 56899999999999


Q ss_pred             HHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc--
Q 018702          153 LDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--  230 (351)
Q Consensus       153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--  230 (351)
                      |.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........  
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999964   245689999999999999999999999   99999999999999999999999999998764332221  


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       231 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......      ...........         ...
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~~~---------~~~  560 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGKR---------MEC  560 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------HHHHHHHTTCC---------CCC
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCC---------CCC
Confidence            112235689999999998999999999999999999998 99999764321      11111111111         123


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      |..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            44556889999999999999999999999999988643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.9e-45  Score=321.13  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=207.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46888899999999999999874 67899999997653 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999985     35689999999999999999999999   99999999999999999999999999997654432


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .. .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ...........         .
T Consensus       174 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~---------~  237 (303)
T 3a7i_A          174 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIPKNNP---------P  237 (303)
T ss_dssp             CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC---------C
T ss_pred             cc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhhcCCC---------C
Confidence            22 23346899999999999999999999999999999999999998653211      11111111111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                      ..+...+..+.+++.+||+.||.+|||+.|++++..
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            123334477999999999999999999999988643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-45  Score=328.54  Aligned_cols=249  Identities=25%  Similarity=0.474  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ..+|...+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357888999999999999999986 4678999998653   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999863    35689999999999999999999999   99999999999999999999999999998654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ...........       
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-------  258 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY-------  258 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCCC-------
Confidence            3322 123346899999999999889999999999999999999999999654221      11111111110       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1233344779999999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=320.32  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      +|.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3444558999999999999974 578899999987666666779999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeeccccccCcccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +++|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++. ++.+||+|||++........
T Consensus       103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            999999997532 234567888999999999999999998   9999999999999987 89999999999976543221


Q ss_pred             cccccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                       ......||+.|+|||.+.+..  ++.++||||||+++|+|++|+.||.......    ...........         .
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~---------~  244 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGMFKV---------H  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHHHCC---------C
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhccccc---------c
Confidence             123346899999999987643  7899999999999999999999996432111    11111111110         1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            12344455789999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=331.70  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=191.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEe--------c
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYT--------S  137 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~  137 (351)
                      ...+|+..+.||+|+||.||++.+. +++.||+|++........+.+.+|+.++.++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457889999999999999999974 67899999997776666778899999999996 999999999983        4


Q ss_pred             CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEcCCCceEEe
Q 018702          138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       138 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                      ....+++|||++ |+|.+++.... ....+++..++.++.|++.||.|||+.   +  ++||||||+|||++.++.+||+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence            456799999995 69999886432 245689999999999999999999998   8  9999999999999999999999


Q ss_pred             eeccccccCccccc-----------ccccccccccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcc
Q 018702          216 DFGLATLMEAEKTH-----------VSTIVAGTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE  281 (351)
Q Consensus       216 dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  281 (351)
                      |||++.........           ......+|+.|+|||.+   .+..++.++||||||+++|+|++|..||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999865433221           11134589999999998   56678999999999999999999999996532110


Q ss_pred             cccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          282 GTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                                .......        ...+...+..+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus       261 ----------~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          261 ----------IVNGKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------hhcCccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                      0000000        001122234588999999999999999999999999988653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-45  Score=321.10  Aligned_cols=246  Identities=25%  Similarity=0.403  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... ++..||+|++....   ......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999976 46789999986532   122456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999973    34689999999999999999999998   999999999999999999999999999875543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..   .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      ..........         
T Consensus       167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~---------  228 (284)
T 2vgo_A          167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNVD---------  228 (284)
T ss_dssp             SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC---------
T ss_pred             cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhccc---------
Confidence            22   22346899999999999999999999999999999999999999653221      1111221111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence             11233445789999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=330.69  Aligned_cols=268  Identities=22%  Similarity=0.361  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHH--HHHHHhhcCCCCceeeeeeEEe-----cCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFE--RELEAMGDIKHRNIVTLHGYYT-----SSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~-----~~~~~~  142 (351)
                      .+|+..+.||+|+||.||+|.. +++.||+|++.....   ..+.  .|+..+..++||||+++++.+.     .....+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            4788899999999999999977 578899999865332   2333  3444455689999999998543     233678


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCcEEEcCCCceEEee
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC------IPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~------~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                      +||||+++|+|.+++..     ...++..+..++.|++.||+|||+..      .++|+||||||+|||++.++.+||+|
T Consensus        89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            99999999999999963     33488899999999999999999862      23899999999999999999999999


Q ss_pred             eccccccCcccc-------cccccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc
Q 018702          217 FGLATLMEAEKT-------HVSTIVAGTFGYLAPEYFDT-------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG  282 (351)
Q Consensus       217 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  282 (351)
                      ||++........       .......||+.|+|||.+.+       ..++.++||||||+++|+|++|..||........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999986543221       11223468999999999976       3566789999999999999999776543221111


Q ss_pred             -c----------cHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          283 -T----------KLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       283 -~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                       .          ...................+.. .......++.+.+++.+||+.||++|||++|+++.|+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence             0          0011111111111111111111 11234567789999999999999999999999999998764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-45  Score=353.91  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=201.2

Q ss_pred             cccccCceEEEEEEEC---CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           77 VIGSGGFGTVYRLTVN---DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .||+|+||.||+|.+.   .++.||||+++....  ...+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus       376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g  454 (635)
T 4fl3_A          376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG  454 (635)
T ss_dssp             EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence            6999999999999753   456799999976432  335679999999999999999999999975 4578999999999


Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc--
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--  229 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  229 (351)
                      +|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........  
T Consensus       455 ~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          455 PLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999997    345689999999999999999999998   9999999999999999999999999999866543321  


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......      ..........         ...
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~~---------~~~  592 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGE---------RMG  592 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTC---------CCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC---------CCC
Confidence            1222346789999999999999999999999999999998 99999664321      1111111111         112


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .+..++.++.+++.+||+.||++|||+.++++.|+++..+
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            3445568899999999999999999999999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.8e-46  Score=330.44  Aligned_cols=263  Identities=20%  Similarity=0.304  Sum_probs=194.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ....+|+..+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34458999999999999999999865 6788999999754332  23467899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-----CCCceEEeeec
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-----QNMEARVSDFG  218 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~-----~~~~~kl~dfg  218 (351)
                      ||||+++ +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++     +++.+||+|||
T Consensus       111 v~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9999975 99999973    45689999999999999999999999   999999999999994     45569999999


Q ss_pred             cccccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ++......... .....+|+.|+|||.+.+. .++.++||||||+++|+|++|..||.......  ....... ......
T Consensus       183 ~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~-~~~~~~  258 (329)
T 3gbz_A          183 LARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFE-VLGLPD  258 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCC
T ss_pred             CccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHH-HhCCCc
Confidence            99865433222 2234579999999998764 58999999999999999999999996543211  1111111 111000


Q ss_pred             cceecc----c-------cCCC------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVID----T-------SLEG------CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~----~-------~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......    +       ....      .+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            000000    0       0000      011144778999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=330.78  Aligned_cols=253  Identities=17%  Similarity=0.170  Sum_probs=203.2

Q ss_pred             hcCCCCCCcccccCceEEEEEE------ECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCC
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLT------VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQ  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  139 (351)
                      ..+|...+.||+|+||.||+|.      ..+++.||+|++.....   .++.+|..++..++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4568888899999999999994      45678899999976543   34666777777775   999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC----------
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV-NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ----------  208 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~----------  208 (351)
                      ..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999964321 346799999999999999999999998   9999999999999998          


Q ss_pred             -CCceEEeeeccccccCcc-cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH
Q 018702          209 -NMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV  286 (351)
Q Consensus       209 -~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  286 (351)
                       ++.+||+|||+++..... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----  292 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----  292 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence             899999999999754322 2223344569999999999999999999999999999999999999986532211     


Q ss_pred             HHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcccc
Q 018702          287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKR-PTMTEVVKMLELIKS  347 (351)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~e~l~~L~~~~~  347 (351)
                                   ..........+  ..+.+.+++..||+.+|.+| |+++++.+.|+.+..
T Consensus       293 -------------~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 -------------CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             -------------EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -------------eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                         01111122222  24678899999999999999 578888887776543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.3e-45  Score=340.18  Aligned_cols=262  Identities=25%  Similarity=0.286  Sum_probs=195.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC------
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS------  138 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  138 (351)
                      ...+|+..+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3468999999999999999999875 5788999999764  333456788999999999999999999998654      


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      +..++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            356999999976 5666664      2388999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH------------
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV------------  286 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------------  286 (351)
                      +++......  ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||......+.....            
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998654322  223456899999999999999999999999999999999999999764321110000            


Q ss_pred             ----HHHHHHHhcCcc--ce----eccccC-C---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          287 ----TWVKAVMQDKRE--EY----VIDTSL-E---GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       287 ----~~~~~~~~~~~~--~~----~~~~~~-~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ............  ..    ...... .   ......+.++.+|+.+||+.||++|||++|++++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                000000000000  00    000000 0   0011225779999999999999999999999976

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=328.27  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=198.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-----hHHHHHHHHHHhhcCCCCceeeeeeEEecCCee
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-----VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  141 (351)
                      ...+|+..+.||+|+||.||+|... +++.||+|++......     ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3458999999999999999999975 5889999998653221     123578999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ++||||+++ +|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999976 89888864   235688899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|.+||.......   ................
T Consensus       161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTT
T ss_pred             eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhh
Confidence            6543322 2233468999999999865 458999999999999999999999986542211   1111111111111100


Q ss_pred             ecc----------ccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          301 VID----------TSLEGCP-----INEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       301 ~~~----------~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ..+          ......+     ...+.++.+|+.+||+.||++|||+.|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            000          0000111     23457899999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.9e-45  Score=317.92  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+..++.++||||+++++++.+.+..+++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            47888999999999999999986 68899999986532   123456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           91 EYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             eccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999973    34689999999999999999999999   999999999999999999999999999976544


Q ss_pred             ccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ...  .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.....      ...........        
T Consensus       164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~--------  227 (276)
T 2h6d_A          164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGV--------  227 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC--------
T ss_pred             Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc--------
Confidence            322  223458999999999987765 6899999999999999999999965321      11112211111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus       228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              11233344789999999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.8e-45  Score=326.37  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=200.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357888999999999999999986 478899999865433  33456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999998876    345689999999999999999999999   999999999999999999999999999976543


Q ss_pred             ccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH--------HHHHHHHhcC
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV--------TWVKAVMQDK  296 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~  296 (351)
                      ... ......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||............        ..........
T Consensus       177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            322 22334589999999998765 7899999999999999999999999764322110000        0000000000


Q ss_pred             -ccceeccccCC-C-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 -REEYVIDTSLE-G-----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 -~~~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       .......+... .     .....++.+.+|+.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00000000000 0     112345789999999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.2e-45  Score=342.95  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|+||.||+|... ++..+|+|++....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46889999999999999999985 67889999987643  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CceEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN---MEARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~  223 (351)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||++...
T Consensus       117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999998863    35689999999999999999999998   99999999999999764   45999999999866


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .....  .....||+.|+|||++. +.++.++||||+|+++|+|++|.+||......      .............  ..
T Consensus       190 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~--~~  258 (494)
T 3lij_A          190 ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYTF--DS  258 (494)
T ss_dssp             BTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCC--CS
T ss_pred             CCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC--Cc
Confidence            54322  23356999999999886 56999999999999999999999999654321      2222222211110  01


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +.    ....++.+.+++.+||+.||.+|||+.|++++
T Consensus       259 ~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          259 PE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             GG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             hh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            11    12334779999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3e-45  Score=343.40  Aligned_cols=250  Identities=27%  Similarity=0.368  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|+||+||+|... +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            47999999999999999999975 68899999985422  2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCceEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~  223 (351)
                      |+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||++...
T Consensus       102 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          102 LYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999998863    35689999999999999999999999   999999999999995   4567999999999865


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      .....  .....||+.|+|||++.+ .++.++||||+|+++|+|++|.+||.....      ................  
T Consensus       175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~--  243 (486)
T 3mwu_A          175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAFDL--  243 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSCS--
T ss_pred             CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCCC--
Confidence            44322  233468999999999875 599999999999999999999999965422      1222222221111000  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ......++++.+++.+||+.||.+|||+.|++++
T Consensus       244 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 ----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                1123345789999999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-45  Score=322.57  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|+..+.||+|+||.||+|... ++..+|+|.+........+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            357888999999999999999986 5788999999776666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999998642   35689999999999999999999998   99999999999999999999999999875432111


Q ss_pred             ccccccccccccccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          228 THVSTIVAGTFGYLAPEYF-----DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                       .......||+.|+|||.+     .+..++.++||||||+++|+|++|..||.....      ..............   
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~---  241 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPT---  241 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC---
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCcc---
Confidence             112234589999999988     467789999999999999999999999865421      11122222211111   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          242 ----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                01233445789999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-44  Score=334.17  Aligned_cols=200  Identities=26%  Similarity=0.329  Sum_probs=167.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----C
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----Q  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  139 (351)
                      ...+|+..+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3468999999999999999999975 5678999999764  233456789999999999999999999998766     5


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..++||||++ ++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            7899999986 59999997    345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCccccc---------------------ccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 018702          220 ATLMEAEKTH---------------------VSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMD  275 (351)
Q Consensus       220 ~~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~  275 (351)
                      ++........                     ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            9865433211                     12445789999999985 56679999999999999999998655543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-46  Score=341.90  Aligned_cols=242  Identities=18%  Similarity=0.206  Sum_probs=188.8

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCC---ChhhHHHHHHHH---HHhhcCCCCceeeee-------eEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRG---TTEVDRGFEREL---EAMGDIKHRNIVTLH-------GYY  135 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~  135 (351)
                      .+|+..+.||+|+||.||+|.+ .+++.||+|++...   .....+.+.+|+   ..+++++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4678889999999999999996 56889999998743   334456788999   555666899999998       666


Q ss_pred             ecCC-----------------eeEEEEEecCCCCHHHhhcCCC---CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 018702          136 TSSQ-----------------YNLLIYELMPNGSLDTFLHGKS---VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHII  195 (351)
Q Consensus       136 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~  195 (351)
                      .+.+                 ..+++|||+ +|+|.+++....   .....+++..++.++.|++.||+|||+.   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            5553                 278999999 679999997421   1122344578889999999999999999   999


Q ss_pred             ecCCCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccCC-----------CCCchhhHHHHHHHH
Q 018702          196 HRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-----------RATAKGDVYSFGVVL  264 (351)
Q Consensus       196 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~il  264 (351)
                      ||||||+|||++.++.+||+|||+++....    ......| +.|+|||.+.+.           .++.++||||||+++
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999985332    2233457 999999999877           899999999999999


Q ss_pred             HHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          265 LELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       265 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      |+|++|+.||..........               ... .    .+...++++.+++.+||+.||++|||+.|+++
T Consensus       304 ~elltg~~Pf~~~~~~~~~~---------------~~~-~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSE---------------WIF-R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CCSG---------------GGG-S----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccchh---------------hhh-h----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999996543211110               000 0    11223477999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.8e-45  Score=342.36  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-------------hhHHHHHHHHHHhhcCCCCceeeeee
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-------------EVDRGFERELEAMGDIKHRNIVTLHG  133 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~  133 (351)
                      ...+|...+.||+|+||+||+|... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3468999999999999999999975 578899999875431             23456889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---
Q 018702          134 YYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---  210 (351)
Q Consensus       134 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---  210 (351)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999999863    45689999999999999999999998   999999999999998775   


Q ss_pred             ceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH
Q 018702          211 EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       211 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      .+||+|||++........  .....||+.|+|||.+. +.++.++||||+|+++|+|++|..||......      ....
T Consensus       187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~  257 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIK  257 (504)
T ss_dssp             SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred             cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence            699999999986654322  23346899999999987 46999999999999999999999999754221      2222


Q ss_pred             HHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..........  .+.    ....+.++.+++.+||+.||.+|||++|++++
T Consensus       258 ~i~~~~~~~~--~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          258 KVEKGKYYFD--FND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHCCCCCC--HHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHcCCCCCC--ccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            2222111100  000    12234779999999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.5e-45  Score=336.31  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=192.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--------hhHHHHHHHHHHhhcCCCCceeeeeeEEecC
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--------EVDRGFERELEAMGDIKHRNIVTLHGYYTSS  138 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  138 (351)
                      ...+|...+.||+|+||.||+|... +++.||+|++.....        .....+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3568999999999999999999875 578899999865321        112247899999999999999999999865 


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---ceEEe
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM---EARVS  215 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~  215 (351)
                      +..++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++   .+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            45799999999999999987    346789999999999999999999998   999999999999997544   59999


Q ss_pred             eeccccccCcccccccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      |||+++......  ......||+.|+|||++.+   ..++.++||||||+++|+|++|..||......  ......    
T Consensus       285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~----  356 (419)
T 3i6u_A          285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQ----  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHH----
T ss_pred             ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHH----
Confidence            999998654322  2234568999999999853   67888999999999999999999999753211  111111    


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........ ...    .....++.+.+++.+||+.||++|||+.|++++
T Consensus       357 i~~~~~~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGKYNF-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTCCCC-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCC-Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111100 000    011234779999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.6e-46  Score=326.31  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=188.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            458999999999999999999864 67889999886543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCC----CCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          147 LMPNGSLDTFLHGK----SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       147 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      |+++++|.+++...    ......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999998631    11245689999999999999999999998   999999999999999999999999999876


Q ss_pred             cCcccc----cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          223 MEAEKT----HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       223 ~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ......    .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.......      ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~  244 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQNDP  244 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTSSC
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhccCC
Confidence            543211    11233468999999999865 568999999999999999999999997643211      1111111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ................+..+.+++.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            10000000011222344779999999999999999999999973

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-45  Score=322.28  Aligned_cols=259  Identities=26%  Similarity=0.411  Sum_probs=199.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CCC--EEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--DST--AFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      .+|+..+.||+|+||.||+|.+.  +++  .||+|++....   ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            47888999999999999999863  233  58999887542   334567889999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            999999999999999742   34588999999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          223 MEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       223 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....      ............. 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGER-  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCC-
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCC-
Confidence            6543322  1223457888999999988889999999999999999999 9999965422      1222222221111 


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                             ...+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       244 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          244 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                   1123344578999999999999999999999999999887654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.7e-45  Score=328.73  Aligned_cols=252  Identities=30%  Similarity=0.465  Sum_probs=203.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--------hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--------EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS  138 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  138 (351)
                      ..+|+..+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            356888899999999999999985 689999999876431        1234578899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      +..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999973    45689999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDT------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      ++........  .....||+.|+|||.+.+      ..++.++||||||+++|+|++|..||.....      .......
T Consensus       246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i  317 (365)
T 2y7j_A          246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMI  317 (365)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred             cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHHHH
Confidence            9986654322  233568999999998853      3688999999999999999999999965321      1111111


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .......  ..+..    ...+..+.+++.+||+.||++|||+.|++++
T Consensus       318 ~~~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          318 MEGQYQF--SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHTCCCC--CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCCCC--CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111100  00000    1223679999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-44  Score=315.64  Aligned_cols=247  Identities=27%  Similarity=0.423  Sum_probs=198.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEec----CCeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS----SQYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  143 (351)
                      .|...+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677778999999999999875 5678999998654  23445678899999999999999999998865    456899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEc-CCCceEEeeeccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLD-QNMEARVSDFGLA  220 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~  220 (351)
                      ||||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +  ++|+||||+||+++ +++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999973    35689999999999999999999998   8  99999999999998 7899999999999


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      .......   .....||+.|+|||.+. +.++.++||||||+++|+|++|..||....     ................ 
T Consensus       180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~-  249 (290)
T 1t4h_A          180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVKPA-  249 (290)
T ss_dssp             GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCCCG-
T ss_pred             ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhccCCcc-
Confidence            7543332   22345899999999887 459999999999999999999999996532     1122222222211111 


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                             ..+...++.+.+++.+||+.||.+|||+.|++++
T Consensus       250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   0122223679999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=318.53  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            457889999999999999999976 48899999997643  345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus       106 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          106 CGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999863   245689999999999999999999998   99999999999999999999999999997654332


Q ss_pred             ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          228 THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      . ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......      .............       .
T Consensus       180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-------~  245 (314)
T 3com_A          180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNPPPT-------F  245 (314)
T ss_dssp             S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCC-------C
T ss_pred             c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCcc-------c
Confidence            2 123345899999999999999999999999999999999999999653211      1111111111110       0


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1233345789999999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.5e-45  Score=351.65  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            356888889999999999999975 57789999987532   22335678899999988 69999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       420 V~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999973    35689999999999999999999999   9999999999999999999999999999854


Q ss_pred             CcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ..... .....+||+.|+|||++.+..++.++||||||+++|||++|..||.....      ...........       
T Consensus       493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~-------  558 (674)
T 3pfq_A          493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN-------  558 (674)
T ss_dssp             CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSC-------
T ss_pred             ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC-------
Confidence            32222 23456799999999999999999999999999999999999999975422      22222222211       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTM-----TEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~e~l~~  341 (351)
                         ...|...+.++.+|+.+||+.||++||++     +|++++
T Consensus       559 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence               12344556889999999999999999997     677653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-45  Score=330.91  Aligned_cols=266  Identities=20%  Similarity=0.270  Sum_probs=197.9

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh-----------hhHHHHHHHHHHhhcCCCCceeeee
Q 018702           64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT-----------EVDRGFERELEAMGDIKHRNIVTLH  132 (351)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~~~  132 (351)
                      ++.....+|+..+.||+|+||.||+|...++..||+|++.....           ...+.+.+|+.++++++||||++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            44556789999999999999999999988899999999854221           1236789999999999999999999


Q ss_pred             eEEec-----CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          133 GYYTS-----SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       133 ~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      +++..     ....++||||++ |+|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA  168 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence            99843     346799999997 588888864   345689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV  286 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  286 (351)
                      .++.+||+|||++........  .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........   .
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~  243 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---L  243 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H
T ss_pred             CCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence            999999999999975433222  233468999999998876 6789999999999999999999999976432111   1


Q ss_pred             HHHHHHHhcCcc-------------------ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          287 TWVKAVMQDKRE-------------------EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       287 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ............                   ...........+...++.+.+|+.+||+.||.+|||+.|++++
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            111111100000                   0000000001122335679999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.8e-45  Score=351.39  Aligned_cols=257  Identities=30%  Similarity=0.420  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----CCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence            467778899999999999998743    3569999987643 3344678999999999999999999999854 568999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       469 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          469 MELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999742   34589999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......      ...........      
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~~~~~------  610 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGER------  610 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHHTCC------
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCC------
Confidence            443333333456789999999998899999999999999999997 99999654221      11222221111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         ...+...+..+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus       611 ---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          611 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence               113444557899999999999999999999999999988654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=316.40  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC----hhhHHHHHHHHHHhhcCCCCceeeeeeEE--ecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKHRNIVTLHGYY--TSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~~  142 (351)
                      .+|...+.||+|+||.||++... ++..+|+|++....    ......+.+|+.+++.++||||+++++++  .+.+..+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            58999999999999999999974 57889999986532    23346789999999999999999999998  4456889


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||++++ |.+++...  ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            999999876 77777643  345789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCccc-ccccccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          223 MEAEK-THVSTIVAGTFGYLAPEYFDTGR--ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       223 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ..... ........||+.|+|||.+.+..  ++.++||||||+++|+|++|..||....      .............  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~~--  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGSY--  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCCC--
Confidence            54322 22223445899999999987644  3789999999999999999999996532      1122222221111  


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                              ..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       231 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 --------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    1233445789999999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.3e-45  Score=327.13  Aligned_cols=262  Identities=19%  Similarity=0.277  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEec--------C
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTS--------S  138 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  138 (351)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++.....  .....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4788999999999999999998 4688999999865432  224567899999999999999999999876        4


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      +..++||||+++ +|.+.+...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999975 777777542   35689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCccc---ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          219 LATLMEAEK---THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       219 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ++.......   ........||+.|+|||.+.+ ..++.++||||||+++|+|++|.+||.......   ..........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~  246 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG  246 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence            998654222   112233468999999998876 568999999999999999999999997643221   1111111111


Q ss_pred             cCccceeccc-------cC---C--CCC-H------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYVIDT-------SL---E--GCP-I------NEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~~~~-------~~---~--~~~-~------~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..........       ..   .  ... .      ..++.+.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1111100000       00   0  000 0      013568899999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.5e-45  Score=327.07  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhh-----------------HHHHHHHHHHhhcCCCCceeeee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEV-----------------DRGFERELEAMGDIKHRNIVTLH  132 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~  132 (351)
                      .+|+..+.||+|+||.||+|.. +++.||+|.+.......                 .+.+.+|+.++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4789999999999999999999 88999999986432211                 16789999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHh------hcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEE
Q 018702          133 GYYTSSQYNLLIYELMPNGSLDTF------LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNIL  205 (351)
Q Consensus       133 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil  205 (351)
                      +++.+.+..++||||+++++|.++      +...  ....+++..++.++.|++.||.|||+ .   +++|+||+|+||+
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            999999999999999999999999      5422  25679999999999999999999999 7   9999999999999


Q ss_pred             EcCCCceEEeeeccccccCcccccccccccccccccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCcchhcccc
Q 018702          206 LDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATA-KGDVYSFGVVLLELLTGKRPMDEAFLEEGT  283 (351)
Q Consensus       206 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  283 (351)
                      ++.++.+||+|||.+......   ......+|+.|+|||.+.+. .++. ++||||||+++|+|++|..||......   
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence            999999999999999865433   22334689999999999877 6666 999999999999999999999754221   


Q ss_pred             cHHHHHHHHHhcCccceecccc----------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          284 KLVTWVKAVMQDKREEYVIDTS----------LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ........... .....+..          ........+..+.+++.+||+.||.+|||+.|++++
T Consensus       259 --~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          259 --VELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             --HHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --HHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              11122221111 11100000          000113455789999999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.7e-45  Score=330.57  Aligned_cols=266  Identities=21%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecC---
Q 018702           64 AIFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSS---  138 (351)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  138 (351)
                      +.+....+|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++...   
T Consensus        21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            33444568999999999999999999875 577899999975433 3346788999999999999999999998654   


Q ss_pred             --CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          139 --QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       139 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                        ...+++|||+. ++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEe
Confidence              36899999997 599999853     4589999999999999999999999   999999999999999999999999


Q ss_pred             eccccccCcccccc--cccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          217 FGLATLMEAEKTHV--STIVAGTFGYLAPEYFD-TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       217 fg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      ||++..........  .....||+.|+|||.+. +..++.++||||||+++|+|++|+.||......+   .........
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~  248 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGIL  248 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHH
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHh
Confidence            99998665433221  23456899999999864 4568999999999999999999999997643222   111111111


Q ss_pred             hcCcccee---------------cccc---CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          294 QDKREEYV---------------IDTS---LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       294 ~~~~~~~~---------------~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........               ....   ........+.++.+|+.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11000000               0000   000112334779999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-45  Score=332.21  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec---------
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS---------  137 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  137 (351)
                      ...+|+..+.||+|+||.||+|.. .+++.||+|++......    ..+|+.+++.++||||+++++++..         
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            346899999999999999999987 46889999998764332    2479999999999999999999843         


Q ss_pred             -----------------------------CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 018702          138 -----------------------------SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH  188 (351)
Q Consensus       138 -----------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  188 (351)
                                                   ....++||||++ ++|.+.+.........+++..+..++.|++.||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                         334789999997 48877776433356779999999999999999999999


Q ss_pred             cCCCCeeecCCCCCcEEEc-CCCceEEeeeccccccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHH
Q 018702          189 DCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLE  266 (351)
Q Consensus       189 ~~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~  266 (351)
                      .   +|+||||||+||+++ .++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++||||+||++|+
T Consensus       160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            8   999999999999997 688999999999986544322  2234579999999988764 58999999999999999


Q ss_pred             HHhCCCCCCcchhcccccHHHHHHHHHhcCc-----------cceeccc----cCC-CCCHHHHHHHHHHHHHhcCCCCC
Q 018702          267 LLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR-----------EEYVIDT----SLE-GCPINEINDVFSIASMCLEPEPS  330 (351)
Q Consensus       267 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~-~~~~~~~~~l~~li~~cl~~~p~  330 (351)
                      |++|+.||......+.  +..... ......           .......    ... ..+...+.++.+|+.+||+.||.
T Consensus       235 ll~g~~pf~~~~~~~~--~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQ--LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999976432211  111111 110000           0000000    000 12334567899999999999999


Q ss_pred             CCCCHHHHHHH
Q 018702          331 KRPTMTEVVKM  341 (351)
Q Consensus       331 ~Rps~~e~l~~  341 (351)
                      +|||+.|++++
T Consensus       312 ~R~t~~e~l~h  322 (383)
T 3eb0_A          312 LRINPYEAMAH  322 (383)
T ss_dssp             GSCCHHHHHTS
T ss_pred             hCCCHHHHhcC
Confidence            99999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-44  Score=322.15  Aligned_cols=257  Identities=18%  Similarity=0.254  Sum_probs=199.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEec--CCeeEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTS--SQYNLLI  144 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  144 (351)
                      ..+|+..+.||+|+||.||+|.. .+++.||+|++....   .+.+.+|+.+++.++ ||||+++++++.+  ....+++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            35788899999999999999986 467899999987543   356889999999997 9999999999987  6678999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeecccccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLM  223 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  223 (351)
                      |||+++++|.+++.       .+++..+..++.|++.||+|||+.   +++||||||+|||++.++ .+||+|||++...
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999984       378889999999999999999998   999999999999999766 8999999999865


Q ss_pred             CcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH--------HHHh
Q 018702          224 EAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK--------AVMQ  294 (351)
Q Consensus       224 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~  294 (351)
                      .....  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ .+.....        ....
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHH
Confidence            44332  233458999999999876 6789999999999999999999999954221110 0000000        0000


Q ss_pred             cC---------------ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DK---------------REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..               ......+......+...+.++.+|+.+||+.||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00               000000000011223346789999999999999999999999984

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-44  Score=321.02  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             cCCCCC-CcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSK-DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|... +.||+|+||.||+|... +++.||+|++....  ......+.+|+.++..+. ||||+++++++.+.+..++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            456666 78999999999999975 58899999987543  233567889999999995 69999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeecccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLAT  221 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~  221 (351)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||++.
T Consensus       108 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             EEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            9999999999998643  346789999999999999999999999   9999999999999987   7899999999998


Q ss_pred             ccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .......  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......      .......... ... 
T Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~-~~~-  252 (327)
T 3lm5_A          183 KIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLNISQVN-VDY-  252 (327)
T ss_dssp             EC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-CCC-
T ss_pred             ccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHHHhcc-ccc-
Confidence            6543322  23346899999999999999999999999999999999999999654221      1111111111 000 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ....+...+..+.+++.+||+.||++|||+++++++
T Consensus       253 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          253 ----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                011223345789999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.6e-45  Score=318.29  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=189.5

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|+||.||++.. .+++.||+|++......  ..+.+.++...++.++||||+++++++.+.+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            5788899999999999999997 46788999999765322  22334555566888899999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++ +|.+++.........+++..+..++.|++.||+|||++  .+++||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            9974 88888764333456799999999999999999999995  28999999999999999999999999999765443


Q ss_pred             cccccccccccccccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          227 KTHVSTIVAGTFGYLAPEYF----DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ...  ....||+.|+|||.+    .+..++.++||||||+++|+|++|..||....     ................   
T Consensus       164 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---  233 (290)
T 3fme_A          164 VAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEPSPQ---  233 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----CHHHHHHHHHHSCCCC---
T ss_pred             ccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----chHHHHHHHhccCCCC---
Confidence            222  223589999999996    56678999999999999999999999996421     1112222222221111   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       234 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          234 -----LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -----cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                 1122345789999999999999999999999873

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.6e-45  Score=331.25  Aligned_cols=259  Identities=24%  Similarity=0.329  Sum_probs=185.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----  138 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  138 (351)
                      ....+|+..+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            34468999999999999999999864 5788999998654  233456788999999999999999999998654     


Q ss_pred             -CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          139 -QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       139 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                       ...++++|++ +++|.+++.     ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             CCeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence             5679999999 789999885     35689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      |+++.....    .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......   ............
T Consensus       177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p  249 (367)
T 2fst_X          177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTP  249 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSC
T ss_pred             ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence            999765432    223468999999999876 678999999999999999999999997643211   111111111100


Q ss_pred             ccce------------------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          297 REEY------------------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       297 ~~~~------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....                  .............++.+.+|+.+||+.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0000                  00000000011234678999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-44  Score=315.71  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=204.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---------hhhHHHHHHHHHHhhcCC-CCceeeeeeEEec
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---------TEVDRGFERELEAMGDIK-HRNIVTLHGYYTS  137 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  137 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++....         ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            357889999999999999999985 57889999997543         122356789999999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeee
Q 018702          138 SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDF  217 (351)
Q Consensus       138 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~df  217 (351)
                      .+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999973    35689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHH
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFD------TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      |++........  .....+++.|+|||.+.      ...++.++||||||+++|+|++|..||.....      ......
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~  240 (298)
T 1phk_A          169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRM  240 (298)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred             cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHH
Confidence            99976543322  23345899999999884      45788999999999999999999999965321      111122


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ....... . .    .......+..+.+++.+||+.||.+|||+.|++++
T Consensus       241 ~~~~~~~-~-~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 IMSGNYQ-F-G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHTCCC-C-C----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhcCCcc-c-C----cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            2211111 0 0    01123445789999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-44  Score=323.01  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCC------ceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV--NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR------NIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||+|..  .+++.||+|++... ....+.+.+|+.+++.++|+      +++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            4789999999999999999987  35788999998754 33445678899998888665      499999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------------
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-------------  208 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-------------  208 (351)
                      ++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||+++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 88999999754  234688999999999999999999998   9999999999999987             


Q ss_pred             ------CCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc
Q 018702          209 ------NMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG  282 (351)
Q Consensus       209 ------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  282 (351)
                            ++.+||+|||++.......    ....||+.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  6689999999997644322    234689999999999999999999999999999999999999976432211


Q ss_pred             ccHHHHHHHHHhcCcc---------cee----------------------ccccCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 018702          283 TKLVTWVKAVMQDKRE---------EYV----------------------IDTSLEGCPINEINDVFSIASMCLEPEPSK  331 (351)
Q Consensus       283 ~~~~~~~~~~~~~~~~---------~~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  331 (351)
                         .............         ...                      ........+...++++.+++.+||+.||.+
T Consensus       243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence               1111111110000         000                      000011224456788999999999999999


Q ss_pred             CCCHHHHHHH--Hhccc
Q 018702          332 RPTMTEVVKM--LELIK  346 (351)
Q Consensus       332 Rps~~e~l~~--L~~~~  346 (351)
                      |||+.|++++  ++.++
T Consensus       320 Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          320 RITLREALKHPFFDLLK  336 (339)
T ss_dssp             SCCHHHHTTSGGGGGGG
T ss_pred             ccCHHHHhcCHHHHHHh
Confidence            9999999965  55544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.8e-44  Score=333.39  Aligned_cols=262  Identities=20%  Similarity=0.257  Sum_probs=206.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC-CceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH-RNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||.||+|.+ .+++.||||++......  ..+.+|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            35799999999999999999997 56889999987654332  347889999999986 556666666778888999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCceEEeeecccccc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---DQNMEARVSDFGLATLM  223 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~  223 (351)
                      |+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 99999999742   45689999999999999999999999   99999999999999   57899999999999876


Q ss_pred             Cccccc------ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          224 EAEKTH------VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       224 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            543321      12245699999999999999999999999999999999999999976432221111111111111111


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ..    .    .+...+.++.+++.+||+.||++||++.++++.|+.+..
T Consensus       237 ~~----~----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          237 IE----A----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HH----H----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HH----H----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            00    0    011223679999999999999999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.1e-45  Score=333.01  Aligned_cols=251  Identities=11%  Similarity=0.061  Sum_probs=181.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHH---HHhhcCCCCceeeee-------eEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFEREL---EAMGDIKHRNIVTLH-------GYY  135 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~  135 (351)
                      .+|+..+.||+|+||.||+|.+. +++.||+|++.....   ...+.+.+|+   ..++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            35888899999999999999975 678899999987543   2334567774   55555 799988755       444


Q ss_pred             ecC-----------------CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHH------HHHHHHHHHHHHHHHhcCCC
Q 018702          136 TSS-----------------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR------YKIAVGAARGIAYLHHDCIP  192 (351)
Q Consensus       136 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~~~~  192 (351)
                      ...                 ...++||||++ |+|.+++...   ...+.+..+      ..++.|++.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            332                 33799999998 8999999753   223455555      78889999999999998   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhC
Q 018702          193 HIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTG  270 (351)
Q Consensus       193 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g  270 (351)
                      +|+||||||+|||++.++.+||+|||+++.......    ...+|+.|+|||.+.+  ..++.++||||||+++|+|++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999986543221    2346799999999987  6799999999999999999999


Q ss_pred             CCCCCcchhcccccHHHHHHHHHhcCccceeccccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          271 KRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL-EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       271 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                      +.||..........        .............. ...+...++.+.+++.+||+.||++|||+.|+++
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99997653221110        00000000000000 0112345678999999999999999999999976

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.3e-44  Score=323.73  Aligned_cols=260  Identities=24%  Similarity=0.284  Sum_probs=192.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC------e
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------Y  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  140 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57899999999999999999875 5788999999754  2334467889999999999999999999987654      7


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .++||||+++ +|.+++.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             eEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            7999999975 7888875      3478999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc----------------
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK----------------  284 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----------------  284 (351)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..........                
T Consensus       175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            7654322  1233468999999999999999999999999999999999999997643211000                


Q ss_pred             HHHHHHHHHhcCccc--ee----cccc-CC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          285 LVTWVKAVMQDKREE--YV----IDTS-LE---GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       285 ~~~~~~~~~~~~~~~--~~----~~~~-~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      +..............  ..    .... ..   ..+...+..+.+|+.+||+.||.+|||++|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            000000000000000  00    0000 00   0112336789999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-44  Score=330.16  Aligned_cols=198  Identities=25%  Similarity=0.345  Sum_probs=170.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC------CCCceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI------KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  141 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            347889999999999999999875 4788999999764 33345566777777666      578999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc--eEEeeecc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME--ARVSDFGL  219 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~  219 (351)
                      +++|||+. ++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999995 6999998754  234589999999999999999999999   9999999999999999887  99999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      +.......    ....||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus       249 a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            97543322    2346899999999999999999999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-44  Score=329.24  Aligned_cols=262  Identities=22%  Similarity=0.270  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC--------CCceeeeeeEEe----
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK--------HRNIVTLHGYYT----  136 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~----  136 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++        ||||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            57999999999999999999874 5778999999754 344566889999998885        888999999987    


Q ss_pred             cCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC------
Q 018702          137 SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM------  210 (351)
Q Consensus       137 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~------  210 (351)
                      +....++||||+ +++|.+++...  ....+++..++.++.|++.||.|||+++  +|+||||||+|||++.++      
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence            566889999999 55776666533  2356899999999999999999999952  899999999999999775      


Q ss_pred             -------------------------------------------ceEEeeeccccccCcccccccccccccccccCccccc
Q 018702          211 -------------------------------------------EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD  247 (351)
Q Consensus       211 -------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  247 (351)
                                                                 .+||+|||++.......    ....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCChhhc
Confidence                                                       79999999998654332    2345899999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH---HHHhcCccc----------ee-ccc---------
Q 018702          248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK---AVMQDKREE----------YV-IDT---------  304 (351)
Q Consensus       248 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~----------~~-~~~---------  304 (351)
                      +..++.++|||||||++|+|++|..||................   .........          .. .+.         
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            9999999999999999999999999997644332211111111   111110000          00 000         


Q ss_pred             ---------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 ---------SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                               .....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                     0012456778889999999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=322.58  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=197.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEec------C
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTS------S  138 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~  138 (351)
                      ....+|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            34568899999999999999999974 688999999875433 345688999999999 79999999999876      4


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence            6789999999999999999754  235688999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      ++........ ......||+.|+|||.+.     +..++.++||||||+++|+|++|..||......      .......
T Consensus       175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~  247 (326)
T 2x7f_A          175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP  247 (326)
T ss_dssp             TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH
T ss_pred             CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhh
Confidence            9876543221 123345899999999986     567899999999999999999999999653211      1111111


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......        ..+...+..+.+++.+||..||.+|||+.+++++
T Consensus       248 ~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          248 RNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HSCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCcccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            111110        0122234789999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.7e-44  Score=318.77  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh--------hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT--------EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  140 (351)
                      .+|...+.||+|+||.||+|... +++.||+|.+.....        .....+.+|+.+++.++||||+++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            47889999999999999999975 468899999865321        12234789999999999999999999987665 


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc---eEEeee
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDF  217 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~df  217 (351)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+||
T Consensus        89 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            799999999999999987    346789999999999999999999998   9999999999999987665   999999


Q ss_pred             ccccccCcccccccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          218 GLATLMEAEKTHVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       218 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      |++.......  ......||+.|+|||.+.   ...++.++||||||+++|+|++|..||......  ..+......   
T Consensus       162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~---  234 (322)
T 2ycf_A          162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS---  234 (322)
T ss_dssp             TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHH---
T ss_pred             ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHh---
Confidence            9998654332  122345899999999873   567899999999999999999999999654221  111111111   


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      . .... ..    ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus       235 ~-~~~~-~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          235 G-KYNF-IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             T-CCCC-CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             C-cccc-Cc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1 0000 00    0011234779999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=319.24  Aligned_cols=257  Identities=21%  Similarity=0.320  Sum_probs=194.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe------------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT------------  136 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------------  136 (351)
                      .+|+..+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            578889999999999999999864 7889999998777666778999999999999999999999873            


Q ss_pred             --cCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCceE
Q 018702          137 --SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEAR  213 (351)
Q Consensus       137 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~-~~~~~k  213 (351)
                        +.+..+++|||++ |+|.+++.     ...+++..++.++.|++.||+|||+.   +++||||||+||+++ +++.+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence              4467899999997 59999985     35688999999999999999999998   999999999999997 567999


Q ss_pred             EeeeccccccCcccc--cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH
Q 018702          214 VSDFGLATLMEAEKT--HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       214 l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      |+|||++........  .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......      ...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~  235 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQ  235 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence            999999986543221  11223457899999998765 678999999999999999999999997643211      111


Q ss_pred             HHHhcC--------------cccee----cccc--CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          291 AVMQDK--------------REEYV----IDTS--LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       291 ~~~~~~--------------~~~~~----~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......              .....    ..+.  ....+...+.++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            111000              00000    0000  000112345789999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=321.00  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ..+|+..+.||+|+||.||+|...+  .+|+|.+.....  ...+.+.+|+.++++++||||+++++++.+.+..+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4578999999999999999999864  489999865422  223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++ ++.+||+|||++......
T Consensus       110 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          110 LCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             cccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999742   34689999999999999999999999   999999999999998 679999999998754321


Q ss_pred             c----ccccccccccccccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          227 K----THVSTIVAGTFGYLAPEYFDT---------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       227 ~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      .    ........|++.|+|||.+.+         ..++.++||||||+++|+|++|..||......      .......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~  256 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQMG  256 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHhc
Confidence            1    111223458999999999864         45788999999999999999999999654221      1112221


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ...... .       .+...+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus       257 ~~~~~~-~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          257 TGMKPN-L-------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             TTCCCC-C-------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             cCCCCC-C-------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            111110 0       1112335689999999999999999999999999998765

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.7e-44  Score=312.91  Aligned_cols=257  Identities=26%  Similarity=0.362  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            357999999999999999999985 68889999986532  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CceEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN---MEARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~  222 (351)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.+   +.+||+|||++..
T Consensus       101 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999998863    34689999999999999999999998   99999999999999764   4699999999976


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ......  .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||......      .............. .
T Consensus       174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~-~  243 (287)
T 2wei_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFD-L  243 (287)
T ss_dssp             BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC-S
T ss_pred             ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCCC-c
Confidence            543322  122347899999999875 4899999999999999999999999654211      12222222111100 0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccc
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK--MLELIKS  347 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~--~L~~~~~  347 (351)
                       +    .....+.++.+++.+||+.||++|||+.|+++  .+.+...
T Consensus       244 -~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          244 -P----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             -G----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             -h----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence             0    01223477999999999999999999999998  3444443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-44  Score=329.79  Aligned_cols=265  Identities=26%  Similarity=0.345  Sum_probs=197.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC------eeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------YNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  143 (351)
                      .+|+..+.||+|+||.||+|...++..+|+|++......    ..+|+.+++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468899999999999999999987777999988654322    236999999999999999999985443      3789


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCceEEeeeccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSDFGLATL  222 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~  222 (351)
                      ||||++++ +.+.+.........+++..+..++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|||+++.
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999774 4443332212356789999999999999999999998   999999999999999 799999999999986


Q ss_pred             cCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH---------
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV---------  292 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  292 (351)
                      .......  ....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......+.  +.......         
T Consensus       192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred             ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHH
Confidence            5433222  234589999999998664 589999999999999999999999976432211  11111100         


Q ss_pred             -HhcCccceeccccCC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcccc
Q 018702          293 -MQDKREEYVIDTSLE------GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIKS  347 (351)
Q Consensus       293 -~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~~  347 (351)
                       ........... ...      ..+...++++.+|+.+||+.||.+|||+.|++++  +++++.
T Consensus       268 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          268 TMNPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHCGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhChhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence             00000000000 000      1122345789999999999999999999999986  444443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.1e-44  Score=322.69  Aligned_cols=269  Identities=19%  Similarity=0.253  Sum_probs=191.9

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe-
Q 018702           63 DAIFKKTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY-  140 (351)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  140 (351)
                      ........+|+..+.||+|+||.||+|... +++.||+|++..... ......+++..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566779999999999999999999985 578999999865432 23346678888889999999999999865433 


Q ss_pred             ------eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCcEEEcC-CCc
Q 018702          141 ------NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH--HDCIPHIIHRDIKSSNILLDQ-NME  211 (351)
Q Consensus       141 ------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~~~~i~H~dlkp~Nil~~~-~~~  211 (351)
                            .+++|||+++ +|...+.........+++..+..++.|++.|+.|||  +.   +|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999976 555544332224567889999999999999999999  87   9999999999999997 899


Q ss_pred             eEEeeeccccccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHH
Q 018702          212 ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK  290 (351)
Q Consensus       212 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  290 (351)
                      +||+|||++.........  ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||........   .....
T Consensus       171 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~  245 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIV  245 (360)
T ss_dssp             EEECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred             EEEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHH
Confidence            999999999866543322  234589999999998654 489999999999999999999999976432211   11111


Q ss_pred             HHHhcC------------ccceecc-------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          291 AVMQDK------------REEYVID-------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       291 ~~~~~~------------~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......            ......+       ......+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111000            0000000       00111222356789999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.7e-44  Score=318.01  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE--CCCCEEEEEEecCCChh--hHHHHHHHHHHhhcC---CCCceeeeeeEEe----
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV--NDSTAFAVKRLHRGTTE--VDRGFERELEAMGDI---KHRNIVTLHGYYT----  136 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  136 (351)
                      ...+|+..+.||+|+||.||+|..  .+++.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            446899999999999999999998  35788999998643221  122455677666655   8999999999987    


Q ss_pred             -cCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 018702          137 -SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVS  215 (351)
Q Consensus       137 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  215 (351)
                       .....+++|||++ |+|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5667899999997 5999998754  234589999999999999999999999   99999999999999999999999


Q ss_pred             eeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          216 DFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       216 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      |||++.......  ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ...........
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence            999997654322  2233568999999999999999999999999999999999999997543211   11111111110


Q ss_pred             Ccccee--------------ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYV--------------IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ......              ............+..+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000              0000111223455789999999999999999999999964

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=331.04  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=182.4

Q ss_pred             CCC-CCcccccCceEEEEEEEC---CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEe--cCCeeEEEE
Q 018702           72 FSS-KDVIGSGGFGTVYRLTVN---DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYT--SSQYNLLIY  145 (351)
Q Consensus        72 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~  145 (351)
                      |.. .++||+|+||.||+|...   ++..||+|++....  ....+.+|+.+++.++||||+++++++.  .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            444 458999999999999975   46789999987542  2345789999999999999999999994  467899999


Q ss_pred             EecCCCCHHHhhcCCC-----CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCceEEee
Q 018702          146 ELMPNGSLDTFLHGKS-----VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL----DQNMEARVSD  216 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~d  216 (351)
                      ||+.+ +|.+++....     .....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99964 8888775221     1223589999999999999999999999   99999999999999    6778999999


Q ss_pred             eccccccCcccc--cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc---c---cHHH
Q 018702          217 FGLATLMEAEKT--HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG---T---KLVT  287 (351)
Q Consensus       217 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~  287 (351)
                      ||+++.......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........   .   ....
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999987653322  22334568999999999877 4589999999999999999999999965432110   0   0011


Q ss_pred             HHHHHHhcCccceecc----------------ccCCCC---------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          288 WVKAVMQDKREEYVID----------------TSLEGC---------PINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       288 ~~~~~~~~~~~~~~~~----------------~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ...............+                .....+         ....+..+.+|+.+||+.||.+|||++|++++=
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            1111111000000000                000000         001145788999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-44  Score=324.82  Aligned_cols=257  Identities=23%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCee---
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYN---  141 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  141 (351)
                      ...+|...+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3458889999999999999999875 57889999997643  33346788999999999999999999999877655   


Q ss_pred             ---EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          142 ---LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       142 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                         +++|||+. ++|.+++.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999997 58988873      3489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      ++.......    ....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.   ............
T Consensus       190 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~  262 (371)
T 4exu_A          190 LARHADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPG  262 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred             cccccccCc----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCc
Confidence            997554322    23458999999999877 7889999999999999999999999975432111   000000000000


Q ss_pred             cce---------------e---ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEY---------------V---IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~---------------~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...               .   ........+...++.+.+|+.+||+.||++|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000               0   0000001122345789999999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.9e-44  Score=315.03  Aligned_cols=253  Identities=24%  Similarity=0.419  Sum_probs=198.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCC--CCceeeeeeEEecCCeeEE
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGT--TEVDRGFERELEAMGDIK--HRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l  143 (351)
                      ...+|+..+.||+|+||.||++...+++.||+|++....  ....+.+.+|+.++.+++  ||||+++++++.+.+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            445789999999999999999998889999999986543  334567889999999997  5999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|| +.+++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++++ +.+||+|||++...
T Consensus       106 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            999 558899999973    45689999999999999999999999   9999999999999965 79999999999865


Q ss_pred             Cccccc-ccccccccccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHH
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDT-----------GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ...... ......||+.|+|||.+.+           ..++.++||||||+++|+|++|..||.....     .......
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~  251 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA  251 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHH
Confidence            443221 2234468999999999865           4788899999999999999999999965321     1112222


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      .......        ...+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus       252 ~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          252 IIDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHhcccc--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            2211111        012223347899999999999999999999998753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3e-44  Score=330.22  Aligned_cols=259  Identities=28%  Similarity=0.367  Sum_probs=195.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC------CeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS------QYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  142 (351)
                      .+|+..+.||+|+||.||+|.+. +++.||||++......    ..+|+++++.++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36888899999999999999985 5889999998754322    34799999999999999999998532      2367


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CceEEeeecccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLAT  221 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~  221 (351)
                      +||||+++ +|.+.+.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999975 67666643322456799999999999999999999998   99999999999999965 678999999998


Q ss_pred             ccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH--------
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV--------  292 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  292 (351)
                      .......  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+  .+.......        
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence            6543322  2234689999999998764 78999999999999999999999997643211  111111110        


Q ss_pred             --HhcCccceeccccCCC------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          293 --MQDKREEYVIDTSLEG------CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       293 --~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .......... +....      .+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       282 ~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCC-CCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhcc-CccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              0000000000 00111      122345789999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.8e-44  Score=313.29  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=193.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec----------
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS----------  137 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  137 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            346888899999999999999974 6889999998653 3445678899999999999999999998754          


Q ss_pred             ---CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          138 ---SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       138 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                         .+..+++|||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence               45679999999999999999742   34577889999999999999999999   9999999999999999999999


Q ss_pred             eeeccccccCccc-------------ccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhc
Q 018702          215 SDFGLATLMEAEK-------------THVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLE  280 (351)
Q Consensus       215 ~dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  280 (351)
                      +|||++.......             ........||+.|+|||.+.+. .++.++||||||+++|+|++   ||..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence            9999997654221             1112334589999999998764 78999999999999999998   5532211 


Q ss_pred             ccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          .......... ....  .   ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       234 ----~~~~~~~~~~-~~~~--~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 ----RVNILKKLRS-VSIE--F---PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ----HHHHHHHHHS-TTCC--C---CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----HHHHHHhccc-cccc--c---CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence                1111111111 1110  0   112344455779999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-44  Score=324.40  Aligned_cols=261  Identities=24%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----Cee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----QYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  141 (351)
                      ..+|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357888999999999999999975 57889999997543 33445688999999999999999999987654     678


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++|||+. ++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999996 599999863     4689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCccccc---------ccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHH
Q 018702          222 LMEAEKTH---------VSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       222 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ........         ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........   ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence            65432211         1123468999999998754 7789999999999999999999999976432111   001111


Q ss_pred             HHhcCccc-------------ee------ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          292 VMQDKREE-------------YV------IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       292 ~~~~~~~~-------------~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........             ..      ............+.++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11000000             00      0000000112345789999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.3e-44  Score=328.63  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=188.7

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .|...+.||+|+||+||.+...+++.||||++...   ..+.+.+|+.++..+ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556789999999998877778999999998653   234577899999876 89999999999999999999999996


Q ss_pred             CCCHHHhhcCCCCCCCC---CChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-------------CceE
Q 018702          150 NGSLDTFLHGKSVNKKN---LDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-------------MEAR  213 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~-------------~~~k  213 (351)
                       |+|.+++.........   .++..++.++.|++.||+|||+.   +|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             5999999754322211   13345678999999999999998   99999999999999754             4899


Q ss_pred             EeeeccccccCccccc---ccccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCcchhccc
Q 018702          214 VSDFGLATLMEAEKTH---VSTIVAGTFGYLAPEYFDT-------GRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEG  282 (351)
Q Consensus       214 l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~  282 (351)
                      |+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            9999999876543321   1234569999999999865       678999999999999999999 999996532211 


Q ss_pred             ccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                             .........   .+......+...+.++.+++.+||+.||.+|||+.|++++
T Consensus       248 -------~~i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -------SNIIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -------HHHHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------HHHhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                   111111100   0000111245677899999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=316.86  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=197.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe------
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY------  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  140 (351)
                      .+|...+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999975 57889999997643  2334678899999999999999999999987654      


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+++|||+. ++|.+++.      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence            499999997 58888774      3489999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc--
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR--  297 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  297 (351)
                      ......    .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||........   ............  
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTE  246 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence            764332    223458999999999876 6789999999999999999999999975432110   110000000000  


Q ss_pred             ----------------cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 ----------------EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                      ................+..+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                            00000111122334456889999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-43  Score=317.30  Aligned_cols=254  Identities=21%  Similarity=0.254  Sum_probs=174.3

Q ss_pred             hcCCCCC-CcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec----CCeeE
Q 018702           69 TLKFSSK-DVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS----SQYNL  142 (351)
Q Consensus        69 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  142 (351)
                      ..+|... +.||+|+||.||+|... +++.||+|++.... ...   .+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4578874 46999999999999986 68899999986532 211   222334566789999999999876    45589


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeecc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGL  219 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~  219 (351)
                      +||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||+
T Consensus       103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            999999999999999754  235689999999999999999999999   9999999999999986   45599999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      +.......   .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||..........   ........... 
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-  250 (336)
T 3fhr_A          178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY-  250 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc-
Confidence            97654322   223458999999999988889999999999999999999999996543221100   00000000000 


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML  342 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L  342 (351)
                      ....    ......+..+.+++.+||+.||.+|||+.|++++-
T Consensus       251 ~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          251 GFPN----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             CCCT----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ccCc----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000    11233457899999999999999999999999843

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.2e-43  Score=317.99  Aligned_cols=200  Identities=22%  Similarity=0.290  Sum_probs=168.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CC-----ceeeeeeEEecCCee
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HR-----NIVTLHGYYTSSQYN  141 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~  141 (351)
                      ..+|+..+.||+|+||+||+|... +++.||+|++... ......+..|+.++..++ |+     +++++.+++...+..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            357899999999999999999975 5678999999753 333456777888877774 44     599999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCceEEeeecc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD--QNMEARVSDFGL  219 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~--~~~~~kl~dfg~  219 (351)
                      ++||||++ ++|.+++...  ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+
T Consensus       132 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            99999996 5999999754  235689999999999999999999952 12899999999999995  478899999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      +.......    ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       208 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          208 SCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            98664322    2346899999999999999999999999999999999999999764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-43  Score=320.06  Aligned_cols=262  Identities=19%  Similarity=0.283  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----------CCceeeeeeEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----------HRNIVTLHGYYTS  137 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  137 (351)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5799999999999999999997 46788999999753 334456788999888876           8999999999876


Q ss_pred             CC----eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc------
Q 018702          138 SQ----YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD------  207 (351)
Q Consensus       138 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~------  207 (351)
                      .+    ..+++||++ +++|.+++...  ....+++..+..++.|++.||+|||++.  +|+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence            54    789999999 88999999754  2455899999999999999999999952  899999999999994      


Q ss_pred             CCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHH
Q 018702          208 QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT  287 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  287 (351)
                      ..+.+||+|||++.......    ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            44589999999997654322    22458999999999999999999999999999999999999997643222111111


Q ss_pred             HHHHHH---hcCccc-------------------eec----------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 018702          288 WVKAVM---QDKREE-------------------YVI----------DTSLEGCPINEINDVFSIASMCLEPEPSKRPTM  335 (351)
Q Consensus       288 ~~~~~~---~~~~~~-------------------~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  335 (351)
                      ......   ......                   ...          .......+...+.++.+|+.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            111111   000000                   000          000113567788999999999999999999999


Q ss_pred             HHHHHH
Q 018702          336 TEVVKM  341 (351)
Q Consensus       336 ~e~l~~  341 (351)
                      .|++++
T Consensus       329 ~ell~h  334 (373)
T 1q8y_A          329 GGLVNH  334 (373)
T ss_dssp             HHHHTC
T ss_pred             HHHhhC
Confidence            999884

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.8e-43  Score=313.81  Aligned_cols=258  Identities=22%  Similarity=0.319  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CC-CEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc------eeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN------IVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  141 (351)
                      .+|+..+.||+|+||.||+|... ++ ..||+|++... ....+.+.+|+.+++.++|++      ++.+.+++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            57999999999999999999975 33 67999999753 344566788999999887665      99999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---------------
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL---------------  206 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~---------------  206 (351)
                      +++|||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||+               
T Consensus        98 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence            9999999 66777777543  235689999999999999999999998   99999999999999               


Q ss_pred             ----cCCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhccc
Q 018702          207 ----DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG  282 (351)
Q Consensus       207 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  282 (351)
                          +.++.+||+|||++.......    ....||+.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                567899999999997643322    234689999999999999999999999999999999999999976432211


Q ss_pred             ccHHHHHHHHHhcCcc---------ceecc----------------------ccCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 018702          283 TKLVTWVKAVMQDKRE---------EYVID----------------------TSLEGCPINEINDVFSIASMCLEPEPSK  331 (351)
Q Consensus       283 ~~~~~~~~~~~~~~~~---------~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~  331 (351)
                         .............         .....                      ..........+..+.+|+.+||+.||++
T Consensus       248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence               1111111110000         00000                      0001123345678999999999999999


Q ss_pred             CCCHHHHHHH
Q 018702          332 RPTMTEVVKM  341 (351)
Q Consensus       332 Rps~~e~l~~  341 (351)
                      |||+.|++++
T Consensus       325 Rpt~~e~l~h  334 (355)
T 2eu9_A          325 RITLAEALLH  334 (355)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHhcC
Confidence            9999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.5e-43  Score=312.43  Aligned_cols=257  Identities=26%  Similarity=0.345  Sum_probs=179.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHH-HhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELE-AMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++..... .....+..|.. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57888999999999999999985 678899999976533 33345555665 7788899999999999999999999999


Q ss_pred             ecCCCCHHHhhcCC-CCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGK-SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |+++ +|.+++... ......+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            9975 888777521 11246789999999999999999999995  3899999999999999999999999999976543


Q ss_pred             ccccccccccccccccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          226 EKTHVSTIVAGTFGYLAPEYF----DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...  .....||+.|+|||.+    .+..++.++||||||+++|+|++|..||.......         .......... 
T Consensus       179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~-  246 (327)
T 3aln_A          179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------DQLTQVVKGD-  246 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCCSC-
T ss_pred             ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------HHHHHHhcCC-
Confidence            322  1223589999999998    45678999999999999999999999996532110         0000000000 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ........+...+..+.+++.+||+.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            0000001122345789999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=313.74  Aligned_cols=242  Identities=24%  Similarity=0.409  Sum_probs=192.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh------hHHHHHHHHHHhhcC----CCCceeeeeeEEe
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE------VDRGFERELEAMGDI----KHRNIVTLHGYYT  136 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~~~  136 (351)
                      ...+|+..+.||+|+||.||+|.. .+++.||+|++......      ....+.+|+.++.++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            345799999999999999999986 46788999999764321      122355788888888    8999999999999


Q ss_pred             cCCeeEEEEEe-cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCceEE
Q 018702          137 SSQYNLLIYEL-MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEARV  214 (351)
Q Consensus       137 ~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~-~~~~~kl  214 (351)
                      ..+..++++|+ +.+++|.+++..    ...+++..++.++.|++.||.|||+.   +++||||||+||+++ .++.+||
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999 789999999973    34689999999999999999999999   999999999999999 7899999


Q ss_pred             eeeccccccCcccccccccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH
Q 018702          215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRAT-AKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM  293 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  293 (351)
                      +|||++........   ....|++.|+|||.+.+..+. .++||||||+++|+|++|+.||.....            ..
T Consensus       182 ~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~  246 (312)
T 2iwi_A          182 IDFGSGALLHDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------IL  246 (312)
T ss_dssp             CCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HH
T ss_pred             EEcchhhhcccCcc---cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hh
Confidence            99999986654322   234589999999998776664 589999999999999999999965311            11


Q ss_pred             hcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...          ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 EAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            110          11233445789999999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.5e-44  Score=316.39  Aligned_cols=242  Identities=23%  Similarity=0.365  Sum_probs=198.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh------hHHHHHHHHHHhhcCC--CCceeeeeeEEecC
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE------VDRGFERELEAMGDIK--HRNIVTLHGYYTSS  138 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  138 (351)
                      ...+|+..+.||+|+||.||+|... +++.||+|.+......      ..+.+.+|+.++++++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4457999999999999999999864 6788999998654221      1234667899999996  59999999999999


Q ss_pred             CeeEEEEEecCC-CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCceEEee
Q 018702          139 QYNLLIYELMPN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD-QNMEARVSD  216 (351)
Q Consensus       139 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~-~~~~~kl~d  216 (351)
                      +..++++|++.+ ++|.+++..    ...+++..++.++.|++.||+|||+.   +++||||||+||+++ +++.+||+|
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999976 899999973    45689999999999999999999998   999999999999999 789999999


Q ss_pred             eccccccCcccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhc
Q 018702          217 FGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD  295 (351)
Q Consensus       217 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  295 (351)
                      ||++.......   .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.....            ....
T Consensus       194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~  258 (320)
T 3a99_A          194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG  258 (320)
T ss_dssp             CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC
T ss_pred             Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhcc
Confidence            99998664332   223458999999999877665 6789999999999999999999965311            1111


Q ss_pred             CccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          296 KREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..          ..+...++++.+++.+||+.||++|||+.|++++
T Consensus       259 ~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10          1122334789999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=322.22  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=188.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|...+.||+|+||+|+.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.+.+..+++|||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            468888899999999977666678899999999654332   256899999999 7999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCceEEeeecccccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-----NMEARVSDFGLATLM  223 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~dfg~~~~~  223 (351)
                      . |+|.+++....   .......+..++.|++.||.|||+.   +|+||||||+|||++.     ...+||+|||+++..
T Consensus       101 ~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          101 A-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             S-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             C-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            6 59999997542   2344556678999999999999999   9999999999999953     235789999999866


Q ss_pred             Ccccc--cccccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          224 EAEKT--HVSTIVAGTFGYLAPEYFD---TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       224 ~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      .....  .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||......       ..........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCC
Confidence            53321  1223456999999999997   4567889999999999999999 99998543211       1111111110


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .      .....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 L------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             C------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0      0111233456678999999999999999999999854

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-43  Score=335.56  Aligned_cols=269  Identities=25%  Similarity=0.351  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEec------CCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS------SQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  141 (351)
                      .+|+..+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            58999999999999999999874 5788999998764 33445678999999999999999999998765      6778


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCc---eEEeeec
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNME---ARVSDFG  218 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg  218 (351)
                      ++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999997543 234688999999999999999999998   9999999999999997765   8999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHH-----
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM-----  293 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  293 (351)
                      ++........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......     ..|.....     
T Consensus       170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred             cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence            9986644322  23356899999999999999999999999999999999999999653211     01000000     


Q ss_pred             ----hcCccc-eecc---ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhcccccc
Q 018702          294 ----QDKREE-YVID---TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE-----VVKMLELIKSEK  349 (351)
Q Consensus       294 ----~~~~~~-~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e-----~l~~L~~~~~~~  349 (351)
                          ...... ....   +.....+...++.+.+++.+||+.||++|||+.|     +++.++.+.+..
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                000000 0000   1112345667899999999999999999999988     556666555443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=305.19  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=181.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-h-HHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-V-DRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .+|+..+.||+|+||.||+|... +++.||+|++...... . .+.+.++..+++.++||||+++++++.+.+..+++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            46888899999999999999985 6889999999765332 2 2334455567888899999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |+ ++.+..+...   ....+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||++.....
T Consensus       105 ~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          105 LM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99 5566655542   24568999999999999999999998 5   899999999999999999999999999976543


Q ss_pred             ccccccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ...  .....+|+.|+|||.+.     ...++.++||||||+++|+|++|..||....     .................
T Consensus       178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~  250 (318)
T 2dyl_A          178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----TDFEVLTKVLQEEPPLL  250 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHHSCCCCC
T ss_pred             Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccHHHHHHHhccCCCCC
Confidence            322  22345899999999984     4578899999999999999999999996421     11122222222221110


Q ss_pred             eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                             ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       251 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          251 -------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                   0112234779999999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-41  Score=296.13  Aligned_cols=232  Identities=11%  Similarity=0.087  Sum_probs=184.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-CCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-STAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+|+..+.||+|+||.||+|.+.. ++.||+|++.....   ...+.+.+|+..+..++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            479999999999999999999864 78899999976532   33467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++|++|.+++..     . .....+..++.|++.||+|||++   +|+||||||+||+++.+|.+||+++|       
T Consensus       111 e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            99999999999952     2 35557888999999999999999   99999999999999999999998443       


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                                    |++       .++.++||||||+++|+|++|+.||...........       ...........  
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~--  224 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------AERDTAGQPIE--  224 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------CCBCTTSCBCC--
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------HHHHhccCCCC--
Confidence                          333       368899999999999999999999976432211000       00000000000  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      ....+...++.+.+++.+||+.||.+| |+.|+++.|+.+...
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            001122345779999999999999999 999999999987654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-41  Score=330.96  Aligned_cols=238  Identities=20%  Similarity=0.327  Sum_probs=192.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCe-----e
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN--DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQY-----N  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~  141 (351)
                      .+|+..+.||+|+||.||++.+.  +++.||+|++.... ......+.+|+.++.+++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            58999999999999999999985  57889999986543 3445678899999999999999999999987665     6


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      |+||||++|++|.+++.      ..+++..+..++.|++.||.|||++   +|+||||||+|||++.+ .+||+|||+++
T Consensus       160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence            99999999999998764      2689999999999999999999998   99999999999999886 89999999998


Q ss_pred             ccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          222 LMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      .....     ....||+.|+|||++.++ ++.++||||||+++|+|++|.+||.........                  
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------  285 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------  285 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred             hcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence            65443     234689999999998765 489999999999999999999987643211100                  


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRP-TMTEVVKMLELI  345 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~e~l~~L~~~  345 (351)
                       .   .......+..+.+++.+||+.||.+|| +++++.+.|..+
T Consensus       286 -~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 -E---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -T---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -c---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             0   000112336789999999999999999 466666666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.5e-41  Score=293.96  Aligned_cols=226  Identities=23%  Similarity=0.328  Sum_probs=177.9

Q ss_pred             CCCCC-CcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHh-hcCCCCceeeeeeEEec----CCeeEE
Q 018702           71 KFSSK-DVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAM-GDIKHRNIVTLHGYYTS----SQYNLL  143 (351)
Q Consensus        71 ~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~l  143 (351)
                      +|... +.||+|+||.||++.. .+++.||+|++...     ..+.+|+.++ +..+||||+++++++..    .+..++
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            56665 7799999999999997 46789999998642     3466788887 66689999999999876    678899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeeccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLA  220 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~  220 (351)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||++
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999753  234689999999999999999999998   9999999999999998   788999999988


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY  300 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (351)
                      ....                       +..++.++||||||+++|+|++|..||........          .. .....
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~-~~~~~  213 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SP-GMKTR  213 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------C-CSCCS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hH-HHHHH
Confidence            6432                       13467899999999999999999999965422110          00 00000


Q ss_pred             eccccCCCCC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 VIDTSLEGCP----INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 ~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .. ......+    ...+.++.+++.+||+.||.+|||+.|++++
T Consensus       214 ~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          214 IR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SC-TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Hh-hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00 0000112    2345789999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-41  Score=311.40  Aligned_cols=242  Identities=17%  Similarity=0.182  Sum_probs=180.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh---hHHHHHHHHHHhhcCCC-Cce---------eeee----
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE---VDRGFERELEAMGDIKH-RNI---------VTLH----  132 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h-~ni---------v~~~----  132 (351)
                      .|...+.||+|+||.||+|.+. +++.||||++......   ..+.+.+|+.+++.++| +|.         +...    
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4666788999999999999964 6889999998743322   24678899999999976 211         1111    


Q ss_pred             --------eEEec-----CCeeEEEEEecCCCCHHHhhcCC---CCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 018702          133 --------GYYTS-----SQYNLLIYELMPNGSLDTFLHGK---SVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIH  196 (351)
Q Consensus       133 --------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H  196 (351)
                              .++..     ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||++   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                    11111     22356777766 67999988421   11345678889999999999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEeeeccccccCcccccccccccccccccCcccc----------cCCCCCchhhHHHHHHHHHH
Q 018702          197 RDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF----------DTGRATAKGDVYSFGVVLLE  266 (351)
Q Consensus       197 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~slG~il~~  266 (351)
                      |||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||++|+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999999999999999998765433    233457 999999999          55668899999999999999


Q ss_pred             HHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          267 LLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       267 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      |++|+.||..........               .... .    ....++.+.+|+.+||+.||++|||+.+++++
T Consensus       310 lltg~~Pf~~~~~~~~~~---------------~~~~-~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSE---------------WIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSG---------------GGGS-S----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHCCCCCCCcchhhhHH---------------HHHh-h----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999997643222111               0000 0    11223779999999999999999998887653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-41  Score=303.72  Aligned_cols=243  Identities=15%  Similarity=0.154  Sum_probs=182.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh--------hhHHHHHHHHHHhhcCC---------CCceeeee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT--------EVDRGFERELEAMGDIK---------HRNIVTLH  132 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv~~~  132 (351)
                      .+|+..+.||+|+||+||+|.. +++.||+|++.....        ...+.+.+|+.+++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4688899999999999999998 578899999975432        22356788888887775         66666665


Q ss_pred             eE-----------------Eec-------------CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHH
Q 018702          133 GY-----------------YTS-------------SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG  182 (351)
Q Consensus       133 ~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~  182 (351)
                      +.                 +.+             .+..++||||+++|++.+.+.     ...+++..+..++.|++.|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHH
Confidence            54                 333             678999999999997766663     2568999999999999999


Q ss_pred             HHHHH-hcCCCCeeecCCCCCcEEEcCCC--------------------ceEEeeeccccccCccccccccccccccccc
Q 018702          183 IAYLH-HDCIPHIIHRDIKSSNILLDQNM--------------------EARVSDFGLATLMEAEKTHVSTIVAGTFGYL  241 (351)
Q Consensus       183 l~~Lh-~~~~~~i~H~dlkp~Nil~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~  241 (351)
                      |+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 88   999999999999999887                    8999999999865432      236899999


Q ss_pred             CcccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHH
Q 018702          242 APEYFDTGRATAKGDVYSFGVV-LLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSI  320 (351)
Q Consensus       242 aPE~~~~~~~~~~~Dv~slG~i-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  320 (351)
                      |||++.+.. +.++||||+|++ .+++++|..||......     ..............   .......+...++++.+|
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-----HYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-----HHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-----hHHHHhhhhhhccC---cccchhhhhhcCHHHHHH
Confidence            999998766 899999998777 77788899998432100     00011111110000   000111244678899999


Q ss_pred             HHHhcCCCCCCCCCHHHHH-HH
Q 018702          321 ASMCLEPEPSKRPTMTEVV-KM  341 (351)
Q Consensus       321 i~~cl~~~p~~Rps~~e~l-~~  341 (351)
                      +.+||+.|     |++|++ ++
T Consensus       316 i~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHhccC-----CHHHHHhcC
Confidence            99999976     999998 53

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.8e-33  Score=264.43  Aligned_cols=185  Identities=18%  Similarity=0.148  Sum_probs=128.4

Q ss_pred             ccccCceEEEEEE-ECCCCEEEEEEecCCC----------hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEEE
Q 018702           78 IGSGGFGTVYRLT-VNDSTAFAVKRLHRGT----------TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        78 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      .+.|+.|.+..+. ...|+.+++|.+....          ....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4555555555433 2346779999986531          11234689999999999 6999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++|++|.+++..    ..+++..   +|+.||+.||+|+|++   ||+||||||+|||++++|.+||+|||+++....
T Consensus       322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999973    3455543   5889999999999999   999999999999999999999999999986654


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPM  274 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  274 (351)
                      .... ..+.+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus       392 ~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            3322 334579999999999875 5677899999999988876665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=8.7e-30  Score=240.15  Aligned_cols=185  Identities=15%  Similarity=0.189  Sum_probs=145.3

Q ss_pred             CCCCcccccCceEEEEEEECCCCEEEEEEecCCChh--------hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE--------VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ...+.||+|+||.||++.. .+..+++|+.......        ..+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 4677899886443211        124578999999999999999666666677778999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++++|.+++..            +..++.|+++||.|||++   +|+||||||+|||+++  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999963            468999999999999998   9999999999999998  99999999998775


Q ss_pred             cccccc------cccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 018702          225 AEKTHV------STIVAGTFGYLAPEYFDT--GRATAKGDVYSFGVVLLELLTGKRPMD  275 (351)
Q Consensus       225 ~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~  275 (351)
                      ......      .....||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            533221      235679999999999976  568888999999988888888777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.8e-26  Score=200.12  Aligned_cols=150  Identities=17%  Similarity=0.166  Sum_probs=119.3

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCCh------------------hhHHHHHHHHHHhhcCCCC
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT------------------EVDRGFERELEAMGDIKHR  126 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  126 (351)
                      .......|...+.||+|+||.||+|.+.+++.||+|.++....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344556667799999999999999997789999999865322                  12456889999999999  


Q ss_pred             ceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 018702          127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILL  206 (351)
Q Consensus       127 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~  206 (351)
                      | +++.+++.. +..++||||++|++|.+ +..          .....++.|++.||.|||+.   +++||||||+|||+
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl  226 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  226 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence            4 555555443 55699999999999988 421          22457999999999999998   99999999999999


Q ss_pred             cCCCceEEeeeccccccCcccccccccccccccccCccccc
Q 018702          207 DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD  247 (351)
Q Consensus       207 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  247 (351)
                      + ++.+||+|||+++.              +..+.|||.+.
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9 99999999999963              34567888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.1e-21  Score=168.04  Aligned_cols=136  Identities=21%  Similarity=0.213  Sum_probs=105.7

Q ss_pred             CCCCCcccccCceEEEEEEE-CCCCE--EEEEEecCCChh------------------------hHHHHHHHHHHhhcCC
Q 018702           72 FSSKDVIGSGGFGTVYRLTV-NDSTA--FAVKRLHRGTTE------------------------VDRGFERELEAMGDIK  124 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  124 (351)
                      |+..+.||+|+||.||+|.. .+|+.  ||+|+++.....                        ....+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778899999999999998 67888  999987543211                        1135788999999998


Q ss_pred             CCce--eeeeeEEecCCeeEEEEEecCC-C----CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 018702          125 HRNI--VTLHGYYTSSQYNLLIYELMPN-G----SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH-HDCIPHIIH  196 (351)
Q Consensus       125 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~~~~i~H  196 (351)
                      |+++  ..+++.    +..++||||+.+ |    +|.++...       .++.....++.|++.|+.||| +.   +++|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            7754  333432    356899999942 3    67766532       234567889999999999999 87   9999


Q ss_pred             cCCCCCcEEEcCCCceEEeeecccccc
Q 018702          197 RDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       197 ~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      |||||+|||+++  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=1.3e-18  Score=154.94  Aligned_cols=140  Identities=14%  Similarity=0.129  Sum_probs=102.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh--------------hH--------HHHHHHHHHhhcCC
Q 018702           67 KKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE--------------VD--------RGFERELEAMGDIK  124 (351)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~--------~~~~~e~~~l~~l~  124 (351)
                      ....=|++.+.||+|++|.||+|...+|+.||||+++.....              ..        -...+|...|.++.
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~  171 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY  171 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence            333348889999999999999999999999999987532100              00        01235666677665


Q ss_pred             CCcee--eeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 018702          125 HRNIV--TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSS  202 (351)
Q Consensus       125 h~niv--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~  202 (351)
                      +.++.  ..++.    ...++||||++|++|..+..          ......++.|++.+|.+||+.   |++||||||.
T Consensus       172 ~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~  234 (397)
T 4gyi_A          172 EEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEF  234 (397)
T ss_dssp             HTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             hcCCCCCeeeec----cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence            44332  22222    22379999999988876542          123356889999999999998   9999999999


Q ss_pred             cEEEcCCC----------ceEEeeecccccc
Q 018702          203 NILLDQNM----------EARVSDFGLATLM  223 (351)
Q Consensus       203 Nil~~~~~----------~~kl~dfg~~~~~  223 (351)
                      |||+++++          .+.|+||+-+...
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99998876          3899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=1.3e-13  Score=118.20  Aligned_cols=143  Identities=17%  Similarity=0.091  Sum_probs=110.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEe
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      -..|+....++.|+.+.||++... ++.+++|............+.+|+.+++.+. +..+.++++++.+.+..+++|||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            346777777888889999998754 6789999986532222335788999988884 67788899998888899999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC-------------------------------------  190 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------  190 (351)
                      ++|.+|.+.+.         +......++.++++++..||+..                                     
T Consensus        92 i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           92 ADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             cCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999987642         11223477889999999999821                                     


Q ss_pred             -------------------CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          191 -------------------IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       191 -------------------~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                                         ...++|+|++|.||++++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               1359999999999999876666799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=1.5e-12  Score=111.15  Aligned_cols=128  Identities=16%  Similarity=0.105  Sum_probs=95.5

Q ss_pred             cccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc--eeeeeeEEecCCeeEEEEEecCCCCHHHh
Q 018702           79 GSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN--IVTLHGYYTSSQYNLLIYELMPNGSLDTF  156 (351)
Q Consensus        79 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~  156 (351)
                      +.|..+.||++...+|..+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+..+++|||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456679999998777788999987654   2234678888888885433  556888888778889999999998884  


Q ss_pred             hcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 018702          157 LHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC----------------------------------------------  190 (351)
Q Consensus       157 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------------  190 (351)
                      ...       .+   ...++.+++..+..||+..                                              
T Consensus       104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            211       11   2356777888888888742                                              


Q ss_pred             ---------CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          191 ---------IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       191 ---------~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                               ...++|+|++|.||++++++.+.|+||+.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                     1139999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=3.7e-11  Score=107.61  Aligned_cols=142  Identities=18%  Similarity=0.238  Sum_probs=105.8

Q ss_pred             CCCcccccCceEEEEEEECCCCEEEEEEec--CCC-hhhHHHHHHHHHHhhcCC--CCceeeeeeEEecC---CeeEEEE
Q 018702           74 SKDVIGSGGFGTVYRLTVNDSTAFAVKRLH--RGT-TEVDRGFERELEAMGDIK--HRNIVTLHGYYTSS---QYNLLIY  145 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  145 (351)
                      ..+.++.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            34578999999999988654 578898775  322 122345778999998886  45678888888766   4579999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC-----------------------------------  190 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------  190 (351)
                      ||++|..+.+..      ...++...+..++.+++..|+.||+..                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999997774421      234677888889999999999999731                                   


Q ss_pred             --------------------CCCeeecCCCCCcEEEcCCCc--eEEeeeccccc
Q 018702          191 --------------------IPHIIHRDIKSSNILLDQNME--ARVSDFGLATL  222 (351)
Q Consensus       191 --------------------~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~  222 (351)
                                          ...++|||++|.||++++++.  +.++||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                247999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=4.2e-11  Score=104.72  Aligned_cols=184  Identities=20%  Similarity=0.235  Sum_probs=119.9

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCc--eeeeeeEEecCC---eeEEEEEec
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRN--IVTLHGYYTSSQ---YNLLIYELM  148 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  148 (351)
                      .+.++.|....||++.    ..+++|....  ......+.+|...++.+. +..  +.+.+......+   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999754    4589998643  234456888999998773 322  344554443333   348899999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD---------------------------------------  189 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------------------------------------  189 (351)
                      +|.+|.+...      ..++...+..++.+++..++.||+.                                       
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988865321      2356667777888888888888861                                       


Q ss_pred             ----------------CCCCeeecCCCCCcEEEcC--CCceEEeeeccccccCcccccccccccccccc---cCcccccC
Q 018702          190 ----------------CIPHIIHRDIKSSNILLDQ--NMEARVSDFGLATLMEAEKTHVSTIVAGTFGY---LAPEYFDT  248 (351)
Q Consensus       190 ----------------~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~  248 (351)
                                      ..+.++|+|++|.||++++  ++.+.++||+.+....+...- .    .....   .+|+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~----~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-I----SLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-H----TTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-H----HHHhhccccCHHHHHH
Confidence                            1135899999999999998  556789999988643221100 0    00000   12221110


Q ss_pred             -----CCC---------CchhhHHHHHHHHHHHHhCCCCCC
Q 018702          249 -----GRA---------TAKGDVYSFGVVLLELLTGKRPMD  275 (351)
Q Consensus       249 -----~~~---------~~~~Dv~slG~il~~l~~g~~p~~  275 (351)
                           +..         ....+.|++|.++|.+.+|..+|.
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                 111         123689999999999999998863

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.71  E-value=1e-07  Score=81.55  Aligned_cols=133  Identities=18%  Similarity=0.173  Sum_probs=94.9

Q ss_pred             ccccCce-EEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEEecCCCCHH
Q 018702           78 IGSGGFG-TVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSLD  154 (351)
Q Consensus        78 lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  154 (351)
                      +..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4556555 68987754 4567999986542   3456788998888774 334677888888888999999999998887


Q ss_pred             HhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 018702          155 TFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC--------------------------------------------  190 (351)
Q Consensus       155 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------------  190 (351)
                      +....        .......+..+++..+..||+..                                            
T Consensus       109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            66531        11223445566666666666421                                            


Q ss_pred             -----------CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          191 -----------IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       191 -----------~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                                 .+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1248999999999999988777799998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.67  E-value=2.1e-07  Score=81.13  Aligned_cols=136  Identities=15%  Similarity=0.139  Sum_probs=93.0

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCC---ceeeeeeEEe-cCCeeEEEEEecCC
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHR---NIVTLHGYYT-SSQYNLLIYELMPN  150 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  150 (351)
                      .+.++.|....||+.    +..+++|...  .......+.+|..+++.+.+.   .+.+.+.+.. ..+..+++||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            345788889999987    4568999753  233456788999999998642   3556666664 45567899999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD-----------------------------------------  189 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----------------------------------------  189 (351)
                      .++.+...      ..++......++.+++..++.||+.                                         
T Consensus        98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            88866321      1123444445555555555555542                                         


Q ss_pred             ----------------CCCCeeecCCCCCcEEEcC---CCce-EEeeeccccc
Q 018702          190 ----------------CIPHIIHRDIKSSNILLDQ---NMEA-RVSDFGLATL  222 (351)
Q Consensus       190 ----------------~~~~i~H~dlkp~Nil~~~---~~~~-kl~dfg~~~~  222 (351)
                                      ..+.++|+|++|.||++++   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            2235799999999999987   4554 8999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.54  E-value=1.3e-07  Score=84.33  Aligned_cols=80  Identities=6%  Similarity=0.011  Sum_probs=53.4

Q ss_pred             Ccc-cccCceEEEEEEEC-------CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCC-C--CceeeeeeEEecC---
Q 018702           76 DVI-GSGGFGTVYRLTVN-------DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIK-H--RNIVTLHGYYTSS---  138 (351)
Q Consensus        76 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~---  138 (351)
                      +.| +.|..+.+|+....       ++..+++|......   ......+.+|..+++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78889999988754       25678999765422   001234667777777774 2  3466777776654   


Q ss_pred             CeeEEEEEecCCCCHHH
Q 018702          139 QYNLLIYELMPNGSLDT  155 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~  155 (351)
                      +..+++||+++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=5.7e-06  Score=73.03  Aligned_cols=141  Identities=21%  Similarity=0.323  Sum_probs=77.6

Q ss_pred             CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcC-----CCCceeeee-e--EEecCCeeEEEEEe
Q 018702           76 DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-----KHRNIVTLH-G--YYTSSQYNLLIYEL  147 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e~  147 (351)
                      +.|+.|..+.||++...++ .+++|......    ..+..|..+++.+     ..|.++... |  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999887655 48999887532    2233344444433     234444311 1  12345677899999


Q ss_pred             cCCCCHH-----------Hh---hcC--CCC--C-C-----CCCChHHH-------------------------------
Q 018702          148 MPNGSLD-----------TF---LHG--KSV--N-K-----KNLDWPSR-------------------------------  172 (351)
Q Consensus       148 ~~~g~L~-----------~~---l~~--~~~--~-~-----~~~~~~~~-------------------------------  172 (351)
                      ++|.++.           ..   ++.  ...  . .     ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           00   110  000  0 0     01122210                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          173 YKIAVGAARGIAYLHH----------DCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       173 ~~i~~~i~~~l~~Lh~----------~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ..+..++..++.+|++          .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345666653          123589999999999999888899999998774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=3.9e-06  Score=75.88  Aligned_cols=75  Identities=12%  Similarity=0.064  Sum_probs=47.7

Q ss_pred             CCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-------hhHHHHHHHHHHhhcCCC--C-ceeeeeeEEecCCeeEE
Q 018702           75 KDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-------EVDRGFERELEAMGDIKH--R-NIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l  143 (351)
                      .+.+|.|..+.||++... +++.+++|.......       .....+..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            356899999999999754 467899997653221       122345678888877632  3 34455544  3445689


Q ss_pred             EEEecCCC
Q 018702          144 IYELMPNG  151 (351)
Q Consensus       144 v~e~~~~g  151 (351)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.18  E-value=6.9e-06  Score=70.77  Aligned_cols=78  Identities=18%  Similarity=0.197  Sum_probs=56.0

Q ss_pred             CCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-C--CceeeeeeEEecCCeeEEEEEec
Q 018702           72 FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-H--RNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ....+.+|.|..+.||+....+|+.+++|+...........+.+|...|+.+. .  -.+.+.+++.    ..+++|||.
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            34456789999999999999999999999876554444455778888888774 2  1244455442    237999999


Q ss_pred             CCCCH
Q 018702          149 PNGSL  153 (351)
Q Consensus       149 ~~g~L  153 (351)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.14  E-value=2.7e-05  Score=67.73  Aligned_cols=139  Identities=17%  Similarity=0.206  Sum_probs=90.0

Q ss_pred             CCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEEEEEecCCC
Q 018702           75 KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLLIYELMPNG  151 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  151 (351)
                      .+.|+.|....+|+... ++..+++|.....   ....+.+|...|+.+.   ...+.+++.+....+..+++|||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            45689999999999875 4667999987542   2456788888888774   356888888888788899999999987


Q ss_pred             CHHH--------h---hcCCCC------------------CCCCCChHHHH---HHH----------------HHHHHHH
Q 018702          152 SLDT--------F---LHGKSV------------------NKKNLDWPSRY---KIA----------------VGAARGI  183 (351)
Q Consensus       152 ~L~~--------~---l~~~~~------------------~~~~~~~~~~~---~i~----------------~~i~~~l  183 (351)
                      .+..        .   ++....                  +...-+|....   ++.                ..++..+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521        1   111110                  00012343221   111                1111111


Q ss_pred             -HHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          184 -AYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       184 -~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                       ..|.. ...+.++|+|+.+.|++++.++ +.+.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23322 2246899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.13  E-value=6.9e-06  Score=74.85  Aligned_cols=77  Identities=14%  Similarity=0.160  Sum_probs=47.2

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccccccc-cccccccCcccccCC---CCCchhhHHHHHHHHHHH
Q 018702          192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV-AGTFGYLAPEYFDTG---RATAKGDVYSFGVVLLEL  267 (351)
Q Consensus       192 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l  267 (351)
                      ..++|||++|.||++++++ +.++||+.+..-..... ..... .....|++|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4899999999999998876 99999998875432111 00000 012346666655321   112234555777777777


Q ss_pred             HhC
Q 018702          268 LTG  270 (351)
Q Consensus       268 ~~g  270 (351)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.81  E-value=7.9e-05  Score=64.51  Aligned_cols=73  Identities=11%  Similarity=0.078  Sum_probs=43.0

Q ss_pred             CCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCce-eeeeeEEecCCeeEEEEEec-CC
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-VTLHGYYTSSQYNLLIYELM-PN  150 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~  150 (351)
                      ...+.|+.|....+|+.     ..+++|+........ ....+|...++.+....+ .++++..  .+.-++++||+ +|
T Consensus        21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             cceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            33667889999999998     458999876532211 112356666665532112 3455443  33347899999 66


Q ss_pred             CCH
Q 018702          151 GSL  153 (351)
Q Consensus       151 g~L  153 (351)
                      .++
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.73  E-value=0.00021  Score=62.73  Aligned_cols=32  Identities=31%  Similarity=0.363  Sum_probs=27.7

Q ss_pred             CCeeecCCCCCcEEEcCC----CceEEeeecccccc
Q 018702          192 PHIIHRDIKSSNILLDQN----MEARVSDFGLATLM  223 (351)
Q Consensus       192 ~~i~H~dlkp~Nil~~~~----~~~kl~dfg~~~~~  223 (351)
                      ..++|||+.+.||+++.+    +.+.++||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            489999999999999874    67999999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.64  E-value=0.00014  Score=66.25  Aligned_cols=72  Identities=13%  Similarity=0.168  Sum_probs=47.4

Q ss_pred             CcccccCceEEEEEEECC--------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc-eeeeeeEEecCCeeEEEEE
Q 018702           76 DVIGSGGFGTVYRLTVND--------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-IVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  146 (351)
                      +.|+.|....+|++...+        +..+++|+.....  ....+.+|..+++.+...+ ..++++.+.+    .+++|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            457888899999998753        4679999884421  1134557888887774222 3556665542    38999


Q ss_pred             ecCCCCH
Q 018702          147 LMPNGSL  153 (351)
Q Consensus       147 ~~~~g~L  153 (351)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.59  E-value=0.00068  Score=59.25  Aligned_cols=142  Identities=13%  Similarity=0.142  Sum_probs=78.1

Q ss_pred             cccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC--CceeeeeeE-----EecCCeeEEEEEecC
Q 018702           77 VIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH--RNIVTLHGY-----YTSSQYNLLIYELMP  149 (351)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~-----~~~~~~~~lv~e~~~  149 (351)
                      .++ |....||++...+|+.+++|...... .....+..|..++..+..  -.+.+++..     ....+..+++|++++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            466 88899998877777779999986432 123345667776666631  113333332     122456678999998


Q ss_pred             CCCHH-----Hh---------hc----CCCC-CCCCCChHHH----HH---------------HHHHHHHHHHHHHhc--
Q 018702          150 NGSLD-----TF---------LH----GKSV-NKKNLDWPSR----YK---------------IAVGAARGIAYLHHD--  189 (351)
Q Consensus       150 ~g~L~-----~~---------l~----~~~~-~~~~~~~~~~----~~---------------i~~~i~~~l~~Lh~~--  189 (351)
                      |..+.     .+         ++    .... .....++...    ..               +...+-..+..+...  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            75432     10         00    0100 0111121110    00               011111122233221  


Q ss_pred             --CCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          190 --CIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       190 --~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                        ....++|||+++.||+++ + .+.++||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              234689999999999999 4 899999987753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.59  E-value=0.0024  Score=55.51  Aligned_cols=159  Identities=14%  Similarity=0.163  Sum_probs=83.5

Q ss_pred             CChHHHHHHhcCCCCC-----CcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----CCcee
Q 018702           60 LQSDAIFKKTLKFSSK-----DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----HRNIV  129 (351)
Q Consensus        60 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  129 (351)
                      ++.+++...-.+|...     +.|+.|....+|+....++ .+++|......  ....+..|..++..+.     .|.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4444444444455542     3466788899999887666 58899886521  1223445666655553     33333


Q ss_pred             eee-e--EEecCCeeEEEEEecCCCCHHH-----------h---hcC--CCCCCC---CC---ChHHHHH----------
Q 018702          130 TLH-G--YYTSSQYNLLIYELMPNGSLDT-----------F---LHG--KSVNKK---NL---DWPSRYK----------  174 (351)
Q Consensus       130 ~~~-~--~~~~~~~~~lv~e~~~~g~L~~-----------~---l~~--~~~~~~---~~---~~~~~~~----------  174 (351)
                      ... |  +....+..+++++|++|..+..           .   ++.  ......   ..   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            211 1  1122356789999998865321           0   110  000000   01   1211000          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          175 --IAVGAARGIAYLHHD----CIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       175 --i~~~i~~~l~~Lh~~----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                        +...+...+..++..    ...+++|+|+++.||++++++.+.++||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              001133445555432    13479999999999999987666899998775

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.57  E-value=0.00065  Score=54.83  Aligned_cols=102  Identities=12%  Similarity=0.089  Sum_probs=66.9

Q ss_pred             CHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccccc
Q 018702          152 SLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS  231 (351)
Q Consensus       152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  231 (351)
                      ||.+.|..   ...+++++++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            78888875   3678999999999999999887762210  112333457999999999988874 1111          


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 018702          232 TIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP  273 (351)
Q Consensus       232 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  273 (351)
                         .....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0123466888763 3557889999999999998874433

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.55  E-value=0.0012  Score=58.04  Aligned_cols=31  Identities=23%  Similarity=0.365  Sum_probs=27.7

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          192 PHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       192 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.44  E-value=0.00083  Score=61.55  Aligned_cols=73  Identities=19%  Similarity=0.215  Sum_probs=45.1

Q ss_pred             CcccccCceEEEEEEECC-CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCce-eeeeeEEecCCeeEEEEEecCCCCH
Q 018702           76 DVIGSGGFGTVYRLTVND-STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNI-VTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      +.|+.|-...+|++...+ +..+++|+......... .-.+|..++..+...++ .++++.+.  +  .+++||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            357788889999998765 46788998744321111 12467777777753333 45666663  2  359999987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.40  E-value=0.00053  Score=61.21  Aligned_cols=142  Identities=15%  Similarity=0.145  Sum_probs=80.3

Q ss_pred             CcccccCceEEEEEEEC--------CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEE
Q 018702           76 DVIGSGGFGTVYRLTVN--------DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +.|..|-...+|++...        ++..+++|+.-.. ........+|..+++.+. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45777888999998864        2467999986332 222344568888887774 2223556666543    29999


Q ss_pred             ecCCCCHHHh-----------------hcCCCC-CCCCCC--hHHHHHHHHHHHH-------------------HHHHHH
Q 018702          147 LMPNGSLDTF-----------------LHGKSV-NKKNLD--WPSRYKIAVGAAR-------------------GIAYLH  187 (351)
Q Consensus       147 ~~~~g~L~~~-----------------l~~~~~-~~~~~~--~~~~~~i~~~i~~-------------------~l~~Lh  187 (351)
                      |++|.+|..-                 ++.... -.+...  +..+.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9988655311                 011100 111222  3344444433321                   122332


Q ss_pred             ----hc-CCCCeeecCCCCCcEEEcCC----CceEEeeeccccc
Q 018702          188 ----HD-CIPHIIHRDIKSSNILLDQN----MEARVSDFGLATL  222 (351)
Q Consensus       188 ----~~-~~~~i~H~dlkp~Nil~~~~----~~~kl~dfg~~~~  222 (351)
                          .. ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 22479999999999999876    7899999988763

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.26  E-value=0.00043  Score=61.72  Aligned_cols=73  Identities=15%  Similarity=0.144  Sum_probs=41.8

Q ss_pred             CcccccCceEEEEEEECC---------CCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc-eeeeeeEEecCCeeEEEE
Q 018702           76 DVIGSGGFGTVYRLTVND---------STAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-IVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  145 (351)
                      +.++.|....+|++...+         +..+++|+........ .....|..+++.+...+ ..++++..  .  -+++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            357788889999988654         2678888875432221 12346677766664222 33555543  2  27899


Q ss_pred             EecCCCCH
Q 018702          146 ELMPNGSL  153 (351)
Q Consensus       146 e~~~~g~L  153 (351)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.58  E-value=0.0041  Score=56.26  Aligned_cols=73  Identities=11%  Similarity=0.076  Sum_probs=45.2

Q ss_pred             CcccccCceEEEEEEECC--------CCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEE
Q 018702           76 DVIGSGGFGTVYRLTVND--------STAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +.+..|-...+|+....+        +..+++|+....... .-...+|..+++.+. +.-..++++.+.    -++|++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            457778889999988753        577999986443211 111346666666663 222344554332    278999


Q ss_pred             ecCCCCH
Q 018702          147 LMPNGSL  153 (351)
Q Consensus       147 ~~~~g~L  153 (351)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.91  E-value=0.11  Score=46.61  Aligned_cols=30  Identities=27%  Similarity=0.440  Sum_probs=25.3

Q ss_pred             CeeecCCCCCcEEE------cCCCceEEeeeccccc
Q 018702          193 HIIHRDIKSSNILL------DQNMEARVSDFGLATL  222 (351)
Q Consensus       193 ~i~H~dlkp~Nil~------~~~~~~kl~dfg~~~~  222 (351)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999988863

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.98  E-value=0.047  Score=31.46  Aligned_cols=32  Identities=9%  Similarity=0.236  Sum_probs=15.5

Q ss_pred             ceeeEEehhHHHHHHHHHHHHHHHHHhhhhhc
Q 018702            4 ARIIAFYVTICCIAFVISKIIISVLLYRRWKR   35 (351)
Q Consensus         4 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~r   35 (351)
                      +.+-+|+.+++..+++++++.+.++++.|+|+
T Consensus         8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B            8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             CCcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            34445566666545544444444444444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.98  E-value=0.28  Score=39.46  Aligned_cols=118  Identities=8%  Similarity=0.088  Sum_probs=79.3

Q ss_pred             CCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 018702          124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSN  203 (351)
Q Consensus       124 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  203 (351)
                      .||+++.. .+-.+++.+.+.++.  ..+..+|-.     -+..+...+++++.+|+....++++     -+|--|+|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEc--CcccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            57888866 355555655554444  333444331     2346788999999999887755554     4899999999


Q ss_pred             EEEcCCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 018702          204 ILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA  277 (351)
Q Consensus       204 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  277 (351)
                      ++++.++.+++.--|+....                  +|.     ..++..=.-.+=+++..+++++..|...
T Consensus       110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999999877654322                  222     1122223335778999999999998653

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.66  E-value=0.044  Score=31.50  Aligned_cols=30  Identities=13%  Similarity=0.147  Sum_probs=13.7

Q ss_pred             eeEEehhHHHHHHHHHHHHHHHHHhhhhhc
Q 018702            6 IIAFYVTICCIAFVISKIIISVLLYRRWKR   35 (351)
Q Consensus         6 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~r   35 (351)
                      +-+++.+++..+++++++.+.++++.|+|+
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence            334455555544444444444444444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.72  E-value=0.35  Score=39.04  Aligned_cols=115  Identities=13%  Similarity=0.137  Sum_probs=76.1

Q ss_pred             CCCceeeeeeEEecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCC
Q 018702          124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA-YLHHDCIPHIIHRDIKSS  202 (351)
Q Consensus       124 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~-~Lh~~~~~~i~H~dlkp~  202 (351)
                      .||++  -..+-.+++.+.+.++.-+++.=...+       +.++...+++++.+++.... +++     .-+|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57777  333446667766666665333222233       34678889999998877666 444     4589999999


Q ss_pred             cEEEcCCCceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHH-HHHHHHHHHHhCCCCCCc
Q 018702          203 NILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVY-SFGVVLLELLTGKRPMDE  276 (351)
Q Consensus       203 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~-slG~il~~l~~g~~p~~~  276 (351)
                      |++++.++.+++.-.|+-..                  ++|...     + ..|.| ++=+++..++.++..|..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999999987765432                  233221     1 22333 577888889998888754

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=85.89  E-value=0.2  Score=28.46  Aligned_cols=14  Identities=7%  Similarity=-0.017  Sum_probs=5.6

Q ss_pred             EEehhHHHHHHHHH
Q 018702            8 AFYVTICCIAFVIS   21 (351)
Q Consensus         8 ~~i~~~~~~~~~~~   21 (351)
                      +++.+++..+.+++
T Consensus        14 ~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           14 AVIGGVAVGVVLLL   27 (41)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             EEEeehhHHHHHHH
Confidence            33444443433333

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.41  E-value=0.1  Score=47.77  Aligned_cols=60  Identities=8%  Similarity=0.078  Sum_probs=17.1

Q ss_pred             CCCcccccCceEEEEEEECC-CCEEEE------EEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEe
Q 018702           74 SKDVIGSGGFGTVYRLTVND-STAFAV------KRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYT  136 (351)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~  136 (351)
                      ..+.||   ||.||+|.+.. ..+||+      |..+....  +....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345565   99999999864 367888      76654322  22345788889999999999999988743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	351
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-77
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-72
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-67
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-65
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-64
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-64
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-63
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-63
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-57
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-43
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-36
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 3e-77
 Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 21/280 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           + +    IGSG FGTVY+   +   A  +  +   T +  + F+ E+  +   +H NI+ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
             GY T+ Q   ++ +     SL   LH     +   +      IA   A+G+ YLH   
Sbjct: 69  FMGYSTAPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGTFGYLAPEYF--- 246
              IIHRD+KS+NI L +++  ++ DFGLAT+      +H    ++G+  ++APE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
           D    + + DVY+FG+VL EL+TG+ P       +           +        +   L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----------QIIFMVGRGYLSPDL 231

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
                N    +  + + CL+ +  +RP   +++  +EL+ 
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 2e-72
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 21/273 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
                + +G+G FG V+    N  T  AVK L +G+   D  F  E   M  ++H+ +V 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 72

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L+   T      +I E M NGSL  FL     +   L       +A   A G+A++    
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
             + IHRD++++NIL+   +  +++DFGLA L+E  +            + APE  + G 
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
            T K DV+SFG++L E++T  R         G      ++ + +  R            P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNLERGYRMVR---------P 232

Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
            N   +++ +  +C +  P  RPT   +  +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 2e-69
 Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 21/273 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
               +  +G G FG V+  T N +T  A+K L  GT   +  F +E + M  ++H  +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQ 76

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L+   +      ++ E M  GSL  FL G+    K L  P    +A   A G+AY+    
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
             + +HRD++++NIL+ +N+  +V+DFGLA L+E  +            + APE    GR
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 251 ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCP 310
            T K DV+SFG++L EL T  R         G      +  V +  R           CP
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMP---------CP 236

Query: 311 INEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                 +  +   C   EP +RPT   +   LE
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (547), Expect = 1e-68
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 21/282 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
             + K  +G G +G VY           AVK L   T EV+  F +E   M +IKH N+V
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLV 76

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L G  T      +I E M  G+L  +L     N++ +       +A   +  + YL   
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK- 133

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
              + IHRD+ + N L+ +N   +V+DFGL+ LM  +             + APE     
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
           + + K DV++FGV+L E+ T            G  L    + + +D R E          
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMER--------- 237

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKVV 351
           P      V+ +   C +  PS RP+  E+ +  E +  E  +
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-68
 Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 21/274 (7%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
            +    IGSG FG V+     +    A+K +  G    +  F  E E M  + H  +V L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQL 65

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           +G         L++E M +G L  +L  +          +   + +    G   + +   
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEG---MAYLEE 119

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             +IHRD+ + N L+ +N   +VSDFG+   +  ++   ST       + +PE F   R 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           ++K DV+SFGV++ E+ +  +        E       V+ +    R            P 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPY-----ENRSNSEVVEDISTGFRLY---------KPR 225

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
                V+ I + C +  P  RP  + +++ L  I
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 5e-68
 Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 29/304 (9%)

Query: 54  SPLIHSLQSDAIFKKTLKFSSKDVIGSGGFGTVYRLTVNDS----TAFAVKRLHRGTTEV 109
             L+ ++Q   I   +L     +VIG G FG VY  T+ D+       AVK L+R T   
Sbjct: 11  PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70

Query: 110 D-RGFERELEAMGDIKHRNIVTLHGYYTSSQYN-LLIYELMPNGSLDTFLHGKSVNKKNL 167
           +   F  E   M D  H N+++L G    S+ + L++   M +G L  F+  +     N 
Sbjct: 71  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNP 127

Query: 168 DWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM---E 224
                    +  A+G   +        +HRD+ + N +LD+    +V+DFGLA  M   E
Sbjct: 128 TVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184

Query: 225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK 284
            +  H  T       ++A E   T + T K DV+SFGV+L EL+T   P           
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVN 239

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLEL 344
                  ++Q +R            P    + ++ +   C  P+   RP+ +E+V  +  
Sbjct: 240 TFDITVYLLQGRRLLQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

Query: 345 IKSE 348
           I S 
Sbjct: 291 IFST 294

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-67
 Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 21/272 (7%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTL 131
            +    +G+G FG V           A+K +  G+   D  F  E + M ++ H  +V L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQL 64

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
           +G  T  +   +I E M NG L  +L      +         ++       + YL     
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
              +HRD+ + N L++     +VSDFGL+  +  ++   S        +  PE     + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
           ++K D+++FGV++ E+ +  +   E F           + + Q  R            P 
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLRLY---------RPH 224

Query: 312 NEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                V++I   C   +  +RPT   ++  + 
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 1e-66
 Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 27/281 (9%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVT 130
           +      IG G FG V  L        AVK +    T   + F  E   M  ++H N+V 
Sbjct: 8   ELKLLQTIGKGEFGDVM-LGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64

Query: 131 LHGYYTSSQYNL-LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
           L G     +  L ++ E M  GSL  +L  +   +  L      K ++     + YL   
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG- 121

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
              + +HRD+ + N+L+ ++  A+VSDFGL     + +            + APE     
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREK 175

Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
           + + K DV+SFG++L E+ +  R            L   V  V +  + +       +GC
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAP-----DGC 225

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
           P      V+ +   C   + + RP+  ++ + LE IK+ ++
Sbjct: 226 P----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-66
 Identities = 69/287 (24%), Positives = 128/287 (44%), Gaps = 30/287 (10%)

Query: 65  IFKKTLKFSSKDV-IGSGGFGTVYRLTV---NDSTAFAVKRLHRGTTEVDRG-FERELEA 119
           +F K       D+ +G G FG+V +            A+K L +GT + D     RE + 
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           M  + +  IV L G   +    +L+ E+   G L  FL GK   ++ +   +  ++    
Sbjct: 63  MHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQV 118

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVAGT 237
           + G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A+ ++    +     
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDK 296
             + APE  +  + +++ DV+S+GV + E L+ G++P  +    E       +  + Q K
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGK 229

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           R E         CP     +++++ S C   +   RP    V + + 
Sbjct: 230 RME---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-65
 Identities = 64/299 (21%), Positives = 110/299 (36%), Gaps = 31/299 (10%)

Query: 75  KDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
           ++ IG G FG V+R         AVK       E     E E+     ++H NI+     
Sbjct: 8   QESIGKGRFGEVWR-GKWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 135 YTSSQYNL----LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
                       L+ +   +GSL  +L+     +  +      K+A+  A G+A+LH + 
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 191 I-----PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVS---TIVAGTFGYLA 242
           +     P I HRD+KS NIL+ +N    ++D GLA   ++    +        GT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 243 PEYFDT------GRATAKGDVYSFGVVLLELLTGKRPM----DEAFLEEGTKLVTWVKAV 292
           PE  D         +  + D+Y+ G+V  E+           D                 
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 293 MQDKREEYVIDTSLEG--CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
           M+    E  +  ++         +  +  I   C     + R T   + K L  +  ++
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 7e-65
 Identities = 68/315 (21%), Positives = 127/315 (40%), Gaps = 41/315 (13%)

Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG-FERELEAMGDIKH 125
           K   F     +G+G  G V++++   S    A K +H       R    REL+ + +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
             IV  +G + S     +  E M  GSLD  L         +      K+++   +G+ Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTY 119

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
           L       I+HRD+K SNIL++   E ++ DFG++  +      ++    GT  Y++PE 
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPER 174

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEE-----------------------G 282
                 + + D++S G+ L+E+  G+ P+     +E                       G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFS-----IASMCLEPEPSKRPTMTE 337
             L ++            ++D  +   P    + VFS       + CL   P++R  + +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 338 VVKM--LELIKSEKV 350
           ++    ++   +E+V
Sbjct: 295 LMVHAFIKRSDAEEV 309

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 9e-65
 Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 29/285 (10%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDST-----AFAVKRLHRGTTEVDR-GFERELEAMGDIKH 125
            + + VIG+G FG VY+  +  S+       A+K L  G TE  R  F  E   MG   H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 126 RNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
            NI+ L G  +  +  ++I E M NG+LD FL  K              +  G A G+ Y
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKY 125

Query: 186 LHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME--AEKTHVSTIVAGTFGYLAP 243
           L +    + +HRD+ + NIL++ N+  +VSDFGL+ ++E   E T+ ++       + AP
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
           E     + T+  DV+SFG+V+ E++T                   +KA+    R      
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFRLPT--- 234

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKS 347
                 P++  + ++ +   C + E ++RP   ++V +L+ LI++
Sbjct: 235 ------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (521), Expect = 1e-64
 Identities = 79/283 (27%), Positives = 131/283 (46%), Gaps = 32/283 (11%)

Query: 77  VIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDIKHRNIVTL 131
           VIG+G FG V      L        A+K L  G TE   R F  E   MG   H N++ L
Sbjct: 33  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G  T S   ++I E M NGSLD+FL                 +  G A G+ YL     
Sbjct: 93  EGVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLAD--- 146

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA----GTFGYLAPEYFD 247
            + +HRD+ + NIL++ N+  +VSDFGL+  +E + +  +   A        + APE   
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206

Query: 248 TGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
             + T+  DV+S+G+V+ E+++ G+RP  +   ++       + A+ QD R         
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDYRLPP------ 254

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKSE 348
              P++  + +  +   C + + + RP   ++V  L+ +I++ 
Sbjct: 255 ---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (520), Expect = 2e-64
 Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 45/303 (14%)

Query: 71  KFSSKDVIGSGGFGTVYR------LTVNDSTAFAVKRLHR-GTTEVDRGFERELEAMGDI 123
                  IG G FG V++      L     T  AVK L    + ++   F+RE   M + 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------------SVN 163
            + NIV L G     +   L++E M  G L+ FL                       S  
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM 223
              L    +  IA   A G+AYL        +HRD+ + N L+ +NM  +++DFGL+  +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 224 -EAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG 282
             A+        A    ++ PE     R T + DV+++GVVL E+ +           E 
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                            YV D ++  CP N   +++++  +C    P+ RP+   + ++L
Sbjct: 251 VI--------------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

Query: 343 ELI 345
           + +
Sbjct: 297 QRM 299

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-64
 Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 36/295 (12%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVD-RGFERELEAMGDI-KHR 126
              +DVIG G FG V +  +         A+KR+    ++ D R F  ELE +  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYK 174
           NI+ L G      Y  L  E  P+G+L  FL    V                L       
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIV 234
            A   ARG+ YL        IHRD+ + NIL+ +N  A+++DFGL+   E       T+ 
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186

Query: 235 AGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ 294
                ++A E  +    T   DV+S+GV+L E+++            G       + + Q
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-----CGMTCAELYEKLPQ 241

Query: 295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
             R E          P+N  ++V+ +   C   +P +RP+  +++  L  +  E+
Sbjct: 242 GYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-63
 Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 23/277 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRN 127
            +     IG+G +G   ++   +D      K L  G  T    +    E+  + ++KH N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 128 IVTLHGYYT--SSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAY 185
           IV  +      ++    ++ E    G L + +   +  ++ LD     ++       +  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 186 LH--HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAP 243
            H   D    ++HRD+K +N+ LD     ++ DFGLA ++  + +       GT  Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183

Query: 244 EYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
           E  +      K D++S G +L EL     P                  + + K       
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKFRRIPYR 237

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            S         +++  I +  L  +   RP++ E+++
Sbjct: 238 YS---------DELNEIITRMLNLKDYHRPSVEEILE 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 74/301 (24%), Positives = 121/301 (40%), Gaps = 39/301 (12%)

Query: 71  KFSSKDVIGSGGFGTVYRLTV------NDSTAFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           + S    +G+G FG V   T       + +   AVK L       +R     EL+ +  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 124 K-HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK--------------SVNKKNLD 168
             H NIV L G  T     L+I E    G L  FL  K                ++  LD
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  +   A+G+A+L      + IHRD+ + NILL      ++ DFGLA  ++ +  
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 229 H-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT 287
           + V         ++APE       T + DV+S+G+ L EL +           +      
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----K 256

Query: 288 WVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS 347
           + K + +  R            P +   +++ I   C + +P KRPT  ++V+++E   S
Sbjct: 257 FYKMIKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 348 E 348
           E
Sbjct: 308 E 308

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-62
 Identities = 63/285 (22%), Positives = 118/285 (41%), Gaps = 32/285 (11%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLTVNDS---TAFAVKRLHRGTTEVD--RGFERELEAMG 121
           +K L    K  +GSG FGTV +            AVK L     +         E   M 
Sbjct: 5   RKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63

Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
            + +  IV + G   +  + +L+ E+   G L+ +L       +++   +  ++    + 
Sbjct: 64  QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSM 118

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST--IVAGTFG 239
           G+ YL      + +HRD+ + N+LL     A++SDFGL+  + A++ +            
Sbjct: 119 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKRE 298
           + APE  +  + ++K DV+SFGV++ E  + G++P        G K       + + +R 
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR------GMKGSEVTAMLEKGERM 229

Query: 299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
                     CP     +++ + ++C   +   RP    V   L 
Sbjct: 230 G---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-61
 Identities = 68/301 (22%), Positives = 105/301 (34%), Gaps = 44/301 (14%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDS------TAFAVKRLHRGTTEVDR-GFERELEAMGDI 123
                 V+GSG FG V   T             AVK L       +R     EL+ M  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 124 -KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK-------------------SVN 163
             H NIV L G  T S    LI+E    G L  +L  K                     +
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 164 KKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA-TL 222
              L +      A   A+G+ +L        +HRD+ + N+L+      ++ DFGLA  +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG 282
           M      V         ++APE    G  T K DV+S+G++L E+ +             
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI---- 270

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKML 342
                + K +    + +          P     +++ I   C   +  KRP+   +   L
Sbjct: 271 PVDANFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 343 E 343
            
Sbjct: 322 G 322

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 3e-61
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 35/288 (12%)

Query: 62  SDAIFKK--TLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG---TTEVDRGFER 115
           ++  FK      FS    IG G FG VY    V +S   A+K++      + E  +   +
Sbjct: 5   AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 116 ELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKI 175
           E+  +  ++H N +   G Y       L+ E     + D        +KK L       +
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAV 120

Query: 176 AVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVA 235
             GA +G+AYLH     ++IHRD+K+ NILL +    ++ DFG A++M    + V     
Sbjct: 121 THGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----- 172

Query: 236 GTFGYLAPEYF---DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV 292
           GT  ++APE     D G+   K DV+S G+  +EL   K P+           ++ +  +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHI 226

Query: 293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            Q++        +L+    +E     +    CL+  P  RPT   ++K
Sbjct: 227 AQNES------PALQSGHWSE--YFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-61
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 28/280 (10%)

Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDIKHRNIVT 130
             IG G FG V++       N + A A+K     T++  R  F +E   M    H +IV 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 131 LHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC 190
           L G  T +    +I EL   G L +FL  +   K +LD  S    A   +  +AYL    
Sbjct: 73  LIGVITENPV-WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-- 126

Query: 191 IPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
               +HRDI + N+L+  N   ++ DFGL+  ME    + ++       ++APE  +  R
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 251 ATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
            T+  DV+ FGV + E+L  G +P       +       +  +   +R     +      
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNCP---- 235

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK 349
                  ++S+ + C   +PS+RP  TE+   L  I  E+
Sbjct: 236 -----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-60
 Identities = 73/274 (26%), Positives = 112/274 (40%), Gaps = 30/274 (10%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG---TTEVDRGFERELEAMGDIKHR 126
            F     +G G FG VY           A+K L +       V+    RE+E    ++H 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           NI+ L+GY+  +    LI E  P G++   L          D           A  ++Y 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 122

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +IHRDIK  N+LL    E +++DFG +    + +      + GT  YL PE  
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMI 176

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
           +      K D++S GV+  E L GK P +    +E  K ++ V+    D   E   D   
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--- 233

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                        + S  L+  PS+RP + EV++
Sbjct: 234 -------------LISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-60
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 32/279 (11%)

Query: 70  LKFSSKDVIGSGGFGTVYRLTVNDST-AFAVKRLH--RGTTEVDRGFERELEAMGDIKHR 126
           LKF  +  IG G F TVY+    ++T   A   L   + T    + F+ E E +  ++H 
Sbjct: 11  LKFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 127 NIVTLHGYYTSS----QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           NIV  +  + S+    +  +L+ ELM +G+L T+L       K +             +G
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 124

Query: 183 IAYLHHDCIPHIIHRDIKSSNILL-DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
           + +LH    P IIHRD+K  NI +       ++ D GLATL        +  V GT  ++
Sbjct: 125 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFM 180

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           APE ++  +     DVY+FG+ +LE+ T + P  E              A +  +    V
Sbjct: 181 APEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC----------QNAAQIYRRVTSGV 229

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
              S +   I E+ +   I   C+     +R ++ +++ 
Sbjct: 230 KPASFDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-59
 Identities = 55/271 (20%), Positives = 105/271 (38%), Gaps = 26/271 (9%)

Query: 76  DVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGY 134
             +G G FG VY+      S   A K +   + E    +  E++ +    H NIV L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHI 194
           +       ++ E    G++D  +      ++ L       +       + YLH      I
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHD---NKI 131

Query: 195 IHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA--- 251
           IHRD+K+ NIL   + + +++DFG++           + + GT  ++APE      +   
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190

Query: 252 --TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
               K DV+S G+ L+E+   + P  E            ++ +++  + E          
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHEL---------NPMRVLLKIAKSEPPTLAQPSRW 241

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                ++       CLE     R T +++++
Sbjct: 242 S----SNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 6e-59
 Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 29/291 (9%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLTVNDS-----TAFAVKRLHRGTT-EVDRGFERELE 118
           I K+T +F    V+GSG FGTVY+              A+K L   T+ + ++    E  
Sbjct: 5   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 119 AMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG 178
            M  + + ++  L G   +S    LI +LMP G L  ++      K N+         V 
Sbjct: 64  VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 119

Query: 179 AARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAGT 237
            A+G+ YL       ++HRD+ + N+L+      +++DFGLA L+   EK + +      
Sbjct: 120 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
             ++A E       T + DV+S+GV + EL+T           +G         + + +R
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-----YDGIPASEISSILEKGER 231

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE 348
                       P     DV+ I   C   +   RP   E++     +  +
Sbjct: 232 LPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-58
 Identities = 61/271 (22%), Positives = 113/271 (41%), Gaps = 23/271 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K++  + IG G  GTVY    V      A+++++            E+  M + K+ NIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
                Y       ++ E +  GSL   +      +  +D      +     + + +LH +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               +IHRDIKS NILL  +   +++DFG    +  E++  ST+V GT  ++APE     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 250 RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
               K D++S G++ +E++ G+ P            +  +  +  +   E      L   
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLS-- 243

Query: 310 PINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                       + CL+ +  KR +  E+++
Sbjct: 244 -----AIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-58
 Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 24/274 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLH-RGTTEVDRGFERELEAMGDIKHRNI 128
            +     +G G +G V          A AVK +  +   +     ++E+     + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V  +G+        L  E    G L   +         +  P   +       G+ YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA-EKTHVSTIVAGTFGYLAPEYFD 247
                I HRDIK  N+LLD+    ++SDFGLAT+     +  +   + GT  Y+APE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 248 TGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
                    DV+S G+VL  +L G+ P D+          +       D +E+       
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQP---------SDSCQEYSDWKEKKTYLNPW 229

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           +       +   ++    L   PS R T+ ++ K
Sbjct: 230 KKID----SAPLALLHKILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-57
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 31/287 (10%)

Query: 71  KFSSKDVIGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVDR-GFERELEAMGDI 123
           K +    +G G FG VY       +     T  A+K ++   +  +R  F  E   M + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 124 KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLH------GKSVNKKNLDWPSRYKIAV 177
              ++V L G  +  Q  L+I ELM  G L ++L         +            ++A 
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM-EAEKTHVSTIVAG 236
             A G+AYL+       +HRD+ + N ++ ++   ++ DFG+   + E +          
Sbjct: 141 EIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 237 TFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK 296
              +++PE    G  T   DV+SFGVVL E+ T           +G      ++ VM+  
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVMEGG 252

Query: 297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             +          P N  + +F +  MC +  P  RP+  E++  ++
Sbjct: 253 LLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 3e-57
 Identities = 68/277 (24%), Positives = 108/277 (38%), Gaps = 29/277 (10%)

Query: 76  DVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGTTEVDRG---FERELEAMGDIKHRNI 128
           + +G G FG V R         + + AVK L             F RE+ AM  + HRN+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           + L+G   +    + + EL P GSL   L      + +    +  + AV  A G+ YL  
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH--VSTIVAGTFGYLAPEYF 246
                 IHRD+ + N+LL      ++ DFGL   +     H  +       F + APE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
            T   +   D + FGV L E+ T  +                 + + +  +E   +    
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGERLP-RP 237

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           E CP     D++++   C   +P  RPT   +   L 
Sbjct: 238 EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 4e-56
 Identities = 77/298 (25%), Positives = 120/298 (40%), Gaps = 40/298 (13%)

Query: 71  KFSSKDVIGSGGFGTVY--------RLTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMG 121
           +      +G G FG V         +   N  T  AVK L    TE D      E+E M 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 122 DI-KHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGK------------SVNKKNLD 168
            I KH+NI+ L G  T      +I E    G+L  +L  +               ++ L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 169 WPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT 228
                  A   ARG+ YL        IHRD+ + N+L+ ++   +++DFGLA  +     
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 229 HVSTIVA-GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVT 287
           +  T        ++APE       T + DV+SFGV+L E+ T            G  +  
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-----PGVPVEE 245

Query: 288 WVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI 345
             K + +  R +          P N  N+++ +   C    PS+RPT  ++V+ L+ I
Sbjct: 246 LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 57/273 (20%), Positives = 110/273 (40%), Gaps = 23/273 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            +   + +G+G FG V+R+T       FA K +            +E++ M  ++H  +V
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            LH  +      ++IYE M  G L   +  +      +      +      +G+ ++H  
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 190 CIPHIIHRDIKSSNILL--DQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
              + +H D+K  NI+    ++ E ++ DFGL   ++ +++   T   GT  + APE  +
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                   D++S GV+   LL+G  P      +E  + V      M D     + +    
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE---- 254

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                   D        L  +P+ R T+ + ++
Sbjct: 255 --------DGKDFIRKLLLADPNTRMTIHQALE 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 39/300 (13%)

Query: 71  KFSSKDVIGSGGFGTVYR------LTVNDSTAFAVKRLHRGTTEVD-RGFERELEAMGDI 123
           +      +G G FG V                 AVK L  G T  + R    EL+ +  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 124 KHR-NIVTLHGYYTS-SQYNLLIYELMPNGSLDTFLHGK------------SVNKKNLDW 169
            H  N+V L G  T      ++I E    G+L T+L  K             + K  L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 170 PSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH 229
                 +   A+G+ +L        IHRD+ + NILL +    ++ DFGLA  +  +  +
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 230 V-STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW 288
           V          ++APE       T + DV+SFGV+L E+ +                  +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEF 246

Query: 289 VKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE-LIKS 347
            + + +  R            P     +++     C   EPS+RPT +E+V+ L  L+++
Sbjct: 247 CRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-53
 Identities = 57/285 (20%), Positives = 105/285 (36%), Gaps = 28/285 (9%)

Query: 67  KKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG---FERELEAMGD 122
           K+   F    ++G G F TV     +  S  +A+K L +     +       RE + M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
           + H   V L+  +   +          NG L  ++        + D           A  
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDET---CTRFYTAEI 117

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE-KTHVSTIVAGTFGYL 241
           ++ L +     IIHRD+K  NILL+++M  +++DFG A ++  E K   +    GT  Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           +PE      A    D+++ G ++ +L+ G  P                + +++ + +   
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYD--- 228

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK 346
                   P         +    L  + +KR    E+     L  
Sbjct: 229 -------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (447), Expect = 7e-53
 Identities = 61/273 (22%), Positives = 104/273 (38%), Gaps = 23/273 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
            +   + +GSG FG V+R         F  K ++          + E+  M  + H  ++
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            LH  +      +LI E +  G L   +  +      +           A  G+ ++H  
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 190 CIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
               I+H DIK  NI+ +    + V   DFGLAT +  ++    T    T  + APE  D
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVD 201

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
                   D+++ GV+   LL+G  P      E+  + +  VK    +  E+     S E
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWEFDEDAFSSVSPE 258

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                            L+ EP KR T+ + ++
Sbjct: 259 AK---------DFIKNLLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 2e-50
 Identities = 66/272 (24%), Positives = 104/272 (38%), Gaps = 20/272 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG-FERELEAMGDIKHRNI 128
            +  +DV+G+G F  V            A+K + +   E   G  E E+  +  IKH NI
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L   Y S  +  LI +L+  G L   +      K         ++       + YLH 
Sbjct: 70  VALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
             I H   +        LD++ +  +SDFGL+ +   +   V +   GT GY+APE    
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQ 183

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG 308
              +   D +S GV+   LL G  P  +   E   KL   +     +    Y  D S   
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYWDDIS--- 237

Query: 309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                 +         +E +P KR T  + ++
Sbjct: 238 ------DSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-49
 Identities = 52/273 (19%), Positives = 102/273 (37%), Gaps = 24/273 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIV 129
           K+   + +G G FG V+R    +    +  K +    T+     ++E+  +   +HRNI+
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNIL 64

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            LH  + S +  ++I+E +    +   ++    +   L+              + +LH  
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 190 CIPHIIHRDIKSSNILLDQNMEARV--SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
              +I H DI+  NI+      + +   +FG A  ++               Y APE   
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQ 176

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE 307
               +   D++S G ++  LL+G  P      E   +++  +        EE   + S+E
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                            L  E   R T +E ++
Sbjct: 234 AM---------DFVDRLLVKERKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  163 bits (413), Expect = 8e-49
 Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 32/289 (11%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHR 126
           ++   +++G GG   V+    +      AVK L             F RE +    + H 
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 127 NIVTLHGYYTS----SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
            IV ++    +         ++ E +   +L   +H     +  +      ++   A + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQA 123

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV--STIVAGTFGY 240
           + + H      IIHRD+K +NI++      +V DFG+A  +      V  +  V GT  Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 241 LAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY 300
           L+PE        A+ DVYS G VL E+LTG+ P             + V    Q  RE+ 
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---------SPVSVAYQHVREDP 231

Query: 301 VIDTSL-EGCPINEINDVFSIASMCLEPEPSKRP-TMTEVVKMLELIKS 347
           +  ++  EG       D+ ++    L   P  R  T  E+   L  + +
Sbjct: 232 IPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  163 bits (414), Expect = 6e-48
 Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 31/274 (11%)

Query: 72  FSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRG------FERELEAMGDIK 124
           FS   +IG GGFG VY     D+   +A+K L +   ++ +G          L  +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 125 HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIA 184
              IV +   + +      I +LM  G L   L                  A     G+ 
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLE 121

Query: 185 YLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPE 244
           ++H+     +++RD+K +NILLD++   R+SD GLA     +K H S    GT GY+APE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 175

Query: 245 YFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID 303
               G A  +  D +S G +L +LL G  P    F +  TK    +  +      E    
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDS 231

Query: 304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTE 337
            S          ++ S+    L+ + ++R     
Sbjct: 232 FS---------PELRSLLEGLLQRDVNRRLGCLG 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (404), Expect = 2e-47
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 38/287 (13%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTT---------EVDRGFERELEAM 120
            +  K+++G G    V R         +AVK +              E+     +E++ +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 121 GDIK-HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
             +  H NI+ L   Y ++ +  L+++LM  G L  +L      K  L      KI    
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
              I  LH     +I+HRD+K  NILLD +M  +++DFG +  +  +       V GT  
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174

Query: 240 YLAPEYFDTGRA------TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVM 293
           YLAPE  +            + D++S GV++  LL G  P          K +  ++ +M
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIM 228

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
               +        +       + V  + S  L  +P KR T  E + 
Sbjct: 229 SGNYQ--FGSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 57/274 (20%), Positives = 101/274 (36%), Gaps = 29/274 (10%)

Query: 72  FSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFE---RELEAMG-DIKHR 126
           F    ++G G FG V+       +  FA+K L +    +D   E    E   +    +H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +  +   + + +    + E +  G L   +     +    D       A     G+ +L
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFL 119

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      I++RD+K  NILLD++   +++DFG+           +T   GT  Y+APE  
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
              +     D +SFGV+L E+L G+ P                +     + +       L
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---------DEEELFHSIRMDNPFYPRWL 226

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           E        +   +       EP KR  +   ++
Sbjct: 227 E-------KEAKDLLVKLFVREPEKRLGVRGDIR 253

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 3e-45
 Identities = 54/296 (18%), Positives = 113/296 (38%), Gaps = 24/296 (8%)

Query: 65  IFKKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG-FERELEAMGD 122
           +F    ++++   IG G +G V       +    A+K++     +       RE++ +  
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62

Query: 123 IKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARG 182
            +H NI+ ++    +     +    +    +   L+ K +  ++L             RG
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRG 121

Query: 183 IAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTI--VAGTFGY 240
           + Y+H     +++HRD+K SN+LL+   + ++ DFGLA + + +  H   +     T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 241 LAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRP---------------MDEAFLEEGTK 284
            APE     +  T   D++S G +L E+L+ +                 +  +  +E   
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            +  +KA        +           N  +    +    L   P KR  + + + 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-45
 Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 25/285 (8%)

Query: 76  DVIGSGGFGTVY--RLTVNDSTAFAVKRLHR--GTTEVDRGFERELEAM---GDIKHRNI 128
             IG G +G V+  R   N     A+KR+    G   +     RE+  +      +H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSL--DTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
           V L    T S+ +      +    +  D   +   V +  +   +   +     RG+ +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      ++HRD+K  NIL+  + + +++DFGLA +   +    S +   T  Y APE  
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV------MQDKREEY 300
                    D++S G +  E+   K     +   +    +  V  +       +D     
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 301 VIDTSLEGCPINEINDVFS-----IASMCLEPEPSKRPTMTEVVK 340
               S    PI +           +   CL   P+KR +    + 
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-45
 Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 27/285 (9%)

Query: 76  DVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTT-----EVDRGFERELEAMGDIKHRNIV 129
           D +G G F TVY+    N +   A+K++  G        ++R   RE++ + ++ H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 130 TLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD 189
            L   +       L+++ M              N   L         +   +G+ YLH  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 190 CIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTG 249
               I+HRD+K +N+LLD+N   +++DFGLA    +     +  V  T  Y APE     
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 250 RA-TAKGDVYSFGVVLLELLTGKRPM----DEAFLEEGTKLVTWVKAVMQDKREEYVIDT 304
           R      D+++ G +L ELL     +    D   L    + +                  
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 305 SLEGCPINEINDVFSIAS--------MCLEPEPSKRPTMTEVVKM 341
           + +  P   ++ +FS A               P  R T T+ +KM
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 8e-45
 Identities = 54/284 (19%), Positives = 97/284 (34%), Gaps = 28/284 (9%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-I 128
           ++     IGSG FG +Y  T +      A+K     T         E +    ++    I
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGI 65

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
            T+        YN+++ EL+     D F        +     +   +A      I Y+H 
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 189 DCIPHIIHRDIKSSNIL---LDQNMEARVSDFGLATLMEAEKTHV------STIVAGTFG 239
               + IHRD+K  N L     +     + DFGLA      +TH       +  + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           Y +         + + D+ S G VL+    G  P                   + +K+  
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMS 234

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
             I+   +G P    ++  +  + C       +P  + + ++  
Sbjct: 235 TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 9e-45
 Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 35/290 (12%)

Query: 65  IFKK---TLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG------FE 114
           +F++      + + + +GSG F  V +    +    +A K + +  T+  R        E
Sbjct: 2   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 115 RELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYK 174
           RE+  + +I+H N++TLH  Y +    +LI EL+  G L  FL      K++L      +
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117

Query: 175 IAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEAR----VSDFGLATLMEAEKTHV 230
                  G   +++     I H D+K  NI+L      +    + DFGLA  ++      
Sbjct: 118 FLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173

Query: 231 STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVK 290
              + GT  ++APE  +      + D++S GV+   LL+G  P      +E    +  V 
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS 229

Query: 291 AVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           AV  +  +EY  +TS                   L  +P KR T+ + ++
Sbjct: 230 AVNYEFEDEYFSNTSALAK---------DFIRRLLVKDPKKRMTIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-44
 Identities = 50/286 (17%), Positives = 95/286 (33%), Gaps = 22/286 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRN 127
            F   + IG G +G VY+          A+K++     T  V     RE+  + ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV L     +     L++E +            +     +  P          +G+A+ H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                 ++HRD+K  N+L++     +++DFGLA          +  V   +         
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMD-----EAFLEEGTKLVTWVKAVMQDKREEYVI 302
               +   D++S G +  E++T +         +        L T  + V          
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 303 DTSLEGCPINEINDVFSIAS--------MCLEPEPSKRPTMTEVVK 340
             S       + + V               L  +P+KR +    + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  152 bits (384), Expect = 2e-44
 Identities = 52/285 (18%), Positives = 109/285 (38%), Gaps = 22/285 (7%)

Query: 71  KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLH--RGTTEVDRGFERELEAMGDIKHRNI 128
           K+   + IG G +G VY+   N    FA+K++   +    +     RE+  + ++KH NI
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
           V L+    + +  +L++E +               +  L+  +     +    GIAY H 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 189 DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDT 248
                ++HRD+K  N+L+++  E +++DFGLA          +  +   +         +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 249 GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID----- 303
            + +   D++S G +  E++ G          +    +  +      K    V +     
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 304 --------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                      E            + S  L+ +P++R T  + ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 4e-44
 Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 32/295 (10%)

Query: 68  KTLKFSSKDVIGSGGFGTVYRLTVNDS-TAFAVKRLHRGTTEVDRGFERELEAMGDIKHR 126
           + + ++   VIG+G FG VY+  + DS    A+K++ +      R   REL+ M  + H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHC 73

Query: 127 NIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAA 180
           NIV L  ++ SS       Y  L+ + +P        H     K+ L             
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLF 132

Query: 181 RGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
           R +AY+H      I HRDIK  N+LLD +    ++ DFG A  +   + +VS I   +  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 187

Query: 240 YLAP-EYFDTGRATAKGDVYSFGVVLLELLTGKRP---------MDEAFLEEGTKLVTWV 289
           Y AP   F     T+  DV+S G VL ELL G+           + E     GT     +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 290 KAVMQDKRE----EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
           + +  +  E    +       +        +  ++ S  LE  P+ R T  E   
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (384), Expect = 5e-44
 Identities = 58/263 (22%), Positives = 102/263 (38%), Gaps = 31/263 (11%)

Query: 76  DVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG---FERELEAMGDIKHRNIVTL 131
             +G+G FG V+ +   ++   +A+K L +      +       E   +  + H  I+ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 132 HGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
            G +  +Q   +I + +  G L + L                     AA     L +   
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHS 122

Query: 192 PHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA 251
             II+RD+K  NILLD+N   +++DFG A  +      V+  + GT  Y+APE   T   
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPY 178

Query: 252 TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGCPI 311
               D +SFG+++ E+L G  P  ++           +K   +    E            
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDS---------NTMKTYEKILNAELRFPPFFN---- 225

Query: 312 NEINDVFSIASMCLEPEPSKRPT 334
               DV  + S  +  + S+R  
Sbjct: 226 ---EDVKDLLSRLITRDLSQRLG 245

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-43
 Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 29/285 (10%)

Query: 75  KDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDI-KHRNIVTLH 132
             V+G G  G V ++        FA+K L            RE+E      +  +IV + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 71

Query: 133 GYY----TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             Y       +  L++ E +  G L + +  +    +        +I       I YLH 
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 189 DCIPHIIHRDIKSSNILLDQNME---ARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEY 245
               +I HRD+K  N+L          +++DFG A    +  +  +     T  Y+APE 
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEV 184

Query: 246 FDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS 305
               +     D++S GV++  LL G  P            +     +    R       +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTRIRMGQYEFPN 238

Query: 306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV 350
            E   ++E  +V  +    L+ EP++R T+TE +    +++S KV
Sbjct: 239 PEWSEVSE--EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-41
 Identities = 56/287 (19%), Positives = 101/287 (35%), Gaps = 24/287 (8%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRN 127
           K+   + IG G +GTV++          A+KR+        V     RE+  + ++KH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 128 IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLH 187
           IV LH    S +   L++E         F                  +     + +  L 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLG 115

Query: 188 HDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFD 247
                +++HRD+K  N+L+++N E ++++FGLA          S  V   +       F 
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 248 TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGT--------------KLVTWVKAVM 293
               +   D++S G +  EL    RP+      +                +  +  K   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 294 QDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                 Y   TSL             +    L+  P +R +  E ++
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (359), Expect = 1e-40
 Identities = 41/286 (14%), Positives = 87/286 (30%), Gaps = 30/286 (10%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-I 128
            +     IG G FG ++  T + ++   A+K   R +         E      +     I
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGI 63

Query: 129 VTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH 188
             ++ +     +N+L+ +L+     D          +     +    A      +  +H 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 189 DCIPHIIHRDIKSSNILLDQNME-----ARVSDFGLATLMEAEKTHVSTI------VAGT 237
                +++RDIK  N L+ +          V DFG+        T           ++GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR 297
             Y++         + + D+ + G V +  L G  P          +    +     +K+
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----EKK 232

Query: 298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE 343
           +   +     G P     + +              P    +  +  
Sbjct: 233 QSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-40
 Identities = 59/281 (20%), Positives = 104/281 (37%), Gaps = 42/281 (14%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHR------GTTEVDRGFERELEAMGDI 123
           ++    ++GSGGFG+VY    V+D+   A+K + +      G          E+  +  +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 124 K--HRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
                 ++ L  ++      +LI E             +   +  L              
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLE 121

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTIVAGTFGY 240
            + + H+     ++HRDIK  NIL+D N  E ++ DFG   L+   K  V T   GT  Y
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVY 175

Query: 241 LAPEYFDTGRATAKG-DVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
             PE+    R   +   V+S G++L +++ G  P +                  +  R +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------------EEIIRGQ 220

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
                 +        ++   +   CL   PS RPT  E+  
Sbjct: 221 VFFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 53/274 (19%), Positives = 100/274 (36%), Gaps = 29/274 (10%)

Query: 67  KKTL-KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG---FERELEAMG 121
           K T+  F    ++G G FG V  +        +A+K L +              E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 122 DIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           + +H  +  L   + +      + E    G L   L  +          +  +     A 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAE 113

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            ++ L +     +++RDIK  N++LD++   +++DFGL     ++   + T   GT  YL
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172

Query: 242 APEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV 301
           APE  +        D +  GVV+ E++ G+ P                +       EE  
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---------DHERLFELILMEEIR 223

Query: 302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
              +L         +  S+ +  L+ +P +R   
Sbjct: 224 FPRTLS-------PEAKSLLAGLLKKDPKQRLGG 250

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 54/298 (18%), Positives = 108/298 (36%), Gaps = 28/298 (9%)

Query: 65  IFKKTLKFSSK----DVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG--TTEVDRGFEREL 117
           + K   +  +       +GSG +G V            A+K+L+R   +    +   REL
Sbjct: 9   VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 118 EAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAV 177
             +  ++H N++ L   +T  +      +            GK +  + L       +  
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY 128

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGT 237
              +G+ Y+H      IIHRD+K  N+ ++++ E ++ DFGLA   +   + ++  V   
Sbjct: 129 QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTR 182

Query: 238 FGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEA---------------FLEEG 282
           +        +  R T   D++S G ++ E++TGK     +                  E 
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 283 TKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            + +   +A    K    +          N      ++    L  +  +R T  E + 
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 49/301 (16%), Positives = 100/301 (33%), Gaps = 38/301 (12%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRN 127
           K+     IG G FG V++          A+K++              RE++ +  +KH N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 128 IVTLHGYYTSSQYN--------LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           +V L     +             L+++   +       +               ++    
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQML 126

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT---HVSTIVAG 236
             G   L++     I+HRD+K++N+L+ ++   +++DFGLA      K    +  T    
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 237 TFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQD 295
           T  Y  PE     R      D++  G ++ E+ T    M     +    L++ +   +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 296 KREEYVIDTSLEGC----------------PINEINDVFSIASMCLEPEPSKRPTMTEVV 339
           +    V +  L                             +    L  +P++R    + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 340 K 340
            
Sbjct: 304 N 304

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (334), Expect = 1e-36
 Identities = 51/267 (19%), Positives = 97/267 (36%), Gaps = 31/267 (11%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRG---FERELEAMGDIKHR 126
           +F     +G+G FG V  +        +A+K L +      +       E   +  +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 127 NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYL 186
            +V L   +  +    ++ E +  G + + L            P     A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 187 HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYF 246
           H      +I+RD+K  N+L+DQ    +V+DFG A  ++     +     GT   LAPE  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEII 210

Query: 247 DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL 306
            +       D ++ GV++ E+  G  P          + +   + ++  K          
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFF------ADQPIQIYEKIVSGKVR-------- 256

Query: 307 EGCPINEINDVFSIASMCLEPEPSKRP 333
              P +  +D+  +    L+ + +KR 
Sbjct: 257 --FPSHFSSDLKDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 30/276 (10%)

Query: 71  KFSSKDVIGSGGFGTVYR----LTVNDSTAFAVKRLHRGT----TEVDRGFERELEAMGD 122
            F    V+G+G +G V+        +    +A+K L + T     +       E + +  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 123 IKHR-NIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           I+    +VTLH  + +     LI + +  G L T L  +       +  + +++ +    
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGE 137

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYL 241
            +  L H     II+RDIK  NILLD N    ++DFGL+    A++T  +    GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 242 APEYFDTGRA--TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE 299
           AP+    G +      D +S GV++ ELLTG  P    F  +G K  +  +   +  + E
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEK-NSQAEISRRILKSE 252

Query: 300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTM 335
                 +             +    L  +P KR   
Sbjct: 253 PPYPQEMS-------ALAKDLIQRLLMKDPKKRLGC 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 7e-34
 Identities = 60/296 (20%), Positives = 110/296 (37%), Gaps = 24/296 (8%)

Query: 63  DAIFKKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVD--RGFERELEA 119
             I++   ++ +   +GSG +G+V            AVK+L R    +   +   REL  
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 120 MGDIKHRNIVTLHGYYTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGA 179
           +  +KH N++ L   +T ++      ++     L        V  + L       +    
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 180 ARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVSTIVAGTFG 239
            RG+ Y+H      IIHRD+K SN+ ++++ E ++ DFGLA   + E T     VA  + 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWY 184

Query: 240 YLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP---------------MDEAFLEEGTK 284
                  +        D++S G ++ ELLTG+                 +      E  K
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 285 LVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK 340
            ++   A    +    +   +     I        +    L  +  KR T  + + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 51/294 (17%), Positives = 107/294 (36%), Gaps = 45/294 (15%)

Query: 76  DVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHG 133
             +G G +  V+    + ++    VK L        +  +RE++ + +++   NI+TL  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLAD 97

Query: 134 YYTS--SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCI 191
                 S+   L++E + N              + L             + + Y H    
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS--- 147

Query: 192 PHIIHRDIKSSNILLD-QNMEARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGR 250
             I+HRD+K  N+++D ++ + R+ D+GLA      + +   +   +  +  PE     +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQ 205

Query: 251 A-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC 309
                 D++S G +L  ++  K P      +   +LV   K +  +   +Y+   ++E  
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 310 P-INEI----------------------NDVFSIASMCLEPEPSKRPTMTEVVK 340
           P  N+I                       +        L  +   R T  E ++
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 5e-31
 Identities = 67/314 (21%), Positives = 114/314 (36%), Gaps = 47/314 (14%)

Query: 62  SDAIFKKTLKFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRG--TTEVDRGFERELE 118
            D+ F    ++ +   IGSG  G V            A+K+L R        +   REL 
Sbjct: 9   GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 119 AMGDIKHRNIVTLHGYYTSS------QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSR 172
            M  + H+NI++L   +T        Q   L+ ELM               +  LD    
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERM 121

Query: 173 YKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHVST 232
             +      GI +LH   I   IHRD+K SNI++  +   ++ DFGLA       + + T
Sbjct: 122 SYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMT 176

Query: 233 IVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRP---------MDEAFLEEGT 283
               T  Y APE           D++S G ++ E++  K            ++   + GT
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 284 KLVTWVKAVMQDKREEYVIDTSLEGCPINEI-----------------NDVFSIASMCLE 326
               ++K +    R          G    ++                 +    + S  L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 327 PEPSKRPTMTEVVK 340
            +P+KR ++ + ++
Sbjct: 297 IDPAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (278), Expect = 1e-28
 Identities = 52/317 (16%), Positives = 107/317 (33%), Gaps = 50/317 (15%)

Query: 71  KFSSKDVIGSGGFGTVYRLT-VNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-- 127
           ++     +G G F TV+    + ++T  A+K +       +   E E++ +  +   +  
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNT 72

Query: 128 ---------IVTLHGYYTSSQYNLLIYELMPNGSLDTFLHG-KSVNKKNLDWPSRYKIAV 177
                    I+ L  ++     N +   ++     +  L   K    + +      +I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 178 GAARGIAYLHHDCIPHIIHRDIKSSNILLDQN-MEARVSDFGLATLMEAEKTHVSTI-VA 235
               G+ Y+H  C   IIH DIK  N+L++       +    +A L  A           
Sbjct: 133 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 236 GTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ- 294
            T  Y +PE           D++S   ++ EL+TG    +       TK    +  +++ 
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 295 -------------------DKREEYVIDTSLEGCPINEI------------NDVFSIASM 323
                              + R      + L+  P+ ++             ++    S 
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 324 CLEPEPSKRPTMTEVVK 340
            L+ +P KR     +V 
Sbjct: 311 MLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 3e-16
 Identities = 25/159 (15%), Positives = 45/159 (28%), Gaps = 29/159 (18%)

Query: 76  DVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE----------VDRGFERELEAMGDIKH 125
            ++G G    V+           VK    G T            D  F          + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 126 RNIVTLHGYYTSSQY----NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAAR 181
           R +  L G      Y    N ++ EL+                  +   +  ++      
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILE 114

Query: 182 GIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA 220
            +A  +H     I+H D+   N+L+       + DF  +
Sbjct: 115 EVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	351
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.84
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.44
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.53
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.23
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.07
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	80.08

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-59  Score=397.69  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .+|+..+.||+|+||+||+|.+.+++.||||+++... ...+++.+|++++++++||||++++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4678888999999999999999888899999997643 345679999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus        84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            9999999874   345688999999999999999999998   9999999999999999999999999999876555444


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG-KRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      ......||+.|+|||.+.+..++.++||||||+++|||+|+ .+||....      ..............         .
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~~~---------~  222 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRL---------Y  222 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTCCC---------C
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcCCC---------C
Confidence            44445689999999999999999999999999999999995 55554321      12222222221111         1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      .|..+++++.+++.+||+.||++|||++|++++|+++.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            234445789999999999999999999999999998864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=393.86  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=210.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999996 468899999997655555677999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      +||+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999999885     34689999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      . .....||+.|+|||++.+..++.++||||+||++|+|++|+.||......      .............       ..
T Consensus       172 ~-~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~-------~~  237 (293)
T d1yhwa1         172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-------LQ  237 (293)
T ss_dssp             C-BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-------CS
T ss_pred             c-ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC-------CC
Confidence            2 23456999999999999999999999999999999999999999653211      1122222211111       01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            244556889999999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=387.64  Aligned_cols=255  Identities=22%  Similarity=0.366  Sum_probs=216.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      +++|+..+.||+|+||+||+|.+++++.||||+++.... ..+++.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            357899999999999999999998888999999987543 3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++..   ....+++..+.+++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999999764   345688999999999999999999998   999999999999999999999999999987655544


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                      .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......      +..........         .
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i~~~~~---------~  220 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLR---------L  220 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCC---------C
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHHHhCCC---------C
Confidence            44444568999999999999999999999999999999998 89999754322      11222222111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                      ..|...++.+.+|+.+||+.||++|||++|++++|.++
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            23444557899999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=391.64  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|+..+.||+|+||+||+|..++  .||||+++..  .....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            578999999999999999998653  5999998654  33445678999999999999999999998765 567999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          85 CEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999642   35689999999999999999999998   99999999999999999999999999998665432


Q ss_pred             -ccccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          228 -THVSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       228 -~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                       ........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||......     . ...........    .
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-----~-~~~~~~~~~~~----~  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----D-QIIFMVGRGYL----S  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H-HHHHHHHHTSC----C
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----H-HHHHHHhcCCC----C
Confidence             223345679999999999864   45899999999999999999999999653211     1 11111111111    1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      +.....+.++++++.+|+.+||+.||++|||++|++++|+.++.
T Consensus       229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11112344455789999999999999999999999999998865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-58  Score=398.06  Aligned_cols=259  Identities=28%  Similarity=0.402  Sum_probs=215.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .+|+..+.||+|+||+||+|.+. +++.||||+++.+.. ..+++.+|+.++++++||||++++++|.+++..+++|||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            46888889999999999999986 477899999876543 3567999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        96 ~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          96 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            999999998653  346789999999999999999999998   999999999999999999999999999987765544


Q ss_pred             cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          229 HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                      .......|++.|+|||.+.++.|+.++|||||||++|||++|..|+....     ..............         ..
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~~~~~i~~~~~---------~~  236 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKDYR---------ME  236 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHTTCC---------CC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHHHHHHHhcCCC---------CC
Confidence            44444568999999999999999999999999999999999776653321     11111121111111         12


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      .|...++++.+|+.+||+.||++|||++|+++.|+.+.++
T Consensus       237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            3445567899999999999999999999999999987655

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=394.05  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||+||+|.+. +++.||+|++..... +..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46888999999999999999975 688999999976432 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +++|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999997    456799999999999999999999998   99999999999999999999999999998765432


Q ss_pred             -ccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          228 -THVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       228 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                       .......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.......     ............       
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~~~~~~~~~-------  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY-------  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHHHHHTTCTT-------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCC-------
Confidence             223345679999999999988776 578999999999999999999996542111     111111111100       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ...+...++++.+|+.+||+.||++|||++|++++
T Consensus       226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             01123445789999999999999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=389.33  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=207.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||+||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            36888899999999999999985 57889999986432   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999973    45689999999999999999999998   999999999999999999999999999976543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ............        
T Consensus       159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~--------  221 (263)
T d2j4za1         159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEF--------  221 (263)
T ss_dssp             CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC--------
T ss_pred             Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC--------
Confidence            32   2345699999999999999999999999999999999999999965422      122222222111        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ..|...++++.+|+.+||+.||++|||++|++++
T Consensus       222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence              1244456889999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-57  Score=393.05  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      ++|+..+.||+|+||+||+|.+++++.||||+++.... ..+.+.+|++++++++||||++++|++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            46788889999999999999999888999999976443 34679999999999999999999998865 55799999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++...  ....+++..++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus        91 ~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999988643  234589999999999999999999998   9999999999999999999999999999877655444


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      ......||+.|+|||.+.++.++.++|||||||++|||+||..|+....     ..............         ...
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~~~~~---------~~~  231 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERGYR---------MVR  231 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCC---------CCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCC---------CCC
Confidence            4445568999999999998999999999999999999999655543211     11112222221111         112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      |...++++.+|+.+||+.||++|||++|+++.|+++-
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            4455578999999999999999999999999998753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-58  Score=392.05  Aligned_cols=256  Identities=20%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec--CCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS--SQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  144 (351)
                      ++|+..+.||+|+||+||+|... +|+.||+|.+....  ....+.+.+|++++++++||||+++++++.+  ++..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            46888999999999999999975 67899999987653  2334568899999999999999999999864  4568999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC--IPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      |||+++|+|.+++.........+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998754434567999999999999999999999971  11499999999999999999999999999987


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      +.........      
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~~------  230 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGK------  230 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC------
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC------
Confidence            654332 233457999999999999999999999999999999999999999654221      1222222211      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ....|...++++.+|+.+||+.||.+|||++|++++
T Consensus       231 ---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 ---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence               112344556789999999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-57  Score=393.03  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-C---CEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND-S---TAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      .+|+..+.||+|+||+||+|.+.. +   ..||||.+.... ....+.+.+|+.++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            356677899999999999999753 2   258899886643 34456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++..   ....+++..+..++.||++||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999998874   245689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccccc----cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          225 AEKTHV----STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       225 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ......    .....+|+.|+|||.+.++.++.++|||||||++|||+| |..||......      ...........  
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~~~--  251 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQDYR--  251 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC--
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC--
Confidence            433221    112347899999999999999999999999999999998 89999654321      12222222111  


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                             ...|.++++.+.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus       252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                   12344556889999999999999999999999999988643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-57  Score=389.20  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=208.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      .|+..+.||+|+||+||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            5788899999999999999975 578899999987666666778999999999999999999999999999999999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++.+   ..+.+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|........ 
T Consensus        93 ~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          93 GGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            9999999763   245699999999999999999999999   999999999999999999999999999976543221 


Q ss_pred             ccccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          230 VSTIVAGTFGYLAPEYFD-----TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ......||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.......      ...........      
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~~------  233 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPP------  233 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCCC------
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCC------
Confidence            223456999999999983     4568999999999999999999999997543221      11222222111      


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ....+...++++.+|+.+||+.||++|||++|++++
T Consensus       234 -~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 -TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             112244556889999999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-57  Score=389.23  Aligned_cols=248  Identities=22%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||+||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46899999999999999999974 68899999986432   223356899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++||+|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999987    346799999999999999999999999   999999999999999999999999999987654


Q ss_pred             cc-ccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          226 EK-THVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       226 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ............       
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~-------  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLEY-------  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCC-------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCCC-------
Confidence            32 2233445799999999999999999999999999999999999999965321      112222222111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVK  340 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~  340 (351)
                         ..|...++++.+|+.+||+.||++|||++|+++
T Consensus       228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               124445678999999999999999999999644

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=395.55  Aligned_cols=271  Identities=22%  Similarity=0.353  Sum_probs=208.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .++|+..+.||+|+||+||+|... +++.||+|+++... ....+.+.+|+.+++.++||||++++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457889999999999999999975 57889999997653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      |++||+|.+++.+    ...+++..+..++.|++.||.|||+ +   +|+||||||+|||++++|.+||+|||+|+....
T Consensus        85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999973    4568999999999999999999997 5   899999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH-----HHHH------HHHh
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV-----TWVK------AVMQ  294 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~------~~~~  294 (351)
                      ..   .....||+.|+|||++.+..|+.++||||+||++|||++|+.||............     ....      ....
T Consensus       158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            22   23457999999999999999999999999999999999999999653221110000     0000      0000


Q ss_pred             cCcccee----------------ccccCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcccccc
Q 018702          295 DKREEYV----------------IDTSLEGCP-INEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIKSEK  349 (351)
Q Consensus       295 ~~~~~~~----------------~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~~~~  349 (351)
                      .......                ........+ ...+.++.+|+.+||+.||.+|||++|++++  +.+...++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence            0000000                000000011 1234679999999999999999999999984  55544443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=383.34  Aligned_cols=254  Identities=25%  Similarity=0.428  Sum_probs=207.1

Q ss_pred             CCCCCCc-ccccCceEEEEEEEC---CCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           71 KFSSKDV-IGSGGFGTVYRLTVN---DSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        71 ~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      +|...+. ||+|+||+||+|.+.   ++..||||+++... ....+.+.+|++++++++||||++++|++.++ ..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEE
Confidence            4555564 999999999999864   34579999997654 33456799999999999999999999998754 579999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        88 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          88 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999853   345789999999999999999999998   999999999999999999999999999987654


Q ss_pred             cccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          226 EKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       226 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      ....  ......||+.|+|||.+.++.++.++|||||||++|||+| |..||......      +..........     
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~~~i~~~~~-----  230 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGKR-----  230 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTTCC-----
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC-----
Confidence            4322  2233458999999999999999999999999999999998 99999754211      11122221111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                          ...|..+++++.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                1234556688999999999999999999999999887654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=381.00  Aligned_cols=248  Identities=24%  Similarity=0.413  Sum_probs=201.1

Q ss_pred             CcccccCceEEEEEEECC---CCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecCC
Q 018702           76 DVIGSGGFGTVYRLTVND---STAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMPN  150 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  150 (351)
                      +.||+|+||+||+|.+.+   ++.||||+++...  ....+.+.+|++++++++||||++++|+|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            469999999999998643   3579999996543  33446799999999999999999999999754 56899999999


Q ss_pred             CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccccc
Q 018702          151 GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTHV  230 (351)
Q Consensus       151 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  230 (351)
                      |+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+++.........
T Consensus        92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999997    346699999999999999999999998   99999999999999999999999999998765443222


Q ss_pred             --cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCC
Q 018702          231 --STIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLE  307 (351)
Q Consensus       231 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (351)
                        .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......      +.........+         .
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~~~~i~~~~~---------~  229 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGER---------M  229 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC---------C
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HHHHHHHcCCC---------C
Confidence              233468999999999999999999999999999999998 89999754211      11122222111         1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          308 GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       308 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ..|..+++++.+|+.+||+.||++|||++++++.|+..-
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            234555688999999999999999999999999887653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=381.61  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC-----CEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS-----TAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      ..|+..++||+|+||+||+|.++++     ..||||++..... .....+.+|++++++++||||++++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3567788999999999999987542     3699999976543 334578999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +|||+.++++.+++..   ....+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999998764   345789999999999999999999998   9999999999999999999999999999876


Q ss_pred             Cccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ......  ......||+.|+|||.+.++.++.++||||||+++|||++|..|+....     ...+.........+    
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~~~----  231 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKAINDGFR----  231 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCC----
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHHHHhccCC----
Confidence            443222  2223458999999999999999999999999999999999665543321     11122222222111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           ...|.+.+..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus       232 -----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                 12344455789999999999999999999999999987643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-56  Score=386.57  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=193.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||+||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            46888999999999999999975 5788999999765432 335678999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCceEEeeeccccccC
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD---QNMEARVSDFGLATLME  224 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~  224 (351)
                      ++||+|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+||+++   +++.+||+|||+++...
T Consensus        89 ~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999997    456799999999999999999999998   999999999999995   57899999999998654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      ....  .....||+.|+|||++.+..|+.++|||||||++|+|++|..||......      .............  .  
T Consensus       162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~~--~--  229 (307)
T d1a06a_         162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYEF--D--  229 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCCC--C--
T ss_pred             CCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCCC--C--
Confidence            3322  23456999999999999999999999999999999999999999653221      1122222211110  0  


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        ...+...++++.+|+.+||+.||++|||++|++++
T Consensus       230 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 --SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              11233455789999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=376.07  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=196.8

Q ss_pred             CCCCcccccCceEEEEEEEC-CCCEEEEEEecCC--ChhhHHHHHHHHHHhhcCCCCceeeeeeEEec----CCeeEEEE
Q 018702           73 SSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRG--TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS----SQYNLLIY  145 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  145 (351)
                      +..+.||+|+||+||+|.+. ++..||+|++...  .....+.+.+|++++++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45567999999999999975 5778999998654  23344578999999999999999999999864    34679999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCcEEEc-CCCceEEeeeccccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPH--IIHRDIKSSNILLD-QNMEARVSDFGLATL  222 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~  222 (351)
                      ||+++|+|.+++.+    ...+++..+..++.||++||+|||++   +  |+||||||+|||++ +++.+||+|||+++.
T Consensus        92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            99999999999973    45689999999999999999999998   7  99999999999997 478999999999975


Q ss_pred             cCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI  302 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (351)
                      .....   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....     ................   
T Consensus       165 ~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~~~~~~~---  232 (270)
T d1t4ha_         165 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVKPA---  232 (270)
T ss_dssp             CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCCCG---
T ss_pred             ccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHHcCCCCc---
Confidence            43322   234579999999999875 69999999999999999999999996432     1112222222211111   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 DTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                           ..+...++++.+++.+||++||++|||++|++++
T Consensus       233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                 1122234679999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=384.07  Aligned_cols=257  Identities=31%  Similarity=0.448  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELMP  149 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  149 (351)
                      ++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4788899999999999999999888889999997543 345679999999999999999999999865 56799999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|..++...  ..+.+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus        95 ~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          95 KGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            99999998643  234689999999999999999999998   9999999999999999999999999999876544444


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEGC  309 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (351)
                      ......||+.|+|||.+.++.++.++||||||+++|||++|..|+....     ...+..........         ...
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~~~---------~~~  235 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGYR---------MPC  235 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCC---------CCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCC---------CCC
Confidence            4444568999999999999999999999999999999999766653321     11222222222111         123


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          310 PINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       310 ~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      +..+++++.+++.+||+.||++|||+++|+++|+..-.
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            44556789999999999999999999999999987653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-55  Score=389.02  Aligned_cols=252  Identities=21%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999975 67889999998776666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ--NMEARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~~~~~~  226 (351)
                      +||+|.+++..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999863   245699999999999999999999999   9999999999999964  688999999999876543


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ..............   +   
T Consensus       180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~---~---  245 (350)
T d1koaa2         180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNM---D---  245 (350)
T ss_dssp             SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCS---C---
T ss_pred             cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---C---
Confidence            32  2345689999999999999999999999999999999999999965422      12222222211110   0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .......++++.+|+.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01123445789999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-55  Score=384.34  Aligned_cols=245  Identities=28%  Similarity=0.403  Sum_probs=202.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      .|+..+.||+|+||+||+|... +++.||||++.....   ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888899999999999999975 577899999876532   333568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      ||++|+|..++.    ..+.+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999987765    346799999999999999999999999   9999999999999999999999999999865432


Q ss_pred             cccccccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDT---GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                           ....||+.|+|||++.+   +.|+.++|||||||++|+|++|..||.....      ..............    
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~~~----  233 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESPA----  233 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC----
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC----
Confidence                 23469999999999853   5689999999999999999999999965321      11222222221111    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ..+...++.+.+|+.+||+.||++|||++|++++
T Consensus       234 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         234 ----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             ----CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                1122345789999999999999999999999873

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=388.55  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=206.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC------CEEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS------TAFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      ++|+..+.||+|+||+||+|.+.+.      ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            4688889999999999999986432      258999986543 23345788999999998 899999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 018702          142 LLIYELMPNGSLDTFLHGKSV-------------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSS  202 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~  202 (351)
                      ++||||+++|+|.+++.....                   ....+++..++.++.|+++||+|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            999999999999999975421                   124589999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhc
Q 018702          203 NILLDQNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLE  280 (351)
Q Consensus       203 Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~  280 (351)
                      |||++.++.+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999865544332 2334568999999999999999999999999999999998 89999653221


Q ss_pred             ccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 018702          281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLE  343 (351)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~  343 (351)
                            ..+.........        ...|...++++.+|+.+||+.||++|||++||+++|.
T Consensus       274 ------~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ------ANFYKLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ------HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHHHhcCCC--------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                  111222222111        1234455688999999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.9e-55  Score=386.54  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=211.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|+..+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46899999999999999999974 68899999998776666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD--QNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~--~~~~~kl~dfg~~~~~~~~  226 (351)
                      +||+|.+++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||++......
T Consensus       109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999988763   234689999999999999999999998   999999999999997  5789999999999876554


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ............   .   .
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~---~---~  248 (352)
T d1koba_         183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWE---F---D  248 (352)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCC---C---C
T ss_pred             Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---C---C
Confidence            32  23456899999999999999999999999999999999999999654221      122222221111   0   0


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11234455789999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=379.70  Aligned_cols=257  Identities=30%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----CCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND----STAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++|+..+.||+|+||.||+|.+..    +..||+|.++.... ...+.+.+|+.++++++||||++++|++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            468888999999999999998743    34689998865433 33467899999999999999999999986 4678999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++..   ....+++..++.++.|+++||.|||++   +++||||||+||++++++.+||+|||+++...
T Consensus        86 ~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          86 MELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999998764   345689999999999999999999999   99999999999999999999999999998765


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceecc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID  303 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (351)
                      ...........||+.|+|||.+.+..++.++|||||||++|||++ |.+||......   .+.   ........      
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~---~~i~~~~~------  227 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI---GRIENGER------  227 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH---HHHHTTCC------
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCCC------
Confidence            544444445568999999999999999999999999999999998 89998664322   111   11222111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          304 TSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       304 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                         ...|.+.++.+.+|+.+||+.||++|||++|+++.|+.+.++
T Consensus       228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               123445568899999999999999999999999999988655

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=377.65  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEec-CCeeEEEEEecC
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTS-SQYNLLIYELMP  149 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  149 (351)
                      +|+..+.||+|+||.||+|.++ |+.||||+++.+  ...+.+.+|++++++++||||++++|+|.+ .+..++||||++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            5677889999999999999985 678999999653  334678999999999999999999999865 466899999999


Q ss_pred             CCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccccc
Q 018702          150 NGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKTH  229 (351)
Q Consensus       150 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  229 (351)
                      +|+|.+++...  ....+++..++.++.||+.||+|||+.   +++||||||+||+++.++.+|++|||+++......  
T Consensus        85 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          85 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            99999999643  223589999999999999999999998   99999999999999999999999999998654322  


Q ss_pred             ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccceeccccCCC
Q 018702          230 VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSLEG  308 (351)
Q Consensus       230 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (351)
                        ....+|+.|+|||.+.++.+++++||||||+++|||+| |++||......   ++.   .......+         ..
T Consensus       158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~---~~i~~~~~---------~~  220 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PRVEKGYK---------MD  220 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH---HHHTTTCC---------CC
T ss_pred             --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHH---HHHHcCCC---------CC
Confidence              22357899999999999999999999999999999998 78887653222   222   22211111         12


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccccC
Q 018702          309 CPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEKV  350 (351)
Q Consensus       309 ~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~~  350 (351)
                      .|...++.+.+|+.+||+.||.+|||+.+++++|+.+++.+|
T Consensus       221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~~  262 (262)
T d1byga_         221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  262 (262)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCCC
Confidence            344455789999999999999999999999999999998765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=377.89  Aligned_cols=251  Identities=26%  Similarity=0.358  Sum_probs=206.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh------hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT------EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            47899999999999999999974 688999999865321      23467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----ceEEeeec
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM----EARVSDFG  218 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg  218 (351)
                      +||||+++|+|.+++..    .+.+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+|++|||
T Consensus        90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999973    45799999999999999999999999   999999999999998776    49999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ++........  .....||+.|+|||++.+..++.++||||+||++|+|++|+.||......      ............
T Consensus       163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~  234 (293)
T d1jksa_         163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE  234 (293)
T ss_dssp             TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCCC
T ss_pred             hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcCCC
Confidence            9987644322  23456899999999999999999999999999999999999999754221      122222221110


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .  ..    ..+...+..+.+|+.+||+.||++|||++|++++
T Consensus       235 ~--~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         235 F--ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             C--CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C--Cc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  00    0112344779999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=381.62  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=208.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            36888999999999999999974 68899999997532   223456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++||+|.+++.    ....+++..++.++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999997    345789999999999999999999999   999999999999999999999999999986543


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ... .....+||+.|+|||++.+..|+.++||||+||++|||++|++||......      ..........         
T Consensus       158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~---------  221 (337)
T d1o6la_         158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE---------  221 (337)
T ss_dssp             TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC---------
T ss_pred             CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCC---------
Confidence            322 234467999999999999999999999999999999999999999764321      1222222211         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                       ...|...++++.+|+.+||++||.+||+     ++|++++
T Consensus       222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence             1234556688999999999999999995     8888874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-54  Score=375.93  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=207.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||+||+|... +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            36888899999999999999974 58899999986532   223457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||++||+|..++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999999987    456678889999999999999999999   999999999999999999999999999987644


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..    ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.....      ............        
T Consensus       157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~--------  218 (316)
T d1fota_         157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL--------  218 (316)
T ss_dssp             CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC--------
T ss_pred             cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCC--------
Confidence            32    345799999999999999999999999999999999999999965322      222222222211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                        ..|...++++.+++.+||+.||.+||     |+++++++
T Consensus       219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              12444557899999999999999996     89999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.9e-54  Score=370.31  Aligned_cols=259  Identities=23%  Similarity=0.332  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC----ee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ----YN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  141 (351)
                      ++|++.+.||+|+||+||+|.+. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999974 68889999997643   233457899999999999999999999987644    37


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      |+||||++|++|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++..+++|||.+.
T Consensus        87 ~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            89999999999999987    345789999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccc--cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          222 LMEAEKT--HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       222 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......  .......||+.|+|||++.+..+++++|||||||++|+|++|+.||.....      ..............
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence            5543222  223445799999999999999999999999999999999999999965321      12222222222111


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRP-TMTEVVKMLELIKS  347 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~e~l~~L~~~~~  347 (351)
                        ..    ..+...++++.+++.+||+.||++|| |++++++.|..+++
T Consensus       234 --~~----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         234 --PS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             --GG----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             --Cc----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence              00    11223447899999999999999999 89999999987764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-53  Score=373.35  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=210.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCChh-hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTTE-VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||+||+|...      +++.||||++...... ..+++.+|+.++++++||||++++++|...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            46889999999999999999864      3467999999765433 3467999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCC--------------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 018702          143 LIYELMPNGSLDTFLHGKS--------------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSS  202 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~  202 (351)
                      ++|||+++|+|.+++....                    .....+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEccc
Confidence            9999999999999986322                    1234588999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCcchhc
Q 018702          203 NILLDQNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK-RPMDEAFLE  280 (351)
Q Consensus       203 Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~  280 (351)
                      |||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++|. +||......
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            99999999999999999986544332 2233456899999999999999999999999999999999985 677553221


Q ss_pred             ccccHHHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          281 EGTKLVTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                            +....+....         ....|...++++.+|+.+||+.||++|||+.||+++|+++.
T Consensus       250 ------e~~~~v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         250 ------EVIYYVRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             ------HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ------HHHHHHHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                  1222222211         11234455678999999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=376.64  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCC----EEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DST----AFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  143 (351)
                      .+|+..+.||+|+||+||+|.+. +|+    +||+|+++.. .....+.+.+|++++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            36888999999999999999874 333    5899988654 334456799999999999999999999999875 4578


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLM  223 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  223 (351)
                      +++++.+|+|.+++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            8899999999998764   356789999999999999999999998   9999999999999999999999999999876


Q ss_pred             Cccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          224 EAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       224 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ...... ......||+.|+|||.+.++.++.++||||||+++|||+| |.+||......   .+....   .....    
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i---~~~~~----  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL---EKGER----  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHH---HHTCC----
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH---HcCCC----
Confidence            544332 2233458999999999999999999999999999999998 78888654322   121111   11111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                           ...|..+++++.+|+.+||+.||.+|||+.|++++|+.+..
T Consensus       232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                 12344556889999999999999999999999999987653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=369.68  Aligned_cols=255  Identities=27%  Similarity=0.411  Sum_probs=198.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC--C--CEEEEEEecCC---ChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND--S--TAFAVKRLHRG---TTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||.||+|....  +  ..||||++...   .....+.+.+|++++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            468888999999999999998642  2  36899988654   23344678999999999999999999999976 4678


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||+++|++.+++..   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            99999999999988764   235689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccc--ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          223 MEAEKTH--VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       223 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......      ............ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~-  233 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER-  233 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC-
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCC-
Confidence            6544322  2233457889999999999999999999999999999998 89999654222      222233222111 


Q ss_pred             eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 018702          300 YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELI  345 (351)
Q Consensus       300 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~  345 (351)
                             ...+...+..+.+|+.+||+.||++|||++|+++.|.+.
T Consensus       234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   112344557899999999999999999999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.5e-53  Score=364.69  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCChh---------hHHHHHHHHHHhhcCC-CCceeeeeeEEecC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTE---------VDRGFERELEAMGDIK-HRNIVTLHGYYTSS  138 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  138 (351)
                      ++|+..+.||+|+||+||+|.. .+++.||||++......         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788999999999999999997 46789999998764321         2245789999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      +..|+||||+++|+|.+++.    ....+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999997    345799999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHH
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFD------TGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAV  292 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  292 (351)
                      +++.......  .....||+.|+|||.+.      ...++.++||||+||++|+|++|+.||......      ......
T Consensus       156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i  227 (277)
T d1phka_         156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMI  227 (277)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred             heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHH
Confidence            9987654322  23356999999999884      345788999999999999999999999754321      111222


Q ss_pred             HhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          293 MQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ...... . .    .....+.++++.+|+.+||+.||++|||++|++++
T Consensus       228 ~~~~~~-~-~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQ-F-G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCC-C-C----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCC-C-C----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            222111 0 0    11233556889999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=370.13  Aligned_cols=254  Identities=29%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             CCcccccCceEEEEEEECCC----CEEEEEEecCC-ChhhHHHHHHHHHHhhcCCCCceeeeeeEEec-CCeeEEEEEec
Q 018702           75 KDVIGSGGFGTVYRLTVNDS----TAFAVKRLHRG-TTEVDRGFERELEAMGDIKHRNIVTLHGYYTS-SQYNLLIYELM  148 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  148 (351)
                      .++||+|+||+||+|.+.++    ..||||+++.. .....+++.+|++++++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999997542    25899999753 34445779999999999999999999999765 56889999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      ++|+|.+++..   .....++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999874   345577888999999999999999998   999999999999999999999999999987654322


Q ss_pred             c---ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          229 H---VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       229 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      .   ......||+.|+|||.+.++.++.++||||||+++|||++|..||......     .+.........+.       
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~g~~~-------  253 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQGRRL-------  253 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCC-------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCC-------
Confidence            2   222346899999999999999999999999999999999988777543211     1112222222211       


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                        ..|..+++.+.+|+.+||+.||++|||+.|++++|+++.++
T Consensus       254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence              12344557899999999999999999999999999998765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=373.61  Aligned_cols=259  Identities=28%  Similarity=0.454  Sum_probs=207.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCC-C--EEEEEEecCCC-hhhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDS-T--AFAVKRLHRGT-TEVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++|+..+.||+|+||+||+|.++++ .  .||||++.... .+..+.+.+|++++.++ +||||++++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            4677889999999999999997543 3  47888876543 33445799999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCce
Q 018702          145 YELMPNGSLDTFLHGKS------------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEA  212 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~  212 (351)
                      |||+++|+|.+++....            .....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999997531            2346789999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCcchhcccccHHHHHHH
Q 018702          213 RVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK-RPMDEAFLEEGTKLVTWVKA  291 (351)
Q Consensus       213 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~  291 (351)
                      ||+|||+++........  ....||..|+|||.+.++.++.++||||||+++|||++|. +||....      .......
T Consensus       167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK  238 (309)
T ss_dssp             EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH
T ss_pred             EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHH
Confidence            99999999755433222  2345899999999999999999999999999999999965 5664432      1122222


Q ss_pred             HHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          292 VMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                      +.....         ...|...++++.+|+.+||+.||++|||++|++++|+.+.++
T Consensus       239 i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         239 LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             GGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            222111         123445568899999999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-53  Score=375.87  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=207.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  145 (351)
                      ++|+..+.||+|+||.||+|.+. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46889999999999999999975 68899999986432   223356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEA  225 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  225 (351)
                      ||+.+|+|.+++..    .+.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus       121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999873    45689999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecccc
Q 018702          226 EKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTS  305 (351)
Q Consensus       226 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (351)
                      ..    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....      .............        
T Consensus       194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~--------  255 (350)
T d1rdqe_         194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV--------  255 (350)
T ss_dssp             CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC--------
T ss_pred             cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCC--------
Confidence            32    23569999999999999999999999999999999999999996532      1222222222211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 018702          306 LEGCPINEINDVFSIASMCLEPEPSKRP-----TMTEVVKM  341 (351)
Q Consensus       306 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e~l~~  341 (351)
                        ..|...++++.+++.+||+.||.+|+     |++|++++
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              12444567899999999999999994     89999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-53  Score=370.25  Aligned_cols=251  Identities=19%  Similarity=0.290  Sum_probs=206.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      ++|++.+.||+|+||+||+|.+. +++.||+|.++....+ ...+.+|+++|+.++||||+++++++.+++..|+|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            47899999999999999999985 5778999999765433 456889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CceEEeeeccccccCcc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQN--MEARVSDFGLATLMEAE  226 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~--~~~kl~dfg~~~~~~~~  226 (351)
                      +||+|.+++...   ...+++..+..++.||++||+|||+.   +|+||||||+|||++.+  ..+||+|||++......
T Consensus        84 ~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999642   34689999999999999999999998   99999999999999854  58999999999865443


Q ss_pred             cccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccccC
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDTSL  306 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (351)
                      ..  .....+|+.|+|||...+..++.++||||+||++|+|++|..||......      .............  ...  
T Consensus       158 ~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~--~~~--  225 (321)
T d1tkia_         158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF--DEE--  225 (321)
T ss_dssp             CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC--CHH--
T ss_pred             Cc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC--Chh--
Confidence            22  23456899999999999999999999999999999999999999654321      2222222211110  000  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          307 EGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       307 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                        .+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       226 --~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 --AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              011234779999999999999999999999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-52  Score=375.37  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh---hhHHHH---HHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT---EVDRGF---ERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....   .....+   ..++.+++.++||||+++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            46888999999999999999975 588999999864221   112223   34577888889999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                      +||||++||+|.+++..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.
T Consensus        84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999973    45688999999999999999999999   999999999999999999999999999986


Q ss_pred             cCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV  301 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (351)
                      ......   ....||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.......   ... ........     
T Consensus       157 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~-~~~~~~~~-----  224 (364)
T d1omwa3         157 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHE-IDRMTLTM-----  224 (364)
T ss_dssp             CSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHH-HHHHSSSC-----
T ss_pred             cCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHH-HHHhcccC-----
Confidence            654332   33569999999999864 568999999999999999999999997643221   111 11111110     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          302 IDTSLEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       302 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                          ....|...++++.+|+.+||+.||.+|||     ++|++++
T Consensus       225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                11234445688999999999999999999     6888764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=369.14  Aligned_cols=260  Identities=27%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------CCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecC-Ce
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND------STAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSS-QY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  140 (351)
                      ++|+..+.||+|+||.||+|.+..      ++.||+|+++.... ...+.+.+|...+.++ +|+||+.+++++.++ +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            478889999999999999998642      35799999875433 3345677888887777 689999999997654 46


Q ss_pred             eEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 018702          141 NLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ  208 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~  208 (351)
                      .+++|||+++|+|.+++.....            ....+++..+..++.||++||+|||++   +|+||||||+|||+++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            8999999999999999964321            234588999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCcchhcccccHH
Q 018702          209 NMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTG-KRPMDEAFLEEGTKLV  286 (351)
Q Consensus       209 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g-~~p~~~~~~~~~~~~~  286 (351)
                      ++.+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||++| .+||......      
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~------  243 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------  243 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH------
Confidence            999999999999865443322 23345699999999999999999999999999999999986 5677543211      


Q ss_pred             HHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          287 TWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      ..+.........        ...|...++++.+++.+||+.||++|||++|++++|+++.
T Consensus       244 ~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 EEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111122211111        1234445578999999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-53  Score=367.15  Aligned_cols=260  Identities=29%  Similarity=0.414  Sum_probs=207.5

Q ss_pred             cCCCCCCcccccCceEEEEEEECC--------CCEEEEEEecCCChh-hHHHHHHHHHHhhcC-CCCceeeeeeEEecCC
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVND--------STAFAVKRLHRGTTE-VDRGFERELEAMGDI-KHRNIVTLHGYYTSSQ  139 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (351)
                      ++|...+.||+|+||.||+|...+        +..||||+++.+... ...++.+|...+.++ +||||++++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            468888999999999999998532        246999999775543 346788898888888 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSV------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      ..++||||+++|+|.+++.....            ..+.+++..++.++.|++.||+|||+.   +++||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence            99999999999999999975421            235689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      .++.+||+|||+++........ ......+|+.|+|||.+.++.|+.++||||||+++|||++ |.+||......     
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-----  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence            9999999999999876544322 2344568999999999999999999999999999999998 78888653221     


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                       ... ........        ...|...++++.+|+.+||+.||++|||+.|+++.|+++-+
T Consensus       245 -~~~-~~i~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 -ELF-KLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -HHH-HHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHH-HHHHcCCC--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence             111 22221111        12344556789999999999999999999999999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=371.26  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC---hhhHHHHHHHHHHhh-cCCCCceeeeeeEEecCCeeEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT---TEVDRGFERELEAMG-DIKHRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  144 (351)
                      ++|...+.||+|+||+||+|... +++.||+|+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888899999999999999985 57889999996532   122344566666654 68999999999999999999999


Q ss_pred             EEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccC
Q 018702          145 YELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLME  224 (351)
Q Consensus       145 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  224 (351)
                      |||+++|+|.+++.    ....+++..+..++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999997    345689999999999999999999999   99999999999999999999999999998654


Q ss_pred             cccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceeccc
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVIDT  304 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (351)
                      .... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......      .......... .      
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~-~------  220 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDN-P------  220 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C------
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-C------
Confidence            3322 233456999999999999999999999999999999999999999754321      1222222111 1      


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 018702          305 SLEGCPINEINDVFSIASMCLEPEPSKRPTMT-EVVK  340 (351)
Q Consensus       305 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-e~l~  340 (351)
                         ..|...++++.+|+.+||+.||++|||+. |+++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               12444567899999999999999999995 6764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-53  Score=367.68  Aligned_cols=269  Identities=23%  Similarity=0.291  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC----eeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ----YNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  145 (351)
                      ++|...+.||+|+||.||+|.++ |+.||||+++.... .......|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            35667788999999999999974 77899999865322 2222344566667789999999999987654    578999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHD-----CIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      ||+++|+|.+++++     ..+++..++.++.|++.||+|||+.     ..++|+||||||+|||+++++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999999999963     3589999999999999999999973     1249999999999999999999999999999


Q ss_pred             cccCccccc---ccccccccccccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCcchhccc--------c
Q 018702          221 TLMEAEKTH---VSTIVAGTFGYLAPEYFDTGR------ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEG--------T  283 (351)
Q Consensus       221 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~  283 (351)
                      +........   ......||+.|+|||++.+..      ++.++|||||||++|||++|..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            866443221   233457999999999987643      56789999999999999999988754221111        1


Q ss_pred             cHHHHHHHHHhcCccceeccccCC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccccc
Q 018702          284 KLVTWVKAVMQDKREEYVIDTSLE--GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSEK  349 (351)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~~  349 (351)
                      ...............    ++...  ..+......+.+|+.+||+.||++|||+.|+++.|+++..++
T Consensus       236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            111222222211111    11111  112334567999999999999999999999999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=368.39  Aligned_cols=262  Identities=28%  Similarity=0.425  Sum_probs=212.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcC-CCCceeeeeeEEecCCee
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDI-KHRNIVTLHGYYTSSQYN  141 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (351)
                      ++|+..+.||+|+||.||+|.+.      +++.||||+++.... .....+.+|+.++.++ +||||+++++++.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57888999999999999999862      346799999976543 3445788999999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHhhcCCCC--------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 018702          142 LLIYELMPNGSLDTFLHGKSV--------------NKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLD  207 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~  207 (351)
                      +++|||+++|+|.+++.....              ....+++..+..++.||++||+|||++   +++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            999999999999999874321              234689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccccccCcccc-cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCcchhcccccH
Q 018702          208 QNMEARVSDFGLATLMEAEKT-HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLT-GKRPMDEAFLEEGTKL  285 (351)
Q Consensus       208 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~  285 (351)
                      .++.+|++|||.++....... .......||+.|+|||.+.++.++.++||||||+++|||++ |.+||......     
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-----  254 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----  254 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999987654332 23344578999999999999999999999999999999999 55555432211     


Q ss_pred             HHHHHHHHhcCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccccc
Q 018702          286 VTWVKAVMQDKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKSE  348 (351)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~~  348 (351)
                       ..+.........        ...+...++.+.+|+.+||+.||.+|||++|++++|+++.+|
T Consensus       255 -~~~~~~i~~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         255 -SKFYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             -HHHHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCC--------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence             112222222111        112344557899999999999999999999999999987655

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=364.99  Aligned_cols=256  Identities=26%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             CCcccccCceEEEEEEEC-CCCEEEEEEecCCChh-----hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEec
Q 018702           75 KDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTE-----VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYELM  148 (351)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  148 (351)
                      .++||+|+||+||+|.+. +++.||||+++.....     ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            467999999999999974 5889999998654322     1245889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcccc
Q 018702          149 PNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEKT  228 (351)
Q Consensus       149 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  228 (351)
                      .++++..+..    ....+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9887776664    456788999999999999999999999   999999999999999999999999999986554332


Q ss_pred             cccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceecc----
Q 018702          229 HVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVID----  303 (351)
Q Consensus       229 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  303 (351)
                      . .....||+.|+|||++.+ ..|+.++||||+||++|||++|.+||......+   ......+...........+    
T Consensus       156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence            2 233568999999998865 467999999999999999999999996543221   1111111111111100000    


Q ss_pred             ------ccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          304 ------TSLEGCP-----INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       304 ------~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                            ......+     ...++++.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                  0000111     2345789999999999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=370.31  Aligned_cols=251  Identities=24%  Similarity=0.300  Sum_probs=197.8

Q ss_pred             cCCCCC-CcccccCceEEEEEEE-CCCCEEEEEEecCCChhhHHHHHHHHHHhhc-CCCCceeeeeeEEec----CCeeE
Q 018702           70 LKFSSK-DVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTTEVDRGFERELEAMGD-IKHRNIVTLHGYYTS----SQYNL  142 (351)
Q Consensus        70 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~  142 (351)
                      ++|.+. +.||+|+||+||+|.+ .+++.||||+++.     ...+.+|+.++.+ .+||||++++++|.+    .+..|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            467765 4699999999999997 4688999999864     2346789988655 589999999999865    46789


Q ss_pred             EEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeecc
Q 018702          143 LIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGL  219 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~  219 (351)
                      +|||||+||+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||+++   ++.+||+|||+
T Consensus        86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence            999999999999999743  235799999999999999999999998   9999999999999985   56799999999


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREE  299 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (351)
                      ++.......  .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||........   .....   ......
T Consensus       161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~---~~i~~~  232 (335)
T d2ozaa1         161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMK---TRIRMG  232 (335)
T ss_dssp             CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCCSC
T ss_pred             eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHH---HHHhcC
Confidence            987654332  2345699999999999999999999999999999999999999965432111   00000   000000


Q ss_pred             eeccccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          300 YVIDTSLE-GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       300 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                         ..... ......++++.+|+.+||+.||++|||+.|++++
T Consensus       233 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         233 ---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ---SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               00000 1123456789999999999999999999999884

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=363.81  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=212.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------CCCEEEEEEecCCCh-hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN------DSTAFAVKRLHRGTT-EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNL  142 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (351)
                      ++|+..+.||+|+||+||+|.++      +++.||||+++.... .....+.+|+.++++++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            57888899999999999999863      246799999976433 33356899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhcCCC------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          143 LIYELMPNGSLDTFLHGKS------VNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       143 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                      +||||+++|+|.+++....      .....+++..+..++.|+++||.|||++   +|+||||||+|||+++++.+||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence            9999999999999986321      1234578899999999999999999998   999999999999999999999999


Q ss_pred             eccccccCccccc-ccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCcchhcccccHHHHHHHHHh
Q 018702          217 FGLATLMEAEKTH-VSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGK-RPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       217 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ||+++........ ......+|+.|+|||.+.++.++.++||||||+++|||++|. +||...      ...+.......
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~  250 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVME  250 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHT
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHh
Confidence            9999866544332 233345899999999999999999999999999999999984 676443      22223333322


Q ss_pred             cCccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccc
Q 018702          295 DKREEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIKS  347 (351)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~~  347 (351)
                      ..         ....|...++.+.+++.+||+.||++|||+++++++|++..+
T Consensus       251 ~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         251 GG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            22         112344556789999999999999999999999999987654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=362.77  Aligned_cols=266  Identities=21%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCCh--hhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGTT--EVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|+..+.||+|+||+||+|.+ .+++.||+|+++....  ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4788899999999999999997 4688999999965432  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      |+.++ +.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99764 44444322  356799999999999999999999998   9999999999999999999999999999866443


Q ss_pred             cccccccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcccee----
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYV----  301 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  301 (351)
                      .. ......||+.|+|||.+.... ++.++|+||+||++|+|++|+.||......+  .+....... ........    
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~-~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTL-GTPDEVVWPGVT  231 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH-CCCCTTTSTTGG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhc-CCCchhhccccc
Confidence            32 233446899999999876655 5789999999999999999999996542211  111111111 00000000    


Q ss_pred             -ccc------cCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 018702          302 -IDT------SLEG-----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELI  345 (351)
Q Consensus       302 -~~~------~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~  345 (351)
                       .+.      ....     .....++++.+|+.+||+.||++|||++|++++  ++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             000      0000     012334778999999999999999999999986  5554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.7e-52  Score=361.68  Aligned_cols=261  Identities=22%  Similarity=0.345  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChh--hHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTE--VDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|+..+.||+|+||+||+|.+++++.||||++......  ..+.+.+|+.++++++||||+++++++.+++..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            478889999999999999999999999999999765332  246789999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAEK  227 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  227 (351)
                      +.++.+..+..    ..+.+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.+.......
T Consensus        82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            98877766665    456799999999999999999999998   99999999999999999999999999998654432


Q ss_pred             ccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccceec----
Q 018702          228 THVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEYVI----  302 (351)
Q Consensus       228 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  302 (351)
                      .. .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.  +..... ...........    
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFR-ILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH-HHCCCCTTTSTTGGG
T ss_pred             cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHH-hhCCCChhhccchhh
Confidence            22 233458999999998865 4568999999999999999999999975432111  111111 11110000000    


Q ss_pred             ----cc--------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          303 ----DT--------SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       303 ----~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                          ..        .........++++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00        0001223345789999999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=360.44  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCCh------hhHHHHHHHHHHhhcCC--CCceeeeeeEEecCCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTT------EVDRGFERELEAMGDIK--HRNIVTLHGYYTSSQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~  140 (351)
                      .+|++.+.||+|+||+||+|... +++.||||++.....      ....++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999975 688999999864321      11234668999999986  8999999999999999


Q ss_pred             eEEEEEecCC-CCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCceEEeeec
Q 018702          141 NLLIYELMPN-GSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-NMEARVSDFG  218 (351)
Q Consensus       141 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg  218 (351)
                      .++||||+.+ +++.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||++. ++.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 67888876    345689999999999999999999998   9999999999999985 5799999999


Q ss_pred             cccccCcccccccccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc
Q 018702          219 LATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRA-TAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR  297 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  297 (351)
                      +++......   .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||....            .......
T Consensus       157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~  221 (273)
T d1xwsa_         157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV  221 (273)
T ss_dssp             TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC
T ss_pred             cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc
Confidence            998654332   234569999999999987665 567999999999999999999996531            1111110


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                ..+...++++.+|+.+||+.||++|||++|++++
T Consensus       222 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                      1233345789999999999999999999999884

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=362.22  Aligned_cols=268  Identities=20%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-C-CCEEEEEEecCCCh--hhHHHHHHHHHHhhcC---CCCceeeeeeEEec----
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-D-STAFAVKRLHRGTT--EVDRGFERELEAMGDI---KHRNIVTLHGYYTS----  137 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  137 (351)
                      .++|+..+.||+|+||+||+|.+. + ++.||||+++....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 55689999864322  1223455677766655   79999999999853    


Q ss_pred             -CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 018702          138 -SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSD  216 (351)
Q Consensus       138 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~d  216 (351)
                       ....+++|||++++++......   ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             3467999999988776554432   456789999999999999999999998   999999999999999999999999


Q ss_pred             eccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          217 FGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       217 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      ||++.......  ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.  +...........
T Consensus       160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~  235 (305)
T d1blxa_         160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPG  235 (305)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred             hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCc
Confidence            99987654332  23445799999999999999999999999999999999999999975432211  111111110000


Q ss_pred             cccee-------------ccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 018702          297 REEYV-------------IDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIK  346 (351)
Q Consensus       297 ~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~  346 (351)
                      .....             ........+...++.+.+|+.+||+.||++|||++|++++  +++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            00000             0000111233455789999999999999999999999885  55543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=349.38  Aligned_cols=262  Identities=18%  Similarity=0.249  Sum_probs=196.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec--------C
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS--------S  138 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  138 (351)
                      .+|+..+.||+|+||+||+|.+. +++.||||++....  ......+.+|+.++++++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            57899999999999999999974 68899999986542  2234568899999999999999999999755        3


Q ss_pred             CeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeec
Q 018702          139 QYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFG  218 (351)
Q Consensus       139 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  218 (351)
                      +..+++|||+.++++..+..    ....++...+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            46799999998877766554    456788999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCccccc---ccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHh
Q 018702          219 LATLMEAEKTH---VSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQ  294 (351)
Q Consensus       219 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  294 (351)
                      ++.........   ......||+.|+|||.+.+. .+++++||||+||++|+|++|+.||........   .........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~  239 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCG  239 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcC
Confidence            99766533221   22334689999999998754 689999999999999999999999975432211   111111111


Q ss_pred             cCccceecc-----------c-cCCCCC-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 DKREEYVID-----------T-SLEGCP-------INEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 ~~~~~~~~~-----------~-~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .........           . .....+       ...++.+.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            111100000           0 000000       1113567899999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=354.56  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=198.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC------
Q 018702           69 TLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ------  139 (351)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  139 (351)
                      .++|+..+.||+|+||+||+|.+. +++.||||+++...  ....+.+.+|+.+|+.++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            358999999999999999999975 58899999997542  233467889999999999999999999997655      


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..++||||+ +.+|..+..     ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            569999999 668888774     35699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCc-
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKR-  297 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  297 (351)
                      ++......    ....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.........  .. ......... 
T Consensus       168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--KE-IMKVTGTPPA  240 (346)
T ss_dssp             CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCH
T ss_pred             eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH--HH-HHhccCCCcH
Confidence            98664432    23468999999998865 46789999999999999999999999764321110  00 000000000 


Q ss_pred             -----------------cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 018702          298 -----------------EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIK  346 (351)
Q Consensus       298 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~  346 (351)
                                       ................++++.+|+.+||+.||++|||++|+|++  ++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             00000011112233445788999999999999999999999986  55543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=354.46  Aligned_cols=263  Identities=20%  Similarity=0.314  Sum_probs=197.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEE-CCCCEEEEEEecCCC-hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCC----ee
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTV-NDSTAFAVKRLHRGT-TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQ----YN  141 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  141 (351)
                      .+.+|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            345799999999999999999987 478899999997543 334467899999999999999999999987653    23


Q ss_pred             EEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          142 LLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       142 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      +++++++.+|+|.+++..     ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            555666779999999963     4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCccccc--ccccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          222 LMEAEKTH--VSTIVAGTFGYLAPEYF-DTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       222 ~~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      ........  ......||+.|+|||.+ .+..++.++||||+||++|+|++|+.||......+...   ...........
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~---~~~~~~~~~~~  234 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQ  234 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH---HHhhhccCCCh
Confidence            66543222  23445689999999988 44567899999999999999999999997643221110   00000000000


Q ss_pred             ce-------------eccccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 EY-------------VIDTSLEG-----CPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~~-------------~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      ..             ...+....     .....+.++.+|+.+||+.||.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00             00000000     112234678999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=353.96  Aligned_cols=267  Identities=25%  Similarity=0.300  Sum_probs=197.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEEecC------CeeEE
Q 018702           71 KFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYYTSS------QYNLL  143 (351)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  143 (351)
                      +|+..++||+|+||+||+|.+. +++.||||++......    ..+|++++++++||||++++++|...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6788889999999999999985 5889999999765332    34799999999999999999998542      35789


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccc
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATL  222 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~  222 (351)
                      ||||++++.+ ..+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999976543 33322222456799999999999999999999998   999999999999999765 899999999986


Q ss_pred             cCcccccccccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc---------HHHHHHHH
Q 018702          223 MEAEKTHVSTIVAGTFGYLAPEYFDT-GRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK---------LVTWVKAV  292 (351)
Q Consensus       223 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------~~~~~~~~  292 (351)
                      .......  ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+...         ........
T Consensus       173 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         173 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            6543322  33468999999998764 578999999999999999999999997543221100         00011111


Q ss_pred             HhcCccceecc---c-cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcccc
Q 018702          293 MQDKREEYVID---T-SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM--LELIKS  347 (351)
Q Consensus       293 ~~~~~~~~~~~---~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~--L~~~~~  347 (351)
                      ...........   . .........++++.+|+.+||+.||++|||+.|++++  +++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            10000000000   0 0001123345789999999999999999999999975  555544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=350.90  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----CCCEEEEEEecCCC----hhhHHHHHHHHHHhhcCCC-CceeeeeeEEecCCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN----DSTAFAVKRLHRGT----TEVDRGFERELEAMGDIKH-RNIVTLHGYYTSSQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  140 (351)
                      ++|+..+.||+|+||+||+|...    +|+.||+|+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            46889999999999999999852    47889999986532    2234567899999999976 899999999999999


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .+++|||+.+|+|.+++..    .+.+++.....++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999973    45678889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccccccccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTG--RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +..............|++.|++||.+.+.  .++.++|||||||++|+|++|+.||.......  .............  
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~~--  252 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--  252 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC--
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccCC--
Confidence            87665555545556799999999998654  46889999999999999999999997653322  2222222222111  


Q ss_pred             ceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 018702          299 EYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPT-----MTEVVKM  341 (351)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~e~l~~  341 (351)
                              ...|...++++.+|+.+||++||.+|||     ++|++++
T Consensus       253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                    1134455688999999999999999994     7888874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=338.69  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecCCeeEEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      ++|+..+.||+|+||+||+|.+. +++.||||+++...  ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47888999999999999999974 67889999986543  2345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccccCcc
Q 018702          147 LMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATLMEAE  226 (351)
Q Consensus       147 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  226 (351)
                      ++.+++|..++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.++.....
T Consensus        82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999999988876    456788999999999999999999998   9999999999999999999999999999876543


Q ss_pred             cccccccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCccce-----
Q 018702          227 KTHVSTIVAGTFGYLAPEYFDTGR-ATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKREEY-----  300 (351)
Q Consensus       227 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  300 (351)
                      ... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||......  ..................     
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence            322 22334788899999887654 689999999999999999999997432111  111111111111110000     


Q ss_pred             -----------eccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          301 -----------VIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       301 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                                 .........+...++.+.+|+.+||+.||.+|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       00011112334456789999999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-48  Score=341.28  Aligned_cols=259  Identities=20%  Similarity=0.237  Sum_probs=198.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCc-eeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRN-IVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  147 (351)
                      ++|++.+.||+|+||.||+|.+. +++.||||++.....  ..++..|+++++.++|+| |+.+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999974 578899998876432  235788999999998766 55555666778888999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCceEEeeeccccccC
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ---NMEARVSDFGLATLME  224 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~~  224 (351)
                      + +++|...+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..++++|||+++...
T Consensus        85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9 5566666543   346789999999999999999999999   9999999999999864   4579999999998765


Q ss_pred             cccc------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHH-HHHHHHHhcCc
Q 018702          225 AEKT------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLV-TWVKAVMQDKR  297 (351)
Q Consensus       225 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  297 (351)
                      ....      .......||+.|+|||.+.+..++.++|||||||++|||++|..||............ ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            4322      1233457999999999999999999999999999999999999999765333222211 11111111110


Q ss_pred             cceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          298 EEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .         ..+.+.++++.+++.+||+.||++||+++++.+.|+.+.
T Consensus       238 ~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         238 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             H---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             h---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            0         011233477999999999999999999999988887653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.8e-48  Score=335.65  Aligned_cols=260  Identities=16%  Similarity=0.212  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCCC-CceeeeeeEEecCCeeEEEEEe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIKH-RNIVTLHGYYTSSQYNLLIYEL  147 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~  147 (351)
                      .+|++.+.||+|+||+||+|.+. +++.||+|++.....  ...+.+|++.+..++| +|++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57899999999999999999975 578899998865432  2346788889988875 8999999999999999999999


Q ss_pred             cCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCceEEeeeccccc
Q 018702          148 MPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQ-----NMEARVSDFGLATL  222 (351)
Q Consensus       148 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~dfg~~~~  222 (351)
                      + +++|.+++...   ...++...+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+++.
T Consensus        83 ~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          83 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             c-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9 78999988642   45689999999999999999999999   9999999999999964     57899999999987


Q ss_pred             cCcccc------cccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcC
Q 018702          223 MEAEKT------HVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDK  296 (351)
Q Consensus       223 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  296 (351)
                      ......      .......||+.|+|||.+.+..++.++||||||+++|||++|..||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            643321      12334579999999999999999999999999999999999999997543222111111111111100


Q ss_pred             ccceeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 018702          297 REEYVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKMLELIK  346 (351)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~L~~~~  346 (351)
                      .    ...    .+.+.++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus       236 ~----~~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         236 P----LRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             C----HHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             C----hHH----hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            0    000    11223367999999999999999999999888887653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.3e-48  Score=344.26  Aligned_cols=257  Identities=17%  Similarity=0.236  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEec--CCeeEEEE
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTS--SQYNLLIY  145 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  145 (351)
                      ++|++.+.||+|+||+||+|.+. +++.||+|+++...   .+.+.+|+.+|+.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57899999999999999999974 67889999987543   356889999999995 9999999999874  45689999


Q ss_pred             EecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-ceEEeeeccccccC
Q 018702          146 ELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNM-EARVSDFGLATLME  224 (351)
Q Consensus       146 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~  224 (351)
                      ||+.+++|..+.       +.+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++....
T Consensus       112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence            999999997764       3589999999999999999999999   999999999999998654 69999999998665


Q ss_pred             cccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhccccc--HHH-----HHHHHHh--
Q 018702          225 AEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTK--LVT-----WVKAVMQ--  294 (351)
Q Consensus       225 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~-----~~~~~~~--  294 (351)
                      ....  .....+|+.|+|||.+.+. .++.++|+||+||++|+|++|+.||..........  +..     .......  
T Consensus       182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            4332  2345689999999998764 57999999999999999999999996532211100  000     0000000  


Q ss_pred             -cCccceecc-----------c-cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          295 -DKREEYVID-----------T-SLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       295 -~~~~~~~~~-----------~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ........+           . .........++++.+|+.+||+.||.+|||++|+|++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000000           0 0001123345789999999999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=340.87  Aligned_cols=260  Identities=24%  Similarity=0.266  Sum_probs=191.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEec------CCe
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTS------SQY  140 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  140 (351)
                      ++|+..+.||+|+||+||+|.+. +|+.||||++....  ......+.+|+.++++++||||++++++|..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999975 58899999997643  3334568899999999999999999999864      467


Q ss_pred             eEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeeccc
Q 018702          141 NLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLA  220 (351)
Q Consensus       141 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  220 (351)
                      .|+||||+.++.+. .+.      ..+++..++.++.|++.||.|||++   ||+||||||+|||++.++.++++|||++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            89999999765554 442      3578999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccH---------------
Q 018702          221 TLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKL---------------  285 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---------------  285 (351)
                      +.......  .....+|+.|+|||++.+..+++++||||+||++++|++|+.||...........               
T Consensus       167 ~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hccccccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            76543322  2344689999999999999999999999999999999999999965422111000               


Q ss_pred             -HHHHHHHHhcCccce------ec-cccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          286 -VTWVKAVMQDKREEY------VI-DTSLE---GCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       286 -~~~~~~~~~~~~~~~------~~-~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                       ...............      .. +....   ..+...++++.+|+.+||+.||++|||++|+|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             000111111110000      00 00000   1123457789999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=343.35  Aligned_cols=259  Identities=23%  Similarity=0.308  Sum_probs=195.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCC--hhhHHHHHHHHHHhhcCCCCceeeeeeEEecC-----C
Q 018702           68 KTLKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGT--TEVDRGFERELEAMGDIKHRNIVTLHGYYTSS-----Q  139 (351)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  139 (351)
                      .+++|+..+.||+|+||+||+|.+. +++.||||++....  ....+.+.+|+.++++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3568999999999999999999974 68899999997643  33445788999999999999999999998643     3


Q ss_pred             eeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEEeeecc
Q 018702          140 YNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARVSDFGL  219 (351)
Q Consensus       140 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  219 (351)
                      ..+++++++.+|+|.+++.     .+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.
T Consensus        96 ~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             ceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            4467778888999999985     34699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHHHHHHHhcCcc
Q 018702          220 ATLMEAEKTHVSTIVAGTFGYLAPEYFDTG-RATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTWVKAVMQDKRE  298 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  298 (351)
                      +......    .....||+.|+|||...+. .++.++||||+||++|+|++|+.||.........   ............
T Consensus       168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~~~~~  240 (348)
T d2gfsa1         168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGA  240 (348)
T ss_dssp             --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCH
T ss_pred             hcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCh
Confidence            8754332    2335689999999987654 5688999999999999999999999754221111   000000000000


Q ss_pred             c------------------eeccccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 018702          299 E------------------YVIDTSLEGCPINEINDVFSIASMCLEPEPSKRPTMTEVVKM  341 (351)
Q Consensus       299 ~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e~l~~  341 (351)
                      .                  ..............++++.+|+.+||+.||.+|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            0                  000000000112334678999999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-42  Score=310.34  Aligned_cols=263  Identities=19%  Similarity=0.224  Sum_probs=190.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----------CCceeeeeeEEec
Q 018702           70 LKFSSKDVIGSGGFGTVYRLTVN-DSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----------HRNIVTLHGYYTS  137 (351)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  137 (351)
                      .+|++.+.||+|+||+||+|... +|+.||||+++.... ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            36999999999999999999974 688999999976432 3456778888887775           5789999988754


Q ss_pred             --CCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCC----
Q 018702          138 --SQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHH-DCIPHIIHRDIKSSNILLDQNM----  210 (351)
Q Consensus       138 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nil~~~~~----  210 (351)
                        ....+++++++..+......... .....+++..+..++.|++.|+.|||+ .   +|+||||||+|||++.++    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              45666777776554433222211 145678899999999999999999998 5   999999999999998655    


Q ss_pred             --ceEEeeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCcchhcccccHHHH
Q 018702          211 --EARVSDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVVLLELLTGKRPMDEAFLEEGTKLVTW  288 (351)
Q Consensus       211 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  288 (351)
                        .++++|||.+.......    ....||+.|+|||.+.+..++.++|+||+||++++|++|+.||..............
T Consensus       168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              39999999987554322    334689999999999999999999999999999999999999975432211111111


Q ss_pred             HHH---HHhcC---------c---------c-ceecc----------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 018702          289 VKA---VMQDK---------R---------E-EYVID----------TSLEGCPINEINDVFSIASMCLEPEPSKRPTMT  336 (351)
Q Consensus       289 ~~~---~~~~~---------~---------~-~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  336 (351)
                      ...   .....         .         . .....          ......+...++++.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            110   00000         0         0 00000          001123466788999999999999999999999


Q ss_pred             HHHHH
Q 018702          337 EVVKM  341 (351)
Q Consensus       337 e~l~~  341 (351)
                      |+|++
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=6.8e-26  Score=183.42  Aligned_cols=168  Identities=16%  Similarity=0.137  Sum_probs=119.5

Q ss_pred             CCCCcccccCceEEEEEEECCCCEEEEEEecCCCh------------------hhHHHHHHHHHHhhcCCCCceeeeeeE
Q 018702           73 SSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTT------------------EVDRGFERELEAMGDIKHRNIVTLHGY  134 (351)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  134 (351)
                      .+.+.||+|+||+||+|.+.+|+.||||+++....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34678999999999999998899999998753211                  011234568889999999999988866


Q ss_pred             EecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCceEE
Q 018702          135 YTSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDCIPHIIHRDIKSSNILLDQNMEARV  214 (351)
Q Consensus       135 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  214 (351)
                      ..    .+++|||+++..+.+           ++......++.|++.+++|||+.   +|+||||||+|||++++ .++|
T Consensus        83 ~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             cC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            32    379999998765533           23344568899999999999998   99999999999999976 4899


Q ss_pred             eeeccccccCcccccccccccccccccCcccccCCCCCchhhHHHHHHH
Q 018702          215 SDFGLATLMEAEKTHVSTIVAGTFGYLAPEYFDTGRATAKGDVYSFGVV  263 (351)
Q Consensus       215 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i  263 (351)
                      +|||.+.............  .... .-.+. ....|+.++|+||..--
T Consensus       144 iDFG~a~~~~~~~~~~~l~--rd~~-~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILE--RDVR-NIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHH--HHHH-HHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHH--HHHH-HHHHH-HcCCCCCcccHHHHHHH
Confidence            9999997654322211000  0000 00111 13567889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.84  E-value=9.2e-09  Score=85.60  Aligned_cols=147  Identities=16%  Similarity=0.096  Sum_probs=97.2

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEE
Q 018702           65 IFKKTLKFSSKDVIGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLL  143 (351)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  143 (351)
                      +.+....|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            334445666555544445578998764 45668899886554444445677887776664 3335677777788888899


Q ss_pred             EEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 018702          144 IYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVGAARGIAYLHHDC---------------------------------  190 (351)
Q Consensus       144 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------  190 (351)
                      ||++++|.++.+.....         .....++.+++..++.||+..                                 
T Consensus        88 v~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999998886654210         112234445555555555321                                 


Q ss_pred             -----------------------CCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          191 -----------------------IPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       191 -----------------------~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                                             ...++|+|+.|.||++++++..-+.||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                   1247999999999999987666799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.44  E-value=8.6e-07  Score=72.89  Aligned_cols=73  Identities=16%  Similarity=0.190  Sum_probs=51.8

Q ss_pred             ccccCc-eEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC--CCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018702           78 IGSGGF-GTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK--HRNIVTLHGYYTSSQYNLLIYELMPNGSL  153 (351)
Q Consensus        78 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L  153 (351)
                      +..|.. +.||+....++..+++|........   .+.+|...++.+.  .-.+.+++.+..+++..+++|++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            445553 6889998888888999987654332   3556676666653  23366677888888888999999988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.90  E-value=2.2e-05  Score=68.62  Aligned_cols=75  Identities=12%  Similarity=0.069  Sum_probs=46.2

Q ss_pred             CcccccCceEEEEEEECC-CCEEEEEEecCC-------ChhhHHHHHHHHHHhhcCC---CCceeeeeeEEecCCeeEEE
Q 018702           76 DVIGSGGFGTVYRLTVND-STAFAVKRLHRG-------TTEVDRGFERELEAMGDIK---HRNIVTLHGYYTSSQYNLLI  144 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  144 (351)
                      +.||.|....||++...+ ++.+++|.-...       ......+...|.+.++.+.   ...+.+++.+  ++...+++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 567899964321       1112233456777776552   2345556654  44456899


Q ss_pred             EEecCCCC
Q 018702          145 YELMPNGS  152 (351)
Q Consensus       145 ~e~~~~g~  152 (351)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.53  E-value=0.00026  Score=59.92  Aligned_cols=162  Identities=13%  Similarity=0.145  Sum_probs=86.7

Q ss_pred             ccCChHHHHHHhcCC--C-CCCccc-ccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----CCce
Q 018702           58 HSLQSDAIFKKTLKF--S-SKDVIG-SGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----HRNI  128 (351)
Q Consensus        58 ~~~~~~~~~~~~~~~--~-~~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni  128 (351)
                      .+++++.+..+...+  . ..+++- .+..-.||++...+|+.+++|..+.. ....+++..|...+..+.     .+..
T Consensus         6 ~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p   84 (325)
T d1zyla1           6 QTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAP   84 (325)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             cccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCc
Confidence            456666665443322  1 112211 24457899999999999999987653 333455777887776663     1221


Q ss_pred             eeee--eEEecCCeeEEEEEecCCCCHH-----Hh------h-------cCCCC-CCCCCCh------------------
Q 018702          129 VTLH--GYYTSSQYNLLIYELMPNGSLD-----TF------L-------HGKSV-NKKNLDW------------------  169 (351)
Q Consensus       129 v~~~--~~~~~~~~~~lv~e~~~~g~L~-----~~------l-------~~~~~-~~~~~~~------------------  169 (351)
                      +..-  ..+...+..+.++++++|..+.     .+      +       ..... .....+.                  
T Consensus        85 ~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~  164 (325)
T d1zyla1          85 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  164 (325)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCC
Confidence            2211  1234456678899998764321     11      0       00000 0111111                  


Q ss_pred             -HH---HHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEEEcCCCceEEeeeccccc
Q 018702          170 -PS---RYKIAVGAARGIAYL-HHDCIPHIIHRDIKSSNILLDQNMEARVSDFGLATL  222 (351)
Q Consensus       170 -~~---~~~i~~~i~~~l~~L-h~~~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  222 (351)
                       ..   ....+.++...+.-. .+....+++|+|+.|.|||++++  ..+.||+.+..
T Consensus       165 ~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         165 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence             11   112222333222222 12223579999999999999754  45899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.23  E-value=0.00082  Score=58.34  Aligned_cols=72  Identities=11%  Similarity=0.124  Sum_probs=47.2

Q ss_pred             CcccccCceEEEEEEECCC--------CEEEEEEecCCChhhHHHHHHHHHHhhcCC-CCceeeeeeEEecCCeeEEEEE
Q 018702           76 DVIGSGGFGTVYRLTVNDS--------TAFAVKRLHRGTTEVDRGFERELEAMGDIK-HRNIVTLHGYYTSSQYNLLIYE  146 (351)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  146 (351)
                      +.|+.|-.-.+|++...++        ..|++++.-...  ......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4678888999999886542        457777664322  2234567888888775 3334466776643    68999


Q ss_pred             ecCCCCH
Q 018702          147 LMPNGSL  153 (351)
Q Consensus       147 ~~~~g~L  153 (351)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.07  E-value=0.003  Score=52.70  Aligned_cols=159  Identities=13%  Similarity=0.083  Sum_probs=81.3

Q ss_pred             CChHHHHHHhcCCCCCCc-----ccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCC-----CCcee
Q 018702           60 LQSDAIFKKTLKFSSKDV-----IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIK-----HRNIV  129 (351)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  129 (351)
                      ++.+++.....+|..+++     |..|---+.|+...++|+ +++|+.....  ...++..|++.+..+.     .|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            445566666667776554     345667888998877665 9999886532  1233455566665553     22222


Q ss_pred             eee-e--EEecCCeeEEEEEecCCCCHHHh-----------h-------cCCCCCC-CCC------------------Ch
Q 018702          130 TLH-G--YYTSSQYNLLIYELMPNGSLDTF-----------L-------HGKSVNK-KNL------------------DW  169 (351)
Q Consensus       130 ~~~-~--~~~~~~~~~lv~e~~~~g~L~~~-----------l-------~~~~~~~-~~~------------------~~  169 (351)
                      ... |  +.........++.+..+......           +       ....... ...                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            211 1  11223455666776655432110           0       0000000 000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCceEEeeecccc
Q 018702          170 PSRYKIAVGAARGIAYLHHD-CIPHIIHRDIKSSNILLDQNMEARVSDFGLAT  221 (351)
Q Consensus       170 ~~~~~i~~~i~~~l~~Lh~~-~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  221 (351)
                      ......+......+...+.. ...+++|+|+.+.|++++++...-+.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            01112222222222222221 23479999999999999988777899999875

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=80.08  E-value=3.5  Score=33.05  Aligned_cols=132  Identities=15%  Similarity=0.083  Sum_probs=74.5

Q ss_pred             ccccCceEEEEEEECCCCEEEEEEecCCChhhHHHHHHHHHHhhcCCCCceeeeeeEE----------------------
Q 018702           78 IGSGGFGTVYRLTVNDSTAFAVKRLHRGTTEVDRGFERELEAMGDIKHRNIVTLHGYY----------------------  135 (351)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~----------------------  135 (351)
                      +..+|.+-|+.+..+ +..+++|.-.   .-..+.+-.++...-.++.|...-+. .+                      
T Consensus        76 ~s~~Gs~Gv~FV~~e-~gaiVlK~s~---tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~  150 (342)
T d1cjaa_          76 RSEKGTEGLFFVETE-SGVFIVKRST---NIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVIT  150 (342)
T ss_dssp             ECCSTTSCEEEEEES-SCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHH
T ss_pred             EeecCCceEEEEEcC-CceEEEecCC---chHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHH
Confidence            445555556656555 4457888522   23334566677777777788765543 11                      


Q ss_pred             -ecCCeeEEEEEecCCCCHHHhhcCCCCCCCCCChHHHHHHHHH---HHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCC
Q 018702          136 -TSSQYNLLIYELMPNGSLDTFLHGKSVNKKNLDWPSRYKIAVG---AARGIAYLHHDCIPHIIHRDI-KSSNILLDQNM  210 (351)
Q Consensus       136 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~---i~~~l~~Lh~~~~~~i~H~dl-kp~Nil~~~~~  210 (351)
                       .-....+++|||.+|..|.+.-...  ....+..    +.+.+   |+--=.++++.++-++.+++- .+.|+++++++
T Consensus       151 sel~~A~~liMeYvpG~~l~e~~~~~--a~~~fs~----~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~  224 (342)
T d1cjaa_         151 TLANQANILLMELVRGITLNKLTTTS--APEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERG  224 (342)
T ss_dssp             HHTTCSEEEEEECCCEEESTTCCSSS--HHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBT
T ss_pred             HHHhcccceeeeccCCcccccccccc--chhhhcH----HHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEecCC
Confidence             1123568999999988775543211  0011222    22333   222234566665555666632 78999998876


Q ss_pred             -ceEEeeeccc
Q 018702          211 -EARVSDFGLA  220 (351)
Q Consensus       211 -~~kl~dfg~~  220 (351)
                       .+..+|=|..
T Consensus       225 ~~~~~IDs~i~  235 (342)
T d1cjaa_         225 ATVVPIDSKII  235 (342)
T ss_dssp             TCEEECSCCCC
T ss_pred             cEEEEecCCcc
Confidence             5677775544